{"meta":{"query_hash":"274f257c934d","filters":{"topic":"Lung Cancer Research Studies"},"cohort_total":587,"direct_labels_cover":0,"predictions_cover":587,"exported":587,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/274f257c934d","api":"https://metacan.xera.ac/api/v1/cohort?topic=Lung+Cancer+Research+Studies"},"results":[{"id":"W1109143382","doi":"10.7759/cureus.296","title":"Small Cell Cancer of the Bladder and Prostate: A Retrospective Review from a Tertiary Cancer Center","year":2015,"lang":"en","type":"review","venue":"Cureus","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Boniface Hospital; University of Manitoba; Manitoba Health; CancerCare Manitoba","funders":"","keywords":"Medicine; Malignancy; Stage (stratigraphy); Cancer; Radiation therapy; Prostate cancer; Retrospective cohort study; Prostate; Bladder cancer; Genitourinary system; Surgery; Internal medicine","score_opus":0.08220793046755934,"score_gpt":0.4057025673212575,"score_spread":0.32349463685369817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1109143382","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655456,0.026123945,0.0002576254,0.00022330604,0.0000316003,0.00022104925,0.0049257777,0.000021558555,0.002649541],"genre_scores_gemma":[0.9852203,0.010935481,0.00028307296,0.00037834328,0.000040959665,0.00014155463,0.002685592,0.000010366056,0.00030414364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998304,0.00022774124,0.00045346687,0.00030846847,0.0004890313,0.00021737604],"domain_scores_gemma":[0.9923229,0.001435611,0.003827369,0.00028053042,0.0015195103,0.0006139737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009657297,0.0002633297,0.00070582854,0.0037644876,0.0010989106,0.0010726127,0.00091661233,0.00042085734,0.0022551634],"category_scores_gemma":[0.0034237062,0.00043025223,0.00036864448,0.00882053,0.0004931566,0.00047616402,0.0007732744,0.00032573508,0.00038985242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051651827,0.000024891468,0.9908082,0.00061107264,0.000086926004,0.0023051854,0.00056879275,0.000023068138,0.0002815833,0.00003063239,0.0007761064,0.0044318396],"study_design_scores_gemma":[0.000012859754,0.00009981913,0.98371744,0.0005491422,0.00019947793,0.009133932,0.0022158846,0.000048202033,0.0001780083,0.000015372012,0.0038161287,0.000013686813],"about_ca_topic_score_codex":0.05253842,"about_ca_topic_score_gemma":0.100971326,"teacher_disagreement_score":0.05253842,"about_ca_system_score_codex":0.0022253818,"about_ca_system_score_gemma":0.0060294685,"threshold_uncertainty_score":0.104465246},"labels":[],"label_agreement":null},{"id":"W1138370978","doi":"10.1097/jto.0000000000000652","title":"Refining Prognosis in Lung Cancer","year":2015,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institutes of Health","keywords":"Medicine; Lung cancer; Population; Disease; Cancer; Oncology; Identification (biology); Medical physics; Intensive care medicine; Personalized medicine; Internal medicine; Bioinformatics","score_opus":0.09822665380393408,"score_gpt":0.5511675105923424,"score_spread":0.4529408567884083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1138370978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96766424,0.011347517,0.003311632,0.0071439384,0.00042316888,0.000112054724,0.0026597292,0.0000794825,0.007258284],"genre_scores_gemma":[0.99496233,0.0016228067,0.0014249239,0.00028197115,0.00013463378,0.000032057225,0.0009334872,0.0000121403355,0.00059568265],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99477404,0.0030376727,0.00063817285,0.00039242816,0.00064484,0.00051273004],"domain_scores_gemma":[0.9825982,0.007185979,0.0036987765,0.0024533158,0.003017037,0.0010467115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010537271,0.0005217325,0.00074201694,0.0025216881,0.001214576,0.0020497036,0.0010929169,0.00078618946,0.0025804562],"category_scores_gemma":[0.0487166,0.00027786614,0.00096947845,0.0030444365,0.0006985043,0.0028950763,0.001540298,0.0016327702,0.00077853655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002486707,0.000081849365,0.9654281,0.000072982955,0.00016716836,0.000040207116,0.00022880778,0.00023944069,0.000068026624,0.0002930909,0.0012959489,0.03183568],"study_design_scores_gemma":[0.000059697657,0.00089667446,0.9796091,0.00035776704,0.0012746223,0.00045331012,0.0024143541,0.00227665,0.0009929144,0.0046070786,0.007015262,0.000042512012],"about_ca_topic_score_codex":0.011719882,"about_ca_topic_score_gemma":0.016280003,"teacher_disagreement_score":0.011719882,"about_ca_system_score_codex":0.0012053066,"about_ca_system_score_gemma":0.0029693902,"threshold_uncertainty_score":0.055727065},"labels":[],"label_agreement":null},{"id":"W129944274","doi":"10.1200/jco.2007.25.18_suppl.7627","title":"Phase II study of the efficacy and safety of intravenous (IV) AVE0005 (VEGF Trap) given every 2 weeks in patients (Pts) with platinum- and erlotinib- resistant adenocarcinoma of the lung (NSCLA)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Febrile neutropenia; Performance status; Adverse effect; Progressive disease; Nausea; Oncology; Neutropenia; Lung cancer; Carboplatin; Sunitinib; Surgery; Cancer; Chemotherapy","score_opus":0.05390957801326977,"score_gpt":0.43178274645929626,"score_spread":0.3778731684460265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W129944274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550396,0.0008463118,0.0004806659,0.00015503299,0.000054807224,0.0014588633,0.0005536907,0.000070716036,0.00087594514],"genre_scores_gemma":[0.99219394,0.0007812071,0.0014211856,0.00029159052,0.00012161054,0.0016631742,0.0015063649,0.000023209597,0.0019976925],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99970883,0.00015475051,0.000014689462,0.00004638298,0.000024041152,0.00005129576],"domain_scores_gemma":[0.9992549,0.00016456567,0.0001684496,0.000049145816,0.000037403355,0.0003255372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001196048,0.0013813516,0.0013975479,0.00034476182,0.00027789184,0.00069283776,0.0007586462,0.0010612048,0.00382923],"category_scores_gemma":[0.0008764931,0.00049252564,0.0008693206,0.00031445353,0.000833403,0.0006623767,0.0002497099,0.0022443219,0.0008094871],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.811476,0.06300595,0.004637258,0.00070692,0.0006585189,0.00026432303,0.00024674746,0.0032123795,0.04406483,0.00021804999,0.0023814896,0.06912751],"study_design_scores_gemma":[0.452235,0.53478396,0.0066965134,0.000019033367,0.00017353788,0.00026850222,0.000035914854,0.0014123748,0.0030534586,0.000089733425,0.0012123617,0.000019475943],"about_ca_topic_score_codex":0.00067097275,"about_ca_topic_score_gemma":0.0015084896,"teacher_disagreement_score":0.00382923,"about_ca_system_score_codex":0.000774541,"about_ca_system_score_gemma":0.0012248718,"threshold_uncertainty_score":0.012810111},"labels":[],"label_agreement":null},{"id":"W1481967818","doi":"10.1002/cncr.10841","title":"Twenty‐five years of clinical research for patients with limited‐stage small cell lung carcinoma in North America","year":2002,"lang":"en","type":"article","venue":"Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clinical trial; Stage (stratigraphy); Internal medicine; Epidemiology; Radiation therapy; Surgery; Confidence interval; Survival analysis; Carcinoma; Small-cell carcinoma","score_opus":0.12748944845242452,"score_gpt":0.4271477782755311,"score_spread":0.2996583298231066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1481967818","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42928058,0.54801005,0.00057072804,0.010156422,0.0008307981,0.0015743105,0.0021599259,0.000041393978,0.007375757],"genre_scores_gemma":[0.8474641,0.123293996,0.0026158267,0.012147415,0.0020841348,0.003906229,0.0045735873,0.000016538548,0.0038981533],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99329364,0.0045509525,0.0008697556,0.00043451317,0.0005542466,0.00029696064],"domain_scores_gemma":[0.9817054,0.006229868,0.0075375624,0.00062064914,0.0012801538,0.0026263127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010691347,0.000338291,0.0008230747,0.0007601376,0.0006931458,0.0014967287,0.00042648058,0.0010196373,0.0021578295],"category_scores_gemma":[0.011563108,0.00030763834,0.001089854,0.0013406907,0.000752934,0.00065401127,0.0010515517,0.00065267435,0.0003763332],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05249353,0.0022701027,0.38990867,0.019638235,0.0072759767,0.0011467035,0.0015676448,0.0010927289,0.008131753,0.0013346034,0.027269935,0.4878701],"study_design_scores_gemma":[0.022494497,0.026693434,0.7780018,0.007212487,0.0053738276,0.0017427125,0.00087980065,0.00019112509,0.001682078,0.0005384603,0.15510291,0.00008686621],"about_ca_topic_score_codex":0.0013132015,"about_ca_topic_score_gemma":0.005479656,"teacher_disagreement_score":0.010691347,"about_ca_system_score_codex":0.0019399049,"about_ca_system_score_gemma":0.004734061,"threshold_uncertainty_score":0.05654192},"labels":[],"label_agreement":null},{"id":"W1491079171","doi":"10.1186/1471-2407-7-31","title":"Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment","year":2007,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Queen's University; University of Saskatchewan","funders":"Saskatchewan Cancer Agency","keywords":"Surgical oncology; Medicine; Lung cancer; Disease; Stage (stratigraphy); Oncology; Internal medicine; Biology","score_opus":0.07400920070106777,"score_gpt":0.45228970089932247,"score_spread":0.3782805001982547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1491079171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95658135,0.004625727,0.034739055,0.00062781316,0.00014730272,0.00010028633,0.0009917095,0.00019697339,0.001989782],"genre_scores_gemma":[0.9948441,0.00026298602,0.0040121875,0.000039880928,0.000035673424,0.000071097136,0.0004144918,0.000035400673,0.00028410606],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9924603,0.005672841,0.00031144396,0.00041350888,0.0010149551,0.00012698141],"domain_scores_gemma":[0.9099061,0.07179004,0.009131924,0.0056153988,0.0030586014,0.0004979897],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.019027455,0.00029317237,0.00029589672,0.001284442,0.00019520806,0.0005951169,0.00044920432,0.00035214273,0.0021039806],"category_scores_gemma":[0.07651884,0.00010591385,0.00075203524,0.0009373061,0.00092821906,0.00057725376,0.00073601736,0.0004840576,0.00025388927],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015173424,0.00004857482,0.9307721,0.00025329084,0.00047885653,0.00027404222,0.0003561943,0.0035119513,0.0014041797,0.0011077309,0.0015066476,0.058769014],"study_design_scores_gemma":[0.00006728033,0.0014714806,0.9638512,0.00017070505,0.0004095912,0.002022173,0.0001900829,0.020956831,0.0026228915,0.003419041,0.004763809,0.00005500333],"about_ca_topic_score_codex":0.0006283128,"about_ca_topic_score_gemma":0.00086082565,"teacher_disagreement_score":0.9809725,"about_ca_system_score_codex":0.00060360867,"about_ca_system_score_gemma":0.0007058921,"threshold_uncertainty_score":0.10062802},"labels":[],"label_agreement":null},{"id":"W1491400775","doi":"10.20381/ruor-7451","title":"A comparative study of high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation versus conventional chemotherapy as treatment for metastatic breast cancer.","year":2000,"lang":"en","type":"dissertation","venue":"Library and Archives Canada (Government of Canada)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemotherapy; Medicine; Oncology; Breast cancer; Hematopoietic stem cell transplantation; Transplantation; Cancer; Internal medicine; Metastatic breast cancer; Progenitor cell; Stem cell; Biology","score_opus":0.010383982507922256,"score_gpt":0.2590640237222782,"score_spread":0.24868004121435597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1491400775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97994757,0.012460506,0.0005013033,0.00037906363,0.00059920555,0.0030494398,0.00058824435,0.000030070965,0.0024447222],"genre_scores_gemma":[0.98557764,0.006318262,0.0015333322,0.00077168277,0.0009223053,0.002419558,0.000668335,0.000011130579,0.001777795],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9972254,0.0020127795,0.0001935337,0.00019972837,0.0002007347,0.00016773836],"domain_scores_gemma":[0.99669254,0.0019476704,0.00055194047,0.00018601495,0.00012825175,0.0004937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035336239,0.00070858747,0.0018027363,0.0006602489,0.00027319786,0.00052686187,0.0008009929,0.0010548437,0.0073010535],"category_scores_gemma":[0.004916087,0.00023956416,0.0016399989,0.0007693318,0.0008436341,0.00059516646,0.00032415637,0.0012521901,0.00048992084],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9560978,0.010222435,0.0012775881,0.0007617486,0.001310208,0.000037543938,0.00003900919,0.00022028519,0.0011237694,0.0001213748,0.00030412723,0.028484134],"study_design_scores_gemma":[0.44296408,0.54506016,0.008047127,0.000095866315,0.0018280075,0.00005974228,0.000031019405,0.00024975894,0.00062176795,0.00013336657,0.0008945951,0.000014405018],"about_ca_topic_score_codex":0.0010627938,"about_ca_topic_score_gemma":0.0020478452,"teacher_disagreement_score":0.0073010535,"about_ca_system_score_codex":0.0010011251,"about_ca_system_score_gemma":0.0012675481,"threshold_uncertainty_score":0.024424493},"labels":[],"label_agreement":null},{"id":"W1524781181","doi":"10.1038/bjc.2015.171","title":"Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Lung cancer; Medicine; Value (mathematics); Parametric statistics; Lung; Pathology; Internal medicine; Oncology; Statistics; Mathematics","score_opus":0.04659178315381654,"score_gpt":0.36188258368458565,"score_spread":0.3152908005307691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1524781181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972703,0.0009979189,0.00095676543,0.000073764604,0.0000067392907,0.000015075665,0.0001638082,0.000050286493,0.00046535622],"genre_scores_gemma":[0.9992994,0.000058007343,0.0004145181,0.000013800939,0.000009311193,0.000004626153,0.0001248401,0.000003015522,0.00007246887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990934,0.0004893214,0.000039990282,0.00014594352,0.00015921674,0.00007205318],"domain_scores_gemma":[0.99791414,0.0010371781,0.0003717727,0.00018447136,0.0002657606,0.00022674401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025588423,0.0005321441,0.00053080387,0.0009756837,0.0002538977,0.0007850377,0.00030927427,0.00045396094,0.0008501768],"category_scores_gemma":[0.004804271,0.0001526009,0.00043156775,0.0006270174,0.00027370706,0.00033913058,0.0005430968,0.00048078943,0.0002241059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017476063,0.00006749851,0.9699342,0.000033337383,0.00027212227,0.000114510025,0.000055996137,0.0014236746,0.010136129,0.00002787922,0.0001993568,0.015987651],"study_design_scores_gemma":[0.000031849468,0.0010245806,0.97176975,0.000011882882,0.00030296767,0.0006479545,0.00006311045,0.016809404,0.008334886,0.00012381244,0.00085774314,0.000022164057],"about_ca_topic_score_codex":0.0014328026,"about_ca_topic_score_gemma":0.0017634118,"teacher_disagreement_score":0.0025588423,"about_ca_system_score_codex":0.00042613538,"about_ca_system_score_gemma":0.00032269422,"threshold_uncertainty_score":0.013532639},"labels":[],"label_agreement":null},{"id":"W1597090878","doi":"10.1046/j.0306-5251.2001.01468.x","title":"Population pharmacokinetics and pharmacodynamics of oral etoposide","year":2001,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Etoposide; Pharmacokinetics; Pharmacodynamics; Medicine; Population; Pharmacology; Bioavailability; Cmax; Neutropenia; Creatinine; Internal medicine; Chemotherapy; Gastroenterology","score_opus":0.07223844834311155,"score_gpt":0.5034119110384546,"score_spread":0.43117346269534307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1597090878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749666,0.000708283,0.0013451077,0.000027701484,0.0000035861563,0.000020756814,0.00009453082,0.000018307748,0.0002850606],"genre_scores_gemma":[0.99890554,0.00016264367,0.0004609237,0.00003479565,0.000015828811,0.00002164386,0.00024795136,0.0000043970995,0.00014617444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996165,0.00013926213,0.00002574872,0.00010490556,0.00008296583,0.000030594227],"domain_scores_gemma":[0.99917334,0.0003358875,0.0002566046,0.00008993523,0.00007145755,0.00007281808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070439756,0.00023647895,0.00054887746,0.00015136779,0.000107857886,0.00038510404,0.0001244288,0.0002962106,0.0006543906],"category_scores_gemma":[0.0018882134,0.0001286678,0.00021255309,0.00015905836,0.00018509846,0.00029247388,0.00016606126,0.0004526219,0.00015289016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012032689,0.00078754604,0.8697238,0.00014645679,0.000792688,0.0007183724,0.00031651597,0.00566339,0.0470914,0.00023081331,0.00051926164,0.061976995],"study_design_scores_gemma":[0.00045511103,0.017937051,0.9610398,0.000012258759,0.00037249696,0.0033266197,0.000110263616,0.0066663935,0.0074637705,0.00034409913,0.0022507135,0.000021380778],"about_ca_topic_score_codex":0.0002293374,"about_ca_topic_score_gemma":0.00019350262,"teacher_disagreement_score":0.00070439756,"about_ca_system_score_codex":0.00017449542,"about_ca_system_score_gemma":0.00016373614,"threshold_uncertainty_score":0.0037252307},"labels":[],"label_agreement":null},{"id":"W167503670","doi":"10.1007/978-3-642-18832-9_23","title":"The Treated Thorax in Patients with Hematological Malignancies","year":2004,"lang":"en","type":"book-chapter","venue":"Medical radiology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Autopsy; Thorax (insect anatomy); Chemotherapy; Radiation therapy; Disease; Natural history; Intensive care medicine; Internal medicine; Surgery","score_opus":0.016007417969919075,"score_gpt":0.2923789079195005,"score_spread":0.27637148994958144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W167503670","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065690437,0.2833396,0.008967912,0.018094234,0.009290848,0.00008405505,0.0002583772,0.00014311206,0.6732529],"genre_scores_gemma":[0.056050707,0.19228333,0.013132149,0.019607788,0.007563636,0.00016697912,0.00041508378,0.00016672388,0.71061355],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99991465,0.000030820644,0.0000064654305,0.00000914515,0.000028016655,0.000010932876],"domain_scores_gemma":[0.9998914,0.00007564776,0.0000071763557,0.000003987366,0.000009450105,0.000012420958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021736528,0.00033622968,0.00035485273,0.0004570963,0.00037919707,0.00087238004,0.0003786953,0.0010455014,0.014322617],"category_scores_gemma":[0.00059871783,0.00020519817,0.00031290983,0.00029723524,0.0003737226,0.00072019774,0.000515817,0.002287023,0.0025357276],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060058774,0.000131817,0.0018457464,0.0006802462,0.000021807658,0.0050292546,0.0010185167,0.0011219066,0.002021349,0.049774144,0.42144558,0.51684964],"study_design_scores_gemma":[0.000015689511,0.00007484769,0.0044773743,0.0010392256,0.000024601284,0.014346142,0.0005265675,0.0002993148,0.00067970355,0.012635392,0.9658644,0.000016797574],"about_ca_topic_score_codex":0.0012621316,"about_ca_topic_score_gemma":0.007070755,"teacher_disagreement_score":0.014322617,"about_ca_system_score_codex":0.0004460812,"about_ca_system_score_gemma":0.0006360836,"threshold_uncertainty_score":0.04791391},"labels":[],"label_agreement":null},{"id":"W1733892693","doi":"10.1016/j.ebiom.2015.09.031","title":"Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium","year":2015,"lang":"en","type":"article","venue":"EBioMedicine","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; Canadian Cancer Society Research Institute; National Institutes of Health; Natural Science Foundation of Jiangsu Province; Ministry of Health, Labour and Welfare; National Natural Science Foundation of China; Roy Castle Lung Cancer Foundation; National Institute on Drug Abuse; Bundesamt für Strahlenschutz; Ministry of Education, Culture, Sports, Science and Technology; National Cancer Center; Mayo Clinic","keywords":"Medicine; COPD; Lung cancer; Internal medicine; Logistic regression; Smoking cessation; Oncology; Physical therapy; Pathology","score_opus":0.017790462779392426,"score_gpt":0.32884565884980616,"score_spread":0.3110551960704137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1733892693","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38794208,0.5825184,0.005698954,0.001017638,0.0005046531,0.0007378642,0.018911818,0.00021367143,0.002454892],"genre_scores_gemma":[0.9634001,0.026175605,0.0023050045,0.00049556664,0.00024878123,0.0009098326,0.0058099953,0.00006249759,0.0005926153],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98291653,0.0104788635,0.0028552427,0.001919474,0.0011880733,0.0006417649],"domain_scores_gemma":[0.9848763,0.0071012424,0.0036359152,0.0025707248,0.0014103287,0.00040552614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01830819,0.0016527206,0.0049800905,0.006333358,0.00053144456,0.002234438,0.0010655096,0.001387814,0.0021356083],"category_scores_gemma":[0.027924534,0.0008185609,0.016530495,0.008599382,0.00037228956,0.0006380742,0.0020423993,0.00064703095,0.00023000332],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054512634,0.00006010006,0.2993712,0.012249474,0.6675504,0.00022616352,0.00014914683,0.0008333011,0.00046996903,0.00016155372,0.002129406,0.011347909],"study_design_scores_gemma":[0.0010147307,0.0004728847,0.29334134,0.0023625088,0.6973578,0.00021366551,0.00025495334,0.0006363484,0.00030267693,0.00034446968,0.0036386552,0.00005994138],"about_ca_topic_score_codex":0.016915634,"about_ca_topic_score_gemma":0.01947151,"teacher_disagreement_score":0.01830819,"about_ca_system_score_codex":0.0009653078,"about_ca_system_score_gemma":0.0019849904,"threshold_uncertainty_score":0.09682411},"labels":[],"label_agreement":null},{"id":"W1824988371","doi":"10.1200/jco.2015.64.0888","title":"Limited-Stage Small-Cell Lung Cancer: An Age Limit for Combined Modality Therapy?","year":2015,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Stage (stratigraphy); Lung cancer; Oncology; Internal medicine; Radiology","score_opus":0.3601170311879099,"score_gpt":0.5497337496686522,"score_spread":0.1896167184807423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1824988371","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014128063,0.8741608,0.0005533207,0.10978251,0.011708428,0.000008073443,0.000117265576,0.000021609607,0.0022351267],"genre_scores_gemma":[0.0294935,0.78062654,0.0014516548,0.09332349,0.09261116,0.00008753129,0.0002457722,0.00005331223,0.002107021],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800044,0.00065282424,0.0005161064,0.0003275395,0.00038694937,0.00011613563],"domain_scores_gemma":[0.9889698,0.007005168,0.0013766665,0.0002955487,0.0017567226,0.0005960986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004612297,0.00038824868,0.0023093775,0.0004779452,0.0003850016,0.0021863878,0.0009671932,0.002416806,0.004155484],"category_scores_gemma":[0.012814763,0.00022064109,0.0011304849,0.00060730154,0.0010296877,0.0062931334,0.0010865565,0.005660775,0.0014630257],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013687541,0.000060225033,0.0018660459,0.011057548,0.00070365256,0.0004206547,0.00028727125,0.00033648056,0.0014315727,0.0134645,0.1861604,0.7828428],"study_design_scores_gemma":[0.00025616612,0.00045642516,0.0044555482,0.010129215,0.0011350302,0.0017969587,0.00039616087,0.0002734713,0.00044289092,0.024513917,0.95604986,0.000094298666],"about_ca_topic_score_codex":0.0006616943,"about_ca_topic_score_gemma":0.0017964098,"teacher_disagreement_score":0.004612297,"about_ca_system_score_codex":0.0008020255,"about_ca_system_score_gemma":0.0015054302,"threshold_uncertainty_score":0.024392426},"labels":[],"label_agreement":null},{"id":"W1861909078","doi":"10.1111/neup.12172","title":"Metastatic ovarian carcinoma to the brain: An approach to identification and classification for neuropathologists","year":2014,"lang":"en","type":"article","venue":"Neuropathology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Ovarian carcinoma; Brain metastasis; Metastatic carcinoma; Serous carcinoma; Pathology; Carcinoma; Serous fluid; Malignancy; Metastasis; Stage (stratigraphy); Carcinosarcoma; Ovarian carcinomas; Oncology; Internal medicine; Ovarian cancer; Cancer; Biology","score_opus":0.08332343353206814,"score_gpt":0.36709460151055273,"score_spread":0.28377116797848456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1861909078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9272112,0.014809537,0.031969514,0.012721304,0.00057883305,0.0008036627,0.0003753094,0.0003033454,0.01122716],"genre_scores_gemma":[0.9226506,0.0064152405,0.06660849,0.0008292126,0.0006817951,0.00051966513,0.00035571476,0.000038955193,0.0019003296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914265,0.00036163896,0.00021732869,0.00005534706,0.00012374586,0.0000992205],"domain_scores_gemma":[0.99810755,0.00039613224,0.0003361265,0.00019746418,0.0007142256,0.00024847192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033366343,0.00050389743,0.00036434096,0.005361686,0.0014547749,0.0020491865,0.0012493707,0.0008411522,0.0012290388],"category_scores_gemma":[0.005364741,0.00024425075,0.00030398084,0.0014166711,0.0013127344,0.0021206078,0.0022710704,0.0011215563,0.0004375936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027429382,0.00013632857,0.7657084,0.0002624804,0.00003834828,0.02187969,0.0026091195,0.0009250498,0.009522226,0.0041047605,0.0062528434,0.18828656],"study_design_scores_gemma":[0.00016907818,0.0011179096,0.60533154,0.0013632744,0.00018140374,0.2568347,0.039967865,0.015310863,0.006153216,0.02286572,0.050401058,0.00030332542],"about_ca_topic_score_codex":0.0043210285,"about_ca_topic_score_gemma":0.00909117,"teacher_disagreement_score":0.005361686,"about_ca_system_score_codex":0.0011986855,"about_ca_system_score_gemma":0.0015029552,"threshold_uncertainty_score":0.017646015},"labels":[],"label_agreement":null},{"id":"W1903523058","doi":"10.1038/nature14664","title":"Comprehensive genomic profiles of small cell lung cancer","year":2015,"lang":"en","type":"article","venue":"Nature","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2386,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Vancouver General Hospital","funders":"National Cancer Institute; National Institutes of Health; Stand Up To Cancer; Deutschen Konsortium für Translationale Krebsforschung; Associazione Italiana per la Ricerca sul Cancro; Bundesministerium für Bildung und Forschung; Deutsches Zentrum für Lungenforschung; European Regional Development Fund; Roy Castle Lung Cancer Foundation; European Commission; Universität zu Köln; Ministero della Salute; Deutsche Forschungsgemeinschaft; Genentech; Deutsche Krebshilfe","keywords":"Biology; Cancer research; Somatic cell; Gene; Chromothripsis; Cancer; Cyclin D1; Mutation; Suppressor; Mutant; Genetics; Tumor suppressor gene; Lung cancer; SMARCA4; Carcinogenesis; Genome instability; Gene expression; Cell cycle; Medicine; Pathology; DNA damage; DNA","score_opus":0.03260873819400115,"score_gpt":0.36216059487962293,"score_spread":0.3295518566856218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1903523058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9557332,0.0062730797,0.002020962,0.00081632717,0.000031257357,0.00005261735,0.030169928,0.00006626024,0.004836371],"genre_scores_gemma":[0.9666225,0.0026562754,0.0020745168,0.00039076642,0.000045879864,0.00006136629,0.025955781,0.00002850795,0.0021645182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959475,0.00006397911,0.000044739092,0.00010944946,0.000095798765,0.000091346286],"domain_scores_gemma":[0.9993187,0.00016055188,0.00017917778,0.00010198858,0.00013573827,0.00010395511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003517567,0.00013309548,0.00028428232,0.0018459134,0.0004097723,0.00053515605,0.00022180982,0.00024024284,0.0023821453],"category_scores_gemma":[0.0011517627,0.000111027744,0.0003473506,0.002745317,0.00015986878,0.0002529508,0.00068750215,0.00032224352,0.0004410431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008838534,0.00010070102,0.80388767,0.00046348118,0.0005752381,0.00050439883,0.0008862243,0.00053567236,0.1048423,0.0011454626,0.007527338,0.07864767],"study_design_scores_gemma":[0.000007503017,0.00008937119,0.9825435,0.000031825704,0.00019514954,0.00063649047,0.0003331872,0.00014310611,0.00427171,0.0004445369,0.0112950625,0.000008432208],"about_ca_topic_score_codex":0.004329621,"about_ca_topic_score_gemma":0.011395196,"teacher_disagreement_score":0.004329621,"about_ca_system_score_codex":0.00035647702,"about_ca_system_score_gemma":0.0006687664,"threshold_uncertainty_score":0.008608818},"labels":[],"label_agreement":null},{"id":"W1940768002","doi":"10.1186/s12935-015-0231-z","title":"Etoposide induces cell death via mitochondrial-dependent actions of p53","year":2015,"lang":"en","type":"article","venue":"Cancer Cell International","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research","keywords":"Etoposide; Programmed cell death; Mitochondrion; Cancer research; Apoptosis; Cell; Medicine; Cell biology; Biology; Neuroscience; Genetics; Chemotherapy; Internal medicine","score_opus":0.08949637099171534,"score_gpt":0.3952874771036114,"score_spread":0.3057911061118961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1940768002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896423,0.00489701,0.0027684062,0.0001639493,0.000049284186,0.000040600502,0.0003019875,0.00006281909,0.0020736372],"genre_scores_gemma":[0.9961146,0.0020559826,0.0006843332,0.000043915243,0.000011775074,0.000021515814,0.00026629757,0.000004706184,0.0007967699],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986744,0.000029865598,0.000018821775,0.000018682125,0.00004239854,0.000022784385],"domain_scores_gemma":[0.9998642,0.00004250496,0.000042441283,0.000017041097,0.000018348226,0.000015430229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013141331,0.00032187198,0.00016828779,0.00025203792,0.00011056224,0.0002076238,0.00012070648,0.00023468632,0.0017730243],"category_scores_gemma":[0.00016633605,0.00007276317,0.00021940963,0.00015557343,0.00020777986,0.00022604372,0.00017314564,0.00045869141,0.00029514814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002598091,0.000050053226,0.00044565985,0.000072318864,0.000009620048,0.00012607295,0.000010911125,0.00005782321,0.99716717,0.00009312692,0.00004460402,0.0016627995],"study_design_scores_gemma":[0.00002515916,0.00045537658,0.0042216238,0.000011299186,0.00001289689,0.00037185577,0.000017116086,0.00023063543,0.99368733,0.00006347212,0.0009015106,0.0000018044435],"about_ca_topic_score_codex":0.00010533229,"about_ca_topic_score_gemma":0.00015966207,"teacher_disagreement_score":0.0017730243,"about_ca_system_score_codex":0.0001789993,"about_ca_system_score_gemma":0.00010527115,"threshold_uncertainty_score":0.0059313774},"labels":[],"label_agreement":null},{"id":"W1946837456","doi":"10.1186/s12014-015-9090-9","title":"Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned medium","year":2015,"lang":"en","type":"article","venue":"Clinical Proteomics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"School of Medicine, New York University; York University; George Washington University; National Cancer Institute; University of Pennsylvania","keywords":"Medicine; Lung cancer; National Lung Screening Trial; Biomarker; Biomarker discovery; Lung cancer screening; Oncology; Cancer; Population; Internal medicine; Proteomics; Pathology; Biology","score_opus":0.09832630586585482,"score_gpt":0.45723278813987484,"score_spread":0.35890648227402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1946837456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563658,0.0006501296,0.0402833,0.000093590395,0.000014215675,0.00023885703,0.001344375,0.00027777374,0.0007318762],"genre_scores_gemma":[0.9288668,0.0008482665,0.06460741,0.000096744305,0.000010361638,0.0005117825,0.003254937,0.00003261608,0.001771057],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99965215,0.00004366298,0.000019893603,0.00012902329,0.000113258975,0.000042108575],"domain_scores_gemma":[0.9997553,0.000073444775,0.00007570695,0.000026442613,0.000041598047,0.000027562415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090868794,0.0006494193,0.00065389567,0.0006680469,0.0002565682,0.00064317323,0.00048038425,0.00029415954,0.0005105844],"category_scores_gemma":[0.00053764676,0.00021072807,0.0006225879,0.0006532245,0.00039762436,0.0004114947,0.0006166221,0.00057259895,0.00035241764],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018323546,0.0007661517,0.052962758,0.00033249453,0.00027840395,0.00030006623,0.00008505785,0.0342452,0.87706524,0.0008125753,0.00046900177,0.03085072],"study_design_scores_gemma":[0.00020491726,0.0041848696,0.093800806,0.000029746427,0.0006099844,0.00079247594,0.000111884234,0.4224885,0.47057682,0.002542147,0.0045807287,0.00007704335],"about_ca_topic_score_codex":0.002404869,"about_ca_topic_score_gemma":0.0025752296,"teacher_disagreement_score":0.002404869,"about_ca_system_score_codex":0.00079936004,"about_ca_system_score_gemma":0.00093733956,"threshold_uncertainty_score":0.0057997704},"labels":[],"label_agreement":null},{"id":"W1964109435","doi":"10.1016/j.lungcan.2008.06.017","title":"Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer","year":2008,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Lévis; Jewish General Hospital","funders":"","keywords":"Medicine; Oncology; Internal medicine; Phase (matter); Lung cancer","score_opus":0.05241453114756632,"score_gpt":0.41515913076825106,"score_spread":0.3627445996206847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964109435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99211276,0.0017002629,0.0006701216,0.0004894646,0.00023601657,0.0021698144,0.0009944381,0.00013907738,0.0014880192],"genre_scores_gemma":[0.9851216,0.0021000325,0.0013361739,0.00069109217,0.0003066633,0.003126677,0.0021276472,0.0000604591,0.005129738],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992805,0.000332525,0.000025610194,0.000112602786,0.000047372265,0.0002013451],"domain_scores_gemma":[0.9988996,0.0001968829,0.00014163008,0.00013837272,0.000055535013,0.00056803675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018530778,0.0024901894,0.0040590656,0.001108576,0.00085939176,0.0014065123,0.0019611863,0.0026590026,0.0049315533],"category_scores_gemma":[0.0011235704,0.0011087023,0.0018470795,0.00069402397,0.0016636186,0.001421663,0.0004962135,0.005309558,0.0013895902],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74894565,0.13823904,0.0025421442,0.00053758535,0.0009857503,0.00024615735,0.00031160444,0.0025845373,0.04365346,0.00031074503,0.0032697264,0.05837364],"study_design_scores_gemma":[0.4699133,0.5185177,0.0041347025,0.00001763844,0.00028510008,0.00014093451,0.00007587723,0.00072013034,0.0045965677,0.00011725696,0.0014552923,0.000025565678],"about_ca_topic_score_codex":0.0030550908,"about_ca_topic_score_gemma":0.004677507,"teacher_disagreement_score":0.0049315533,"about_ca_system_score_codex":0.0014105197,"about_ca_system_score_gemma":0.0024324663,"threshold_uncertainty_score":0.016497672},"labels":[],"label_agreement":null},{"id":"W1965202985","doi":"10.1016/j.ijrobp.2010.01.056","title":"Temporal Lung Tumor Volume Changes in Small-Cell Lung Cancer Patients Undergoing Chemoradiotherapy","year":2010,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Chemoradiotherapy; Lung cancer; Radiation therapy; Nuclear medicine; Lung; Radiology; Stage (stratigraphy); Pathology; Internal medicine","score_opus":0.016928184786724264,"score_gpt":0.3557150194412565,"score_spread":0.33878683465453224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965202985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990646,0.00015774311,0.000064264554,0.000020395153,0.0000042802744,0.0000047362055,0.00013234405,0.000004074431,0.00054747454],"genre_scores_gemma":[0.99966943,0.000048234193,0.000022155407,0.000008448076,0.000005941924,0.0000031983038,0.00010749973,0.0000017245395,0.00013340209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99991083,0.00001680306,0.0000072597454,0.000020645028,0.000019640293,0.00002472546],"domain_scores_gemma":[0.99946684,0.00016694522,0.00020455336,0.000024512377,0.00005341358,0.0000837515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014013935,0.00009267954,0.00024033105,0.00035833378,0.00019585241,0.00038998696,0.00014017048,0.00027822296,0.0013056744],"category_scores_gemma":[0.0011468038,0.00010022281,0.00021006509,0.00041414256,0.00015411335,0.00035155154,0.00018898945,0.00032082485,0.0002262956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003199586,0.0000974939,0.979645,0.000024308849,0.00005970383,0.0009357598,0.00027632664,0.00024605705,0.008421148,0.00005143524,0.00014224958,0.006900851],"study_design_scores_gemma":[0.000008364866,0.0003209645,0.9975682,0.0000014946661,0.0000316864,0.00065653026,0.00016187818,0.00028057056,0.00071876834,0.000029527675,0.00021654156,0.000005435092],"about_ca_topic_score_codex":0.0028353,"about_ca_topic_score_gemma":0.0032173467,"teacher_disagreement_score":0.0028353,"about_ca_system_score_codex":0.0002776818,"about_ca_system_score_gemma":0.00018138454,"threshold_uncertainty_score":0.0056375265},"labels":[],"label_agreement":null},{"id":"W1966470979","doi":"10.1016/j.radonc.2011.08.042","title":"Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer","year":2011,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Chemotherapy; Radiation therapy; Conventional PCI; Esophagitis; Lung cancer; Stage (stratigraphy); Progressive disease; Surgery; Internal medicine; Disease; Myocardial infarction; Reflux","score_opus":0.10003562707364677,"score_gpt":0.46711241006866594,"score_spread":0.36707678299501917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966470979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993523,0.001869894,0.00019344398,0.00042853865,0.0004000067,0.0013513443,0.00031616664,0.000035758123,0.0018818758],"genre_scores_gemma":[0.99378973,0.0010437919,0.00039693355,0.00033513282,0.0003478193,0.000984396,0.00069947203,0.000016400742,0.0023863201],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984249,0.0008264434,0.000111105,0.0002462937,0.000076560056,0.00031478505],"domain_scores_gemma":[0.9973792,0.0006960215,0.0003199298,0.000477672,0.00015850957,0.0009687255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027422912,0.0017843599,0.0044616335,0.0006297547,0.0011374273,0.0013140949,0.0016936517,0.0025780567,0.007143892],"category_scores_gemma":[0.0026889292,0.0007368469,0.0018890486,0.0010474115,0.0027955822,0.0012824159,0.00068790594,0.00453422,0.0016931397],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95344216,0.023134971,0.001354706,0.00020790756,0.0004424335,0.000060920036,0.00010444463,0.00071712513,0.0037513424,0.00016150743,0.0004025369,0.016219871],"study_design_scores_gemma":[0.42627826,0.56444055,0.005565037,0.000026756576,0.0004224902,0.00006756292,0.000060123464,0.00043966944,0.001529466,0.00009959769,0.0010476428,0.000022903425],"about_ca_topic_score_codex":0.0020888716,"about_ca_topic_score_gemma":0.0035837386,"teacher_disagreement_score":0.007143892,"about_ca_system_score_codex":0.0012567341,"about_ca_system_score_gemma":0.002608955,"threshold_uncertainty_score":0.023898661},"labels":[],"label_agreement":null},{"id":"W1967004095","doi":"10.3857/roj.2013.31.3.175","title":"Timing of thoracic irradiation in limited stage small-cell lung cancer: is it still a star on the rise?","year":2013,"lang":"en","type":"article","venue":"Radiation Oncology Journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Stage (stratigraphy); Lung cancer; Irradiation; Star (game theory); Lung; Cancer; Oncology; Internal medicine; Biology; Astrophysics","score_opus":0.05834887739361485,"score_gpt":0.41637091521042524,"score_spread":0.3580220378168104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967004095","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11121158,0.86692876,0.0011852984,0.014964213,0.0032091064,0.00010474951,0.00028910823,0.00005580554,0.002051335],"genre_scores_gemma":[0.7377532,0.24111472,0.0029491205,0.009212451,0.0071747806,0.00015410285,0.0004908034,0.00006941542,0.0010813623],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99878556,0.00053750095,0.00021402343,0.00019343299,0.00021024887,0.000059157566],"domain_scores_gemma":[0.99448377,0.0026799531,0.0017359913,0.00018564239,0.00051816774,0.00039644822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034408155,0.00027053486,0.0019889995,0.00033693705,0.00024324143,0.0013215799,0.00087359286,0.0010585211,0.0040551815],"category_scores_gemma":[0.008690278,0.0002308408,0.0011960343,0.00097024126,0.00034313853,0.0018356319,0.0003436312,0.002226766,0.00057129445],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05792823,0.0009512212,0.033353064,0.0139510725,0.002065124,0.00007840963,0.00024623005,0.0011014947,0.0021545445,0.0012727376,0.009548441,0.87734944],"study_design_scores_gemma":[0.055256367,0.116163574,0.41719615,0.031874713,0.05092507,0.0018895048,0.003096603,0.008991107,0.008625518,0.027780248,0.27771503,0.0004861191],"about_ca_topic_score_codex":0.0007645838,"about_ca_topic_score_gemma":0.0021655848,"teacher_disagreement_score":0.0040551815,"about_ca_system_score_codex":0.0008474664,"about_ca_system_score_gemma":0.001114313,"threshold_uncertainty_score":0.018197},"labels":[],"label_agreement":null},{"id":"W1968673033","doi":"10.1016/s0169-5002(99)00132-4","title":"An estimate of the cost of conducting phase II trials in lung cancer","year":2000,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Gemcitabine; Docetaxel; Clinical trial; Lung cancer; Pharmacy; Oncology; Cancer; Internal medicine; Intensive care medicine; Family medicine","score_opus":0.10718475209156585,"score_gpt":0.5220729525916058,"score_spread":0.41488820050003994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968673033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32890764,0.24384879,0.13917376,0.07510102,0.0056527737,0.009839037,0.04954138,0.0011004104,0.14683512],"genre_scores_gemma":[0.9070904,0.02679334,0.041088916,0.006618161,0.00096259604,0.0033722827,0.0057410323,0.00011267334,0.00822056],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9758213,0.019980561,0.001038405,0.00042000334,0.00217233,0.0005673296],"domain_scores_gemma":[0.894513,0.087633766,0.0068126502,0.0032725662,0.0059353197,0.0018326478],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.023964554,0.0011022168,0.0015262899,0.0026590328,0.00040432785,0.002203674,0.0010453146,0.002282852,0.0054516015],"category_scores_gemma":[0.095319964,0.000631485,0.0033908484,0.0022807666,0.0006461315,0.0018664746,0.0010898302,0.002140199,0.0007003079],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045190167,0.0011887522,0.08606417,0.010917112,0.015691038,0.0012778445,0.00048966875,0.07816786,0.0052652084,0.034958456,0.04547041,0.6753194],"study_design_scores_gemma":[0.024458518,0.021098992,0.41855967,0.0098501155,0.063606426,0.011593865,0.0021215777,0.10830892,0.012753678,0.051030844,0.2759864,0.0006309402],"about_ca_topic_score_codex":0.009079822,"about_ca_topic_score_gemma":0.007991812,"teacher_disagreement_score":0.9760355,"about_ca_system_score_codex":0.004429322,"about_ca_system_score_gemma":0.0045835725,"threshold_uncertainty_score":0.12673819},"labels":[],"label_agreement":null},{"id":"W1970574485","doi":"10.1016/j.lungcan.2015.04.006","title":"Prophylactic cranial irradiation (PCI). Still a no-brainer?","year":2015,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"Sunnybrook Foundation","keywords":"Prophylactic cranial irradiation; Conventional PCI; Medicine; Intensive care medicine; Medical physics; Surgery; Radiology; Internal medicine","score_opus":0.03641837392901453,"score_gpt":0.38552492142454425,"score_spread":0.3491065474955297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970574485","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017009322,0.93809396,0.00074101094,0.053844158,0.0016589755,0.000012264073,0.000052096297,0.0000168198,0.0038796677],"genre_scores_gemma":[0.026953448,0.9339675,0.001638019,0.029755589,0.005194765,0.000035749996,0.0000736197,0.000029902678,0.0023514838],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989172,0.00051807566,0.0001598111,0.00015824656,0.00018799826,0.000058660164],"domain_scores_gemma":[0.9957973,0.0029978184,0.0005122428,0.0001302699,0.00036061546,0.00020182447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028395893,0.00029901852,0.0012716085,0.00040738026,0.00040102433,0.0017548833,0.0006989161,0.0016126857,0.0058355024],"category_scores_gemma":[0.0059776832,0.00014045574,0.00050728634,0.00079890655,0.0017931481,0.002783555,0.00066077267,0.0029021462,0.0016927965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068058097,0.00010157792,0.0016888711,0.0077815014,0.00023527743,0.00020318771,0.00019194599,0.00013565678,0.0007687218,0.016275687,0.036310695,0.9356264],"study_design_scores_gemma":[0.00048643682,0.0018404871,0.008505527,0.028910981,0.00097318727,0.00369273,0.0018408672,0.00015336514,0.0014598637,0.037871696,0.91417015,0.00009478091],"about_ca_topic_score_codex":0.0013875425,"about_ca_topic_score_gemma":0.004044538,"teacher_disagreement_score":0.0058355024,"about_ca_system_score_codex":0.0007769605,"about_ca_system_score_gemma":0.0019912878,"threshold_uncertainty_score":0.019521713},"labels":[],"label_agreement":null},{"id":"W1973891678","doi":"10.1016/j.hoc.2003.12.010","title":"Treatment of recurrent small cell lung cancer","year":2004,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Canada Research Chairs; McMaster University; University of Toronto; Cancer Care Ontario","funders":"","keywords":"Topotecan; Irinotecan; Medicine; Oncology; Etoposide; Internal medicine; Chemotherapy; Lung cancer; Cancer","score_opus":0.09102166533395653,"score_gpt":0.47604534604582516,"score_spread":0.38502368071186865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973891678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007346652,0.9995528,0.00001951701,0.00006039573,0.000057902762,0.0000028549784,0.000008809212,0.0000019326042,0.00022231077],"genre_scores_gemma":[0.0008909691,0.9986656,0.0000656285,0.00015385349,0.00006458552,0.0000039053975,0.000018337349,6.26649e-7,0.00013647546],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996126,0.00010556642,0.000078688274,0.00007211111,0.000106505344,0.00002459262],"domain_scores_gemma":[0.9993099,0.00043142049,0.00013727321,0.000015766595,0.000079267804,0.000026418837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010193756,0.0007643633,0.0031261335,0.0023321672,0.00024567638,0.00089124136,0.0012917086,0.0010498702,0.003296506],"category_scores_gemma":[0.0016770886,0.0003250473,0.0012524418,0.0026127012,0.0005258456,0.0008135759,0.0004367853,0.0013178398,0.0008205579],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020219454,0.00008014558,0.00045374894,0.05458645,0.0005807034,0.00023703523,0.000047496284,0.00033100156,0.00058731384,0.0007604484,0.018633218,0.9235001],"study_design_scores_gemma":[0.00045814563,0.0009389512,0.007041349,0.039553575,0.0040073595,0.0043909703,0.00029063894,0.00021177247,0.00079687376,0.0012105869,0.9410388,0.000060901886],"about_ca_topic_score_codex":0.0026245248,"about_ca_topic_score_gemma":0.007489862,"teacher_disagreement_score":0.003296506,"about_ca_system_score_codex":0.00071707106,"about_ca_system_score_gemma":0.0009938896,"threshold_uncertainty_score":0.011027873},"labels":[],"label_agreement":null},{"id":"W1974953539","doi":"10.5863/1551-6776-17.4.395","title":"Cisplatin-Induced Ototoxicity and the Role of Pharmacogenetic Testing","year":2012,"lang":"en","type":"article","venue":"The Journal of Pediatric Pharmacology and Therapeutics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ototoxicity; Thiopurine methyltransferase; Cisplatin; Nephrotoxicity; Body surface area; Surgery; Urology; Chemotherapy; Internal medicine; Toxicity; Inflammatory bowel disease","score_opus":0.05196197375354968,"score_gpt":0.3743509210687343,"score_spread":0.32238894731518464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974953539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518946,0.01822245,0.009089717,0.006324331,0.000154513,0.00027718686,0.00090060785,0.0001455691,0.0129909925],"genre_scores_gemma":[0.9964759,0.0014069441,0.0011754349,0.0005041696,0.000067049164,0.000021869258,0.00015342029,0.0000133831045,0.00018188103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960199,0.0020029242,0.00046600925,0.0004954173,0.00071194436,0.0003038466],"domain_scores_gemma":[0.9869125,0.008565661,0.0023479133,0.00085003726,0.0009234642,0.00040049697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004517169,0.000610891,0.00066852616,0.0013680323,0.0004489331,0.0013273908,0.0008357104,0.0010209832,0.0018305358],"category_scores_gemma":[0.020812638,0.0002530958,0.0006248802,0.0015207046,0.001111053,0.0010357936,0.0007446865,0.00091406656,0.0003048777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005766226,0.00019698124,0.9129746,0.00013841872,0.00036326906,0.024339722,0.00028750204,0.0015074563,0.0019587956,0.0021138818,0.0012070775,0.05433561],"study_design_scores_gemma":[0.00022840526,0.0010707931,0.7915239,0.0007315778,0.0010814416,0.14986105,0.0011444718,0.02236952,0.004620615,0.013304719,0.013964425,0.000099169076],"about_ca_topic_score_codex":0.0017753096,"about_ca_topic_score_gemma":0.0011450219,"teacher_disagreement_score":0.004517169,"about_ca_system_score_codex":0.0007376897,"about_ca_system_score_gemma":0.0007617101,"threshold_uncertainty_score":0.023889363},"labels":[],"label_agreement":null},{"id":"W1977262321","doi":"10.1016/j.ijrobp.2010.07.1158","title":"Treatment of Cranial Metastases Following Prophylactic Cranial Irradiation (PCI) for Small Cell Lung Cancer (SCLC)","year":2010,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Conventional PCI; Prophylactic cranial irradiation; Retrospective cohort study; Brain metastasis; Radiation therapy; Surgery; Population; Internal medicine; Cancer; Nuclear medicine; Metastasis; Myocardial infarction","score_opus":0.029857473229881006,"score_gpt":0.391150800310649,"score_spread":0.361293327080768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977262321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987553,0.004094009,0.0010641731,0.00042301323,0.00012851,0.00021105498,0.00020290999,0.00005301402,0.006270306],"genre_scores_gemma":[0.9978861,0.0010382426,0.00029376836,0.000091652844,0.000082369144,0.000045939953,0.000098180164,0.000007629398,0.00045611817],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99993265,0.000013812134,0.0000044316903,0.00000814609,0.000015398178,0.000025643678],"domain_scores_gemma":[0.9998441,0.0000415271,0.000045526198,0.000018712448,0.000009334722,0.00004086519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013064778,0.00029130172,0.0004849117,0.00028337308,0.00042067282,0.00023724906,0.00030734812,0.00030501114,0.001250802],"category_scores_gemma":[0.00074204593,0.00009114628,0.00041730283,0.00032860244,0.00030361535,0.00016264844,0.00019948836,0.0006647032,0.00016278375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07013988,0.0047269897,0.09638574,0.0019188981,0.0008062492,0.04847058,0.0007809645,0.009115926,0.14300025,0.0017824125,0.009348708,0.6135233],"study_design_scores_gemma":[0.005670734,0.07969799,0.75064737,0.0002759151,0.0014892773,0.07012345,0.00046920733,0.009286254,0.058442395,0.0021373623,0.02165698,0.0001031519],"about_ca_topic_score_codex":0.004392449,"about_ca_topic_score_gemma":0.009149036,"teacher_disagreement_score":0.004392449,"about_ca_system_score_codex":0.0004951228,"about_ca_system_score_gemma":0.0006132313,"threshold_uncertainty_score":0.008733749},"labels":[],"label_agreement":null},{"id":"W1979699724","doi":"10.1097/jto.0b013e3181c8cbf5","title":"Surgery for Limited Stage Small Cell Lung Cancer: Time to Fish or Cut Bait","year":2010,"lang":"en","type":"letter","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Fish <Actinopterygii>; Stage (stratigraphy); Lung cancer; Surgery; Oncology; Fishery; Biology","score_opus":0.05446420084354163,"score_gpt":0.4431004005296949,"score_spread":0.38863619968615326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979699724","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03386787,0.009880346,0.00016179346,0.9290141,0.011867331,0.000042153282,0.00014700291,0.000021492824,0.014997929],"genre_scores_gemma":[0.2513739,0.012915871,0.0008381655,0.67802745,0.03546445,0.00011811932,0.00014101349,0.000024109866,0.021096926],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999534,0.0001463722,0.00007735032,0.000050849543,0.00006670273,0.00012475754],"domain_scores_gemma":[0.99795365,0.0012487965,0.00019894731,0.00004198098,0.000112738795,0.00044389899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009071049,0.0002563931,0.0006925661,0.00023775357,0.0013294935,0.0008025958,0.0005604917,0.0140145,0.007639889],"category_scores_gemma":[0.0066945977,0.0002710851,0.00068851915,0.000408769,0.00095199625,0.0014205065,0.0003841419,0.0063206297,0.0014261724],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00792823,0.0010945214,0.06919435,0.0010263674,0.00023613799,0.07193569,0.00072980794,0.0006936518,0.00470398,0.007329386,0.70777667,0.12735124],"study_design_scores_gemma":[0.0043511395,0.009763099,0.10702421,0.0022973118,0.00062901457,0.1220831,0.007374566,0.002245259,0.0032096477,0.023738807,0.71697646,0.00030742085],"about_ca_topic_score_codex":0.0041780635,"about_ca_topic_score_gemma":0.018831873,"teacher_disagreement_score":0.0140145,"about_ca_system_score_codex":0.0023524347,"about_ca_system_score_gemma":0.0022322587,"threshold_uncertainty_score":0.025557935},"labels":[],"label_agreement":null},{"id":"W1981402488","doi":"10.1016/j.cllc.2014.11.008","title":"Correlation of Dosimetric and Clinical Factors With the Development of Esophagitis and Radiation Pneumonitis in Patients With Limited-Stage Small-Cell Lung Carcinoma","year":2014,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Esophagitis; Pneumonitis; Esophagus; Radiation therapy; Chemoradiotherapy; Nuclear medicine; Internal medicine; Gastroenterology; Lung; Cumulative incidence; Stage (stratigraphy); Lung cancer; Incidence (geometry); Radiology; Reflux; Disease","score_opus":0.026204664064820776,"score_gpt":0.3468570903380057,"score_spread":0.3206524262731849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981402488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990839,0.0003105239,0.000056543213,0.000033302964,0.000004715511,0.000004288406,0.000068117486,0.0000018579346,0.00043677568],"genre_scores_gemma":[0.999747,0.000055240016,0.000029060848,0.000010187977,0.0000094679435,0.0000024830651,0.00007627027,8.3432764e-7,0.00006949403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957937,0.00019218723,0.00005642373,0.000051132003,0.000065318854,0.000055521585],"domain_scores_gemma":[0.9969137,0.0011820798,0.0010104208,0.00023238272,0.00025955707,0.00040188758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069294404,0.00024635778,0.00038158282,0.00071524334,0.00033878753,0.00054302695,0.00030275367,0.00054137915,0.0012626715],"category_scores_gemma":[0.0042153797,0.00025209296,0.00048260632,0.0010262209,0.00047746752,0.00055420434,0.00031430428,0.0006407299,0.00017330122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028977057,0.000036097677,0.9987633,0.00000431092,0.000026307618,0.00006032657,0.00001888282,0.000049249647,0.00022471143,0.000008708223,0.000014126754,0.00050412596],"study_design_scores_gemma":[0.000007964229,0.00021427296,0.99914455,0.000001501436,0.000027408374,0.00021822027,0.000093420305,0.00012276485,0.00008694876,0.000018224215,0.00006180644,0.000002925308],"about_ca_topic_score_codex":0.0015438956,"about_ca_topic_score_gemma":0.0016275777,"teacher_disagreement_score":0.0015438956,"about_ca_system_score_codex":0.00027920774,"about_ca_system_score_gemma":0.00029854622,"threshold_uncertainty_score":0.004224062},"labels":[],"label_agreement":null},{"id":"W1986783484","doi":"10.1016/s0169-5002(00)00240-3","title":"Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control","year":2001,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Epirubicin; Toxicity; Population; Gastroenterology; Cyclophosphamide; Radiation therapy; Chemotherapy; Mucositis; Vincristine; Progressive disease; Cancer; Oncology; Surgery; Urology","score_opus":0.08057751619949674,"score_gpt":0.4081317458969609,"score_spread":0.32755422969746417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986783484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726288,0.019400332,0.001147983,0.0010813732,0.00028289412,0.0002020192,0.0002712023,0.000084311854,0.0049010306],"genre_scores_gemma":[0.9907336,0.0055007716,0.0011898153,0.00040104086,0.00025070016,0.00017052218,0.0002858221,0.000021918577,0.0014457786],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99941456,0.00026853263,0.00005797962,0.00007290564,0.00011293301,0.000073010924],"domain_scores_gemma":[0.99659014,0.0017767332,0.0008653855,0.0003383812,0.00010945274,0.0003199567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013595684,0.0002833839,0.00075398915,0.00022285238,0.00038731899,0.0002724498,0.00042128225,0.00053549383,0.0030436188],"category_scores_gemma":[0.004839318,0.0001271275,0.0006695406,0.00051219953,0.0002319335,0.0004157424,0.00016907381,0.0016444902,0.000250234],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057511277,0.014465255,0.06442072,0.0018088521,0.0016708627,0.00021214454,0.0005812666,0.0023953696,0.027148234,0.001304937,0.0050200173,0.8234611],"study_design_scores_gemma":[0.019786423,0.14889449,0.74914354,0.00052578765,0.004148348,0.0011978894,0.00055403897,0.0027758067,0.018664509,0.0021572027,0.05208577,0.00006613178],"about_ca_topic_score_codex":0.0018435513,"about_ca_topic_score_gemma":0.003916801,"teacher_disagreement_score":0.0030436188,"about_ca_system_score_codex":0.0004533516,"about_ca_system_score_gemma":0.0006973403,"threshold_uncertainty_score":0.010181904},"labels":[],"label_agreement":null},{"id":"W1988586595","doi":"10.1053/sonc.2003.50017","title":"Thoracic radiotherapy for limited-stage small cell lung cancer: Issues of timing, volumes, dose, and fractionation","year":2003,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Radiation therapy; Medicine; Chemotherapy; Dose fractionation; Randomized controlled trial; Oncology; Lung cancer; Stage (stratigraphy); Internal medicine; Surgery","score_opus":0.08208530181503791,"score_gpt":0.4927384745917523,"score_spread":0.41065317277671437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988586595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000089505505,0.99953055,0.00003934434,0.000100200414,0.000047950853,0.00000185887,0.0000026691432,0.000001465165,0.0001864852],"genre_scores_gemma":[0.0005648348,0.99901545,0.00010591022,0.00011678602,0.000052031126,0.0000033825752,0.0000053259037,5.8026205e-7,0.00013564467],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996929,0.00008983143,0.000048407215,0.000049960498,0.000100453326,0.000018454946],"domain_scores_gemma":[0.9993748,0.0004207671,0.00008680887,0.000015490305,0.00008539027,0.000016717608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016150828,0.000715985,0.0026989756,0.0011252901,0.00024713436,0.00073973153,0.001295103,0.0008955478,0.002063915],"category_scores_gemma":[0.0014826625,0.0002955133,0.00063598115,0.0026161761,0.0005656376,0.00090201123,0.00037797072,0.0010979081,0.00076712895],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019691908,0.000049668433,0.00027488792,0.021375677,0.00016548141,0.00014339332,0.000046167635,0.00040877637,0.0011269634,0.0008651023,0.008981416,0.9663657],"study_design_scores_gemma":[0.00028212406,0.0008905329,0.0060679773,0.017101958,0.0015130074,0.0045201797,0.0002867563,0.00019351898,0.001426989,0.0025326859,0.9651359,0.000048427617],"about_ca_topic_score_codex":0.0027905842,"about_ca_topic_score_gemma":0.008070012,"teacher_disagreement_score":0.0027905842,"about_ca_system_score_codex":0.00093722664,"about_ca_system_score_gemma":0.001578976,"threshold_uncertainty_score":0.008541465},"labels":[],"label_agreement":null},{"id":"W1989020905","doi":"10.1111/j.1440-1843.2006.00850.x","title":"Small cell lung cancer: Treatment review","year":2006,"lang":"en","type":"review","venue":"Respirology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Contraindication; Lung cancer; Radiation therapy; Cancer; Quarter (Canadian coin); Intensive care medicine; Oncology; Surgery; Internal medicine; Pathology; Alternative medicine","score_opus":0.11090579267032195,"score_gpt":0.46033283413422255,"score_spread":0.3494270414639006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989020905","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000503453,0.99912804,0.000036206548,0.00011536051,0.00012620696,0.000006572414,0.000012082779,0.0000039105307,0.00052131293],"genre_scores_gemma":[0.00036454905,0.99910516,0.00007742014,0.0001108137,0.00008074872,0.0000080692025,0.000019605255,7.9609487e-7,0.0002328347],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966943,0.00007037175,0.00006311705,0.000053075277,0.000121609795,0.000022448701],"domain_scores_gemma":[0.9994923,0.00027642483,0.000091982736,0.000012578048,0.00009728061,0.00002947637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056518544,0.0009352071,0.00239402,0.0027956804,0.00035922497,0.0009837671,0.0011955935,0.0009967914,0.0060159583],"category_scores_gemma":[0.0013498887,0.00034845786,0.00072723115,0.0040331674,0.00040237032,0.0012043563,0.0004943407,0.001211236,0.002238445],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006639206,0.00007052182,0.00016717488,0.048161667,0.00013357647,0.00021072247,0.000048100326,0.00034758516,0.00050230796,0.0008650586,0.050597202,0.89882976],"study_design_scores_gemma":[0.00004972929,0.00013709604,0.0017723986,0.034086257,0.0005055748,0.0026420173,0.00012341404,0.00010663486,0.00029258343,0.0011110808,0.9591499,0.00002331783],"about_ca_topic_score_codex":0.002101828,"about_ca_topic_score_gemma":0.0042263647,"teacher_disagreement_score":0.0060159583,"about_ca_system_score_codex":0.0007539967,"about_ca_system_score_gemma":0.0015281666,"threshold_uncertainty_score":0.02012539},"labels":[],"label_agreement":null},{"id":"W1996846809","doi":"10.1080/1042819021000002901","title":"Phase II Study of Sequential Topotecan and Etoposide in Patients with Intermediate Grade Non-Hodgkin's Lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study","year":2002,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Queen Elizabeth II Health Sciences Centre; Saskatoon Medical Imaging; Humber River Regional Hospital; Hamilton Health Sciences; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Topotecan; Medicine; Etoposide; Neutropenia; Internal medicine; Gastroenterology; Lymphoma; Regimen; Febrile neutropenia; Phases of clinical research; Chemotherapy; Surgery","score_opus":0.05278015313966829,"score_gpt":0.37454118198458514,"score_spread":0.32176102884491686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996846809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832017,0.003401394,0.00049533264,0.00087779004,0.00012442589,0.007256016,0.0016032218,0.00007116017,0.0029688643],"genre_scores_gemma":[0.98116255,0.0028684626,0.0020002152,0.0017088592,0.00017605144,0.005465662,0.0027620404,0.000014652404,0.003841536],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999382,0.00028718106,0.00002449032,0.00006448483,0.000091514994,0.00015025953],"domain_scores_gemma":[0.9990552,0.000074118805,0.00010103226,0.00004351564,0.00007928836,0.0006468177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022356734,0.0014520143,0.002028723,0.00038605256,0.0005416328,0.000934564,0.001032657,0.0011334098,0.002627602],"category_scores_gemma":[0.00080282614,0.00060009555,0.00092062406,0.00057501654,0.0009288489,0.00041445834,0.0003127777,0.0024147134,0.00054031843],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81447744,0.07298088,0.012326198,0.00076388574,0.0016024875,0.00049000286,0.00030882895,0.0021288285,0.02248025,0.00041422414,0.006082705,0.06594427],"study_design_scores_gemma":[0.77584577,0.19697641,0.02079096,0.000029308503,0.00036768202,0.00018957791,0.00006016623,0.0008942256,0.0011408129,0.00012944882,0.003552976,0.000022717533],"about_ca_topic_score_codex":0.027088743,"about_ca_topic_score_gemma":0.070473164,"teacher_disagreement_score":0.027088743,"about_ca_system_score_codex":0.002675967,"about_ca_system_score_gemma":0.0060517313,"threshold_uncertainty_score":0.053862095},"labels":[],"label_agreement":null},{"id":"W1997036848","doi":"10.1097/jto.0b013e31820d782d","title":"Selecting Patients with Extensive-Stage Small Cell Lung Cancer for Prophylactic Cranial Irradiation by Predicting Brain Metastases","year":2011,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Stage (stratigraphy); Lung cancer; Radiology; Lung; Oncology; Brain metastasis; Cancer; Internal medicine; Metastasis","score_opus":0.03521243200563374,"score_gpt":0.4076535004350479,"score_spread":0.37244106842941416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997036848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988312,0.00031690756,0.000071062095,0.00008616482,0.000015477228,0.000011042632,0.000032514,0.0000015251414,0.000634011],"genre_scores_gemma":[0.9994166,0.00016201721,0.00012860609,0.00004723539,0.000031960026,0.000006032974,0.00007869641,0.0000010513993,0.00012783936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999848,0.00005963922,0.00001706022,0.000020520385,0.000019954528,0.000034818517],"domain_scores_gemma":[0.9992424,0.00038144324,0.00010649403,0.000028964027,0.000044828157,0.00019593528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035925204,0.00034595284,0.0004339892,0.00053165434,0.00038220172,0.00050026743,0.00023051177,0.00052395195,0.001565285],"category_scores_gemma":[0.0021478299,0.00014275765,0.00035486286,0.00059577974,0.00029611008,0.00040897465,0.00017028431,0.00040911167,0.00021121267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000818182,0.00009254768,0.99324036,0.000010933453,0.00002605669,0.00023580287,0.00003655934,0.00012585582,0.00060206075,0.000017904249,0.00014387736,0.004649826],"study_design_scores_gemma":[0.00015691979,0.0018539428,0.993418,0.000016033331,0.00021390663,0.0015683757,0.00041951583,0.00079250115,0.00071621715,0.00015249637,0.0006801078,0.000012054386],"about_ca_topic_score_codex":0.001565484,"about_ca_topic_score_gemma":0.003552786,"teacher_disagreement_score":0.001565484,"about_ca_system_score_codex":0.0001970401,"about_ca_system_score_gemma":0.00035027342,"threshold_uncertainty_score":0.0052363873},"labels":[],"label_agreement":null},{"id":"W1998967593","doi":"10.1016/j.clinbiochem.2014.06.039","title":"Closing the gaps in pediatric population reference values for cancer biomarkers: A CALIPER study of healthy community children","year":2014,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Carcinoembryonic antigen; Oncology; Internal medicine; Cancer; Metastatic breast cancer; Cancer antigen; CA15-3; Metastasis; Pathological; Tumor marker; Gastroenterology; Antigen; Pathology; Immunology","score_opus":0.11114169739447531,"score_gpt":0.4922531227846824,"score_spread":0.3811114253902071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998967593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463344,0.0013129478,0.0016683833,0.00044719115,0.000025200316,0.000020951273,0.0009479699,0.0000125033375,0.00093132094],"genre_scores_gemma":[0.9963869,0.0005975316,0.001648119,0.00028613966,0.00003368147,0.000046468336,0.0007980525,0.000016435622,0.00018675697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99352807,0.0031521313,0.000509066,0.0011310641,0.001013549,0.0006661143],"domain_scores_gemma":[0.99012893,0.0030403256,0.0026897273,0.0019827292,0.001770442,0.000387764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008020362,0.00054260343,0.0011230675,0.0011894527,0.0010450139,0.0016466461,0.0013989307,0.0009585005,0.00063032995],"category_scores_gemma":[0.016464198,0.0004606654,0.0006175881,0.0032746957,0.0008192421,0.0013892971,0.0018631421,0.0010972249,0.00017597397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024733008,0.00007500875,0.9865905,0.00006137802,0.00015096106,0.00010033662,0.0016821396,0.00019358916,0.00037814857,0.00052316196,0.0008031804,0.0091941655],"study_design_scores_gemma":[0.000024771998,0.00018029603,0.99380255,0.000047315334,0.00012453976,0.00021742273,0.0017558099,0.00025139615,0.00035320403,0.00023220273,0.0029992824,0.000011029166],"about_ca_topic_score_codex":0.043076262,"about_ca_topic_score_gemma":0.041268207,"teacher_disagreement_score":0.043076262,"about_ca_system_score_codex":0.0010228744,"about_ca_system_score_gemma":0.0017007622,"threshold_uncertainty_score":0.0856511},"labels":[],"label_agreement":null},{"id":"W1999139776","doi":"10.1016/s0093-7754(01)90077-6","title":"The importance of drug diversity in the treatment of small cell lung cancer","year":2001,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Etoposide; Cisplatin; Oncology; Lung cancer; Drug; Chemotherapy; Population; Internal medicine; Combination chemotherapy; Pharmacology","score_opus":0.03271828028642188,"score_gpt":0.3800493503969207,"score_spread":0.34733107011049885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999139776","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.781516,0.17219283,0.0031174254,0.017417865,0.00032855337,0.00010979847,0.0001886539,0.000024721168,0.02510407],"genre_scores_gemma":[0.97700673,0.020075241,0.00062239956,0.0009953423,0.00029892122,0.000018026085,0.00004036433,0.000005425312,0.0009374014],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981693,0.0011963805,0.00006839001,0.00011672172,0.00026085338,0.00018827827],"domain_scores_gemma":[0.99337995,0.0050210496,0.0006144217,0.00026991198,0.0002866506,0.00042798524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028848862,0.00011560596,0.00069455925,0.0007873249,0.00063048524,0.0012067851,0.00037815093,0.00044589778,0.0021117146],"category_scores_gemma":[0.005146931,0.000087241555,0.00027398538,0.0007018951,0.0014878268,0.0017622665,0.0009933757,0.00093602284,0.00013635907],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009867241,0.0014004891,0.037676457,0.0015115577,0.00051830284,0.0004470142,0.0014713823,0.0057947244,0.06150737,0.04470313,0.0022416704,0.8328607],"study_design_scores_gemma":[0.0030827925,0.072139606,0.32056814,0.0015248242,0.0020118824,0.00792343,0.0064809015,0.0074750073,0.12793684,0.20067418,0.24997853,0.00020389444],"about_ca_topic_score_codex":0.0007365061,"about_ca_topic_score_gemma":0.0014398271,"teacher_disagreement_score":0.0028848862,"about_ca_system_score_codex":0.0008058578,"about_ca_system_score_gemma":0.0009762369,"threshold_uncertainty_score":0.015256882},"labels":[],"label_agreement":null},{"id":"W2000232364","doi":"10.1053/s1043-0679(03)00098-4","title":"Small-cell lung cancer: a review of clinical trials","year":2003,"lang":"en","type":"review","venue":"Seminars in Thoracic and Cardiovascular Surgery","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; National Comprehensive Cancer Network","keywords":"Medicine; Prophylactic cranial irradiation; Clinical trial; Disease; Lung cancer; Radiation therapy; Oncology; Cancer; Chemotherapy; Modalities; Stage (stratigraphy); Intensive care medicine; Internal medicine; Surgery","score_opus":0.2576794840656253,"score_gpt":0.5220665338572965,"score_spread":0.2643870497916712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000232364","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011517654,0.9995326,0.000039722796,0.00010845218,0.00004155219,0.000025270592,0.00004725493,0.000002949239,0.00008708005],"genre_scores_gemma":[0.0011090763,0.99817264,0.0002656475,0.00027806216,0.000049060764,0.000029111427,0.00004046172,0.0000014836827,0.000054461634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985839,0.00040485014,0.0004961364,0.00017549138,0.000290726,0.000048877137],"domain_scores_gemma":[0.99316794,0.0051512755,0.0010266325,0.000088346555,0.00045182407,0.000114065915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041305833,0.0015443822,0.008171329,0.0039472813,0.0003120221,0.0016321773,0.0022227122,0.0015176545,0.0039364486],"category_scores_gemma":[0.00870321,0.0006376952,0.0027379952,0.0064933123,0.0006061494,0.0015208458,0.0007684994,0.0011813157,0.00048158885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015310758,0.00010119585,0.00071537733,0.4389772,0.0052517196,0.00022028974,0.00011169007,0.00046495209,0.00095988926,0.0006045586,0.013521003,0.53754103],"study_design_scores_gemma":[0.0037523678,0.0027818864,0.009856019,0.3865649,0.0863269,0.0023989158,0.0005784611,0.00043996214,0.0013810694,0.0022720986,0.50346303,0.00018443537],"about_ca_topic_score_codex":0.002268699,"about_ca_topic_score_gemma":0.0084237205,"teacher_disagreement_score":0.008171329,"about_ca_system_score_codex":0.0012408693,"about_ca_system_score_gemma":0.002963274,"threshold_uncertainty_score":0.021844864},"labels":[],"label_agreement":null},{"id":"W2001238669","doi":"10.1016/s0360-3016(03)00070-1","title":"Twenty-year follow-up study of long-term survival of limited-stage small-cell lung cancer and overview of prognostic and treatment factors","year":2003,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Lung cancer; Stage (stratigraphy); Radiation therapy; Survival analysis; Internal medicine; Cohort; Multivariate analysis; Incidence (geometry); Oncology; Cancer; Survival rate; Surgery","score_opus":0.06544769733230364,"score_gpt":0.39486723071124424,"score_spread":0.3294195333789406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001238669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998536,0.0005776244,0.00006769072,0.000031223415,0.00001022486,0.000008496307,0.00047599105,0.0000031808086,0.00028962563],"genre_scores_gemma":[0.9979715,0.00016523521,0.00004002145,0.000030044223,0.000015920235,0.000015036337,0.0011647227,0.000003083666,0.0005943996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956137,0.000109505214,0.00004587887,0.00009226999,0.00005430748,0.00013664934],"domain_scores_gemma":[0.99825305,0.00029338102,0.00039761656,0.00016196723,0.00033698583,0.00055703195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011540601,0.0004322924,0.00073324156,0.001133252,0.0011352408,0.0006346137,0.00043176464,0.00074383616,0.0010083521],"category_scores_gemma":[0.0019733028,0.00024292346,0.0009941246,0.0013708619,0.0004364877,0.00068918517,0.0005624056,0.0006875091,0.00037210577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003299766,0.00030898055,0.9905571,0.000020616262,0.00022759581,0.00051185384,0.00028540322,0.000114429604,0.0011233694,0.000023072014,0.00017572135,0.0033520896],"study_design_scores_gemma":[0.000033321805,0.000930983,0.99789655,0.000004188023,0.0001636518,0.00022397214,0.00015262885,0.00006611272,0.0001269268,0.000020936024,0.00037226768,0.000008490923],"about_ca_topic_score_codex":0.0062204106,"about_ca_topic_score_gemma":0.0068325987,"teacher_disagreement_score":0.0062204106,"about_ca_system_score_codex":0.00055742485,"about_ca_system_score_gemma":0.0004560061,"threshold_uncertainty_score":0.012368381},"labels":[],"label_agreement":null},{"id":"W2003901423","doi":"10.1097/01.jto.0000283006.34791.31","title":"E05-06: Clinical staging of small cell lung cancer: report of the International Association for the Study of Lung Cancer Staging Initiative, Small Cell Lung Cancer Subcommittee","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; TNM staging system; Lung cancer; Stage (stratigraphy); Oncology; Internal medicine; Lung cancer staging; Pleural effusion; Cancer; Radiology; Neoplasm staging; Mediastinoscopy","score_opus":0.07672109753829616,"score_gpt":0.5107732582045514,"score_spread":0.4340521606662553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003901423","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21898727,0.016111823,0.021545295,0.07620983,0.023595491,0.027890233,0.47135994,0.0015206536,0.14277956],"genre_scores_gemma":[0.25390863,0.008665742,0.0380575,0.02308096,0.009799253,0.018178837,0.5783598,0.0008508101,0.06909844],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99150205,0.0024448186,0.0020740519,0.00039685253,0.0028590336,0.0007230717],"domain_scores_gemma":[0.960357,0.006224727,0.004174971,0.00188205,0.01998701,0.0073742885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026317853,0.0014371243,0.0015505324,0.0032893098,0.0014185106,0.0018750874,0.0052983505,0.0037854612,0.004499392],"category_scores_gemma":[0.02055063,0.00083726825,0.001368873,0.0055038137,0.0009320128,0.0011176516,0.00285176,0.0024974714,0.0043814043],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013436266,0.0016182142,0.40797004,0.0011601911,0.00024459447,0.00037587612,0.0004243513,0.0019234662,0.0028214152,0.0007809468,0.53237444,0.04896281],"study_design_scores_gemma":[0.0005257686,0.00055148755,0.8535237,0.00038843355,0.00020702966,0.0003913132,0.00051069655,0.0016719565,0.002313047,0.00028125788,0.13957578,0.000059616064],"about_ca_topic_score_codex":0.05539182,"about_ca_topic_score_gemma":0.09425208,"teacher_disagreement_score":0.05539182,"about_ca_system_score_codex":0.0031360863,"about_ca_system_score_gemma":0.011455917,"threshold_uncertainty_score":0.13918376},"labels":[],"label_agreement":null},{"id":"W2004731110","doi":"10.1053/sonc.2003.50016","title":"Surgical treatment of small cell lung cancer","year":2003,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Chemoradiotherapy; Radiation therapy; Lung cancer; Chemotherapy; Surgery; Clinical trial; Oncology; Internal medicine","score_opus":0.07881713051370332,"score_gpt":0.48020935050552593,"score_spread":0.4013922199918226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004731110","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000063490894,0.999546,0.000018398148,0.00005740018,0.00006246462,0.0000018971537,0.000004307962,0.0000011614787,0.00024492343],"genre_scores_gemma":[0.00063316367,0.9989561,0.00004897861,0.00012552174,0.00007727376,0.0000024188257,0.000009738028,3.934232e-7,0.00014643397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974006,0.000067546694,0.00005137256,0.000048960144,0.00007327211,0.000018753983],"domain_scores_gemma":[0.99946874,0.00034989268,0.00009045528,0.000011896832,0.000056996138,0.000022056438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007461836,0.00072317367,0.001871988,0.0020686975,0.00025517886,0.0007423872,0.0007851589,0.00079404534,0.0029247012],"category_scores_gemma":[0.0012177593,0.0002548494,0.0008690374,0.002348309,0.0005666669,0.00076576613,0.00038769728,0.0010057014,0.00076514576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017515944,0.000071082366,0.0003696114,0.052739177,0.00036074925,0.0002760911,0.000044122073,0.00029054133,0.00076554524,0.0009865022,0.017725896,0.92619556],"study_design_scores_gemma":[0.0002465842,0.0005818578,0.0060535404,0.03223165,0.001952542,0.0043399716,0.00030270504,0.00013490056,0.00081004086,0.0015676441,0.95173204,0.000046513585],"about_ca_topic_score_codex":0.002157348,"about_ca_topic_score_gemma":0.006452121,"teacher_disagreement_score":0.0029247012,"about_ca_system_score_codex":0.0006220473,"about_ca_system_score_gemma":0.001016077,"threshold_uncertainty_score":0.009784102},"labels":[],"label_agreement":null},{"id":"W2005412601","doi":"10.1016/s0360-3016(01)01448-1","title":"Practice guideline on prophylactic cranial irradiation in small-cell lung cancer","year":2001,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Cancer Care Ontario; Ottawa Regional Cancer Foundation; Lakehead University","funders":"","keywords":"Prophylactic cranial irradiation; Medicine; Guideline; Conventional PCI; Radiation therapy; Regimen; Oncology; Randomized controlled trial; Quality of life (healthcare); Chemoradiotherapy; Lung cancer; Internal medicine; Adverse effect; Clinical trial; Surgery; Pathology","score_opus":0.03023396410218973,"score_gpt":0.41367273148740846,"score_spread":0.38343876738521876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005412601","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021979757,0.07480058,0.07235748,0.6051168,0.033606935,0.003983838,0.005670008,0.0024223973,0.18006223],"genre_scores_gemma":[0.1737047,0.073089726,0.24168578,0.38026398,0.021699179,0.011564284,0.009408392,0.0006682218,0.087915815],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945911,0.0016037057,0.0014798706,0.00030112398,0.001647191,0.00037692045],"domain_scores_gemma":[0.9834013,0.0061118,0.0015459479,0.00050184294,0.0069737174,0.0014654555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005724867,0.0007961297,0.0017477293,0.0016761586,0.0016519773,0.00082127744,0.0028745912,0.010616083,0.0057441243],"category_scores_gemma":[0.013880961,0.00047150438,0.0014789968,0.001655888,0.0011295899,0.00080979447,0.0011108186,0.007535899,0.0038798796],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021982919,0.00040533853,0.005589128,0.001743894,0.0001248424,0.00155209,0.00043228024,0.0020984812,0.002505803,0.0030463047,0.8014251,0.1808569],"study_design_scores_gemma":[0.00042202638,0.00048280976,0.027935965,0.006234128,0.00043613694,0.004984544,0.0006116526,0.0025931562,0.0019988057,0.0069120633,0.9472717,0.00011703836],"about_ca_topic_score_codex":0.014742868,"about_ca_topic_score_gemma":0.037238173,"teacher_disagreement_score":0.014742868,"about_ca_system_score_codex":0.0025250353,"about_ca_system_score_gemma":0.0061494703,"threshold_uncertainty_score":0.030276299},"labels":[],"label_agreement":null},{"id":"W2006230590","doi":"10.1093/jnci/djg013","title":"An Advance in Small-Cell Lung Cancer Treatment--More or Less","year":2003,"lang":"en","type":"review","venue":"JNCI Journal of the National Cancer Institute","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Topotecan; Irinotecan; Carboplatin; Etoposide; Regimen; Internal medicine; Oncology; Chemotherapy; Anthracycline; Disease; Radiation therapy; Lung cancer; Cancer; Surgery; Cisplatin; Colorectal cancer; Breast cancer","score_opus":0.20230522890686956,"score_gpt":0.5144856095733713,"score_spread":0.3121803806665018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006230590","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038064392,0.62497383,0.005223539,0.3006862,0.034843363,0.000075791206,0.0005779351,0.00034521686,0.029467698],"genre_scores_gemma":[0.054313928,0.675224,0.011564963,0.15840156,0.06866643,0.00008903576,0.0013333361,0.00017798044,0.030228827],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987134,0.00032095503,0.00014598029,0.0002488889,0.00043330295,0.00013759667],"domain_scores_gemma":[0.99555004,0.0012676747,0.00030291395,0.000282093,0.0010912667,0.001506035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032840364,0.0006662469,0.0006864232,0.00066137116,0.00064320606,0.0024376437,0.0012622788,0.0031671063,0.018445423],"category_scores_gemma":[0.004365823,0.00017230422,0.0007524137,0.0006603181,0.001089059,0.003799098,0.0014844192,0.007686883,0.0072497483],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036165744,0.0003918068,0.0016342328,0.0033112925,0.00008171186,0.00033966993,0.00013905582,0.00032880346,0.0022280102,0.022857182,0.28341234,0.6849143],"study_design_scores_gemma":[0.00007046,0.00037305453,0.0014951519,0.0009437632,0.00005051648,0.00076300424,0.00011209271,0.00020066848,0.00046905363,0.00575475,0.98974997,0.000017558312],"about_ca_topic_score_codex":0.001135774,"about_ca_topic_score_gemma":0.0029867552,"teacher_disagreement_score":0.018445423,"about_ca_system_score_codex":0.0013334309,"about_ca_system_score_gemma":0.002215641,"threshold_uncertainty_score":0.061706126},"labels":[],"label_agreement":null},{"id":"W2011868684","doi":"10.1016/j.ijrobp.2004.01.055","title":"Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer","year":2004,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Etoposide; Radiation therapy; Randomization; Internal medicine; Esophagitis; Prophylactic cranial irradiation; Lung cancer; Cisplatin; Gastroenterology; Randomized controlled trial; Chemotherapy; Surgery; Urology; Conventional PCI","score_opus":0.04023676340957497,"score_gpt":0.40169895818336204,"score_spread":0.36146219477378705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011868684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98964465,0.0045477496,0.0005909975,0.00079992047,0.0004943043,0.0014332645,0.00092641334,0.000099184406,0.0014635359],"genre_scores_gemma":[0.9849486,0.002500618,0.0018495297,0.0014510667,0.0004569473,0.0025483172,0.0022587648,0.000080252335,0.0039058207],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99882704,0.0005973743,0.00007074602,0.00022512687,0.000076756296,0.00020295563],"domain_scores_gemma":[0.99651706,0.0010000828,0.0005152455,0.00044157775,0.00018396592,0.001342075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038384045,0.0019203356,0.005356651,0.0005491483,0.000964159,0.0013830509,0.0017676885,0.0030460707,0.0053943214],"category_scores_gemma":[0.0029886516,0.0006991646,0.0031912918,0.00068698084,0.0018574664,0.0018167641,0.00058529974,0.006071039,0.0013051734],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9407679,0.022343526,0.0010145085,0.000356655,0.0013791282,0.000032082025,0.0001211717,0.0008712582,0.006302024,0.00008987455,0.0008616762,0.025860205],"study_design_scores_gemma":[0.66936296,0.32326567,0.0044197105,0.000034161116,0.0007015755,0.000052916024,0.000048111804,0.0003279967,0.00090127357,0.00015181884,0.0007102704,0.000023506256],"about_ca_topic_score_codex":0.0015188805,"about_ca_topic_score_gemma":0.0022698508,"teacher_disagreement_score":0.0053943214,"about_ca_system_score_codex":0.0011879383,"about_ca_system_score_gemma":0.0015257748,"threshold_uncertainty_score":0.020299673},"labels":[],"label_agreement":null},{"id":"W2011961706","doi":"10.1016/j.path.2013.10.005","title":"Ancillary Studies, Including Immunohistochemistry and Molecular Studies, in Lung Cytology","year":2013,"lang":"en","type":"review","venue":"Surgical pathology clinics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cytology; Lung cancer; Pathology; Lung; Molecular diagnostics; Immunocytochemistry; Immunohistochemistry; Internal medicine; Bioinformatics","score_opus":0.2108921984330582,"score_gpt":0.5501329081952359,"score_spread":0.3392407097621777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011961706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007165461,0.99940574,0.00009252894,0.00010936909,0.000048073158,0.0000034198463,0.000011796169,0.0000024954907,0.00025491964],"genre_scores_gemma":[0.0008172229,0.9985097,0.00029914678,0.00015002672,0.00009601052,0.000003993417,0.000021566437,0.0000010735793,0.00010125221],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99885714,0.0002984935,0.00024571657,0.00020197121,0.00034422905,0.000052361946],"domain_scores_gemma":[0.9954845,0.0033587874,0.00040558528,0.00010216761,0.0005603176,0.000088601526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027652476,0.0011794481,0.002455664,0.006189757,0.00032950466,0.0015082353,0.0018218317,0.0013868515,0.0022338564],"category_scores_gemma":[0.0044829547,0.00053326064,0.00096265686,0.0053500114,0.0013424354,0.0022202537,0.0010728018,0.0013950432,0.001047994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071689654,0.000039402075,0.0014835146,0.04894797,0.00017647726,0.0006869227,0.00008513179,0.00021526052,0.0015836618,0.0016841962,0.011317138,0.9337086],"study_design_scores_gemma":[0.000037814367,0.00014486497,0.008209762,0.06130024,0.0014966923,0.012294386,0.0005346096,0.00023416069,0.0023275372,0.003446502,0.909881,0.00009229832],"about_ca_topic_score_codex":0.0022213398,"about_ca_topic_score_gemma":0.005497298,"teacher_disagreement_score":0.006189757,"about_ca_system_score_codex":0.0009055996,"about_ca_system_score_gemma":0.001911269,"threshold_uncertainty_score":0.014624238},"labels":[],"label_agreement":null},{"id":"W2012290550","doi":"10.1016/s0169-5002(00)80349-9","title":"Concurrent chemo- (cisplatin and etoposide) radiation for stage III non-small cell lung cancer: Lack of correlation of p53 expression to treatment response","year":2000,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Etoposide; Oncology; Cisplatin; Lung cancer; Internal medicine; Stage (stratigraphy); Radiation therapy; Correlation; Cancer research; Chemotherapy; Biology","score_opus":0.028126937392692876,"score_gpt":0.391023161995535,"score_spread":0.3628962246028421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012290550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978212,0.0009688813,0.00010078909,0.000057753747,0.000008750183,0.000017146755,0.00006011284,0.000003867551,0.0009612928],"genre_scores_gemma":[0.99966586,0.000108288245,0.000033944314,0.000016885808,0.00000804319,0.0000048224792,0.000046562203,0.0000010817057,0.000114578244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991942,0.0003947267,0.000093852344,0.00008763782,0.00016403657,0.00006554518],"domain_scores_gemma":[0.9943487,0.0036949955,0.00060942606,0.00047259938,0.00044261446,0.00043167511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017258173,0.00012453135,0.00038785083,0.00040402522,0.00020747143,0.00041375015,0.00027792124,0.00033530986,0.001639998],"category_scores_gemma":[0.004951948,0.00013153379,0.0003432969,0.0004731829,0.00037138828,0.00030449947,0.00019594727,0.00048780453,0.00021072426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029107535,0.0009152425,0.8457627,0.00017803007,0.0005299827,0.00046193038,0.00047089224,0.0005215191,0.07307673,0.00018338239,0.0003053202,0.048486773],"study_design_scores_gemma":[0.00022777022,0.007015596,0.98261815,0.000016428477,0.00028385065,0.0008032742,0.00014991825,0.0004478601,0.007535625,0.00006790731,0.00082805514,0.0000056066824],"about_ca_topic_score_codex":0.0017504118,"about_ca_topic_score_gemma":0.0025303988,"teacher_disagreement_score":0.0017504118,"about_ca_system_score_codex":0.00042427387,"about_ca_system_score_gemma":0.00052237464,"threshold_uncertainty_score":0.00912714},"labels":[],"label_agreement":null},{"id":"W2012372031","doi":"10.3892/ijo.23.6.1607","title":"Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia","year":2003,"lang":"en","type":"article","venue":"International Journal of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Dysplasia; Medicine; Retinol; Internal medicine; Gastroenterology; Lung cancer; Bronchopulmonary dysplasia; Pathology; Cancer; Vitamin; Biology","score_opus":0.03372050695342879,"score_gpt":0.40900700009038976,"score_spread":0.37528649313696094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012372031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697757,0.001700863,0.00030196627,0.00013760138,0.00007189318,0.00036817364,0.000077995704,0.000011619304,0.00035232265],"genre_scores_gemma":[0.99683726,0.0005380875,0.00054623047,0.00022400895,0.00009651472,0.0010001848,0.00020105806,0.0000037138675,0.00055292685],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9976052,0.0016895769,0.0001785961,0.00019281932,0.00017881136,0.00015492995],"domain_scores_gemma":[0.99842525,0.00050685304,0.00036825283,0.00017335993,0.00013757846,0.00038872188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004964532,0.0005705539,0.0022250747,0.00021899893,0.00031570406,0.0006844642,0.0003036243,0.0014087886,0.0012128373],"category_scores_gemma":[0.0031192685,0.00043131027,0.0012373751,0.00024760986,0.00048843294,0.0004937537,0.0003887943,0.0012780823,0.0002653737],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97343653,0.0034585383,0.0075052083,0.00013309231,0.00052654714,0.000024830782,0.000042898544,0.00015957163,0.005596573,0.00003418918,0.00009287638,0.008989054],"study_design_scores_gemma":[0.33382198,0.57632786,0.08033792,0.00006796631,0.002144158,0.00010779898,0.00006785214,0.0018051883,0.003696144,0.00029985682,0.0012871482,0.00003619743],"about_ca_topic_score_codex":0.00021974796,"about_ca_topic_score_gemma":0.00040051638,"teacher_disagreement_score":0.004964532,"about_ca_system_score_codex":0.0002708172,"about_ca_system_score_gemma":0.0005426733,"threshold_uncertainty_score":0.02625525},"labels":[],"label_agreement":null},{"id":"W2015102817","doi":"10.3816/clc.2009.n.044","title":"Cooperative Group Research Endeavors in Small-Cell Lung Cancer: Current and Future Directions","year":2009,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Lung cancer; Etoposide; Clinical trial; Oncology; Radiation therapy; Internal medicine; Clinical Oncology; Chemotherapy; Intensive care medicine; Cancer; Family medicine","score_opus":0.09840935802406386,"score_gpt":0.519429932824909,"score_spread":0.42102057480084515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015102817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09300454,0.43948287,0.008307223,0.40317214,0.008718402,0.001902956,0.0007240096,0.0001972313,0.044490606],"genre_scores_gemma":[0.56770885,0.2810766,0.03727694,0.07320179,0.020007681,0.008994741,0.0023309765,0.000094368814,0.0093080215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9362246,0.053614516,0.0019029551,0.002047645,0.0031281332,0.0030821334],"domain_scores_gemma":[0.70686257,0.20093094,0.011693469,0.011823784,0.02137012,0.047319163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15699571,0.0007587272,0.0019878678,0.0028241486,0.007368357,0.0070690047,0.006857332,0.007530373,0.015772905],"category_scores_gemma":[0.0761066,0.0005362025,0.0021067685,0.008578901,0.01079855,0.0113908835,0.0075841676,0.0050357315,0.0015320801],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076832264,0.01036887,0.11706559,0.008599764,0.0008966634,0.0005851362,0.011964963,0.0013376756,0.0009828879,0.109258175,0.07926145,0.65199554],"study_design_scores_gemma":[0.0154679855,0.023596479,0.12912196,0.019765314,0.0013468342,0.0018781697,0.10269008,0.0023422667,0.0013399274,0.18495618,0.5170848,0.000410061],"about_ca_topic_score_codex":0.013612804,"about_ca_topic_score_gemma":0.0175853,"teacher_disagreement_score":0.15699571,"about_ca_system_score_codex":0.0055571906,"about_ca_system_score_gemma":0.04184656,"threshold_uncertainty_score":0.8302826},"labels":[],"label_agreement":null},{"id":"W2015179401","doi":"10.1158/1055-9965.epi-06-0923","title":"The Association between the Anti-inflammatory Protein CC10 and Smoking Status among Participants in a Chemoprevention Trial","year":2007,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Bronchoalveolar lavage; Internal medicine; Gastroenterology; Lung cancer; Cigarette smoking; Smoking cessation; Lung; Pathology","score_opus":0.07211029146092054,"score_gpt":0.42442204531863315,"score_spread":0.35231175385771263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015179401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965432,0.0022183831,0.00010074537,0.00017347347,0.000059737096,0.00004982456,0.0002868636,0.0000059202303,0.0005618451],"genre_scores_gemma":[0.9984646,0.0005162583,0.00008716447,0.00013879276,0.000060451384,0.000072605064,0.0003378712,0.0000035838316,0.00031864227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986235,0.0006206613,0.00015388355,0.00024201175,0.00018377585,0.0001761244],"domain_scores_gemma":[0.99680257,0.0012333618,0.000819599,0.00022858327,0.00027945882,0.00063643465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026528614,0.0003125172,0.0008972385,0.00029030722,0.00044151713,0.00096963876,0.0003934953,0.001108094,0.0013288365],"category_scores_gemma":[0.0058463896,0.0002643525,0.0008764936,0.00070947566,0.0002927587,0.00053627667,0.00034211678,0.0011998358,0.00015059742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06648503,0.0007259382,0.9138603,0.00037701064,0.004009994,0.00014814328,0.00014801577,0.00018077907,0.0023414663,0.0000915659,0.0008065253,0.010825214],"study_design_scores_gemma":[0.0025426082,0.0044333553,0.98741907,0.00006874604,0.0033878204,0.00015453572,0.00009457603,0.00065341155,0.00035631473,0.00013231483,0.00073847733,0.000018731977],"about_ca_topic_score_codex":0.0017384083,"about_ca_topic_score_gemma":0.002129592,"teacher_disagreement_score":0.0026528614,"about_ca_system_score_codex":0.00023014897,"about_ca_system_score_gemma":0.0003703091,"threshold_uncertainty_score":0.0140298605},"labels":[],"label_agreement":null},{"id":"W2018754160","doi":"10.1097/jto.0b013e3181b27799","title":"The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":492,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"University of Texas MD Anderson Cancer Center; Barbara Ann Karmanos Cancer Institute; Wayne State University; Institut Gustave-Roussy; International Association for the Study of Lung Cancer; Eli Lilly and Company","keywords":"Medicine; Lung cancer staging; Lung cancer; Stage (stratigraphy); TNM staging system; Oncology; Internal medicine; Population; Malignancy; Cancer; Survival analysis; Radiology; Neoplasm staging; Mediastinoscopy","score_opus":0.04987874132873191,"score_gpt":0.4713034335580689,"score_spread":0.421424692229337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018754160","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035538588,0.022807568,0.039528616,0.7457568,0.078801155,0.007543352,0.017810684,0.0008192636,0.051394004],"genre_scores_gemma":[0.123953305,0.017326076,0.3870693,0.31473556,0.037940986,0.014964964,0.061533604,0.0010005813,0.04147569],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.95605844,0.0148667535,0.008408996,0.0014486257,0.016213745,0.0030034462],"domain_scores_gemma":[0.8327969,0.044514205,0.009066611,0.0071653263,0.09006086,0.016396223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15545379,0.001249535,0.0022051833,0.0049268804,0.0035438132,0.006647757,0.013399454,0.014837608,0.0024085783],"category_scores_gemma":[0.13123235,0.0014052485,0.0034411834,0.007161435,0.00642293,0.0038042665,0.0060421247,0.016349137,0.001798001],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000898203,0.0007477822,0.05935284,0.0012224183,0.00019802261,0.00034213183,0.0019641893,0.0028931675,0.0028855952,0.043552928,0.7420547,0.1438881],"study_design_scores_gemma":[0.0008618397,0.0012083965,0.18475355,0.0040507168,0.0007388055,0.0006313387,0.0031957775,0.004829854,0.0042118616,0.021866884,0.77307415,0.0005769329],"about_ca_topic_score_codex":0.07305665,"about_ca_topic_score_gemma":0.1028834,"teacher_disagreement_score":0.15545379,"about_ca_system_score_codex":0.009662429,"about_ca_system_score_gemma":0.07017073,"threshold_uncertainty_score":0.82212806},"labels":[],"label_agreement":null},{"id":"W2020966893","doi":"10.1371/journal.pone.0071670","title":"Genomic Deregulation of the E2F/Rb Pathway Leads to Activation of the Oncogene EZH2 in Small Cell Lung Cancer","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"EZH2; Cancer research; PRC2; Oncogene; Biology; Gene knockdown; E2F; DNA methylation; Carcinogenesis; Methylation; Cell cycle; Cancer; Cell culture; Gene; Genetics; Gene expression","score_opus":0.04963951948847328,"score_gpt":0.2844435283209572,"score_spread":0.23480400883248392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020966893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935727,0.0022546914,0.0023932953,0.00012972218,0.000020950518,0.000015462092,0.00039813214,0.00011463903,0.0011003211],"genre_scores_gemma":[0.99810624,0.00047725337,0.00032879802,0.00002223803,0.0000025047814,0.000007677873,0.00023703332,0.0000078814155,0.0008102393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990726,0.000014559575,0.000008902975,0.000019624624,0.000028354592,0.000021216283],"domain_scores_gemma":[0.9999409,0.000016098458,0.000015742537,0.0000089680225,0.00000462333,0.000013650002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102499536,0.00018859505,0.00019268737,0.00026832084,0.00010071602,0.00022785204,0.0001139659,0.00021567759,0.0018253512],"category_scores_gemma":[0.00014768475,0.00010102979,0.00017902644,0.00017963449,0.00017690868,0.0001204618,0.00015445746,0.00029544625,0.0003345346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095252064,0.000013891547,0.00062045926,0.000025269654,0.0000084416215,0.00011171281,0.0000063266566,0.00009344848,0.997218,0.000100065976,0.000048864116,0.0016582696],"study_design_scores_gemma":[0.000021057174,0.00021480388,0.023449743,0.0000035150626,0.000035539255,0.0011047432,0.00003931009,0.0013515824,0.97062206,0.00013600262,0.0030170707,0.0000046369323],"about_ca_topic_score_codex":0.0005064399,"about_ca_topic_score_gemma":0.00096287514,"teacher_disagreement_score":0.0018253512,"about_ca_system_score_codex":0.00023393902,"about_ca_system_score_gemma":0.00016489255,"threshold_uncertainty_score":0.0061064363},"labels":[],"label_agreement":null},{"id":"W2026867617","doi":"10.1016/j.ijrobp.2005.12.013","title":"Phase I study of hypofractionated dose-escalated thoracic radiotherapy for limited-stage small-cell lung cancer","year":2006,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Interior Health; Alberta Cancer Foundation","funders":"","keywords":"Medicine; Radiation therapy; Chemotherapy; Esophagitis; Lung cancer; Prophylactic cranial irradiation; Etoposide; Stage (stratigraphy); Acute toxicity; Induction chemotherapy; Toxicity; Surgery; Radiology; Oncology; Internal medicine; Conventional PCI; Disease","score_opus":0.03901653506255092,"score_gpt":0.4343916082421459,"score_spread":0.39537507317959497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026867617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992867,0.0010371754,0.00072793325,0.00034703783,0.0001886964,0.0026756437,0.0009154768,0.00010479165,0.0011362407],"genre_scores_gemma":[0.9834468,0.0019353303,0.0025704426,0.0007880067,0.00017429805,0.0040973676,0.0025216383,0.00008053593,0.004385655],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99940944,0.00022006083,0.000024332357,0.0001430856,0.00005123845,0.00015193502],"domain_scores_gemma":[0.9991823,0.000091321046,0.00011766664,0.00014011771,0.0000497477,0.00041878445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016907268,0.0021537738,0.003513354,0.00080477196,0.0008194779,0.001408043,0.0022568603,0.0017872619,0.004601139],"category_scores_gemma":[0.0008514816,0.0010301174,0.0020380663,0.00080916315,0.0019304842,0.0010253999,0.00059599726,0.0046518324,0.0012683608],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6475384,0.19274995,0.0038235618,0.0009204161,0.0018457182,0.00019659684,0.0007529908,0.008270566,0.07907785,0.00042852663,0.0037813557,0.06061399],"study_design_scores_gemma":[0.37216556,0.6117078,0.006498654,0.000027369237,0.0005431638,0.00013126926,0.00012707424,0.001467584,0.005198514,0.0002320989,0.0018642133,0.000036719877],"about_ca_topic_score_codex":0.0035189162,"about_ca_topic_score_gemma":0.0058092065,"teacher_disagreement_score":0.004601139,"about_ca_system_score_codex":0.0014037591,"about_ca_system_score_gemma":0.002778893,"threshold_uncertainty_score":0.015392363},"labels":[],"label_agreement":null},{"id":"W2029712223","doi":"10.1038/bjc.2012.21","title":"A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Medical Association","funders":"National Cancer Institute; Moffitt Cancer Center","keywords":"Carboplatin; Medicine; Etoposide; Adverse effect; Clinical endpoint; Internal medicine; Chemotherapy; Anesthesia; Clinical trial; Cisplatin","score_opus":0.02277835739252881,"score_gpt":0.3474266205460649,"score_spread":0.32464826315353607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029712223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963898,0.00093531696,0.00020544992,0.0001800064,0.00005409254,0.0012243646,0.00025600594,0.000038041544,0.0007169355],"genre_scores_gemma":[0.99355066,0.0011684294,0.0009282873,0.00047189096,0.00010887568,0.0016325468,0.0009202415,0.000015292404,0.0012038776],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997907,0.000091013215,0.0000126236055,0.000039887655,0.000016289812,0.000049446324],"domain_scores_gemma":[0.9992409,0.00011490336,0.0001481824,0.00004262581,0.000033117674,0.00042034793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010370906,0.0013490706,0.0017231405,0.0003047443,0.00042213954,0.0007557127,0.0008832167,0.0010555685,0.0028462235],"category_scores_gemma":[0.0006420852,0.0004217431,0.0008828313,0.0003809687,0.0010415412,0.00065827725,0.00031621312,0.0029187915,0.0005693796],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83513814,0.058432586,0.005506434,0.00068272476,0.0008304688,0.00025571263,0.00026880615,0.0023905642,0.03671749,0.00017871242,0.0021148445,0.057483405],"study_design_scores_gemma":[0.5412202,0.4461374,0.007096237,0.000027743281,0.00027989273,0.00022017043,0.000049743026,0.0009497427,0.002804885,0.00013145448,0.001063605,0.000018930048],"about_ca_topic_score_codex":0.00081861275,"about_ca_topic_score_gemma":0.0021726938,"teacher_disagreement_score":0.0028462235,"about_ca_system_score_codex":0.0007657891,"about_ca_system_score_gemma":0.0016781898,"threshold_uncertainty_score":0.009521544},"labels":[],"label_agreement":null},{"id":"W2030500811","doi":"10.1097/jto.0b013e318160c0cb","title":"Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer","year":2008,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Oncology; Lung cancer; Multivariate analysis; Disease; Cancer","score_opus":0.02656031899069337,"score_gpt":0.41168510553714527,"score_spread":0.3851247865464519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030500811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974491,0.001060122,0.00003282434,0.00015988057,0.000018102292,0.00000907234,0.00030995844,0.0000028101608,0.0009581072],"genre_scores_gemma":[0.9988385,0.00022419209,0.0000136958415,0.00007016307,0.000026619218,0.000005653512,0.0006227039,0.0000014941222,0.0001969687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971396,0.000080438804,0.000029764971,0.000046512203,0.00004958617,0.00007972762],"domain_scores_gemma":[0.9987423,0.0002404063,0.000533152,0.000057194917,0.0000975023,0.00032949517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039933337,0.00020364337,0.00051074184,0.00033902712,0.00031443796,0.00070824986,0.00030825692,0.0005339946,0.0014418584],"category_scores_gemma":[0.0020959955,0.00009716154,0.00096344494,0.000512149,0.00022268308,0.0005504484,0.00045932693,0.00060786004,0.00013948198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036272896,0.00022543583,0.9874973,0.000038480157,0.00027628776,0.00043168294,0.00009535318,0.00039638847,0.00035363666,0.00006543205,0.000512966,0.006479742],"study_design_scores_gemma":[0.00012360017,0.00093451614,0.9973556,0.000013065449,0.00016821538,0.0005056133,0.00016365825,0.00030426512,0.00008614385,0.000055257497,0.00028248067,0.0000076063707],"about_ca_topic_score_codex":0.004526388,"about_ca_topic_score_gemma":0.0070755337,"teacher_disagreement_score":0.004526388,"about_ca_system_score_codex":0.0010263689,"about_ca_system_score_gemma":0.0004461788,"threshold_uncertainty_score":0.009000063},"labels":[],"label_agreement":null},{"id":"W2032700254","doi":"","title":"Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Internal medicine; Oncology; Proliferating cell nuclear antigen; Exact test; Logistic regression; Chemotherapy; Gastroenterology; Immunohistochemistry","score_opus":0.026496780706113693,"score_gpt":0.2775490660371601,"score_spread":0.2510522853310464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032700254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99958414,0.0001851876,0.000032905617,0.00001303695,0.0000019428935,0.000002256439,0.000051591065,0.0000017685,0.00012727793],"genre_scores_gemma":[0.9997813,0.00004600684,0.000021675194,0.000005223721,0.000005371406,0.0000028038723,0.00008884786,4.3003368e-7,0.000048331225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988306,0.000025479474,0.000014279842,0.00002623123,0.000021901864,0.000028956129],"domain_scores_gemma":[0.9991941,0.00020688679,0.0003244562,0.000029301762,0.000073876814,0.00017139156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021258471,0.0002104815,0.00022779839,0.0004860256,0.00028573905,0.00025815898,0.00013210306,0.00032496182,0.0010348177],"category_scores_gemma":[0.0012056177,0.00011886275,0.00016930111,0.00046206723,0.00029298375,0.0002251865,0.00019752448,0.00029437558,0.0001791323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017448439,0.000012067745,0.9980848,0.000005235083,0.000014139659,0.00019371785,0.000030337556,0.00002570054,0.000626575,0.0000029139514,0.000025548514,0.0008044006],"study_design_scores_gemma":[0.000008732778,0.00025928402,0.99755496,0.0000023898826,0.000023118659,0.0016354983,0.000072734816,0.000115360155,0.00019522366,0.000011169297,0.00011913519,0.0000022938912],"about_ca_topic_score_codex":0.00084593956,"about_ca_topic_score_gemma":0.0010168779,"teacher_disagreement_score":0.0010348177,"about_ca_system_score_codex":0.00017471434,"about_ca_system_score_gemma":0.00013113454,"threshold_uncertainty_score":0.0034618378},"labels":[],"label_agreement":null},{"id":"W2033893059","doi":"10.1053/j.seminoncol.2003.12.021","title":"Targeted molecules in small cell lung cancer","year":2004,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lung cancer; Imatinib mesylate; Cancer research; Tyrosine kinase; Targeted therapy; Cancer; Immunoconjugate; Clinical trial; Imatinib; Immunology; Oncology; Antibody; Pathology; Internal medicine; Receptor; Monoclonal antibody","score_opus":0.04207325589161267,"score_gpt":0.44114568123938175,"score_spread":0.3990724253477691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033893059","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000632056,0.99895465,0.00008158549,0.00017235661,0.00024799502,0.000005433146,0.0000095686355,0.0000058400815,0.00045932646],"genre_scores_gemma":[0.0004960464,0.99829334,0.000114650196,0.00023994833,0.00016696849,0.000008425641,0.000014777874,9.066152e-7,0.0006648582],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982315,0.00003735474,0.000028413164,0.00003020916,0.000058824167,0.00002209692],"domain_scores_gemma":[0.99967206,0.00017733495,0.000050461807,0.000012081175,0.000061002625,0.000027117834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009308946,0.0011877583,0.0024969287,0.0027774968,0.00031381028,0.0012677907,0.00092676264,0.001490253,0.004041429],"category_scores_gemma":[0.00082410075,0.0004067198,0.00062800094,0.0030055442,0.0006886727,0.0017940585,0.0006785855,0.0018829494,0.0022630673],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020214441,0.00011037795,0.00012634177,0.019845232,0.00015655825,0.00028374922,0.00004604055,0.0004130218,0.0030623297,0.0025376142,0.049942795,0.9232738],"study_design_scores_gemma":[0.00009489592,0.000209135,0.0005580903,0.003076194,0.000317351,0.0011198847,0.000040782747,0.000076651435,0.000851044,0.00095885777,0.9926797,0.000017485176],"about_ca_topic_score_codex":0.001270049,"about_ca_topic_score_gemma":0.003341266,"teacher_disagreement_score":0.004041429,"about_ca_system_score_codex":0.0009850153,"about_ca_system_score_gemma":0.0012508776,"threshold_uncertainty_score":0.013519943},"labels":[],"label_agreement":null},{"id":"W2034304549","doi":"10.1097/jto.0b013e3182572ead","title":"Effect of Chemotherapy in Patients With Resected Small-Cell or Large-Cell Neuroendocrine Carcinoma","year":2012,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Chemotherapy; Perioperative; Surgery; Hazard ratio; Radiation therapy; Lung cancer; Small-cell carcinoma; Retrospective cohort study; Carcinoma; Internal medicine; Confidence interval","score_opus":0.0170289900780441,"score_gpt":0.3991541811091218,"score_spread":0.3821251910310777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034304549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552816,0.0031770775,0.000038773233,0.00017676243,0.000064867716,0.000030904645,0.00009526975,0.0000043945156,0.0008838034],"genre_scores_gemma":[0.99778533,0.0014241963,0.00005850391,0.00011482509,0.00008869138,0.000017319404,0.00018806949,0.0000031608129,0.00031986117],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9996606,0.00020129129,0.000026406895,0.00003491286,0.000018372413,0.000058321795],"domain_scores_gemma":[0.99899024,0.0005488549,0.00012755411,0.000060133123,0.000030024943,0.00024315646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053593813,0.0004396302,0.0011082682,0.0002837976,0.00034200933,0.0003387352,0.00027081356,0.00049538247,0.0015216301],"category_scores_gemma":[0.0021167607,0.00018480376,0.00093040697,0.0004194861,0.00046990212,0.0005399905,0.00023737464,0.00089256663,0.00012034997],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7066525,0.008236811,0.16336802,0.00087799877,0.0019470674,0.0011915944,0.00047292578,0.0039988756,0.018491141,0.00032738468,0.0011534188,0.09328226],"study_design_scores_gemma":[0.03934998,0.25153318,0.69524455,0.00014229183,0.0033911665,0.0008465652,0.0004214571,0.0015046293,0.0034935924,0.00029962393,0.003713551,0.000059402675],"about_ca_topic_score_codex":0.0024669159,"about_ca_topic_score_gemma":0.0063120583,"teacher_disagreement_score":0.0024669159,"about_ca_system_score_codex":0.0006036265,"about_ca_system_score_gemma":0.0005829303,"threshold_uncertainty_score":0.0050902963},"labels":[],"label_agreement":null},{"id":"W2035885090","doi":"10.1093/annonc/mdv104","title":"Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses","year":2015,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Chemoradiotherapy; Internal medicine; Placebo; Clinical endpoint; Oncology; Subgroup analysis; Biomarker; Lung cancer; Surrogate endpoint; Stage (stratigraphy); Phases of clinical research; Cancer; Gastroenterology; Clinical trial; Pathology; Confidence interval","score_opus":0.22608756890889636,"score_gpt":0.5120381683515557,"score_spread":0.2859505994426593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035885090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644452,0.020841848,0.0012483232,0.0006391348,0.00019789691,0.0005169369,0.008407864,0.000085571155,0.0036173344],"genre_scores_gemma":[0.9657718,0.010067285,0.002514395,0.0009627916,0.00026035553,0.00076295907,0.017881852,0.00006191882,0.0017166743],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99940526,0.00025631487,0.000039385206,0.00008479495,0.00012284594,0.00009134953],"domain_scores_gemma":[0.99838305,0.0005501298,0.00048174628,0.00017101433,0.00020200381,0.00021206007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003960985,0.0007895635,0.0019752814,0.00052802823,0.00027130303,0.0017155437,0.00058648665,0.0005451163,0.0011508387],"category_scores_gemma":[0.0023266189,0.00032250228,0.002127776,0.0010052746,0.0003488468,0.0014576585,0.0005523528,0.0015877814,0.00025207544],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2543181,0.0037130543,0.34430912,0.003074985,0.023207035,0.00028642034,0.0003689723,0.008528064,0.011918182,0.00097200734,0.019121662,0.33018246],"study_design_scores_gemma":[0.1003663,0.057147294,0.7714948,0.00084333343,0.031764705,0.0009842628,0.00059136725,0.0045208735,0.005144048,0.0024805309,0.02450018,0.00016240576],"about_ca_topic_score_codex":0.00087176723,"about_ca_topic_score_gemma":0.0038278224,"teacher_disagreement_score":0.003960985,"about_ca_system_score_codex":0.00057610084,"about_ca_system_score_gemma":0.0009082175,"threshold_uncertainty_score":0.020947933},"labels":[],"label_agreement":null},{"id":"W2035891246","doi":"10.1016/j.cllc.2013.11.003","title":"Third-Line Chemotherapy in Small-Cell Lung Cancer: An International Analysis","year":2013,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; University of British Columbia; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Chemotherapy; Regimen; Internal medicine; Lung cancer; Chemotherapy regimen; Oncology; Multivariate analysis; Surgery","score_opus":0.055800522048560286,"score_gpt":0.47713408424617715,"score_spread":0.42133356219761686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035891246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8388404,0.14385399,0.0007346178,0.0011055403,0.00010185924,0.000104182305,0.00355082,0.000009796309,0.011698824],"genre_scores_gemma":[0.96590817,0.030831832,0.00024942745,0.0003360803,0.000082295286,0.000057718044,0.0019090365,0.000014068501,0.0006113337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978841,0.0009585045,0.00029053996,0.00026030376,0.00034261376,0.0002640378],"domain_scores_gemma":[0.99296373,0.0022152506,0.0030062397,0.00049607235,0.0007687402,0.00054999307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00297897,0.0003820724,0.00086707785,0.0029456934,0.00034658948,0.0011508375,0.0004601028,0.00031104672,0.0030979132],"category_scores_gemma":[0.0052629337,0.0001589357,0.0024101795,0.008004607,0.00044658943,0.0006802091,0.00093222153,0.00079360994,0.00019789944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008893481,0.00026292077,0.9027085,0.0016937052,0.0076759076,0.00022496139,0.0006144815,0.0004919836,0.0009798305,0.0016348758,0.002091775,0.07272761],"study_design_scores_gemma":[0.00032186718,0.0006521746,0.98183435,0.00094169774,0.006752609,0.00035375016,0.0013002364,0.00013034258,0.00039172388,0.00021063781,0.007089592,0.00002096767],"about_ca_topic_score_codex":0.008282663,"about_ca_topic_score_gemma":0.011512745,"teacher_disagreement_score":0.008282663,"about_ca_system_score_codex":0.0010236913,"about_ca_system_score_gemma":0.0014162422,"threshold_uncertainty_score":0.016468883},"labels":[],"label_agreement":null},{"id":"W2036318642","doi":"10.1016/j.ijrobp.2014.05.1783","title":"Is Prophylactic Cranial Irradiation (PCI) With Hippocampal Avoidance (HA) Justified in Limited-Stage Small Cell Lung Cancer (LS-SCLC)?","year":2014,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Medicine; Conventional PCI; Prophylactic cranial irradiation; Neurocognitive; Oncology; Internal medicine; Lung cancer; Radiation therapy; Cognition","score_opus":0.027017089394324977,"score_gpt":0.3565873919246701,"score_spread":0.32957030253034514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036318642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80579895,0.14903997,0.0013344276,0.027501246,0.0019067727,0.00010295045,0.0006693941,0.00003845173,0.013607871],"genre_scores_gemma":[0.96273273,0.030535553,0.0010289116,0.003050277,0.0018363274,0.000036234647,0.00037208703,0.000008712719,0.00039916867],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998192,0.000048714835,0.000024694727,0.000035661003,0.000029708604,0.000042087388],"domain_scores_gemma":[0.9992059,0.0002630654,0.00023309125,0.00004408742,0.00007554213,0.00017839781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037478222,0.0001958903,0.0004923137,0.00018305039,0.00031638442,0.00048384815,0.0004948808,0.0007907629,0.002507824],"category_scores_gemma":[0.002912217,0.000079510515,0.0004630582,0.00046448637,0.0006563922,0.0006667442,0.00021136376,0.0008854513,0.0002661199],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02986922,0.0012611004,0.24143127,0.003205111,0.0009626469,0.0014849661,0.00021957023,0.0025450015,0.007470882,0.0053812875,0.014209351,0.6919596],"study_design_scores_gemma":[0.0045032683,0.024386184,0.81979626,0.0059038918,0.0072379396,0.009376139,0.0035494447,0.0031487285,0.0058229878,0.02453258,0.091540925,0.00020155263],"about_ca_topic_score_codex":0.00351287,"about_ca_topic_score_gemma":0.009818209,"teacher_disagreement_score":0.00351287,"about_ca_system_score_codex":0.0005639091,"about_ca_system_score_gemma":0.0018955105,"threshold_uncertainty_score":0.008389533},"labels":[],"label_agreement":null},{"id":"W2036953209","doi":"10.1016/s1547-4127(04)00004-0","title":"Should aggressive surgery ever be part of the management of small cell lung cancer?","year":2004,"lang":"en","type":"review","venue":"Thoracic surgery clinics/Thorac. surg. clin.","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Mediastinoscopy; Stage (stratigraphy); Chemotherapy; Thoracotomy; Mediastinum; Surgery; Lung cancer; Mediastinal lymph node; Radiation therapy; Disease; Cancer; Radiology; Metastasis; Oncology; Internal medicine","score_opus":0.2358553025352921,"score_gpt":0.4828800507153279,"score_spread":0.2470247481800358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036953209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009448408,0.9983699,0.000011118139,0.0010153991,0.00023049768,8.422523e-7,0.0000052898736,9.897569e-7,0.00027154293],"genre_scores_gemma":[0.00093327736,0.9976363,0.000052316354,0.0008981355,0.00033979263,0.0000020376226,0.000009910886,3.29839e-7,0.00012789186],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99951005,0.00013646262,0.00007889751,0.00006289394,0.00017491227,0.0000368373],"domain_scores_gemma":[0.9987411,0.0007621025,0.00022590302,0.00002525511,0.00017257831,0.000073027644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014912923,0.0005435546,0.0023840987,0.0010571933,0.00030004114,0.0008725945,0.0008967889,0.0018119895,0.0026300675],"category_scores_gemma":[0.0037933595,0.00029389324,0.00078969775,0.002160889,0.00074646174,0.0017021034,0.00043112904,0.0021535207,0.0008231241],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003735067,0.00006859806,0.0017199358,0.028145965,0.0005165134,0.00064669986,0.00006245043,0.00017295539,0.00065523933,0.0019560808,0.033750437,0.9319316],"study_design_scores_gemma":[0.00046018788,0.0005509777,0.019261291,0.048949014,0.002977106,0.006146542,0.0005715945,0.00012367907,0.00044705466,0.00376041,0.91668195,0.000070173184],"about_ca_topic_score_codex":0.0027777373,"about_ca_topic_score_gemma":0.013912253,"teacher_disagreement_score":0.0027777373,"about_ca_system_score_codex":0.0006436893,"about_ca_system_score_gemma":0.0018281379,"threshold_uncertainty_score":0.00879842},"labels":[],"label_agreement":null},{"id":"W2040800229","doi":"10.1016/j.ijrobp.2008.06.705","title":"Differential Regional Brain Atrophy Following Prophylactic Cranial Irradiation in Small Cell Lung Cancer Patients","year":2008,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Atrophy; Radiology; Radiation therapy; Nuclear medicine; Internal medicine; Myocardial infarction","score_opus":0.024810192212339925,"score_gpt":0.349156272627218,"score_spread":0.32434608041487806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040800229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905676,0.0002955912,0.000015428504,0.000027941089,0.0000037956722,0.0000029662388,0.000049568793,0.0000019251422,0.0005459439],"genre_scores_gemma":[0.9997652,0.00010016929,0.000008353918,0.000010188376,0.0000064317005,0.000001560925,0.000051117764,7.2582e-7,0.00005620799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999224,0.000016314254,0.0000065828917,0.00001657066,0.000014141017,0.00002394788],"domain_scores_gemma":[0.9996561,0.00009788597,0.00011903607,0.000015961381,0.000028438504,0.00008258467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011754143,0.00020232516,0.00031205453,0.00059786165,0.00029527195,0.0002653889,0.00025159642,0.00033337667,0.0013332875],"category_scores_gemma":[0.0011492042,0.0001278022,0.00023760991,0.00053098553,0.0003526246,0.00029817186,0.00018929568,0.00036179437,0.00016927948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034152777,0.00010879295,0.9702555,0.000042342752,0.00009641822,0.008440133,0.00021114977,0.0002971448,0.008004046,0.000051143637,0.00023867628,0.008839303],"study_design_scores_gemma":[0.000015014922,0.00038776893,0.9956202,0.0000027756648,0.00004121399,0.003343828,0.00009565666,0.00006027722,0.0003213643,0.000034354423,0.00007378118,0.0000037064656],"about_ca_topic_score_codex":0.005165858,"about_ca_topic_score_gemma":0.006805298,"teacher_disagreement_score":0.005165858,"about_ca_system_score_codex":0.000461274,"about_ca_system_score_gemma":0.0003451339,"threshold_uncertainty_score":0.010271549},"labels":[],"label_agreement":null},{"id":"W2043428486","doi":"10.1097/jto.0b013e3181952678","title":"Defining Genomic Alteration Boundaries for a Combined Small Cell and Non-small Cell Lung Carcinoma","year":2009,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Small Cell Lung Carcinoma; Lung; Small-cell carcinoma; Cell; Carcinoma; Cancer research; Pathology; Internal medicine; Genetics; Biology","score_opus":0.023514930183573268,"score_gpt":0.38241518063877733,"score_spread":0.3589002504552041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043428486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99340963,0.0006693566,0.0019388795,0.0001127965,0.00001805226,0.00004183864,0.00020672113,0.000030460062,0.0035723099],"genre_scores_gemma":[0.9980422,0.00006636206,0.0014184469,0.000033393768,0.00001208265,0.000014509555,0.00013277684,0.000010380544,0.00026973052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998879,0.00028643792,0.00017181956,0.00023913963,0.00027015293,0.00015335529],"domain_scores_gemma":[0.9951911,0.0031738156,0.00058491254,0.0003816372,0.00037750448,0.0002910737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001639126,0.00021987937,0.0005108638,0.0029936756,0.0007433553,0.0009964221,0.00046834748,0.00061397377,0.005938091],"category_scores_gemma":[0.0052305283,0.00018560904,0.0005294628,0.00093675393,0.0008208393,0.0007049731,0.0010237064,0.0005244641,0.0005059294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077416245,0.00028144932,0.6710584,0.00033423604,0.0003856953,0.0057357512,0.0011943807,0.0011353793,0.2649124,0.0019554663,0.00044942586,0.04481584],"study_design_scores_gemma":[0.00016532329,0.0012290782,0.90377253,0.00006707893,0.0008359265,0.015915954,0.0019669556,0.0056252866,0.06275099,0.0027751655,0.004865978,0.000029626392],"about_ca_topic_score_codex":0.0012539577,"about_ca_topic_score_gemma":0.0023821807,"teacher_disagreement_score":0.005938091,"about_ca_system_score_codex":0.0003309948,"about_ca_system_score_gemma":0.0003732462,"threshold_uncertainty_score":0.019864857},"labels":[],"label_agreement":null},{"id":"W2044016668","doi":"10.1200/jco.2014.57.9235","title":"Reply to P. Niravath et al","year":2014,"lang":"fr","type":"letter","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.24465761939170472,"score_gpt":0.5869392432318591,"score_spread":0.34228162384015437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044016668","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015444886,0.0006057122,0.000028454928,0.98845685,0.009914826,0.0000060133443,0.00004733517,0.000016408045,0.0007700458],"genre_scores_gemma":[0.0017301802,0.0004466027,0.000087595596,0.9785351,0.016517544,0.000026621452,0.00002179716,0.000013532021,0.0026210127],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99643916,0.0012035102,0.0004160682,0.00050333043,0.0009199445,0.0005179196],"domain_scores_gemma":[0.9884139,0.006401501,0.00089259,0.00033536158,0.0023041328,0.0016526103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004649499,0.0008135762,0.0018014351,0.0010390863,0.0041424334,0.0038883528,0.002824444,0.058712725,0.008307752],"category_scores_gemma":[0.03907292,0.0010999559,0.001332435,0.0010670425,0.0033799228,0.0043456075,0.0018987688,0.039632875,0.007842769],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043224314,0.000011817783,0.0002981667,0.000026259788,0.000008577555,0.00054518395,0.0000633096,0.000019005582,0.000036330515,0.0006256737,0.9963781,0.0019444118],"study_design_scores_gemma":[0.00024081723,0.00010966482,0.0019126523,0.00042424677,0.00008088706,0.0041184984,0.0008268313,0.00048314434,0.00046820965,0.009540215,0.98166335,0.00013141843],"about_ca_topic_score_codex":0.006218386,"about_ca_topic_score_gemma":0.008294089,"teacher_disagreement_score":0.058712725,"about_ca_system_score_codex":0.0042444924,"about_ca_system_score_gemma":0.0049130674,"threshold_uncertainty_score":0.03079611},"labels":[],"label_agreement":null},{"id":"W2045359677","doi":"10.1016/s0360-3016(03)00635-7","title":"Shifting from hypofractionated to “conventionally” fractionated thoracic radiotherapy: A single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation","year":2003,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; BC Cancer Agency","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Etoposide; Regimen; Radiation therapy; Lung cancer; Vincristine; Conventional PCI; Cyclophosphamide; Chemotherapy; Oncology; Surgery; Internal medicine","score_opus":0.0662570391408563,"score_gpt":0.42014297887011887,"score_spread":0.3538859397292626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045359677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99921787,0.00019788626,0.00022622973,0.00007039216,0.000010434403,0.000014613923,0.0000076001133,0.0000050279646,0.00024992725],"genre_scores_gemma":[0.9985091,0.00026326356,0.0008019022,0.00009622276,0.000019944027,0.000010651878,0.000042217558,0.000008259126,0.00024835576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999483,0.00016149667,0.00006261103,0.0000879331,0.00005763879,0.00014728859],"domain_scores_gemma":[0.99938524,0.00015332944,0.00012572209,0.00007213769,0.000049034523,0.00021449942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097469595,0.00041527598,0.00033210145,0.00019680017,0.0010767285,0.00047556186,0.00077273184,0.00051285245,0.0006067184],"category_scores_gemma":[0.0017118541,0.0002049301,0.0006239596,0.00040949933,0.00055867265,0.00037009787,0.00065957475,0.0006829056,0.00018389396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006354979,0.017250823,0.4636111,0.0003723507,0.00056268845,0.019633617,0.011636599,0.012824917,0.052227557,0.0004148704,0.002668271,0.41244224],"study_design_scores_gemma":[0.0016460147,0.048846316,0.8538432,0.000092054994,0.00057495735,0.043455724,0.006801752,0.008305524,0.02387276,0.0005937328,0.011770236,0.0001977237],"about_ca_topic_score_codex":0.0046020234,"about_ca_topic_score_gemma":0.012831562,"teacher_disagreement_score":0.0046020234,"about_ca_system_score_codex":0.00069057767,"about_ca_system_score_gemma":0.0008279636,"threshold_uncertainty_score":0.009150445},"labels":[],"label_agreement":null},{"id":"W2045410673","doi":"10.1200/jco.2003.10.089","title":"Continued Cigarette Smoking by Patients Receiving Concurrent Chemoradiotherapy for Limited-Stage Small-Cell Lung Cancer Is Associated With Decreased Survival","year":2003,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":249,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Lung cancer; Toxicity; Etoposide; Chemotherapy; Cyclophosphamide; Vincristine; Chemoradiotherapy; Radiation therapy; Stage (stratigraphy); Surgery; Gastroenterology","score_opus":0.10128393816825154,"score_gpt":0.4610338190641434,"score_spread":0.3597498808958919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045410673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99875677,0.0008752647,0.000043500153,0.000034248733,0.0000043909386,0.0000031139475,0.000055512886,0.0000020747082,0.00022506231],"genre_scores_gemma":[0.999595,0.00019652174,0.000031763222,0.000022628263,0.00001162974,0.0000020130515,0.00007864713,9.2669046e-7,0.000060813734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972445,0.00007825329,0.000031414966,0.000046244306,0.000074962336,0.000044575514],"domain_scores_gemma":[0.9978085,0.00065754686,0.0010478928,0.00008751077,0.00016036644,0.00023820357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041382134,0.00009969028,0.0002797177,0.0002812339,0.0002038555,0.00036106285,0.00015483539,0.00031169772,0.0011041589],"category_scores_gemma":[0.0022550614,0.000121525314,0.00029261052,0.00042280945,0.00023380744,0.00020729347,0.00014338504,0.00029585246,0.00014471452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011245825,0.000009817575,0.99748117,0.0000065672834,0.000028960936,0.00007058563,0.000016477006,0.000018575096,0.00023821834,0.000002522295,0.000021333124,0.0019933493],"study_design_scores_gemma":[0.0000050926997,0.0001453123,0.9987779,0.0000061041333,0.00004545589,0.00066767714,0.000030096644,0.00009014243,0.00007418351,0.000006066192,0.0001505115,0.0000013884928],"about_ca_topic_score_codex":0.001467734,"about_ca_topic_score_gemma":0.0035091448,"teacher_disagreement_score":0.001467734,"about_ca_system_score_codex":0.00019705777,"about_ca_system_score_gemma":0.00022041691,"threshold_uncertainty_score":0.0036937594},"labels":[],"label_agreement":null},{"id":"W2048869426","doi":"10.1002/cncr.24833","title":"Treatment of small‐cell lung cancer in elderly patients","year":2010,"lang":"en","type":"review","venue":"Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lung cancer; Radiation therapy; Disease; Stage (stratigraphy); Population; Chemotherapy; Retrospective cohort study; Cancer; Internal medicine; Oncology; Intensive care medicine; Surgery","score_opus":0.05950808557390528,"score_gpt":0.4324454076823065,"score_spread":0.3729373221084012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048869426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016613794,0.99953747,0.000010508414,0.00004487639,0.000029482766,0.000002544004,0.0000065181307,9.3573146e-7,0.00020159382],"genre_scores_gemma":[0.0012710504,0.99848676,0.000041644787,0.00006813608,0.000042254676,0.000004583332,0.000011559941,2.869655e-7,0.00007366557],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974674,0.00007409977,0.00005999792,0.00003115107,0.0000714114,0.000016630342],"domain_scores_gemma":[0.99968815,0.0001649427,0.00007701554,0.0000063793555,0.00004773369,0.000015785594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005324239,0.0004418563,0.0014022692,0.0015527125,0.00018647542,0.0004929991,0.00069849595,0.0006180433,0.0020571533],"category_scores_gemma":[0.0010074476,0.00017706142,0.00068477896,0.001693156,0.00023983866,0.00052927184,0.00030002795,0.00057380856,0.00059384684],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020700187,0.00008837523,0.0005950626,0.061885793,0.00030262757,0.0002464687,0.000060546758,0.00017163857,0.0007567779,0.00039603593,0.014419962,0.92086965],"study_design_scores_gemma":[0.00041539784,0.000892533,0.018244483,0.08739056,0.0030368108,0.0075712795,0.00040581403,0.00023526451,0.0016513066,0.0012982062,0.8788126,0.000045739955],"about_ca_topic_score_codex":0.0013838473,"about_ca_topic_score_gemma":0.0034263819,"teacher_disagreement_score":0.0020571533,"about_ca_system_score_codex":0.00044931198,"about_ca_system_score_gemma":0.00074988895,"threshold_uncertainty_score":0.0068818927},"labels":[],"label_agreement":null},{"id":"W2049426090","doi":"10.1016/j.radonc.2011.12.009","title":"Locoregional failures following thoracic irradiation in patients with limited-stage small cell lung carcinoma","year":2012,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Radiation therapy; Carcinoma; Lung; Retrospective cohort study; Surgery; Radiology; Nuclear medicine; Internal medicine","score_opus":0.0204053157260985,"score_gpt":0.3263769555936294,"score_spread":0.3059716398675309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049426090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981597,0.0010327129,0.000028504355,0.000060479746,0.000008269261,0.000010222332,0.00009611224,0.0000019583815,0.0006021128],"genre_scores_gemma":[0.9992712,0.00031853738,0.000011474953,0.000042860476,0.000023167093,0.0000086129185,0.00012917352,0.0000011468055,0.0001938481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971205,0.00010612152,0.000027384816,0.0000370589,0.000032562606,0.00008476421],"domain_scores_gemma":[0.99890745,0.00040900666,0.00034847006,0.000057908994,0.00006936698,0.0002077647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005846279,0.00029001097,0.00046428698,0.0006847784,0.00067507004,0.0004843989,0.00051215535,0.0005997479,0.0020748384],"category_scores_gemma":[0.002698593,0.00018364882,0.00046601996,0.00070592714,0.0006005696,0.0007042684,0.0005197887,0.0005017522,0.00025853462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026418243,0.00020482055,0.9876237,0.000069472684,0.00005765511,0.0015026256,0.0004870144,0.00034745716,0.00069391937,0.000033388682,0.00024357444,0.0060944827],"study_design_scores_gemma":[0.00008288927,0.0019056356,0.9947702,0.000018767085,0.00011405366,0.001521131,0.00073742174,0.00012349949,0.00020664172,0.000056978155,0.00045339926,0.000009456413],"about_ca_topic_score_codex":0.0058680363,"about_ca_topic_score_gemma":0.0070098704,"teacher_disagreement_score":0.0058680363,"about_ca_system_score_codex":0.0006064085,"about_ca_system_score_gemma":0.00048762717,"threshold_uncertainty_score":0.011667788},"labels":[],"label_agreement":null},{"id":"W2049657582","doi":"10.1158/0008-5472.sabcs13-p6-11-05","title":"Abstract P6-11-05: ANG4043, a brain-penetrant anti-HER2 mAb increases survival in mice bearing intracranial BT-474 breast tumor cells","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Angiochem (Canada)","funders":"","keywords":"Transcytosis; Brain tumor; In vivo; Cancer research; Receptor; Medicine; Monoclonal antibody; Pharmacology; Internal medicine; Biology; Antibody; Pathology; Immunology","score_opus":0.0437908769327742,"score_gpt":0.3827641558444934,"score_spread":0.33897327891171924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049657582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936912,0.00075312325,0.0012642451,0.00020261476,0.00006340746,0.000086528555,0.0012101328,0.00024438024,0.002484358],"genre_scores_gemma":[0.9868787,0.00071380107,0.0027358902,0.00013029827,0.000039789393,0.00013109623,0.0021746536,0.00006157538,0.0071341996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998374,0.000024595663,0.000011323563,0.000029145549,0.00004747544,0.000050030943],"domain_scores_gemma":[0.99986136,0.000025961956,0.000039454695,0.000011524273,0.00001471599,0.000047074733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019142237,0.0005195014,0.00036713306,0.0004090417,0.00017627893,0.00029484043,0.0002938403,0.0004776391,0.0024882464],"category_scores_gemma":[0.00009575901,0.00014346615,0.00028774922,0.00021978609,0.00023492203,0.00024142906,0.000108286695,0.0011522027,0.0006386635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008650904,0.00044338606,0.00017777404,0.000038749426,0.000010711325,0.0000821249,0.000016216833,0.000121097546,0.99565804,0.00006968826,0.00035484502,0.0021622272],"study_design_scores_gemma":[0.00018419883,0.004289976,0.0030669153,0.000006176207,0.000026398917,0.00030167363,0.00002179545,0.0008340505,0.989141,0.000035725363,0.0020863786,0.0000057688667],"about_ca_topic_score_codex":0.0010091715,"about_ca_topic_score_gemma":0.0012716424,"teacher_disagreement_score":0.0024882464,"about_ca_system_score_codex":0.00043360278,"about_ca_system_score_gemma":0.00034759706,"threshold_uncertainty_score":0.008324027},"labels":[],"label_agreement":null},{"id":"W2049906715","doi":"10.3389/fonc.2014.00271","title":"A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients with Extensive Small-Cell Lung Cancer","year":2014,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Center for Advancing Translational Sciences; LUNGevity Foundation","keywords":"Medicine; Circulating tumor cell; Internal medicine; Oncology; Etoposide; Lung cancer; Prostate cancer; Biomarker; Chemotherapy; Cancer; Lung; Gastroenterology; Metastasis","score_opus":0.013040215679648309,"score_gpt":0.2908344038407549,"score_spread":0.27779418816110657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049906715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99922764,0.00008338768,0.000093017334,0.000037448415,0.00000802788,0.0002052776,0.00013249826,0.0000057771945,0.00020699024],"genre_scores_gemma":[0.99886656,0.000041237792,0.0002961161,0.00009258572,0.000038567392,0.00021284308,0.00030203882,0.0000029628386,0.00014714048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985233,0.00078599754,0.00008228147,0.0003286256,0.000101846774,0.00017796727],"domain_scores_gemma":[0.99631447,0.0008182088,0.0006515035,0.00031716865,0.00049638253,0.0014023411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026825748,0.0008639819,0.0007508744,0.00040793343,0.0007722085,0.0007426933,0.00044521972,0.0006766362,0.0016301406],"category_scores_gemma":[0.0034183902,0.00041255637,0.0004863801,0.00047530895,0.00077104557,0.00080102345,0.00053835823,0.0010325231,0.0005425308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033076167,0.0122155845,0.93790966,0.00005047025,0.00020759433,0.0006752658,0.0005834155,0.0001694439,0.0070197424,0.00004564968,0.00040531796,0.0076416684],"study_design_scores_gemma":[0.0072162244,0.15678008,0.8310071,0.000014610916,0.00024314283,0.0011008692,0.00051705877,0.00079182984,0.0012262592,0.00006195469,0.0010097597,0.000031146832],"about_ca_topic_score_codex":0.0015083769,"about_ca_topic_score_gemma":0.0014231565,"teacher_disagreement_score":0.0026825748,"about_ca_system_score_codex":0.0006189204,"about_ca_system_score_gemma":0.0010725085,"threshold_uncertainty_score":0.014187038},"labels":[],"label_agreement":null},{"id":"W2051653983","doi":"10.1007/s11864-002-0045-9","title":"Elderly patients with lung cancer: Biases and evidence","year":2002,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Medicine; Lung cancer; Internal medicine; Radiation therapy; Neutropenia; Chemotherapy; Clinical trial; Performance status; Oncology; Cancer; Surgery","score_opus":0.26352508198025576,"score_gpt":0.5318729844685911,"score_spread":0.26834790248833534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051653983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00079787377,0.9973424,0.0001236239,0.0009971958,0.00024082467,0.0000637491,0.00015298204,0.000002000822,0.00027940734],"genre_scores_gemma":[0.026569985,0.9677948,0.0010386878,0.003382877,0.00055977685,0.00020786971,0.00022019877,0.000007566694,0.0002181433],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9349551,0.031650316,0.021695333,0.0029808753,0.008173805,0.0005445959],"domain_scores_gemma":[0.65697247,0.29271474,0.03748345,0.004174744,0.008056405,0.0005981878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0754874,0.0014472323,0.0073654973,0.0070013385,0.00070352777,0.004017959,0.002193358,0.0025867647,0.0042162086],"category_scores_gemma":[0.23937261,0.0013355719,0.005115957,0.008976822,0.002196352,0.0034299267,0.0025134173,0.0012702692,0.00034171878],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013635207,0.000045342174,0.020600822,0.6481083,0.050597496,0.00034161776,0.0009694713,0.0003253801,0.00018912095,0.0022932312,0.0072365846,0.26792917],"study_design_scores_gemma":[0.001240916,0.00030706287,0.028782098,0.6782164,0.17836192,0.0016198059,0.0014992462,0.0003034312,0.00070690695,0.0064369556,0.10241113,0.00011417236],"about_ca_topic_score_codex":0.0056024017,"about_ca_topic_score_gemma":0.018844927,"teacher_disagreement_score":0.0754874,"about_ca_system_score_codex":0.004315167,"about_ca_system_score_gemma":0.0075181597,"threshold_uncertainty_score":0.3992203},"labels":[],"label_agreement":null},{"id":"W2052267217","doi":"10.1097/jto.0b013e31820c2f2e","title":"Characteristics and Outcomes of Small Cell Lung Cancer Patients Diagnosed During Two Lung Cancer Computed Tomographic Screening Programs in Heavy Smokers","year":2011,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Stage (stratigraphy); Lung cancer screening; Retrospective cohort study; Lung cancer; Radiation therapy; Cancer; Computed tomographic; Interim; Computed tomography; Disease; Interim analysis; Radiology; Clinical trial; Internal medicine","score_opus":0.04729657512002468,"score_gpt":0.40958893375337474,"score_spread":0.3622923586333501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052267217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99959546,0.000053484786,0.00000990534,0.000020623684,0.0000035339535,0.000003973274,0.00014589466,8.601293e-7,0.0001663537],"genre_scores_gemma":[0.99958414,0.000030134155,0.000007889465,0.00001813796,0.0000073892575,0.000004443313,0.00024326507,9.4342045e-7,0.00010369296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994332,0.000094220995,0.000073487936,0.00010907627,0.00006905693,0.00022085049],"domain_scores_gemma":[0.9973732,0.00055189873,0.0008748249,0.000091500355,0.0001931068,0.0009154893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043758945,0.00026047212,0.00047406057,0.001178937,0.0008493849,0.00093486323,0.00048643182,0.00087511615,0.0019471704],"category_scores_gemma":[0.0030770719,0.00042346574,0.00077383756,0.0013787078,0.00048224578,0.00087090046,0.0007824331,0.00095787644,0.0002348665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016617734,0.000048714282,0.99934846,0.0000018861613,0.0000150586775,0.000056145243,0.00006034309,0.000013213412,0.0000775446,0.0000045232764,0.00001877657,0.00018909902],"study_design_scores_gemma":[0.0000063885304,0.00010080562,0.99934405,0.0000013865877,0.000013063724,0.00008901021,0.00033670102,0.00005191786,0.00002027351,0.000007859368,0.000025505304,0.000003169587],"about_ca_topic_score_codex":0.018968953,"about_ca_topic_score_gemma":0.018803129,"teacher_disagreement_score":0.018968953,"about_ca_system_score_codex":0.00071320205,"about_ca_system_score_gemma":0.0007377048,"threshold_uncertainty_score":0.037717044},"labels":[],"label_agreement":null},{"id":"W2054724578","doi":"10.1097/jto.0b013e318200e509","title":"Phase II Multicenter Trial of Voreloxin as Second-Line Therapy in Chemotherapy-Sensitive or Refractory Small Cell Lung Cancer","year":2011,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital","funders":"Sunesis","keywords":"Medicine; Refractory (planetary science); Chemotherapy; Lung cancer; Oncology; Internal medicine; Multicenter study; Randomized controlled trial","score_opus":0.07526664195801742,"score_gpt":0.48279497794253895,"score_spread":0.40752833598452154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054724578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942415,0.0016740479,0.00036902408,0.00055450463,0.00022124402,0.0010862199,0.0005938908,0.00008267277,0.0011768983],"genre_scores_gemma":[0.9889432,0.001656258,0.0010665876,0.00078847783,0.0002129421,0.00186669,0.0019279233,0.000037854115,0.0035000823],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995969,0.00019492696,0.000013938953,0.000063962776,0.000022041055,0.000108259504],"domain_scores_gemma":[0.9993383,0.00011733291,0.00010389907,0.000056208104,0.000029736908,0.00035441542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001521108,0.0015839473,0.0029223382,0.0004569144,0.0005597939,0.0012658035,0.000974359,0.0015558314,0.003985833],"category_scores_gemma":[0.0008257806,0.00055118685,0.0011724667,0.00041937458,0.0012202517,0.0010179456,0.00042045294,0.003419625,0.0008435393],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88465786,0.034248892,0.0026247601,0.0004610841,0.0010727777,0.00017438103,0.00020270496,0.0026682995,0.020639023,0.00038314413,0.0038483355,0.04901873],"study_design_scores_gemma":[0.75819117,0.23346078,0.003738425,0.00002152966,0.00025444376,0.00013686423,0.000061215425,0.0009658467,0.0017768401,0.00015859261,0.0012146707,0.000019668632],"about_ca_topic_score_codex":0.0014438233,"about_ca_topic_score_gemma":0.0031262615,"teacher_disagreement_score":0.003985833,"about_ca_system_score_codex":0.0011091,"about_ca_system_score_gemma":0.0016249493,"threshold_uncertainty_score":0.013333917},"labels":[],"label_agreement":null},{"id":"W2054807753","doi":"10.1097/mph.0b013e31821f0eaf","title":"Survival and Long-term Outcomes in Children With Hepatoblastoma Treated With Continuous Infusion of Cisplatin and Doxorubicin","year":2011,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Hepatoblastoma; Ototoxicity; Audiogram; Chemotherapy; Cohort; Cisplatin; Dosing; Retrospective cohort study; Cardiomyopathy; Surgery; Internal medicine; Hearing loss; Heart failure","score_opus":0.025338809194596888,"score_gpt":0.32289955981027596,"score_spread":0.29756075061567905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054807753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997179,0.00011156933,0.000032495875,0.00001543998,0.000001327819,0.0000020573,0.00004946319,0.0000017663061,0.000067921406],"genre_scores_gemma":[0.9996141,0.00010915283,0.00004927078,0.000010681865,0.0000043283367,0.0000054069283,0.00016528492,0.000001415076,0.000040320014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973196,0.000053872573,0.00002936309,0.000048782455,0.000050437553,0.00008570067],"domain_scores_gemma":[0.9986292,0.0002548027,0.0007178858,0.000062278894,0.00007634646,0.0002596088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003844324,0.00017264133,0.00031933538,0.00045621372,0.00035566607,0.0004255983,0.00020001478,0.00027471856,0.00037160644],"category_scores_gemma":[0.0017195359,0.0001838724,0.00033997968,0.0005165302,0.00037502527,0.00034010853,0.0002975775,0.0004083373,0.00010455963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023517356,0.00005132224,0.9954146,0.0000056811273,0.000027651335,0.0009834301,0.00012909045,0.00014644836,0.00057375716,0.000020513484,0.00007066102,0.002341631],"study_design_scores_gemma":[0.000037368307,0.00093579857,0.9914824,0.000016046732,0.000062338775,0.006070707,0.00031727398,0.00032812485,0.00040721655,0.00003282289,0.0003010325,0.000008960537],"about_ca_topic_score_codex":0.005060337,"about_ca_topic_score_gemma":0.005623435,"teacher_disagreement_score":0.005060337,"about_ca_system_score_codex":0.0007198245,"about_ca_system_score_gemma":0.00045930065,"threshold_uncertainty_score":0.0100618005},"labels":[],"label_agreement":null},{"id":"W2056504493","doi":"10.1097/coc.0b013e31828aab2a","title":"Outcomes of Small Cell Lung Cancer Patients Treated With Cisplatin-Etoposide Versus Carboplatin-Etoposide","year":2013,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Carboplatin; Internal medicine; Population; Gastroenterology; Cisplatin; Retrospective cohort study; Chemotherapy; Surgery","score_opus":0.05152157600792551,"score_gpt":0.4453391437418046,"score_spread":0.3938175677338791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056504493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993174,0.00031947272,0.00002858639,0.000026486694,0.0000038277176,0.0000065915065,0.000060269038,0.0000014306601,0.00023604407],"genre_scores_gemma":[0.9996959,0.00006096988,0.000016881322,0.000020530711,0.0000074515965,0.0000050804624,0.00015866003,4.4065186e-7,0.00003402523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975234,0.00007193786,0.000035817233,0.00004365457,0.00005258054,0.00004362702],"domain_scores_gemma":[0.99933535,0.00016988307,0.00027023588,0.000018130886,0.00006179207,0.00014456754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002866537,0.00010497323,0.00035411245,0.00029534628,0.0001731861,0.00037157262,0.00010766162,0.0002015194,0.00052973314],"category_scores_gemma":[0.0015064721,0.000066899556,0.00032362924,0.00033086608,0.00018626235,0.00029233252,0.0002082662,0.00023712649,0.000096126794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002034117,0.00015316764,0.98816967,0.000033327207,0.00015312953,0.00023954525,0.00007626273,0.00039580226,0.0007667433,0.00001965831,0.00012660764,0.007831959],"study_design_scores_gemma":[0.00015669172,0.0029338752,0.9940339,0.000015461274,0.00012542368,0.0011002913,0.00017532264,0.0005064099,0.00044133773,0.00004347688,0.00046216213,0.0000057024026],"about_ca_topic_score_codex":0.0007703299,"about_ca_topic_score_gemma":0.0016369022,"teacher_disagreement_score":0.0007703299,"about_ca_system_score_codex":0.00039382986,"about_ca_system_score_gemma":0.00023780481,"threshold_uncertainty_score":0.002857387},"labels":[],"label_agreement":null},{"id":"W2057138654","doi":"10.1016/s0360-3016(01)01748-5","title":"Prophylactic cranial irradiation revisited: cost-effectiveness and quality of life in small-cell lung cancer","year":2002,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Conventional PCI; Medicine; Prophylactic cranial irradiation; Quality of life (healthcare); Surgery; Internal medicine; Lung cancer; Cost effectiveness; Toxicity; Retrospective cohort study; Myocardial infarction","score_opus":0.0632273612866845,"score_gpt":0.4132628435005799,"score_spread":0.3500354822138954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057138654","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3069201,0.52254975,0.0019961616,0.15572308,0.001980959,0.000040507522,0.0008807352,0.000023050838,0.0098856855],"genre_scores_gemma":[0.95174867,0.041312747,0.0006796234,0.004220057,0.0015661644,0.000017786877,0.00013363894,0.0000099632425,0.00031128104],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99816555,0.0013535491,0.00011497888,0.00008397895,0.00020162648,0.000080441845],"domain_scores_gemma":[0.98859054,0.009376237,0.0011280891,0.00015379871,0.0004385101,0.00031285302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044483757,0.00041082565,0.0010571107,0.0010421283,0.00026422652,0.0020083007,0.0012455336,0.0019549076,0.0030771405],"category_scores_gemma":[0.02138971,0.0001914041,0.0010122085,0.002771274,0.0011445382,0.0019848119,0.0006608687,0.0029253282,0.00013908712],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011510976,0.00054145564,0.1282236,0.006204473,0.005440097,0.0013780388,0.00047471566,0.036743794,0.0016885124,0.056849517,0.034335088,0.7166098],"study_design_scores_gemma":[0.004870603,0.008072671,0.53342146,0.011305418,0.023113916,0.0117152035,0.008353298,0.070412606,0.0019228432,0.21923952,0.10708402,0.0004884833],"about_ca_topic_score_codex":0.0057318225,"about_ca_topic_score_gemma":0.014616906,"teacher_disagreement_score":0.0057318225,"about_ca_system_score_codex":0.003589988,"about_ca_system_score_gemma":0.0017627699,"threshold_uncertainty_score":0.02604729},"labels":[],"label_agreement":null},{"id":"W2058732484","doi":"10.3816/clc.2000.n.001","title":"Small-Cell Lung Cancer at the Millennium: Radiotherapy Innovations Improve Survival While New Chemotherapy Treatments Remain Unproven","year":2000,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Radiation therapy; Lung cancer; Etoposide; Oncology; Chemotherapy; Regimen; Vincristine; Internal medicine; Cyclophosphamide; Surgery","score_opus":0.05962236724209133,"score_gpt":0.42511883145126506,"score_spread":0.3654964642091737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058732484","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030263899,0.44261745,0.00080118026,0.5068046,0.0044951723,0.00008209587,0.00035562483,0.000043327625,0.014536678],"genre_scores_gemma":[0.39022443,0.4319874,0.0054473807,0.1413946,0.02165992,0.00016510786,0.00055170007,0.0000680548,0.0085014235],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955788,0.002698668,0.00029970377,0.00031435746,0.0007427112,0.00036575954],"domain_scores_gemma":[0.96598065,0.022291701,0.0033876058,0.0018168662,0.0029609248,0.0035621808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017332494,0.0005068538,0.0011262551,0.0008997649,0.000799858,0.0041353344,0.0012557805,0.004016616,0.017445523],"category_scores_gemma":[0.027657388,0.00020352649,0.0009419866,0.0015918572,0.003618134,0.008164786,0.0025134676,0.005262145,0.0016812587],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007972829,0.0015601044,0.021914447,0.0051057204,0.0010160597,0.00025977648,0.0005278175,0.0006250528,0.005417117,0.049922243,0.07405893,0.83161986],"study_design_scores_gemma":[0.003809373,0.0114922365,0.10171019,0.019639337,0.0026135535,0.0013433626,0.009277315,0.0007776654,0.007918204,0.109372176,0.7317824,0.0002642633],"about_ca_topic_score_codex":0.002217631,"about_ca_topic_score_gemma":0.0047935606,"teacher_disagreement_score":0.017445523,"about_ca_system_score_codex":0.0021133823,"about_ca_system_score_gemma":0.0071020755,"threshold_uncertainty_score":0.091664076},"labels":[],"label_agreement":null},{"id":"W2059355012","doi":"10.1097/jto.0b013e318282707b","title":"A Phase I Study of Pomalidomide (CC-4047) in Combination with Cisplatin and Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer","year":2013,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Etoposide; Neutropenia; Pomalidomide; Internal medicine; Adverse effect; Regimen; Chemotherapy; Gastroenterology; Surgery; Thalidomide; Multiple myeloma","score_opus":0.022202202067033938,"score_gpt":0.42377374883985286,"score_spread":0.4015715467728189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059355012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99113244,0.0024875582,0.00040578522,0.00057018286,0.00017571732,0.0025316172,0.00090416044,0.000076858756,0.0017157344],"genre_scores_gemma":[0.98620725,0.003500044,0.0020846198,0.0010720112,0.00034464448,0.0027562212,0.0021330602,0.000053993477,0.0018481272],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990128,0.00052374206,0.000050809456,0.00016872534,0.00006655271,0.00017721309],"domain_scores_gemma":[0.9986193,0.00024009215,0.00017625371,0.00014256702,0.00006720889,0.00075446937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002089009,0.0019988662,0.0036619978,0.0008694743,0.0006872303,0.0016667276,0.0016662951,0.0017041853,0.0036510762],"category_scores_gemma":[0.0014997149,0.0012012223,0.0029896267,0.0010582065,0.0018222558,0.001514529,0.00059752644,0.005722854,0.0009773229],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85561526,0.0664258,0.0043111932,0.0005824289,0.0016385157,0.00018592499,0.00032188697,0.0021439302,0.016289225,0.00026570825,0.0022907155,0.049929358],"study_design_scores_gemma":[0.6907009,0.30006695,0.0051430934,0.000027527785,0.0005522111,0.00012996914,0.00007326308,0.0005477912,0.0012976323,0.00010908985,0.0013227445,0.000028811313],"about_ca_topic_score_codex":0.0029576386,"about_ca_topic_score_gemma":0.0062698964,"teacher_disagreement_score":0.0036619978,"about_ca_system_score_codex":0.0017927352,"about_ca_system_score_gemma":0.0033124194,"threshold_uncertainty_score":0.013007224},"labels":[],"label_agreement":null},{"id":"W2059793948","doi":"10.1097/01.coc.0000195092.25516.19","title":"Examining Time Intervals Between Diagnosis and Treatment in the Management of Patients With Limited Stage Small Cell Lung Cancer","year":2006,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; BC Cancer Agency","funders":"","keywords":"Medicine; Lung cancer; Confidence interval; Odds ratio; Stage (stratigraphy); Internal medicine; Radiation therapy; Proportional hazards model; Chemotherapy; Cancer; Logistic regression; Oncology","score_opus":0.09451095105498074,"score_gpt":0.44607742118003774,"score_spread":0.351566470125057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059793948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758255,0.0017046402,0.0002007769,0.00011034208,0.000012529077,0.000010607219,0.00013982347,0.0000036563997,0.00023515233],"genre_scores_gemma":[0.99926347,0.00021405928,0.00020868266,0.000025022806,0.000029364726,0.000012844843,0.00020554865,0.00000150808,0.000039424598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984818,0.00067584653,0.00019729271,0.0001903134,0.0003185484,0.0001361588],"domain_scores_gemma":[0.98254895,0.0071639046,0.008945471,0.00018960936,0.00044315588,0.000708925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020718134,0.00015755805,0.00030762397,0.0009520552,0.00020097906,0.0004261652,0.00038822816,0.0005026816,0.0007632625],"category_scores_gemma":[0.01718286,0.00013432084,0.00041182415,0.0012702843,0.00020043345,0.00054586946,0.00042067104,0.000606843,0.00011903652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009322305,0.0000561479,0.99479526,0.00002678425,0.000044588105,0.00008419479,0.000050427847,0.00017879401,0.00013294967,0.000010979976,0.000054249256,0.0036334966],"study_design_scores_gemma":[0.0000305855,0.00072292803,0.9978288,0.00001635565,0.000052779716,0.0002907567,0.0001437302,0.00054939016,0.000099410994,0.000022460492,0.00023784295,0.000004880104],"about_ca_topic_score_codex":0.0020615621,"about_ca_topic_score_gemma":0.0031804119,"teacher_disagreement_score":0.0020718134,"about_ca_system_score_codex":0.0004196389,"about_ca_system_score_gemma":0.00051446306,"threshold_uncertainty_score":0.010956943},"labels":[],"label_agreement":null},{"id":"W2062668422","doi":"10.1002/1097-0142(20001101)89:9<1953::aid-cncr11>3.3.co;2-y","title":"Similar outcome of elderly patients in Intergroup Trial 0096","year":2000,"lang":"en","type":"article","venue":"Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Toxicity; Internal medicine; Etoposide; Retrospective cohort study; Survival rate; Performance status; Radiation therapy; Surgery; Chemotherapy","score_opus":0.038670754912903546,"score_gpt":0.4024898100377814,"score_spread":0.36381905512487783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062668422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886778,0.003659983,0.0003329441,0.00029003972,0.00011049183,0.00020517099,0.0023297293,0.000015568025,0.0043782336],"genre_scores_gemma":[0.99215204,0.00051432167,0.00022465826,0.0006174498,0.00013086828,0.0002907743,0.005346626,0.000014271196,0.000709062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831414,0.000880738,0.00019268713,0.00021982657,0.00017810165,0.00021445556],"domain_scores_gemma":[0.9968418,0.0008367588,0.0011704745,0.00042839517,0.00022510794,0.0004975213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044189994,0.00036508325,0.00100936,0.00034901092,0.00037501237,0.00085375115,0.00023028287,0.0008321762,0.002419706],"category_scores_gemma":[0.004367057,0.00011183018,0.0010837282,0.0005264813,0.00029807125,0.0005631992,0.00044761275,0.0007817489,0.0004238318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30642605,0.0011437216,0.6109744,0.00068808685,0.0040591555,0.0012683239,0.0003061048,0.002431504,0.007163079,0.00062594377,0.006265807,0.058647823],"study_design_scores_gemma":[0.039167374,0.05958602,0.8630013,0.00032781844,0.0036140024,0.0042867805,0.0002672233,0.0016306433,0.002701489,0.0018268548,0.023501651,0.00008898575],"about_ca_topic_score_codex":0.00026668247,"about_ca_topic_score_gemma":0.0004840299,"teacher_disagreement_score":0.0044189994,"about_ca_system_score_codex":0.00043875581,"about_ca_system_score_gemma":0.0005120721,"threshold_uncertainty_score":0.023370206},"labels":[],"label_agreement":null},{"id":"W2063405814","doi":"10.1155/2012/708936","title":"Uptake and Tolerance of Chemotherapy in Elderly Patients with Small Cell Lung Cancer and Impact on Survival","year":2012,"lang":"en","type":"article","venue":"Journal of Cancer Epidemiology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Medicine; Chemotherapy; Lung cancer; Internal medicine; Cancer; Cancer registry; Oncology; Surgery","score_opus":0.0412040762676599,"score_gpt":0.4009334681823219,"score_spread":0.359729391914662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063405814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883515,0.00054527516,0.00002009045,0.000080956954,0.0000023323641,0.0000022331303,0.0000741227,9.3262224e-7,0.00043887546],"genre_scores_gemma":[0.9996729,0.00014103454,0.000017601405,0.00002967017,0.0000038971866,9.2095127e-7,0.00006979572,3.9207112e-7,0.000063932996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996414,0.00010047603,0.000028639544,0.000027406237,0.00011230257,0.00008978886],"domain_scores_gemma":[0.99801445,0.00035084717,0.0009587221,0.000053185104,0.00025026198,0.00037246634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050183083,0.00010160027,0.00022493779,0.00047513092,0.0002827529,0.00045910192,0.00019973273,0.00022111597,0.0006739975],"category_scores_gemma":[0.0034399242,0.0000988233,0.00026402957,0.0007343429,0.00021867032,0.00022556621,0.00025233728,0.0003444525,0.00006517605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007067485,0.000013030936,0.99828005,0.0000037001175,0.00001767348,0.000029635272,0.000068666675,0.00003502815,0.000030905278,0.0000055019555,0.000037607002,0.0014075848],"study_design_scores_gemma":[0.0000021299284,0.00005194403,0.9995455,0.0000053772164,0.0000120005325,0.000061780374,0.00016024288,0.00006390004,0.00001020434,0.000009286613,0.00007605953,0.0000015596565],"about_ca_topic_score_codex":0.1303898,"about_ca_topic_score_gemma":0.22615159,"teacher_disagreement_score":0.1303898,"about_ca_system_score_codex":0.0010800349,"about_ca_system_score_gemma":0.0007929009,"threshold_uncertainty_score":0.25926173},"labels":[],"label_agreement":null},{"id":"W2063481154","doi":"10.1016/j.lungcan.2003.08.026","title":"Impaired diffusion capacity predicts for decreased treatment tolerance and survival in limited stage small cell lung cancer patients treated with concurrent chemoradiation","year":2004,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Western University","funders":"","keywords":"Medicine; DLCO; Internal medicine; Pulmonary function testing; Pulmonary toxicity; Toxicity; Diffusing capacity; Etoposide; Vincristine; Cumulative incidence; Gastroenterology; Urology; Surgery; Cyclophosphamide; Lung; Chemotherapy; Cohort","score_opus":0.02322103713015736,"score_gpt":0.3031683424275841,"score_spread":0.27994730529742673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063481154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99968266,0.00012567524,0.000017633247,0.0000156949,0.0000012233551,0.0000017811989,0.000021772428,7.414661e-7,0.0001328489],"genre_scores_gemma":[0.9998447,0.000040228744,0.000014685462,0.000006368913,0.000002962981,0.00000202502,0.000038542807,4.4364356e-7,0.000049895698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986076,0.00005521091,0.0000129889495,0.000022412009,0.000022415814,0.000026163265],"domain_scores_gemma":[0.9986632,0.00040564558,0.0004829203,0.00011143026,0.000082947845,0.00025387312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035872945,0.00020434435,0.00028666106,0.00031135764,0.00027285767,0.00042335817,0.00024070896,0.0003351884,0.00094128546],"category_scores_gemma":[0.001976138,0.00013241771,0.00031189123,0.00036972214,0.00030734402,0.00026008673,0.00020955535,0.0004121446,0.000089655136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00182082,0.00015817092,0.9933177,0.000010759879,0.00007383715,0.00005305378,0.000060415532,0.00013884783,0.0019295347,0.000019845142,0.000048438043,0.0023686674],"study_design_scores_gemma":[0.000026618376,0.000603467,0.9983032,0.000002469304,0.0000631268,0.00017762152,0.000067358334,0.00026931058,0.00036481407,0.000023619197,0.000095352254,0.0000029892888],"about_ca_topic_score_codex":0.0036615506,"about_ca_topic_score_gemma":0.0031111874,"teacher_disagreement_score":0.0036615506,"about_ca_system_score_codex":0.00033563416,"about_ca_system_score_gemma":0.00032390922,"threshold_uncertainty_score":0.007280469},"labels":[],"label_agreement":null},{"id":"W2064508141","doi":"10.1097/jto.0000000000000058","title":"NCIC CTG IND.190 Phase I Trial of Dalotuzumab (MK-0646) in Combination with Cisplatin and Etoposide in Extensive-Stage Small-Cell Lung Cancer","year":2014,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Queen's University; McMaster University; University of Ottawa; Ottawa Hospital; Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Neutropenia; Leukopenia; Etoposide; Internal medicine; Gastroenterology; Cancer; Anemia; Surgery; Chemotherapy","score_opus":0.03256486841170175,"score_gpt":0.46006590205995973,"score_spread":0.427501033648258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064508141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766054,0.0056009404,0.0008903747,0.0016650913,0.00054587517,0.0027981836,0.0041941344,0.00041470802,0.0072852173],"genre_scores_gemma":[0.9730854,0.005043762,0.0022856898,0.0016071938,0.0002623299,0.001972421,0.006786952,0.00010183608,0.008854416],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99962234,0.0001605895,0.000016045346,0.00005893121,0.00003348331,0.00010851913],"domain_scores_gemma":[0.99948275,0.000067695226,0.00007487764,0.000043150187,0.000021818705,0.00030979078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013511524,0.0017213894,0.0024565577,0.00056930067,0.00047419817,0.0014539375,0.0014523919,0.0012645875,0.0062161293],"category_scores_gemma":[0.0007399328,0.00074379,0.0016514128,0.00063444255,0.0011545005,0.0010218098,0.0005273729,0.004262545,0.0019060584],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73615944,0.04053741,0.0046564233,0.0013458974,0.0019380072,0.00026548645,0.00032031402,0.0067352722,0.03176577,0.0011072776,0.019290801,0.1558779],"study_design_scores_gemma":[0.7196175,0.25803936,0.008793839,0.00007176627,0.0006642459,0.00036409838,0.00007721751,0.0019630578,0.0032203682,0.0004059544,0.006734142,0.000048479345],"about_ca_topic_score_codex":0.0033183047,"about_ca_topic_score_gemma":0.0117551815,"teacher_disagreement_score":0.0062161293,"about_ca_system_score_codex":0.0016509271,"about_ca_system_score_gemma":0.002225906,"threshold_uncertainty_score":0.020795047},"labels":[],"label_agreement":null},{"id":"W2065188377","doi":"10.1097/jto.0b013e31815bdc0d","title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals Regarding the Clinical Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the Tumor, Node, Metastasis Classification for Lung Cancer","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":547,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; TNM staging system; Lung cancer; Oncology; Stage (stratigraphy); Internal medicine; Lung cancer staging; Cancer; Radiology; Neoplasm staging; Mediastinoscopy","score_opus":0.08743869756397145,"score_gpt":0.5345343729513192,"score_spread":0.4470956753873478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065188377","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.103661396,0.14119378,0.038104545,0.25693083,0.112686425,0.013348226,0.24610451,0.0014953917,0.08647495],"genre_scores_gemma":[0.24917424,0.095190346,0.18932213,0.031502265,0.031089446,0.040970974,0.32371938,0.0011619831,0.03786926],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927288,0.00243612,0.0013431022,0.0003651085,0.00240727,0.0007195659],"domain_scores_gemma":[0.9532722,0.0064026704,0.004736479,0.0029668012,0.027215216,0.005406547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025249898,0.0017572808,0.0042198077,0.0046033366,0.0022831692,0.0034341037,0.004620507,0.0040649995,0.0035574988],"category_scores_gemma":[0.027670557,0.0010131878,0.0025720582,0.012044044,0.0015682725,0.0018063963,0.0028688018,0.00951327,0.0023067235],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003008624,0.0011532053,0.3594071,0.0021197253,0.0012679198,0.0003115595,0.0012655413,0.0010704994,0.00239169,0.01257789,0.47182187,0.1436044],"study_design_scores_gemma":[0.0013886186,0.0005987518,0.7539008,0.0011325687,0.0013327459,0.0004426473,0.000994232,0.0009810361,0.000894474,0.0035825875,0.23460658,0.00014486306],"about_ca_topic_score_codex":0.04745008,"about_ca_topic_score_gemma":0.055617962,"teacher_disagreement_score":0.04745008,"about_ca_system_score_codex":0.004442614,"about_ca_system_score_gemma":0.034483742,"threshold_uncertainty_score":0.1335358},"labels":[],"label_agreement":null},{"id":"W2065276159","doi":"10.1097/01.jto.0000283329.83483.2b","title":"PD6-1-7: A phase II study of UCN-01 in combination with topotecan in patients (pts) with chemosensitive relapsed small cell lung cancer (SCLC): a study of the Princess Margaret Hospital phase II consortium (PMH-C).","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Ottawa Hospital; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"","keywords":"Topotecan; Medicine; Oncology; Internal medicine; Apoptosis; Chemotherapy; Cell cycle checkpoint; Pharmacology; Cancer; Cell cycle","score_opus":0.016519547986206362,"score_gpt":0.4052030107723295,"score_spread":0.38868346278612315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065276159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908082,0.002765716,0.00039227336,0.00069844443,0.00015311566,0.0017510321,0.0013424907,0.00011071872,0.001978222],"genre_scores_gemma":[0.9819188,0.0044956156,0.002669512,0.0012042675,0.00024742846,0.001955735,0.004600756,0.00006430092,0.0028435595],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990896,0.00057008705,0.000030874642,0.000095563526,0.00007329234,0.00014062355],"domain_scores_gemma":[0.9984754,0.00027223077,0.00021238957,0.00010632748,0.00007402925,0.0008597275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029852663,0.0018585585,0.002452321,0.0006710636,0.00055992085,0.0013057982,0.0018701962,0.001793336,0.0033992622],"category_scores_gemma":[0.0017880712,0.0008385497,0.001621116,0.00072540797,0.0016322442,0.0014289941,0.0005665097,0.0056882906,0.0010038859],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7665416,0.09462559,0.0063981744,0.000837486,0.0020330136,0.0002634554,0.00042946127,0.0039798436,0.025032813,0.0004092065,0.0064370926,0.09301238],"study_design_scores_gemma":[0.65070176,0.33547089,0.0069837994,0.00003605207,0.00062059803,0.00027704804,0.000087486354,0.001186925,0.002453729,0.00017077324,0.0019738248,0.00003698609],"about_ca_topic_score_codex":0.0028074551,"about_ca_topic_score_gemma":0.006217585,"teacher_disagreement_score":0.0033992622,"about_ca_system_score_codex":0.001378255,"about_ca_system_score_gemma":0.0024915447,"threshold_uncertainty_score":0.01578778},"labels":[],"label_agreement":null},{"id":"W2066832802","doi":"10.1007/s00280-003-0711-z","title":"Pharmacokinetics of etoposide in cancer patients treated with high-dose etoposide and with dexrazoxane (ICRF-187) as a rescue agent","year":2003,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Etoposide; Pharmacokinetics; Dexrazoxane; Pharmacology; Medicine; Toxicity; Chemotherapy; Cancer; Internal medicine; Breast cancer; Anthracycline","score_opus":0.019167464852908944,"score_gpt":0.35378738882824584,"score_spread":0.3346199239753369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066832802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997419,0.0011917003,0.00032418233,0.00010077777,0.000027517444,0.00004161835,0.00015671381,0.00004671804,0.00069189304],"genre_scores_gemma":[0.99861026,0.00023342666,0.0003046241,0.000062030296,0.00003643744,0.000026226686,0.0002510108,0.00002033266,0.00045570347],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9994185,0.00035500812,0.000027239996,0.00006414107,0.00006787393,0.000067211375],"domain_scores_gemma":[0.9989562,0.00037784214,0.00019967528,0.00013572449,0.000053718868,0.0002767655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007177308,0.00043854173,0.0013186553,0.0003150384,0.00031958392,0.00070647424,0.00038633126,0.0006127009,0.0014933029],"category_scores_gemma":[0.0026418036,0.0005128622,0.00057405856,0.00034733204,0.0005724388,0.0010918305,0.00019033236,0.0015005291,0.0004125894],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5770436,0.0047248392,0.072219655,0.00023758425,0.001312616,0.0020152815,0.0011003315,0.009601157,0.25553542,0.00082757085,0.0032980447,0.07208388],"study_design_scores_gemma":[0.033684824,0.24913107,0.5240502,0.000066822286,0.0016481227,0.0076929396,0.0010085043,0.026386779,0.14452443,0.00086230936,0.010704433,0.00023961971],"about_ca_topic_score_codex":0.0012631039,"about_ca_topic_score_gemma":0.0012055115,"teacher_disagreement_score":0.0014933029,"about_ca_system_score_codex":0.00061473204,"about_ca_system_score_gemma":0.000568454,"threshold_uncertainty_score":0.0049955845},"labels":[],"label_agreement":null},{"id":"W2074044989","doi":"10.1016/j.radonc.2010.05.013","title":"Phase I dose escalation trial of hypofractionated limited-field external beam thoracic radiotherapy for limited-stage small cell carcinoma of the lung","year":2010,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital","funders":"Alberta Cancer Foundation","keywords":"Medicine; Radiation therapy; Lung cancer; Clinical endpoint; Chemotherapy; Stage (stratigraphy); Oncology; Nuclear medicine; Toxicity; Dose fractionation; Acute toxicity; Internal medicine; Radiology; Urology; Randomized controlled trial","score_opus":0.03476654564473217,"score_gpt":0.3886735354685558,"score_spread":0.3539069898238236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074044989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929148,0.0011665747,0.0005242879,0.0005207482,0.00023052734,0.0019655144,0.0007527459,0.00011525328,0.001809467],"genre_scores_gemma":[0.9812215,0.0014960733,0.002373838,0.0012660408,0.00021303238,0.004287121,0.0022660536,0.00007103786,0.0068053156],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993247,0.00029322744,0.000032241718,0.00014956083,0.000054336837,0.00014596297],"domain_scores_gemma":[0.99904877,0.00015764826,0.0002189218,0.00016491362,0.00004449932,0.00036521378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019661495,0.0021875438,0.0032021818,0.0007992252,0.00062509166,0.0013302775,0.0018352721,0.0018292998,0.00605462],"category_scores_gemma":[0.0012174735,0.00085659744,0.0021235573,0.0007947005,0.001989368,0.0012422097,0.0007050907,0.004964612,0.0012045383],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86539763,0.054585315,0.0017576067,0.0005999308,0.0012134734,0.00006873019,0.00040582803,0.004091905,0.02215401,0.00042794406,0.0024101567,0.04688751],"study_design_scores_gemma":[0.737401,0.2515205,0.0053193136,0.000028785827,0.0004282759,0.00006259929,0.00008214362,0.0014012266,0.0020186044,0.00035215914,0.0013488167,0.000036609767],"about_ca_topic_score_codex":0.0022221792,"about_ca_topic_score_gemma":0.003985886,"teacher_disagreement_score":0.00605462,"about_ca_system_score_codex":0.0017335461,"about_ca_system_score_gemma":0.0016729294,"threshold_uncertainty_score":0.020254672},"labels":[],"label_agreement":null},{"id":"W2074144195","doi":"10.1016/j.cllc.2011.03.013","title":"A Phase II Study of Carboplatin and Irinotecan in Extensive Stage Small-Cell Lung Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Pfizer","keywords":"Medicine; Carboplatin; Irinotecan; Lung cancer; Oncology; Internal medicine; Stage (stratigraphy); Cancer; Chemotherapy; Cisplatin; Colorectal cancer","score_opus":0.1242241102550383,"score_gpt":0.4814820898648671,"score_spread":0.35725797960982886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074144195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940526,0.0016565383,0.00028714308,0.0002951221,0.00010123174,0.0019978876,0.00043834597,0.000032888773,0.0011382697],"genre_scores_gemma":[0.9885803,0.0024432417,0.001330594,0.00063584355,0.00029470545,0.0024063094,0.0017403599,0.000029376584,0.002539201],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9979765,0.0013179068,0.000082616076,0.00020604552,0.00012372066,0.00029327345],"domain_scores_gemma":[0.99737334,0.0006020215,0.00033242442,0.00034757704,0.00015711244,0.0011875774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004538809,0.0021379436,0.00417703,0.00084434147,0.0010223653,0.0013483757,0.001600312,0.0018787339,0.0034658075],"category_scores_gemma":[0.0019805375,0.0010634668,0.0021732822,0.0010287513,0.0027296776,0.0014164817,0.000610313,0.004821627,0.0007600323],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8384958,0.10030049,0.0044967765,0.00044868237,0.0011216614,0.00019000834,0.00030569683,0.0012881528,0.020620503,0.00018648613,0.0013150151,0.031230714],"study_design_scores_gemma":[0.5469948,0.4410258,0.007473573,0.000017368533,0.0004887267,0.00013248203,0.0001062757,0.00031837,0.0021190029,0.00008707412,0.0012158498,0.000020706684],"about_ca_topic_score_codex":0.00439346,"about_ca_topic_score_gemma":0.008619528,"teacher_disagreement_score":0.004538809,"about_ca_system_score_codex":0.0016212796,"about_ca_system_score_gemma":0.003488803,"threshold_uncertainty_score":0.024003804},"labels":[],"label_agreement":null},{"id":"W2075136921","doi":"10.1016/j.cllc.2011.03.028","title":"Clinical Outcomes of Extensive Stage Small Cell Lung Carcinoma Patients Treated With Consolidative Thoracic Radiotherapy","year":2011,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Stage (stratigraphy); Lung cancer; Lung; Radiology; Carcinoma; Oncology; Small Cell Lung Carcinoma; Internal medicine; Small-cell carcinoma","score_opus":0.09780638833724518,"score_gpt":0.4554487585161819,"score_spread":0.3576423701789367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075136921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984231,0.00040104467,0.000022212844,0.000035592326,0.0000064863216,0.000009677688,0.00018832309,0.0000010273192,0.00091250794],"genre_scores_gemma":[0.9992446,0.00011438936,0.0000116281235,0.000024165738,0.000013568438,0.000005545032,0.0003980865,7.356963e-7,0.00018731099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970204,0.00009218692,0.000032979373,0.000050715018,0.00004873143,0.000073232644],"domain_scores_gemma":[0.99909997,0.00021712115,0.00027924465,0.000042045805,0.0001217973,0.00023974654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044190683,0.00017146114,0.00043863853,0.00037294795,0.00034734365,0.00054918206,0.00020892054,0.00029824095,0.0014903523],"category_scores_gemma":[0.0015873777,0.000090593785,0.0004948272,0.0007296361,0.00035022467,0.00041055022,0.00039111843,0.0003484285,0.00019106458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047566565,0.00033138954,0.9836998,0.00003142096,0.00019655435,0.0004184281,0.00019015995,0.00029067224,0.0010508773,0.000046879068,0.00024600758,0.008741049],"study_design_scores_gemma":[0.00009521867,0.0015938964,0.99709177,0.0000055560868,0.00012483283,0.00026380175,0.00022104825,0.00010787774,0.00012861306,0.000037535487,0.00032298834,0.000006880443],"about_ca_topic_score_codex":0.003193143,"about_ca_topic_score_gemma":0.0047380463,"teacher_disagreement_score":0.003193143,"about_ca_system_score_codex":0.0005243819,"about_ca_system_score_gemma":0.00036913468,"threshold_uncertainty_score":0.0063490868},"labels":[],"label_agreement":null},{"id":"W2076643424","doi":"10.1016/s0360-3016(02)04576-5","title":"Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? a community-based population analysis","year":2003,"lang":"en","type":"review","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Comorbidity; Internal medicine; Population; Chemoradiotherapy; Lung cancer; Multivariate analysis; Cancer; Radiation therapy; Retrospective cohort study; Stage (stratigraphy); Cancer registry; Oncology","score_opus":0.09335179534133689,"score_gpt":0.46796316600748544,"score_spread":0.3746113706661486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076643424","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12488421,0.8737276,0.00013308568,0.00037313555,0.00005199775,0.000026238908,0.00022893242,0.0000020820892,0.00057272636],"genre_scores_gemma":[0.42457905,0.5740242,0.00042543098,0.00027603257,0.00009827351,0.000041597454,0.00035018486,0.0000016091857,0.0002036288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984963,0.0008206116,0.0001891442,0.00014075132,0.00028598597,0.000067149354],"domain_scores_gemma":[0.99744356,0.0018603675,0.00039459113,0.000061792845,0.00018383726,0.000055794844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002216277,0.00025724742,0.0017081748,0.0010261568,0.00018770111,0.0005713083,0.0005158819,0.00057540723,0.0008151655],"category_scores_gemma":[0.0056780404,0.00022590668,0.002217567,0.002866402,0.00017623961,0.00042866505,0.00026489596,0.00036558256,0.000091186965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038572538,0.00023783464,0.5900969,0.014386863,0.024494594,0.00036147117,0.0002808252,0.00071838126,0.0003237575,0.0003419639,0.0019002055,0.36299995],"study_design_scores_gemma":[0.0006343986,0.0012411621,0.948328,0.003328144,0.032825086,0.0011412398,0.0005589281,0.00047862402,0.00021032793,0.00060090976,0.01060417,0.0000490967],"about_ca_topic_score_codex":0.008040681,"about_ca_topic_score_gemma":0.01961115,"teacher_disagreement_score":0.008040681,"about_ca_system_score_codex":0.0005748064,"about_ca_system_score_gemma":0.0012755875,"threshold_uncertainty_score":0.015987754},"labels":[],"label_agreement":null},{"id":"W2080644517","doi":"10.4103/0970-2113.92345","title":"Surgery in limited-disease small-cell lung cancer","year":2012,"lang":"en","type":"article","venue":"Lung India","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Disease; Surgery; Oncology; Internal medicine","score_opus":0.030971374175624126,"score_gpt":0.3396830649898023,"score_spread":0.30871169081417815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080644517","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13493936,0.7541463,0.0012903926,0.061315935,0.01786176,0.00011009207,0.00036438002,0.00009376491,0.029878007],"genre_scores_gemma":[0.5579666,0.3564829,0.0011314208,0.015763413,0.06304338,0.00006851798,0.000751284,0.000030646584,0.0047619315],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997665,0.000057354453,0.000042597465,0.00003180669,0.00006558804,0.000036164343],"domain_scores_gemma":[0.99899966,0.00048454147,0.0001686065,0.0000319466,0.000062801126,0.00025245143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052138476,0.00020155477,0.000453864,0.0006186061,0.0003503242,0.0005585843,0.00043890768,0.0013075635,0.0032600856],"category_scores_gemma":[0.001973006,0.0001035684,0.00043441533,0.00054009113,0.00048555073,0.00060926256,0.00037272595,0.0013816785,0.0005194774],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034123342,0.00060768606,0.116078205,0.0032250131,0.00025737967,0.037208978,0.00042261233,0.0009670428,0.0023906094,0.0041043265,0.13688971,0.694436],"study_design_scores_gemma":[0.0008456601,0.0048220027,0.32786503,0.004384469,0.0007197402,0.14881583,0.0013546261,0.001384152,0.0018147018,0.008701602,0.499149,0.00014318548],"about_ca_topic_score_codex":0.00094019197,"about_ca_topic_score_gemma":0.002800574,"teacher_disagreement_score":0.0032600856,"about_ca_system_score_codex":0.00049239444,"about_ca_system_score_gemma":0.00087160565,"threshold_uncertainty_score":0.010906041},"labels":[],"label_agreement":null},{"id":"W2089171902","doi":"10.1002/cncr.25341","title":"Utilization of prophylactic cranial irradiation in patients with limited stage small cell lung carcinoma","year":2010,"lang":"en","type":"article","venue":"Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Stage (stratigraphy); Lung; Small Cell Lung Carcinoma; Carcinoma; Oncology; Small-cell carcinoma; Pathology; Internal medicine","score_opus":0.021788731753863824,"score_gpt":0.2982805176712885,"score_spread":0.2764917859174247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089171902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959765,0.0032674796,0.00004895908,0.00011132577,0.0000037464893,0.0000076878105,0.000076966455,0.0000018858806,0.0005053356],"genre_scores_gemma":[0.9987185,0.001039972,0.000060096816,0.000045220357,0.000012863892,0.000005455951,0.000085335334,8.9375493e-7,0.000031724656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994438,0.00018477616,0.0000915947,0.000057415662,0.00016643587,0.000055922996],"domain_scores_gemma":[0.9958643,0.0012748116,0.002304941,0.000091649024,0.0002667323,0.0001974839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005573353,0.000061098806,0.00019391783,0.00072601036,0.0001998394,0.00032098545,0.00021064894,0.00020973127,0.00092643296],"category_scores_gemma":[0.0041761557,0.000075082135,0.00017093748,0.001046457,0.00018565258,0.00019070385,0.00018966605,0.00024536386,0.0000649003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009178044,0.000015511896,0.9921753,0.00005814696,0.000033748012,0.000320535,0.000065275766,0.00004577677,0.00019710335,0.0000118769485,0.000121630845,0.0068633086],"study_design_scores_gemma":[0.000010285295,0.00023963193,0.9947413,0.00005464483,0.000063749336,0.0035484338,0.0002044158,0.00008566826,0.0002676126,0.000012157518,0.00076902984,0.0000029889468],"about_ca_topic_score_codex":0.0030717433,"about_ca_topic_score_gemma":0.0051011033,"teacher_disagreement_score":0.0030717433,"about_ca_system_score_codex":0.00042983986,"about_ca_system_score_gemma":0.0005580963,"threshold_uncertainty_score":0.0061077476},"labels":[],"label_agreement":null},{"id":"W2090674284","doi":"10.1007/s00262-011-1083-6","title":"Immunization with N-propionyl polysialic acid–KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Institute for Biological Sciences","funders":"National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Polysialic acid; Conjugate; Immunization; Antibody; Medicine; Group A; Immunology; Cancer research; Cell; Chemistry; Internal medicine","score_opus":0.014581903922429659,"score_gpt":0.25844688750645256,"score_spread":0.2438649835840229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090674284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998447,0.00025057825,0.00024592364,0.00017515752,0.00002079681,0.00002144668,0.000017883487,0.000026987786,0.00079424196],"genre_scores_gemma":[0.999353,0.000080325226,0.00008484592,0.00008290402,0.00002090357,0.00000841934,0.00004333014,0.0000024897158,0.0003238323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989355,0.0000447096,0.0000052361343,0.000013276325,0.00001374795,0.0000294875],"domain_scores_gemma":[0.9998229,0.000058089117,0.000023688877,0.000022663098,0.0000135397,0.00005908931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035557436,0.00026666568,0.00029738716,0.0001460453,0.000301505,0.00023032833,0.00012116129,0.0003325348,0.0013278921],"category_scores_gemma":[0.00045793908,0.00012518009,0.00021881006,0.000088683075,0.00028520235,0.00021898911,0.00011769138,0.00055470667,0.00027105302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043263923,0.014744895,0.19635782,0.00024867,0.0003956458,0.0034723387,0.0009167071,0.00066637015,0.53950524,0.0006734444,0.0046948874,0.19506],"study_design_scores_gemma":[0.0074344934,0.24553375,0.525097,0.000052951465,0.0004779578,0.0070742075,0.00045898958,0.0024441874,0.20037156,0.0005027902,0.010523286,0.000028794404],"about_ca_topic_score_codex":0.00048685085,"about_ca_topic_score_gemma":0.0005636001,"teacher_disagreement_score":0.0013278921,"about_ca_system_score_codex":0.00023369156,"about_ca_system_score_gemma":0.00025848925,"threshold_uncertainty_score":0.0044422746},"labels":[],"label_agreement":null},{"id":"W2091163157","doi":"10.1007/s11864-001-0017-5","title":"Limited stage small cell lung cancer","year":2001,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Radiation therapy; Prophylactic cranial irradiation; Chemotherapy; Oncology; Stage (stratigraphy); Cisplatin; Lung cancer; Internal medicine; Surgery; Conventional PCI","score_opus":0.23981062934101902,"score_gpt":0.5337653040662865,"score_spread":0.2939546747252675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091163157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005156361,0.99926656,0.00003154889,0.00012057879,0.00010241258,0.0000051404645,0.000012642064,0.000002353162,0.00040721975],"genre_scores_gemma":[0.00042414907,0.9989454,0.00007981804,0.0001629192,0.00007418237,0.0000065767294,0.000017895041,4.116674e-7,0.00028868468],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972624,0.00006911428,0.000064331216,0.000043924414,0.00007734167,0.000019041858],"domain_scores_gemma":[0.9992785,0.00043242885,0.00012780791,0.000018004832,0.000109382796,0.00003395392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097373716,0.00071078417,0.0027016646,0.002844811,0.00029579547,0.00094808725,0.00067575654,0.0007623971,0.004676426],"category_scores_gemma":[0.0015717773,0.00030129464,0.0006328057,0.0040268437,0.000489406,0.001350675,0.00055462687,0.0009063541,0.0012930933],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011402854,0.000045762845,0.0002674168,0.043135956,0.00015918179,0.00016790595,0.00003813683,0.00015681557,0.00053664995,0.0007437006,0.025631957,0.92900246],"study_design_scores_gemma":[0.00010394496,0.00022317278,0.0025956505,0.021390356,0.0010686856,0.0017610331,0.000147075,0.00007398732,0.00038225795,0.00088767643,0.9713458,0.0000204213],"about_ca_topic_score_codex":0.0022267702,"about_ca_topic_score_gemma":0.007865011,"teacher_disagreement_score":0.004676426,"about_ca_system_score_codex":0.00097261113,"about_ca_system_score_gemma":0.001798715,"threshold_uncertainty_score":0.015644193},"labels":[],"label_agreement":null},{"id":"W2091582167","doi":"10.3816/clc.2003.n.024","title":"A Phase I Study of Pegylated Liposomal Doxorubicin Hydrochloride (Caelyx™) in Combination with Cyclophosphamide and Vincristine as Second-Line Treatment of Patients with Small-Cell Lung Cancer","year":2003,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Humber River Regional Hospital; Credit Valley Hospital; Mount Sinai Hospital; Toronto East General Hospital; University of Toronto; University Health Network; Essar Steel Algoma (Canada); Northeast Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Doxorubicin Hydrochloride; Lung cancer; Cyclophosphamide; Vincristine; Doxorubicin; Oncology; Internal medicine; Chemotherapy","score_opus":0.028322384938492345,"score_gpt":0.390273185052095,"score_spread":0.3619508001136027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091582167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934274,0.001869805,0.00048102107,0.00039993657,0.00021080211,0.0017889306,0.00048665915,0.000087160275,0.0012483116],"genre_scores_gemma":[0.9915766,0.0022749451,0.0010936636,0.00039812407,0.00022301472,0.0015234173,0.0010622633,0.000028347218,0.0018195068],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995289,0.00021035939,0.000020681475,0.000094622286,0.00003817097,0.00010731941],"domain_scores_gemma":[0.9991708,0.00014470717,0.000118764925,0.000082964754,0.00004308516,0.00043967992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013333237,0.0015662996,0.0029083467,0.00065426313,0.0005257462,0.0010491278,0.0013285853,0.0015176255,0.0028229442],"category_scores_gemma":[0.0009089577,0.0008425761,0.0013952644,0.00066691363,0.0012913832,0.0011099909,0.00036000114,0.0037624312,0.0008616216],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7599078,0.101778194,0.0030528794,0.0007857108,0.0013013084,0.0002806345,0.00041676947,0.0023959847,0.05351666,0.0003557574,0.0026926256,0.07351583],"study_design_scores_gemma":[0.52723974,0.4610789,0.0044464874,0.000020981386,0.00040379996,0.000168166,0.00006272391,0.0007339252,0.004159445,0.00007173755,0.0015852073,0.000028829218],"about_ca_topic_score_codex":0.0017979249,"about_ca_topic_score_gemma":0.0037073283,"teacher_disagreement_score":0.0029083467,"about_ca_system_score_codex":0.0010721955,"about_ca_system_score_gemma":0.0018551147,"threshold_uncertainty_score":0.009443641},"labels":[],"label_agreement":null},{"id":"W2092041185","doi":"10.1016/s0169-5002(01)00289-6","title":"Commentary on “Carboplatin–etoposide association in small cell lung cancer patients older than 70 years: a phase II trial”","year":2002,"lang":"en","type":"letter","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Carboplatin; Etoposide; Lung cancer; Oncology; Internal medicine; Clinical trial; Chemotherapy; Cisplatin","score_opus":0.020139594596299222,"score_gpt":0.34367419092856416,"score_spread":0.32353459633226495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092041185","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007916107,0.0015902744,0.0000687757,0.9678639,0.02714328,0.00004863648,0.00034468703,0.000026691976,0.002122211],"genre_scores_gemma":[0.0023994981,0.00057715515,0.00013292175,0.9698601,0.023613362,0.0001284461,0.000099263976,0.000018196488,0.0031710716],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99153465,0.0041318326,0.0010109629,0.0008941888,0.0013367614,0.0010916429],"domain_scores_gemma":[0.97411704,0.017795049,0.0018566116,0.0005227363,0.0022512397,0.0034573323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011404225,0.0011063726,0.003547867,0.0008245949,0.0041373144,0.0032305922,0.0032255277,0.06738254,0.008369563],"category_scores_gemma":[0.03917702,0.0013558135,0.002641825,0.0014467831,0.002231818,0.0025619783,0.0017152262,0.04039774,0.005321392],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000815209,0.000042250475,0.00043947963,0.00015292941,0.00006540969,0.000389176,0.000080062324,0.00006022536,0.00014214501,0.000714826,0.99071246,0.006385902],"study_design_scores_gemma":[0.003616888,0.00066422904,0.0033900745,0.0011711752,0.0005692281,0.0007389303,0.00029708643,0.00051212474,0.0006244859,0.0045398683,0.9837533,0.00012262168],"about_ca_topic_score_codex":0.006630125,"about_ca_topic_score_gemma":0.015121898,"teacher_disagreement_score":0.06738254,"about_ca_system_score_codex":0.005040866,"about_ca_system_score_gemma":0.007664224,"threshold_uncertainty_score":0.060312033},"labels":[],"label_agreement":null},{"id":"W2092880963","doi":"10.1002/gcc.20260","title":"Gain of a region on 7p22.3, containing <i>MAD1L1</i>, is the most frequent event in small‐cell lung cancer cell lines","year":2005,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Comparative genomic hybridization; Biology; Loss of heterozygosity; Gene dosage; Copy-number variation; Cancer research; Gene expression profiling; Gene; Genetics; Computational biology; Genome; Gene expression; Allele","score_opus":0.02566807577442347,"score_gpt":0.32627308882556183,"score_spread":0.30060501305113835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092880963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972465,0.00042134066,0.0012103348,0.000027182377,0.0000032840608,0.000011907989,0.00031575307,0.00004701009,0.0007167807],"genre_scores_gemma":[0.9969856,0.0002706293,0.0012763543,0.000016004717,0.0000029394862,0.000019550776,0.0008350109,0.0000083681325,0.0005854637],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998864,0.00001463849,0.00000958073,0.000029497276,0.00004226031,0.000017574903],"domain_scores_gemma":[0.999841,0.00004456154,0.000036444093,0.00001979006,0.000025319841,0.00003286893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092386945,0.0002077127,0.00020010826,0.00080293353,0.00028291444,0.00024689085,0.0001540571,0.00016947053,0.0014431792],"category_scores_gemma":[0.00020939158,0.00009584159,0.00015214195,0.00035838352,0.00025354937,0.00009304544,0.00020440982,0.00025157674,0.00035919657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087258384,0.000013977874,0.0089566605,0.000025594927,0.000010530386,0.00037888697,0.00004943588,0.000045223445,0.9873482,0.000034862984,0.000052395368,0.0029970712],"study_design_scores_gemma":[0.00001762934,0.00032844007,0.21453695,0.0000079163865,0.00004390079,0.005280391,0.00014197876,0.00070359634,0.7752511,0.00010377556,0.0035747264,0.000009548457],"about_ca_topic_score_codex":0.00085482845,"about_ca_topic_score_gemma":0.0012022675,"teacher_disagreement_score":0.0014431792,"about_ca_system_score_codex":0.0001823327,"about_ca_system_score_gemma":0.000108240245,"threshold_uncertainty_score":0.0048279166},"labels":[],"label_agreement":null},{"id":"W2093469730","doi":"10.1017/s0266462304001485","title":"Estimating the benefit and cost of radiotherapy for lung cancer","year":2004,"lang":"en","type":"article","venue":"International Journal of Technology Assessment in Health Care","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Queen's University; Sunnybrook Health Science Centre","funders":"","keywords":"Lung cancer; Radiation therapy; Medicine; Intensive care medicine; Oncology; General surgery; Internal medicine","score_opus":0.020547052937520793,"score_gpt":0.4871723609361508,"score_spread":0.46662530799863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093469730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.872652,0.045751624,0.03301682,0.0060554114,0.00019262722,0.0015553244,0.013891649,0.00019270954,0.026691759],"genre_scores_gemma":[0.9818779,0.0065240706,0.008513168,0.00020497644,0.0000401596,0.00019593396,0.0018017358,0.000017525821,0.00082454085],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9964461,0.0022690783,0.00014275509,0.00017671936,0.000713636,0.00025166542],"domain_scores_gemma":[0.98967665,0.008213408,0.00090978923,0.0002251079,0.00080916483,0.00016593841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041377544,0.0010509909,0.0009220638,0.0027990178,0.00029440786,0.0015754108,0.0010686946,0.0010196592,0.002272296],"category_scores_gemma":[0.028818345,0.00051006465,0.0018314971,0.00283466,0.0005829214,0.0010945278,0.0007091623,0.0009171964,0.00022111449],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002334739,0.00022605532,0.14707834,0.0036087744,0.006951301,0.0005296955,0.00018997374,0.6923217,0.00068544614,0.010812549,0.0052802023,0.1299812],"study_design_scores_gemma":[0.0014050253,0.0022482472,0.2659087,0.0030701964,0.013419828,0.0019680331,0.00096033077,0.6487092,0.0028135392,0.03196334,0.02717823,0.00035536],"about_ca_topic_score_codex":0.26584113,"about_ca_topic_score_gemma":0.18479003,"teacher_disagreement_score":0.26584113,"about_ca_system_score_codex":0.017979397,"about_ca_system_score_gemma":0.009997903,"threshold_uncertainty_score":0.5285875},"labels":[],"label_agreement":null},{"id":"W2095839943","doi":"10.1634/theoncologist.2009-0298","title":"Limited-Stage Small Cell Lung Cancer: Current Chemoradiotherapy Treatment Paradigms","year":2010,"lang":"en","type":"review","venue":"The Oncologist","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemoradiotherapy; Stage (stratigraphy); Oncology; Current (fluid); Lung cancer; Internal medicine; Cancer; Intensive care medicine","score_opus":0.14461746522540633,"score_gpt":0.4771418083636698,"score_spread":0.3325243431382635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095839943","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024097478,0.94576794,0.0014302563,0.045888543,0.0008895641,0.000060293838,0.000086050575,0.000035371508,0.0034322059],"genre_scores_gemma":[0.045403037,0.9139589,0.0040320195,0.02948232,0.0049304166,0.00032999853,0.00035424647,0.000054236418,0.001454867],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980317,0.0008015757,0.00026530493,0.0004417772,0.00034859413,0.000110996865],"domain_scores_gemma":[0.99524766,0.00255742,0.0005892371,0.00022658867,0.0010209369,0.0003582626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008202293,0.00061074307,0.0019557246,0.0009271879,0.0005171571,0.0026605988,0.002242102,0.0015404739,0.0035811258],"category_scores_gemma":[0.006109517,0.00035937192,0.001692969,0.0013271365,0.0018074517,0.0038429382,0.0014720423,0.005106442,0.0013668766],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010331463,0.0003172761,0.0024569407,0.009614144,0.000389399,0.00004851363,0.00022441952,0.001518408,0.00080459594,0.014675759,0.02653298,0.9423845],"study_design_scores_gemma":[0.0014075225,0.003884449,0.011157017,0.02950032,0.002003711,0.0007522083,0.0010901756,0.0036489733,0.001228791,0.07279866,0.87234986,0.00017833053],"about_ca_topic_score_codex":0.0040156394,"about_ca_topic_score_gemma":0.011238693,"teacher_disagreement_score":0.008202293,"about_ca_system_score_codex":0.004102354,"about_ca_system_score_gemma":0.003435099,"threshold_uncertainty_score":0.043378413},"labels":[],"label_agreement":null},{"id":"W2100319754","doi":"10.5430/jbgc.v4n1p21","title":"Prognostic value of FDG-PET scans at diagnosis in small cell lung cancer","year":2013,"lang":"en","type":"article","venue":"Journal of Biomedical Graphics and Computing","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Standardized uptake value; Positron emission tomography; Hazard ratio; Stage (stratigraphy); Lung cancer; PET-CT; Nuclear medicine; Imaging biomarker; Radiology; Biomarker; Predictive value; Prospective cohort study; Oncology; Internal medicine; Magnetic resonance imaging; Confidence interval","score_opus":0.014998057485935171,"score_gpt":0.309217830347643,"score_spread":0.2942197728617078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100319754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974148,0.0015885787,0.00015030293,0.00007901313,0.000019689713,0.000007670711,0.00024031676,0.000007849337,0.0004916175],"genre_scores_gemma":[0.99943286,0.00013920217,0.00008425077,0.00001123665,0.000016728305,0.000003752921,0.00026795783,0.0000015696149,0.000042553245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995716,0.0001526904,0.000056137433,0.000047066922,0.000105434614,0.00006706589],"domain_scores_gemma":[0.9940281,0.0025902023,0.00187957,0.00014088333,0.00063994504,0.00072131894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011042899,0.00033133454,0.00028278472,0.0010811656,0.00024185482,0.0006429152,0.0003466526,0.0007137259,0.0011647668],"category_scores_gemma":[0.0077784713,0.00015619742,0.00028555197,0.00079396134,0.00040277827,0.00048857287,0.00029042957,0.00056065357,0.00032261084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001854376,0.0000066360844,0.9979627,0.0000064048345,0.0000123027885,0.0001753777,0.000007614304,0.00009564747,0.00014791074,0.000004156127,0.000051777068,0.0013440835],"study_design_scores_gemma":[0.000013151237,0.00016314846,0.9960919,0.000016153113,0.000045959103,0.0019995228,0.00006270671,0.000988835,0.00035221383,0.000041989308,0.00021630361,0.000008069269],"about_ca_topic_score_codex":0.0015276675,"about_ca_topic_score_gemma":0.0028072419,"teacher_disagreement_score":0.0015276675,"about_ca_system_score_codex":0.0004070957,"about_ca_system_score_gemma":0.00031442687,"threshold_uncertainty_score":0.0058401227},"labels":[],"label_agreement":null},{"id":"W2101599998","doi":"10.1158/1535-7163.mct-09-0243","title":"Drug ratio–dependent antitumor activity of irinotecan and cisplatin combinations <i>in vitro</i> and <i>in vivo</i>","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Irinotecan; Cisplatin; In vivo; Pharmacology; Drug; In vitro; Cytotoxicity; Chemistry; Medicine; Liposome; Chemotherapy; Cancer; Biology; Internal medicine; Biochemistry","score_opus":0.01875205029635636,"score_gpt":0.32668222912345213,"score_spread":0.3079301788270958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101599998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99382234,0.001933085,0.0022113293,0.00005222202,0.000015816984,0.000051866897,0.0001721122,0.000073005926,0.0016680484],"genre_scores_gemma":[0.99444157,0.0010229615,0.0032078545,0.00003108335,0.0000080981035,0.00006129895,0.00027187384,0.000019374556,0.00093589124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972004,0.000090534304,0.000029361536,0.00004771842,0.00007693739,0.00003534076],"domain_scores_gemma":[0.99985087,0.00004505382,0.000038539954,0.000013562009,0.000028103603,0.000023852104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028031785,0.00036526742,0.00038973577,0.0002786206,0.00008786145,0.00024363579,0.00019974589,0.00016879417,0.00069479994],"category_scores_gemma":[0.00022673553,0.00019663773,0.00020034099,0.00022968664,0.00016697838,0.00026232735,0.00013618858,0.00044295893,0.00021015543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023801687,0.00005654313,0.00016849843,0.00002846097,0.0000102587765,0.000016456965,0.000010900382,0.00026697028,0.99742967,0.000029516425,0.00003440252,0.001710345],"study_design_scores_gemma":[0.000012579245,0.0006478286,0.00086010323,0.0000015827302,0.000016583319,0.00005858186,0.0000048738457,0.000811538,0.9971624,0.0000081009,0.00041263562,0.0000030907129],"about_ca_topic_score_codex":0.00039391362,"about_ca_topic_score_gemma":0.0006460872,"teacher_disagreement_score":0.00069479994,"about_ca_system_score_codex":0.00028170945,"about_ca_system_score_gemma":0.00025139187,"threshold_uncertainty_score":0.0023244023},"labels":[],"label_agreement":null},{"id":"W2105518844","doi":"10.1016/j.lungcan.2010.05.022","title":"A phase I trial of sorafenib combined with cisplatin/etoposide or carboplatin/pemetrexed in refractory solid tumor patients","year":2010,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Cancer Institute; Bayer Canada; Eli Lilly and Company","keywords":"Medicine; Sorafenib; Carboplatin; Pemetrexed; Internal medicine; Etoposide; Oncology; Refractory (planetary science); Lung cancer; Cisplatin; Urology; Chemotherapy; Hepatocellular carcinoma","score_opus":0.01762870376819342,"score_gpt":0.3877932423721357,"score_spread":0.3701645386039423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105518844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909637,0.0025945546,0.00038813718,0.0012202814,0.00035409944,0.0016042261,0.00093151594,0.00009371826,0.0018497964],"genre_scores_gemma":[0.9877643,0.0025447686,0.00133155,0.001022169,0.0003082452,0.0018388467,0.0021491367,0.00004407732,0.0029968263],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993957,0.00030545943,0.000028363827,0.000107631335,0.000031022988,0.0001318665],"domain_scores_gemma":[0.9989147,0.00020099997,0.00013244615,0.00008034797,0.00004812048,0.0006234015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018003337,0.002138079,0.0031559633,0.0005935831,0.0006809151,0.0012956292,0.0010897664,0.0015543854,0.0058626174],"category_scores_gemma":[0.0014109967,0.0008230331,0.002674775,0.0005727286,0.0014984338,0.0015536043,0.0005388568,0.004889515,0.001192952],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9286229,0.021547105,0.0013972488,0.0005313532,0.001304585,0.00013845111,0.00017460564,0.0015873308,0.009244852,0.00022679652,0.0027789783,0.032445814],"study_design_scores_gemma":[0.852589,0.14270398,0.0020560073,0.00001781151,0.0003425875,0.000084226136,0.000045934805,0.00037856447,0.0007412364,0.00011043804,0.0009152278,0.000014912562],"about_ca_topic_score_codex":0.0018954842,"about_ca_topic_score_gemma":0.0044959784,"teacher_disagreement_score":0.0058626174,"about_ca_system_score_codex":0.0013009158,"about_ca_system_score_gemma":0.002084454,"threshold_uncertainty_score":0.019612432},"labels":[],"label_agreement":null},{"id":"W2107266701","doi":"10.1016/j.ijrobp.2010.07.1159","title":"Patterns of Failure in Patients with Limited-Stage Small Cell Lung Carcinoma","year":2010,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Lung; Radiation therapy; Survival analysis; Surgery; Internal medicine","score_opus":0.01384009817909699,"score_gpt":0.31110163759689613,"score_spread":0.29726153941779915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107266701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988638,0.00024842317,0.000053302705,0.000040352927,0.0000027480655,0.0000054979114,0.00019312742,0.0000046994564,0.00058793795],"genre_scores_gemma":[0.9996799,0.00005041285,0.000019421028,0.000011954237,0.000003725176,0.000003780012,0.00013324416,0.000002497242,0.00009508947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996258,0.00008431511,0.00004963209,0.00006737204,0.000046927973,0.00012591916],"domain_scores_gemma":[0.9980288,0.00048350493,0.00071417674,0.000096152995,0.00019081027,0.00048647108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036982578,0.00029630636,0.0005293513,0.001505603,0.00059413386,0.00068867794,0.0005103491,0.00046269796,0.0031806373],"category_scores_gemma":[0.002987021,0.00019781587,0.0004724478,0.0013336354,0.0005530656,0.00083120813,0.00077368633,0.00046820467,0.0004452282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016163656,0.000012988513,0.99852353,0.0000048748093,0.0000108549275,0.0001419583,0.000075464195,0.000049905004,0.00021806364,0.000013434082,0.00003973647,0.0007475977],"study_design_scores_gemma":[0.0000032980242,0.00010259618,0.9986236,0.0000036239676,0.000009569925,0.0006305833,0.0003470132,0.000118585616,0.000042297077,0.000037133537,0.0000770222,0.000004712996],"about_ca_topic_score_codex":0.004529797,"about_ca_topic_score_gemma":0.005228762,"teacher_disagreement_score":0.004529797,"about_ca_system_score_codex":0.00048129403,"about_ca_system_score_gemma":0.0003791461,"threshold_uncertainty_score":0.010640264},"labels":[],"label_agreement":null},{"id":"W2112870137","doi":"10.1200/jco.2005.03.171","title":"Influence of Sex on Toxicity and Treatment Outcome in Small-Cell Lung Cancer","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Cancer Care Ontario; University of Toronto; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Toxicity; Leukopenia; Gastroenterology; Vomiting; Vincristine; Etoposide; Chemotherapy; Stomatitis; Cyclophosphamide; Lung cancer; Surgery","score_opus":0.16985025298338588,"score_gpt":0.5546774789976718,"score_spread":0.384827226014286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112870137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99237424,0.006140789,0.00014234039,0.00012214282,0.000018621242,0.000019233792,0.0002923146,0.0000037609432,0.0008866545],"genre_scores_gemma":[0.9993383,0.00032784164,0.000026781383,0.000042313266,0.000015463407,0.0000068713666,0.00016796765,0.0000018786759,0.00007238633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991014,0.00044128133,0.00009344247,0.00008517207,0.00019746278,0.000081216895],"domain_scores_gemma":[0.99725014,0.0009856867,0.0012572502,0.00009316735,0.00015283388,0.0002608235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017138419,0.00012712761,0.00039961288,0.00037958933,0.00021573498,0.00045566758,0.0001461215,0.00019792681,0.0013206607],"category_scores_gemma":[0.004548855,0.000073625946,0.00054317503,0.00054637465,0.0002726725,0.0002722068,0.0001988336,0.00024264616,0.00014281932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023263597,0.00003686386,0.98459584,0.00004357461,0.00022382413,0.00014687343,0.000036538982,0.00009858556,0.00027731183,0.000026563643,0.00014224726,0.012045435],"study_design_scores_gemma":[0.00012481598,0.001489802,0.99535155,0.000031067822,0.00021273401,0.0013277022,0.000054169963,0.0002087792,0.00025117473,0.00011256844,0.00082958053,0.0000058447063],"about_ca_topic_score_codex":0.0005560438,"about_ca_topic_score_gemma":0.0009057947,"teacher_disagreement_score":0.0017138419,"about_ca_system_score_codex":0.00032440742,"about_ca_system_score_gemma":0.00029135976,"threshold_uncertainty_score":0.00906378},"labels":[],"label_agreement":null},{"id":"W2113396130","doi":"10.1007/s13277-012-0379-2","title":"EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays","year":2012,"lang":"en","type":"article","venue":"Tumor Biology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"University of Nottingham","keywords":"Medicine; Lung cancer; Autoantibody; Internal medicine; Population; Cancer; Lung; Prospective cohort study; Oncology; Immunology; Gastroenterology; Pathology; Antibody","score_opus":0.068781475045296,"score_gpt":0.4493550002952464,"score_spread":0.38057352524995036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113396130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96630526,0.0064011803,0.016413406,0.00043399772,0.00016319925,0.0002482653,0.0019356943,0.00060630095,0.007492593],"genre_scores_gemma":[0.97588253,0.000998968,0.017249528,0.00040458378,0.0001821742,0.00013731942,0.0020192473,0.000052340536,0.003073321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794334,0.0006759286,0.0001385693,0.0004421244,0.0006526431,0.00014741486],"domain_scores_gemma":[0.9969721,0.0015057208,0.00038082243,0.00019192592,0.00068138784,0.00026808082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027313111,0.00071063987,0.000902423,0.0020496957,0.00015761335,0.000859925,0.0006534698,0.0008117101,0.0023097028],"category_scores_gemma":[0.0042030998,0.00027835136,0.00049197994,0.00087414816,0.00026301053,0.00047909873,0.0006318056,0.0007045282,0.0008485929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047338544,0.00048788,0.8067175,0.00033219781,0.00027702577,0.0007648489,0.00012994595,0.0015407694,0.0347142,0.00023920192,0.003583279,0.14647923],"study_design_scores_gemma":[0.0006119414,0.003205284,0.90625274,0.00010935903,0.0003570188,0.015022203,0.00009902527,0.02144706,0.040950023,0.00044223006,0.011395017,0.000108110835],"about_ca_topic_score_codex":0.0010105969,"about_ca_topic_score_gemma":0.0012701747,"teacher_disagreement_score":0.0027313111,"about_ca_system_score_codex":0.00032470134,"about_ca_system_score_gemma":0.00025262978,"threshold_uncertainty_score":0.014444709},"labels":[],"label_agreement":null},{"id":"W2116664839","doi":"10.1016/j.lungcan.2006.02.006","title":"Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer","year":2006,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Humber River Regional Hospital; Ottawa Regional Cancer Foundation; Mount Sinai Hospital; Toronto East General Hospital; University of Toronto; Northeast Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mucositis; Vincristine; Internal medicine; Cyclophosphamide; Gastroenterology; Chemotherapy; Oncology; Surgery","score_opus":0.009898937503427602,"score_gpt":0.31056079973476003,"score_spread":0.3006618622313324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116664839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99351525,0.0016225643,0.0005580677,0.00036527964,0.00020633281,0.0018373624,0.0005664026,0.00009744595,0.001231403],"genre_scores_gemma":[0.99144745,0.001731979,0.0010459912,0.00034850018,0.00021251077,0.0017356994,0.0010346351,0.000036181667,0.0024071017],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994466,0.00025909406,0.000020602998,0.000111745176,0.000038167098,0.00012378716],"domain_scores_gemma":[0.9991708,0.00014226642,0.000115543604,0.00009372224,0.00003984981,0.00043786052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015240975,0.0017863469,0.0033368357,0.00069308444,0.0005738113,0.001352369,0.0014985722,0.0017186424,0.0037235336],"category_scores_gemma":[0.000903761,0.00093249744,0.0013009376,0.0006845017,0.0014227403,0.0012828301,0.00043288455,0.0039684703,0.0010319513],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7594244,0.11096323,0.0029608372,0.00062530435,0.0011878883,0.00025304075,0.00040457956,0.002954288,0.058842372,0.00041336974,0.0022747396,0.059696045],"study_design_scores_gemma":[0.53744674,0.44830963,0.0046747774,0.000018704202,0.00037880597,0.00015724199,0.00007969928,0.0010625224,0.005992958,0.000080640064,0.0017682111,0.000030062723],"about_ca_topic_score_codex":0.0021434105,"about_ca_topic_score_gemma":0.0040737092,"teacher_disagreement_score":0.0037235336,"about_ca_system_score_codex":0.0012431802,"about_ca_system_score_gemma":0.002137658,"threshold_uncertainty_score":0.012456477},"labels":[],"label_agreement":null},{"id":"W2118797321","doi":"10.1590/s0100-39842006000100009","title":"Tratamento do câncer de pequenas células de pulmão: doença limitada: resultados de uma única instituição","year":2006,"lang":"pt","type":"article","venue":"Radiologia Brasileira","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Medicine; Conventional PCI; Surgery; Internal medicine","score_opus":0.03517528740010017,"score_gpt":0.33421031900655923,"score_spread":0.29903503160645906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118797321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941606,0.004670561,0.00025979686,0.00008813419,0.000006956656,0.000027577207,0.000067390385,0.0000071740346,0.0007116533],"genre_scores_gemma":[0.9981823,0.001065345,0.0003548112,0.000042097377,0.000011382059,0.00002857394,0.000084378065,0.0000030608753,0.00022801424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993826,0.00032062017,0.000043279844,0.00007889204,0.00010374564,0.00007080124],"domain_scores_gemma":[0.99797314,0.000861953,0.00052572007,0.0001679192,0.00032142046,0.00014986536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011293327,0.00019152039,0.00052932557,0.0003110986,0.00038675172,0.0005354569,0.00022036441,0.00034374144,0.0016194746],"category_scores_gemma":[0.0029122808,0.00010567214,0.00038474516,0.00053194095,0.00032281852,0.00035670222,0.00064754265,0.00027092334,0.00013201528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015917398,0.0020378993,0.641751,0.0025748184,0.00063691224,0.0036862039,0.003838527,0.0051623657,0.10228493,0.00029847445,0.0010257678,0.22078568],"study_design_scores_gemma":[0.00069360767,0.03429698,0.8724164,0.00037346152,0.0014510087,0.008513943,0.00401261,0.0021202455,0.0632516,0.0003522222,0.012449467,0.000068425485],"about_ca_topic_score_codex":0.0032507034,"about_ca_topic_score_gemma":0.004560116,"teacher_disagreement_score":0.0032507034,"about_ca_system_score_codex":0.00070288236,"about_ca_system_score_gemma":0.0005863788,"threshold_uncertainty_score":0.0064635873},"labels":[],"label_agreement":null},{"id":"W2119063943","doi":"10.1259/bjr.20130653","title":"Is pre-trial quality assurance necessary? Experiences of the CONVERT Phase III randomized trial for good performance status patients with limited-stage small-cell lung cancer","year":2014,"lang":"en","type":"article","venue":"British Journal of Radiology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"Cancer Research UK; National Cancer Research Institute","keywords":"Medicine; Quality assurance; Context (archaeology); Protocol (science); Medical physics; Clinical trial; Randomized controlled trial; Radiation treatment planning; Radiation therapy; Randomization; Stage (stratigraphy); Physical therapy; Surgery; Alternative medicine; Internal medicine; Pathology","score_opus":0.021258187998997067,"score_gpt":0.34746975815077225,"score_spread":0.32621157015177515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119063943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.942898,0.009597807,0.007117383,0.018421186,0.00055337296,0.00807267,0.0007084924,0.00015403051,0.012477116],"genre_scores_gemma":[0.98343027,0.0010454378,0.0067289933,0.0038935053,0.00032481973,0.0033102508,0.00032921263,0.00005284998,0.0008846255],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.74432755,0.23015727,0.00837479,0.0028065278,0.010478051,0.003855882],"domain_scores_gemma":[0.7009684,0.1821009,0.06854828,0.017858759,0.021241108,0.009282554],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.20734243,0.0003270797,0.0012043689,0.00039876183,0.0015653208,0.0033209187,0.0011301183,0.0017106843,0.003103998],"category_scores_gemma":[0.36051002,0.0004282507,0.0011238379,0.0011733371,0.0020919752,0.0017705584,0.002311069,0.0018919016,0.00044258113],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11203273,0.00671836,0.19559005,0.0065893694,0.0026322224,0.0006875487,0.03253584,0.0075489846,0.0022915557,0.0032716293,0.02881015,0.60129166],"study_design_scores_gemma":[0.06471251,0.18181673,0.50643736,0.008352626,0.0024126384,0.0023461336,0.029455347,0.010748809,0.007359433,0.010222741,0.17539781,0.0007378784],"about_ca_topic_score_codex":0.003321869,"about_ca_topic_score_gemma":0.0078430185,"teacher_disagreement_score":0.79265755,"about_ca_system_score_codex":0.0043289815,"about_ca_system_score_gemma":0.010982369,"threshold_uncertainty_score":0.9774879},"labels":[],"label_agreement":null},{"id":"W2120616064","doi":"10.1016/j.lungcan.2003.07.004","title":"Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia","year":2003,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Stage (stratigraphy); Radiation therapy; Population; Lung cancer; Chemotherapy; Cancer; Disease; Internal medicine; Surgery","score_opus":0.015905256602102007,"score_gpt":0.3731261203917312,"score_spread":0.3572208637896292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120616064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894629,0.0014877348,0.00008259138,0.00239929,0.00004328492,0.000035998706,0.0031867484,0.000012570899,0.003288915],"genre_scores_gemma":[0.9963491,0.00060512585,0.00006791354,0.00028674127,0.0000086870405,0.000030592586,0.0013650222,0.000004893591,0.0012819582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951656,0.0017389833,0.00033387248,0.00035586074,0.0010666903,0.0013390272],"domain_scores_gemma":[0.9887404,0.0023486298,0.0013953834,0.00070250354,0.0047829184,0.0020301556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041174935,0.0003190442,0.0008253759,0.0012750159,0.0014031283,0.0015601276,0.0020079126,0.0010483919,0.001979309],"category_scores_gemma":[0.018470423,0.00035511146,0.0008715733,0.004288251,0.0009538184,0.0008197321,0.0018092608,0.0016011557,0.00018868642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009925767,0.00026056773,0.9779571,0.00009950774,0.00037666058,0.00017360435,0.0008906875,0.001091684,0.00016758744,0.00062178285,0.00426697,0.013101245],"study_design_scores_gemma":[0.000059807062,0.00009216828,0.99692386,0.000051541178,0.0001381744,0.000028113758,0.0010792966,0.0003911317,0.00006834116,0.00010939348,0.0010389367,0.000019156985],"about_ca_topic_score_codex":0.98505396,"about_ca_topic_score_gemma":0.99043685,"teacher_disagreement_score":0.02942243,"about_ca_system_score_codex":0.02942243,"about_ca_system_score_gemma":0.035912197,"threshold_uncertainty_score":0.2134757},"labels":[],"label_agreement":null},{"id":"W2121478471","doi":"10.1016/j.ijrobp.2010.07.1230","title":"Phase II Trial of Consolidation Chest Radiotherapy for Extensive Stage Small Cell Lung Cancer","year":2010,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Chemotherapy; Radiation therapy; Lung cancer; Esophagitis; Conventional PCI; Progressive disease; Surgery; Internal medicine; Disease; Myocardial infarction; Reflux","score_opus":0.0360691853938333,"score_gpt":0.4247224750977204,"score_spread":0.3886532897038871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121478471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99042666,0.0022504863,0.0006250585,0.0006971043,0.00034149466,0.0023302266,0.00079064246,0.00017040271,0.002367884],"genre_scores_gemma":[0.9830919,0.002271485,0.0017738112,0.0011740585,0.00026250855,0.0032731353,0.002471418,0.00007140592,0.0056102504],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994917,0.00020282899,0.000020747077,0.00011559195,0.000034961133,0.00013423026],"domain_scores_gemma":[0.998803,0.00016164573,0.00016295984,0.00015641071,0.000049375245,0.00066653534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001745202,0.0024391608,0.0036421919,0.00067449256,0.0008110216,0.0015864492,0.0017477293,0.0019860098,0.0071119135],"category_scores_gemma":[0.0010790958,0.00078420585,0.0018769018,0.0006900609,0.0022281099,0.0011696345,0.000814213,0.005102185,0.002154569],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7999737,0.06787496,0.0035556043,0.0008271661,0.001408249,0.00020186408,0.00047250194,0.0052619735,0.030061474,0.0005618078,0.004883742,0.08491682],"study_design_scores_gemma":[0.63486695,0.35331336,0.0058718245,0.000038320082,0.00036107737,0.00016807296,0.00010751037,0.0013049518,0.0017168105,0.00032823323,0.0018954625,0.0000274297],"about_ca_topic_score_codex":0.002507572,"about_ca_topic_score_gemma":0.0046336222,"teacher_disagreement_score":0.0071119135,"about_ca_system_score_codex":0.0013001629,"about_ca_system_score_gemma":0.0021726133,"threshold_uncertainty_score":0.02379167},"labels":[],"label_agreement":null},{"id":"W2124177114","doi":"","title":"Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Protein kinase B; MAPK/ERK pathway; Kinase; Cancer research; Protein kinase A; Biology; Medicine; Internal medicine; Pathology; Signal transduction; Cell biology","score_opus":0.01654411216181807,"score_gpt":0.24520256669132096,"score_spread":0.2286584545295029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124177114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990128,0.000557721,0.000060508177,0.000052091116,0.000004617141,0.0000045258003,0.00010096845,0.000004249524,0.00020246403],"genre_scores_gemma":[0.9995602,0.00009509385,0.000061339204,0.000015103279,0.00001701445,0.000008550452,0.0001854106,9.761472e-7,0.000056253622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997762,0.000056772387,0.000025295587,0.00003656608,0.00006003975,0.000045114346],"domain_scores_gemma":[0.9988858,0.00039818938,0.00029208744,0.000036460387,0.00010927988,0.00027819021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039187382,0.0003324093,0.00028956254,0.0007209205,0.0003280725,0.00032767613,0.00021077871,0.00054019253,0.0010320639],"category_scores_gemma":[0.0016738941,0.00015374202,0.00020833392,0.00059840095,0.00039442576,0.00033465135,0.00020575595,0.00038932892,0.00021905135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026857603,0.000019851363,0.99685055,0.000009367226,0.00001757211,0.00020465239,0.000013835323,0.000057432735,0.00091624825,0.0000065563063,0.000083892315,0.001551584],"study_design_scores_gemma":[0.000021793747,0.00021341596,0.99696547,0.0000053192853,0.00003783447,0.0017042586,0.000058022724,0.00042195249,0.00038046882,0.000029618413,0.00015845153,0.0000034836785],"about_ca_topic_score_codex":0.000817551,"about_ca_topic_score_gemma":0.0011232846,"teacher_disagreement_score":0.0010320639,"about_ca_system_score_codex":0.00024767456,"about_ca_system_score_gemma":0.00029173977,"threshold_uncertainty_score":0.0034525394},"labels":[],"label_agreement":null},{"id":"W2125430981","doi":"10.1200/jco.2005.05.3181","title":"Early Compared With Late Radiotherapy in Combined Modality Treatment for Limited Disease Small-Cell Lung Cancer: A London Lung Cancer Group Multicenter Randomized Clinical Trial and Meta-Analysis","year":2006,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Etoposide; Radiation therapy; Chemotherapy; Vincristine; Lung cancer; Hazard ratio; Prophylactic cranial irradiation; Internal medicine; Cyclophosphamide; Surgery; Oncology; Confidence interval","score_opus":0.30821068473514257,"score_gpt":0.571832692282891,"score_spread":0.26362200754774845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125430981","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37153417,0.6146788,0.004047597,0.0014872331,0.0021426023,0.0019829539,0.0020084283,0.00021447275,0.0019037663],"genre_scores_gemma":[0.9618526,0.029942006,0.0031174647,0.0012712337,0.0005629736,0.001527659,0.00087650813,0.00004380823,0.0008056795],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99152386,0.006018732,0.000872706,0.0010110001,0.00035145428,0.00022230129],"domain_scores_gemma":[0.9925538,0.004524652,0.0015913005,0.00053905026,0.00041539274,0.00037575827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011696234,0.0023443555,0.010493135,0.0013656925,0.0005470549,0.0025025904,0.0014506868,0.002921178,0.0032783772],"category_scores_gemma":[0.016817722,0.0011640864,0.02660525,0.0014445336,0.00067710807,0.0013342046,0.0008841989,0.0028335173,0.0003154799],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3471771,0.00043830657,0.008680068,0.024295589,0.6055968,0.00012952383,0.00006937296,0.0017538568,0.0009892819,0.00015021775,0.0006772649,0.010042663],"study_design_scores_gemma":[0.12378508,0.01037139,0.008079114,0.0019863534,0.8522979,0.00011759992,0.0000375442,0.0013930327,0.00039609152,0.0003649859,0.0011192232,0.000051612697],"about_ca_topic_score_codex":0.003326259,"about_ca_topic_score_gemma":0.0057190945,"teacher_disagreement_score":0.011696234,"about_ca_system_score_codex":0.0017005298,"about_ca_system_score_gemma":0.0011588307,"threshold_uncertainty_score":0.06185633},"labels":[],"label_agreement":null},{"id":"W2125702108","doi":"10.1158/1078-0432.ccr-04-1036","title":"Antitumor Efficacy of Oblimersen Bcl-2 Antisense Oligonucleotide Alone and in Combination with Vinorelbine in Xenograft Models of Human Non–Small Cell Lung Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Vinorelbine; Lung cancer; Cancer research; Cancer; Pharmacology; Apoptosis; Paclitaxel; Medicine; Biology; Chemotherapy; Pathology; Internal medicine; Biochemistry; Cisplatin","score_opus":0.1256711117554593,"score_gpt":0.4880451359847064,"score_spread":0.3623740242292471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125702108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975949,0.00094607007,0.00053365674,0.00006328134,0.00005164724,0.00004311841,0.00016963201,0.000053396427,0.0005442663],"genre_scores_gemma":[0.99613047,0.0009203448,0.0010456189,0.000024176803,0.000015390915,0.000057645382,0.00030828954,0.00001465455,0.0014832555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983287,0.000048973565,0.000014263907,0.000029841618,0.00003263699,0.00004133958],"domain_scores_gemma":[0.9998605,0.000026128475,0.00002976604,0.000020028963,0.000011050184,0.000052428295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000303499,0.0005492757,0.0008408705,0.00035356262,0.0001346431,0.00023215475,0.00028703382,0.00032841013,0.0008151621],"category_scores_gemma":[0.00013393702,0.0001995658,0.00030923597,0.00022048627,0.00020721817,0.00032681943,0.00012401043,0.0007368374,0.0001421331],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015008313,0.0008754259,0.0002326022,0.00006377659,0.000026222457,0.00003514797,0.00003193999,0.00034651312,0.99320215,0.00007392206,0.0000976555,0.0035138654],"study_design_scores_gemma":[0.00068707246,0.026143325,0.005166677,0.000013140686,0.00010534492,0.00023714187,0.00006636132,0.0030519436,0.9621891,0.00006016884,0.0022640731,0.000015635593],"about_ca_topic_score_codex":0.0009337189,"about_ca_topic_score_gemma":0.0020196943,"teacher_disagreement_score":0.0009337189,"about_ca_system_score_codex":0.00034282316,"about_ca_system_score_gemma":0.00030414318,"threshold_uncertainty_score":0.002726972},"labels":[],"label_agreement":null},{"id":"W2125817273","doi":"10.1016/j.ijrobp.2014.12.026","title":"Risk of Hippocampal Metastases in Small Cell Lung Cancer Patients at Presentation and After Cranial Irradiation: A Safety Profile Study for Hippocampal Sparing During Prophylactic or Therapeutic Cranial Irradiation","year":2015,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Internal medicine; Confidence interval; Lung cancer; Radiation therapy; Logistic regression; Cancer; Neurocognitive; Oncology; Clinical trial; Hazard ratio; Incidence (geometry); Surgery; Conventional PCI","score_opus":0.030822629929344612,"score_gpt":0.36617453287702667,"score_spread":0.3353519029476821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125817273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994947,0.00020994376,0.00004000123,0.000013635001,0.000002407825,0.000005856885,0.00006772948,8.2442057e-7,0.00016490935],"genre_scores_gemma":[0.9997129,0.000073753494,0.000020532569,0.000013114603,0.000005390009,0.000004109154,0.00009428997,0.0000013723677,0.0000746221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997093,0.00007738964,0.000023349987,0.00006664117,0.00006000483,0.000063202686],"domain_scores_gemma":[0.99876475,0.00039361184,0.00041646196,0.000074063355,0.00010609693,0.0002450809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003697835,0.0002691982,0.00041813072,0.00034563753,0.00025618222,0.00056802935,0.00028064894,0.0004098514,0.0010811847],"category_scores_gemma":[0.0019366954,0.00014716532,0.00085134536,0.0005297957,0.00024178703,0.00038560806,0.00030656852,0.0004621831,0.00014280964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008489439,0.00020058476,0.98369503,0.000031474556,0.0002797135,0.0002569801,0.00014855785,0.0001960154,0.0017054413,0.000028109029,0.00007551102,0.00489311],"study_design_scores_gemma":[0.00011219745,0.003774487,0.9940136,0.0000071129607,0.00024548682,0.0005420511,0.00032595303,0.0002707002,0.00046295687,0.000053707958,0.0001793182,0.000012468988],"about_ca_topic_score_codex":0.0022769764,"about_ca_topic_score_gemma":0.002536432,"teacher_disagreement_score":0.0022769764,"about_ca_system_score_codex":0.00040352865,"about_ca_system_score_gemma":0.0004312893,"threshold_uncertainty_score":0.00452739},"labels":[],"label_agreement":null},{"id":"W2126286484","doi":"10.1097/cco.0b013e328011bec3","title":"Small cell lung cancer and targeted therapies","year":2007,"lang":"en","type":"review","venue":"Current Opinion in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lung cancer; Oncology; Cancer research","score_opus":0.23965804037608615,"score_gpt":0.5356286030227594,"score_spread":0.2959705626466732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126286484","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004936258,0.9981165,0.00004358776,0.00027527456,0.00033455977,0.000005104269,0.0000067720284,0.00000462509,0.001164315],"genre_scores_gemma":[0.0004337421,0.99804854,0.000089563415,0.00027927232,0.00044731554,0.000007922459,0.000017213453,0.0000011578634,0.0006751832],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997093,0.00006260436,0.000035025747,0.00003949997,0.00012678093,0.000026707881],"domain_scores_gemma":[0.9996468,0.00016687244,0.000050965395,0.00001210151,0.00008227684,0.000040970597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000708601,0.000963132,0.0018163007,0.0021251966,0.0003004734,0.0009969125,0.00090905296,0.0011599797,0.005833749],"category_scores_gemma":[0.0008821641,0.00024089609,0.0004441877,0.002477352,0.00065295777,0.0013753604,0.0005393886,0.0016471705,0.004207683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006506062,0.00006985367,0.0001892438,0.012411776,0.00006942842,0.0004071031,0.000044266104,0.00034765562,0.0008640741,0.0025634337,0.0748874,0.9080807],"study_design_scores_gemma":[0.000023197532,0.000049937174,0.00055642973,0.0030111147,0.000059624417,0.0018752676,0.00004378178,0.00004279752,0.00019016342,0.000989842,0.9931498,0.00000800272],"about_ca_topic_score_codex":0.0011819651,"about_ca_topic_score_gemma":0.0018146477,"teacher_disagreement_score":0.005833749,"about_ca_system_score_codex":0.0009368789,"about_ca_system_score_gemma":0.0013311704,"threshold_uncertainty_score":0.019515812},"labels":[],"label_agreement":null},{"id":"W2126709547","doi":"10.1158/1078-0432.ccr-11-3090","title":"Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":551,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"National Cancer Institute; U.S. Food and Drug Administration","keywords":"Medicine; Internal medicine; Oncology; Biomarker; Toxicity; Phases of clinical research; Clinical endpoint; Lung cancer; Clinical trial; Biology","score_opus":0.1977189728280281,"score_gpt":0.5160958239841599,"score_spread":0.3183768511561318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126709547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977564,0.00051999366,0.0001855661,0.00007752073,0.000025971742,0.0008172336,0.00024165917,0.000027349526,0.00034834212],"genre_scores_gemma":[0.99557436,0.00043927672,0.0007176253,0.00023470692,0.00007711263,0.0010358153,0.0011056155,0.000011975652,0.0008036463],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99961394,0.0001877591,0.000019245259,0.00006392319,0.000048528786,0.00006655396],"domain_scores_gemma":[0.99914455,0.000120294295,0.0001437757,0.00007062315,0.000064970125,0.0004558849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014909882,0.0013802549,0.0018130919,0.00037466345,0.00046150954,0.000706244,0.00070633256,0.0009638315,0.0018784623],"category_scores_gemma":[0.0009113763,0.00047348972,0.00084261823,0.00041644028,0.0010191328,0.00056107965,0.00032398335,0.0018996774,0.00061055506],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6903481,0.093028136,0.051362082,0.00048188423,0.00097140763,0.0005808228,0.00047984123,0.003808775,0.08455473,0.00017049588,0.0018105514,0.07240317],"study_design_scores_gemma":[0.15165688,0.8013475,0.03829591,0.000017597424,0.00031226408,0.00033635693,0.0000929448,0.0014429605,0.00515469,0.000100945006,0.0012127792,0.00002916477],"about_ca_topic_score_codex":0.0011595379,"about_ca_topic_score_gemma":0.0023770889,"teacher_disagreement_score":0.0018784623,"about_ca_system_score_codex":0.00088972726,"about_ca_system_score_gemma":0.002013883,"threshold_uncertainty_score":0.007885218},"labels":[],"label_agreement":null},{"id":"W2127363643","doi":"10.1093/annonc/mdp300","title":"The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit","year":2009,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Mucositis; Lung cancer; Chemotherapy; Confidence interval; Univariate analysis; Randomized controlled trial; Performance status; Gastroenterology; Surgery; Multivariate analysis","score_opus":0.46529234876494757,"score_gpt":0.5755875765724024,"score_spread":0.11029522780745488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127363643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5081797,0.48085058,0.0036963734,0.0011630135,0.00093376724,0.00047817244,0.0026664026,0.00007852471,0.0019535203],"genre_scores_gemma":[0.9826194,0.013645915,0.00092203653,0.00054710166,0.00059957936,0.00021087399,0.0009966969,0.00004292426,0.00041554237],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9482624,0.04199956,0.004855283,0.0025675297,0.0015798026,0.00073554926],"domain_scores_gemma":[0.9162116,0.06467981,0.010113547,0.0058344123,0.0018363416,0.0013243043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.045234103,0.0022206034,0.011391065,0.001946569,0.00059812097,0.0029910295,0.0013838541,0.0024275053,0.002848051],"category_scores_gemma":[0.06129666,0.0013176793,0.024822583,0.0026851492,0.0012244852,0.002050932,0.0016431567,0.0025777405,0.00025661345],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21946345,0.00007813388,0.06190035,0.008374409,0.69369376,0.0001949226,0.00013521507,0.001469514,0.0011871078,0.00016484974,0.00081355014,0.012524727],"study_design_scores_gemma":[0.040644746,0.0074846637,0.09742962,0.00074815727,0.84906965,0.00026830257,0.00013474218,0.0011679757,0.00057680556,0.00065167004,0.0017048861,0.0001187355],"about_ca_topic_score_codex":0.0016722773,"about_ca_topic_score_gemma":0.003913788,"teacher_disagreement_score":0.045234103,"about_ca_system_score_codex":0.00088696874,"about_ca_system_score_gemma":0.0008269283,"threshold_uncertainty_score":0.23922366},"labels":[],"label_agreement":null},{"id":"W2128083415","doi":"10.1016/s1470-2045(13)70510-2","title":"Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":526,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Juravinski Cancer Centre; Institut universitaire de cardiologie et de pneumologie de Québec; Alberta Cancer Foundation","funders":"Merck KGaA","keywords":"Medicine; Placebo; Chemoradiotherapy; Clinical endpoint; Internal medicine; Population; Lung cancer; Surgery; Phases of clinical research; Hazard ratio; Cancer; Clinical trial; Oncology; Confidence interval; Pathology","score_opus":0.08993665752350942,"score_gpt":0.43539217495574034,"score_spread":0.3454555174322309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128083415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718168,0.010312694,0.0014355275,0.00092845404,0.0014176887,0.007302948,0.002374579,0.00047375885,0.0039375545],"genre_scores_gemma":[0.97366387,0.004668603,0.0019359929,0.0014185596,0.0006481945,0.008136789,0.001596551,0.000057476238,0.007873814],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99949634,0.00023193084,0.000027778176,0.00009432945,0.0000375193,0.0001121479],"domain_scores_gemma":[0.999411,0.0001719724,0.00011372189,0.000049009323,0.000029642997,0.00022456504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015215714,0.0022295944,0.0037449861,0.0005758571,0.0005005682,0.0012386605,0.0011021502,0.002458773,0.009692902],"category_scores_gemma":[0.0012174004,0.00087281235,0.0025027762,0.0005107832,0.0015845055,0.0014866684,0.0005187819,0.0037057225,0.0021010912],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9881495,0.0021792653,0.000109468005,0.0004953792,0.00041480424,0.00002211364,0.000028946224,0.00015929263,0.0012967812,0.00007125848,0.00057703274,0.006496032],"study_design_scores_gemma":[0.97386485,0.025077527,0.00029823597,0.000022083843,0.00016213016,0.000010496915,0.000011222885,0.00011127761,0.00014212508,0.000061654035,0.00022990549,0.00000848329],"about_ca_topic_score_codex":0.0011544912,"about_ca_topic_score_gemma":0.0025902092,"teacher_disagreement_score":0.009692902,"about_ca_system_score_codex":0.00070273376,"about_ca_system_score_gemma":0.0010006231,"threshold_uncertainty_score":0.032426},"labels":[],"label_agreement":null},{"id":"W2128284305","doi":"10.2174/157488708784223880","title":"Combined Modality Treatment of Limited Stage Small Cell Carcinoma of the Lung","year":2008,"lang":"en","type":"review","venue":"Reviews on Recent Clinical Trials","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Radiation therapy; Etoposide; Lung cancer; Oncology; Chemotherapy; Chemoradiotherapy; Prophylactic cranial irradiation; Small-cell carcinoma; Small Cell Lung Carcinoma; Stage (stratigraphy); Regimen; Internal medicine","score_opus":0.695592279869349,"score_gpt":0.5919639224378469,"score_spread":0.10362835743150212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128284305","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016824513,0.9993963,0.000021381198,0.000033907956,0.000034323264,0.000006080562,0.000009670571,0.0000014717571,0.0003285596],"genre_scores_gemma":[0.0012055676,0.9983972,0.00006405701,0.000063674815,0.00004149727,0.00000824638,0.000017786702,5.045506e-7,0.00020149889],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999765,0.000069112466,0.00003676975,0.000038742746,0.00007659148,0.000013729661],"domain_scores_gemma":[0.9997085,0.00015848977,0.0000714398,0.0000072964685,0.000038190676,0.000016181086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005518492,0.00056558615,0.0023132502,0.0014385162,0.0001687356,0.00051083823,0.0008146914,0.00062218757,0.0042910106],"category_scores_gemma":[0.0008357542,0.00020155536,0.0009220673,0.0019178533,0.00025111903,0.00056488084,0.0003362845,0.00059190404,0.0008737614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034315654,0.00009948791,0.00023442297,0.08024819,0.0008637092,0.00019331902,0.00003227455,0.00019512215,0.0009956138,0.00045922876,0.012188781,0.9041468],"study_design_scores_gemma":[0.0010405035,0.0018725375,0.011889373,0.058399606,0.0069465176,0.007413619,0.00022270934,0.0002869044,0.0022946147,0.0018711763,0.9077066,0.000055874298],"about_ca_topic_score_codex":0.0010284544,"about_ca_topic_score_gemma":0.0030092804,"teacher_disagreement_score":0.0042910106,"about_ca_system_score_codex":0.00039684388,"about_ca_system_score_gemma":0.00058332656,"threshold_uncertainty_score":0.014354825},"labels":[],"label_agreement":null},{"id":"W2129527916","doi":"10.1097/01.jto.0000263720.15062.51","title":"Chemotherapy for Relapsed Small Cell Lung Cancer: A Systematic Review and Practice Guideline","year":2007,"lang":"en","type":"review","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Princess Margaret Cancer Centre; Hamilton Health Sciences; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Topotecan; Carboplatin; Internal medicine; Randomized controlled trial; Vincristine; Oncology; Lung cancer; Guideline; Chemotherapy; Cyclophosphamide; Surgery; Cisplatin; Pathology","score_opus":0.10232241946579926,"score_gpt":0.576323181801895,"score_spread":0.4740007623360958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129527916","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00081501174,0.9930837,0.00039014954,0.003219382,0.0005916675,0.0007006997,0.0004725884,0.00001960225,0.0007071591],"genre_scores_gemma":[0.019535001,0.9702706,0.004616055,0.0034577488,0.0003821986,0.00090480596,0.0003570772,0.000010117972,0.00046637867],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9920332,0.0030347048,0.003187643,0.00048169674,0.0011099568,0.00015272723],"domain_scores_gemma":[0.9810168,0.010289558,0.0054591126,0.00030500043,0.0025329238,0.00039657924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009980541,0.00095860683,0.0063208393,0.0042005023,0.00043571446,0.0012454297,0.0020957442,0.0018799012,0.002654102],"category_scores_gemma":[0.029366938,0.00094541686,0.0052986746,0.0036869894,0.0006372292,0.0013788549,0.0009975258,0.0017168875,0.00035125224],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007131814,0.000059863327,0.0024761944,0.6798573,0.02005489,0.00032454004,0.00031242965,0.0004472498,0.00070663996,0.00085142854,0.044317756,0.24987836],"study_design_scores_gemma":[0.0031589484,0.0005668405,0.01192555,0.7547308,0.113091856,0.0009777952,0.0003152395,0.00043992352,0.00062306604,0.001377146,0.11269966,0.00009308629],"about_ca_topic_score_codex":0.0106016435,"about_ca_topic_score_gemma":0.05476219,"teacher_disagreement_score":0.0106016435,"about_ca_system_score_codex":0.0039983653,"about_ca_system_score_gemma":0.00844532,"threshold_uncertainty_score":0.052782774},"labels":[],"label_agreement":null},{"id":"W2129638180","doi":"10.1200/jco.2007.12.3083","title":"Phase II Study of Vandetanib or Placebo in Small-Cell Lung Cancer Patients After Complete or Partial Response to Induction Chemotherapy With or Without Radiation Therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Vandetanib; Medicine; Internal medicine; Placebo; Gastroenterology; Oncology; Cancer; Phases of clinical research; Chemotherapy; Surgery; Pathology; Sorafenib","score_opus":0.2888795793822542,"score_gpt":0.5751775702922032,"score_spread":0.28629799090994895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129638180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95426524,0.01055676,0.0016439289,0.0023557448,0.00097194966,0.020127974,0.004359681,0.00032184646,0.00539684],"genre_scores_gemma":[0.95996124,0.0054976717,0.0036410934,0.0028517751,0.0005640213,0.015811626,0.0029979881,0.00004927493,0.008625156],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992449,0.0004350517,0.000030678257,0.00010309603,0.000073125,0.00011312241],"domain_scores_gemma":[0.9991755,0.00015368342,0.00018617875,0.000060436243,0.000054487762,0.00036973052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025172697,0.0019344849,0.0034305186,0.0004733038,0.0005223779,0.00092679664,0.0012992765,0.00182899,0.00657947],"category_scores_gemma":[0.0018225375,0.0008148522,0.0012768881,0.0005198115,0.0013484193,0.00061629486,0.0002969622,0.003176582,0.0012650044],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9332426,0.023234995,0.0014159806,0.0009034162,0.0010653035,0.00009250302,0.000093044844,0.00060302403,0.006630928,0.0002062098,0.004280685,0.028231313],"study_design_scores_gemma":[0.9566301,0.04111402,0.0011162958,0.000012042935,0.00010457053,0.000022970768,0.0000073246038,0.00017846566,0.00017941157,0.000055176733,0.00057414,0.00000541807],"about_ca_topic_score_codex":0.004841282,"about_ca_topic_score_gemma":0.0135773085,"teacher_disagreement_score":0.00657947,"about_ca_system_score_codex":0.0017281685,"about_ca_system_score_gemma":0.0031044835,"threshold_uncertainty_score":0.022010505},"labels":[],"label_agreement":null},{"id":"W2130774003","doi":"10.1002/cncy.21435","title":"Accuracy of bronchial brush and wash specimens prepared by the ThinPrep method in the diagnosis of pulmonary small cell carcinoma","year":2014,"lang":"en","type":"article","venue":"Cancer Cytopathology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Dalhousie University; Alberta Health Services","funders":"","keywords":"Medicine; Brush; Positive predicative value; Gastroenterology; Carcinoma; Internal medicine; Pathology; Predictive value","score_opus":0.028201559662309268,"score_gpt":0.34191097670112697,"score_spread":0.3137094170388177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130774003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746025,0.0013229721,0.00065902976,0.00003134011,0.000009224596,0.000006805898,0.00012830122,0.000017441236,0.0003646119],"genre_scores_gemma":[0.9989027,0.00020477801,0.00053970446,0.000016146718,0.000009358523,0.0000036185113,0.00023225932,0.0000030440335,0.0000883866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991818,0.00021322664,0.00013851639,0.00015380756,0.00026351304,0.000049090228],"domain_scores_gemma":[0.9949669,0.0025784029,0.0012294011,0.00035300278,0.00069033366,0.00018199102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023869993,0.00019397924,0.00017731906,0.0009830015,0.00020668737,0.0004595987,0.00035667044,0.00046517185,0.0007270284],"category_scores_gemma":[0.01008851,0.00018509314,0.00017226642,0.00033968937,0.00029714854,0.00048245478,0.0002567919,0.00022578952,0.00029838743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002435796,0.000012681394,0.990531,0.000017948198,0.000023664685,0.000062387095,0.00005746289,0.0001223231,0.0028856264,0.000005438456,0.00005727288,0.0059806113],"study_design_scores_gemma":[0.0000053966464,0.00019566322,0.99428046,0.000013740452,0.000038217135,0.0009585488,0.00007559406,0.0010307404,0.0031581111,0.000015735413,0.0002240816,0.0000036207018],"about_ca_topic_score_codex":0.0022266028,"about_ca_topic_score_gemma":0.0032615967,"teacher_disagreement_score":0.0023869993,"about_ca_system_score_codex":0.0002791183,"about_ca_system_score_gemma":0.00014633148,"threshold_uncertainty_score":0.0126238465},"labels":[],"label_agreement":null},{"id":"W2132247116","doi":"10.1016/j.lungcan.2003.09.002","title":"Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer","year":2003,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"Cancer Care Ontario","keywords":"Medicine; Regimen; Etoposide; Guideline; Vincristine; Oncology; Randomized controlled trial; Chemotherapy; Internal medicine; Anthracycline; Chemotherapy regimen; Intensive care medicine; Cyclophosphamide; Cancer; Breast cancer; Pathology","score_opus":0.06482960285760901,"score_gpt":0.47039443093817324,"score_spread":0.4055648280805642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132247116","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00069851073,0.9037665,0.0087760305,0.052572187,0.0130812675,0.0016467081,0.002580355,0.00033537418,0.016543062],"genre_scores_gemma":[0.004332901,0.87898636,0.062922835,0.032683577,0.00277369,0.0025286633,0.003639159,0.00005508828,0.012077725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971424,0.00090558256,0.00092983455,0.00018691282,0.00073399453,0.000101261794],"domain_scores_gemma":[0.9930773,0.0029153565,0.0011069066,0.00013342389,0.0024268054,0.00034028545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049070353,0.001719279,0.003775826,0.004517043,0.00076189626,0.001266252,0.0056479387,0.0060242643,0.006523884],"category_scores_gemma":[0.007853667,0.0007830861,0.0032951743,0.0041150423,0.0009400338,0.0018292546,0.0010544821,0.0053139166,0.004808128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018907206,0.00020029195,0.00045753588,0.033579834,0.00036662034,0.0006254323,0.00012818011,0.00068597344,0.000855066,0.0027538082,0.47873122,0.48142698],"study_design_scores_gemma":[0.00058239227,0.00019817075,0.0041549783,0.08492488,0.0014256262,0.0020546908,0.00019508127,0.0007231358,0.00048690898,0.0057602325,0.8994144,0.00007955809],"about_ca_topic_score_codex":0.0155925825,"about_ca_topic_score_gemma":0.032363806,"teacher_disagreement_score":0.0155925825,"about_ca_system_score_codex":0.0027750663,"about_ca_system_score_gemma":0.008670566,"threshold_uncertainty_score":0.031003654},"labels":[],"label_agreement":null},{"id":"W2135547180","doi":"10.1586/17476348.2.1.37","title":"BLP-25 liposomal vaccine: a promising potential therapy in nonsmall-cell lung cancer","year":2008,"lang":"en","type":"article","venue":"Expert Review of Respiratory Medicine","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Lung cancer; Immunotherapy; Oncology; MUC1; Immune system; Cancer vaccine; Clinical trial; Cancer; Vaccine therapy; Internal medicine; Immunology; Cancer research","score_opus":0.04224112573535768,"score_gpt":0.4048146357692714,"score_spread":0.3625735100339137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135547180","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22748567,0.7447651,0.0072696535,0.008363857,0.000689909,0.00039319767,0.00023957425,0.00027136368,0.010521622],"genre_scores_gemma":[0.7061797,0.2652222,0.006663167,0.0029849384,0.00054861297,0.0002749336,0.0005328904,0.000031958425,0.01756162],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999577,0.000013720814,0.0000023786147,0.000008043613,0.000008764629,0.000009381738],"domain_scores_gemma":[0.9999734,0.0000069050284,0.000005234865,9.759624e-7,0.0000039238184,0.000009489118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003084389,0.00024483268,0.00036277107,0.00033368636,0.00010232932,0.0004000983,0.0002378708,0.00063547154,0.0025375746],"category_scores_gemma":[0.00014530259,0.00007589448,0.00020443731,0.00016620067,0.00022687975,0.0003766736,0.00017636064,0.00043502264,0.0006697356],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033002521,0.001152528,0.001147285,0.002279975,0.000105352054,0.0014867289,0.000109823275,0.0013830303,0.2309085,0.0035997494,0.009915605,0.7446112],"study_design_scores_gemma":[0.009426135,0.042137653,0.020296257,0.0013859961,0.0006431971,0.008510197,0.000475097,0.009047617,0.29939547,0.0076640258,0.600854,0.00016438225],"about_ca_topic_score_codex":0.00038606286,"about_ca_topic_score_gemma":0.0008215401,"teacher_disagreement_score":0.0025375746,"about_ca_system_score_codex":0.0003041339,"about_ca_system_score_gemma":0.00030718435,"threshold_uncertainty_score":0.008489072},"labels":[],"label_agreement":null},{"id":"W2136962513","doi":"10.1016/j.oraloncology.2015.03.014","title":"Extra-pulmonary small cell carcinoma in the head and neck setting: The role of prophylactic cranial irradiation","year":2015,"lang":"en","type":"letter","venue":"Oral Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cape Breton University; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Prophylactic cranial irradiation; Conventional PCI; Medicine; Head and neck; Retrospective cohort study; Population; Carcinoma; Overall survival; Head and neck squamous-cell carcinoma; Surgery; Radiology; Head and neck cancer; Radiation therapy; Internal medicine","score_opus":0.0422524130871455,"score_gpt":0.33182169034737596,"score_spread":0.28956927726023046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136962513","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03232946,0.082325466,0.00013237454,0.8656864,0.0074528027,0.000018452805,0.000085800624,0.000013730496,0.011955457],"genre_scores_gemma":[0.34844565,0.09037305,0.0006150022,0.4656858,0.09017473,0.000047214216,0.00008102409,0.000014092638,0.004563411],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9988589,0.00057995797,0.00016222883,0.00009960792,0.0001852404,0.00011402538],"domain_scores_gemma":[0.99350643,0.0045221155,0.00064997876,0.00016489674,0.0004308398,0.00072568725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020634779,0.00024662074,0.00092896575,0.00062244636,0.0010610203,0.001740228,0.00081139803,0.009640679,0.003517674],"category_scores_gemma":[0.009425313,0.00025297084,0.00060079485,0.0011523586,0.001431332,0.0020258173,0.0005539023,0.004902567,0.0006347906],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002316686,0.00071429694,0.1376403,0.0024050963,0.00041671345,0.14192332,0.0010358178,0.00065994164,0.0036087628,0.013693865,0.43999872,0.25558653],"study_design_scores_gemma":[0.0018399879,0.0017347808,0.11279736,0.0058563235,0.0012593422,0.2073917,0.0052489764,0.0013126646,0.0018119575,0.020591898,0.6399581,0.00019703917],"about_ca_topic_score_codex":0.0030864272,"about_ca_topic_score_gemma":0.008935387,"teacher_disagreement_score":0.009640679,"about_ca_system_score_codex":0.002444612,"about_ca_system_score_gemma":0.002569796,"threshold_uncertainty_score":0.017736971},"labels":[],"label_agreement":null},{"id":"W2137119609","doi":"10.1016/j.ijrobp.2013.02.033","title":"Decline in Tested and Self-Reported Cognitive Functioning After Prophylactic Cranial Irradiation for Lung Cancer: Pooled Secondary Analysis of Radiation Therapy Oncology Group Randomized Trials 0212 and 0214","year":2013,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Lung cancer; Randomized controlled trial; Prophylactic cranial irradiation; Radiation therapy; Radiation oncology; Internal medicine; Surgery; Oncology; Conventional PCI","score_opus":0.030814886788619655,"score_gpt":0.4027891035192069,"score_spread":0.3719742167305872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137119609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.908539,0.07332434,0.002818285,0.0005198496,0.0014952648,0.002322066,0.008248462,0.00034425492,0.0023884866],"genre_scores_gemma":[0.98605585,0.0052742623,0.001152978,0.00063894334,0.00049151026,0.001318904,0.0035986558,0.000055878536,0.001413076],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98865664,0.007389225,0.001222337,0.0015322127,0.00063133414,0.00056834135],"domain_scores_gemma":[0.98980814,0.004896287,0.0025604833,0.001470885,0.00070436025,0.00055995665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012546881,0.0028668274,0.009283096,0.0012239984,0.000526066,0.00230152,0.0015929434,0.002214956,0.0035299489],"category_scores_gemma":[0.016132493,0.0013069211,0.024697816,0.0016322115,0.0011371786,0.0013571384,0.0013892904,0.0035442763,0.0005058137],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76629776,0.0004264074,0.011478007,0.0056944177,0.20640254,0.000071032795,0.0000696993,0.0005824964,0.0007975233,0.00008464097,0.001067399,0.007028074],"study_design_scores_gemma":[0.4893087,0.031770635,0.09146424,0.000701995,0.38160914,0.00018145154,0.0001271821,0.0010987035,0.0010415757,0.00060609664,0.001950054,0.00014008321],"about_ca_topic_score_codex":0.0041715177,"about_ca_topic_score_gemma":0.005740084,"teacher_disagreement_score":0.012546881,"about_ca_system_score_codex":0.0012485749,"about_ca_system_score_gemma":0.0013128433,"threshold_uncertainty_score":0.06635505},"labels":[],"label_agreement":null},{"id":"W2138416295","doi":"10.1093/annonc/mdl353","title":"Randomised phase II study comparing topotecan/carboplatin administration for 5 versus 3 days in the treatment of extensive-stage small-cell lung cancer","year":2006,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Smiths Detection (Canada)","funders":"","keywords":"Topotecan; Carboplatin; Medicine; Regimen; Internal medicine; Lung cancer; Chemotherapy; Phases of clinical research; Progressive disease; Surgery; Cisplatin; Toxicity; Oncology","score_opus":0.19003189340734147,"score_gpt":0.49725881214030293,"score_spread":0.3072269187329615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138416295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98520863,0.0033959362,0.00077574496,0.00077497377,0.001158059,0.004731434,0.0013550628,0.00013905477,0.0024612274],"genre_scores_gemma":[0.98208237,0.0029879466,0.0017011627,0.0013426807,0.00074934406,0.0036513407,0.001573223,0.000061825354,0.005850009],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99906546,0.0005193567,0.000050182338,0.00015213861,0.000061316976,0.00015162441],"domain_scores_gemma":[0.99810386,0.0005602665,0.00030493512,0.0002127118,0.00010080081,0.00071736786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022402338,0.0021513607,0.005198161,0.00072042807,0.00073222315,0.0017063512,0.0022375262,0.0027076325,0.009354648],"category_scores_gemma":[0.0024467886,0.0012550002,0.002422757,0.0008386648,0.0022394038,0.0016977846,0.0005888195,0.005233998,0.0016026732],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9892069,0.0050544264,0.00010618227,0.00016957395,0.0003836145,0.000016808006,0.00002180813,0.00017909725,0.0012896219,0.000055508735,0.00024105594,0.003275428],"study_design_scores_gemma":[0.94646996,0.052021325,0.00058868254,0.000010958315,0.00022520358,0.000013675012,0.000016182865,0.00013552474,0.00017775646,0.000073588504,0.0002583324,0.000008806093],"about_ca_topic_score_codex":0.0042526643,"about_ca_topic_score_gemma":0.0070532016,"teacher_disagreement_score":0.009354648,"about_ca_system_score_codex":0.0018556145,"about_ca_system_score_gemma":0.002544598,"threshold_uncertainty_score":0.031294405},"labels":[],"label_agreement":null},{"id":"W2140014443","doi":"10.1200/jco.2014.60.3845","title":"Cisplatin and Etoposide Versus Carboplatin and Paclitaxel With Concurrent Radiation for Stage III Non–Small-Cell Lung Cancer: Is There an Impact on Radiation Pneumonitis Rates?","year":2015,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Carboplatin; Internal medicine; Oncology; Etoposide; Chemoradiotherapy; Lung cancer; Radiation therapy; Veterans Affairs; Mucositis; Pneumonitis; Surgery; Cisplatin; Chemotherapy; Lung","score_opus":0.1505962876777015,"score_gpt":0.525359451233374,"score_spread":0.3747631635556725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140014443","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8938243,0.09012891,0.0011135396,0.0050961897,0.0030336275,0.0011520903,0.0007089911,0.000045579807,0.0048967362],"genre_scores_gemma":[0.9832575,0.010648538,0.0009518916,0.002363847,0.0009358344,0.00033224866,0.0002944096,0.000016089825,0.0011996508],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99660265,0.0021996128,0.0004235641,0.00031213125,0.00032698098,0.00013514284],"domain_scores_gemma":[0.9950447,0.0030008769,0.001109547,0.00021319337,0.0003236806,0.00030799903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037889765,0.00045402715,0.0019447994,0.0003901963,0.00020870312,0.0009933619,0.0005577719,0.0014393156,0.0023027994],"category_scores_gemma":[0.013160855,0.0002548098,0.007619814,0.00055137917,0.00033229144,0.000922617,0.00043136167,0.0024214333,0.00026818275],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71984047,0.0033255317,0.01607762,0.0051024565,0.027493227,0.00010519934,0.00020150258,0.001880929,0.0019136448,0.00057850755,0.0024151697,0.22106573],"study_design_scores_gemma":[0.34348154,0.4057323,0.10538198,0.003229778,0.10423458,0.000432616,0.00046100855,0.006749692,0.0043800594,0.0026368387,0.023123125,0.00015649556],"about_ca_topic_score_codex":0.0012376314,"about_ca_topic_score_gemma":0.003074582,"teacher_disagreement_score":0.0037889765,"about_ca_system_score_codex":0.0010259276,"about_ca_system_score_gemma":0.00090933795,"threshold_uncertainty_score":0.020038247},"labels":[],"label_agreement":null},{"id":"W2149519864","doi":"10.1002/cncr.22235","title":"Extrapulmonary small cell cancer","year":2006,"lang":"en","type":"article","venue":"Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; University of Alberta; University of Saskatchewan","funders":"","keywords":"Medicine; Confidence interval; Internal medicine; Odds ratio; Genitourinary system; Gastroenterology; Carcinoma; Cancer; Medical record; Survival analysis; Surgery","score_opus":0.030557794521675365,"score_gpt":0.3429949897304098,"score_spread":0.3124371952087345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149519864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942211,0.002642372,0.00016380742,0.0001465136,0.000017435903,0.000016279475,0.0006753684,0.000011469475,0.0021057988],"genre_scores_gemma":[0.9980646,0.00069622416,0.0001044276,0.00008609935,0.000024958534,0.0000061204364,0.00068609405,0.0000018827035,0.00032958513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986386,0.000016643142,0.000014473582,0.00002313505,0.000035878667,0.000046070352],"domain_scores_gemma":[0.99911433,0.00015643322,0.00038438494,0.000037442205,0.00013314147,0.00017422216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014559439,0.00019093584,0.00023845279,0.00028977852,0.00025466358,0.00029407264,0.00019157081,0.000179912,0.0028511605],"category_scores_gemma":[0.0009588649,0.000061320614,0.0001295683,0.0005745799,0.00026320294,0.0001599011,0.00025290475,0.00023586603,0.0005052976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051465173,0.0000117885465,0.99238354,0.00003174538,0.000016229345,0.001529435,0.000022300055,0.000042974236,0.0006283374,0.000015376147,0.00028182857,0.00498493],"study_design_scores_gemma":[0.000009603256,0.00010124172,0.98079795,0.000036764974,0.000031839776,0.016627116,0.0001048728,0.0001187747,0.00035911606,0.000034007946,0.0017757015,0.0000029892092],"about_ca_topic_score_codex":0.0052070455,"about_ca_topic_score_gemma":0.012652369,"teacher_disagreement_score":0.0052070455,"about_ca_system_score_codex":0.00035055287,"about_ca_system_score_gemma":0.0005669308,"threshold_uncertainty_score":0.010353446},"labels":[],"label_agreement":null},{"id":"W2151968455","doi":"10.1016/j.ijrobp.2014.05.1902","title":"Dosimetry and Survival From an Adaptive Radiation Therapy Clinical Trial for Limited-Stage Small Cell Lung Cancer","year":2014,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Radiation therapy; Stage (stratigraphy); Radiation treatment planning; Dosimetry; Radiology; Nuclear medicine; Lung cancer; Oncology","score_opus":0.08063952840790334,"score_gpt":0.45077018271872277,"score_spread":0.37013065431081943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151968455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986368,0.00026918997,0.00021273874,0.00008956289,0.00000954262,0.00003109889,0.00025624482,0.000014034652,0.0004808574],"genre_scores_gemma":[0.9987644,0.00006547414,0.00013312873,0.000056129877,0.000012188819,0.000033786673,0.0005136897,0.000012088638,0.00040913903],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99917823,0.0004569763,0.000055199955,0.000121569276,0.00009621279,0.00009175936],"domain_scores_gemma":[0.99769956,0.0011004033,0.00044266414,0.0003680575,0.00012126834,0.00026802887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021761514,0.00044591815,0.0009480823,0.00032354504,0.0002912609,0.00053707336,0.00059682317,0.0007892701,0.002037373],"category_scores_gemma":[0.0029924747,0.00017567453,0.00088939496,0.0004933573,0.0007687389,0.0004968082,0.0005431571,0.0009386999,0.00029775428],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42418453,0.013549501,0.32377422,0.00039938703,0.0021200841,0.0006092751,0.00071815186,0.077097386,0.053613912,0.001111302,0.0035603703,0.09926197],"study_design_scores_gemma":[0.017136592,0.22245046,0.70328933,0.000048705428,0.0023270047,0.00083435944,0.000335532,0.030178163,0.017442852,0.0019720246,0.0038768786,0.00010811895],"about_ca_topic_score_codex":0.0012026563,"about_ca_topic_score_gemma":0.0010850396,"teacher_disagreement_score":0.0021761514,"about_ca_system_score_codex":0.00070366054,"about_ca_system_score_gemma":0.00045017846,"threshold_uncertainty_score":0.011508703},"labels":[],"label_agreement":null},{"id":"W2156739226","doi":"10.1111/j.1365-2354.2005.00638.x","title":"Comparing the predictive value of neural network models to logistic regression models on the risk of death for small-cell lung cancer patients","year":2005,"lang":"en","type":"article","venue":"European Journal of Cancer Care","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; University of Ontario Institute of Technology","funders":"","keywords":"Logistic regression; Medicine; Lung cancer; Artificial neural network; Regression; Cancer; Regression analysis; Predictive value; Predictive modelling; Intensive care medicine; Artificial intelligence; Statistics; Machine learning; Oncology; Internal medicine; Computer science","score_opus":0.08443507997770791,"score_gpt":0.35035932792913027,"score_spread":0.26592424795142233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156739226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866382,0.0012173672,0.008186575,0.001257727,0.00012852608,0.000049311835,0.000549888,0.00009519266,0.0018772491],"genre_scores_gemma":[0.99763536,0.0002617515,0.0012514265,0.000059156537,0.000053133477,0.000019985306,0.00047181002,0.000009518008,0.00023783813],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9954501,0.0034747696,0.0002059921,0.00031337337,0.00036197001,0.00019384877],"domain_scores_gemma":[0.9202167,0.07253057,0.002227779,0.0017381104,0.0024851793,0.0008016208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014892422,0.0009894577,0.0008529473,0.0020232054,0.00029449235,0.0012533183,0.00086151937,0.00088827923,0.0016753497],"category_scores_gemma":[0.07531201,0.00024463856,0.0009173414,0.001528264,0.00052069617,0.0013540708,0.0009945001,0.0012172642,0.00039989414],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007830633,0.0007000058,0.48620772,0.00025033756,0.001833481,0.00033448142,0.00024276253,0.40852305,0.00028589935,0.0014237907,0.0031536226,0.08921417],"study_design_scores_gemma":[0.0001764389,0.0005580756,0.053497847,0.0000699994,0.00026902027,0.00010964936,0.00016356414,0.9416756,0.00032723515,0.0027851714,0.0003268949,0.00004062881],"about_ca_topic_score_codex":0.008915756,"about_ca_topic_score_gemma":0.0061201937,"teacher_disagreement_score":0.014892422,"about_ca_system_score_codex":0.0010027603,"about_ca_system_score_gemma":0.0008431769,"threshold_uncertainty_score":0.07875955},"labels":[],"label_agreement":null},{"id":"W2160506158","doi":"10.1158/1078-0432.ccr-07-0437","title":"A Phase I and Pharmacokinetic Trial of Erlotinib in Combination with Weekly Docetaxel in Patients with Taxane-Naive Malignancies","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; Sanofi","keywords":"Docetaxel; Medicine; Erlotinib; Neutropenia; Taxane; Internal medicine; Pharmacokinetics; Gastroenterology; Oncology; Mucositis; Pharmacology; Chemotherapy; Cancer; Epidermal growth factor receptor; Breast cancer","score_opus":0.18398884871801144,"score_gpt":0.5254690886657982,"score_spread":0.34148023994778676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160506158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966869,0.0014391124,0.0002453326,0.00018595377,0.00006061536,0.0005583928,0.00016320137,0.000042893294,0.00061768555],"genre_scores_gemma":[0.995786,0.00093981833,0.0008559947,0.00028944894,0.00011904989,0.0005622578,0.0005889107,0.000012518769,0.0008460717],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99958175,0.00018266191,0.00003328415,0.00008117648,0.00004445297,0.00007671633],"domain_scores_gemma":[0.9995552,0.00006659475,0.000116595096,0.00003488781,0.00001845471,0.00020816011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094674545,0.0012708289,0.0018496661,0.00033258589,0.00035172518,0.0008031375,0.0007161471,0.00087131007,0.0016943985],"category_scores_gemma":[0.0007516336,0.0005106576,0.0008101352,0.00042687877,0.00068511843,0.0006734292,0.00026201564,0.0027649952,0.00043611732],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6795384,0.06896081,0.0139137255,0.0008561511,0.001574645,0.0005038247,0.00031859087,0.004095886,0.06226662,0.00020273127,0.0027739906,0.16499466],"study_design_scores_gemma":[0.52829593,0.44107214,0.019537022,0.00004092512,0.0005153634,0.00067267526,0.000049405575,0.0016743732,0.005216388,0.00011424431,0.00277534,0.00003619508],"about_ca_topic_score_codex":0.0005893144,"about_ca_topic_score_gemma":0.0023608676,"teacher_disagreement_score":0.0018496661,"about_ca_system_score_codex":0.00096148485,"about_ca_system_score_gemma":0.0012583003,"threshold_uncertainty_score":0.006976068},"labels":[],"label_agreement":null},{"id":"W2164730570","doi":"10.1093/annonc/mdt009","title":"Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Lung cancer; Oncology; Chemotherapy; Cisplatin; Chemotherapy regimen; Small Cell Lung Carcinoma; Small-cell carcinoma; Gastroenterology","score_opus":0.05888404863705851,"score_gpt":0.45237937195816075,"score_spread":0.39349532332110226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164730570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938606,0.0011202014,0.00044405286,0.0005253353,0.00010667011,0.0013654243,0.0012782529,0.00006717758,0.0012322287],"genre_scores_gemma":[0.98829556,0.0012821776,0.0017291158,0.0011661184,0.00015853773,0.002113239,0.0029739693,0.000060092592,0.002221206],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99875057,0.00079933676,0.000041973457,0.00014528712,0.00009684505,0.00016600634],"domain_scores_gemma":[0.99873275,0.00020167738,0.00024645473,0.00016771223,0.000084307845,0.0005671133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032013478,0.0019524086,0.0026152085,0.00044998474,0.000616067,0.0015148346,0.0016178732,0.0016346889,0.003053777],"category_scores_gemma":[0.0014846065,0.0008263541,0.0022284733,0.00094788946,0.0016010466,0.0011140747,0.0006959089,0.0038878748,0.0011488758],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8873033,0.03286568,0.009656569,0.00041135633,0.001977107,0.00028792743,0.00026958657,0.0025760983,0.018831661,0.0002945191,0.00407424,0.041452043],"study_design_scores_gemma":[0.7691088,0.20447002,0.020982822,0.000022265924,0.00083146675,0.00022602707,0.00010298005,0.0008654701,0.0011467283,0.00013618243,0.0020632371,0.000043985234],"about_ca_topic_score_codex":0.004777988,"about_ca_topic_score_gemma":0.007648233,"teacher_disagreement_score":0.004777988,"about_ca_system_score_codex":0.0019074931,"about_ca_system_score_gemma":0.0028830501,"threshold_uncertainty_score":0.01693058},"labels":[],"label_agreement":null},{"id":"W2165132221","doi":"10.1200/jco.2002.02.108","title":"Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Marimastat After Response to First-Line Chemotherapy in Patients With Small-Cell Lung Cancer: A Trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer","year":2002,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Chemotherapy; Lung cancer; Clinical trial; Cancer; Placebo; Oncology; Surgery; Gastroenterology; Pathology","score_opus":0.178127568875417,"score_gpt":0.49852558092779165,"score_spread":0.3203980120523746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165132221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974854,0.008118392,0.00075007306,0.0010510755,0.001732101,0.009637473,0.0014298714,0.00019474376,0.002232332],"genre_scores_gemma":[0.97522837,0.0036593508,0.001839396,0.0013801305,0.0009482649,0.01137816,0.0010719155,0.000024787492,0.004469604],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992455,0.00038330824,0.000054823777,0.00015800039,0.00005568314,0.00010275175],"domain_scores_gemma":[0.99871206,0.00034086386,0.00036447844,0.00010523339,0.00008413286,0.00039327837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018076022,0.0019273444,0.0040306244,0.00048945897,0.0006793477,0.001180377,0.0011022356,0.002670893,0.008119116],"category_scores_gemma":[0.0022849087,0.0008834015,0.0018758534,0.0004917305,0.001687991,0.0009641893,0.00042207612,0.0030904382,0.0011807521],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99165314,0.0028432626,0.00018768835,0.0003330066,0.0003314048,0.000014079459,0.000017252338,0.0000828651,0.00088996504,0.000050174312,0.00027618356,0.0033210546],"study_design_scores_gemma":[0.9765995,0.02241677,0.00037700465,0.000013782288,0.00013122369,0.0000073570973,0.0000055108894,0.00012443123,0.00010118851,0.000040646475,0.00017808576,0.0000046098407],"about_ca_topic_score_codex":0.0011028107,"about_ca_topic_score_gemma":0.0028086423,"teacher_disagreement_score":0.008119116,"about_ca_system_score_codex":0.0007863696,"about_ca_system_score_gemma":0.0015280661,"threshold_uncertainty_score":0.027161121},"labels":[],"label_agreement":null},{"id":"W2166536412","doi":"10.1200/jco.2011.38.6672","title":"Reply to P.G. Tsoutsou et al and A.H. Trainer et al","year":2011,"lang":"fr","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Gynecology","score_opus":0.320163013477212,"score_gpt":0.5827577782536111,"score_spread":0.2625947647763991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166536412","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017531752,0.0015568443,0.000091897884,0.94341433,0.054151595,0.000011568164,0.00008388978,0.000037982132,0.00047660474],"genre_scores_gemma":[0.0015568781,0.0012393198,0.00016726741,0.9432801,0.051117502,0.00003114326,0.000046232595,0.000020900203,0.0025406068],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967367,0.00087884505,0.000609332,0.00049865537,0.00092970143,0.00034676585],"domain_scores_gemma":[0.982025,0.008859748,0.0013077161,0.00063268654,0.005482293,0.0016924175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052260496,0.0011245244,0.0018834565,0.0012368249,0.0022993663,0.0029057816,0.0033271143,0.037472032,0.0071436544],"category_scores_gemma":[0.039773885,0.0010022183,0.0015446175,0.0011731823,0.0031411634,0.004449778,0.002057536,0.039451372,0.009151237],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004063658,0.000010647748,0.00021589862,0.00006749064,0.000012280287,0.0003339378,0.00005429065,0.000021185293,0.00006711734,0.00032951293,0.9966363,0.002210809],"study_design_scores_gemma":[0.00010324827,0.000059434795,0.0019807038,0.00032889177,0.000075108765,0.0032456366,0.00061804947,0.00027775633,0.0005386532,0.0037471976,0.98890334,0.00012195286],"about_ca_topic_score_codex":0.0039583487,"about_ca_topic_score_gemma":0.004491635,"teacher_disagreement_score":0.037472032,"about_ca_system_score_codex":0.0029394622,"about_ca_system_score_gemma":0.0031271828,"threshold_uncertainty_score":0.027638316},"labels":[],"label_agreement":null},{"id":"W2168227366","doi":"10.1016/j.lungcan.2005.02.008","title":"A randomised phase II study of the efficacy and safety of intravenous topotecan in combination with either cisplatin or etoposide in patients with untreated extensive disease small-cell lung cancer","year":2005,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Humber River Regional Hospital","funders":"","keywords":"Medicine; Topotecan; Neutropenia; Etoposide; Internal medicine; Gastroenterology; Regimen; Surgery; Febrile neutropenia; Lung cancer; Chemotherapy","score_opus":0.00883246383519371,"score_gpt":0.30646718245021914,"score_spread":0.29763471861502544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168227366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99152035,0.0012930756,0.00064711925,0.00046531152,0.00036259237,0.0033356557,0.0007872974,0.000069557536,0.0015189252],"genre_scores_gemma":[0.9884105,0.0015915678,0.0013755107,0.0008093393,0.0005738738,0.0033909066,0.0013989299,0.00004182216,0.002407545],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980134,0.0013155908,0.00008751439,0.00024114602,0.000104959996,0.00023735758],"domain_scores_gemma":[0.9967002,0.0010690619,0.00052851584,0.00041427507,0.00014137622,0.0011465084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003093641,0.0028678172,0.00513934,0.0007923164,0.0008012177,0.0015788677,0.0018189567,0.0023521283,0.006301742],"category_scores_gemma":[0.0035983985,0.0015723521,0.0023768828,0.001032,0.0032619347,0.0021341017,0.0007368835,0.0061447425,0.001169034],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98154473,0.010598524,0.0003849993,0.00012233251,0.00037950967,0.00003237593,0.000037649686,0.0002913892,0.0020352928,0.0000670105,0.00024028392,0.0042660167],"study_design_scores_gemma":[0.90421367,0.09415873,0.0007079832,0.0000058728833,0.00020710428,0.000018323686,0.000013171589,0.00013519553,0.0002724199,0.000053681862,0.00020490198,0.000009031349],"about_ca_topic_score_codex":0.0028800676,"about_ca_topic_score_gemma":0.0039210985,"teacher_disagreement_score":0.006301742,"about_ca_system_score_codex":0.0019235518,"about_ca_system_score_gemma":0.0028986628,"threshold_uncertainty_score":0.021081388},"labels":[],"label_agreement":null},{"id":"W2171023584","doi":"10.1016/j.cllc.2012.04.005","title":"Prophylactic Cranial Irradiation for Patients With Limited-Stage Small-Cell Lung Cancer With Response to Chemoradiation","year":2012,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Cancer Care Ontario; University of Alberta","funders":"Saskatchewan Cancer Agency","keywords":"Conventional PCI; Prophylactic cranial irradiation; Medicine; Chemotherapy; Radiation therapy; Lung cancer; Stage (stratigraphy); Internal medicine; Surgery; Oncology; Urology; Myocardial infarction","score_opus":0.038873565552808374,"score_gpt":0.408409128966218,"score_spread":0.36953556341340965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171023584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779718,0.01773094,0.00011632621,0.0007557024,0.0000869894,0.00014208045,0.00016905797,0.000013232478,0.0030138544],"genre_scores_gemma":[0.9942491,0.0049342234,0.00014468968,0.00016625195,0.00009186289,0.00005046735,0.00015207678,0.0000022785314,0.00020903042],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99970967,0.00016288874,0.000021074453,0.000023057106,0.000028646744,0.00005462832],"domain_scores_gemma":[0.999637,0.00015331396,0.000072334245,0.000034497996,0.00001413035,0.0000887083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005727537,0.0003570382,0.0006586635,0.00034487783,0.00045759784,0.00028568567,0.0004195753,0.00055555877,0.0015055671],"category_scores_gemma":[0.0016244015,0.00011993892,0.00056087674,0.00067686033,0.00040163053,0.0002924786,0.00021582942,0.00063034106,0.00013363952],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29574788,0.0064949063,0.22985932,0.002354042,0.0014665663,0.0015145313,0.0005509837,0.0022157885,0.018761352,0.001047153,0.0069058803,0.43308157],"study_design_scores_gemma":[0.031965535,0.123063356,0.8174578,0.00040294277,0.0026260738,0.0032601017,0.0005677133,0.0008321837,0.0058849347,0.00095807697,0.012933146,0.000048145444],"about_ca_topic_score_codex":0.0046168724,"about_ca_topic_score_gemma":0.007525115,"teacher_disagreement_score":0.0046168724,"about_ca_system_score_codex":0.00069394393,"about_ca_system_score_gemma":0.0012965705,"threshold_uncertainty_score":0.009180009},"labels":[],"label_agreement":null},{"id":"W2171079592","doi":"10.1158/1078-0432.ccr-08-0810","title":"Retinoblastoma Tumor Suppressor Gene Expression Determines the Response to Sequential Flavopiridol and Doxorubicin Treatment in Small-Cell Lung Carcinoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Doxorubicin; Cancer research; Gene knockdown; Retinoblastoma protein; In vivo; Apoptosis; Cell cycle; Cell growth; Cell culture; Small interfering RNA; Biology; Cell cycle checkpoint; Retinoblastoma; Transfection; Chemotherapy; Gene; Biochemistry","score_opus":0.15630511695266835,"score_gpt":0.5023661816812044,"score_spread":0.34606106472853604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171079592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985417,0.00054582866,0.00028087973,0.000028571938,0.000008333342,0.00002145334,0.00014140797,0.000019262585,0.0004124711],"genre_scores_gemma":[0.9983725,0.00023491003,0.0004721897,0.00001547372,0.0000029953324,0.000026819927,0.00020824243,0.000004752917,0.0006621905],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998741,0.000019300249,0.000014911119,0.000028192466,0.000037643207,0.000025845018],"domain_scores_gemma":[0.9998734,0.000032344415,0.000026634147,0.000012770261,0.000016406693,0.000038480925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014345451,0.00014594535,0.0002727141,0.00023161132,0.00014296932,0.00022115286,0.00013276047,0.00023977121,0.0010342057],"category_scores_gemma":[0.00017438729,0.00014780069,0.00019419797,0.00017383497,0.0002103196,0.00018348481,0.0000936653,0.00033489388,0.00028673979],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029951934,0.00005254149,0.00065707404,0.0000136523095,0.0000030293986,0.000026879494,0.000012503786,0.00006188397,0.99817944,0.000017768192,0.000022108254,0.00065371295],"study_design_scores_gemma":[0.00003325267,0.0009229893,0.016529273,0.0000028128031,0.00001564454,0.00017016674,0.000044420038,0.0010831748,0.9806033,0.000013235882,0.00057801895,0.0000037395237],"about_ca_topic_score_codex":0.0013712138,"about_ca_topic_score_gemma":0.0020605824,"teacher_disagreement_score":0.0013712138,"about_ca_system_score_codex":0.000560057,"about_ca_system_score_gemma":0.0002644246,"threshold_uncertainty_score":0.0040635467},"labels":[],"label_agreement":null},{"id":"W2189143821","doi":"10.1016/j.cllc.2015.09.007","title":"Thoracic Radiotherapy for Extensive Stage Small-Cell Lung Cancer: A Meta-Analysis","year":2015,"lang":"en","type":"review","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Radiation therapy; Stage (stratigraphy); Lung cancer; Meta-analysis; Oncology; Radiology; Internal medicine","score_opus":0.4089820723585534,"score_gpt":0.6118290681439336,"score_spread":0.20284699578538018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189143821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062987986,0.992312,0.00040614072,0.00012857963,0.00013930764,0.0000627543,0.0003829176,0.000017386265,0.00025211624],"genre_scores_gemma":[0.25363335,0.7414682,0.0015543705,0.0013385793,0.0003136096,0.00019295838,0.000796524,0.00004393279,0.00065853103],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967955,0.001415764,0.00077861344,0.00049801683,0.00033801288,0.00017414552],"domain_scores_gemma":[0.99555403,0.003074812,0.0007802281,0.00023274355,0.00026730433,0.00009090505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005074622,0.0023229292,0.008975519,0.0023405678,0.00037431036,0.001593812,0.0014262538,0.0014056192,0.0044455384],"category_scores_gemma":[0.009575675,0.0012160029,0.026949892,0.003784632,0.0004708336,0.0011174477,0.0011848103,0.0018772868,0.0003974423],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035774997,0.000039217415,0.0067548053,0.1420628,0.8274173,0.00013781273,0.00007329461,0.00059003837,0.00049364363,0.00011176136,0.00093936344,0.017802555],"study_design_scores_gemma":[0.0006353554,0.00018150722,0.0043355958,0.004754981,0.987948,0.00008182669,0.00003112655,0.00006993057,0.00008849018,0.00014223979,0.0017140835,0.00001681796],"about_ca_topic_score_codex":0.0057347747,"about_ca_topic_score_gemma":0.019829985,"teacher_disagreement_score":0.008975519,"about_ca_system_score_codex":0.0013986515,"about_ca_system_score_gemma":0.0015787414,"threshold_uncertainty_score":0.026837468},"labels":[],"label_agreement":null},{"id":"W2189851308","doi":"10.7759/cureus.400","title":"SBRT Treatment of Metachronous Small-Cell and Non-Small-Cell Lung Carcinomas in a Patient with Severe COPD","year":2015,"lang":"en","type":"article","venue":"Cureus","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Radiation therapy; Etoposide; Lung cancer; Stage (stratigraphy); Prophylactic cranial irradiation; Chemoradiotherapy; Radiology; Chemotherapy; Lung; COPD; Oncology; Surgery; Internal medicine; Conventional PCI","score_opus":0.03317657058405306,"score_gpt":0.2874784316596297,"score_spread":0.2543018610755767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189851308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98960704,0.004160716,0.000837059,0.0015527362,0.000120244345,0.000057676647,0.000069372094,0.00004246965,0.0035527167],"genre_scores_gemma":[0.99736255,0.00090006273,0.00040744807,0.0004300358,0.00016683381,0.000008168724,0.00004849662,0.000007065094,0.0006693841],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99989474,0.000014473312,0.000015069783,0.000019598663,0.000016697568,0.000039517545],"domain_scores_gemma":[0.9997315,0.00004758082,0.00003456884,0.000017442117,0.000013407035,0.00015555124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012675032,0.00038055456,0.00071336963,0.0006132652,0.0012733921,0.0004393231,0.00033308944,0.0013848856,0.00070853106],"category_scores_gemma":[0.00062559254,0.00030104743,0.00095687585,0.00034555086,0.00043786774,0.00029361487,0.0004055612,0.0010816714,0.0002833939],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007501833,0.00031203876,0.059668906,0.00011098611,0.000066100445,0.91368216,0.00042678454,0.00046451695,0.007981095,0.00034749744,0.0006180351,0.015571824],"study_design_scores_gemma":[0.000099021665,0.0014460019,0.052086223,0.000030086492,0.000069240356,0.93961656,0.00016427913,0.0012297917,0.0026677945,0.00025559985,0.0023136362,0.000021915002],"about_ca_topic_score_codex":0.0015598848,"about_ca_topic_score_gemma":0.004244976,"teacher_disagreement_score":0.0015598848,"about_ca_system_score_codex":0.00057163404,"about_ca_system_score_gemma":0.00045396807,"threshold_uncertainty_score":0.0041475296},"labels":[],"label_agreement":null},{"id":"W2200087787","doi":"10.1200/jco.2015.33.15_suppl.7504","title":"Results from a randomized study of carboplatin and etoposide (CE) with or without palifosfamide (Pa) in extensive stage small cell lung cancer (ES-SCLC): The MATISSE study.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Lakeridge Health","funders":"","keywords":"Medicine; Etoposide; Carboplatin; Internal medicine; Ifosfamide; Clinical endpoint; Regimen; Oncology; Chemotherapy; Lung cancer; Cisplatin; Randomized controlled trial","score_opus":0.1812571299523963,"score_gpt":0.5058153914415326,"score_spread":0.32455826148913636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2200087787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876106,0.0034935514,0.00040827473,0.00082197017,0.0005105571,0.0034543043,0.0011671805,0.00005898022,0.00247449],"genre_scores_gemma":[0.9864922,0.0021957343,0.00093071396,0.0013202957,0.000589825,0.0027983934,0.0021669816,0.000024296392,0.0034815725],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99836034,0.0011486612,0.00008255931,0.00017001086,0.000072743715,0.00016571232],"domain_scores_gemma":[0.99778205,0.00086341804,0.0003551985,0.00016559011,0.000103390594,0.0007303727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004191359,0.0017242753,0.0026763997,0.00040160332,0.00042642426,0.0011359222,0.00092799705,0.002343412,0.008721471],"category_scores_gemma":[0.0031974153,0.00069714827,0.0027790177,0.00042574454,0.0012458361,0.0011855859,0.0005406981,0.0034330152,0.0010011967],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98851496,0.0047694305,0.0006112642,0.00013993705,0.00081550103,0.000021417576,0.000020988027,0.00013013574,0.0008290775,0.00003271261,0.0002843109,0.0038302515],"study_design_scores_gemma":[0.9354863,0.06062442,0.002173882,0.000015331863,0.0008774571,0.000020860642,0.000013956226,0.00013898217,0.00015943049,0.00006765974,0.0004138048,0.000007925882],"about_ca_topic_score_codex":0.0010407427,"about_ca_topic_score_gemma":0.0026371866,"teacher_disagreement_score":0.008721471,"about_ca_system_score_codex":0.0009205727,"about_ca_system_score_gemma":0.001338024,"threshold_uncertainty_score":0.029176235},"labels":[],"label_agreement":null},{"id":"W2212041110","doi":"10.1016/s1556-0864(15)31579-3","title":"A Review of First-Line Treatment for Small-cell Lung Cancer","year":2006,"lang":"en","type":"review","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Prophylactic cranial irradiation; Radiation therapy; Chemotherapy; Oncology; Regimen; Lung cancer; Cisplatin; Clinical trial; Internal medicine","score_opus":0.13951046375844217,"score_gpt":0.5695194519831677,"score_spread":0.4300089882247255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2212041110","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047116126,0.99963796,0.000019768482,0.00006850062,0.000065289554,0.0000033062454,0.000017081507,0.0000020944483,0.00013886447],"genre_scores_gemma":[0.0004050777,0.99920243,0.00010464651,0.00013234855,0.000054366366,0.0000047099843,0.00002299761,5.888561e-7,0.00007275759],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995859,0.000086119726,0.0001350273,0.000067852685,0.00010567037,0.000019382269],"domain_scores_gemma":[0.99883646,0.00074429234,0.00022190582,0.000021076698,0.00013525368,0.00004103252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010090292,0.0008404764,0.0035034702,0.0034540552,0.0003203505,0.0009939588,0.0014321628,0.0010907276,0.004418632],"category_scores_gemma":[0.0018992443,0.0004433454,0.0015133511,0.003534811,0.00042219684,0.0012267645,0.0004727501,0.0014368403,0.0009212805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022708515,0.000092332666,0.00036323335,0.14441834,0.0007004164,0.00026028615,0.000057840785,0.00024131262,0.00088375964,0.000740665,0.026081383,0.8259333],"study_design_scores_gemma":[0.00029920557,0.00078095665,0.005927012,0.07558439,0.005121697,0.004919972,0.0001973438,0.00019822788,0.0010163843,0.00087654206,0.9050013,0.0000770656],"about_ca_topic_score_codex":0.002199411,"about_ca_topic_score_gemma":0.0062933215,"teacher_disagreement_score":0.004418632,"about_ca_system_score_codex":0.0008638691,"about_ca_system_score_gemma":0.0015437367,"threshold_uncertainty_score":0.014781833},"labels":[],"label_agreement":null},{"id":"W2229481660","doi":"10.1097/jto.0000000000000588","title":"Cabazitaxel Versus Topotecan in Patients with Small-Cell Lung Cancer with Progressive Disease During or After First-Line Platinum-Based Chemotherapy","year":2015,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"American Society of Clinical Oncology; Genentech; AstraZeneca; Celgene; Merck KGaA; Sanofi; Eli Lilly and Company","keywords":"Cabazitaxel; Topotecan; Taxane; Medicine; Hazard ratio; Internal medicine; Oncology; Chemotherapy; Lung cancer; Confidence interval; Surgery; Cancer; Prostate cancer; Breast cancer","score_opus":0.0301059198192701,"score_gpt":0.4078467590959927,"score_spread":0.37774083927672264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2229481660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99325657,0.005309159,0.000041171665,0.00023781828,0.00009980971,0.00004036806,0.00016229387,0.0000073121546,0.0008455015],"genre_scores_gemma":[0.9974347,0.0018420953,0.00006476135,0.0001356005,0.000090571026,0.000015976142,0.00016015446,0.0000025113623,0.00025363898],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996513,0.00013165253,0.000026750658,0.000045212506,0.000038365248,0.00010679477],"domain_scores_gemma":[0.9992563,0.00033224147,0.0001155956,0.000029151926,0.00002689469,0.00023981197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069886615,0.00035228996,0.0016679713,0.0003145615,0.00030794556,0.0007244798,0.00042776865,0.00061055017,0.0012812958],"category_scores_gemma":[0.0019120151,0.00018778956,0.0013339256,0.000475017,0.00034529087,0.0006122067,0.00020580422,0.0014224978,0.00013667214],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7864582,0.0023243865,0.09152871,0.0009429215,0.0029715043,0.0010436956,0.00033377323,0.00240828,0.006795011,0.0002862857,0.0017264513,0.103180654],"study_design_scores_gemma":[0.12803604,0.22731845,0.61256874,0.00033936612,0.010907426,0.0024402877,0.0007235027,0.005249826,0.004518383,0.00071185123,0.0070654876,0.00012065556],"about_ca_topic_score_codex":0.004325641,"about_ca_topic_score_gemma":0.0139693925,"teacher_disagreement_score":0.004325641,"about_ca_system_score_codex":0.0011472863,"about_ca_system_score_gemma":0.0011895195,"threshold_uncertainty_score":0.008600891},"labels":[],"label_agreement":null},{"id":"W2242665894","doi":"10.1200/jco.2009.27.15_suppl.8108","title":"An open label phase II trial of the Plk1 inhibitor BI 2536, in patients with sensitive relapse small cell lung cancer (SCLC)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Progressive disease; Chemotherapy; Phases of clinical research; Gastroenterology; Oncology; Surgery; Adverse effect","score_opus":0.12108365241612293,"score_gpt":0.5261446769068916,"score_spread":0.40506102449076864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2242665894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555725,0.00074980466,0.00029343792,0.00016818901,0.000053566222,0.0016117285,0.00047499538,0.0000654349,0.0010255708],"genre_scores_gemma":[0.9919077,0.00080813846,0.0010996428,0.0004573875,0.000115878735,0.002181381,0.0014823193,0.000019168254,0.0019283298],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997186,0.00012896027,0.000018670564,0.000053347503,0.00002469354,0.00005570042],"domain_scores_gemma":[0.999493,0.00008279735,0.00010061606,0.000042270603,0.000029296583,0.0002520448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010137212,0.0014069973,0.0017138502,0.0004090325,0.000489954,0.0007967406,0.0006479069,0.00090877665,0.0046061687],"category_scores_gemma":[0.00065601105,0.0005364011,0.0007306419,0.00038720507,0.00092571205,0.0008606718,0.00036867222,0.0024416603,0.0012833806],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7687394,0.07893934,0.008190866,0.0007137237,0.00054361665,0.00056654663,0.0003413315,0.0019920391,0.052084673,0.00021983418,0.002947556,0.08472112],"study_design_scores_gemma":[0.4419269,0.5424557,0.010310902,0.000024923735,0.000177884,0.0003328922,0.000060769064,0.0010837456,0.002331541,0.00013625372,0.0011381776,0.000020351707],"about_ca_topic_score_codex":0.00086611876,"about_ca_topic_score_gemma":0.0021270239,"teacher_disagreement_score":0.0046061687,"about_ca_system_score_codex":0.0006837063,"about_ca_system_score_gemma":0.001324473,"threshold_uncertainty_score":0.015409112},"labels":[],"label_agreement":null},{"id":"W2247345771","doi":"10.1200/jco.2006.24.18_suppl.7092","title":"Compliance with oral topotecan in patients with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Topotecan; Internal medicine; Lung cancer; Docetaxel; Tolerability; Etoposide; Chemotherapy; Population; Regimen; Performance status; Oncology; Surgery; Adverse effect","score_opus":0.06969167848800148,"score_gpt":0.4408552272446751,"score_spread":0.37116354875667357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2247345771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790514,0.0010972596,0.00008317731,0.00010355216,0.000012004651,0.0001081336,0.00025790272,0.0000056619174,0.00042720974],"genre_scores_gemma":[0.9988146,0.00026738836,0.00013410939,0.000171107,0.00002384832,0.000100374156,0.00037517355,0.0000016170093,0.000111931055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824154,0.000833966,0.00023763836,0.00022174722,0.00030969892,0.00015535187],"domain_scores_gemma":[0.9956741,0.0014706422,0.0018169839,0.0001876279,0.00020635505,0.0006443029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025327106,0.00022178868,0.00077305775,0.0004553825,0.00043065706,0.0005160037,0.0002761508,0.0007915168,0.0011391937],"category_scores_gemma":[0.0042158463,0.0003090503,0.0010701988,0.0009146341,0.00035253185,0.00050644233,0.00031104553,0.0009578897,0.00016936763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029199637,0.0015517889,0.94707376,0.00020972447,0.00078021735,0.00028728798,0.00016188936,0.00031440795,0.0012396593,0.000048031983,0.000513204,0.018620376],"study_design_scores_gemma":[0.0034802924,0.030768292,0.96175843,0.00004661843,0.00060174416,0.000763335,0.000102634556,0.00064571574,0.00045089668,0.00008777158,0.0012717961,0.000022521408],"about_ca_topic_score_codex":0.0010625437,"about_ca_topic_score_gemma":0.0016440268,"teacher_disagreement_score":0.0025327106,"about_ca_system_score_codex":0.00063657935,"about_ca_system_score_gemma":0.0008402702,"threshold_uncertainty_score":0.013394415},"labels":[],"label_agreement":null},{"id":"W2259828625","doi":"10.1200/jco.2005.23.16_suppl.7017","title":"Oral topotecan demonstrates clinical activity in relapsed non-small cell lung cancer. Results from an open-label, phase III study (387) comparing oral topotecan to intravenous docetaxel","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Topotecan; Docetaxel; Medicine; Maximum tolerated dose; Lung cancer; Oncology; Internal medicine; Phases of clinical research; Cancer; Pharmacology; Chemotherapy","score_opus":0.2571557998899412,"score_gpt":0.5700849347029274,"score_spread":0.31292913481298623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2259828625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99092674,0.0049287975,0.0003020595,0.00029290572,0.00011642777,0.0005143823,0.00089260825,0.00007913038,0.0019469647],"genre_scores_gemma":[0.9921234,0.00333561,0.0005465045,0.00027241153,0.00017082947,0.00021699618,0.0018439812,0.00003768204,0.0014525381],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992061,0.00040127692,0.000041275223,0.00008011621,0.00010805331,0.00016314273],"domain_scores_gemma":[0.99839264,0.00068452494,0.00021746315,0.000110290865,0.0000770467,0.00051812397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017834888,0.0010099799,0.0028743888,0.000503367,0.00046134874,0.0012359039,0.00114272,0.0010669698,0.0033194877],"category_scores_gemma":[0.0016810858,0.00063307985,0.0015209862,0.0006648809,0.0013165089,0.0008373201,0.00020993133,0.0038660348,0.00084601855],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6997952,0.037707817,0.006276298,0.0014810502,0.0029421325,0.0005972296,0.00035244206,0.0024299368,0.062327947,0.00039300512,0.0068319393,0.178865],"study_design_scores_gemma":[0.3801604,0.575355,0.025268279,0.00009031193,0.0016009617,0.0006556109,0.00010766362,0.0013855438,0.011274336,0.00019722008,0.0038402744,0.00006448218],"about_ca_topic_score_codex":0.0038319628,"about_ca_topic_score_gemma":0.008442616,"teacher_disagreement_score":0.0038319628,"about_ca_system_score_codex":0.0013918914,"about_ca_system_score_gemma":0.0016750155,"threshold_uncertainty_score":0.011104822},"labels":[],"label_agreement":null},{"id":"W2275579275","doi":"10.1159/000416199","title":"Sequential Wide Field Irradiation and Systemic Chemotherapy as Part of the Induction Treatment of Small Cell Lung Cancer1","year":2015,"lang":"en","type":"article","venue":"Antibiotics and chemotherapy/Antibiotica et chemotherapia","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lung; Chemotherapy; Medicine; Irradiation; Internal medicine; Physics","score_opus":0.026951768991937988,"score_gpt":0.30884052375384974,"score_spread":0.2818887547619118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275579275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797435,0.014246333,0.00072277954,0.0001779661,0.00014174817,0.00041210887,0.00015732947,0.00002852782,0.0043695862],"genre_scores_gemma":[0.9873267,0.0076147304,0.0017778242,0.0001522641,0.00026675823,0.00021986544,0.0003015091,0.0000123572745,0.002327936],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99960595,0.00018861599,0.000029883995,0.00006775549,0.00006168914,0.00004606137],"domain_scores_gemma":[0.99962616,0.00013822678,0.000074640535,0.000056188812,0.000021748125,0.000082961174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006415925,0.00033879673,0.00093061617,0.00037912081,0.0003816385,0.00026771115,0.00035324375,0.0003151838,0.0027975806],"category_scores_gemma":[0.00080624304,0.00015790503,0.0004590479,0.0006888223,0.00034278704,0.0002629343,0.00023944862,0.000784454,0.0002908039],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27375403,0.030250689,0.027193112,0.0018307167,0.0007569833,0.0006007118,0.0004367176,0.001342322,0.082216606,0.00091873197,0.00262143,0.5780779],"study_design_scores_gemma":[0.018411575,0.6286879,0.25159574,0.00040013538,0.001452511,0.0024110044,0.00035734117,0.00082188554,0.06863297,0.0005871872,0.02657858,0.00006310966],"about_ca_topic_score_codex":0.0012260982,"about_ca_topic_score_gemma":0.0029425174,"teacher_disagreement_score":0.0027975806,"about_ca_system_score_codex":0.00032508542,"about_ca_system_score_gemma":0.0009931249,"threshold_uncertainty_score":0.009358823},"labels":[],"label_agreement":null},{"id":"W2278015318","doi":"10.1016/j.jtho.2015.12.095","title":"Contrasting Management of Small Cell Lung Cancer and Non–Small Cell Lung Cancer: Emerging Data for Low-Dose Computed Tomography Screening","year":2016,"lang":"en","type":"letter","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lung cancer; Computed tomography; Lung; Cancer; Lung cancer screening; Radiology; Oncology; Internal medicine","score_opus":0.04530686336755013,"score_gpt":0.422963664208508,"score_spread":0.3776568008409579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2278015318","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053775716,0.019186147,0.00026953322,0.96278435,0.009007645,0.000013422828,0.000050538758,0.000009429704,0.0033014629],"genre_scores_gemma":[0.079730004,0.022477118,0.0015389926,0.7514812,0.14306849,0.000045552642,0.00014489114,0.000027875341,0.0014859649],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947901,0.0024745965,0.0010697555,0.00043538155,0.0008449587,0.0003852216],"domain_scores_gemma":[0.9611204,0.03074745,0.0024268352,0.00065289077,0.002644344,0.002408085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006093344,0.0003631619,0.0017212533,0.00074767024,0.0012938343,0.0027304357,0.0014044329,0.014292134,0.003444169],"category_scores_gemma":[0.04850245,0.00035842194,0.0011029274,0.0010745868,0.002275152,0.0043130494,0.0015252422,0.017251814,0.0009527548],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019035145,0.0005302576,0.089415506,0.0021035913,0.00034643183,0.04899961,0.0012658004,0.0011338315,0.0027281411,0.028630612,0.55451757,0.26842508],"study_design_scores_gemma":[0.0017396081,0.0013745582,0.049740892,0.0074150865,0.000807061,0.08321873,0.00504494,0.0033745542,0.0017210537,0.0881001,0.7571367,0.0003267489],"about_ca_topic_score_codex":0.0017947372,"about_ca_topic_score_gemma":0.0054350123,"teacher_disagreement_score":0.014292134,"about_ca_system_score_codex":0.002987914,"about_ca_system_score_gemma":0.0030945616,"threshold_uncertainty_score":0.032225013},"labels":[],"label_agreement":null},{"id":"W2299648334","doi":"10.1159/000416205","title":"Complications of Treatment of Small Cell Carcinoma of the Lung","year":2015,"lang":"en","type":"article","venue":"Antibiotics and chemotherapy/Antibiotica et chemotherapia","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Lung; Medicine; Oncology; Internal medicine","score_opus":0.03769688040493961,"score_gpt":0.3169588049791568,"score_spread":0.27926192457421717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299648334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96837,0.027372772,0.00013501223,0.0002804001,0.000036543086,0.000065543805,0.00012954586,0.0000027306194,0.003607377],"genre_scores_gemma":[0.9931283,0.006191969,0.000061328785,0.00014076736,0.00007019916,0.000024666231,0.00008304925,9.93995e-7,0.00029869904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975243,0.0014349971,0.00026985444,0.00008144218,0.00045766274,0.00023176282],"domain_scores_gemma":[0.99366415,0.0031521001,0.0020845619,0.00018781553,0.00044833007,0.00046309058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012479092,0.00016988456,0.00041544644,0.00087079586,0.00063142396,0.000820358,0.0003134138,0.0004362822,0.0009966927],"category_scores_gemma":[0.0065016113,0.00012195019,0.00080909295,0.0016323141,0.00042011403,0.00040099391,0.0004362163,0.0006669095,0.00006606235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0142359845,0.0032981916,0.8486298,0.0018079623,0.0011726897,0.0061096232,0.0009580853,0.00046832673,0.0023117156,0.0010652263,0.0009784495,0.118963875],"study_design_scores_gemma":[0.00043511632,0.013702876,0.964299,0.00035245414,0.00068468915,0.010274183,0.0016918089,0.00024543863,0.0018771095,0.0003800884,0.0060190735,0.000038148923],"about_ca_topic_score_codex":0.0020062106,"about_ca_topic_score_gemma":0.0023165431,"teacher_disagreement_score":0.0020062106,"about_ca_system_score_codex":0.0010443656,"about_ca_system_score_gemma":0.0009634505,"threshold_uncertainty_score":0.0075774193},"labels":[],"label_agreement":null},{"id":"W2308706242","doi":"10.1136/bmjopen-2015-009849","title":"Protocol for the CONVERT trial—Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status","year":2016,"lang":"en","type":"article","venue":"BMJ Open","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cancer Research UK; National Cancer Research Institute","keywords":"Medicine; Radiation therapy; Activities of daily living; Physical therapy; Randomized controlled trial; Protocol (science); Chemoradiotherapy; Surgery; Alternative medicine; Pathology","score_opus":0.08849882217331131,"score_gpt":0.42856883699955367,"score_spread":0.34007001482624233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308706242","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024905428,0.0005481402,0.0015068583,0.0005045815,0.0011346334,0.98784876,0.0033250921,0.0001554104,0.0024859086],"genre_scores_gemma":[0.0031758365,0.00025199936,0.0022801436,0.0004236543,0.0001767518,0.9911902,0.00092028786,0.000021182412,0.0015598902],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98554176,0.009166366,0.0013248821,0.0017111533,0.0012348859,0.0010209755],"domain_scores_gemma":[0.99111897,0.0018092821,0.002252735,0.0015234054,0.0017838054,0.0015117399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020838654,0.0054559745,0.0077909417,0.001557545,0.0024752896,0.0047876635,0.0037345153,0.005793893,0.072882965],"category_scores_gemma":[0.022753907,0.002419569,0.0049028154,0.0022986762,0.0038976653,0.0030549357,0.0019613926,0.009722294,0.014930125],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9200235,0.0036187964,0.0006295444,0.012186551,0.0017750115,0.00022348392,0.00028267427,0.0011025164,0.0020134924,0.004593425,0.035647493,0.017903468],"study_design_scores_gemma":[0.9270851,0.0087927375,0.0012235811,0.001973726,0.0005863594,0.00006439281,0.000078455436,0.0010865884,0.0007139891,0.00204923,0.056266904,0.00007893824],"about_ca_topic_score_codex":0.0017473482,"about_ca_topic_score_gemma":0.003945195,"teacher_disagreement_score":0.072882965,"about_ca_system_score_codex":0.005215799,"about_ca_system_score_gemma":0.011325847,"threshold_uncertainty_score":0.2438178},"labels":[],"label_agreement":null},{"id":"W2317710868","doi":"10.1097/00007890-200004271-00077","title":"ALLOPEPTIDE/MHC-TCR AFFINITY DETERMINES PHOSPHORYLATION KINETICS.","year":2000,"lang":"en","type":"article","venue":"Transplantation","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"T-cell receptor; Phosphorylation; Kinetics; Chemistry; Cell biology; Major histocompatibility complex; Biology; Biochemistry; Immunology; T cell; Immune system; Physics; Gene","score_opus":0.02132749771224245,"score_gpt":0.3126142987883511,"score_spread":0.29128680107610866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317710868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911971,0.0022651493,0.00096087233,0.0001411626,0.00003350604,0.0000146699595,0.00026824715,0.000023116972,0.0050960686],"genre_scores_gemma":[0.9967078,0.0007906997,0.00043043785,0.00005787782,0.0000120949635,0.000007437193,0.00019942413,0.000017063418,0.0017771387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998535,0.000024233168,0.000008689424,0.000037198566,0.000030226936,0.00004609216],"domain_scores_gemma":[0.9997423,0.000134952,0.000038206723,0.000014307491,0.00002394261,0.000046239267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025503756,0.00012529605,0.00010737035,0.0001745688,0.0001541044,0.00047813976,0.000116569565,0.00020426564,0.008644586],"category_scores_gemma":[0.0005723098,0.00015800745,0.00014452422,0.00011737085,0.00008395247,0.0003823564,0.00016760672,0.0003976304,0.0012530783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007623772,0.000048357433,0.005272912,0.00004411199,0.000007556552,0.000052624222,0.00002740261,0.0001508609,0.98457634,0.00037153106,0.00046091332,0.008225076],"study_design_scores_gemma":[0.000086359134,0.0006296626,0.1840849,0.00003802218,0.00005498626,0.0013109936,0.00012947818,0.006397302,0.8020195,0.00061535696,0.004608184,0.000025367488],"about_ca_topic_score_codex":0.00060383946,"about_ca_topic_score_gemma":0.0014454486,"teacher_disagreement_score":0.008644586,"about_ca_system_score_codex":0.00022854589,"about_ca_system_score_gemma":0.00010412651,"threshold_uncertainty_score":0.028918982},"labels":[],"label_agreement":null},{"id":"W2334091744","doi":"10.1016/j.ejca.2016.03.004","title":"Development of molecularly targeted agents and immunotherapies in small cell lung cancer","year":2016,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"British Lung Foundation; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Lung cancer; Malignancy; Immunotherapy; Targeted therapy; Clinical trial; Oncology; Biomarker; Disease; Cancer; Cancer research; Bioinformatics; Internal medicine; Biology","score_opus":0.05263321894245841,"score_gpt":0.3856924144383269,"score_spread":0.3330591954958685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334091744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010471173,0.9994543,0.000058424986,0.00008054171,0.00004931546,0.0000043690093,0.0000086288865,0.0000021950016,0.00023751061],"genre_scores_gemma":[0.0008020909,0.99867696,0.00015295068,0.00011689908,0.000061545645,0.000005563604,0.000015480875,6.54473e-7,0.00016790419],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978894,0.000038692684,0.00004041793,0.000035246692,0.00007439689,0.000022409266],"domain_scores_gemma":[0.99963653,0.00020549072,0.000071772396,0.000008933747,0.00005923508,0.000018108005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009415945,0.0007090238,0.0018276949,0.0022221515,0.00023505984,0.0010728366,0.00089707354,0.0011533194,0.0024442016],"category_scores_gemma":[0.0009161653,0.0003434948,0.00073522807,0.0020091026,0.0004669039,0.0011452629,0.0006140048,0.0017289114,0.0008114247],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019014894,0.00015327058,0.00020244996,0.033304367,0.0002221047,0.00017379945,0.00005190447,0.00042186872,0.0030400266,0.0028997792,0.01078386,0.9485564],"study_design_scores_gemma":[0.0001627492,0.00049980055,0.0015572758,0.007695592,0.0007902667,0.0015950055,0.00008075893,0.00020403475,0.0019399286,0.0021128505,0.9833234,0.000038412934],"about_ca_topic_score_codex":0.0009203263,"about_ca_topic_score_gemma":0.0018459555,"teacher_disagreement_score":0.0024442016,"about_ca_system_score_codex":0.0005312501,"about_ca_system_score_gemma":0.0010070959,"threshold_uncertainty_score":0.008176684},"labels":[],"label_agreement":null},{"id":"W2335023411","doi":"10.1097/ftd.0000000000000298","title":"Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers","year":2016,"lang":"en","type":"review","venue":"Therapeutic Drug Monitoring","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary; Child and Family Research Institute; University of Toronto; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Pharmacogenetics; Hearing loss; Medicine; Cisplatin; Context (archaeology); Intensive care medicine; Chemotherapy; Audiology; Pharmacology; Internal medicine","score_opus":0.3370780127387425,"score_gpt":0.5732328798191023,"score_spread":0.23615486708035982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335023411","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00095475605,0.89713675,0.0116532715,0.066221125,0.0026009267,0.00076749,0.00096278125,0.00029127026,0.019411698],"genre_scores_gemma":[0.006884045,0.929801,0.043981113,0.013118635,0.0010864051,0.000822966,0.0008349904,0.000031598876,0.0034392008],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971807,0.0011687081,0.0007281453,0.00019940348,0.0006378867,0.00008525571],"domain_scores_gemma":[0.9929069,0.0037568074,0.00076107564,0.00018916345,0.0020994062,0.00028655046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048764725,0.0009859655,0.0015126028,0.003444866,0.0006938094,0.0015990073,0.00234338,0.0031888888,0.0096359],"category_scores_gemma":[0.01620059,0.0003578658,0.0018838734,0.0020231053,0.0007279196,0.0020712614,0.0015246638,0.0032901042,0.0039210278],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009904724,0.0002303684,0.001169208,0.025807926,0.00026582993,0.00049440336,0.00027840785,0.00056307984,0.00060696364,0.00563523,0.12145915,0.8433904],"study_design_scores_gemma":[0.00018284343,0.00015269988,0.0036005566,0.07614278,0.00093461823,0.001736461,0.0006026633,0.00047374578,0.0005260096,0.013884489,0.90167904,0.00008397633],"about_ca_topic_score_codex":0.004042322,"about_ca_topic_score_gemma":0.007993441,"teacher_disagreement_score":0.0096359,"about_ca_system_score_codex":0.0012989728,"about_ca_system_score_gemma":0.0061531207,"threshold_uncertainty_score":0.032235265},"labels":[],"label_agreement":null},{"id":"W2407143741","doi":"","title":"Latest advances and research in lung cancer.","year":2006,"lang":"en","type":"article","venue":"PubMed","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Quarter (Canadian coin); Medicine; Cancer; Cigarette smoking; Demography; Environmental health; Oncology; Internal medicine; Geography; Sociology","score_opus":0.05508771946178657,"score_gpt":0.4137895656211896,"score_spread":0.35870184615940304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407143741","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010797775,0.9880911,0.000116206145,0.0052676853,0.0038781108,0.000008883646,0.00005786118,0.000016754098,0.0024555041],"genre_scores_gemma":[0.0009946793,0.9861632,0.00064096326,0.0022804935,0.006960292,0.000016471826,0.00016214793,0.000006954246,0.0027747862],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99805045,0.0004995036,0.0003873003,0.00017026145,0.0007274885,0.00016499695],"domain_scores_gemma":[0.99280655,0.0028484475,0.00049954565,0.00037238427,0.0025696056,0.00090338266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062289177,0.0010032118,0.0017206848,0.0055913143,0.0006283646,0.0034013968,0.0013321235,0.0025424266,0.011747474],"category_scores_gemma":[0.005865033,0.00044120877,0.00093734363,0.0076415655,0.0013139015,0.005331338,0.0013013354,0.0033245508,0.008165118],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018740074,0.00008210679,0.000786518,0.015349125,0.000120030534,0.00035922226,0.00032409682,0.000053678414,0.0020945878,0.0054698857,0.20384467,0.7713287],"study_design_scores_gemma":[0.00001953175,0.00008960201,0.001436363,0.0032110412,0.00010357028,0.0006334524,0.00019674964,0.000020058282,0.00028795243,0.0024945694,0.9914938,0.00001327187],"about_ca_topic_score_codex":0.001743397,"about_ca_topic_score_gemma":0.004605061,"teacher_disagreement_score":0.011747474,"about_ca_system_score_codex":0.001395012,"about_ca_system_score_gemma":0.003564065,"threshold_uncertainty_score":0.03929925},"labels":[],"label_agreement":null},{"id":"W2411638242","doi":"10.1007/s11060-016-2155-4","title":"Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study","year":2016,"lang":"en","type":"article","venue":"Journal of Neuro-Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Astellas Pharma Global Development","keywords":"Medicine; Erlotinib; Etoposide; Internal medicine; Randomized controlled trial; Oncology; Surgery; Gastroenterology; Chemotherapy; Epidermal growth factor receptor; Cancer","score_opus":0.1056974383727223,"score_gpt":0.41323130484330145,"score_spread":0.3075338664705791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411638242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914158,0.003956298,0.000526384,0.000371097,0.0004703474,0.001679642,0.00065828883,0.000059225542,0.00086288195],"genre_scores_gemma":[0.99046725,0.0033202763,0.0010018452,0.00054879417,0.00047966457,0.0019275984,0.00074932334,0.000025441712,0.0014799776],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990079,0.0004823692,0.000082555605,0.00018826312,0.00006798219,0.00017102054],"domain_scores_gemma":[0.99847466,0.00049437286,0.00032993723,0.00017466262,0.000083889754,0.00044245578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020369512,0.002257352,0.0053744544,0.0005357282,0.00054787577,0.001680245,0.0013469453,0.0020087776,0.0047927485],"category_scores_gemma":[0.0022461356,0.0009801801,0.002789381,0.00062355347,0.0018976325,0.0028713197,0.0005540517,0.0042495476,0.0009186797],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9834327,0.005074518,0.00045235304,0.00033280408,0.0007673881,0.000038411228,0.000036927144,0.00027209354,0.0011031735,0.00005503855,0.00021809562,0.008216455],"study_design_scores_gemma":[0.89929426,0.096859686,0.0014307946,0.000038563165,0.0009752714,0.000049210845,0.000044988185,0.0003988381,0.00034490696,0.00012653724,0.00041198998,0.00002496435],"about_ca_topic_score_codex":0.0009263001,"about_ca_topic_score_gemma":0.0019523556,"teacher_disagreement_score":0.0053744544,"about_ca_system_score_codex":0.0012566347,"about_ca_system_score_gemma":0.0012844641,"threshold_uncertainty_score":0.016033351},"labels":[],"label_agreement":null},{"id":"W2424105215","doi":"10.3747/co.23.3116","title":"Response to: “Small-Cell Carcinoma of the Genitourinary Tract: A Point of View”","year":2016,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Genitourinary system; Medicine; Reading (process); Carcinoma; Oncology; Pathology; Internal medicine; Philosophy; Linguistics","score_opus":0.11017347782939417,"score_gpt":0.42497434381398175,"score_spread":0.31480086598458756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2424105215","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034026924,0.0012835572,0.00011405057,0.9455036,0.050698645,0.00006781249,0.00028027807,0.00011889607,0.0015929563],"genre_scores_gemma":[0.0020959657,0.00099338,0.00015732196,0.9615471,0.030248951,0.00009729555,0.00014625432,0.000037503054,0.0046763234],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975291,0.00071899657,0.00045393448,0.00031167382,0.0006908616,0.0002954535],"domain_scores_gemma":[0.9898449,0.0041932035,0.00082897616,0.00024130438,0.0035989909,0.0012926628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034499299,0.0012831093,0.0018153795,0.0008689078,0.0024214264,0.0019405836,0.0030855676,0.027718196,0.01890572],"category_scores_gemma":[0.02996353,0.00065250555,0.0014075488,0.00085042627,0.0025180362,0.0032546376,0.001989422,0.024059989,0.013447397],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006163709,0.000010330321,0.0002803354,0.00010781619,0.000007554257,0.0003594828,0.000051996383,0.00003389211,0.00006570464,0.00015994949,0.9968442,0.0020171427],"study_design_scores_gemma":[0.000115083036,0.00009255581,0.0024610555,0.0005561304,0.000041469346,0.0021397118,0.0007294207,0.0002542632,0.0003886261,0.0009495293,0.9921698,0.00010234526],"about_ca_topic_score_codex":0.006819116,"about_ca_topic_score_gemma":0.0070310687,"teacher_disagreement_score":0.027718196,"about_ca_system_score_codex":0.0039240946,"about_ca_system_score_gemma":0.0036216218,"threshold_uncertainty_score":0.06324595},"labels":[],"label_agreement":null},{"id":"W2437950242","doi":"10.3747/co.23.3023","title":"Management of Small-Cell Lung Cancer with Radiotherapy—A Pan-Canadian Survey of Radiation Oncologists","year":2016,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Institute of Health Economics; University of Alberta; McMaster University; Alberta Health Services; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"Hamilton Health Sciences","keywords":"Medicine; Radiation therapy; Lung cancer; Cancer; Medical physics; Family medicine; Oncology; Internal medicine","score_opus":0.10165716570343747,"score_gpt":0.44068697077890456,"score_spread":0.3390298050754671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2437950242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798508,0.0033034892,0.00014711334,0.0047740242,0.000037086873,0.000111968424,0.004871876,0.000031045394,0.0068724942],"genre_scores_gemma":[0.9941847,0.0026888524,0.00028496675,0.0008588386,0.000019398425,0.000032511172,0.0013391803,0.000005782324,0.00058584905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850357,0.00012192523,0.00011215742,0.00012744516,0.00080651365,0.00032834813],"domain_scores_gemma":[0.9954743,0.00028153136,0.0014433796,0.00006765793,0.0016149335,0.0011181539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094195694,0.0002088556,0.00018087332,0.0012637838,0.0013839633,0.000674708,0.00088697387,0.00045605935,0.0018770599],"category_scores_gemma":[0.003315486,0.0002494453,0.00031348076,0.0038611272,0.00054147124,0.00043069175,0.0007593336,0.00048359155,0.00022052454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004184189,0.000025836764,0.98628104,0.00015754471,0.000022505501,0.00008098067,0.0010984495,0.0000814972,0.0002710544,0.00005545883,0.0037313264,0.008152364],"study_design_scores_gemma":[0.000004817198,0.000027290685,0.9948487,0.000049519233,0.000009766448,0.00011726518,0.001613217,0.00012075001,0.000033006556,0.0000073012666,0.0031603032,0.000008056302],"about_ca_topic_score_codex":0.97072494,"about_ca_topic_score_gemma":0.9792586,"teacher_disagreement_score":0.02927506,"about_ca_system_score_codex":0.01335557,"about_ca_system_score_gemma":0.017817436,"threshold_uncertainty_score":0.09690189},"labels":[],"label_agreement":null},{"id":"W2464196345","doi":"10.1016/s1470-2045(16)30065-1","title":"Prophylactic cranial irradiation for patients with lung cancer","year":2016,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Neurocognitive; Brain metastasis; Lung cancer; Incidence (geometry); Oncology; Quality of life (healthcare); Internal medicine; Cancer; Lung; Radiation therapy; Surgery; Metastasis","score_opus":0.08109539761877588,"score_gpt":0.47817937414475764,"score_spread":0.39708397652598176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464196345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010590221,0.9994068,0.000011369589,0.00013888108,0.000064300235,0.0000044642698,0.0000228389,0.0000013940657,0.00024419342],"genre_scores_gemma":[0.0022827727,0.99714845,0.000056670335,0.00030258714,0.00008897472,0.00000853993,0.00002339382,8.088509e-7,0.00008781945],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9994074,0.00022484668,0.00014557745,0.000070241076,0.000117886586,0.000034042056],"domain_scores_gemma":[0.9979742,0.0015440393,0.00033406224,0.000030882933,0.00008015583,0.0000365917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013869512,0.00063829985,0.0018693267,0.0017632339,0.00015292778,0.0006917208,0.0007443637,0.0008539029,0.0059572784],"category_scores_gemma":[0.0051036277,0.00027762385,0.0013380877,0.0022440688,0.00044907007,0.0005383796,0.00053251575,0.0012053078,0.00035585463],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006626602,0.000040557486,0.0005175093,0.26779103,0.0028860099,0.000114573384,0.00006126399,0.00027348817,0.00045371125,0.0011463367,0.021078743,0.70497423],"study_design_scores_gemma":[0.0019581083,0.0009710177,0.010670714,0.30807173,0.03572915,0.0019444318,0.00028961615,0.00013647803,0.0010143864,0.002994958,0.6361484,0.000071010254],"about_ca_topic_score_codex":0.0034361929,"about_ca_topic_score_gemma":0.009348689,"teacher_disagreement_score":0.0059572784,"about_ca_system_score_codex":0.0011001608,"about_ca_system_score_gemma":0.0018680362,"threshold_uncertainty_score":0.019929051},"labels":[],"label_agreement":null},{"id":"W2505623435","doi":"10.1093/annonc/mdw263","title":"Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis","year":2016,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; BC Cancer Agency","funders":"Institut Gustave-Roussy; National Cancer Institute; Ligue Contre le Cancer; Sanofi; Eli Lilly and Company","keywords":"Medicine; Radiation therapy; Hazard ratio; Lung cancer; Randomized controlled trial; Meta-analysis; Stage (stratigraphy); Log-rank test; Clinical trial; Survival analysis; Surgery; Internal medicine; Oncology; Confidence interval","score_opus":0.5676325483529087,"score_gpt":0.5740618394205091,"score_spread":0.006429291067600484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2505623435","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010102931,0.98451626,0.0029007408,0.00039696795,0.00061449746,0.000099143945,0.0006547857,0.00004052432,0.00067411765],"genre_scores_gemma":[0.5657041,0.42017606,0.007015525,0.0022627425,0.0011726909,0.00041219845,0.0018378511,0.0001745423,0.0012443969],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9874165,0.00797125,0.0021022505,0.0014281084,0.0008028698,0.0002789209],"domain_scores_gemma":[0.97360206,0.022344718,0.0015035872,0.0015644946,0.0007586169,0.00022653399],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01817231,0.0027730127,0.011354175,0.0021037192,0.00044118482,0.0029130245,0.002203283,0.0022499603,0.0037511291],"category_scores_gemma":[0.038033623,0.0012728142,0.04491331,0.0029977176,0.00053393707,0.0021876644,0.0015173265,0.003546734,0.0003913204],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031653056,0.000019194447,0.005971929,0.03313553,0.94334346,0.00008345643,0.000040992654,0.00085313414,0.00019103312,0.00022266129,0.0004880705,0.012485248],"study_design_scores_gemma":[0.00042303925,0.00017990975,0.0028219256,0.0017442567,0.99244636,0.00005269982,0.000024706129,0.00025314378,0.000094990406,0.00043956348,0.0015043095,0.000015034568],"about_ca_topic_score_codex":0.004243112,"about_ca_topic_score_gemma":0.008001344,"teacher_disagreement_score":0.9818277,"about_ca_system_score_codex":0.0011684179,"about_ca_system_score_gemma":0.0016006038,"threshold_uncertainty_score":0.096105516},"labels":[],"label_agreement":null},{"id":"W2508952936","doi":"10.1016/j.exphem.2016.06.120","title":"G protein-coupled receptor 56 as a potential regulator of normal and leukemic stem cells","year":2016,"lang":"en","type":"article","venue":"Experimental Hematology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University Health Network; McGill University; McGill University Health Centre","funders":"","keywords":"Haematopoiesis; Biology; Stem cell; Progenitor cell; Myeloid leukemia; Myeloid; CD34; Leukemia; Flow cytometry; Cord blood; Cancer research; Molecular biology; Immunology; Cell biology","score_opus":0.011668539340448236,"score_gpt":0.3012452218477054,"score_spread":0.28957668250725715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508952936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930888,0.0024230431,0.000990862,0.00025647864,0.000060008195,0.00003105791,0.00013640962,0.000046372727,0.0029669178],"genre_scores_gemma":[0.99604154,0.0008316679,0.00072215224,0.00008209544,0.000014696865,0.000014369028,0.00017829728,0.000009028056,0.002106036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982196,0.000057765006,0.000011478344,0.000025391806,0.00002228161,0.00006119685],"domain_scores_gemma":[0.9999225,0.00002270876,0.000012293632,0.000013784413,0.0000055499368,0.000023137707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036487952,0.00023298897,0.0003227659,0.0003439011,0.00021692264,0.00056338316,0.00032168793,0.00029458923,0.0022697083],"category_scores_gemma":[0.0002986077,0.00012278647,0.0003315339,0.00016110647,0.0003772788,0.00028405932,0.00029431807,0.00050715246,0.00040658415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026107302,0.00012323898,0.0025288917,0.00007210128,0.000018148703,0.0006011853,0.00009031581,0.00031067786,0.9828835,0.003231095,0.00026886494,0.007261198],"study_design_scores_gemma":[0.0002687161,0.0013939566,0.022490706,0.000021857959,0.000110482775,0.0016498814,0.0002991656,0.0036364503,0.95951414,0.0012342001,0.009364855,0.000015562176],"about_ca_topic_score_codex":0.00037328553,"about_ca_topic_score_gemma":0.00030691942,"teacher_disagreement_score":0.0022697083,"about_ca_system_score_codex":0.0003368089,"about_ca_system_score_gemma":0.00024596794,"threshold_uncertainty_score":0.007592976},"labels":[],"label_agreement":null},{"id":"W2518871594","doi":"10.1097/01.jto.0000283046.50283.51","title":"MTP4-01: Small cell lung cancer","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lung cancer; Oncology","score_opus":0.040807048020115894,"score_gpt":0.498526565168928,"score_spread":0.4577195171488121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518871594","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9056776,0.010135399,0.0008829927,0.017109798,0.0010441412,0.0005768311,0.014462855,0.00012371175,0.04998672],"genre_scores_gemma":[0.9590987,0.0039192876,0.0007520932,0.002302392,0.0005318311,0.0004443649,0.005907491,0.000055568475,0.026988152],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988575,0.0005654947,0.00009726863,0.00012720504,0.00017178245,0.00018071657],"domain_scores_gemma":[0.996801,0.0010559129,0.0005720263,0.00019291871,0.00024027859,0.0011377847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022782453,0.00033948637,0.00041848302,0.00071742723,0.0010516654,0.0010511321,0.0008486543,0.0012027136,0.029501306],"category_scores_gemma":[0.0044997316,0.0001810483,0.00041683784,0.0016708823,0.00051492493,0.0010052334,0.00089441746,0.0011696328,0.0028603654],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04280541,0.0060148817,0.6114284,0.0025467493,0.0009387195,0.005189332,0.000988084,0.00068053196,0.015960716,0.010045507,0.068642735,0.23475894],"study_design_scores_gemma":[0.007174311,0.016894793,0.8093436,0.0004783235,0.0009955792,0.008863276,0.001960549,0.00063053943,0.00935298,0.002421149,0.14182563,0.000059305567],"about_ca_topic_score_codex":0.006899341,"about_ca_topic_score_gemma":0.007841656,"teacher_disagreement_score":0.029501306,"about_ca_system_score_codex":0.001120846,"about_ca_system_score_gemma":0.002834362,"threshold_uncertainty_score":0.09869176},"labels":[],"label_agreement":null},{"id":"W2526309682","doi":"10.1186/s12943-016-0546-y","title":"Synthetic lethality in lung cancer and translation to clinical therapies","year":2016,"lang":"en","type":"review","venue":"Molecular Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Drug Research and Development; BC Cancer Agency; University of British Columbia Hospital","funders":"Canadian Institutes of Health Research; University of British Columbia; Michael Smith Health Research BC","keywords":"Synthetic lethality; Lung cancer; Context (archaeology); Lethality; Cancer; Biology; Translation (biology); Bioinformatics; Computational biology; Disease; Medicine; Oncology; Internal medicine; DNA repair; Genetics; Gene","score_opus":0.11742899543442857,"score_gpt":0.5218766134063233,"score_spread":0.4044476179718947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526309682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015951363,0.9981311,0.0001283165,0.0004166044,0.00012153526,0.0000053409003,0.000014018263,0.000005239861,0.0010183221],"genre_scores_gemma":[0.0013025607,0.9977138,0.00018742916,0.00022357477,0.000113497816,0.0000075282037,0.000019174726,0.0000014709491,0.00043102994],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996855,0.00006968686,0.000045801764,0.000044793065,0.00012718467,0.000027127851],"domain_scores_gemma":[0.9995827,0.00023717555,0.000048384616,0.00001513638,0.00008757629,0.000028988454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009331155,0.0005338656,0.0011176905,0.0017458585,0.00030052438,0.0012442191,0.00073404144,0.0012311689,0.0036369078],"category_scores_gemma":[0.00097498624,0.00026243442,0.0006382944,0.0011330502,0.0007372459,0.0014920344,0.0008387727,0.0024018758,0.0015687541],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010390205,0.00014125169,0.00027776638,0.024598662,0.00009915434,0.00041947392,0.00013158572,0.0007628413,0.0046708486,0.017515223,0.022655621,0.9286237],"study_design_scores_gemma":[0.00001931141,0.00015467327,0.00050464104,0.0035487548,0.00006508849,0.0011326305,0.000076136734,0.000112798276,0.0011494303,0.004220736,0.9889966,0.000019257579],"about_ca_topic_score_codex":0.0006863729,"about_ca_topic_score_gemma":0.0014522965,"teacher_disagreement_score":0.0036369078,"about_ca_system_score_codex":0.00072787906,"about_ca_system_score_gemma":0.0010377453,"threshold_uncertainty_score":0.012166619},"labels":[],"label_agreement":null},{"id":"W2529738115","doi":"10.1016/j.cllc.2016.09.002","title":"Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease","year":2016,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"ImmunoGen","keywords":"Carboplatin; Medicine; Etoposide; Internal medicine; Adverse effect; Phases of clinical research; Lung cancer; Gastroenterology; Chemotherapy; Surgery; Cisplatin","score_opus":0.023026111291990812,"score_gpt":0.39652066178710005,"score_spread":0.3734945504951092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529738115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99366015,0.0010009296,0.00042538348,0.0004102649,0.00011631418,0.002851579,0.0005420431,0.000058392252,0.00093493966],"genre_scores_gemma":[0.9870789,0.0012078721,0.0016730744,0.0008188647,0.00021570433,0.003977095,0.0017230915,0.000024365085,0.0032811144],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995484,0.00025941964,0.000015605667,0.00006538564,0.00003360338,0.00007759525],"domain_scores_gemma":[0.99957925,0.000055268316,0.000098783654,0.000039551975,0.000026404898,0.00020067423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016093281,0.0016151875,0.0017842089,0.0003650375,0.00035089525,0.000844403,0.000838893,0.0011734489,0.004037487],"category_scores_gemma":[0.0007112727,0.00074525306,0.0011109816,0.00024776263,0.00076271023,0.0006811568,0.00033490063,0.0026848784,0.00058037735],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74892837,0.12459391,0.005008798,0.0005963843,0.0009007689,0.00020173372,0.0002270055,0.0022369106,0.054689292,0.00033142365,0.00310903,0.059176363],"study_design_scores_gemma":[0.63123405,0.35735792,0.004634752,0.000022587503,0.00024321747,0.00011170864,0.00002562381,0.00075704197,0.0038241046,0.000144582,0.0016241295,0.00002042094],"about_ca_topic_score_codex":0.0006472801,"about_ca_topic_score_gemma":0.0022177778,"teacher_disagreement_score":0.004037487,"about_ca_system_score_codex":0.0009813907,"about_ca_system_score_gemma":0.0015385507,"threshold_uncertainty_score":0.01350677},"labels":[],"label_agreement":null},{"id":"W2557836851","doi":"10.1016/j.heliyon.2016.e00204","title":"RBM5 reduces small cell lung cancer growth, increases cisplatin sensitivity and regulates key transformation-associated pathways","year":2016,"lang":"en","type":"article","venue":"Heliyon","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North; Laurentian University","funders":"","keywords":"Cancer research; Cisplatin; Lung cancer; Cell cycle; Cell growth; Apoptosis; Biology; Transcriptome; Cell culture; Tumor suppressor gene; Cell; Angiogenesis; Cancer; Gene expression; Medicine; Oncology; Chemotherapy; Gene; Carcinogenesis; Genetics","score_opus":0.01810483696389525,"score_gpt":0.2784925029462149,"score_spread":0.26038766598231966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557836851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99244654,0.0025309313,0.0009969319,0.0003073753,0.00004384902,0.00002296739,0.0005116797,0.00016697941,0.0029727796],"genre_scores_gemma":[0.9946898,0.0005457334,0.00045482788,0.0000628386,0.000004985914,0.00001514725,0.00069204444,0.000017529657,0.0035171069],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998437,0.000031904936,0.000011856365,0.000020962776,0.000046388617,0.000045261506],"domain_scores_gemma":[0.99991405,0.000010187911,0.000019811676,0.00001129154,0.000006986927,0.000037679303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001127978,0.00026950793,0.0001915014,0.00044204443,0.00021355519,0.0003231141,0.00030442345,0.00026850996,0.0036152627],"category_scores_gemma":[0.00011819016,0.00013809612,0.0002999656,0.00015482093,0.00030087127,0.00019309807,0.00022553437,0.0007202832,0.0005465176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005554101,0.00017214048,0.0010004659,0.000056316367,0.000019038367,0.00007372141,0.00001830371,0.00015383365,0.99334234,0.00028821648,0.0002523669,0.004067866],"study_design_scores_gemma":[0.000052245465,0.0009843473,0.016804412,0.000013606238,0.0000421096,0.00036856142,0.00007331149,0.0009619383,0.9751287,0.000105050414,0.005459813,0.000006019449],"about_ca_topic_score_codex":0.0013005058,"about_ca_topic_score_gemma":0.0023249614,"teacher_disagreement_score":0.0036152627,"about_ca_system_score_codex":0.0004540001,"about_ca_system_score_gemma":0.00036398772,"threshold_uncertainty_score":0.012094259},"labels":[],"label_agreement":null},{"id":"W2561485099","doi":"","title":"PET Imaging in Small Cell Lung Cancer","year":2009,"lang":"en","type":"article","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lung cancer; Cancer; Radiology; Pathology; Internal medicine","score_opus":0.016444101095777305,"score_gpt":0.3629799667283767,"score_spread":0.34653586563259936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561485099","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7315802,0.21261868,0.0040069893,0.004503656,0.00027086734,0.00018673358,0.00075143983,0.00011260611,0.045968797],"genre_scores_gemma":[0.9501109,0.04202764,0.0019474761,0.0005792342,0.00017104032,0.000060872993,0.0004399846,0.000040046783,0.004622751],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994772,0.000356163,0.000022870172,0.000037654867,0.000039405022,0.0000666468],"domain_scores_gemma":[0.99954957,0.00028047521,0.000047784048,0.00003701265,0.000051489158,0.0000337213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012151969,0.00039907897,0.00055956264,0.001183994,0.0004316585,0.0013374788,0.00059485115,0.0011760361,0.0034407403],"category_scores_gemma":[0.0017288605,0.00043500896,0.0004033806,0.001634868,0.00059454713,0.0012357368,0.00028747445,0.00075161824,0.0005961574],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033247303,0.002586134,0.23883396,0.004201252,0.0010506532,0.014558211,0.0010144381,0.0037955998,0.22555736,0.008209926,0.013332764,0.45361242],"study_design_scores_gemma":[0.002570499,0.01855669,0.46556786,0.0011034565,0.0039395243,0.06926246,0.0034847008,0.008598236,0.26478204,0.00794013,0.15396766,0.00022678809],"about_ca_topic_score_codex":0.0050500147,"about_ca_topic_score_gemma":0.0035647424,"teacher_disagreement_score":0.0050500147,"about_ca_system_score_codex":0.0010239258,"about_ca_system_score_gemma":0.00068117015,"threshold_uncertainty_score":0.011510432},"labels":[],"label_agreement":null},{"id":"W2562390400","doi":"10.1016/j.lungcan.2016.12.019","title":"An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC)","year":2016,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Nausea; Neutropenia; Internal medicine; Vomiting; Constipation; Phases of clinical research; Adverse effect; Lung cancer; Polo-like kinase; Gastroenterology; Oncology; Cancer; Surgery; Clinical trial; Chemotherapy; Cell cycle","score_opus":0.02410631831682526,"score_gpt":0.36205355458020266,"score_spread":0.3379472362633774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562390400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987588,0.003540557,0.00083472126,0.00056144735,0.00029817136,0.0030660082,0.0016379646,0.00018490978,0.002288224],"genre_scores_gemma":[0.9846126,0.002920758,0.0022731978,0.0011279398,0.00030712454,0.002891789,0.002739659,0.0000531422,0.003073676],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993729,0.00030330525,0.000029294992,0.00011904378,0.00005001314,0.00012547678],"domain_scores_gemma":[0.9990607,0.00017854769,0.00013004917,0.00009097296,0.00005516915,0.00048457243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002103534,0.0021781474,0.0032147265,0.00064579694,0.00071609864,0.0015270204,0.0014535727,0.0017878915,0.004968484],"category_scores_gemma":[0.00108749,0.0011302184,0.0021312363,0.0006297661,0.0015093475,0.0015395597,0.00045276317,0.0058312877,0.0015597756],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8709274,0.052141327,0.002192318,0.000749293,0.0009659275,0.00014042432,0.00022509531,0.0012864948,0.018526899,0.00019176732,0.0021734552,0.050479583],"study_design_scores_gemma":[0.6508949,0.34041476,0.0043718056,0.000028661296,0.00044610747,0.00014310503,0.00007659824,0.0008241117,0.001437329,0.00012427573,0.001206329,0.00003208254],"about_ca_topic_score_codex":0.0019785874,"about_ca_topic_score_gemma":0.005596123,"teacher_disagreement_score":0.004968484,"about_ca_system_score_codex":0.0011381188,"about_ca_system_score_gemma":0.0023242293,"threshold_uncertainty_score":0.016621292},"labels":[],"label_agreement":null},{"id":"W2564674425","doi":"10.1016/j.jtho.2016.12.004","title":"The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases","year":2016,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; H&E stain; Pathology; Immunohistochemistry; Biopsy; Lung cancer; Differential diagnosis; Carcinoma; Medical diagnosis; Radiology","score_opus":0.09684801767149295,"score_gpt":0.481293159134783,"score_spread":0.38444514146329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564674425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97327304,0.0037292766,0.01283839,0.00038622314,0.00022791578,0.00013649403,0.00016556465,0.00006731436,0.009175788],"genre_scores_gemma":[0.99669206,0.00018744537,0.002508891,0.00006296136,0.0000755906,0.000028374308,0.00012632742,0.000032114734,0.0002862546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9749088,0.013838782,0.0032377024,0.0036712894,0.0035002634,0.0008431525],"domain_scores_gemma":[0.93334,0.029418534,0.005717517,0.019905444,0.01047053,0.0011481011],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.042459708,0.00057089626,0.00052093767,0.0019391839,0.0011032977,0.0016414431,0.0009933837,0.000727793,0.0014888388],"category_scores_gemma":[0.056365695,0.00040900346,0.0007640298,0.0010347998,0.0020051931,0.0014483967,0.0015947721,0.00066381914,0.00057153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083195453,0.00012905487,0.9497488,0.00012420806,0.0004910678,0.00031487714,0.001102293,0.00036168814,0.013398017,0.0005731881,0.00048742554,0.032437384],"study_design_scores_gemma":[0.000051947656,0.0009721844,0.9734812,0.00008402902,0.0007199172,0.0035350071,0.00076238386,0.0017000883,0.012858556,0.00074403675,0.005055254,0.00003532897],"about_ca_topic_score_codex":0.00094811985,"about_ca_topic_score_gemma":0.0014629965,"teacher_disagreement_score":0.9575403,"about_ca_system_score_codex":0.0005053814,"about_ca_system_score_gemma":0.00056796387,"threshold_uncertainty_score":0.22455108},"labels":[],"label_agreement":null},{"id":"W2567370351","doi":"10.1055/s-2006-933784","title":"Eine randomisierte Phase III Studie einer Kombinationstherapie Carboplatin/Paclitaxel mit oder ohne Bexarotene (Targretin®) bei nicht vortherapierten Patienten mit fortgeschrittenem oder metastasiertem Nicht-kleinzelligem Bronchialkarzinom (NSCLC)","year":2006,"lang":"de","type":"article","venue":"Pneumologie","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Bexarotene; Carboplatin; Gynecology; Retinoid X receptor; Medicine; Paclitaxel; Chemistry; Cisplatin; Chemotherapy; Internal medicine; Nuclear receptor","score_opus":0.026866498092176228,"score_gpt":0.318347715890344,"score_spread":0.29148121779816777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567370351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8467496,0.034332678,0.007215579,0.001554282,0.0025834523,0.09363818,0.007723894,0.00037014682,0.005832119],"genre_scores_gemma":[0.8912463,0.0101803215,0.007281149,0.0027107722,0.00063253957,0.0750679,0.0037650026,0.00010530961,0.009010676],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99859613,0.0008698226,0.0001360176,0.00017720541,0.00011722005,0.00010348393],"domain_scores_gemma":[0.9988462,0.00038475962,0.00024051203,0.00013939654,0.00016480316,0.00022433371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047393166,0.0013691612,0.0026583956,0.00047639463,0.000367769,0.0012792739,0.0006521903,0.0016628236,0.0069037536],"category_scores_gemma":[0.0030199199,0.0007756323,0.0029307853,0.00053308095,0.0005990335,0.00074093376,0.0004150421,0.002264029,0.0012511249],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95876306,0.0048106336,0.0011501529,0.0023701945,0.0046809306,0.000051466697,0.00009264536,0.0005139879,0.006782807,0.00015342217,0.0016524085,0.018978313],"study_design_scores_gemma":[0.94369644,0.046331603,0.0026262756,0.0001069558,0.0031297456,0.000029871217,0.00002013064,0.0002109688,0.00078567554,0.00017870008,0.0028669506,0.0000166226],"about_ca_topic_score_codex":0.000623728,"about_ca_topic_score_gemma":0.001236538,"teacher_disagreement_score":0.0069037536,"about_ca_system_score_codex":0.00063325727,"about_ca_system_score_gemma":0.0013992451,"threshold_uncertainty_score":0.02506417},"labels":[],"label_agreement":null},{"id":"W2568140973","doi":"10.1016/j.jtho.2016.11.962","title":"P1.07-050 Patterns of Relapse in Small Cell Lung Cancer (SCLC): A Retrospective Analysis of Outcomes from a Single Canadian Center","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Carboplatin; Etoposide; Retrospective cohort study; Chemotherapy; Internal medicine; Single Center; Lung cancer; Radiation therapy; Stage (stratigraphy); Oncology; Surgery; Cisplatin","score_opus":0.04123785998035705,"score_gpt":0.44019176793862125,"score_spread":0.3989539079582642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568140973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913511,0.00042697878,0.00007821758,0.0001534158,0.000010399573,0.000037757993,0.0055439617,0.000012838843,0.002385306],"genre_scores_gemma":[0.9966241,0.00019693223,0.00009892662,0.00007059173,0.0000060605153,0.000015578731,0.0026128388,0.000011277563,0.00036371575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979917,0.00011177187,0.00014273525,0.00036234522,0.0005634129,0.0008280492],"domain_scores_gemma":[0.99609154,0.00018475641,0.0009384585,0.00019471152,0.0018377262,0.0007528877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082034117,0.0004736035,0.0005687068,0.0028368428,0.002925512,0.0014823723,0.002203413,0.0005951367,0.0028426016],"category_scores_gemma":[0.003166432,0.00052991975,0.00087965187,0.007069276,0.0010548579,0.00065013487,0.00137587,0.00073076587,0.00035353517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044350654,0.000011637261,0.99791473,0.000011822448,0.000043336124,0.000052003892,0.00016911804,0.00004082985,0.00010703058,0.000040984847,0.0004549427,0.001109208],"study_design_scores_gemma":[0.000003167011,0.000018135963,0.99854517,0.000013243346,0.000028579614,0.000112206595,0.0007662008,0.00007421016,0.000044047007,0.000014325796,0.0003733632,0.000007218316],"about_ca_topic_score_codex":0.9500397,"about_ca_topic_score_gemma":0.9659411,"teacher_disagreement_score":0.049960315,"about_ca_system_score_codex":0.014396923,"about_ca_system_score_gemma":0.023467667,"threshold_uncertainty_score":0.10445744},"labels":[],"label_agreement":null},{"id":"W2568171230","doi":"10.1016/j.jtho.2018.09.027","title":"Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"Sirtex Medical; European Organisation for Research and Treatment of Cancer; Cancer Research UK; Ministère des Affaires Sociales et de la Santé; Canadian Cancer Society Research Institute; National Institute for Health and Care Research; National Cancer Research Institute; Cancer Research Institute","keywords":"Medicine; Outcome (game theory); Compliance (psychology); Radiation therapy; Patient compliance; Surgery; Emergency medicine","score_opus":0.13159369692412945,"score_gpt":0.5185113461987123,"score_spread":0.38691764927458283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568171230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960802,0.002428697,0.000099277306,0.00016373728,0.00005168517,0.00016977018,0.000273432,0.000011866361,0.00072134536],"genre_scores_gemma":[0.997632,0.00071429525,0.00018059043,0.000249434,0.000120375706,0.00019886329,0.0005607983,0.0000027069814,0.00034091182],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99927765,0.00046815074,0.000062340376,0.000083531464,0.000068962734,0.000039410123],"domain_scores_gemma":[0.9985775,0.00037313555,0.00062781794,0.00013618871,0.000053247044,0.00023222576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002171097,0.0003395639,0.0011958965,0.00014635689,0.00021769488,0.00057106937,0.00027603944,0.0006154346,0.0016758123],"category_scores_gemma":[0.0020932667,0.00015343243,0.0011230846,0.00026984245,0.00033293548,0.0003142965,0.00022473092,0.0009580056,0.00013557068],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.909374,0.0032240134,0.038796093,0.00078891555,0.0027381761,0.00006676027,0.00008569557,0.0010863811,0.0025287694,0.00016003933,0.0010940908,0.04005697],"study_design_scores_gemma":[0.5860793,0.2182695,0.17904602,0.00038411003,0.0057623265,0.00040932934,0.00009432638,0.0024013002,0.0025040482,0.000535604,0.0044615883,0.000052525178],"about_ca_topic_score_codex":0.0004272629,"about_ca_topic_score_gemma":0.00086188194,"teacher_disagreement_score":0.002171097,"about_ca_system_score_codex":0.0003289921,"about_ca_system_score_gemma":0.00057928695,"threshold_uncertainty_score":0.011482},"labels":[],"label_agreement":null},{"id":"W2568673175","doi":"10.1016/j.jtho.2016.11.1985","title":"PUB015 The Use of Immunohistochemistry Improves the Diagnosis of SCLC. An International Reproducibility Study in a Demanding Set of Cases","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Immunohistochemistry; Pathology; Biopsy; Immunostaining; Lung cancer; Carcinoma; Not Otherwise Specified; Cancer; Kappa; Internal medicine","score_opus":0.21427963595774463,"score_gpt":0.5570368561241257,"score_spread":0.34275722016638105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568673175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98040086,0.00295467,0.0053436356,0.00034590502,0.00019951936,0.00010498221,0.00047667517,0.000065325585,0.010108402],"genre_scores_gemma":[0.99798965,0.00012306203,0.0009828873,0.000065844724,0.000057052428,0.000018767196,0.00034342616,0.000027092161,0.00039229274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9816176,0.00992008,0.0021462722,0.0024409285,0.0031208666,0.0007542478],"domain_scores_gemma":[0.9507347,0.02159656,0.0051408797,0.012705235,0.008864948,0.0009577061],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03507635,0.00049225154,0.00047290718,0.0017794736,0.00093975494,0.0019626196,0.00092631375,0.00067331153,0.00215751],"category_scores_gemma":[0.04669743,0.00037635543,0.0007589893,0.0012033357,0.0018364165,0.0011859857,0.0013989846,0.0006290927,0.00076414313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001386963,0.00013241696,0.96153575,0.00013876383,0.0007632477,0.0002548755,0.0006598344,0.00033879056,0.006517207,0.00040020488,0.0007481915,0.027123732],"study_design_scores_gemma":[0.00007727207,0.0009173297,0.9827084,0.00007265647,0.0006790976,0.0016763293,0.000532476,0.0010511201,0.0068358206,0.000522729,0.004901782,0.000025001422],"about_ca_topic_score_codex":0.0013186472,"about_ca_topic_score_gemma":0.0017213328,"teacher_disagreement_score":0.9649236,"about_ca_system_score_codex":0.00046994715,"about_ca_system_score_gemma":0.0005949671,"threshold_uncertainty_score":0.18550366},"labels":[],"label_agreement":null},{"id":"W2569547003","doi":"10.1016/j.jtho.2016.11.058","title":"ED14.05 Immunotherapy of Small Cell Lung Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Immunotherapy; Lung cancer; Cancer immunotherapy; Targeted therapy; Cancer research; Cancer; Clinical trial; Oncology; Immune system; Immunology; Internal medicine","score_opus":0.04548576438345652,"score_gpt":0.5014252161603496,"score_spread":0.4559394517768931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569547003","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96205944,0.009663834,0.0004117862,0.0024232885,0.001289927,0.00019744675,0.00073119387,0.000089754205,0.02313336],"genre_scores_gemma":[0.96365654,0.0036053124,0.0011277216,0.0012951173,0.00039108266,0.00014502525,0.0014090426,0.000016986072,0.028353354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932754,0.00021553956,0.000041059193,0.00005149967,0.000115395436,0.0002488653],"domain_scores_gemma":[0.99973935,0.000046891964,0.000026617321,0.00003428835,0.000030670435,0.00012224239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013625914,0.0003663988,0.00066923694,0.0004759979,0.0004405899,0.0009076379,0.0006029153,0.0011367681,0.011317018],"category_scores_gemma":[0.00045887224,0.00018678629,0.00054079737,0.00028784416,0.00037230158,0.00061354873,0.00050532434,0.0010372832,0.001644776],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07826709,0.043673173,0.025786482,0.0012181571,0.000986737,0.0009197855,0.00022382231,0.0023646841,0.1851751,0.008326669,0.04369121,0.60936713],"study_design_scores_gemma":[0.028034408,0.2906793,0.13186377,0.0004933251,0.001235036,0.004881246,0.0005990534,0.004290346,0.29249477,0.0031449427,0.24214472,0.00013905163],"about_ca_topic_score_codex":0.00025550436,"about_ca_topic_score_gemma":0.0007537514,"teacher_disagreement_score":0.011317018,"about_ca_system_score_codex":0.00069185864,"about_ca_system_score_gemma":0.0010533901,"threshold_uncertainty_score":0.0378592},"labels":[],"label_agreement":null},{"id":"W2571308635","doi":"10.1016/j.jtho.2016.11.927","title":"P1.07-016 Trends, Practice Patterns and Underuse of Surgery in the Treatment of Early Stage Small Cell Lung Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Stage (stratigraphy); Contraindication; Cancer; Logistic regression; Lung cancer; Medicaid; Pneumonectomy; Demographics; Surgery; Internal medicine; Pathology; Health care","score_opus":0.10757032847245042,"score_gpt":0.508546255502176,"score_spread":0.4009759270297256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571308635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865161,0.0008838434,0.0001030394,0.0018961825,0.00006493292,0.000012894864,0.006174854,0.000010299769,0.004337767],"genre_scores_gemma":[0.99549294,0.0004181288,0.0001208395,0.00021302229,0.0000694673,0.0000184451,0.002307732,0.000013162359,0.0013462377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993637,0.00013159808,0.00009885857,0.00009911874,0.00013211265,0.00017459453],"domain_scores_gemma":[0.9937038,0.0013480263,0.002938353,0.000119796794,0.0008303461,0.001059624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062321336,0.00010908128,0.00017791011,0.0008808753,0.0004191008,0.0008517518,0.00049859623,0.0006082078,0.011940417],"category_scores_gemma":[0.0055835675,0.00017516271,0.0005476291,0.0027581614,0.00023401486,0.0009466215,0.00044712765,0.0010397389,0.0010430331],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008794799,0.000032068696,0.9953022,0.000025419478,0.000047073107,0.000033628927,0.0000986727,0.000028020553,0.00006976906,0.00006457453,0.00097582256,0.0032348093],"study_design_scores_gemma":[0.0000059606955,0.000035133024,0.9983808,0.00002310327,0.000021530053,0.00009888122,0.0005065495,0.00011291103,0.00002862119,0.000041362924,0.0007425015,0.0000027369078],"about_ca_topic_score_codex":0.016996589,"about_ca_topic_score_gemma":0.021697454,"teacher_disagreement_score":0.016996589,"about_ca_system_score_codex":0.0004985675,"about_ca_system_score_gemma":0.0013735337,"threshold_uncertainty_score":0.03994471},"labels":[],"label_agreement":null},{"id":"W2574837766","doi":"10.1016/j.radonc.2017.01.005","title":"Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer","year":2017,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Queen's University","funders":"","keywords":"Conventional PCI; Prophylactic cranial irradiation; Medicine; Neurocognitive; Lung cancer; Population; Oncology; Internal medicine; Surgery; Cognition","score_opus":0.04349840953210288,"score_gpt":0.39167082525683067,"score_spread":0.3481724157247278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574837766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98875,0.008841016,0.00016241489,0.00031076706,0.00006982073,0.00014829818,0.00027523664,0.000007570218,0.0014348996],"genre_scores_gemma":[0.997783,0.001661475,0.00017277304,0.000053241372,0.00003086639,0.000042571046,0.00013017798,0.0000016702403,0.00012423446],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9989827,0.00064808776,0.000072803574,0.00007065805,0.00010356744,0.00012214568],"domain_scores_gemma":[0.9988558,0.00056552934,0.00027107494,0.00007399625,0.000046025838,0.0001873794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010191911,0.00060281705,0.0009095399,0.0006543716,0.00022998908,0.00052791653,0.0007907648,0.0006646364,0.0028953142],"category_scores_gemma":[0.0037944375,0.000244888,0.0023463604,0.00089641084,0.00060541497,0.0006835701,0.00047525187,0.00078733015,0.00010611604],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6229203,0.009912479,0.06125321,0.0033446574,0.0073492844,0.00036931993,0.00014695084,0.038852006,0.0031532403,0.0018897146,0.0010651136,0.2497438],"study_design_scores_gemma":[0.10929244,0.35683915,0.46433368,0.0010904943,0.032310307,0.0014487652,0.001013104,0.020099957,0.004710832,0.0033849806,0.005263893,0.00021237697],"about_ca_topic_score_codex":0.012626375,"about_ca_topic_score_gemma":0.012814474,"teacher_disagreement_score":0.012626375,"about_ca_system_score_codex":0.0029895313,"about_ca_system_score_gemma":0.002020345,"threshold_uncertainty_score":0.025105774},"labels":[],"label_agreement":null},{"id":"W2586885021","doi":"10.1016/j.jtho.2016.01.012","title":"Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?","year":2016,"lang":"en","type":"review","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; Cancer Research UK","keywords":"Cancer research; Targeted therapy; Aurora kinase; Medicine; Wnt signaling pathway; Receptor tyrosine kinase; Tyrosine kinase; Biology; Kinase; Bioinformatics; Cancer; Signal transduction; Cell cycle; Receptor; Internal medicine; Genetics","score_opus":0.047730748269638766,"score_gpt":0.530468196576259,"score_spread":0.48273744830662024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586885021","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041387837,0.9989422,0.000024326226,0.0006327434,0.00017772065,0.0000015433409,0.000008017158,0.0000014006814,0.00017066013],"genre_scores_gemma":[0.0005411205,0.9984641,0.00007585379,0.00046021328,0.0003285322,0.0000031157201,0.000012423435,6.2824824e-7,0.00011399011],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996189,0.000087507666,0.00006517496,0.000071774826,0.00011587842,0.000040742765],"domain_scores_gemma":[0.99837923,0.0010880496,0.00016376468,0.000028461995,0.00025294026,0.00008756709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019001674,0.0007848937,0.002410457,0.0014379306,0.00027782877,0.0015276449,0.0009653152,0.0016619785,0.0038240002],"category_scores_gemma":[0.00279184,0.00024792072,0.0009802823,0.0016000477,0.0009284326,0.0019079945,0.0009481158,0.0025746417,0.0010467682],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024737202,0.000091294285,0.0006305971,0.03645425,0.00037634105,0.00016908768,0.0000492445,0.00027710642,0.00086114276,0.0049553122,0.038987387,0.9169009],"study_design_scores_gemma":[0.00014825397,0.00027690252,0.0024936942,0.021866452,0.0009698969,0.0010316083,0.00019214749,0.00012682793,0.00046850563,0.00483445,0.9675413,0.000050023715],"about_ca_topic_score_codex":0.0011241843,"about_ca_topic_score_gemma":0.002921549,"teacher_disagreement_score":0.0038240002,"about_ca_system_score_codex":0.0009387204,"about_ca_system_score_gemma":0.0023031225,"threshold_uncertainty_score":0.012792528},"labels":[],"label_agreement":null},{"id":"W2588051892","doi":"10.1016/j.ijrobp.2015.07.1573","title":"Extrapulmonary Small Cell Cancer: Is There a Role for PCI?","year":2015,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Incidence (geometry); Cumulative incidence; Conventional PCI; Population; Brain metastasis; Internal medicine; Genitourinary system; Cancer registry; Retrospective cohort study; Disease; Cancer; Head and neck cancer; Cohort; Surgery; Oncology; Metastasis; Myocardial infarction","score_opus":0.052538293039701034,"score_gpt":0.39077511086858885,"score_spread":0.3382368178288878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588051892","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058514237,0.6148122,0.002552831,0.26709825,0.008160557,0.00015095448,0.0004217576,0.00013292016,0.048156314],"genre_scores_gemma":[0.41055417,0.4919184,0.00459512,0.044289216,0.037716188,0.00015661947,0.0006027219,0.00014086661,0.010026711],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99934477,0.00021755412,0.00006640887,0.0001122942,0.00013155995,0.00012743824],"domain_scores_gemma":[0.99600816,0.0019435954,0.00050236576,0.00025263475,0.00054559635,0.00074765313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020626532,0.00052359124,0.0011328566,0.0006479183,0.00066639617,0.0028618467,0.0010164396,0.0022298372,0.017870016],"category_scores_gemma":[0.0062646135,0.00021815843,0.000925001,0.0009883582,0.0016880762,0.0045577055,0.00070104003,0.003087422,0.0022865052],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024260557,0.0009711476,0.091288544,0.003882848,0.000428151,0.0029828816,0.0003907748,0.0004945272,0.002669807,0.024101187,0.061600886,0.80876327],"study_design_scores_gemma":[0.0011330842,0.0044925353,0.16235824,0.014053974,0.0025911536,0.01829209,0.006780893,0.0015208846,0.0016737917,0.042315613,0.74455655,0.00023131994],"about_ca_topic_score_codex":0.0017866521,"about_ca_topic_score_gemma":0.0039421194,"teacher_disagreement_score":0.017870016,"about_ca_system_score_codex":0.0009536976,"about_ca_system_score_gemma":0.0036486052,"threshold_uncertainty_score":0.059781134},"labels":[],"label_agreement":null},{"id":"W2593287697","doi":"10.1200/jco.2013.31.15_suppl.tps2622","title":"Phase II, multicenter, open-label, proof of concept study of tasquinimod in patients with advanced/metastatic hepatocellular (HCC), ovarian (OC), renal cell (RCC) and gastric (GC) carcinomas.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Oncology; Combination therapy; Progression-free survival; Clinical endpoint; Phases of clinical research; Clinical trial; Chemotherapy","score_opus":0.1109235187220886,"score_gpt":0.4580474076056311,"score_spread":0.3471238888835425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593287697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831481,0.001688331,0.0021605722,0.0005015128,0.00028541373,0.009239115,0.0015599871,0.00013107182,0.0012858772],"genre_scores_gemma":[0.9745915,0.0012503283,0.0068087517,0.0011770944,0.00023498236,0.011425683,0.0020192065,0.000041097206,0.002451326],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992723,0.0003329716,0.00003169428,0.0001580824,0.00007935173,0.00012564496],"domain_scores_gemma":[0.9989385,0.00015505005,0.00022624739,0.00010899919,0.00012033832,0.0004508323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003887153,0.0017055732,0.0022141763,0.00048678226,0.00038611918,0.0010232959,0.0009820912,0.0013039451,0.003261989],"category_scores_gemma":[0.0014427912,0.00072565686,0.00148843,0.00048474577,0.0013021141,0.0010972541,0.00043267128,0.0029913625,0.00075279915],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7674805,0.09860063,0.0071924394,0.0009894656,0.0018328482,0.000169526,0.00039327756,0.0026348748,0.06363543,0.0004441596,0.0036515791,0.052975234],"study_design_scores_gemma":[0.43986985,0.5451427,0.0070456835,0.000021962302,0.00050223025,0.00014841127,0.00007717699,0.0011697169,0.0037289069,0.00023950913,0.0020231956,0.000030561885],"about_ca_topic_score_codex":0.0005560414,"about_ca_topic_score_gemma":0.0015125631,"teacher_disagreement_score":0.003887153,"about_ca_system_score_codex":0.0010754756,"about_ca_system_score_gemma":0.0023355226,"threshold_uncertainty_score":0.020557463},"labels":[],"label_agreement":null},{"id":"W2593673147","doi":"10.1016/j.athoracsur.2016.11.039","title":"Indications for Adjuvant Mediastinal Radiotherapy in Surgically Resected Small Cell Lung Cancer","year":2017,"lang":"en","type":"article","venue":"The Annals of Thoracic Surgery","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hazard ratio; Confidence interval; Proportional hazards model; Pneumonectomy; Lung cancer; Radiation therapy; Survival analysis; Stage (stratigraphy); Surgery; Internal medicine; Resection margin; Oncology; Resection","score_opus":0.19129051638917777,"score_gpt":0.4913777465979625,"score_spread":0.30008723020878475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593673147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587431,0.033615716,0.00024825367,0.0007739065,0.00018243156,0.000028488721,0.00040722563,0.000007007115,0.0059938296],"genre_scores_gemma":[0.9918087,0.0063111647,0.00026473968,0.0003387348,0.00018707835,0.000034195666,0.00049243047,0.000005511437,0.0005574671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999288,0.00028321674,0.0001767405,0.000043010896,0.000117619966,0.00009140033],"domain_scores_gemma":[0.9974698,0.0014128077,0.00056447374,0.00008948528,0.00012095493,0.0003425287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014145143,0.00020981867,0.00034066098,0.0011649317,0.00032561552,0.0006085971,0.00031027163,0.0006525904,0.0019823962],"category_scores_gemma":[0.003980551,0.00018707932,0.0005601686,0.0011375427,0.0004177518,0.0005983157,0.00028140986,0.00057768746,0.0001896816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059610447,0.0003070894,0.93327355,0.00048673537,0.00013176925,0.0014059904,0.00020894436,0.0004404641,0.0071498672,0.0005854312,0.00093167886,0.049117472],"study_design_scores_gemma":[0.00015459908,0.0014806499,0.9859716,0.0002969303,0.00031969216,0.0031677503,0.0008648342,0.00025613987,0.0012360975,0.00031543864,0.005916142,0.000020157242],"about_ca_topic_score_codex":0.0013822379,"about_ca_topic_score_gemma":0.004751417,"teacher_disagreement_score":0.0019823962,"about_ca_system_score_codex":0.0004521376,"about_ca_system_score_gemma":0.0008107631,"threshold_uncertainty_score":0.0074807405},"labels":[],"label_agreement":null},{"id":"W2595416856","doi":"10.1200/jco.2007.25.18_suppl.7522","title":"Randomized phase II study of maintenance vandetanib (ZD6474) in small cell lung cancer (SCLC) patients who have a complete or partial response to induction therapy: NCIC CTG BR.20","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Niagara Health System; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Vandetanib; Gastroenterology; Hazard ratio; Asymptomatic; Progressive disease; Rash; Maintenance therapy; Performance status; Progression-free survival; Surgery; Chemotherapy; Confidence interval; Sorafenib","score_opus":0.19794544748806914,"score_gpt":0.5368576189100606,"score_spread":0.3389121714219914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595416856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98824954,0.0019596778,0.0004808034,0.0006568417,0.00024655453,0.005102664,0.0014580071,0.0001237787,0.0017221812],"genre_scores_gemma":[0.983478,0.0014217237,0.0015036846,0.0013870716,0.00025776617,0.005343223,0.0024013324,0.00002703107,0.0041802092],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996439,0.0001905031,0.000016053851,0.00005193567,0.00003020432,0.00006744552],"domain_scores_gemma":[0.9993261,0.000121464436,0.00014204247,0.00004511292,0.000035176457,0.0003301493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013428599,0.001243394,0.002048429,0.0003827753,0.00037724464,0.00081861386,0.0008502359,0.0012140058,0.005302081],"category_scores_gemma":[0.0012195952,0.0006300311,0.0006837738,0.00040781606,0.00082036696,0.00054650975,0.00033549516,0.0021312798,0.00097624667],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94102985,0.015385823,0.0030151426,0.00037710206,0.00059142837,0.00012424008,0.00007901271,0.00076649693,0.00790135,0.00014265784,0.0030397836,0.027547091],"study_design_scores_gemma":[0.9340834,0.061516237,0.0028278732,0.000010093353,0.00011845025,0.00004818113,0.000010349031,0.00034508403,0.00030842877,0.000059805214,0.000665918,0.000006155567],"about_ca_topic_score_codex":0.0017677736,"about_ca_topic_score_gemma":0.004798527,"teacher_disagreement_score":0.005302081,"about_ca_system_score_codex":0.0009886746,"about_ca_system_score_gemma":0.0015258357,"threshold_uncertainty_score":0.01773721},"labels":[],"label_agreement":null},{"id":"W2597133748","doi":"10.1016/j.canrad.2016.09.015","title":"Thoracic irradiation in 3 weeks for limited-stage small cell lung cancer: Is twice a day fractionation really needed?","year":2017,"lang":"en","type":"review","venue":"Cancer/Radiothérapie","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Lung cancer; Stage (stratigraphy); Fractionation; Irradiation; Lung; Dose fractionation; Medicine; Oncology; Nuclear medicine; Internal medicine; Biology; Chemistry; Radiation therapy; Chromatography; Physics","score_opus":0.12906043142095702,"score_gpt":0.47469009405384643,"score_spread":0.3456296626328894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597133748","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014757688,0.9995472,0.000014613219,0.000095071315,0.000066363886,0.000005259911,0.0000108374725,0.000001047771,0.00011195132],"genre_scores_gemma":[0.0017376118,0.9977077,0.00008455725,0.00029394362,0.000060501785,0.000008217581,0.000023283823,8.780395e-7,0.00008324019],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996112,0.00011534302,0.000094779636,0.00006466955,0.000084337844,0.000029754478],"domain_scores_gemma":[0.9992011,0.00056079903,0.00014465816,0.000012756211,0.000058269536,0.00002246392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017124442,0.00064619316,0.0035092218,0.0010592287,0.00018256775,0.00091044337,0.0011816476,0.0013047216,0.0037978871],"category_scores_gemma":[0.001874951,0.00033076486,0.0023397272,0.0014860309,0.0005148246,0.00085799553,0.00040840756,0.0016906591,0.0004162746],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012986262,0.00012530663,0.00045222385,0.21694504,0.0028622341,0.000148415,0.00011915715,0.0003116401,0.0012576019,0.0010576213,0.0139420405,0.76148015],"study_design_scores_gemma":[0.0036559945,0.0027742952,0.0115102595,0.22372751,0.034325536,0.0024183416,0.0006055961,0.0002449124,0.0012668236,0.002581203,0.71675175,0.00013772547],"about_ca_topic_score_codex":0.0022456322,"about_ca_topic_score_gemma":0.00548126,"teacher_disagreement_score":0.0037978871,"about_ca_system_score_codex":0.00070761034,"about_ca_system_score_gemma":0.0016817445,"threshold_uncertainty_score":0.012705207},"labels":[],"label_agreement":null},{"id":"W2598968435","doi":"10.1200/jco.2017.35.5_suppl.225","title":"The impact of neurocognitive function on health utility scores (HUS) in Stage 4 (S4) lung cancer patients (pts) with and without brain metastases (BrM).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Neurocognitive; Internal medicine; Quality of life (healthcare); Lung cancer; Asymptomatic; Cancer; Oncology; Stage (stratigraphy); Disease; Gastroenterology; Cognition","score_opus":0.16405613200716299,"score_gpt":0.5830119411110996,"score_spread":0.4189558091039366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598968435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99907565,0.0001970929,0.00001931646,0.000029373743,0.0000036429585,0.000004748804,0.00033119193,0.0000016013853,0.00033728752],"genre_scores_gemma":[0.9996358,0.000027862474,0.000013636146,0.000008749142,0.0000030108295,0.0000031461275,0.00025417688,3.3608748e-7,0.000053343698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999634,0.00012717774,0.00004327599,0.00004867261,0.000076605706,0.000070200746],"domain_scores_gemma":[0.9984823,0.00037205694,0.00067968364,0.000041413154,0.00014045044,0.00028417454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007136511,0.00021638926,0.00023816289,0.00079284125,0.00022268119,0.0005646984,0.00023036457,0.0003114553,0.0011607707],"category_scores_gemma":[0.0032397397,0.00008579808,0.0005182721,0.0005909478,0.00023321924,0.0003949252,0.0005717891,0.0003748251,0.00018578787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021075658,0.000023854385,0.99805343,0.000007208427,0.00005174845,0.00003977538,0.000019967594,0.00008524558,0.000051623843,0.0000062360837,0.000066121225,0.0013840649],"study_design_scores_gemma":[0.0000054377706,0.00021874283,0.9992884,0.0000028544302,0.000022127308,0.000098176555,0.00004996124,0.00022414062,0.000030808358,0.0000122368865,0.00004497273,0.0000021542508],"about_ca_topic_score_codex":0.0040584374,"about_ca_topic_score_gemma":0.0054859645,"teacher_disagreement_score":0.0040584374,"about_ca_system_score_codex":0.0004628872,"about_ca_system_score_gemma":0.00022991716,"threshold_uncertainty_score":0.008069634},"labels":[],"label_agreement":null},{"id":"W2599647662","doi":"10.1200/jco.2004.22.90140.7041","title":"Influence of gender on treatment outcome and toxicity in small cell lung cancer (SCLC)","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Cancer Care Ontario","funders":"","keywords":"Medicine; Internal medicine; Toxicity; Univariate analysis; Vincristine; Etoposide; Chemotherapy; Performance status; Cyclophosphamide; Oncology; Multivariate analysis","score_opus":0.22601284712966604,"score_gpt":0.5548682603600174,"score_spread":0.3288554132303513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599647662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99399406,0.0043989057,0.00013941436,0.00008760996,0.000014339517,0.000023036662,0.0003930812,0.0000036825243,0.0009457753],"genre_scores_gemma":[0.9992124,0.000336618,0.000041701613,0.000047409576,0.000015626581,0.0000104387045,0.00023403252,0.0000021856229,0.00009953299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992041,0.00039277345,0.000081429236,0.00008690453,0.00015842763,0.00007632735],"domain_scores_gemma":[0.99785763,0.00085187575,0.0009059963,0.000079147634,0.00012158507,0.00018375333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020767772,0.00013047038,0.00036316292,0.00040081696,0.00018866232,0.00036660736,0.00011360653,0.00018775034,0.0013123351],"category_scores_gemma":[0.00360965,0.000066718945,0.0005129637,0.0005777871,0.0002353967,0.00024880754,0.00019678233,0.00019181518,0.0001497023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033576954,0.000037791244,0.9804623,0.000054171465,0.00016955592,0.00018488172,0.000046808007,0.00017085201,0.00055797823,0.00002931593,0.00021716417,0.014711618],"study_design_scores_gemma":[0.00009196833,0.0019834738,0.9949699,0.000031391406,0.00019920214,0.0009888437,0.0000573468,0.00018018257,0.0002972273,0.000117490155,0.0010777982,0.0000052627565],"about_ca_topic_score_codex":0.0005843967,"about_ca_topic_score_gemma":0.0013372838,"teacher_disagreement_score":0.0020767772,"about_ca_system_score_codex":0.0003571592,"about_ca_system_score_gemma":0.00026602982,"threshold_uncertainty_score":0.010983169},"labels":[],"label_agreement":null},{"id":"W2600973140","doi":"10.1200/jco.2014.32.15_suppl.e17661","title":"Do patients with small cell lung cancer (SCLC) who have chemotherapy initiated during a hospital admission benefit from therapy?","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre; University of Manitoba","funders":"","keywords":"Medicine; Chemotherapy; Lung cancer; Retrospective cohort study; Cohort; Stage (stratigraphy); Internal medicine; Hospital admission; Cancer; Emergency medicine","score_opus":0.06996706244504795,"score_gpt":0.43963645638551596,"score_spread":0.369669393940468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600973140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997355,0.00061590533,0.000019390221,0.0004504565,0.000008961618,0.00001166072,0.00062095973,0.0000014490529,0.00091632945],"genre_scores_gemma":[0.99891627,0.00035434615,0.00002476377,0.00013990364,0.000020132306,0.000006394815,0.00044474006,6.6111835e-7,0.000092731185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996809,0.00006759779,0.000039391034,0.00005867792,0.00006574906,0.000087669636],"domain_scores_gemma":[0.99809664,0.0004386777,0.0010478278,0.000044401655,0.00013371784,0.00023869427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005268787,0.000101994774,0.0003417269,0.0004976217,0.0003402574,0.00064707815,0.00030719375,0.00063230953,0.0022005267],"category_scores_gemma":[0.0042532864,0.00015200271,0.0005365021,0.0013719845,0.00034401764,0.00069516484,0.00027801108,0.00034797986,0.0002544306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111748275,0.000016113272,0.99782854,0.000011730954,0.000017390017,0.000031424963,0.00002671286,0.000019182966,0.000025023624,0.000007590393,0.000119117416,0.0017854522],"study_design_scores_gemma":[0.000013054212,0.000075816126,0.9993463,0.000012114532,0.000020328349,0.00011066691,0.00013981378,0.00006295606,0.000012473785,0.000021305003,0.00018343383,0.0000016193799],"about_ca_topic_score_codex":0.01063859,"about_ca_topic_score_gemma":0.024576385,"teacher_disagreement_score":0.01063859,"about_ca_system_score_codex":0.00069093314,"about_ca_system_score_gemma":0.00074266497,"threshold_uncertainty_score":0.02115333},"labels":[],"label_agreement":null},{"id":"W2606202551","doi":"10.1016/j.ijrobp.2015.07.1621","title":"Small Cell Lung Cancer Limited Disease (LSCLC): Are Long Treatments With Higher Doses Really Needed?","year":2015,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Etoposide; Radiation therapy; Surgery; Lung cancer; Chemotherapy; Pleural effusion; Internal medicine","score_opus":0.04657598275778986,"score_gpt":0.37380477584635663,"score_spread":0.3272287930885668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606202551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50195205,0.25281405,0.002607946,0.2116424,0.004660382,0.00026401703,0.000976748,0.00007706839,0.02500532],"genre_scores_gemma":[0.8907683,0.055728387,0.0029031725,0.040867448,0.006327133,0.00013221028,0.00090848596,0.00006290168,0.002302031],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99851686,0.0005126322,0.0002143349,0.00018177915,0.0003064934,0.00026783205],"domain_scores_gemma":[0.9908862,0.005202347,0.0018129355,0.00019947578,0.00094482,0.0009540838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036776788,0.00024931427,0.0011559619,0.00033064472,0.00063776475,0.0016026335,0.00066157855,0.0017948408,0.007943449],"category_scores_gemma":[0.0120645845,0.00016114456,0.00086784497,0.00086204376,0.001240644,0.0036404342,0.0005478358,0.0021009194,0.00087413157],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054481803,0.00071667926,0.2823296,0.0038940995,0.00060209975,0.0024290506,0.000905457,0.00044200433,0.0035490298,0.0045356345,0.031753507,0.66339463],"study_design_scores_gemma":[0.0012865266,0.0077256663,0.7403899,0.009150557,0.002961169,0.017078068,0.01755314,0.0012332741,0.002667431,0.03189631,0.16774008,0.00031789497],"about_ca_topic_score_codex":0.0022921753,"about_ca_topic_score_gemma":0.006878883,"teacher_disagreement_score":0.007943449,"about_ca_system_score_codex":0.001556273,"about_ca_system_score_gemma":0.0022701663,"threshold_uncertainty_score":0.02657348},"labels":[],"label_agreement":null},{"id":"W2611025812","doi":"10.1016/j.lungcan.2017.04.021","title":"Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival","year":2017,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Propensity score matching; Radiation therapy; Chemotherapy; Lung cancer; Oncology; Surgery; Internal medicine","score_opus":0.03873701686102035,"score_gpt":0.3714446377825013,"score_spread":0.332707620921481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611025812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616843,0.0016908676,0.0011527163,0.00009588081,0.000058646714,0.000046826404,0.0004047511,0.000007059308,0.00037475687],"genre_scores_gemma":[0.9989473,0.00017725624,0.00021506895,0.000055512148,0.00003929874,0.000024808367,0.0003163691,0.0000048110046,0.00021963815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952311,0.0025753502,0.00047843895,0.0009217,0.0002999081,0.0004933899],"domain_scores_gemma":[0.9937736,0.00300358,0.0015878235,0.00094366964,0.00020021698,0.0004910601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004072069,0.00041915235,0.0012478562,0.0006175172,0.00043369867,0.00088125764,0.0009157922,0.0009478276,0.0032134906],"category_scores_gemma":[0.0094729075,0.00049564603,0.0034981556,0.0012391455,0.000497023,0.0009446393,0.0007217368,0.0011240259,0.000264353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.090639666,0.0006084751,0.8602946,0.0003544857,0.02026433,0.00035682024,0.00028588527,0.0024075413,0.0023874072,0.00070036587,0.0012255671,0.020474868],"study_design_scores_gemma":[0.006767629,0.014355587,0.94271946,0.000089235626,0.015464613,0.0008381709,0.0008672037,0.01256128,0.0010539419,0.0025833538,0.0026095517,0.00008991785],"about_ca_topic_score_codex":0.002601163,"about_ca_topic_score_gemma":0.0026071253,"teacher_disagreement_score":0.004072069,"about_ca_system_score_codex":0.0004582124,"about_ca_system_score_gemma":0.0006482849,"threshold_uncertainty_score":0.021535397},"labels":[],"label_agreement":null},{"id":"W2612146719","doi":"10.1093/annonc/mdx195.001","title":"Use of G-CSF and prophylactic antibiotics with concurrent chemo-radiotherapy in limited-stage small cell lung cancer: Results from the Phase III CONVERT trial","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Antibiotics; Gastroenterology; Chemotherapy; Context (archaeology); Granulocyte colony-stimulating factor; Surgery; Leukocytopenia","score_opus":0.194582472380949,"score_gpt":0.46416702038981633,"score_spread":0.26958454800886733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612146719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902914,0.0062413095,0.00020648538,0.0005368889,0.00020351184,0.0005423433,0.00061632006,0.000043801396,0.001317915],"genre_scores_gemma":[0.9904186,0.004132519,0.0006896102,0.000960823,0.00030517948,0.0007232421,0.0014602586,0.000024183171,0.0012854658],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99935764,0.00035114403,0.000035503,0.00009392553,0.000058899423,0.00010291029],"domain_scores_gemma":[0.9986957,0.00044439788,0.0002859078,0.00014035593,0.00006150361,0.0003720692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001606967,0.0011860812,0.0028991122,0.00036807012,0.00041161184,0.0014852054,0.0010683093,0.0016498435,0.0022804847],"category_scores_gemma":[0.0019736004,0.00038779338,0.0027337929,0.0006137608,0.0014714852,0.0010096845,0.0004872959,0.00365387,0.00046165736],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94218254,0.00832647,0.0026825154,0.0006179625,0.001425685,0.00005973725,0.00007809893,0.00091968506,0.003218644,0.00014361744,0.0010558732,0.039289203],"study_design_scores_gemma":[0.8097402,0.17175803,0.0129039455,0.0001181458,0.0014807263,0.0001633634,0.000098650235,0.0004948824,0.0010841107,0.00027010284,0.0018583172,0.000029419447],"about_ca_topic_score_codex":0.0018004528,"about_ca_topic_score_gemma":0.0034199448,"teacher_disagreement_score":0.0028991122,"about_ca_system_score_codex":0.0010503713,"about_ca_system_score_gemma":0.0015639211,"threshold_uncertainty_score":0.008498549},"labels":[],"label_agreement":null},{"id":"W2613503690","doi":"10.1093/annonc/mdx088.001","title":"Early limited-stage small cell lung cancer: Sub-group analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) trial","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Radiation therapy; Etoposide; Stage (stratigraphy); Conventional PCI; Chemotherapy; Lung cancer; Randomized controlled trial; Internal medicine; Surgery","score_opus":0.14425836304562678,"score_gpt":0.45388087881650246,"score_spread":0.3096225157708757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613503690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922854,0.004442063,0.00036885167,0.00024572483,0.00025204956,0.0004632554,0.0003831013,0.00003864119,0.0015208982],"genre_scores_gemma":[0.99606764,0.0009965411,0.00042199303,0.00024578397,0.00019003038,0.00026382727,0.00052963104,0.000011475445,0.0012731844],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9989686,0.0006487564,0.000055834764,0.00015407654,0.000068240515,0.00010454014],"domain_scores_gemma":[0.9985129,0.00054277194,0.00025659695,0.00030489112,0.000075901946,0.00030688234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022404268,0.0014295677,0.003829401,0.00024330753,0.0003611243,0.0012711061,0.00077815977,0.00093469716,0.0033640843],"category_scores_gemma":[0.0027354066,0.00039036712,0.0033655474,0.00039811683,0.00079501106,0.0008276492,0.00048201648,0.00290487,0.00048448524],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9850033,0.0011702563,0.0012518067,0.0002888392,0.0022863806,0.000025058207,0.000037270158,0.00038772638,0.0012277503,0.00008452226,0.00024541977,0.007991673],"study_design_scores_gemma":[0.86336297,0.10599157,0.017150296,0.000096938755,0.008865742,0.00013400006,0.00012679625,0.0013821033,0.0008680233,0.00064134045,0.0013329455,0.000047324258],"about_ca_topic_score_codex":0.0014980136,"about_ca_topic_score_gemma":0.0034654667,"teacher_disagreement_score":0.003829401,"about_ca_system_score_codex":0.000620795,"about_ca_system_score_gemma":0.00086906715,"threshold_uncertainty_score":0.011848688},"labels":[],"label_agreement":null},{"id":"W2613700593","doi":"10.1016/j.lungcan.2017.05.004","title":"Trends, practice patterns and underuse of surgery in the treatment of early stage small cell lung cancer","year":2017,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Contraindication; Stage (stratigraphy); Lung cancer; Cancer; Logistic regression; Pneumonectomy; Medicaid; Surgical oncology; Surgery; General surgery; Internal medicine; Health care; Pathology","score_opus":0.07380272844780107,"score_gpt":0.41596516259941896,"score_spread":0.3421624341516179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613700593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899545,0.006285908,0.00006336607,0.0011297227,0.00002193357,0.000009028033,0.0010441932,0.0000034143436,0.0014880161],"genre_scores_gemma":[0.9956527,0.0031769066,0.00007105435,0.00014409085,0.000046865633,0.000009109662,0.00063953496,0.000003849578,0.0002559332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981804,0.00053373154,0.00042520332,0.00025460878,0.00034944064,0.00025668376],"domain_scores_gemma":[0.9860525,0.0031239584,0.0071504335,0.0003010043,0.001959738,0.001412343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016675275,0.0000919056,0.00027370392,0.0018709672,0.0003404886,0.00094611425,0.00044547694,0.00053154206,0.0018154512],"category_scores_gemma":[0.012732858,0.00019217691,0.0005358048,0.0039347005,0.00034302927,0.0014183755,0.0005440439,0.0007351979,0.00021926427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010336006,0.000041560557,0.99413496,0.00004810853,0.00005322012,0.0000236872,0.00025066783,0.000030109739,0.00006134684,0.000061874925,0.00026697092,0.0049241083],"study_design_scores_gemma":[0.0000040346654,0.000056874058,0.9978855,0.000052088737,0.000021592497,0.000090613605,0.0011760407,0.000096207885,0.00003355496,0.000026394819,0.00055304205,0.000003995959],"about_ca_topic_score_codex":0.035226293,"about_ca_topic_score_gemma":0.048927,"teacher_disagreement_score":0.035226293,"about_ca_system_score_codex":0.0010057732,"about_ca_system_score_gemma":0.001562597,"threshold_uncertainty_score":0.07004249},"labels":[],"label_agreement":null},{"id":"W2624841205","doi":"10.1200/jco.2016.71.7454","title":"Carboplatin and Etoposide With or Without Palifosfamide in Untreated Extensive-Stage Small-Cell Lung Cancer: A Multicenter, Adaptive, Randomized Phase III Study (MATISSE)","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakeridge Health","funders":"","keywords":"Medicine; Carboplatin; Etoposide; Clinical endpoint; Lung cancer; Phases of clinical research; Internal medicine; Adverse effect; Chemotherapy; Randomized controlled trial; Gastroenterology; Surgery; Cisplatin","score_opus":0.13933934224863498,"score_gpt":0.5256645909311786,"score_spread":0.3863252486825436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624841205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744654,0.00066772435,0.00018250025,0.00012478429,0.000045887144,0.0009369878,0.00012146651,0.000020055215,0.00045404822],"genre_scores_gemma":[0.99429494,0.00079249754,0.0013339221,0.00052883674,0.00022299359,0.0013698837,0.0005154675,0.000009463089,0.0009320496],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995066,0.00031322349,0.000026382339,0.00007144663,0.00003713484,0.00004524055],"domain_scores_gemma":[0.9993611,0.00016223766,0.00016161549,0.000052991192,0.000028881455,0.00023321417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021524378,0.0011445546,0.0016014957,0.000346888,0.00025265073,0.00056018645,0.00080175383,0.00086648733,0.0029458713],"category_scores_gemma":[0.00092519977,0.00044657793,0.00084225263,0.00029911828,0.0009902937,0.00062356866,0.0003530362,0.0016195108,0.00025854545],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9043614,0.032517813,0.006109768,0.000411127,0.00084791065,0.00009774728,0.00008351301,0.0011235182,0.019023713,0.00011199559,0.00054356613,0.034767903],"study_design_scores_gemma":[0.7506789,0.23689726,0.0090697445,0.000016015616,0.00036793787,0.00009201474,0.000023503946,0.00058460777,0.0014712856,0.000067352616,0.00071893237,0.000012412977],"about_ca_topic_score_codex":0.0003933931,"about_ca_topic_score_gemma":0.001258848,"teacher_disagreement_score":0.0029458713,"about_ca_system_score_codex":0.00045559683,"about_ca_system_score_gemma":0.00080256525,"threshold_uncertainty_score":0.011383355},"labels":[],"label_agreement":null},{"id":"W2642802273","doi":"10.1016/j.jtho.2017.06.015","title":"Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Prophylactic cranial irradiation; Medicine; Oncology; Randomized controlled trial; Radiation therapy; Internal medicine; Nuclear medicine; Conventional PCI","score_opus":0.05793151531993769,"score_gpt":0.4838327757027396,"score_spread":0.4259012603828019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2642802273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97652173,0.003978317,0.0010124063,0.0012379645,0.0014040062,0.008050612,0.003506855,0.0002203246,0.004067697],"genre_scores_gemma":[0.96746784,0.0034752358,0.0039290604,0.002421,0.0012806412,0.010227698,0.0037853483,0.00009006307,0.0073231976],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988147,0.0006428307,0.00006794792,0.0002390175,0.000056462522,0.00017900833],"domain_scores_gemma":[0.997895,0.00060675613,0.00036657514,0.00023505173,0.00009624321,0.0008003332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026599462,0.0026982643,0.0051665325,0.0008419417,0.0007060183,0.0014332229,0.0020331542,0.0022403968,0.016634218],"category_scores_gemma":[0.0022375635,0.0012559306,0.0027569367,0.0009513589,0.0026423917,0.0016531338,0.00074868085,0.005121615,0.0025224977],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98452765,0.0072331694,0.0002514134,0.00016936904,0.00050358044,0.000012066865,0.000023626493,0.00020715385,0.0010136425,0.00007862658,0.00052538054,0.0054541766],"study_design_scores_gemma":[0.94424355,0.054031905,0.00064344256,0.000015367381,0.00030382772,0.000011464491,0.000014413714,0.00010818114,0.00014745968,0.00009234807,0.00038064006,0.0000074462755],"about_ca_topic_score_codex":0.0032805295,"about_ca_topic_score_gemma":0.007595173,"teacher_disagreement_score":0.016634218,"about_ca_system_score_codex":0.001895036,"about_ca_system_score_gemma":0.0033519764,"threshold_uncertainty_score":0.055647016},"labels":[],"label_agreement":null},{"id":"W2687777185","doi":"10.1016/j.radonc.2017.06.005","title":"The incidence of symptomatic brain metastases from extra-pulmonary small cell carcinoma: Is there a role for prophylactic cranial irradiation in a clinically relevant population cohort?","year":2017,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Incidence (geometry); Cohort; Oncology; Internal medicine; Population; Radiology","score_opus":0.027319765760346695,"score_gpt":0.3618371475955857,"score_spread":0.33451738183523905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2687777185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99320966,0.0041687847,0.00024642705,0.00053566834,0.000036288453,0.000010941251,0.0004555107,0.000008934828,0.0013278469],"genre_scores_gemma":[0.99876815,0.0006632412,0.00006210143,0.0001039356,0.00004683123,0.000005264701,0.00023559507,0.0000042756838,0.00011057862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892527,0.00046255728,0.00012499705,0.00022548747,0.00013545547,0.0001261515],"domain_scores_gemma":[0.9963211,0.001331985,0.0011002461,0.00056291564,0.00030898288,0.00037463615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017534031,0.00029406758,0.00067565124,0.0010397973,0.00039874643,0.001041137,0.00067545875,0.0008891599,0.0020072993],"category_scores_gemma":[0.009378159,0.00034094462,0.00073444616,0.0015769866,0.0006018396,0.0010409114,0.00045650604,0.0007045856,0.00026670436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031659327,0.000022346323,0.9959174,0.000020491241,0.00019793262,0.00008254813,0.000056129167,0.00003154879,0.00023290001,0.000071605,0.0001492106,0.0029012377],"study_design_scores_gemma":[0.0000128677175,0.00012409444,0.998743,0.000009728145,0.00015245691,0.00031372742,0.00016917998,0.000081711616,0.000060897768,0.00007704897,0.00025035106,0.0000049628634],"about_ca_topic_score_codex":0.00618705,"about_ca_topic_score_gemma":0.006709823,"teacher_disagreement_score":0.00618705,"about_ca_system_score_codex":0.00033560474,"about_ca_system_score_gemma":0.0005173696,"threshold_uncertainty_score":0.012302101},"labels":[],"label_agreement":null},{"id":"W2699278758","doi":"10.1016/s1470-2045(17)30318-2","title":"Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":570,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"Cancer Research UK","keywords":"Medicine; Chemoradiotherapy; Regimen; Lung cancer; Radiation therapy; Etoposide; Chemotherapy regimen; Internal medicine; Clinical endpoint; Performance status; Surgery; Randomized controlled trial; Chemotherapy; Oncology","score_opus":0.15045437894064043,"score_gpt":0.4667886956623838,"score_spread":0.3163343167217434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2699278758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893889,0.004037239,0.0003663499,0.00044314034,0.00046952907,0.0033402652,0.0005375364,0.00007573357,0.0013412861],"genre_scores_gemma":[0.9895141,0.0018969954,0.0014591776,0.0009714154,0.0006527884,0.0034336848,0.0007231755,0.00001764096,0.0013309874],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989623,0.0006384385,0.000075300835,0.0001578901,0.00007827629,0.0000878474],"domain_scores_gemma":[0.99788517,0.0008202411,0.00042498962,0.00021280113,0.000108454384,0.0005483037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031139276,0.0013896815,0.0031303687,0.00038968615,0.00048124083,0.0013488805,0.0009515673,0.0017724548,0.005799573],"category_scores_gemma":[0.0027137154,0.0005236519,0.0021801444,0.00048078803,0.0013714547,0.0011619759,0.00046680466,0.002600453,0.0006987046],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98446566,0.004498863,0.00035016888,0.00047964673,0.0003965735,0.000022118418,0.00003935832,0.00024208808,0.0010706111,0.00006696398,0.00029934486,0.008068545],"study_design_scores_gemma":[0.95023423,0.048242465,0.0006466585,0.00002007706,0.00016234751,0.000021955258,0.000008952817,0.00022291893,0.00011812294,0.0000682442,0.00024675392,0.0000072291473],"about_ca_topic_score_codex":0.00057205895,"about_ca_topic_score_gemma":0.0011772789,"teacher_disagreement_score":0.005799573,"about_ca_system_score_codex":0.0007437277,"about_ca_system_score_gemma":0.0011108234,"threshold_uncertainty_score":0.01940149},"labels":[],"label_agreement":null},{"id":"W2724508033","doi":"10.1371/journal.pone.0180258","title":"RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5","year":2017,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North; Laurentian University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Lung cancer; Transformation (genetics); Cancer research; Biology; Medicine; Oncology; Genetics; Gene","score_opus":0.040349274366560405,"score_gpt":0.3078051572573502,"score_spread":0.2674558828907898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2724508033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98804075,0.005358391,0.0017434789,0.00032814703,0.0001006151,0.000035022582,0.0008462317,0.0003268222,0.003220532],"genre_scores_gemma":[0.99337864,0.0010985326,0.00093657937,0.0001618402,0.00001102074,0.000034754263,0.0011250989,0.000032638833,0.0032208783],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998153,0.000027615244,0.000013747699,0.00003455723,0.000045678753,0.00006318625],"domain_scores_gemma":[0.99986315,0.000019254701,0.000030266372,0.0000151884815,0.000014084219,0.0000580394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014373973,0.0003526493,0.0002541358,0.00032192355,0.00028215698,0.00041623035,0.00018149389,0.0002994176,0.0022347898],"category_scores_gemma":[0.00013419564,0.00016058027,0.0004909046,0.00018985206,0.00027897197,0.00016500328,0.00028728295,0.0007651107,0.0010657234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017074878,0.000049843267,0.00055899867,0.00006604042,0.00000629889,0.00008061402,0.000020933621,0.000043073516,0.9977906,0.00010544306,0.00012627406,0.0009811391],"study_design_scores_gemma":[0.000044335084,0.0004657659,0.049410418,0.000022906654,0.000034844237,0.00042962987,0.00014858361,0.0017788466,0.9393476,0.00012929537,0.008174154,0.000013683132],"about_ca_topic_score_codex":0.0018203615,"about_ca_topic_score_gemma":0.0022677516,"teacher_disagreement_score":0.0022347898,"about_ca_system_score_codex":0.00049929175,"about_ca_system_score_gemma":0.00030698997,"threshold_uncertainty_score":0.0074760914},"labels":[],"label_agreement":null},{"id":"W2739368227","doi":"10.1200/jco.2017.35.15_suppl.2073","title":"Neurocognitive function testing and health related quality of life in stage IV lung cancer patients with and without brain metastases.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Neurocognitive; Lung cancer; Internal medicine; Quality of life (healthcare); Stage (stratigraphy); Oncology; Cancer; Gastroenterology; Cognition","score_opus":0.3114774786996251,"score_gpt":0.5797852137703787,"score_spread":0.2683077350707536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739368227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99922085,0.00021624578,0.000016051496,0.000020362522,0.0000031069028,0.000005961417,0.00022805347,0.0000011982005,0.00028830254],"genre_scores_gemma":[0.9996131,0.000031003972,0.000017105438,0.000011626967,0.0000035248338,0.0000059784834,0.00022658656,3.6028916e-7,0.00009070532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978167,0.000052964177,0.000027817789,0.00003724658,0.000048726848,0.000051625375],"domain_scores_gemma":[0.99922144,0.00013263321,0.000364012,0.000020438605,0.00006480922,0.0001966723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038918847,0.00019859486,0.00025876344,0.0008062484,0.00028449408,0.0004319808,0.00021284979,0.00030305746,0.0018543034],"category_scores_gemma":[0.0014279248,0.00009658898,0.0003374162,0.00073329045,0.00019268994,0.0003546248,0.00041103875,0.00038755554,0.00025958606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002724381,0.000041758547,0.99843186,0.0000071093077,0.000026480744,0.00004354265,0.000020007443,0.000025028416,0.00009380095,0.000003826369,0.000050576054,0.0009834728],"study_design_scores_gemma":[0.000010282703,0.00030358473,0.9992059,0.000002812714,0.000014784049,0.0001801956,0.000057710804,0.00011635855,0.00004211411,0.00000899382,0.000055897475,0.0000015045252],"about_ca_topic_score_codex":0.0035003985,"about_ca_topic_score_gemma":0.003811648,"teacher_disagreement_score":0.0035003985,"about_ca_system_score_codex":0.00040727697,"about_ca_system_score_gemma":0.00021154543,"threshold_uncertainty_score":0.0069600344},"labels":[],"label_agreement":null},{"id":"W2739590162","doi":"10.1158/1538-7445.am2017-2248","title":"Abstract 2248: Common <i>TDP1</i> polymorphisms in relation to survival among small cell lung cancer patients in a multicenter study from the International Lung Cancer Consortium","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Internal medicine; Hazard ratio; Lung cancer; Genotype; Oncology; Medicine; Topotecan; Topoisomerase; Irinotecan; Cancer; Confidence interval; Biology; Genetics; Chemotherapy; Gene; DNA; Colorectal cancer","score_opus":0.07079258910405739,"score_gpt":0.43121373376579725,"score_spread":0.36042114466173986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739590162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998912,0.00014994627,0.000069849564,0.00003313258,0.000005918466,0.000009527697,0.0006470165,0.0000030588976,0.00016952098],"genre_scores_gemma":[0.9990128,0.000035660385,0.000060133625,0.000024911918,0.00001015329,0.000018573888,0.00074090046,0.0000030322776,0.00009382698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920076,0.00019157873,0.00009788599,0.00033204214,0.00010434568,0.00007333322],"domain_scores_gemma":[0.9984952,0.0002253936,0.00066498027,0.00018719603,0.00017077358,0.0002563974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009070608,0.00047609565,0.0005171115,0.0006703199,0.0006801747,0.0008356913,0.0005313463,0.00061391556,0.0016155535],"category_scores_gemma":[0.0016506033,0.0002485157,0.0007774304,0.0014739452,0.0003163992,0.00023959547,0.00044198777,0.0005253224,0.0002169669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005638592,0.00003741427,0.9969836,0.00001593715,0.0004082331,0.00011365653,0.00006112551,0.00005630373,0.0010064765,0.000013024678,0.000191447,0.0005488931],"study_design_scores_gemma":[0.0000581611,0.00011608001,0.9985837,0.000006023274,0.00030757245,0.00031423787,0.00007816071,0.0001661934,0.00014866567,0.00001882283,0.0001970259,0.000005404158],"about_ca_topic_score_codex":0.005428385,"about_ca_topic_score_gemma":0.0047997637,"teacher_disagreement_score":0.005428385,"about_ca_system_score_codex":0.0002654891,"about_ca_system_score_gemma":0.00028846532,"threshold_uncertainty_score":0.010793567},"labels":[],"label_agreement":null},{"id":"W2748804458","doi":"10.1016/j.ijrobp.2014.08.288","title":"Evaluation of Prognostic Variables in Patients With Small Cell Lung Cancer: The Role of Volumetric Response to Initial Therapy in Determining the Benefit of Prophylactic Cranial Irradiation","year":2014,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; American Society of Clinical Oncology; York University; Teva Pharmaceutical Industries; Genentech; National Aeronautics and Space Administration; U.S. Department of Defense","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Lung cancer; Proportional hazards model; Radiation therapy; Stage (stratigraphy); Hazard ratio; Internal medicine; Retrospective cohort study; Nuclear medicine; Chemotherapy; Cancer; Oncology; Surgery; Radiology; Confidence interval; Myocardial infarction","score_opus":0.02379437390616405,"score_gpt":0.35432225058366723,"score_spread":0.33052787667750316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748804458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981452,0.0010468719,0.00017067562,0.000093508796,0.000010092498,0.000008559807,0.00007913602,0.000004396477,0.00044151707],"genre_scores_gemma":[0.9996389,0.000109427674,0.00007103753,0.000013006742,0.000011914732,0.000003741857,0.00009369714,0.0000011534158,0.00005702531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997359,0.00011489518,0.000018938883,0.000029552046,0.000050709965,0.000050025337],"domain_scores_gemma":[0.99877137,0.000699722,0.0002279911,0.000053430398,0.00007622207,0.00017124391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009388976,0.00031966742,0.00046761814,0.00050347304,0.00023866454,0.00051214633,0.0003954097,0.00037897282,0.0006150901],"category_scores_gemma":[0.0033484465,0.00010126996,0.00044249892,0.0006095108,0.00032549727,0.00040453914,0.0002192785,0.00062892545,0.000112723836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003493724,0.00015738564,0.97927123,0.00002552107,0.00012722745,0.0000599535,0.000054585373,0.00059448555,0.0013147205,0.000052352254,0.00009188352,0.014756814],"study_design_scores_gemma":[0.00010205099,0.002387495,0.9930528,0.000013006215,0.00023668852,0.00026774142,0.00012512699,0.0020907926,0.0011811678,0.00014797723,0.00038598396,0.000009165541],"about_ca_topic_score_codex":0.0020338674,"about_ca_topic_score_gemma":0.0020616031,"teacher_disagreement_score":0.0020338674,"about_ca_system_score_codex":0.00046430196,"about_ca_system_score_gemma":0.0005191165,"threshold_uncertainty_score":0.0049654245},"labels":[],"label_agreement":null},{"id":"W2754680561","doi":"10.1016/j.clon.2017.09.002","title":"The CONVERT Trial: Interpretation, Journey and Lessons Learnt","year":2017,"lang":"en","type":"editorial","venue":"Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Cancer Society Research Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Radiation therapy; Chemoradiotherapy; Lung cancer; Clinical trial; Randomized controlled trial; Chemotherapy; Oncology; Internal medicine","score_opus":0.18343334459035662,"score_gpt":0.5933799124866903,"score_spread":0.40994656789633366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754680561","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003288422,0.00959736,0.00032045462,0.09824605,0.8909125,0.00004160993,0.00010385646,0.00006751041,0.00067781785],"genre_scores_gemma":[0.00034499695,0.004260599,0.00040278418,0.06586341,0.9262717,0.00007963909,0.000031797008,0.00006956129,0.0026755244],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.944493,0.022816014,0.00914492,0.0034797997,0.018236415,0.0018297723],"domain_scores_gemma":[0.7128431,0.20974061,0.011619647,0.0063332287,0.048258353,0.011205038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08279296,0.005093631,0.009389556,0.0051638787,0.0048815124,0.016530091,0.009082123,0.04082834,0.009557698],"category_scores_gemma":[0.23748827,0.0028004064,0.0059293606,0.0037965672,0.0062404196,0.007888689,0.0035492477,0.05149802,0.008828554],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008125962,0.000012784645,0.000036593865,0.0005869451,0.00009190095,0.0000803716,0.000027093218,0.00002973449,0.00002091191,0.00056089996,0.9935869,0.0048845015],"study_design_scores_gemma":[0.0006431152,0.00008965285,0.00039489285,0.0042981836,0.0006259796,0.00033371634,0.0001304128,0.00047987924,0.00021005498,0.0058964803,0.98678374,0.000113861905],"about_ca_topic_score_codex":0.0036998088,"about_ca_topic_score_gemma":0.01003362,"teacher_disagreement_score":0.08279296,"about_ca_system_score_codex":0.007481314,"about_ca_system_score_gemma":0.012759974,"threshold_uncertainty_score":0.43785626},"labels":[],"label_agreement":null},{"id":"W2758484518","doi":"10.1016/j.ijrobp.2017.06.1669","title":"Treatment, Technology, and Time Trends in the Management of Limited-Stage Small Cell Lung Cancer","year":2017,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Radiation therapy; Chemoradiotherapy; Conventional PCI; Stage (stratigraphy); Lung cancer; Logistic regression; Statistical significance; Retrospective cohort study; Internal medicine; Oncology","score_opus":0.03237294400331394,"score_gpt":0.3926802650978611,"score_spread":0.36030732109454716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758484518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977965,0.014796876,0.00045183775,0.0023657815,0.00006538289,0.000016311245,0.0009417826,0.000012231679,0.00338478],"genre_scores_gemma":[0.9959577,0.0027705156,0.00015458591,0.00018277453,0.00008295104,0.000007859787,0.00048300542,0.0000071964814,0.0003533932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992786,0.00017243241,0.0001302865,0.00009722866,0.00017160168,0.0001497813],"domain_scores_gemma":[0.99571747,0.0011984053,0.0021855365,0.0000932536,0.00047168147,0.00033373846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096808886,0.0000865178,0.00018894277,0.0010508081,0.00023502397,0.0007866278,0.0003271065,0.0005090318,0.0016335429],"category_scores_gemma":[0.006001032,0.000091535105,0.00038307154,0.0025176746,0.00028389445,0.0010076775,0.00036018997,0.0006280458,0.00019607868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005804998,0.000121649326,0.9729971,0.00007640462,0.00007883463,0.00012975365,0.00016723704,0.00066299905,0.00058296253,0.00047384438,0.00049993704,0.023628833],"study_design_scores_gemma":[0.000010095268,0.0003852884,0.9947725,0.00004023953,0.00009244969,0.00034386528,0.0006785647,0.00062198093,0.00035743785,0.00025030476,0.002439027,0.000008260045],"about_ca_topic_score_codex":0.0072592474,"about_ca_topic_score_gemma":0.011739996,"teacher_disagreement_score":0.0072592474,"about_ca_system_score_codex":0.0011159686,"about_ca_system_score_gemma":0.0010214794,"threshold_uncertainty_score":0.01443398},"labels":[],"label_agreement":null},{"id":"W2767096845","doi":"10.1016/j.athoracsur.2017.07.009","title":"Surgical Treatment for Early Small Cell Lung Cancer: Variability in Practice and Impact on Survival","year":2017,"lang":"en","type":"article","venue":"The Annals of Thoracic Surgery","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Quartile; Hazard ratio; Confidence interval; Odds ratio; Lung cancer; Proportional hazards model; Comorbidity; Logistic regression; Surgery; Cancer; Internal medicine","score_opus":0.1798770833228253,"score_gpt":0.5124172341637343,"score_spread":0.33254015084090904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767096845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903441,0.0058144107,0.00030393724,0.0013690058,0.000058280417,0.000014372988,0.0005126308,0.0000045779934,0.0015785783],"genre_scores_gemma":[0.99855524,0.00074855785,0.00007128243,0.00013776707,0.000057070993,0.0000061943683,0.00031168578,0.0000043022437,0.0001080027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98565835,0.00783198,0.0019323563,0.0013026338,0.002298508,0.00097609207],"domain_scores_gemma":[0.94270724,0.029333988,0.01790768,0.0030171415,0.0043189963,0.0027149755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008399114,0.00015504326,0.00046343644,0.0018424366,0.00048032744,0.0018408344,0.0006124376,0.0007037628,0.0014841816],"category_scores_gemma":[0.041895293,0.00022142884,0.00079218496,0.004332335,0.0007865244,0.0014949057,0.0013967148,0.00078687706,0.00021398548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023780028,0.000052622097,0.9896142,0.000030603587,0.00027708104,0.000027105676,0.00030893943,0.00012501664,0.000061167004,0.00010661978,0.00023966332,0.0089190975],"study_design_scores_gemma":[0.000012315835,0.0001250745,0.9978193,0.00003971424,0.00006443387,0.00006721079,0.0010547888,0.00016933602,0.0000485086,0.00013052845,0.00045976695,0.000008997397],"about_ca_topic_score_codex":0.0081158485,"about_ca_topic_score_gemma":0.0112846205,"teacher_disagreement_score":0.008399114,"about_ca_system_score_codex":0.0014816491,"about_ca_system_score_gemma":0.0015005935,"threshold_uncertainty_score":0.04441929},"labels":[],"label_agreement":null},{"id":"W2767853540","doi":"10.1016/j.jtho.2016.11.929","title":"P1.07-017 Indications for Adjuvant Mediastinal Radiation in Surgically Resected Small Cell Lung Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Proportional hazards model; Pneumonectomy; Resection margin; Hazard ratio; Radiation therapy; Lung cancer; Comorbidity; Survival analysis; Cancer; Stage (stratigraphy); Oncology; Internal medicine; Surgery; Resection; Confidence interval","score_opus":0.05568723844528266,"score_gpt":0.5043517592412755,"score_spread":0.44866452079599284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767853540","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9574009,0.00732437,0.00035679658,0.0029812038,0.00074936164,0.000057112116,0.0042062225,0.000021375725,0.026902514],"genre_scores_gemma":[0.98881626,0.0022727745,0.00042365372,0.0008564752,0.0004138781,0.000073337374,0.0035425136,0.000035711895,0.003565373],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995197,0.00015904255,0.00006734087,0.000048798476,0.00010284054,0.0001023041],"domain_scores_gemma":[0.9984205,0.0006124766,0.00033363904,0.00005071961,0.00017826643,0.00040439956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009637213,0.00016881927,0.0002734809,0.00061515695,0.0004300714,0.00077665184,0.0003367084,0.0006880852,0.012702079],"category_scores_gemma":[0.0025549668,0.00013791503,0.0005385718,0.0010361173,0.00032656838,0.0005047926,0.0003127142,0.00082612457,0.0018629495],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048412774,0.0002787141,0.9207951,0.0004143093,0.00017871655,0.0021269638,0.00018977346,0.00024757074,0.0044245073,0.0011199667,0.011232095,0.054151073],"study_design_scores_gemma":[0.0002490407,0.0008885838,0.9676569,0.00040583962,0.00032865096,0.0054939324,0.0008967217,0.00042819345,0.0008773663,0.0011628353,0.02158534,0.00002657754],"about_ca_topic_score_codex":0.0011070463,"about_ca_topic_score_gemma":0.0026473852,"teacher_disagreement_score":0.012702079,"about_ca_system_score_codex":0.00033885278,"about_ca_system_score_gemma":0.0010598227,"threshold_uncertainty_score":0.042492688},"labels":[],"label_agreement":null},{"id":"W2769343437","doi":"10.21037/jtd.2017.11.23","title":"Surgery for small cell lung cancer in the modern era: opportunities and challenges","year":2017,"lang":"en","type":"letter","venue":"Journal of Thoracic Disease","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Lung cancer; Lung; Surgery; General surgery; Oncology; Internal medicine","score_opus":0.1825703947129138,"score_gpt":0.412831140887854,"score_spread":0.2302607461749402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769343437","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002528384,0.0048619984,0.00007569644,0.8969002,0.09704783,0.000006708984,0.000024633322,0.000013763934,0.0008163759],"genre_scores_gemma":[0.0025168848,0.007061208,0.00018800754,0.49486634,0.49345347,0.000019704705,0.000022472594,0.000017452505,0.0018545153],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99622667,0.0012903339,0.0006621661,0.00036054774,0.0011825294,0.00027782697],"domain_scores_gemma":[0.971194,0.020214817,0.0013956832,0.0006937246,0.004175336,0.0023263628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005009735,0.00063768,0.0015511365,0.0008143415,0.0023278354,0.0032007287,0.0017972216,0.02198654,0.004449258],"category_scores_gemma":[0.029967966,0.00042944195,0.0009384929,0.00074889173,0.002720843,0.004263736,0.001147671,0.026998986,0.00382343],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053055566,0.00004012104,0.0004564501,0.00015806193,0.000014695699,0.0013203842,0.00010102254,0.000042446878,0.00011855307,0.0016178612,0.9796953,0.01638204],"study_design_scores_gemma":[0.00012556813,0.000108740656,0.0013351707,0.0006954821,0.000049579183,0.0044960584,0.00047479165,0.00029131552,0.00020430429,0.008664086,0.98349816,0.000056761666],"about_ca_topic_score_codex":0.0011683778,"about_ca_topic_score_gemma":0.00257336,"teacher_disagreement_score":0.02198654,"about_ca_system_score_codex":0.0025270768,"about_ca_system_score_gemma":0.0024229332,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2769943794","doi":"10.1200/jco.2017.76.0645","title":"Reply to D.T.W. Jones et al","year":2017,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Humanities","score_opus":0.31410172871791164,"score_gpt":0.6230269659975991,"score_spread":0.30892523727968746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769943794","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015829405,0.0008771993,0.000026086218,0.9861057,0.011853743,0.00000550262,0.000044914395,0.00001415702,0.00091440306],"genre_scores_gemma":[0.0016808731,0.0007240771,0.00007719902,0.9773039,0.017405592,0.000022131395,0.00002792816,0.000014807306,0.0027434686],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964804,0.0011755956,0.00048268156,0.00045812348,0.00095939613,0.00044387288],"domain_scores_gemma":[0.9879859,0.0060169944,0.0008194518,0.00037205417,0.0028203009,0.001985298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048213797,0.00071514654,0.0016193435,0.0009299696,0.0037404937,0.003764936,0.0024493344,0.043652438,0.008005653],"category_scores_gemma":[0.035701312,0.0008697203,0.00099053,0.0010210732,0.0034609458,0.00473036,0.0020417336,0.039198924,0.00913162],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003132456,0.0000116068,0.00039025836,0.000028559087,0.000006538091,0.00052345544,0.00007660094,0.000015828935,0.000035584853,0.00067621825,0.9956474,0.0025566397],"study_design_scores_gemma":[0.00013808734,0.00006814547,0.0013256706,0.0003706845,0.00004293494,0.0035032604,0.0010074549,0.0002708241,0.00033316074,0.0074216058,0.985427,0.000091226386],"about_ca_topic_score_codex":0.00521714,"about_ca_topic_score_gemma":0.00823706,"teacher_disagreement_score":0.043652438,"about_ca_system_score_codex":0.0035558105,"about_ca_system_score_gemma":0.005496328,"threshold_uncertainty_score":0.026781559},"labels":[],"label_agreement":null},{"id":"W2789846220","doi":"10.1002/prca.201700084","title":"An MRM‐Based Cytokeratin Marker Assay as a Tool for Cancer Studies: Application to Lung Cancer Pleural Effusions","year":2018,"lang":"en","type":"article","venue":"PROTEOMICS - CLINICAL APPLICATIONS","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Genome British Columbia; Jewish General Hospital; University of Victoria","funders":"Narodowe Centrum Nauki","keywords":"Cytokeratin; Lung cancer; Medicine; Pleural fluid; Pathology; Pleural effusion; Oncology; Tumor marker; Cancer research; Cancer; Internal medicine; Immunohistochemistry","score_opus":0.08450941785232464,"score_gpt":0.5404492689821476,"score_spread":0.455939851129823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789846220","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76609236,0.03307343,0.19652037,0.0004132129,0.00012176948,0.00040802817,0.0005627225,0.00060911657,0.0021990656],"genre_scores_gemma":[0.8634311,0.004330325,0.13030843,0.00025679238,0.000072634015,0.00020384084,0.00029208057,0.000036348,0.0010684194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990409,0.00035373092,0.00006355106,0.00021637513,0.00027682353,0.000048583046],"domain_scores_gemma":[0.99938715,0.00019969456,0.00015637715,0.00007131536,0.00013351522,0.000051810443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014888154,0.00062222814,0.0004153534,0.00090535986,0.00019174367,0.0005036631,0.0003222598,0.00054449134,0.0005573778],"category_scores_gemma":[0.0013399196,0.00019846292,0.00026707584,0.00039756464,0.0004373194,0.000311976,0.00037219407,0.00061652274,0.00032741352],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001791374,0.00004561941,0.007126287,0.00023192274,0.000032109143,0.00011799476,0.000037883714,0.00026568706,0.9701239,0.00012147276,0.00009248672,0.02162546],"study_design_scores_gemma":[0.0000305288,0.001030967,0.021666307,0.000039500952,0.00010681003,0.002266822,0.000048202688,0.0054472284,0.9652227,0.00023211836,0.0038821127,0.000026758744],"about_ca_topic_score_codex":0.00021399894,"about_ca_topic_score_gemma":0.00039937318,"teacher_disagreement_score":0.0014888154,"about_ca_system_score_codex":0.0002747479,"about_ca_system_score_gemma":0.0003183575,"threshold_uncertainty_score":0.007873714},"labels":[],"label_agreement":null},{"id":"W2795047916","doi":"10.1016/j.ijrobp.2018.01.108","title":"A Small Window of Opportunity When Disease Is Limited in Extensive-Stage Small Cell Lung Cancer?","year":2018,"lang":"en","type":"letter","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Radiology; Pulmonary function testing; Radiation therapy; Lung cancer; Stage (stratigraphy); Vital capacity; Small Cell Lung Carcinoma; Small-cell carcinoma; Lung; Thorax (insect anatomy); Diffusing capacity; Biopsy; Conventional PCI; Internal medicine; Myocardial infarction; Lung function; Anatomy","score_opus":0.06398726882915338,"score_gpt":0.37173532529853914,"score_spread":0.30774805646938574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795047916","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006802064,0.0073028295,0.00031794872,0.97351485,0.007041902,0.000010897259,0.00003554459,0.000020435673,0.0049535455],"genre_scores_gemma":[0.20680904,0.0091510825,0.0013371033,0.649486,0.12710999,0.000094204675,0.00010438601,0.000036897378,0.005871207],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999129,0.0003669588,0.000098792945,0.00009739561,0.0001394666,0.00016841327],"domain_scores_gemma":[0.9913639,0.005858886,0.00047442538,0.00022450676,0.00039682334,0.0016815318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022015916,0.00022456663,0.0007526898,0.00033251106,0.0014303514,0.0014502497,0.0007970132,0.012050026,0.0038944653],"category_scores_gemma":[0.017079465,0.00020979546,0.00053628866,0.00025229808,0.002061465,0.0037571252,0.0013018821,0.0123446025,0.0010801855],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001089062,0.00021906079,0.019086655,0.00040925012,0.00007147567,0.06186129,0.0008108552,0.00038216362,0.002536592,0.021895645,0.75357276,0.13806523],"study_design_scores_gemma":[0.0005311289,0.0008645939,0.021981137,0.0013920574,0.0001344233,0.09057229,0.0053206324,0.0009418189,0.0014111853,0.106889635,0.769808,0.00015310071],"about_ca_topic_score_codex":0.0009067851,"about_ca_topic_score_gemma":0.002910812,"teacher_disagreement_score":0.012050026,"about_ca_system_score_codex":0.0016905537,"about_ca_system_score_gemma":0.0017234924,"threshold_uncertainty_score":0.013028324},"labels":[],"label_agreement":null},{"id":"W2800252028","doi":"10.1016/j.ijrobp.2018.04.058","title":"Prophylactic Cranial Irradiation in Extensive Stage Small Cell Lung Cancer: Outcomes at a Comprehensive Cancer Centre","year":2018,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Brain metastasis; Internal medicine; Lung cancer; Multivariate analysis; Oncology; Univariate analysis; Cancer; Radiation therapy; Stage (stratigraphy); Randomized controlled trial; Metastasis; Surgery","score_opus":0.03143533037194826,"score_gpt":0.3892543607506191,"score_spread":0.3578190303786708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800252028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905807,0.00019371398,0.000013856365,0.000100087556,0.0000029703472,0.0000065897584,0.00013048238,0.000002135975,0.00049214734],"genre_scores_gemma":[0.99933225,0.00015209451,0.000021974154,0.00003708784,0.0000073185624,0.0000028628133,0.00022936387,0.0000020910322,0.00021492418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996333,0.000046693065,0.000020553247,0.000057516325,0.000080463076,0.00016157518],"domain_scores_gemma":[0.9994153,0.000046066638,0.0001857564,0.000018147213,0.000079135825,0.00025568853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016170007,0.00022204047,0.00021677089,0.000387434,0.0007062797,0.0007681718,0.000522897,0.00042671605,0.001652148],"category_scores_gemma":[0.0008639,0.00015554362,0.00025861867,0.0010608722,0.00040280976,0.00037066935,0.00080296386,0.00051066227,0.00018885975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053345534,0.0003223871,0.9861438,0.0000347948,0.00005554628,0.00096540246,0.00077910046,0.00041153692,0.0008968636,0.00006438512,0.00095209724,0.008840704],"study_design_scores_gemma":[0.000015965612,0.00036825665,0.9975932,0.000013965899,0.000029033936,0.0005245545,0.00096154574,0.00007569287,0.00009965024,0.00002454151,0.0002844907,0.000009129715],"about_ca_topic_score_codex":0.08047145,"about_ca_topic_score_gemma":0.12047658,"teacher_disagreement_score":0.08047145,"about_ca_system_score_codex":0.0023310625,"about_ca_system_score_gemma":0.001758371,"threshold_uncertainty_score":0.1600061},"labels":[],"label_agreement":null},{"id":"W2802321489","doi":"10.21037/jtd.2018.03.121","title":"A lower level of forced expiratory volume in one second predicts the poor prognosis of small cell lung cancer","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Disease","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Medicine; COPD; Internal medicine; Lung cancer; Hazard ratio; Proportional hazards model; Pulmonary function testing; Multivariate analysis; Vital capacity; Retrospective cohort study; Log-rank test; Oncology; Lung; Confidence interval; Lung function; Diffusing capacity","score_opus":0.0791309594943882,"score_gpt":0.38271467388917485,"score_spread":0.30358371439478665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802321489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99915946,0.00035967948,0.000036596848,0.000050674636,0.000005451331,0.0000027495869,0.00012151113,0.0000017183223,0.00026220636],"genre_scores_gemma":[0.9997055,0.000064088614,0.000024275007,0.000009221594,0.000009621881,0.0000015230794,0.00013446105,3.482949e-7,0.00005088728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980515,0.00004257056,0.000029939647,0.000031176754,0.000048346254,0.000042839394],"domain_scores_gemma":[0.99842995,0.00031520418,0.0007286165,0.000053640826,0.00016222628,0.0003102443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004631741,0.00021100715,0.00020892911,0.00058539736,0.00029398713,0.00047121683,0.00022499205,0.00031818848,0.0020649403],"category_scores_gemma":[0.0017553989,0.000090427464,0.0002875389,0.0005578947,0.00029629475,0.00026980205,0.00028127816,0.00038929164,0.00023270879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004243479,0.0000121837,0.99929845,0.0000045262477,0.000010500152,0.000022162376,0.0000059823324,0.000015472762,0.00010527399,0.0000026912437,0.000029596102,0.00045078492],"study_design_scores_gemma":[0.0000031647244,0.00006739116,0.99933845,0.0000040149807,0.000022049944,0.00021780269,0.000045010984,0.00010929531,0.00008471492,0.000015464795,0.00009133767,0.0000012138405],"about_ca_topic_score_codex":0.0009905098,"about_ca_topic_score_gemma":0.0016710066,"teacher_disagreement_score":0.0020649403,"about_ca_system_score_codex":0.0001835065,"about_ca_system_score_gemma":0.0003191038,"threshold_uncertainty_score":0.00690794},"labels":[],"label_agreement":null},{"id":"W2810830875","doi":"10.1016/j.jval.2018.04.094","title":"Approaches for Estimating the Comparative Efficacy of Treatments for Patients with Recurrent Small Cell Lung Cancer (SCLC) within Connected and Disconnected Networks of Evidence","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Topotecan; Medicine; Nivolumab; Internal medicine; Oncology; Ipilimumab; Randomized controlled trial; Hazard ratio; Chemotherapy; Cancer; Confidence interval; Immunotherapy","score_opus":0.2681648071868797,"score_gpt":0.4290487568621788,"score_spread":0.16088394967529912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810830875","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21510303,0.028005255,0.7273815,0.012035962,0.0003502663,0.0028298975,0.0043563773,0.00034904885,0.009588697],"genre_scores_gemma":[0.71701366,0.005787458,0.2703039,0.0008657883,0.0003608222,0.002757886,0.0017057132,0.00006383882,0.0011409605],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9064054,0.08137971,0.0033727176,0.0054515093,0.0026570156,0.000733613],"domain_scores_gemma":[0.439812,0.5407859,0.0116600655,0.004621618,0.0018776605,0.0012428209],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10260767,0.0023663412,0.0061783423,0.013328954,0.0011776743,0.00740979,0.006218212,0.004344267,0.0054078056],"category_scores_gemma":[0.3593447,0.0021285303,0.0056386217,0.011087495,0.0046556317,0.008466593,0.006920168,0.0047480334,0.00025852647],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030236007,0.0005951728,0.069886714,0.0052155573,0.019476844,0.000883666,0.0018492879,0.47960758,0.0005398428,0.21252331,0.002912924,0.20348555],"study_design_scores_gemma":[0.0006361691,0.00067050743,0.010748442,0.0011299185,0.004502223,0.00040331538,0.00068834913,0.39140058,0.00035455826,0.5858618,0.0034829306,0.00012119059],"about_ca_topic_score_codex":0.005680927,"about_ca_topic_score_gemma":0.0036224218,"teacher_disagreement_score":0.89739233,"about_ca_system_score_codex":0.0043970495,"about_ca_system_score_gemma":0.002831524,"threshold_uncertainty_score":0.5426477},"labels":[],"label_agreement":null},{"id":"W2815764189","doi":"10.1016/j.clon.2018.06.008","title":"Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy","year":2018,"lang":"en","type":"review","venue":"Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Sunnybrook Health Science Centre; Juravinski Cancer Centre; McMaster University; Thunder Bay Regional Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Regimen; Irinotecan; Guideline; Etoposide; Oncology; Chemotherapy; Carboplatin; Lung cancer; Stage (stratigraphy); Internal medicine; Surgery; Cancer; Cisplatin; Colorectal cancer; Pathology","score_opus":0.1655876035082247,"score_gpt":0.5609793436833594,"score_spread":0.39539174017513473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2815764189","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010034496,0.99064386,0.0005108979,0.003314643,0.0012457046,0.00012610611,0.0008274355,0.000037208985,0.0031936846],"genre_scores_gemma":[0.0007788302,0.98961467,0.0025776841,0.0032947867,0.00038873177,0.00017546295,0.0011868065,0.000008456306,0.0019747417],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.998681,0.00026962734,0.0004413654,0.000104700186,0.00043369672,0.00006960635],"domain_scores_gemma":[0.99792457,0.0007840859,0.00045709597,0.0000412532,0.00069825357,0.000094713425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019664948,0.0011509917,0.0026074564,0.004326109,0.00048576482,0.0014056554,0.0029294926,0.0025901378,0.0067103854],"category_scores_gemma":[0.0037487405,0.00053011806,0.0029323772,0.0034963475,0.0005672205,0.0013834251,0.00093948457,0.0027466032,0.0032254525],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012528063,0.00008014924,0.00046319037,0.081237026,0.00043046678,0.00032748794,0.00013503926,0.000418036,0.0007428499,0.00478777,0.32023484,0.59101796],"study_design_scores_gemma":[0.000104015766,0.000056364104,0.0016965687,0.07322739,0.0008837977,0.0009501168,0.000068073474,0.00010219877,0.00015882745,0.0020002506,0.9207198,0.000032622567],"about_ca_topic_score_codex":0.013352321,"about_ca_topic_score_gemma":0.03081864,"teacher_disagreement_score":0.013352321,"about_ca_system_score_codex":0.0019122061,"about_ca_system_score_gemma":0.006931775,"threshold_uncertainty_score":0.02654922},"labels":[],"label_agreement":null},{"id":"W2883045134","doi":"","title":"From Targeted to Pinpoint: The Implementation of Pharmacogenomics in Clinical Oncology","year":2017,"lang":"en","type":"article","venue":"UBC Faculty of Medicine medical journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenomics; Medicine; Tolerability; Pace; Oncology; Imatinib; Cancer; Internal medicine; Intensive care medicine; Bioinformatics; Pharmacology; Biology; Adverse effect","score_opus":0.13131760824608513,"score_gpt":0.5617596773999427,"score_spread":0.4304420691538576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883045134","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008548109,0.19302018,0.16687582,0.5902188,0.008219707,0.00041326016,0.0007168781,0.001226742,0.030760603],"genre_scores_gemma":[0.20383772,0.268969,0.20508675,0.29457527,0.018040579,0.00058007066,0.0006535879,0.00074539613,0.007511661],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98318416,0.010653107,0.0008289973,0.0015814743,0.0033589841,0.00039324095],"domain_scores_gemma":[0.95178324,0.03338895,0.0024577775,0.0041034613,0.0058368677,0.0024296253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037209574,0.0009811163,0.002482926,0.0031477758,0.0013742488,0.012693243,0.0022901522,0.0044328705,0.008578123],"category_scores_gemma":[0.05757229,0.0008080159,0.0013211884,0.0026489925,0.009523965,0.018115532,0.0070102783,0.017666206,0.0029296277],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006544572,0.0003878753,0.008073595,0.0021237098,0.00041816608,0.00046144935,0.00083881436,0.002997708,0.004151294,0.18328309,0.074820094,0.7217898],"study_design_scores_gemma":[0.00025058977,0.0010484256,0.005716558,0.004196355,0.00033923518,0.0010657721,0.0012467353,0.0045298897,0.0027004927,0.59866536,0.37997222,0.0002683236],"about_ca_topic_score_codex":0.0025064205,"about_ca_topic_score_gemma":0.002804244,"teacher_disagreement_score":0.037209574,"about_ca_system_score_codex":0.0038607658,"about_ca_system_score_gemma":0.009053754,"threshold_uncertainty_score":0.19678539},"labels":[],"label_agreement":null},{"id":"W2883956485","doi":"10.1093/icvts/ivy223","title":"Is lobectomy superior to sublobar resection for early-stage small-cell lung cancer discovered intraoperatively?","year":2018,"lang":"en","type":"review","venue":"Interactive Cardiovascular and Thoracic Surgery","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Stage (stratigraphy); Lung cancer; Surgery; Pneumonectomy; Oncology","score_opus":0.09074264587629223,"score_gpt":0.4284799213802781,"score_spread":0.33773727550398586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883956485","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01334057,0.9294246,0.0017092017,0.016531533,0.0058864215,0.01902393,0.0057123876,0.00011479465,0.0082566235],"genre_scores_gemma":[0.10610218,0.8274867,0.008212534,0.023771964,0.004666079,0.021948792,0.004377345,0.00009825052,0.0033362356],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98681414,0.0042168037,0.0068795322,0.0006130844,0.0011104415,0.00036597112],"domain_scores_gemma":[0.96554804,0.022367453,0.007916683,0.0006129134,0.0028293245,0.0007255448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01639425,0.0008778429,0.00624102,0.007159883,0.0007572089,0.0046094037,0.0013959017,0.0040665693,0.014332678],"category_scores_gemma":[0.050456867,0.00082793913,0.008366465,0.005186939,0.0010855416,0.00267111,0.0018796204,0.001626162,0.0017576229],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068018697,0.0000711408,0.0020409918,0.8859986,0.009298229,0.00019145671,0.00015938848,0.000104514475,0.0014180064,0.00075422204,0.004133474,0.089028105],"study_design_scores_gemma":[0.0109810615,0.0027228082,0.011828496,0.8233548,0.0660299,0.00059921376,0.00044838162,0.00019616654,0.0013811634,0.003252807,0.07910141,0.00010367719],"about_ca_topic_score_codex":0.0016506583,"about_ca_topic_score_gemma":0.0037371542,"teacher_disagreement_score":0.01639425,"about_ca_system_score_codex":0.004109217,"about_ca_system_score_gemma":0.007814159,"threshold_uncertainty_score":0.08670205},"labels":[],"label_agreement":null},{"id":"W2885149505","doi":"10.21037/jtd.2018.06.98","title":"The evolving role of radiotherapy in the management of small cell lung cancer","year":2018,"lang":"en","type":"review","venue":"Journal of Thoracic Disease","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Radiation therapy; Lung cancer; Oncology; Intensive care medicine; Medical physics; Pathology; Bioinformatics; Radiology; Biology","score_opus":0.03796293180624902,"score_gpt":0.44578805279646483,"score_spread":0.40782512099021584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885149505","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047028992,0.9994388,0.000027228656,0.00020758342,0.00006260754,0.0000014931678,0.000004578153,0.0000015342644,0.0002091006],"genre_scores_gemma":[0.00036551966,0.9993082,0.00006243427,0.0001258955,0.0000841533,0.000002073778,0.000005692183,5.149597e-7,0.00004559267],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994386,0.000155996,0.00012553016,0.00007726052,0.00017390416,0.00002866619],"domain_scores_gemma":[0.99843436,0.0010995254,0.00015947477,0.00003446392,0.00023073604,0.000041308533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013693887,0.00054502644,0.0015099059,0.0021827787,0.00029840594,0.001108332,0.0010024938,0.0011919609,0.002411528],"category_scores_gemma":[0.0026006633,0.00023392428,0.0008557408,0.002136201,0.00072122936,0.0015879257,0.0006460878,0.0021313932,0.00064806495],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007406883,0.00004528428,0.00024664594,0.051826514,0.00018668146,0.0001415939,0.00011249376,0.0003612949,0.0005478967,0.003592946,0.013503475,0.92936116],"study_design_scores_gemma":[0.00003825049,0.00020310548,0.0020927046,0.04110885,0.00053888286,0.0020564508,0.00020259012,0.00012699439,0.00037327167,0.003489042,0.94973654,0.00003325083],"about_ca_topic_score_codex":0.0016993217,"about_ca_topic_score_gemma":0.0027953747,"teacher_disagreement_score":0.002411528,"about_ca_system_score_codex":0.0007757125,"about_ca_system_score_gemma":0.0017945485,"threshold_uncertainty_score":0.00806731},"labels":[],"label_agreement":null},{"id":"W2886015068","doi":"10.1111/crj.12950","title":"Impact of baseline characteristics on extensive‐stage SCLC patients treated with etoposide/carboplatin: A secondary analysis of a phase III study","year":2018,"lang":"en","type":"article","venue":"The Clinical Respiratory Journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Univariate analysis; Multivariate analysis; Oncology; Carboplatin; Proportional hazards model; Etoposide; Performance status; Univariate; Stage (stratigraphy); Multivariate statistics; Chemotherapy; Cisplatin","score_opus":0.09689549558880146,"score_gpt":0.48052804002598554,"score_spread":0.3836325444371841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886015068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813867,0.0004089847,0.00021767298,0.00003159739,0.000012905832,0.00018936211,0.0005489223,0.000007077696,0.00044474134],"genre_scores_gemma":[0.99790215,0.00007191355,0.00018242141,0.000076784454,0.00002640367,0.00019248073,0.0013542956,0.0000053127646,0.00018813905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792624,0.0011084081,0.00019182403,0.00030495992,0.00034250604,0.00012614329],"domain_scores_gemma":[0.9951403,0.0016271125,0.0016263796,0.0005069025,0.00042114066,0.00067808805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004216919,0.00045308395,0.0012822786,0.00032652853,0.00032670074,0.00078229664,0.0003696978,0.0004353215,0.0015153396],"category_scores_gemma":[0.0036501465,0.00015731277,0.0017364293,0.00056706753,0.00030877403,0.00038833736,0.00036543235,0.0008786308,0.00024242252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1840425,0.005669912,0.7716109,0.00037343986,0.004863046,0.00024947885,0.00012285712,0.0014616558,0.008302242,0.00006194269,0.0010322497,0.022209786],"study_design_scores_gemma":[0.008359718,0.05021106,0.9342075,0.00002515421,0.002008324,0.00028757722,0.000056858054,0.0011669655,0.0022478472,0.00007685613,0.0013302307,0.0000217699],"about_ca_topic_score_codex":0.00034492288,"about_ca_topic_score_gemma":0.00078252476,"teacher_disagreement_score":0.004216919,"about_ca_system_score_codex":0.0004327746,"about_ca_system_score_gemma":0.0008016041,"threshold_uncertainty_score":0.022301495},"labels":[],"label_agreement":null},{"id":"W2888508386","doi":"10.21037/apm.2018.07.10","title":"Immunotherapy and radiotherapy for metastatic cancers","year":2018,"lang":"en","type":"review","venue":"Annals of Palliative Medicine","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Immunotherapy; Radiation therapy; Oncology; Internal medicine; Intensive care medicine; Medical physics; Cancer","score_opus":0.33581688569249024,"score_gpt":0.5592838748085075,"score_spread":0.22346698911601726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888508386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048042544,0.99911135,0.00003193089,0.00022735099,0.00010342807,0.0000025683569,0.000006402814,0.0000020382158,0.00046679855],"genre_scores_gemma":[0.00052865705,0.99879944,0.00006629482,0.00021022731,0.00016963141,0.0000037724892,0.000010442275,6.2655675e-7,0.00021082463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996512,0.00009822831,0.00006605922,0.000045203098,0.0001195415,0.000019863483],"domain_scores_gemma":[0.99944764,0.00034438033,0.000084981184,0.000017979839,0.0000830495,0.000021946615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007078517,0.0005789944,0.0010271422,0.0025098298,0.00028780603,0.00094690785,0.0005840665,0.0010530525,0.004572221],"category_scores_gemma":[0.0013265181,0.0001838275,0.0007950451,0.0019827753,0.0005738969,0.0013116853,0.000613757,0.0016987297,0.0012115285],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061623454,0.000072809744,0.00030081221,0.050052304,0.00021778414,0.00026517914,0.00013337783,0.0003196305,0.0009254086,0.005430589,0.034428384,0.907792],"study_design_scores_gemma":[0.000016748354,0.00007880176,0.0009943481,0.017214153,0.00018784574,0.0024429394,0.00008861586,0.000046476685,0.00027440983,0.0023551744,0.9762864,0.0000140702095],"about_ca_topic_score_codex":0.00095912436,"about_ca_topic_score_gemma":0.0018205114,"teacher_disagreement_score":0.004572221,"about_ca_system_score_codex":0.0005580093,"about_ca_system_score_gemma":0.0012586556,"threshold_uncertainty_score":0.015295565},"labels":[],"label_agreement":null},{"id":"W2890544386","doi":"10.1200/jco.2017.35.15_suppl.e20019","title":"A meta-analysis of trials of etoposide plus platinum agent versus irinotecan/topotecan plus platinum agent in first-line therapy of extensive stage small cell lung cancer (ES SCLC).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; Thunder Bay Regional Health Sciences Centre; Health Sciences Centre; Princess Margaret Cancer Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"","keywords":"Medicine; Irinotecan; Topotecan; Internal medicine; Etoposide; Neutropenia; Randomized controlled trial; Oncology; Meta-analysis; Chemotherapy; Cancer; Colorectal cancer","score_opus":0.5605280711602462,"score_gpt":0.570289572427092,"score_spread":0.009761501266845829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890544386","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023273459,0.9700532,0.0018467153,0.0005626212,0.0005976822,0.0015064784,0.0012216902,0.00008274482,0.0008553939],"genre_scores_gemma":[0.60441995,0.37685192,0.0074914177,0.002182152,0.0005271942,0.005026395,0.002095839,0.000097657365,0.0013074825],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97980976,0.012621166,0.004437876,0.0013652209,0.0013351607,0.0004308277],"domain_scores_gemma":[0.9811421,0.013341863,0.0034708783,0.0006640616,0.0010661591,0.0003150659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024362896,0.0035718256,0.021498393,0.0069544637,0.00068721885,0.003718881,0.002232265,0.0032555428,0.0043974756],"category_scores_gemma":[0.042039234,0.0018957541,0.057794727,0.0057815947,0.0007542094,0.0022276223,0.0017527655,0.0026537233,0.0005666094],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008118358,0.000041433384,0.002084781,0.13084099,0.8533382,0.00012558063,0.000051225896,0.0006355655,0.00022461716,0.000106673055,0.0003473116,0.00408524],"study_design_scores_gemma":[0.0023992646,0.000380174,0.0017025231,0.0064115743,0.987705,0.0000593737,0.00002945876,0.0002631592,0.00010417756,0.00016742371,0.0007584415,0.00001948281],"about_ca_topic_score_codex":0.0054318667,"about_ca_topic_score_gemma":0.01070011,"teacher_disagreement_score":0.024362896,"about_ca_system_score_codex":0.003613609,"about_ca_system_score_gemma":0.0028117532,"threshold_uncertainty_score":0.1288448},"labels":[],"label_agreement":null},{"id":"W2895657963","doi":"10.1016/j.jtho.2018.09.019","title":"Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute; European Organisation for Research and Treatment of Cancer; Ministère des Affaires Sociales et de la Santé; Cancer Research UK","keywords":"Prophylactic cranial irradiation; Medicine; Conventional PCI; Univariate analysis; Chemoradiotherapy; Radiation therapy; Brain metastasis; Lung cancer; Internal medicine; Stage (stratigraphy); Nuclear medicine; Surgery; Multivariate analysis; Oncology; Radiology; Cancer; Metastasis; Myocardial infarction","score_opus":0.02859961238320336,"score_gpt":0.4390860858578507,"score_spread":0.41048647347464734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895657963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828645,0.008550523,0.0007435989,0.0009232662,0.000383033,0.0016368049,0.0016293775,0.00011374036,0.0031552059],"genre_scores_gemma":[0.9892742,0.003623184,0.0010814719,0.001006837,0.00028606027,0.0012723329,0.001982299,0.000035770132,0.0014377745],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99916506,0.0005156513,0.000039526498,0.00011084941,0.00006419897,0.000104739636],"domain_scores_gemma":[0.9986424,0.0005283217,0.00031232295,0.00019856072,0.00006261214,0.00025576138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019684304,0.0013943785,0.0021920844,0.00026991373,0.0003901253,0.0011165667,0.0008766384,0.0010202806,0.00542021],"category_scores_gemma":[0.002682353,0.0003572786,0.0025477963,0.00047569716,0.0009964885,0.0008575827,0.0004518065,0.0032605832,0.0007611484],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9630136,0.0031084423,0.0015699996,0.0006949342,0.002366293,0.000050545248,0.000050580737,0.00054596364,0.0021306165,0.00019581277,0.0015931039,0.024680236],"study_design_scores_gemma":[0.9358622,0.051386278,0.0071379035,0.000092318754,0.0024271891,0.000116165844,0.000046512956,0.00035291133,0.0005724739,0.0004979105,0.0014870845,0.00002119166],"about_ca_topic_score_codex":0.0012146449,"about_ca_topic_score_gemma":0.0030305423,"teacher_disagreement_score":0.00542021,"about_ca_system_score_codex":0.00075941504,"about_ca_system_score_gemma":0.001149962,"threshold_uncertainty_score":0.018132389},"labels":[],"label_agreement":null},{"id":"W2896512435","doi":"10.1016/j.ijrobp.2018.07.1939","title":"A Novel and Practical Prognostic Model for Limited-Stage Small-Cell Lung Cancer","year":2018,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Proportional hazards model; Internal medicine; Clinical endpoint; Recursive partitioning; Oncology; Stage (stratigraphy); Retrospective cohort study; Radiation therapy; Lung cancer; Pleural effusion; Progression-free survival; Hazard ratio; Prophylactic cranial irradiation; Prognostic variable; Population; Chemotherapy; Cancer; Clinical trial; Confidence interval; Conventional PCI","score_opus":0.06688022832148097,"score_gpt":0.43082721582544914,"score_spread":0.36394698750396814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896512435","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11981425,0.0011114713,0.86731094,0.0029674335,0.00038876696,0.00021184923,0.002950139,0.0017409277,0.0035042574],"genre_scores_gemma":[0.9460916,0.0005215474,0.0451936,0.0002550569,0.00025169598,0.00029501718,0.0019855625,0.000055240205,0.005350787],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99964416,0.00008708687,0.000022112252,0.00010810295,0.000065414235,0.00007310275],"domain_scores_gemma":[0.9991511,0.0004479103,0.00007681826,0.000051493327,0.00020662392,0.00006598104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012952418,0.00085101766,0.0012123355,0.0007656333,0.0005021002,0.0012054851,0.0015919222,0.001145354,0.0029850989],"category_scores_gemma":[0.003777051,0.00032107483,0.0007117857,0.00063429226,0.00026383004,0.001156186,0.0007612747,0.00091238774,0.0006922619],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018756368,0.00012144776,0.014989776,0.0000580977,0.0000904109,0.00020101681,0.000040547904,0.9117992,0.00090164336,0.0040272893,0.0052965297,0.062286437],"study_design_scores_gemma":[0.000008400102,0.00001629216,0.0004731996,0.0000026261714,0.000014701432,0.000037301455,0.0000044763774,0.9976584,0.00006202852,0.001482179,0.000235723,0.0000047271396],"about_ca_topic_score_codex":0.01309126,"about_ca_topic_score_gemma":0.011044053,"teacher_disagreement_score":0.01309126,"about_ca_system_score_codex":0.0009864236,"about_ca_system_score_gemma":0.0019506653,"threshold_uncertainty_score":0.026030123},"labels":[],"label_agreement":null},{"id":"W2897369942","doi":"10.1158/1078-0432.ccr-18-2014","title":"A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"AbbVie","keywords":"Veliparib; Carboplatin; Medicine; Etoposide; Internal medicine; Tolerability; Oncology; Pharmacokinetics; Chemotherapy; Pharmacology; Adverse effect; Surgery; Cisplatin","score_opus":0.12093273205170117,"score_gpt":0.5074382325365686,"score_spread":0.3865055004848674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897369942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983606,0.0006155608,0.00020629709,0.000064680855,0.000020089296,0.00037905812,0.00007506482,0.0000128299325,0.00026586812],"genre_scores_gemma":[0.9979697,0.00036991294,0.00056423736,0.00015635967,0.000043140702,0.00031630226,0.00029395128,0.000005274764,0.00028094862],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99951017,0.0002410946,0.00003729116,0.00008718829,0.000053115884,0.00007108856],"domain_scores_gemma":[0.9994808,0.000095787844,0.0001296394,0.000047150203,0.000029983245,0.00021668007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009170906,0.00078352727,0.0014752279,0.00025063704,0.00027906484,0.00060478837,0.00056979386,0.0004954023,0.0011220905],"category_scores_gemma":[0.00068386534,0.00040425966,0.0009890986,0.00032617882,0.00055393606,0.00044805775,0.00024926034,0.002002242,0.00025971432],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50353086,0.114744104,0.04210801,0.0010644128,0.002435933,0.0006847378,0.00064291677,0.004630504,0.1399348,0.00018502171,0.0016383133,0.18840037],"study_design_scores_gemma":[0.28120294,0.6491793,0.05440854,0.00004094075,0.0007977904,0.00068709784,0.00008783359,0.0022441046,0.008799114,0.00011557241,0.002405865,0.00003087357],"about_ca_topic_score_codex":0.0004067115,"about_ca_topic_score_gemma":0.0012802894,"teacher_disagreement_score":0.0014752279,"about_ca_system_score_codex":0.0006583883,"about_ca_system_score_gemma":0.0010897154,"threshold_uncertainty_score":0.0048500896},"labels":[],"label_agreement":null},{"id":"W2897371223","doi":"10.1016/j.jgo.2018.10.001","title":"The effect of age on referral to an oncologist and receipt of chemotherapy among small cell lung cancer patients in Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Geriatric Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; University of Manitoba; CancerCare Manitoba; McMaster University","funders":"Ontario Ministry of Health and Long-Term Care; National Comprehensive Cancer Network; Ontario Institute for Cancer Research; Cancer Care Ontario; McMaster University; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Receipt; Referral; Lung cancer; Chemotherapy; Family medicine; Internal medicine; Oncology","score_opus":0.014602637008806471,"score_gpt":0.3403001184491374,"score_spread":0.3256974814403309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897371223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98815876,0.0018623867,0.00005354591,0.002416106,0.00007679364,0.00004327489,0.0023419363,0.000009079599,0.0050380495],"genre_scores_gemma":[0.99724555,0.0006537709,0.000059471055,0.00028263082,0.000024368102,0.000010696283,0.00049609406,0.000006288513,0.001221115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979802,0.00023576329,0.00019004333,0.00021156229,0.000460625,0.0009218999],"domain_scores_gemma":[0.9920196,0.0008071801,0.0019300496,0.0001652791,0.0022405447,0.0028373303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008186506,0.00031036363,0.00061726914,0.0011890194,0.0039143846,0.002068596,0.0019856733,0.0011573766,0.0055596842],"category_scores_gemma":[0.0056591565,0.0006036297,0.0013550719,0.0043185595,0.0014239697,0.0007500912,0.0012568292,0.0016767891,0.0003229484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011211377,0.000042424002,0.99612087,0.000028995953,0.00005211075,0.000117292475,0.00086916756,0.000083699415,0.00004592902,0.000086940716,0.0010762013,0.001364297],"study_design_scores_gemma":[0.000017173794,0.000024109491,0.9954111,0.00007035314,0.000048018832,0.00006257905,0.0033758432,0.00014212362,0.00001935758,0.00002634567,0.0007895731,0.000013363247],"about_ca_topic_score_codex":0.995993,"about_ca_topic_score_gemma":0.99802494,"teacher_disagreement_score":0.04682023,"about_ca_system_score_codex":0.04682023,"about_ca_system_score_gemma":0.060779825,"threshold_uncertainty_score":0.33970612},"labels":[],"label_agreement":null},{"id":"W2898354241","doi":"10.1016/j.jtho.2018.08.1767","title":"P3.08-16 Prognostic Value of PDL-1 Expression and Correlation Between Primary Tissue and Brain Metastases in Oligometastatic NSCLC","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Oncology; Primary tumor; Biopsy; Lung cancer; Incidence (geometry); Cohort; Immunohistochemistry; Cancer; Pathology; Metastasis","score_opus":0.0320720943749037,"score_gpt":0.44708829714619647,"score_spread":0.41501620277129275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898354241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767965,0.00043850698,0.00015908851,0.000096086354,0.000019976378,0.000005343614,0.00041226068,0.000008302954,0.0011808133],"genre_scores_gemma":[0.9988574,0.00007625126,0.00009816678,0.000022152997,0.00001865763,0.0000070361634,0.00036432242,0.0000028703985,0.0005531493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980396,0.000038490874,0.00002168075,0.000044331555,0.000034639856,0.000056823636],"domain_scores_gemma":[0.9994529,0.0001142307,0.0001946756,0.00002855261,0.00007118903,0.00013834708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038947852,0.00022725172,0.00023630449,0.000485581,0.00035149907,0.00074921787,0.0003170082,0.00037557894,0.0034666886],"category_scores_gemma":[0.0011504813,0.00013436221,0.00032997085,0.0006412529,0.00036893116,0.0003504837,0.00041920328,0.00054600555,0.000578841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009579351,0.000040775245,0.98725677,0.000029208864,0.00008462575,0.00028139344,0.00005206209,0.0001384385,0.004676263,0.00006840288,0.00031858913,0.0060956324],"study_design_scores_gemma":[0.000031105625,0.00022224053,0.9937431,0.000010677009,0.00013695721,0.0013369952,0.00019432399,0.001085085,0.0016351443,0.00033602936,0.0012601799,0.000008143256],"about_ca_topic_score_codex":0.000889409,"about_ca_topic_score_gemma":0.0014590945,"teacher_disagreement_score":0.0034666886,"about_ca_system_score_codex":0.00030041437,"about_ca_system_score_gemma":0.00029518103,"threshold_uncertainty_score":0.011597276},"labels":[],"label_agreement":null},{"id":"W2898447721","doi":"10.1016/j.jtho.2018.08.846","title":"P1.12-11 2010 – 2015 Extensive Stage SCLC Diagnoses in a Canadian Institution: Baseline Characteristics That Impact on the Overall Survival","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Radiation therapy; Lung cancer; Statistical significance; Confidence interval; Internal medicine; Cancer; Survival analysis; Stage (stratigraphy); Oncology; Conventional PCI","score_opus":0.06932617902037251,"score_gpt":0.46729817399630774,"score_spread":0.3979719949759352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898447721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9459275,0.0011840323,0.000135141,0.0014999773,0.00008304646,0.00008938027,0.039756883,0.000036436868,0.011287654],"genre_scores_gemma":[0.9827467,0.00053116895,0.00018203646,0.00037165105,0.000033174478,0.000032928278,0.012946462,0.00001927433,0.0031366225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998298,0.000053883716,0.000073494266,0.0002131246,0.00042014077,0.00094140996],"domain_scores_gemma":[0.99632794,0.00011799367,0.00080558256,0.00008589783,0.0015311572,0.0011313385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006670032,0.00053660595,0.0005043008,0.0019054344,0.0027938492,0.0017066394,0.0020443245,0.0008285393,0.008940735],"category_scores_gemma":[0.003613504,0.0005273801,0.0008549279,0.0056944513,0.0008794106,0.00080814405,0.0013537221,0.0015128029,0.0009338466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014179802,0.000034855406,0.98792845,0.000047504633,0.00006703841,0.0001037462,0.00030282803,0.00016386996,0.00013572813,0.00015454231,0.007531188,0.0033884756],"study_design_scores_gemma":[0.0000049529785,0.000014475658,0.99758303,0.000036482736,0.000022187382,0.00005908955,0.0006537032,0.00009107295,0.000028985087,0.000019748795,0.001475033,0.000011233332],"about_ca_topic_score_codex":0.99179405,"about_ca_topic_score_gemma":0.9963731,"teacher_disagreement_score":0.037050586,"about_ca_system_score_codex":0.037050586,"about_ca_system_score_gemma":0.057806805,"threshold_uncertainty_score":0.26882207},"labels":[],"label_agreement":null},{"id":"W2898452066","doi":"10.1016/j.jtho.2018.08.845","title":"P1.12-10 Patterns of Curative Chemo-Radiotherapy Regimen and Impacts on the Outcome of Limited Stage SCLC in a Canadian Institution: 2010 – 2015 Diagnoses","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Radiation therapy; Statistical significance; Internal medicine; Exact test; Regimen; Stage (stratigraphy); Lung cancer; Confidence interval; Surgery","score_opus":0.07010327992927107,"score_gpt":0.4832179830159742,"score_spread":0.4131147030867031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898452066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707911,0.00208124,0.00010042613,0.001304115,0.00004874795,0.0000487295,0.019509528,0.000030102336,0.006086008],"genre_scores_gemma":[0.9916136,0.0008941534,0.00013815142,0.00019558781,0.00001971159,0.000012724356,0.005421357,0.000014982492,0.0016896838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839777,0.00005037288,0.00010783233,0.00021086428,0.00042379907,0.00080930965],"domain_scores_gemma":[0.9967102,0.00009235007,0.00095852255,0.00006495792,0.001250276,0.0009236818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059619127,0.00038744675,0.00038623458,0.001773666,0.0020229204,0.0013429443,0.00206352,0.00065038836,0.004301193],"category_scores_gemma":[0.002729017,0.00040998642,0.000896788,0.004634029,0.0008859788,0.00054536056,0.0012477784,0.0014496013,0.00045347202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009993883,0.000025405669,0.99260944,0.0000509636,0.000052054827,0.00011051592,0.0003443268,0.00014346233,0.00014089212,0.00012605761,0.002635482,0.0036613955],"study_design_scores_gemma":[0.0000024126427,0.00001350882,0.99788135,0.000041201245,0.000022855922,0.000091730675,0.0006934858,0.00008624,0.00003561732,0.000013743712,0.001107126,0.000010629235],"about_ca_topic_score_codex":0.9888896,"about_ca_topic_score_gemma":0.99403834,"teacher_disagreement_score":0.030861573,"about_ca_system_score_codex":0.030861573,"about_ca_system_score_gemma":0.04379329,"threshold_uncertainty_score":0.22391742},"labels":[],"label_agreement":null},{"id":"W2898568148","doi":"10.1016/j.jtho.2018.08.844","title":"P1.12-09 The Effect of Site of First Chemotherapy on Small Cell Lung Cancer Patient Outcomes","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Cohort; Internal medicine; Neutropenia; Lung cancer; Febrile neutropenia; Chemotherapy; Retrospective cohort study; Cancer; Surgery","score_opus":0.02011478323117746,"score_gpt":0.43761888045381286,"score_spread":0.41750409722263543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898568148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96937764,0.0032792883,0.00044360873,0.003327759,0.00046811943,0.00005838625,0.010854473,0.000053008393,0.012137666],"genre_scores_gemma":[0.99207824,0.00040862168,0.00015855177,0.0005180089,0.00017994476,0.000046971934,0.002694041,0.000048938808,0.0038666853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987863,0.00038317117,0.000083312065,0.0002229068,0.0001853347,0.00033888634],"domain_scores_gemma":[0.99222744,0.0031302732,0.00197593,0.00031637074,0.0005148557,0.0018350946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015982357,0.0002768515,0.0006181546,0.00045160216,0.0004942969,0.0012622302,0.0010106061,0.0009487189,0.027131662],"category_scores_gemma":[0.007927344,0.00021937635,0.0028693173,0.0011318,0.0005402211,0.0012862355,0.0009781002,0.0026441857,0.0021597154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00958743,0.00047316667,0.95048416,0.00031575447,0.0017934162,0.00017925688,0.00012399958,0.0005124184,0.00058267143,0.00037084223,0.008104144,0.027472889],"study_design_scores_gemma":[0.00038039964,0.0014517105,0.993168,0.00011782175,0.0009567201,0.00018272379,0.00027561042,0.00034187143,0.00015828302,0.00041259438,0.0025318784,0.000022338103],"about_ca_topic_score_codex":0.0076864697,"about_ca_topic_score_gemma":0.01113845,"teacher_disagreement_score":0.027131662,"about_ca_system_score_codex":0.00073646224,"about_ca_system_score_gemma":0.0016042183,"threshold_uncertainty_score":0.0907644},"labels":[],"label_agreement":null},{"id":"W2900369182","doi":"10.1097/coc.0000000000000489","title":"Role of Stereotactic Body Radiation Therapy in Early Stage Small Cell Lung Cancer in the Era of Lung Cancer Screening","year":2018,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Lung cancer; Stage (stratigraphy); Radiation therapy; Cancer; Lung cancer screening; Oncology; Chemotherapy; Radiology; Metastasis; Internal medicine","score_opus":0.10745501994803246,"score_gpt":0.5305652655606843,"score_spread":0.4231102456126518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900369182","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027607416,0.9992939,0.000018214709,0.00019464351,0.00003547938,0.000013321667,0.00003209207,9.673643e-7,0.00013520314],"genre_scores_gemma":[0.008962645,0.99001795,0.00017870335,0.000547418,0.00011486849,0.000058136236,0.00006078046,0.0000021659039,0.000057263143],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99251986,0.0034267148,0.0023921938,0.00043352964,0.001082555,0.00014519278],"domain_scores_gemma":[0.9690007,0.02376421,0.004757084,0.00028732148,0.0019812349,0.00020955397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077740857,0.000566235,0.0044732103,0.005503237,0.00030942823,0.0022369418,0.0012269609,0.0017359606,0.0025023846],"category_scores_gemma":[0.030913835,0.00051181257,0.0046829805,0.005681633,0.0007664436,0.0025850872,0.00085123256,0.001114019,0.00024511322],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035068023,0.000032950164,0.0012714643,0.8588146,0.0041573104,0.00017042922,0.00018474212,0.00017252471,0.00021132587,0.0005461844,0.0022307308,0.13185717],"study_design_scores_gemma":[0.00023025028,0.00033319442,0.007472845,0.92687714,0.025625218,0.0008420667,0.00037474438,0.00012061531,0.00027648537,0.00088110135,0.036926582,0.00003961715],"about_ca_topic_score_codex":0.0072613684,"about_ca_topic_score_gemma":0.014210009,"teacher_disagreement_score":0.0077740857,"about_ca_system_score_codex":0.0027746612,"about_ca_system_score_gemma":0.006532219,"threshold_uncertainty_score":0.041113794},"labels":[],"label_agreement":null},{"id":"W2900598696","doi":"10.1186/s12935-018-0683-z","title":"Mifepristone inhibits non-small cell lung carcinoma cellular escape from DNA damaging cisplatin","year":2018,"lang":"en","type":"article","venue":"Cancer Cell International","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; McGill University","keywords":"Cisplatin; Clonogenic assay; Medicine; Lung cancer; Cancer research; Chemotherapy; Cancer cell; Cancer; Bleomycin; Oncology; Immunology; Cell; Internal medicine; Biology","score_opus":0.017717238548344345,"score_gpt":0.30611312166329285,"score_spread":0.2883958831149485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900598696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949885,0.0024377482,0.0006761115,0.00010556583,0.000034638713,0.00008810603,0.00022680008,0.00006365575,0.0013788379],"genre_scores_gemma":[0.9966409,0.0010592237,0.00067204155,0.00003923939,0.000013724062,0.000049030674,0.0004097897,0.000005123008,0.0011108521],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994445,0.000010303756,0.0000053303484,0.000005475891,0.000014889601,0.00001947742],"domain_scores_gemma":[0.9999405,0.00002119709,0.000009886086,0.0000070161313,0.000007910974,0.0000135376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097757256,0.00030071323,0.00021372344,0.0001729798,0.00012536201,0.00011408746,0.00020454261,0.00017951429,0.0010255006],"category_scores_gemma":[0.000110373374,0.00005316251,0.000207683,0.00009045481,0.00014497942,0.00007724077,0.00009577188,0.00033020624,0.00021137444],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005384449,0.0002898006,0.0005273553,0.000111619665,0.000010542295,0.00012756974,0.000023617167,0.00016590998,0.9909566,0.00007237516,0.000243602,0.006932587],"study_design_scores_gemma":[0.00014421894,0.0055546006,0.007554443,0.000011502353,0.000022673305,0.0005533649,0.000026121665,0.00080465415,0.98161674,0.000035456113,0.0036716938,0.000004585909],"about_ca_topic_score_codex":0.00070571626,"about_ca_topic_score_gemma":0.0019342472,"teacher_disagreement_score":0.0010255006,"about_ca_system_score_codex":0.00021917964,"about_ca_system_score_gemma":0.00027008617,"threshold_uncertainty_score":0.003430605},"labels":[],"label_agreement":null},{"id":"W2900603576","doi":"10.14740/wjon1163","title":"Serum Carcinoembryonic Antigen Level Predicts Cancer-Specific Outcomes of Resected Non-Small Cell Lung Cancer With Interstitial Pneumonia","year":2018,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Carcinoembryonic antigen; Internal medicine; Lung cancer; Oncology; Stage (stratigraphy); Univariate analysis; Proportional hazards model; Cancer; Gastroenterology; Multivariate analysis","score_opus":0.04819863471184301,"score_gpt":0.372640469793328,"score_spread":0.324441835081485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900603576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995035,0.0002452863,0.00005204468,0.000013830005,0.00000297274,0.000003334869,0.000048282604,0.0000015686962,0.00012918988],"genre_scores_gemma":[0.99978477,0.000048228532,0.000027902473,0.0000033810759,0.0000036311897,0.0000015161684,0.00010277387,3.0058334e-7,0.00002767657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989474,0.000022379729,0.000018160992,0.000016123557,0.000022504762,0.00002609147],"domain_scores_gemma":[0.99928457,0.00018333348,0.00026731883,0.000026710566,0.00008838591,0.00014967695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002988686,0.00021751455,0.00017200415,0.0003746229,0.00018209033,0.00025727024,0.00013809388,0.00021283825,0.0008629699],"category_scores_gemma":[0.0016226271,0.00009619502,0.00022728226,0.000300799,0.00019522071,0.00022891928,0.00020411456,0.0002287325,0.000109451685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057367357,0.000010498618,0.9990182,0.000004770236,0.000011988644,0.00007891096,0.000007831184,0.000033102024,0.00016900241,0.000002691138,0.000016780185,0.0005888967],"study_design_scores_gemma":[0.0000048978022,0.00008446763,0.99868554,0.0000035340986,0.000030905598,0.0006416446,0.000046286743,0.00026074896,0.00014762554,0.000018507626,0.00007411139,0.0000016025853],"about_ca_topic_score_codex":0.00088327815,"about_ca_topic_score_gemma":0.0014520779,"teacher_disagreement_score":0.00088327815,"about_ca_system_score_codex":0.00013915093,"about_ca_system_score_gemma":0.0002623131,"threshold_uncertainty_score":0.0028868914},"labels":[],"label_agreement":null},{"id":"W2902933008","doi":"10.1016/j.cllc.2018.11.012","title":"Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Patients With Previously Untreated Advanced Non–Small-Cell Lung Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Eli Lilly Japan; Pfizer Japan; Genentech; MSD K.K.; Ono Pharmaceutical; Stiftelsen för Kunskaps- och Kompetensutveckling; Exelixis; Taiho Pharmaceutical; North Carolina GlaxoSmithKline Foundation; Novartis; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Bayer Corporation; Takeda Pharmaceutical Company; AbbVie; MedImmune; Merck; GlaxoSmithKline; Celgene; Bayer","keywords":"Carboplatin; Paclitaxel; Medicine; Lung cancer; Oncology; Internal medicine; Chemotherapy; Cisplatin","score_opus":0.02561469216365942,"score_gpt":0.4055740958390569,"score_spread":0.3799594036753975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902933008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843948,0.0032645243,0.0007339176,0.0011816324,0.0007465508,0.0050913207,0.001983264,0.00016167466,0.0024423138],"genre_scores_gemma":[0.97238714,0.004062295,0.0030626783,0.0020654218,0.0011100534,0.0073445067,0.0033840628,0.000082551225,0.006501221],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99908125,0.0004837997,0.00004813149,0.00016255846,0.000049912596,0.0001743447],"domain_scores_gemma":[0.99893373,0.00022305307,0.00020526753,0.0000992554,0.000060866136,0.000477847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002450362,0.0030540482,0.0052458188,0.00076865393,0.0006741825,0.0015478065,0.0016720822,0.0020978167,0.010033723],"category_scores_gemma":[0.0017511684,0.0014628452,0.0029232888,0.0007847052,0.0020533674,0.0017830295,0.00072778924,0.005849861,0.0016045015],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9792213,0.010047915,0.00041581586,0.00020377545,0.0004974709,0.000022470851,0.000032222004,0.0002766875,0.0020035943,0.000068209694,0.0005933691,0.0066171223],"study_design_scores_gemma":[0.92568606,0.07206287,0.001036512,0.000010179355,0.00030913603,0.000016018743,0.000016111097,0.00017767414,0.00023612147,0.000063654654,0.00037601098,0.000009693128],"about_ca_topic_score_codex":0.002521225,"about_ca_topic_score_gemma":0.0059737004,"teacher_disagreement_score":0.010033723,"about_ca_system_score_codex":0.0016200528,"about_ca_system_score_gemma":0.0023340564,"threshold_uncertainty_score":0.033566177},"labels":[],"label_agreement":null},{"id":"W2905529840","doi":"10.1200/jco.18.01585","title":"<i>EGFR</i> -Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":471,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Centre hospitalier universitaire de Québec","funders":"National Cancer Institute; Foundation Medicine; Pharmacyclics; Genentech; Incyte; Five Prime Therapeutics; Syndax Pharmaceuticals; Clovis Oncology; Exelixis; Alexion Pharmaceuticals; Amgen; Ariad Pharmaceuticals; Gilead Sciences; Jounce Therapeutics; Celgene; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Pfizer; Stop Cancer","keywords":"Medicine; T790M; Internal medicine; Oncology; Epidermal growth factor receptor; Lung cancer; Adenocarcinoma; Cancer; Cancer research; Gefitinib","score_opus":0.18107480095245018,"score_gpt":0.5113336326705391,"score_spread":0.3302588317180889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905529840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991048,0.00022215136,0.00007403552,0.000020109257,0.0000033253118,0.000011430078,0.00013147356,0.000003943437,0.00042880813],"genre_scores_gemma":[0.99945694,0.00006512874,0.000042824966,0.000012318532,0.000009419784,0.0000062717345,0.00033943696,0.0000012180897,0.000066506655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995726,0.00007243001,0.000067018766,0.000087449145,0.00009705203,0.00010358077],"domain_scores_gemma":[0.9980413,0.00026094535,0.0010699604,0.000085222106,0.00016110047,0.000381465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044199615,0.00026559748,0.00028888506,0.00049720996,0.00036964443,0.0005458164,0.00024793844,0.0002929821,0.0011123414],"category_scores_gemma":[0.0018276027,0.00012225605,0.00029894325,0.00045570298,0.00038645742,0.00043160623,0.00047246288,0.00036711097,0.00029339327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011637069,0.000018619845,0.99696094,0.000007820463,0.000016474476,0.00033593207,0.000020593725,0.000043680528,0.00029565042,0.000009113441,0.00006001435,0.0021148624],"study_design_scores_gemma":[0.000020210178,0.0003356766,0.9918236,0.000013378027,0.00004094383,0.0067293267,0.00013761439,0.00023031002,0.000330622,0.000038308644,0.00029501325,0.00000495499],"about_ca_topic_score_codex":0.000924113,"about_ca_topic_score_gemma":0.0014529915,"teacher_disagreement_score":0.0011123414,"about_ca_system_score_codex":0.0003041931,"about_ca_system_score_gemma":0.0002497511,"threshold_uncertainty_score":0.0037211776},"labels":[],"label_agreement":null},{"id":"W2906110772","doi":"10.1016/j.jval.2018.09.103","title":"PCN21 - COMPARATIVE EFFICACY OF NIVOLUMAB±IPILIMUMAB VERSUS STANDARD OF CARE (SOC) FOR THIRD-LINE (3L) PATIENTS WITH RECURRENT SMALL CELL LUNG CANCER (SCLC) USING POPULATION-ADJUSTED INDIRECT COMPARISON","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Nivolumab; Ipilimumab; Medicine; Oncology; Population; Internal medicine; Lung cancer; Hazard ratio; Regimen; Cancer; Immunotherapy; Confidence interval","score_opus":0.146381492280194,"score_gpt":0.4403910053062912,"score_spread":0.29400951302609724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906110772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826345,0.011723595,0.00057950744,0.00026336912,0.00043962031,0.00035890826,0.0018883174,0.000029551902,0.002082758],"genre_scores_gemma":[0.99732345,0.00084433565,0.00029074753,0.00010989447,0.000055404307,0.00014502445,0.0008107485,0.0000047772,0.00041559496],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9920231,0.005846392,0.00051800034,0.0007649681,0.00042835306,0.0004192503],"domain_scores_gemma":[0.9948731,0.0032275303,0.000848759,0.00036596274,0.00027560742,0.00040896435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00652626,0.0015337054,0.0039634653,0.0008360625,0.00029233363,0.001405029,0.0013821464,0.001674051,0.0046074986],"category_scores_gemma":[0.009377304,0.00063034496,0.010162139,0.0009242284,0.00075683265,0.0013887025,0.0010805725,0.0025007722,0.00034947824],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9006904,0.0011140765,0.018344754,0.0017472287,0.05919019,0.00007422977,0.00009431827,0.0022666357,0.0006081448,0.00027319556,0.0004860194,0.015110855],"study_design_scores_gemma":[0.4344028,0.18732797,0.16888475,0.00077050185,0.18661748,0.0003216827,0.00035505145,0.01310745,0.0028692996,0.0018368885,0.0033182565,0.00018786332],"about_ca_topic_score_codex":0.007273905,"about_ca_topic_score_gemma":0.0073086563,"teacher_disagreement_score":0.007273905,"about_ca_system_score_codex":0.0018632272,"about_ca_system_score_gemma":0.0011196769,"threshold_uncertainty_score":0.034514606},"labels":[],"label_agreement":null},{"id":"W2911458603","doi":"","title":"Proceedings of the NAACL HLT 2010 Student Research Workshop","year":2010,"lang":"en","type":"article","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Presentation (obstetrics); Work (physics); Computer science; Medical education; Engineering ethics; Library science; Mathematics education; Psychology; Engineering; Medicine","score_opus":0.1440169142521091,"score_gpt":0.4975021724441452,"score_spread":0.3534852581920361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911458603","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019516427,0.02266394,0.119319655,0.34185958,0.21056008,0.0029247056,0.01569392,0.018431898,0.24902977],"genre_scores_gemma":[0.053647034,0.0097518405,0.052982923,0.03910209,0.036450043,0.0038476437,0.036492854,0.010275968,0.7574496],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98500735,0.007993722,0.00091752055,0.0015988281,0.0035446396,0.00093801855],"domain_scores_gemma":[0.9678705,0.00891215,0.000570795,0.0021491067,0.0113130035,0.009184496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0347856,0.0014180737,0.0015949339,0.001415357,0.0031912709,0.011684306,0.0032965576,0.0042669903,0.121309355],"category_scores_gemma":[0.035229947,0.0012090546,0.0015757686,0.0011119514,0.0014805659,0.0067601167,0.0077879755,0.0068469453,0.08664069],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022379929,0.00014337408,0.00017331315,0.00011909287,0.000011000606,0.0001220333,0.0008327807,0.00018186722,0.00072482484,0.0019155527,0.95912653,0.03642575],"study_design_scores_gemma":[0.00010583405,0.0000767411,0.0004188435,0.00024081022,0.000014928003,0.00014885335,0.0012996406,0.0007315552,0.0007032182,0.0024016406,0.99380386,0.00005412784],"about_ca_topic_score_codex":0.0063211895,"about_ca_topic_score_gemma":0.010512432,"teacher_disagreement_score":0.121309355,"about_ca_system_score_codex":0.004007696,"about_ca_system_score_gemma":0.0072364174,"threshold_uncertainty_score":0.40582025},"labels":[],"label_agreement":null},{"id":"W2916875443","doi":"10.1016/j.ejca.2019.01.003","title":"Role of thoracic consolidation radiation in extensive stage small cell lung cancer: A systematic review and meta-analysis of randomised controlled trials","year":2019,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; University of Toronto; CancerCare Manitoba","funders":"","keywords":"Medicine; Meta-analysis; Hazard ratio; Randomized controlled trial; Confidence interval; Lung cancer; Internal medicine; Relative risk; Systematic review; Radiation therapy; Oncology; Surgery; MEDLINE","score_opus":0.13143423963807155,"score_gpt":0.46120397986925177,"score_spread":0.3297697402311802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916875443","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004157186,0.9948107,0.00030357097,0.00010428726,0.00013650159,0.00017509892,0.00017845983,0.000014536539,0.00011971243],"genre_scores_gemma":[0.15919021,0.8362568,0.0019195641,0.0011356329,0.0002565352,0.0004835114,0.00039610782,0.000029989127,0.00033164973],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99285465,0.0034070527,0.002060749,0.00083492155,0.00060133246,0.00024124463],"domain_scores_gemma":[0.9873584,0.009545878,0.0020907545,0.00038652215,0.00044417646,0.00017418977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010013547,0.0025821456,0.017978353,0.0025527207,0.00051185256,0.0029447258,0.002267773,0.0027864168,0.0042808317],"category_scores_gemma":[0.025314316,0.0013958067,0.027725296,0.0032597028,0.0010384218,0.0020203171,0.0015259128,0.003024615,0.00030631226],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00862803,0.000046850273,0.002154716,0.44818893,0.5226856,0.00008507981,0.000094578616,0.0005511945,0.00035039528,0.00013187138,0.0005382797,0.016544517],"study_design_scores_gemma":[0.003538733,0.00053522526,0.0027598476,0.023802234,0.96713245,0.00007942056,0.00006317452,0.00013368884,0.00012303231,0.0002320906,0.0015697343,0.00003045507],"about_ca_topic_score_codex":0.0058734403,"about_ca_topic_score_gemma":0.01512594,"teacher_disagreement_score":0.017978353,"about_ca_system_score_codex":0.0023674301,"about_ca_system_score_gemma":0.0028439455,"threshold_uncertainty_score":0.052957356},"labels":[],"label_agreement":null},{"id":"W2939133296","doi":"10.1016/j.jtho.2019.03.023","title":"18F-Fludeoxyglucose PET/CT in SCLC: Analysis of the CONVERT Randomized Controlled Trial","year":2019,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Cancer Society Research Institute; NIHR Maudsley Biomedical Research Centre; Manchester Biomedical Research Centre; European Organisation for Research and Treatment of Cancer; National Institute for Health and Care Research; Ministère des Affaires Sociales et de la Santé; Cancer Research UK; Cancer Research UK Manchester Centre; Elekta; University of Manchester; Engineering and Physical Sciences Research Council; National Cancer Research Institute; AstraZeneca; Cancer Research Institute","keywords":"Medicine; Nuclear medicine; Confidence interval; Hazard ratio; Positron emission tomography; Bone scintigraphy; Scintigraphy; Radiology; Internal medicine","score_opus":0.020019066259394966,"score_gpt":0.4464594834922874,"score_spread":0.42644041723289244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939133296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9370375,0.0499618,0.0010638859,0.001075218,0.000988944,0.0041578957,0.0024622222,0.00014655318,0.0031058895],"genre_scores_gemma":[0.9824325,0.007846002,0.0014446846,0.0008126429,0.00064063363,0.0033076382,0.0015993183,0.000024106761,0.0018924791],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980673,0.0012810089,0.00013952436,0.00025543282,0.00013379683,0.00012278145],"domain_scores_gemma":[0.9974957,0.0013224545,0.0005774022,0.00024075122,0.0001615093,0.00020210934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034412195,0.0014420783,0.004248168,0.00056389056,0.00032953042,0.0016074819,0.00080257823,0.0013847445,0.0063788993],"category_scores_gemma":[0.0061884723,0.0004972267,0.0034806593,0.0007817161,0.00093838555,0.001090284,0.00041733548,0.0021314826,0.0004633618],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98119915,0.0005954319,0.0015999381,0.0021866998,0.0056561246,0.00006385045,0.000020826199,0.00028589953,0.00042097297,0.00013301258,0.00056677795,0.007271361],"study_design_scores_gemma":[0.979614,0.009867497,0.00420441,0.00017120455,0.0048026284,0.000055107274,0.000020690963,0.00041154918,0.0001387151,0.00014632523,0.0005533979,0.000014426654],"about_ca_topic_score_codex":0.001303569,"about_ca_topic_score_gemma":0.0018968596,"teacher_disagreement_score":0.0063788993,"about_ca_system_score_codex":0.0009296453,"about_ca_system_score_gemma":0.0007823689,"threshold_uncertainty_score":0.021339536},"labels":[],"label_agreement":null},{"id":"W2941467697","doi":"10.1093/annonc/mdz122","title":"Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Cancer Society Research Institute; Cancer Research UK","keywords":"Medicine; Radiation therapy; Oncology; Lung cancer; Stage (stratigraphy); Randomized controlled trial; Internal medicine","score_opus":0.06480225364933935,"score_gpt":0.4011862293424574,"score_spread":0.33638397569311806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941467697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927468,0.004218215,0.00029568348,0.0003074994,0.0002575394,0.0012060129,0.00030366835,0.000043843887,0.0006208647],"genre_scores_gemma":[0.9953054,0.0010363735,0.0007535159,0.00031474652,0.00030528894,0.0011734045,0.00040094278,0.000008762766,0.00070159324],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99719834,0.0020677831,0.00015313202,0.000294535,0.00016864421,0.00011754147],"domain_scores_gemma":[0.9960401,0.0019713487,0.0008429943,0.00034882172,0.00015405091,0.00064267515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004264637,0.0013114423,0.0040111598,0.00033251045,0.000309251,0.0013226438,0.000946122,0.001578041,0.003029056],"category_scores_gemma":[0.0057287198,0.00043104007,0.0024107883,0.0004380851,0.00125758,0.0007918235,0.0004766115,0.002336715,0.0003236555],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9916517,0.00087575096,0.0009194195,0.00032978316,0.00060684845,0.000016438333,0.000024474037,0.00019101863,0.00069849857,0.000038924325,0.00012180433,0.004525311],"study_design_scores_gemma":[0.91168016,0.08029589,0.0050406004,0.000051140807,0.001127684,0.00005166824,0.00002447532,0.00080995995,0.00037469278,0.00014242121,0.00038295245,0.000018263203],"about_ca_topic_score_codex":0.0007459156,"about_ca_topic_score_gemma":0.0014279493,"teacher_disagreement_score":0.004264637,"about_ca_system_score_codex":0.0008487004,"about_ca_system_score_gemma":0.00097505073,"threshold_uncertainty_score":0.022553802},"labels":[],"label_agreement":null},{"id":"W2947719708","doi":"10.1200/jco.2019.37.15_suppl.9069","title":"Clinical outcomes of EGFR+ NSCLC pts treated with immune checkpoint inhibitors (ICI).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Pemetrexed; Nivolumab; Pembrolizumab; Ipilimumab; Erlotinib; Internal medicine; Oncology; Carboplatin; Atezolizumab; Lung cancer; Cancer; Chemotherapy; Immunotherapy; Epidermal growth factor receptor; Cisplatin","score_opus":0.1224058409726355,"score_gpt":0.5188490254552658,"score_spread":0.3964431844826303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947719708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99798656,0.00025766095,0.00002476596,0.00006206024,0.000004833784,0.000018069775,0.00048306,0.000003142213,0.0011596911],"genre_scores_gemma":[0.9988863,0.0000816871,0.000026121394,0.000045860434,0.000011593775,0.000008585791,0.0007470061,0.0000015142482,0.00019135997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983096,0.000033484386,0.000023418708,0.000035905556,0.000027520215,0.000048712944],"domain_scores_gemma":[0.99928975,0.0000749514,0.00035114228,0.000014741687,0.000055719604,0.00021364927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024026526,0.00012162791,0.00025032705,0.00029595938,0.00028670998,0.00051619404,0.00016148959,0.0002756384,0.0018335092],"category_scores_gemma":[0.0008212963,0.00008261304,0.00028020667,0.00044118267,0.00017801907,0.00035608863,0.00034700704,0.0003767325,0.0004353427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010171791,0.00015314724,0.99160904,0.00002546259,0.00003835193,0.000713539,0.00007969534,0.00017535525,0.00061428256,0.000023301965,0.00044604167,0.0051046885],"study_design_scores_gemma":[0.00008452548,0.0018298767,0.99385226,0.00001310666,0.00004823913,0.0025966351,0.00020144678,0.0003140413,0.00026709918,0.000034892044,0.00075232825,0.0000056168838],"about_ca_topic_score_codex":0.0014341713,"about_ca_topic_score_gemma":0.0019061937,"teacher_disagreement_score":0.0018335092,"about_ca_system_score_codex":0.00045249244,"about_ca_system_score_gemma":0.0001977031,"threshold_uncertainty_score":0.0061336756},"labels":[],"label_agreement":null},{"id":"W2954144408","doi":"10.3747/co.26.4481","title":"Initial Management of Small-Cell Lung Cancer (limited- and Extensive-Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy: A Systematic Review","year":2019,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Sunnybrook Health Science Centre; Juravinski Cancer Centre; McMaster University; Thunder Bay Regional Health Sciences Centre; Princess Margaret Cancer Centre","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Etoposide; Chemotherapy; Radiation therapy; Cisplatin; Oncology; Stage (stratigraphy); Carboplatin; Lung cancer; Internal medicine","score_opus":0.12077251376841378,"score_gpt":0.49878108717061626,"score_spread":0.3780085734022025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954144408","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005979193,0.99888724,0.000035670597,0.000106895364,0.000049779468,0.00009826919,0.00008888862,0.0000023491527,0.00013308278],"genre_scores_gemma":[0.010938895,0.9880392,0.00025367647,0.00032638435,0.000057771354,0.00022124851,0.00009504216,0.0000022690538,0.000065549735],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99539363,0.0018629797,0.0015335066,0.0003302821,0.0007279663,0.00015161271],"domain_scores_gemma":[0.979885,0.014392843,0.0037773026,0.00020023,0.001488105,0.00025662567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005338516,0.0009935455,0.007583838,0.00418615,0.00043385933,0.0018230904,0.0014637511,0.001716577,0.003663409],"category_scores_gemma":[0.02673699,0.00081950444,0.0073548374,0.004986955,0.0005943868,0.0017086042,0.0007957322,0.0011654733,0.00023867207],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028807213,0.000016644844,0.0006052035,0.96064407,0.0064203027,0.000060819653,0.00010141971,0.00008021322,0.00008876305,0.00010142928,0.0009786795,0.030614492],"study_design_scores_gemma":[0.00058234,0.00033900328,0.004905378,0.91021895,0.070486255,0.00034744706,0.00017754584,0.00009001791,0.000108780805,0.00015984803,0.012556666,0.000027710801],"about_ca_topic_score_codex":0.009061993,"about_ca_topic_score_gemma":0.029269863,"teacher_disagreement_score":0.009061993,"about_ca_system_score_codex":0.0034387247,"about_ca_system_score_gemma":0.00776519,"threshold_uncertainty_score":0.02823311},"labels":[],"label_agreement":null},{"id":"W2955554680","doi":"10.1158/1538-7445.am2019-3925","title":"Abstract 3925: A screen for epigenetic radiosensitizers in small cell lung cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Epigenetics; Epigenetic therapy; Cancer research; Lung cancer; Cancer; Malignancy; Cell culture; Cell; Medicine; Chemistry; Biology; Oncology; Genetics; Internal medicine; DNA methylation; Gene expression","score_opus":0.08063073401355869,"score_gpt":0.44443369437175356,"score_spread":0.36380296035819487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955554680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9670302,0.012237673,0.005745109,0.0003677792,0.00011047263,0.000830209,0.0046981596,0.00051733165,0.008463037],"genre_scores_gemma":[0.9630388,0.0062190373,0.007490713,0.0002684617,0.000033618624,0.00026951707,0.008374165,0.000053079766,0.014252626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986017,0.000015699603,0.00001181845,0.000033257624,0.00005760333,0.000021502101],"domain_scores_gemma":[0.99994147,0.00001038648,0.00000948677,0.00000692259,0.000011439771,0.000020229356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014544508,0.0006152833,0.0005253672,0.0007898181,0.00023376799,0.00023239858,0.00040355924,0.00044559818,0.0040555354],"category_scores_gemma":[0.00012795597,0.0002266748,0.00046716837,0.0004345611,0.00013684975,0.000102522696,0.00024417552,0.00028858773,0.0008802514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017242161,0.00012899602,0.00054259633,0.00010923503,0.000024473133,0.00019783607,0.0000123607815,0.00019005651,0.99095047,0.00004929411,0.00028805438,0.0073341904],"study_design_scores_gemma":[0.00012264824,0.0046318406,0.009477025,0.000037238595,0.00019839998,0.00081799465,0.000045433422,0.00073828694,0.9681351,0.000054162207,0.015724845,0.000016997268],"about_ca_topic_score_codex":0.0007935843,"about_ca_topic_score_gemma":0.0025432936,"teacher_disagreement_score":0.0040555354,"about_ca_system_score_codex":0.00022781968,"about_ca_system_score_gemma":0.00029919075,"threshold_uncertainty_score":0.01356709},"labels":[],"label_agreement":null},{"id":"W2955954677","doi":"10.1158/1538-7445.am2019-2699","title":"Abstract 2699: Targeting an ubiquitin-activating enzyme in small-cell lung cancer (SCLC)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Etoposide; Cancer research; Cancer; Lung cancer; Cisplatin; Medicine; Viability assay; Cell culture; Cancer cell; Chemotherapy; Cell; Biology; Oncology; Internal medicine; Genetics","score_opus":0.08719973509604924,"score_gpt":0.4541016868402734,"score_spread":0.3669019517442242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955954677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98877794,0.005403202,0.001799862,0.00020727419,0.00011994646,0.0001316298,0.0010094203,0.00015205024,0.0023986457],"genre_scores_gemma":[0.99058807,0.0027238906,0.0020532801,0.000095705,0.00002841231,0.00008706713,0.001557095,0.000014663966,0.0028516364],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990356,0.000012695189,0.000010679559,0.000017172428,0.00003126105,0.000024591756],"domain_scores_gemma":[0.9999368,0.000011262265,0.000009785815,0.0000058354685,0.0000116579495,0.00002464084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015918171,0.00042323407,0.00034494494,0.00025772245,0.00020095568,0.00029037477,0.00025897572,0.00035491446,0.002326227],"category_scores_gemma":[0.0000902266,0.00011167364,0.00030733258,0.0002669483,0.0001889799,0.0001487576,0.00015267733,0.00067701034,0.00081483397],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047253427,0.00020793371,0.00039286498,0.00019642248,0.000020328309,0.00015352336,0.000011051194,0.0002147885,0.9922978,0.000058398517,0.00035087092,0.005623331],"study_design_scores_gemma":[0.00016316092,0.005409822,0.0045456584,0.000014469386,0.0000874405,0.0011466723,0.000038466173,0.0009925516,0.9829159,0.00005460429,0.004621888,0.00000943343],"about_ca_topic_score_codex":0.0005980514,"about_ca_topic_score_gemma":0.0011975026,"teacher_disagreement_score":0.002326227,"about_ca_system_score_codex":0.0002428086,"about_ca_system_score_gemma":0.00028848898,"threshold_uncertainty_score":0.0077819824},"labels":[],"label_agreement":null},{"id":"W2956067738","doi":"10.1158/1538-7445.am2019-ct073","title":"Abstract CT073: Pembrolizumab after two or more lines of prior therapy in patients with advanced small-cell lung cancer (SCLC): Results from the KEYNOTE-028 and KEYNOTE-158 studies","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Response Evaluation Criteria in Solid Tumors; Clinical endpoint; Oncology; Progression-free survival; Lung cancer; Cancer; Phases of clinical research; Surrogate endpoint; Immunotherapy; Clinical trial; Surgery; Chemotherapy","score_opus":0.057755507929358435,"score_gpt":0.43304730403021957,"score_spread":0.37529179610086116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956067738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857032,0.007058947,0.00023997591,0.00042152527,0.00008362473,0.0005208211,0.0034929912,0.00005191462,0.002426917],"genre_scores_gemma":[0.9903868,0.0015075827,0.00037446103,0.0005515639,0.00012281747,0.00030468055,0.0057066022,0.000011966952,0.0010335513],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99925023,0.00032794624,0.00007946123,0.00014132733,0.00011220169,0.00008876832],"domain_scores_gemma":[0.9983569,0.00032374842,0.00052806444,0.000120523946,0.00015055785,0.0005201927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015914676,0.0006373592,0.001158941,0.0003269394,0.00036718207,0.0009304446,0.0006644714,0.00080791494,0.003854111],"category_scores_gemma":[0.0015325805,0.00021766912,0.0014571185,0.0006484832,0.00032363142,0.0009304943,0.00049515796,0.0016877659,0.0007663238],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72065026,0.0077141435,0.12130833,0.0015643659,0.004447194,0.00037165664,0.00017333095,0.001470148,0.015494212,0.00013885781,0.008097223,0.11857031],"study_design_scores_gemma":[0.20471561,0.2471558,0.51797426,0.000478251,0.005515621,0.0014993805,0.0002434683,0.0030688748,0.0068025542,0.00029625444,0.012141147,0.000108825545],"about_ca_topic_score_codex":0.0018067299,"about_ca_topic_score_gemma":0.0047364095,"teacher_disagreement_score":0.003854111,"about_ca_system_score_codex":0.0011755012,"about_ca_system_score_gemma":0.0012964044,"threshold_uncertainty_score":0.012893319},"labels":[],"label_agreement":null},{"id":"W2966439920","doi":"10.1200/jco.2013.31.15_suppl.tps7609","title":"Cabazitaxel (Cbz) versus topotecan in patients (pts) with small cell lung cancer (SCLC) that has progressed during or after first-line treatment with platinum-based chemotherapy: A randomized phase II study.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Lakeridge Health; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Taxane; Topotecan; Internal medicine; Oncology; Chemotherapy; Regimen; Chemotherapy regimen; Gemcitabine; Refractory (planetary science); Surgery; Cancer; Breast cancer","score_opus":0.10857136224346695,"score_gpt":0.44816974150394057,"score_spread":0.33959837926047365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966439920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890872,0.0023368536,0.0004017686,0.00078216667,0.0004172576,0.0041775573,0.0010337216,0.00010280651,0.0016606211],"genre_scores_gemma":[0.98674613,0.002457263,0.0011634268,0.0009869639,0.00032197236,0.0038194875,0.0009766717,0.000020531206,0.0035076423],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996785,0.00017048536,0.000017777083,0.00004906931,0.000028398461,0.000055885845],"domain_scores_gemma":[0.9992731,0.00017907922,0.00014070883,0.00004512038,0.000037737045,0.0003241852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013437406,0.0014910976,0.0021783123,0.0004991238,0.00032273453,0.00088502496,0.000943172,0.0016195655,0.007316899],"category_scores_gemma":[0.001303052,0.0007420315,0.0013442604,0.0005411642,0.0011148958,0.0010019754,0.0004097848,0.002954572,0.0012944925],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9592585,0.016975546,0.0007969496,0.00045787008,0.00044643128,0.00005650887,0.000055304015,0.00045815052,0.004690629,0.00007849528,0.0009054129,0.015820218],"study_design_scores_gemma":[0.8302838,0.16563462,0.0021264486,0.000022035792,0.0003217263,0.000045280012,0.000026158794,0.00047732343,0.00039912682,0.000095389056,0.0005567041,0.000011547124],"about_ca_topic_score_codex":0.0016038541,"about_ca_topic_score_gemma":0.0041023307,"teacher_disagreement_score":0.007316899,"about_ca_system_score_codex":0.000954648,"about_ca_system_score_gemma":0.0014874727,"threshold_uncertainty_score":0.024477422},"labels":[],"label_agreement":null},{"id":"W2968747111","doi":"10.1200/jco.2012.30.15_suppl.7093","title":"NCIC IND.190: A phase I trial of MK-0646 in combination with cisplatin and etoposide in extensive-stage small cell lung cancer (ES SCLC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Cisplatin; Chemotherapy; Oncology; Cancer","score_opus":0.15381927137870718,"score_gpt":0.5391692761335148,"score_spread":0.38535000475480763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968747111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98504585,0.0027887437,0.00042981145,0.0007826426,0.0001667241,0.0040838723,0.0019739082,0.00020056676,0.0045278706],"genre_scores_gemma":[0.98461837,0.0023144875,0.0013406376,0.0012365147,0.00018981544,0.0026501208,0.0033411856,0.0000347322,0.0042741587],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99963605,0.00019573711,0.000021361988,0.00004044726,0.00003830675,0.00006813778],"domain_scores_gemma":[0.9995111,0.000081808,0.0000696055,0.00003000495,0.000025168674,0.00028237258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013841063,0.0014959574,0.0017060767,0.000645941,0.00054798124,0.0007908846,0.0013164926,0.0015181907,0.0049268007],"category_scores_gemma":[0.0006735528,0.0006208615,0.00090845115,0.0005839212,0.0010074356,0.0006225301,0.0004735179,0.0034768474,0.0014320251],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7060361,0.09350699,0.01092164,0.0018987339,0.0012407085,0.0007870618,0.0004156103,0.0045893504,0.044962708,0.00062529644,0.015862236,0.11915359],"study_design_scores_gemma":[0.5856612,0.38853893,0.014547634,0.00006375371,0.0004012421,0.0004900693,0.0000600259,0.0017704223,0.0035485283,0.000153284,0.004723952,0.00004095469],"about_ca_topic_score_codex":0.0022317986,"about_ca_topic_score_gemma":0.0072570834,"teacher_disagreement_score":0.0049268007,"about_ca_system_score_codex":0.0009393051,"about_ca_system_score_gemma":0.0016353561,"threshold_uncertainty_score":0.016481817},"labels":[],"label_agreement":null},{"id":"W2978687871","doi":"10.1093/annonc/mdz260.097","title":"Preliminary results from phase Ib study of spartalizumab plus chemotherapy for advanced non-small cell lung cancer (NSCLC)","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pemetrexed; Internal medicine; Carboplatin; Lung cancer; Nausea; Chemotherapy; Discontinuation; Oncology; Gastroenterology; Cisplatin","score_opus":0.07776748119648753,"score_gpt":0.4609315789499341,"score_spread":0.38316409775344656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978687871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709122,0.007741797,0.0021056642,0.0020430326,0.00049754395,0.0043849894,0.0049620066,0.00020351198,0.0071492316],"genre_scores_gemma":[0.9684904,0.0059670457,0.004521004,0.0025892474,0.00037377764,0.00272923,0.009713411,0.00009568966,0.0055201044],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993861,0.0003208767,0.00003713245,0.00006128812,0.000053319895,0.0001411593],"domain_scores_gemma":[0.9984705,0.00050454226,0.00016623684,0.00013696679,0.00013217595,0.0005895426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024518822,0.0013334963,0.001857546,0.00033348188,0.00053208374,0.0010481452,0.00084956293,0.0011854147,0.003665204],"category_scores_gemma":[0.0017415166,0.00039899757,0.0018360155,0.00039814154,0.0008171732,0.0008633001,0.00032012703,0.002928636,0.00097157893],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54580116,0.09061059,0.014568656,0.0022240859,0.0032104722,0.0006840955,0.00073484407,0.00618717,0.07311398,0.00060586614,0.014290956,0.24796817],"study_design_scores_gemma":[0.2792994,0.6745873,0.021723859,0.00009964543,0.0016119463,0.0006345503,0.0001958455,0.0011319728,0.009660389,0.000549235,0.010465708,0.00004007468],"about_ca_topic_score_codex":0.0027566522,"about_ca_topic_score_gemma":0.006798929,"teacher_disagreement_score":0.003665204,"about_ca_system_score_codex":0.00071777013,"about_ca_system_score_gemma":0.0021063958,"threshold_uncertainty_score":0.012966931},"labels":[],"label_agreement":null},{"id":"W2979808837","doi":"10.1093/neuros/nyz428","title":"Role of Gamma Knife Radiosurgery in Small Cell Lung Cancer: A Multi-Institutional Retrospective Study of the International Radiosurgery Research Foundation (IRRF)","year":2019,"lang":"en","type":"article","venue":"Neurosurgery","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Radiosurgery; Medicine; Prophylactic cranial irradiation; Hazard ratio; Proportional hazards model; Lung cancer; Recursive partitioning; Retrospective cohort study; Cumulative incidence; Institutional review board; Radiation therapy; Brain metastasis; Salvage therapy; Logistic regression; Oncology; Nuclear medicine; Internal medicine; Confidence interval; Cancer; Surgery; Chemotherapy; Cohort; Metastasis","score_opus":0.04831715106326516,"score_gpt":0.3555535540802199,"score_spread":0.3072364030169547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979808837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99907506,0.00037375625,0.00008416793,0.000026626232,0.0000025084803,0.00000990878,0.00025688173,0.000002941293,0.00016806182],"genre_scores_gemma":[0.9994629,0.00013952852,0.000051805477,0.000020448108,0.0000051164116,0.000008816573,0.00026845624,0.0000023449873,0.000040674877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992513,0.00018762778,0.000112791015,0.00019663168,0.0001491785,0.000102411315],"domain_scores_gemma":[0.9969162,0.0004444553,0.0017518335,0.00029232661,0.00029503577,0.00030005455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012436397,0.0002486157,0.0002848803,0.0011597179,0.00050564477,0.00057805865,0.00039838054,0.00032107788,0.00086736836],"category_scores_gemma":[0.0025161337,0.0002825624,0.0004426345,0.0011854012,0.00034305512,0.000490328,0.00047071718,0.00037265316,0.00022638169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024199775,0.0000089022005,0.99930453,0.000003359702,0.000018639103,0.000066031214,0.000042326767,0.0000116628735,0.00008314577,0.000004131799,0.000039865598,0.000393085],"study_design_scores_gemma":[0.000004001526,0.00007831826,0.9985689,0.0000064627043,0.00003374548,0.0006940238,0.00022961615,0.00007072618,0.00008419536,0.000005665845,0.00022040523,0.0000038513654],"about_ca_topic_score_codex":0.0058425358,"about_ca_topic_score_gemma":0.007019699,"teacher_disagreement_score":0.0058425358,"about_ca_system_score_codex":0.0005196178,"about_ca_system_score_gemma":0.0006985039,"threshold_uncertainty_score":0.0116170645},"labels":[],"label_agreement":null},{"id":"W2981560305","doi":"10.1016/j.jtho.2019.08.2247","title":"EP1.12-02 SCLC Treatment Uptake and Survival Outcomes: A 2-Year Comparison Between 2 Tertiary Referral Centers in Alberta, Canada","year":2019,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Hazard ratio; Internal medicine; Radiation therapy; Referral; Guideline; Proportional hazards model; Lung cancer; Retrospective cohort study; Cancer; Oncology; Conventional PCI; Family medicine; Confidence interval; Pathology","score_opus":0.05230667235199401,"score_gpt":0.4400525911824128,"score_spread":0.3877459188304188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981560305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535793,0.0008241401,0.000048558228,0.0003658282,0.000026565396,0.00004915771,0.0017961563,0.000008219192,0.0015234058],"genre_scores_gemma":[0.9964091,0.0003986624,0.00008556942,0.00022645063,0.000017023576,0.000020862972,0.0015767908,0.000006078122,0.0012594528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812204,0.00017732225,0.000085854954,0.00022975144,0.0004323366,0.0009525653],"domain_scores_gemma":[0.99673367,0.00022812192,0.0005480424,0.000066901244,0.0013064932,0.0011167997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011698261,0.00057384383,0.00076276186,0.0013652763,0.0023236247,0.0019569416,0.0018096563,0.0010601727,0.0024640441],"category_scores_gemma":[0.0024715764,0.0004867815,0.0010639825,0.0038227253,0.0012080198,0.0006297058,0.0012608375,0.0013156848,0.00033536644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016760036,0.00029616826,0.98755974,0.000076786695,0.0002311044,0.00014851599,0.0008638994,0.0003893029,0.0002514197,0.00019251005,0.001755664,0.006558973],"study_design_scores_gemma":[0.000109071305,0.0002287272,0.996049,0.000059220958,0.00012622424,0.000046931076,0.0023742428,0.000349162,0.000055806173,0.000026565314,0.0005572319,0.000017763627],"about_ca_topic_score_codex":0.99001735,"about_ca_topic_score_gemma":0.9942433,"teacher_disagreement_score":0.045191165,"about_ca_system_score_codex":0.045191165,"about_ca_system_score_gemma":0.039143972,"threshold_uncertainty_score":0.3278864},"labels":[],"label_agreement":null},{"id":"W2981636558","doi":"10.1016/j.jtho.2019.10.013","title":"Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses","year":2019,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Université de Sherbrooke; University of Alberta","funders":"Takeda Oncology; EMD Serono; National Institutes of Health; PharmaMar; Daiichi-Sankyo; G1 Therapeutics; Clovis Oncology; University of Texas Southwestern Medical Center; Merck Sharp and Dohme; Genzyme; Takeda Pharmaceuticals U.S.A.; Foundation Medicine; United Therapeutics Corporation; F. Hoffmann-La Roche; Ipsen Biopharmaceuticals; Novartis; Celgene; Merck; Spectrum Pharmaceuticals; Purdue University; MedImmune; Sanofi; GlaxoSmithKline; Roche; AbbVie; Genentech; Aeglea BioTherapeutics; Amgen; Daiichi Sankyo Europe; National Cancer Institute; Intuitive Surgical; Moderna; Pfizer; AstraZeneca; Purdue Pharma; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Paclitaxel; Hazard ratio; Internal medicine; Oncology; Placebo; Clinical endpoint; Population; Gastroenterology; Confidence interval; Randomized controlled trial; Chemotherapy; Pathology","score_opus":0.12534256394026563,"score_gpt":0.5412142173577857,"score_spread":0.4158716534175201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981636558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842977,0.0026250726,0.0010841836,0.0009230747,0.00097183604,0.0055818553,0.0023576359,0.00020315082,0.0019555988],"genre_scores_gemma":[0.97632766,0.0021501842,0.002815275,0.001854228,0.0009915284,0.0073279715,0.002638076,0.00007971152,0.005815458],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984042,0.0008750547,0.000079673984,0.00030991132,0.00009652346,0.00023471168],"domain_scores_gemma":[0.9971301,0.0007883303,0.0005906827,0.00038258414,0.00020995963,0.00089847454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041564354,0.003343039,0.006559975,0.0011176611,0.0009086308,0.0020626984,0.0019153266,0.002763598,0.0095343795],"category_scores_gemma":[0.003005133,0.0015765821,0.0029911748,0.0010759326,0.0027409354,0.002377333,0.0008482683,0.005746706,0.001898843],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9863826,0.006887478,0.00034379077,0.00010673375,0.0005305601,0.000012093438,0.000023720657,0.00020889065,0.0012062564,0.00004273295,0.00025451812,0.0040006214],"study_design_scores_gemma":[0.9201312,0.0772691,0.0011472969,0.000009395464,0.00044793065,0.0000144936985,0.000019447425,0.00024331325,0.00028540276,0.000108288354,0.00031020696,0.000013867532],"about_ca_topic_score_codex":0.0018431303,"about_ca_topic_score_gemma":0.004176921,"teacher_disagreement_score":0.0095343795,"about_ca_system_score_codex":0.0019847173,"about_ca_system_score_gemma":0.0027813336,"threshold_uncertainty_score":0.031895697},"labels":[],"label_agreement":null},{"id":"W2982042823","doi":"10.1016/j.jtho.2019.08.2257","title":"EP1.12-12 Factors Associated with Survival Outcomes Among Relapsed SCLC Diagnosed at a Canadian Cancer Centre","year":2019,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Proportional hazards model; Hazard ratio; Lung cancer; Stage (stratigraphy); Multivariate analysis; Oncology; Survival analysis; Chemotherapy; Retrospective cohort study; Cancer; Confidence interval","score_opus":0.0420348322713473,"score_gpt":0.41250479156459924,"score_spread":0.37046995929325194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982042823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942899,0.00051032234,0.000029231589,0.00049650524,0.000020187335,0.000016400374,0.0022249985,0.000005343987,0.002407143],"genre_scores_gemma":[0.9970783,0.00021408265,0.0000614575,0.000170609,0.000017224966,0.000008996959,0.0011871775,0.0000050309736,0.001257042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991246,0.00005950679,0.00004888168,0.000101947764,0.0001812797,0.00048381332],"domain_scores_gemma":[0.99775165,0.00014280918,0.00050900545,0.000050285442,0.0008481809,0.0006981672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048126307,0.00034378932,0.0003311337,0.0010076253,0.0021388687,0.0015669074,0.001236932,0.0006473421,0.0050798687],"category_scores_gemma":[0.0022289092,0.00026216757,0.0006369973,0.0022247594,0.0007022112,0.00041048485,0.0007013926,0.0013317645,0.00039215595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009412472,0.00003157203,0.9970294,0.000015414931,0.00002989967,0.000164272,0.00021274155,0.00005731357,0.00014163482,0.000053717977,0.00084914616,0.0013208026],"study_design_scores_gemma":[0.000008056377,0.000028027927,0.99759895,0.000026573813,0.000026104553,0.00017992964,0.0011739512,0.00009802609,0.00004772952,0.000021830752,0.00078163575,0.000009081365],"about_ca_topic_score_codex":0.9061861,"about_ca_topic_score_gemma":0.9325158,"teacher_disagreement_score":0.093813896,"about_ca_system_score_codex":0.010582724,"about_ca_system_score_gemma":0.016553752,"threshold_uncertainty_score":0.18873274},"labels":[],"label_agreement":null},{"id":"W2991104201","doi":"10.1016/j.jmir.2019.10.001","title":"Should Stereotactic Radiosurgery Be Considered for Salvage of Intracranial Recurrence after Prophylactic Cranial Irradiation or Whole Brain Radiotherapy in Small Cell Lung Cancer? A Population-Based Analysis and Literature Review","year":2019,"lang":"en","type":"review","venue":"Journal of medical imaging and radiation sciences","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Radiosurgery; Univariate analysis; Hazard ratio; Lung cancer; Proportional hazards model; Salvage therapy; Population; Cohort; Radiation therapy; Surgery; Multivariate analysis; Internal medicine; Oncology; Chemotherapy; Confidence interval","score_opus":0.05551280026917967,"score_gpt":0.4364040362062346,"score_spread":0.38089123593705493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991104201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00091989513,0.99869114,0.000022697,0.00013406342,0.00003699924,0.000007258542,0.000055613782,0.0000010359004,0.00013133818],"genre_scores_gemma":[0.006292767,0.9932213,0.00009533113,0.00021847937,0.00007707423,0.000009521187,0.000057585556,7.085286e-7,0.000027314543],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99931204,0.00012198533,0.00031327992,0.00010481271,0.000117094634,0.000030730655],"domain_scores_gemma":[0.9972977,0.0019189519,0.0005682503,0.000024844236,0.00015142052,0.000038794362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014012207,0.00045666794,0.0023286063,0.0033467377,0.00020018288,0.000975825,0.00085635594,0.0009920647,0.0024737008],"category_scores_gemma":[0.004374342,0.00033026293,0.0023061421,0.0043711266,0.0004632039,0.0011344256,0.00038636386,0.00067687227,0.00022500727],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011397232,0.000117756215,0.0117123285,0.37419096,0.009474543,0.00068996375,0.00021285652,0.00045872972,0.00060963695,0.00063387165,0.00768736,0.59307235],"study_design_scores_gemma":[0.001417747,0.001483358,0.11276122,0.4852555,0.14499749,0.012616986,0.0018940971,0.000605546,0.0010334405,0.0028378863,0.23482038,0.00027631584],"about_ca_topic_score_codex":0.0020870017,"about_ca_topic_score_gemma":0.006161714,"teacher_disagreement_score":0.0033467377,"about_ca_system_score_codex":0.0005703062,"about_ca_system_score_gemma":0.0019648082,"threshold_uncertainty_score":0.00827539},"labels":[],"label_agreement":null},{"id":"W2995682899","doi":"10.1200/jco.19.02748","title":"Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Guideline; Lung cancer; Stage (stratigraphy); Positron emission tomography; Magnetic resonance imaging; Radiology; Randomized controlled trial; Medical physics; Internal medicine; Pathology","score_opus":0.14893239327123653,"score_gpt":0.5650323579464293,"score_spread":0.4160999646751927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995682899","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047799875,0.26992756,0.027854975,0.5626917,0.022170736,0.009086151,0.018175881,0.0013799993,0.08393303],"genre_scores_gemma":[0.04186273,0.31488705,0.24324103,0.30467215,0.013724395,0.014068463,0.040915545,0.0004879412,0.026140595],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9887046,0.004595685,0.0030324447,0.0005318897,0.0025413786,0.0005939232],"domain_scores_gemma":[0.9766673,0.004965872,0.0033651872,0.0005446409,0.0125384955,0.0019184574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013102039,0.0017462599,0.0027323088,0.003766904,0.00133284,0.0030390874,0.0076978547,0.010623789,0.0042404095],"category_scores_gemma":[0.028205555,0.0008988557,0.005690538,0.003480666,0.0010990708,0.0026647483,0.0029449498,0.008873138,0.0042930604],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115774725,0.00016910247,0.0019336214,0.012366364,0.00048320554,0.00031609755,0.00029323332,0.0017948804,0.0005729355,0.0043905787,0.8299686,0.14759558],"study_design_scores_gemma":[0.0007736665,0.00022573274,0.0060341246,0.10549983,0.0018035694,0.00072251423,0.00037027212,0.0023982113,0.0006175243,0.010413904,0.87100977,0.00013092409],"about_ca_topic_score_codex":0.021910826,"about_ca_topic_score_gemma":0.03340303,"teacher_disagreement_score":0.021910826,"about_ca_system_score_codex":0.0057428144,"about_ca_system_score_gemma":0.019699136,"threshold_uncertainty_score":0.069291055},"labels":[],"label_agreement":null},{"id":"W2995889981","doi":"10.1016/j.jtho.2019.12.109","title":"Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies","year":2019,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":438,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Merck Sharp and Dohme; EMD Serono; Genentech; National Institutes of Health; Eli Lilly and Company; Ono Pharmaceutical; National Cancer Institute; Servier; Daiichi-Sankyo; Puma Biotechnology; AbbVie; Aminex Therapeutics; Roche; Celgene; Novartis; Meso Scale Diagnostics; Sanofi; MedImmune; Merck; GlaxoSmithKline; Boehringer Ingelheim; Amgen; Novartis Pharmaceuticals Corporation; Pfizer; PharmaMar; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Pembrolizumab; Oncology; Internal medicine; Cancer; Immunotherapy","score_opus":0.059163210304026236,"score_gpt":0.4761060156971092,"score_spread":0.416942805393083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995889981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95303106,0.040824458,0.00015850202,0.0007433758,0.00020692365,0.00036868537,0.0017123639,0.000013065261,0.0029416524],"genre_scores_gemma":[0.9799722,0.014397679,0.0003730914,0.0011140549,0.00031688233,0.00028891893,0.0024280704,0.000009562576,0.0010994687],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9988469,0.00047506837,0.00010665857,0.00018950948,0.00018543011,0.00019647357],"domain_scores_gemma":[0.99799514,0.00062471716,0.0006262257,0.00015126451,0.00018062771,0.0004220728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003534099,0.00058120524,0.0017645957,0.00044655902,0.00043853337,0.001304475,0.0005699467,0.0011496504,0.001559717],"category_scores_gemma":[0.0032589238,0.00030588446,0.0031672358,0.0008270339,0.00040650176,0.0013018431,0.00057777885,0.0022096836,0.0002729253],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5616761,0.009536147,0.15321518,0.0048738164,0.020643925,0.00041954304,0.00041077205,0.001264061,0.004846759,0.00030459827,0.004892764,0.23791634],"study_design_scores_gemma":[0.20375787,0.1386792,0.60250926,0.0020336274,0.03191094,0.0008208581,0.0005526109,0.000678161,0.002309015,0.00037180222,0.016235294,0.00014135969],"about_ca_topic_score_codex":0.0037194975,"about_ca_topic_score_gemma":0.008082888,"teacher_disagreement_score":0.0037194975,"about_ca_system_score_codex":0.0012345597,"about_ca_system_score_gemma":0.0013011731,"threshold_uncertainty_score":0.018690288},"labels":[],"label_agreement":null},{"id":"W2996673269","doi":"10.1097/coc.0000000000000657","title":"Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Lung cancer; Guideline; Chemotherapy; Radiation therapy; Proportional hazards model; Stage (stratigraphy); Cancer; Oncology; Surgery; Confidence interval","score_opus":0.1688143842316305,"score_gpt":0.5700223225478211,"score_spread":0.4012079383161906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996673269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6192308,0.3434174,0.0011530054,0.008966932,0.0002394823,0.00040169526,0.020563371,0.000041965868,0.0059853937],"genre_scores_gemma":[0.95867735,0.03506269,0.001314639,0.0012280714,0.00009115217,0.0001251928,0.0034110995,0.000005483974,0.000084357875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98245054,0.006930435,0.00462701,0.0011765991,0.0045015365,0.0003137668],"domain_scores_gemma":[0.9111303,0.030940661,0.04141091,0.0017692838,0.013913303,0.00083553366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010975275,0.000118345,0.0005362876,0.00318844,0.00027425692,0.0014584847,0.00082886504,0.00055826147,0.00038165922],"category_scores_gemma":[0.0710314,0.0001745177,0.0007397943,0.006843486,0.0004509268,0.0007046027,0.00037139197,0.00050118,0.000051171544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017782432,0.00004010336,0.8980454,0.01356907,0.002900224,0.00010097861,0.0008894804,0.0004978299,0.00011845947,0.00031330975,0.004604385,0.07874301],"study_design_scores_gemma":[0.00006634118,0.00013439603,0.97411865,0.010588493,0.0014910615,0.00042167908,0.0011496494,0.0005814074,0.00012569416,0.00011585984,0.011174689,0.000032109052],"about_ca_topic_score_codex":0.10632569,"about_ca_topic_score_gemma":0.23657463,"teacher_disagreement_score":0.10632569,"about_ca_system_score_codex":0.0040345583,"about_ca_system_score_gemma":0.008738839,"threshold_uncertainty_score":0.21141362},"labels":[],"label_agreement":null},{"id":"W3003747453","doi":"10.1016/j.jtho.2020.01.016","title":"New Approaches to SCLC Therapy: From the Laboratory to the Clinic","year":2020,"lang":"en","type":"review","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Janssen Pharmaceuticals; National Cancer Institute; National Health and Medical Research Council; Daiichi Sankyo Europe; Agios Pharmaceuticals; Karolinska Institutet; Takeda Oncology; EMD Serono; Ipsen; PharmaMar; Astellas Pharma; Merck; Kyowa Hakko Kirin; Daiichi-Sankyo; Syndax Pharmaceuticals; Cancer Research UK; AstraZeneca; International Association for the Study of Lung Cancer; Genentech; ANGLE; Bayer Fund; Meso Scale Diagnostics; Astex Pharmaceuticals; TG Therapeutics; Aeglea BioTherapeutics; Pfizer Pharmaceuticals; Marshfield Clinic Research Foundation; Memorial Sloan-Kettering Cancer Center; Merck KGaA; National Institutes of Health; Regeneron Pharmaceuticals; Victorian Cancer Agency; Incyte; Medical Research Council; University of Texas Southwestern Medical Center; AbbVie; Celgene; Novartis; Foundation Medicine; GlaxoSmithKline; Eli Lilly and Company; Bristol-Myers Squibb; G1 Therapeutics; Lung Cancer Research Foundation; Cold Spring Harbor Laboratory; Roche; Astellas Pharma US; Amgen; Ariad Pharmaceuticals; Boehringer Ingelheim; Pfizer","keywords":"Medicine; Intensive care medicine; Lung cancer; Clinical trial; Immunotherapy; Disease; Oncology; Cancer; Internal medicine","score_opus":0.36389056416098625,"score_gpt":0.5524615542292449,"score_spread":0.18857099006825867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003747453","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017177634,0.99945813,0.000025231268,0.00025526946,0.00010439664,0.0000012791772,0.000004887569,0.0000019273746,0.00013160436],"genre_scores_gemma":[0.00022649574,0.99918944,0.0000664924,0.0002776627,0.00016363066,0.0000025030204,0.000007872824,5.525229e-7,0.000065296495],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999358,0.00018358455,0.000089799025,0.00010967783,0.00020802519,0.000050948824],"domain_scores_gemma":[0.9978327,0.0015208275,0.00017937312,0.000044920107,0.0003101111,0.00011206218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022050166,0.0010617792,0.0031386348,0.0033904663,0.00038793148,0.0023860137,0.0015987159,0.0018773664,0.005093846],"category_scores_gemma":[0.0031287796,0.00037128135,0.0010447665,0.0035556755,0.0012470465,0.0026852079,0.0012117276,0.0033278782,0.0013475593],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018215843,0.00008882155,0.0003051272,0.0413265,0.00027215967,0.00014041159,0.00006672302,0.00040091312,0.0006080385,0.0060183504,0.031745456,0.91884536],"study_design_scores_gemma":[0.00011459494,0.000249021,0.0015470193,0.03400218,0.00063771475,0.0008673036,0.00021019946,0.00016038936,0.0002538453,0.005331135,0.9565769,0.00004991456],"about_ca_topic_score_codex":0.0022963774,"about_ca_topic_score_gemma":0.005474306,"teacher_disagreement_score":0.005093846,"about_ca_system_score_codex":0.0016654378,"about_ca_system_score_gemma":0.002936645,"threshold_uncertainty_score":0.01704061},"labels":[],"label_agreement":null},{"id":"W3006923011","doi":"10.1016/j.cllc.2020.02.013","title":"Effect of Hospitalization During First Chemotherapy and Performance Status on Small-cell Lung Cancer Outcomes","year":2020,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba; CancerCare Manitoba","funders":"Fondation de l’Hôpital Saint-Boniface; University of Manitoba; Manitoba Medical Service Foundation","keywords":"Medicine; Internal medicine; Lung cancer; Cohort; Performance status; Neutropenia; Chemotherapy; Retrospective cohort study; Cancer; Febrile neutropenia; Oncology","score_opus":0.024733776137534275,"score_gpt":0.40715397650250174,"score_spread":0.3824202003649675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006923011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904011,0.005556083,0.00007671655,0.00042388178,0.00007003978,0.000013284479,0.0012942214,0.000007082245,0.0021575934],"genre_scores_gemma":[0.9980356,0.00046361375,0.000027780809,0.00007990476,0.000060688704,0.000008411802,0.0007588864,0.0000031810464,0.00056196115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784064,0.00090007304,0.00017923022,0.00029021327,0.00017625591,0.00061347993],"domain_scores_gemma":[0.99070054,0.0043925312,0.0026422064,0.0005222783,0.00040045037,0.001342038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026136443,0.0004095825,0.0006969954,0.000983797,0.00046728572,0.0010655071,0.0008340827,0.0009925086,0.0042229625],"category_scores_gemma":[0.009288684,0.00031459358,0.0036389316,0.0012266542,0.0005299627,0.0011126826,0.00093814154,0.0015571335,0.00020607638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052111954,0.0002320825,0.9877949,0.00009221855,0.0018921198,0.00006852428,0.00007447127,0.00021742481,0.00011244965,0.000083729334,0.00039880397,0.0038220922],"study_design_scores_gemma":[0.00008717815,0.0006959101,0.99771035,0.000028362643,0.0006769935,0.00005805999,0.00016959649,0.00016931303,0.00004839302,0.000055462606,0.0002898742,0.000010505884],"about_ca_topic_score_codex":0.023213197,"about_ca_topic_score_gemma":0.022713063,"teacher_disagreement_score":0.023213197,"about_ca_system_score_codex":0.0009477482,"about_ca_system_score_gemma":0.0012894763,"threshold_uncertainty_score":0.046156168},"labels":[],"label_agreement":null},{"id":"W3011743004","doi":"10.1200/jco.2012.30.15_suppl.e17518","title":"Prognostic factors and trends in outcome for small cell lung cancer over 20 years.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Proportional hazards model; Cancer registry; Internal medicine; Lung cancer; Incidence (geometry); Hazard ratio; Population; Cancer; Radiation therapy; Clinical trial; Oncology; Relative survival; Confidence interval","score_opus":0.25374892070157656,"score_gpt":0.5750290758065449,"score_spread":0.3212801551049684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011743004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99030733,0.00228093,0.0001454278,0.00044970258,0.000027432257,0.000018026956,0.0052942554,0.00001777529,0.0014591736],"genre_scores_gemma":[0.99690753,0.00036071948,0.000074833,0.000052908348,0.00002481049,0.0000127593175,0.0022905516,0.0000042357146,0.00027159628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967647,0.000043407,0.00003956438,0.00007472676,0.00008287813,0.00008298648],"domain_scores_gemma":[0.99722666,0.0003854269,0.0014534647,0.00009104676,0.0004728507,0.00037050326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096513453,0.00019707695,0.00021466677,0.0016729797,0.0002837156,0.00046461032,0.00046024975,0.000474704,0.0020042793],"category_scores_gemma":[0.0037247404,0.0001252742,0.0005122596,0.003000147,0.00032526182,0.0004310955,0.00028479204,0.00054271205,0.00032422034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051834606,0.0000043851364,0.9989078,0.0000075580006,0.000021448968,0.000022987826,0.00001649889,0.00003015328,0.00001943857,0.00000814212,0.00017881428,0.0007307847],"study_design_scores_gemma":[0.0000036353842,0.000019849971,0.9994011,0.000007339057,0.000022017957,0.000077031174,0.00004262549,0.00012746888,0.000013450672,0.000011646483,0.00027207265,0.0000017201316],"about_ca_topic_score_codex":0.07079244,"about_ca_topic_score_gemma":0.09069617,"teacher_disagreement_score":0.07079244,"about_ca_system_score_codex":0.0010155434,"about_ca_system_score_gemma":0.0015489955,"threshold_uncertainty_score":0.14076078},"labels":[],"label_agreement":null},{"id":"W3014319679","doi":"10.21037/jtd.2020.03.89","title":"PARP inhibitors for small cell lung cancer and their potential for integration into current treatment approaches","year":2020,"lang":"en","type":"review","venue":"Journal of Thoracic Disease","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Center for Advancing Translational Sciences; Ontario Institute for Cancer Research; American Society of Clinical Oncology; International Association for the Study of Lung Cancer; Conquer Cancer Foundation","keywords":"Medicine; Lung cancer; Immunotherapy; Oncology; Radiation therapy; Chemotherapy; Clinical trial; Biomarker; Cancer; Disease; Internal medicine; Cancer research; Biology","score_opus":0.12099512687709159,"score_gpt":0.44977142235243156,"score_spread":0.32877629547534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014319679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011494613,0.99889237,0.00008813612,0.00021161798,0.00012560391,0.000006568927,0.000016183812,0.0000054086336,0.0005391614],"genre_scores_gemma":[0.00065561367,0.99854493,0.00016182929,0.0001645771,0.00009070748,0.000008917509,0.00002998601,0.0000010937528,0.0003423099],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982685,0.000034834586,0.00002910122,0.000027874974,0.00006644553,0.000015060757],"domain_scores_gemma":[0.9996911,0.00015408522,0.000046401623,0.000008836181,0.000078195764,0.00002140785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064349425,0.00056800444,0.0011017496,0.0017806896,0.00019491513,0.0008228237,0.00063872826,0.000844006,0.0046839807],"category_scores_gemma":[0.0007248997,0.00019954638,0.0006772972,0.0014074583,0.0002537414,0.00095716945,0.00052588905,0.0018093667,0.0017518153],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010187452,0.000082365674,0.00010969378,0.022667466,0.000115224146,0.00015644307,0.000047721496,0.00031235974,0.0017082336,0.00296822,0.015861569,0.9558689],"study_design_scores_gemma":[0.000049761617,0.0002395063,0.0007433275,0.0068043745,0.00023266119,0.0011086431,0.000054278615,0.00011720772,0.00062969106,0.0015945593,0.9884067,0.000019136007],"about_ca_topic_score_codex":0.0005667612,"about_ca_topic_score_gemma":0.0012768843,"teacher_disagreement_score":0.0046839807,"about_ca_system_score_codex":0.00041888852,"about_ca_system_score_gemma":0.0008386225,"threshold_uncertainty_score":0.015669465},"labels":[],"label_agreement":null},{"id":"W3017187232","doi":"10.3747/co.27.5183","title":"Immuno-Oncology—The New Paradigm of Lung Cancer Treatment","year":2020,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University of Manitoba; CancerCare Manitoba","funders":"Manitoba Medical Service Foundation","keywords":"Medicine; Lung cancer; Oncology; Internal medicine; Immunotherapy; Treatment of lung cancer; Chemoradiotherapy; Pembrolizumab; Cancer; Intensive care medicine","score_opus":0.2838468422970253,"score_gpt":0.5795696855701663,"score_spread":0.295722843273141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017187232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006528821,0.9974089,0.0000991245,0.0010920815,0.00039763973,0.0000030376384,0.000008680521,0.000004591621,0.00092060585],"genre_scores_gemma":[0.0006785024,0.9976761,0.00012771791,0.0006814549,0.0004744719,0.0000046622204,0.000011716918,0.0000010937415,0.00034437433],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963784,0.000105849744,0.000041295425,0.00004850815,0.00013309835,0.000033338496],"domain_scores_gemma":[0.9994821,0.00029070233,0.000053990967,0.00001685076,0.00011672919,0.000039640152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010127254,0.00056994834,0.001059742,0.0014790483,0.00029644734,0.0012648634,0.00075500336,0.0010904366,0.0029880307],"category_scores_gemma":[0.0010145729,0.00016667883,0.00060219027,0.0012792454,0.0007144865,0.0020898858,0.0006695234,0.0027710237,0.0011686946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073131756,0.00006907388,0.0002092162,0.02086663,0.00012318532,0.00016100737,0.00010624201,0.00033287358,0.0010574902,0.018663717,0.05752985,0.90080756],"study_design_scores_gemma":[0.0000115277535,0.00007440921,0.0004094381,0.004857783,0.00005579007,0.00059146056,0.000057875615,0.000059163853,0.00013037634,0.0044976193,0.9892457,0.000008788849],"about_ca_topic_score_codex":0.00097202614,"about_ca_topic_score_gemma":0.0016232429,"teacher_disagreement_score":0.0029880307,"about_ca_system_score_codex":0.0010744664,"about_ca_system_score_gemma":0.0018504276,"threshold_uncertainty_score":0.009995997},"labels":[],"label_agreement":null},{"id":"W3019010871","doi":"10.1111/joim.13053","title":"Tumour biomarkers: association with heart failure outcomes","year":2020,"lang":"en","type":"article","venue":"Journal of Internal Medicine","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"European Research Council; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; National Institute for Health and Care Research; China Scholarship Council; Fondation Leducq; European Commission","keywords":"Medicine; Internal medicine; Hazard ratio; Quartile; Heart failure; Gastroenterology; Cohort; Proportional hazards model; Area under the curve; Confidence interval","score_opus":0.022859536971567132,"score_gpt":0.34498561655028953,"score_spread":0.3221260795787224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019010871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511564,0.0032887359,0.00021430856,0.00019888258,0.000013107461,0.000006247161,0.00045467383,0.000009329394,0.00069923466],"genre_scores_gemma":[0.9992899,0.00032151048,0.00008625842,0.000017114835,0.000017936656,0.0000028091622,0.00017377053,0.0000010352541,0.0000895678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997888,0.000058684927,0.000018018116,0.000045974288,0.000043406293,0.00004515331],"domain_scores_gemma":[0.9976979,0.00043314978,0.0014198906,0.000058112888,0.00014781818,0.00024310699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046154932,0.00020294226,0.00023148792,0.00046893983,0.00011465108,0.0004929766,0.00015404975,0.00028729718,0.0012119262],"category_scores_gemma":[0.0022691318,0.000078510326,0.0002316049,0.0006333692,0.00016995941,0.00018250525,0.00026615922,0.00043424865,0.00014960826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025722082,0.000014694044,0.99622464,0.000023606664,0.00008716364,0.000048557195,0.000012797699,0.00011348285,0.0003636331,0.000020072985,0.00010062762,0.0027335405],"study_design_scores_gemma":[0.000007859171,0.00008931579,0.9988607,0.000008714921,0.00005351208,0.00018656543,0.000014226235,0.00028002384,0.00018022596,0.00006709416,0.00024878464,0.0000030303302],"about_ca_topic_score_codex":0.0014138354,"about_ca_topic_score_gemma":0.00135753,"teacher_disagreement_score":0.0014138354,"about_ca_system_score_codex":0.00022604503,"about_ca_system_score_gemma":0.00022849883,"threshold_uncertainty_score":0.0040542483},"labels":[],"label_agreement":null},{"id":"W3021245509","doi":"10.1016/s0923-7534(20)34093-x","title":"Third-Line Chemotherapy in Small Cell Lung Cancer: An International Analysis","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Ottawa Hospital","funders":"","keywords":"Medicine; Chemotherapy; Oncology; Lung cancer; Internal medicine; Chemotherapy regimen","score_opus":0.11391382267285063,"score_gpt":0.4960946420736674,"score_spread":0.3821808194008167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021245509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90584415,0.08316025,0.00052191643,0.0007039491,0.00007147258,0.00007239616,0.003077051,0.000007231001,0.0065416493],"genre_scores_gemma":[0.9789533,0.01839883,0.0001896348,0.00025371317,0.00006178032,0.000040258616,0.0016035014,0.0000134962165,0.00048555303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822587,0.0007304411,0.00026390492,0.00024235068,0.00029261468,0.00024481886],"domain_scores_gemma":[0.99364084,0.001818852,0.0030303216,0.00042508874,0.00056316075,0.0005218165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023737869,0.00036693222,0.0008876937,0.0022931548,0.00032613342,0.0011246562,0.0004622525,0.00031879818,0.0031997978],"category_scores_gemma":[0.004331136,0.00017838132,0.0029040123,0.0062834644,0.00037637947,0.0006640447,0.0008834991,0.00079757086,0.00019391894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008946611,0.00018808953,0.9361593,0.0012599849,0.0087701585,0.00021635926,0.0004265434,0.0004419919,0.0008292807,0.00086177536,0.0013707269,0.040529143],"study_design_scores_gemma":[0.00032301244,0.0005506204,0.98531854,0.00057588465,0.00711528,0.00032227582,0.0009496254,0.00013199332,0.00028687323,0.00014707657,0.0042608134,0.000017990451],"about_ca_topic_score_codex":0.0063928263,"about_ca_topic_score_gemma":0.010419912,"teacher_disagreement_score":0.0063928263,"about_ca_system_score_codex":0.00090393587,"about_ca_system_score_gemma":0.0010677843,"threshold_uncertainty_score":0.012711227},"labels":[],"label_agreement":null},{"id":"W3029908290","doi":"10.1200/jco.2020.38.15_suppl.e19306","title":"Predictors of and longitudinal assessment of health utility scores in patients with small cell lung cancer using real-world data.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Lung cancer; Disease; Cohort; Internal medicine; Clinical trial; Medical record; Cancer; Performance status; Surgery","score_opus":0.3681568588088141,"score_gpt":0.5781826114878956,"score_spread":0.21002575267908152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029908290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967848,0.00025508268,0.00040137413,0.0002046389,0.000010194893,0.000021538483,0.0019519548,0.000007477125,0.0003629268],"genre_scores_gemma":[0.998285,0.00005166365,0.00021230047,0.000024377965,0.0000067696265,0.000016819376,0.0013450311,0.0000017177946,0.000056295936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99592483,0.0025260749,0.0004024331,0.00042738582,0.00045866126,0.00026064858],"domain_scores_gemma":[0.9709278,0.0158409,0.00931146,0.0014541569,0.0014017605,0.0010639987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007939883,0.0002948292,0.00035487217,0.00097013736,0.0002934853,0.0013651906,0.00043498032,0.000601342,0.0014478877],"category_scores_gemma":[0.027529877,0.0002665086,0.0008419822,0.001958735,0.0003128221,0.0010612538,0.000906323,0.0013569677,0.0003798563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050063612,0.00001815442,0.99920493,0.0000037194452,0.00002938581,0.000010008522,0.000017324175,0.00010653737,0.0000076113743,0.000010303061,0.000061326,0.00048070215],"study_design_scores_gemma":[0.000011874176,0.00015953337,0.9939247,0.00001359155,0.000027804423,0.00013682307,0.0001846908,0.00516757,0.000040479354,0.00007384853,0.00025068555,0.000008293181],"about_ca_topic_score_codex":0.005236047,"about_ca_topic_score_gemma":0.0051064733,"teacher_disagreement_score":0.007939883,"about_ca_system_score_codex":0.000529203,"about_ca_system_score_gemma":0.0006486693,"threshold_uncertainty_score":0.041990638},"labels":[],"label_agreement":null},{"id":"W3030178583","doi":"10.1200/jco.20.00793","title":"Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":759,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; University of Toronto","funders":"National Cancer Institute","keywords":"Pembrolizumab; Medicine; Placebo; Internal medicine; Lung cancer; Hazard ratio; Clinical endpoint; Etoposide; Population; Gastroenterology; Progression-free survival; Oncology; Randomized controlled trial; Surgery; Confidence interval; Cancer; Chemotherapy; Immunotherapy; Pathology","score_opus":0.24579924696283775,"score_gpt":0.5415262119285564,"score_spread":0.2957269649657187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030178583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95254374,0.012300466,0.0024596849,0.001320579,0.0014974748,0.02137579,0.003555694,0.00041294,0.004533598],"genre_scores_gemma":[0.9628766,0.007339079,0.0029698634,0.0021748964,0.00088192534,0.01606189,0.0017131848,0.000051798987,0.005930777],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99917525,0.00043559988,0.000061259765,0.00016169717,0.000079271034,0.00008682374],"domain_scores_gemma":[0.9991555,0.00021726124,0.00019775146,0.00006879679,0.00007160048,0.00028914108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025906528,0.0018847388,0.0031842946,0.0005189857,0.000498857,0.0010687847,0.0010906981,0.0021062763,0.008136226],"category_scores_gemma":[0.0018969995,0.0009440356,0.0016310021,0.00044106072,0.0010744863,0.001027729,0.00040300682,0.0027650925,0.0016103834],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9704198,0.011773464,0.00027224477,0.0009005896,0.00076853205,0.000023846878,0.000028263454,0.00017567656,0.0037963998,0.00008773233,0.0007684411,0.010985059],"study_design_scores_gemma":[0.9525111,0.045375887,0.0006129572,0.000028558572,0.00036196306,0.000017781631,0.0000066276,0.00016899986,0.00036654042,0.00006642157,0.00047590653,0.0000072279995],"about_ca_topic_score_codex":0.0006640314,"about_ca_topic_score_gemma":0.0015163962,"teacher_disagreement_score":0.008136226,"about_ca_system_score_codex":0.00058556424,"about_ca_system_score_gemma":0.0013752844,"threshold_uncertainty_score":0.027218342},"labels":[],"label_agreement":null},{"id":"W3030792017","doi":"10.1200/jco.2020.38.15_suppl.9065","title":"Preliminary efficacy data of platinum-pretreated small cell lung cancer (SCLC) cohort of NCI 9881 study: A phase II study of cediranib in combination with olaparib in advanced solid tumors.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health","keywords":"Olaparib; Medicine; PARP inhibitor; Internal medicine; Oncology; Response Evaluation Criteria in Solid Tumors; Clinical endpoint; Adverse effect; Phases of clinical research; Chemotherapy; Gastroenterology; Clinical trial; Poly ADP ribose polymerase","score_opus":0.16719664029712927,"score_gpt":0.5222723428559617,"score_spread":0.3550757025588324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030792017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932708,0.0011716036,0.00025766034,0.00020103634,0.000019650608,0.00105467,0.002687329,0.000046622477,0.0012906234],"genre_scores_gemma":[0.984814,0.0009809814,0.0010141578,0.0004886458,0.000103866194,0.0012525393,0.010368682,0.00003131653,0.00094580225],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991454,0.00050051394,0.00005726937,0.00010577157,0.00010732264,0.00008376074],"domain_scores_gemma":[0.99861276,0.0002567646,0.00030652224,0.00014882888,0.00011747918,0.0005575431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026438688,0.0011690258,0.001785949,0.0004176457,0.0005426557,0.0010221998,0.00076227245,0.000948516,0.0020357778],"category_scores_gemma":[0.0014638668,0.00042126936,0.0011493115,0.0006364347,0.0005361435,0.00055313436,0.0004072166,0.0016455412,0.0006752367],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59659314,0.037283547,0.19938844,0.0010380866,0.006539919,0.0011173362,0.00052188814,0.0040531317,0.068021916,0.00017407301,0.0087147085,0.076553755],"study_design_scores_gemma":[0.32490906,0.25308132,0.39931488,0.00007822149,0.003578121,0.0017773214,0.00013942189,0.0022218076,0.00715801,0.00016635943,0.007499124,0.00007636681],"about_ca_topic_score_codex":0.0013530253,"about_ca_topic_score_gemma":0.0035332043,"teacher_disagreement_score":0.0026438688,"about_ca_system_score_codex":0.0008055308,"about_ca_system_score_gemma":0.0012939742,"threshold_uncertainty_score":0.013982296},"labels":[],"label_agreement":null},{"id":"W3030999222","doi":"10.1001/jamaoncol.2020.1271","title":"Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Sherbrooke","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences","keywords":"Medicine; Radiosurgery; Interquartile range; Lung cancer; Radiation therapy; Brain metastasis; Internal medicine; Prophylactic cranial irradiation; Oncology; Cohort; Retrospective cohort study; Cancer; Metastasis; Conventional PCI","score_opus":0.09586448013135285,"score_gpt":0.42618148420825736,"score_spread":0.3303170040769045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030999222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935741,0.0034871157,0.0006363377,0.0002233027,0.000048619862,0.000301827,0.0009087008,0.000030249135,0.00078975165],"genre_scores_gemma":[0.9978544,0.00059085875,0.0003811685,0.00010473531,0.00006278191,0.00015006833,0.00065942155,0.000007792577,0.00018869317],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9976555,0.0011056769,0.00022619375,0.00044828924,0.0004314524,0.00013279122],"domain_scores_gemma":[0.9931553,0.0021309226,0.0032208299,0.00041248623,0.000501865,0.00057857734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056967414,0.00046827496,0.0010064667,0.00034760917,0.00021605632,0.00071026006,0.0008530566,0.0005516288,0.0019010911],"category_scores_gemma":[0.01022354,0.0001852466,0.002831964,0.00042940228,0.00033243943,0.00082158745,0.0003747047,0.0007737211,0.0002482372],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14988886,0.003099867,0.6607717,0.0019377625,0.012980402,0.00013866655,0.00027371824,0.004054778,0.0033598493,0.00041992468,0.0021125874,0.16096173],"study_design_scores_gemma":[0.012249492,0.12541826,0.83907276,0.00036689173,0.00809693,0.0005028649,0.00019803285,0.006103999,0.0044803293,0.00055287656,0.0029048116,0.000052768053],"about_ca_topic_score_codex":0.0022252938,"about_ca_topic_score_gemma":0.0056698867,"teacher_disagreement_score":0.0056967414,"about_ca_system_score_codex":0.0016902819,"about_ca_system_score_gemma":0.0020356567,"threshold_uncertainty_score":0.030127645},"labels":[],"label_agreement":null},{"id":"W3031395200","doi":"10.1016/j.ccell.2020.04.016","title":"MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quest University Canada","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; University of Virginia","keywords":"Biology; Carcinogenesis; Cancer research; Suppressor; Derepression; Serine; Tumor suppressor gene; Phenotype; Cancer; Gene; Context (archaeology); Lung cancer; Genetics; Gene expression; Medicine; Internal medicine; Psychological repression","score_opus":0.02688124904498969,"score_gpt":0.3181522215302106,"score_spread":0.29127097248522094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031395200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611776,0.0115902545,0.007070765,0.0023914238,0.0005429267,0.000036287172,0.0020018956,0.0006546948,0.014534123],"genre_scores_gemma":[0.98488533,0.0030199946,0.0021047052,0.00031785294,0.00009155282,0.000025512412,0.001070919,0.00023205593,0.00825216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974567,0.000044826615,0.000016682681,0.000066782864,0.00006516446,0.000060869035],"domain_scores_gemma":[0.9997725,0.00005024012,0.000052385243,0.000035588466,0.000021647362,0.00006753208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051153527,0.00063496846,0.00048594375,0.00067847845,0.0006238026,0.0016726173,0.00050696515,0.00049470534,0.0033617634],"category_scores_gemma":[0.00056262466,0.00038270996,0.00053674204,0.00050446985,0.00063715177,0.0009805588,0.00070874277,0.0009895797,0.0008334689],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021687122,0.00014509166,0.0065786773,0.00024369154,0.0000993795,0.00058012287,0.00013053014,0.00069317524,0.95729977,0.0076288236,0.0022400396,0.022192081],"study_design_scores_gemma":[0.00006399395,0.00040487057,0.017075757,0.000026512878,0.00010178955,0.0013758381,0.00022099746,0.00205068,0.94112676,0.0025273447,0.034990396,0.000035149995],"about_ca_topic_score_codex":0.00040149497,"about_ca_topic_score_gemma":0.0006409581,"teacher_disagreement_score":0.0033617634,"about_ca_system_score_codex":0.0007379664,"about_ca_system_score_gemma":0.00043484414,"threshold_uncertainty_score":0.011246204},"labels":[],"label_agreement":null},{"id":"W3031935808","doi":"10.1200/jco.2020.38.15_suppl.e21101","title":"Extensive small cell lung cancer (SCLC) chemotherapy: A population kinetics assessment.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Etoposide; Population; Oncology; Nuclear medicine; Urology","score_opus":0.16877054844918138,"score_gpt":0.5475295781569021,"score_spread":0.3787590297077207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031935808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718294,0.0036648812,0.014145548,0.00025316805,0.000011040613,0.00046321147,0.0015833366,0.00017380845,0.007875661],"genre_scores_gemma":[0.9924706,0.0009493825,0.003425176,0.00008148453,0.000015322687,0.00016135292,0.0014567218,0.000021026906,0.0014188283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966824,0.00014535489,0.000023079601,0.000056743796,0.00008782535,0.000018774323],"domain_scores_gemma":[0.9991565,0.00041548262,0.0001618106,0.00006724184,0.00014745197,0.00005150952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017669072,0.00022647735,0.00031926506,0.0007831159,0.00017064028,0.0005229957,0.0002947879,0.00030289803,0.002088152],"category_scores_gemma":[0.0020604606,0.00016739829,0.00025373706,0.00067161507,0.00018761077,0.0006354331,0.00035074176,0.0002877838,0.00047434578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029195177,0.000708145,0.78252727,0.00048551595,0.00024137623,0.00095740944,0.000238692,0.016853673,0.027396536,0.0017513948,0.0032794327,0.162641],"study_design_scores_gemma":[0.00019588403,0.005742343,0.8545512,0.000089175475,0.0002577852,0.007950644,0.00027255286,0.09383814,0.02046521,0.0021019247,0.014496229,0.00003894536],"about_ca_topic_score_codex":0.0011793785,"about_ca_topic_score_gemma":0.0013378431,"teacher_disagreement_score":0.002088152,"about_ca_system_score_codex":0.0006959152,"about_ca_system_score_gemma":0.00041623335,"threshold_uncertainty_score":0.009344399},"labels":[],"label_agreement":null},{"id":"W3032096744","doi":"10.1200/jco.2020.38.15_suppl.9001","title":"KEYNOTE-604: Pembrolizumab (pembro) or placebo plus etoposide and platinum (EP) as first-line therapy for extensive-stage (ES) small-cell lung cancer (SCLC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; University of Toronto","funders":"","keywords":"Medicine; Placebo; Carboplatin; Internal medicine; Population; Etoposide; Interim analysis; Pembrolizumab; Clinical endpoint; Oncology; Clinical trial; Cisplatin; Chemotherapy; Cancer; Pathology; Immunotherapy","score_opus":0.2029837320610601,"score_gpt":0.5117943962480638,"score_spread":0.30881066418700365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032096744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9553938,0.008682531,0.0030601285,0.0011049843,0.0007792325,0.013134727,0.0043093367,0.00076580216,0.0127694085],"genre_scores_gemma":[0.9796322,0.0027777702,0.0030754958,0.0008145469,0.00023744802,0.0059650955,0.001780784,0.00004764802,0.005669113],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996393,0.0001466082,0.0000412595,0.00007512692,0.000034578374,0.00006317235],"domain_scores_gemma":[0.9996822,0.000050709077,0.00008304412,0.00002848944,0.000011772298,0.00014382563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011520282,0.000972109,0.0013983013,0.00078790163,0.00032813224,0.0006444532,0.0009993488,0.0012125492,0.015973588],"category_scores_gemma":[0.0008118126,0.00044101154,0.0007029819,0.0004468754,0.00061347714,0.0009444404,0.000472564,0.0019464339,0.0016757709],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84876573,0.015896661,0.00088624295,0.0019308338,0.00075284974,0.000111666704,0.00007545586,0.00087835296,0.027148787,0.00066234166,0.004609983,0.098280974],"study_design_scores_gemma":[0.809316,0.17180754,0.0039125923,0.00012424873,0.00073203887,0.0002361427,0.000027962964,0.000742186,0.006640204,0.00048318185,0.0059515988,0.000026280703],"about_ca_topic_score_codex":0.00028551248,"about_ca_topic_score_gemma":0.0009519046,"teacher_disagreement_score":0.015973588,"about_ca_system_score_codex":0.00056155527,"about_ca_system_score_gemma":0.0009446456,"threshold_uncertainty_score":0.053436995},"labels":[],"label_agreement":null},{"id":"W3032296787","doi":"10.1200/jco.2020.38.15_suppl.e21107","title":"Is there a role for hypofractionated thoracic radiotherapy in limited-stage small cell lung cancer? a propensity score matched analysis.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Cancer Care Ontario; University of Toronto; London Health Sciences Centre","funders":"","keywords":"Medicine; Propensity score matching; Chemoradiotherapy; Radiation therapy; Internal medicine; Lung cancer; Proportional hazards model; Performance status; Retrospective cohort study; Gemcitabine; Regimen; Stage (stratigraphy); Surgery; Oncology; Cancer","score_opus":0.26795590326361335,"score_gpt":0.5248756010756432,"score_spread":0.2569196978120299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032296787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9638501,0.010199005,0.018648839,0.0017886638,0.0004165438,0.00048363887,0.0016238743,0.00005810472,0.0029313457],"genre_scores_gemma":[0.9975648,0.00030828296,0.0010472605,0.0002800347,0.000084893356,0.000078358455,0.00036148969,0.000010029691,0.00026491014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933048,0.0036430547,0.0006995212,0.001194293,0.0007919277,0.00036633614],"domain_scores_gemma":[0.9865563,0.0058502937,0.0039720633,0.0024827553,0.00064990734,0.0004887285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017727097,0.00026710134,0.0009427192,0.0008333626,0.00043796896,0.0011538486,0.0010121984,0.00091481674,0.004506078],"category_scores_gemma":[0.022186473,0.00025237675,0.0034564906,0.001662925,0.0005707429,0.0010968554,0.00063406385,0.0007038919,0.00048130524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006241093,0.00011156236,0.95089334,0.0002583265,0.0050494475,0.00018415025,0.00013130838,0.0011719365,0.00050564035,0.0010759331,0.0019531865,0.032424018],"study_design_scores_gemma":[0.0009840394,0.0017077298,0.9562325,0.00017598088,0.0067247916,0.0006823259,0.0002950103,0.0220297,0.00051665434,0.0037338794,0.0068622874,0.000055054636],"about_ca_topic_score_codex":0.0010223269,"about_ca_topic_score_gemma":0.0014105997,"teacher_disagreement_score":0.017727097,"about_ca_system_score_codex":0.0004847511,"about_ca_system_score_gemma":0.00080714433,"threshold_uncertainty_score":0.09375095},"labels":[],"label_agreement":null},{"id":"W3034776875","doi":"10.1016/j.canlet.2020.06.002","title":"ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma","year":2020,"lang":"en","type":"article","venue":"Cancer Letters","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Japan Society for the Promotion of Science; Cancerfonden; Takeda Science Foundation","keywords":"Biology; Cancer research; Immune system; Adenocarcinoma; CCL20; Carcinogenesis; Chemokine; Pathology; Immunology; Chemokine receptor; Cancer; Medicine","score_opus":0.028117049274614864,"score_gpt":0.3251756978793353,"score_spread":0.2970586486047204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034776875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594265,0.0009865945,0.00032605033,0.00039078327,0.000025204818,0.000012401129,0.000294243,0.0000558987,0.0019661365],"genre_scores_gemma":[0.99757963,0.00032260353,0.0001709737,0.000087070104,0.00004034658,0.000009741048,0.0003398788,0.0000069093817,0.0014428437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987996,0.000019672996,0.000007560769,0.000019356286,0.00003884332,0.000034605142],"domain_scores_gemma":[0.9998165,0.000028958648,0.000039536993,0.000029357647,0.00003051778,0.000055191882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014800108,0.00015104338,0.00018136224,0.0003478102,0.0001757139,0.00045679725,0.00016256473,0.00024411245,0.0020515907],"category_scores_gemma":[0.00024256171,0.000100293175,0.0001542692,0.0002125004,0.00016071154,0.00019193372,0.0001514456,0.00051013904,0.0005990041],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001362175,0.00028030644,0.04214059,0.00008559853,0.000028476612,0.0011376797,0.00009273024,0.00021055219,0.935016,0.0004330635,0.0016611109,0.017551858],"study_design_scores_gemma":[0.00018145042,0.0019349045,0.5900437,0.000020200436,0.00011132027,0.008392643,0.00052308006,0.0036604616,0.3732796,0.0009541889,0.020877363,0.000021018497],"about_ca_topic_score_codex":0.00041296816,"about_ca_topic_score_gemma":0.00068206334,"teacher_disagreement_score":0.0020515907,"about_ca_system_score_codex":0.00029534518,"about_ca_system_score_gemma":0.00017649455,"threshold_uncertainty_score":0.0068632364},"labels":[],"label_agreement":null},{"id":"W3035309353","doi":"10.1158/1557-3265.aacrahns19-ia02","title":"Abstract IA02: Utilizing patient-derived xenografts for prognostication and biomarker discovery","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Oncology; Head and neck squamous-cell carcinoma; Internal medicine; Biomarker; Hazard ratio; Radiation therapy; Cohort; Cancer; Precision medicine; Personalized medicine; Bioinformatics; Head and neck cancer; Pathology; Biology; Confidence interval","score_opus":0.4849151068034955,"score_gpt":0.5792740164811869,"score_spread":0.09435890967769145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035309353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97993565,0.0017673861,0.011834564,0.0002783925,0.000110411456,0.00029568217,0.0029939462,0.00030858497,0.002475503],"genre_scores_gemma":[0.98352665,0.0007953041,0.0079801455,0.00013421974,0.00002521058,0.00018787775,0.0060875094,0.00003164408,0.0012313805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995334,0.00018142773,0.000038728493,0.000088514134,0.0001044302,0.00005357754],"domain_scores_gemma":[0.9992588,0.00018279506,0.00011150129,0.00020711735,0.00013597176,0.00010386861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022145628,0.0003951476,0.00040827482,0.00043565736,0.00019184535,0.0012555526,0.00039623416,0.00042522437,0.0014358022],"category_scores_gemma":[0.0010977628,0.00021255351,0.00029713495,0.0004620012,0.0002719606,0.00043718852,0.000493537,0.0010183578,0.0006128614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040547904,0.0019113311,0.081997655,0.00026665215,0.00020476714,0.00034944358,0.0001876413,0.003858282,0.851949,0.0013552733,0.0039279354,0.049937297],"study_design_scores_gemma":[0.0005149729,0.017215457,0.11428901,0.000087455555,0.0004139822,0.0039923056,0.00042500242,0.045165997,0.7928246,0.001029804,0.023967206,0.00007414913],"about_ca_topic_score_codex":0.0007026487,"about_ca_topic_score_gemma":0.0005633606,"teacher_disagreement_score":0.0022145628,"about_ca_system_score_codex":0.0003525616,"about_ca_system_score_gemma":0.00038847193,"threshold_uncertainty_score":0.0117118955},"labels":[],"label_agreement":null},{"id":"W3035392729","doi":"10.1158/2326-6074.tumimm18-b15","title":"Abstract B15: The oral Chk1 inhibitor, SRA737, synergizes with immune checkpoint blockade in small-cell lung cancer (SCLC)","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Positive Living Society of British Columbia","funders":"","keywords":"Immune checkpoint; Cancer research; Immunotherapy; Cancer; CHEK1; Immune system; In vivo; Blockade; Medicine; Lung cancer; T cell; Cancer immunotherapy; Immunology; Biology; Cell cycle checkpoint; Cell cycle; Oncology; Internal medicine; Receptor","score_opus":0.0738198577910945,"score_gpt":0.3948078948909215,"score_spread":0.320988037099827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035392729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98932797,0.0046766084,0.00053235725,0.000331465,0.00015910207,0.00036022847,0.0007191965,0.00031693772,0.003576043],"genre_scores_gemma":[0.99496883,0.0015451867,0.00056967355,0.0001588211,0.000062450636,0.00016442648,0.00088530045,0.00001656969,0.0016286608],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998166,0.000038168553,0.000017966659,0.000020258101,0.00003950338,0.00006752727],"domain_scores_gemma":[0.99986064,0.000023895984,0.000022151766,0.000011822941,0.000012494781,0.00006892504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030108474,0.00076378055,0.0009849656,0.00055161444,0.00029289242,0.00038949726,0.0004218137,0.00057873235,0.0032850276],"category_scores_gemma":[0.00017696587,0.00017281066,0.00057029806,0.00040387944,0.00028823412,0.00023931739,0.0002111736,0.0011426874,0.00079377973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035687096,0.013721001,0.0026029532,0.0012452177,0.0005379818,0.0006653542,0.000088910056,0.001911696,0.7992964,0.00052925316,0.005472676,0.13824147],"study_design_scores_gemma":[0.015417242,0.22454987,0.03338514,0.00012728292,0.0009823424,0.0016341137,0.00012046699,0.005671837,0.7051335,0.00023683913,0.012680054,0.0000613806],"about_ca_topic_score_codex":0.0014390162,"about_ca_topic_score_gemma":0.0038520116,"teacher_disagreement_score":0.0032850276,"about_ca_system_score_codex":0.00039050425,"about_ca_system_score_gemma":0.0010862827,"threshold_uncertainty_score":0.010989487},"labels":[],"label_agreement":null},{"id":"W3035570024","doi":"10.1016/j.ijrobp.2020.06.008","title":"Is There a Role for Hypofractionated Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched Analysis","year":2020,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; London Health Sciences Centre","funders":"","keywords":"Propensity score matching; Stage (stratigraphy); Lung cancer; Radiation therapy; Oncology; Medicine; Internal medicine; Lung cancer screening; Radiology; Biology","score_opus":0.07094110663707079,"score_gpt":0.3963725409874519,"score_spread":0.32543143435038113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035570024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98686856,0.004763599,0.005526188,0.0007431049,0.00025526038,0.00008988804,0.00040770776,0.000018976914,0.0013266879],"genre_scores_gemma":[0.9984744,0.00021627,0.000485583,0.00020153563,0.00009738258,0.000017566912,0.00020084278,0.000009787123,0.0002966422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99517304,0.0024998528,0.0005471823,0.0009064739,0.00048340685,0.00039006796],"domain_scores_gemma":[0.9922714,0.0032886846,0.0017585778,0.0018948849,0.0003840902,0.00040230106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061532366,0.0004044109,0.0010958115,0.0004789688,0.0005310587,0.0013686521,0.001193601,0.0009487275,0.0033976666],"category_scores_gemma":[0.011626488,0.00034846156,0.0040258435,0.0010893766,0.0005795038,0.0010470493,0.00071215513,0.0009130273,0.00033522898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024936011,0.00032012255,0.91171145,0.00032430995,0.015807634,0.00033669072,0.00020770637,0.0018534607,0.002859788,0.0014345681,0.001503603,0.038704593],"study_design_scores_gemma":[0.0027320434,0.0056259343,0.9348834,0.00015257773,0.028125133,0.0006555497,0.0007017481,0.01499639,0.0015645609,0.0043867063,0.006097623,0.00007833435],"about_ca_topic_score_codex":0.001543101,"about_ca_topic_score_gemma":0.0025657744,"teacher_disagreement_score":0.0061532366,"about_ca_system_score_codex":0.00041704535,"about_ca_system_score_gemma":0.000746967,"threshold_uncertainty_score":0.03254181},"labels":[],"label_agreement":null},{"id":"W3036504375","doi":"10.1016/j.clon.2020.05.017","title":"Patient-derived Xenograft Models of Small Cell Lung Cancer for Therapeutic Development","year":2020,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Terry Fox Foundation; Canada Foundation for Innovation; Canadian Institutes of Health Research; Cancer Research Society; Lung Cancer Research Foundation; AstraZeneca; Memorial Sloan-Kettering Cancer Center; Pfizer","keywords":"Medicine; Lung cancer; Cancer; Internal medicine; Oncology; Scopus; Incidence (geometry); Breast cancer; Prostate cancer; Gynecology; MEDLINE","score_opus":0.2502004934547571,"score_gpt":0.4873475968305229,"score_spread":0.23714710337576583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036504375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82129663,0.010517032,0.08957027,0.0027101883,0.002609999,0.0050421436,0.036291208,0.0011219584,0.03084063],"genre_scores_gemma":[0.90565354,0.006326008,0.038953803,0.0007225055,0.00017671834,0.0031451865,0.022880316,0.00026667162,0.021875253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991652,0.00027245574,0.000100734534,0.00012346516,0.00021523837,0.00012287514],"domain_scores_gemma":[0.99913824,0.00028403164,0.00009208688,0.00020656748,0.00014010353,0.0001389496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022292687,0.00083698233,0.00071812933,0.00081731885,0.00044336167,0.0010244948,0.0008869894,0.0011247665,0.012081397],"category_scores_gemma":[0.0007870031,0.00034035585,0.00088976504,0.00060144946,0.0004304116,0.00094336167,0.00033977535,0.0029579056,0.003371967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004262087,0.0037322321,0.002358661,0.00077041704,0.00017302747,0.0011044653,0.00041229077,0.0026324864,0.9555951,0.007360711,0.007833987,0.013764597],"study_design_scores_gemma":[0.0009206453,0.010830379,0.0055300263,0.00012798898,0.00032980615,0.004184247,0.00039719758,0.0061708083,0.9103728,0.0013151251,0.059774324,0.000046752688],"about_ca_topic_score_codex":0.00079191744,"about_ca_topic_score_gemma":0.0013663261,"teacher_disagreement_score":0.012081397,"about_ca_system_score_codex":0.00048305807,"about_ca_system_score_gemma":0.0007103031,"threshold_uncertainty_score":0.04041624},"labels":[],"label_agreement":null},{"id":"W3042800031","doi":"10.3389/fonc.2020.01146","title":"Current Management and Progress in Radiotherapy for Small Cell Lung Cancer","year":2020,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Radiation therapy; Current (fluid); Medicine; Lung cancer; Oncology; Medical physics; Radiology; Physics","score_opus":0.049356620976664566,"score_gpt":0.4536308554047787,"score_spread":0.40427423442811417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042800031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033973178,0.99944586,0.000023875366,0.00014388765,0.000069524795,0.0000023263992,0.000009433543,0.0000023804646,0.00026867475],"genre_scores_gemma":[0.00026810807,0.99935526,0.00006247194,0.0001237467,0.000066449735,0.0000036766794,0.000015613516,6.1119584e-7,0.00010404242],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996656,0.0000805801,0.00007426191,0.000052403528,0.00010473486,0.000022422384],"domain_scores_gemma":[0.99915063,0.0005249182,0.00012043632,0.000016425052,0.00015269524,0.000034934776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010972029,0.0006990913,0.0014501896,0.002706057,0.00027435186,0.0011277399,0.00094450254,0.00092893076,0.0041549415],"category_scores_gemma":[0.0015738928,0.00027093934,0.0007665849,0.0033006964,0.0004465205,0.001355705,0.000708339,0.001243984,0.0012833758],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007862246,0.000033189783,0.00015872938,0.061628338,0.00011760024,0.00010567537,0.000078513076,0.00021587132,0.00045170382,0.0021617603,0.019915318,0.9150547],"study_design_scores_gemma":[0.000030905638,0.00011998352,0.0011250994,0.033719234,0.00046748554,0.00096713507,0.00012849295,0.000082015875,0.00020723348,0.0020601256,0.9610711,0.000021209275],"about_ca_topic_score_codex":0.0016387453,"about_ca_topic_score_gemma":0.0033613115,"teacher_disagreement_score":0.0041549415,"about_ca_system_score_codex":0.00081781787,"about_ca_system_score_gemma":0.0018917469,"threshold_uncertainty_score":0.013899684},"labels":[],"label_agreement":null},{"id":"W3046905571","doi":"10.1183/13993003.00320-2020","title":"Radiotherapy in the era of immunotherapy: teaching an old dog new tricks","year":2020,"lang":"en","type":"article","venue":"European Respiratory Journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Abscopal effect; Immunotherapy; Medicine; Radiation therapy; Ablative case; Vaccination; Immune system; Immunology; Cancer research; Oncology; Internal medicine","score_opus":0.05702394213249148,"score_gpt":0.36812345674914543,"score_spread":0.31109951461665397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046905571","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025549128,0.30828944,0.0059267525,0.63297457,0.029009016,0.00003394889,0.00012002171,0.00027796358,0.020813426],"genre_scores_gemma":[0.059288148,0.47255963,0.011993488,0.31800172,0.09535891,0.00015705079,0.00015680237,0.0006501171,0.04183408],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979607,0.00094295735,0.000104093604,0.00021534145,0.0005851305,0.00019180943],"domain_scores_gemma":[0.9932387,0.0041141864,0.0002761736,0.00054203055,0.0007085887,0.0011203437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00707856,0.0005717131,0.0010490812,0.0012317284,0.0019284768,0.005482817,0.0011390205,0.005339874,0.016306683],"category_scores_gemma":[0.010150802,0.00034961756,0.0007253748,0.0008949276,0.008161183,0.014531304,0.0034260694,0.018654915,0.0056147976],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046121763,0.0003455947,0.0010417039,0.0017909847,0.000105414154,0.0005292432,0.00161835,0.00049185543,0.002684921,0.11689449,0.47303608,0.40100017],"study_design_scores_gemma":[0.00006857117,0.00020664265,0.0006097337,0.0009800514,0.000028373845,0.0008650378,0.0009536848,0.00014546962,0.0006583635,0.10116856,0.89427537,0.00004008549],"about_ca_topic_score_codex":0.0010956081,"about_ca_topic_score_gemma":0.0021535186,"teacher_disagreement_score":0.016306683,"about_ca_system_score_codex":0.0018466709,"about_ca_system_score_gemma":0.0031293523,"threshold_uncertainty_score":0.054551244},"labels":[],"label_agreement":null},{"id":"W3047400464","doi":"10.1016/j.annonc.2020.07.001","title":"The FDA approval of pembrolizumab for patients with TMB &gt;10 mut/Mb: was it a wise decision? No","year":2020,"lang":"en","type":"letter","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Arnold Ventures; Roche; Takeda Pharmaceuticals U.S.A.; Pfizer","keywords":"Medicine; Pembrolizumab; Crizotinib; Nivolumab; Ipilimumab; Oncology; Family medicine; Internal medicine; Lung cancer; Cancer; Immunotherapy","score_opus":0.07303249655138225,"score_gpt":0.4114210955109136,"score_spread":0.33838859895953133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047400464","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00082298124,0.0090234885,0.00052641897,0.9614936,0.021845728,0.000023915529,0.00019324519,0.00006564674,0.0060048634],"genre_scores_gemma":[0.014089064,0.010429815,0.0021459023,0.9343817,0.025166523,0.00006495986,0.00027369554,0.00011060092,0.013337763],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99165803,0.0028068046,0.0007649025,0.0009584539,0.0030639023,0.0007479029],"domain_scores_gemma":[0.9787355,0.009030508,0.0018038121,0.00079014705,0.0052810498,0.004358971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014407028,0.0005037577,0.0011885529,0.00076619093,0.00257271,0.0046567805,0.0016482807,0.019136358,0.018003011],"category_scores_gemma":[0.04657007,0.0005557834,0.0015455487,0.00059246056,0.0042770733,0.0060553635,0.0015668574,0.02192617,0.011619941],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029817552,0.000043124754,0.0003723565,0.00016387607,0.000040333394,0.00019724801,0.000054732962,0.000043796645,0.00036950462,0.0074919686,0.929352,0.061572812],"study_design_scores_gemma":[0.00032302213,0.00023504352,0.00075499015,0.0010251193,0.00010604996,0.0005265993,0.00022472521,0.00020260317,0.0006248129,0.014443806,0.98144114,0.00009209863],"about_ca_topic_score_codex":0.0023664301,"about_ca_topic_score_gemma":0.006578005,"teacher_disagreement_score":0.019136358,"about_ca_system_score_codex":0.0032785921,"about_ca_system_score_gemma":0.0046458133,"threshold_uncertainty_score":0.07619256},"labels":[],"label_agreement":null},{"id":"W3047504968","doi":"10.1093/noajnl/vdaa073.005","title":"13. MANAGEMENT OF BRAIN METASTASES FROM SMALL CELL LUNG CANCER USING SRS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology Advances","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiosurgery; Conventional PCI; Salvage therapy; Prophylactic cranial irradiation; Lung cancer; Surgery; Progression-free survival; Overall survival; Internal medicine; Radiation therapy; Chemotherapy","score_opus":0.05111721896652023,"score_gpt":0.39034540519912575,"score_spread":0.33922818623260553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047504968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9615643,0.010942617,0.0044027455,0.0014476621,0.00008218625,0.00020001919,0.00036276283,0.00013826886,0.02085941],"genre_scores_gemma":[0.99392915,0.002730331,0.001514992,0.00019112494,0.00020667327,0.000060613955,0.00032784033,0.00000954012,0.0010297663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987054,0.000032102933,0.000020765197,0.000017543576,0.000028206026,0.000030759118],"domain_scores_gemma":[0.99977714,0.00003366801,0.00009213135,0.000009039397,0.000033416294,0.000054703065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029156596,0.00019065858,0.00021102505,0.00027405383,0.00028494524,0.0004076409,0.00023133193,0.00024343122,0.0018211838],"category_scores_gemma":[0.0005068062,0.000044087625,0.0003239886,0.00015554139,0.00024059768,0.00018614961,0.000218388,0.00021088526,0.00071385416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095787743,0.00043178478,0.5811805,0.0004917591,0.000114601484,0.018833721,0.00018417336,0.0018745228,0.018415058,0.0005119802,0.0060704746,0.3709335],"study_design_scores_gemma":[0.0003555643,0.0077664056,0.7935348,0.0004259346,0.00029156936,0.1498652,0.0008942126,0.0048467596,0.019294932,0.0011321724,0.021550164,0.000042311476],"about_ca_topic_score_codex":0.0011880661,"about_ca_topic_score_gemma":0.0033034661,"teacher_disagreement_score":0.0018211838,"about_ca_system_score_codex":0.00040540873,"about_ca_system_score_gemma":0.00060604885,"threshold_uncertainty_score":0.0060924888},"labels":[],"label_agreement":null},{"id":"W3049272730","doi":"10.1111/crj.13266","title":"Comparison of oral versus intravenous etoposide in the management of small‐cell lung cancer; A real‐world, population‐based study","year":2020,"lang":"en","type":"article","venue":"The Clinical Respiratory Journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary; University of Alberta","funders":"","keywords":"Etoposide; Carboplatin; Medicine; Chemotherapy; Internal medicine; Population; Dosing; Lung cancer; Surgery; Cisplatin; Gastroenterology","score_opus":0.2842594416249,"score_gpt":0.5312428508591285,"score_spread":0.24698340923422846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049272730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978993,0.0013223445,0.00005217258,0.00006901686,0.000011489445,0.000040528717,0.00025191085,0.0000028427742,0.00035036053],"genre_scores_gemma":[0.99911183,0.00047005518,0.000054368542,0.000081544254,0.000019332529,0.000024685825,0.00017703554,0.0000013904706,0.00005977478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987803,0.000550042,0.00009704986,0.00021343854,0.0002483545,0.00011080916],"domain_scores_gemma":[0.99773514,0.00054542214,0.0011016905,0.000081573904,0.00019945804,0.00033659957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017289122,0.00026507938,0.00041753403,0.00044646024,0.00028597016,0.0008593521,0.00043562416,0.0007186672,0.0007708832],"category_scores_gemma":[0.0037506267,0.0002439647,0.00063591753,0.0011501345,0.00047675328,0.0005259008,0.0003199095,0.0007642662,0.00013796685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009508552,0.0008194438,0.9807904,0.00018482932,0.00057064317,0.00010029656,0.0001772851,0.00013839948,0.00029842643,0.0000357905,0.00023034585,0.0071456353],"study_design_scores_gemma":[0.0014684984,0.00726801,0.98825294,0.00006683416,0.0006943264,0.00029669688,0.00048068562,0.00039156238,0.00011884133,0.000047985155,0.0008964636,0.000017243432],"about_ca_topic_score_codex":0.0123276785,"about_ca_topic_score_gemma":0.019014891,"teacher_disagreement_score":0.0123276785,"about_ca_system_score_codex":0.0013239476,"about_ca_system_score_gemma":0.0010410493,"threshold_uncertainty_score":0.024511814},"labels":[],"label_agreement":null},{"id":"W3080927742","doi":"10.1007/s11136-020-02615-1","title":"The impact of symptoms and comorbidity on health utility scores and health-related quality of life in small cell lung cancer using real world data","year":2020,"lang":"en","type":"article","venue":"Quality of Life Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Comorbidity; Medicine; Internal medicine; Quality of life (healthcare); Lung cancer; Disease; Cohort; Observational study; Physical therapy","score_opus":0.6519851450697941,"score_gpt":0.6026794382328372,"score_spread":0.0493057068369569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080927742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954312,0.00082783424,0.00064432767,0.00021203441,0.000017199334,0.000019336881,0.0025033546,0.0000083584655,0.00033645335],"genre_scores_gemma":[0.99732506,0.00013452316,0.0003913494,0.000022494049,0.000007896937,0.000012444212,0.0020537535,0.0000051075326,0.00004748458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98443466,0.012363742,0.0009919385,0.0008036023,0.0009916537,0.00041433176],"domain_scores_gemma":[0.9278823,0.05990159,0.005993132,0.0034832766,0.0018869505,0.0008528821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014986945,0.00052046916,0.0007748887,0.0021075266,0.00040549762,0.0029447258,0.0008903896,0.0009801353,0.0009742898],"category_scores_gemma":[0.0670123,0.00045667426,0.0025865235,0.0035563512,0.00081829686,0.0017872093,0.0013082947,0.0014400937,0.00020315677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043894022,0.00008755435,0.99232155,0.000050848776,0.0010134103,0.00004264715,0.00006601427,0.00273376,0.000051402752,0.00008183689,0.00023274084,0.002879394],"study_design_scores_gemma":[0.000035625762,0.00018697817,0.9822811,0.00003825394,0.00041445493,0.0001423117,0.00024293606,0.016027665,0.00009012661,0.00020873648,0.0003058505,0.000025946316],"about_ca_topic_score_codex":0.023307735,"about_ca_topic_score_gemma":0.026781999,"teacher_disagreement_score":0.023307735,"about_ca_system_score_codex":0.0010594977,"about_ca_system_score_gemma":0.00062962266,"threshold_uncertainty_score":0.079259515},"labels":[],"label_agreement":null},{"id":"W3081216235","doi":"10.7759/cureus.10011","title":"Case of Complete Remission from Palliative Radiation in Extensive Stage Small Cell Lung Cancer With Large Brain Metastasis Nine Years After Diagnosis: Cure Is Possible","year":2020,"lang":"en","type":"article","venue":"Cureus","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital","funders":"","keywords":"Medicine; Radiation therapy; Stage (stratigraphy); Asymptomatic; Lung cancer; Brain metastasis; Metastasis; Radiology; Chemotherapy; Palliative chemotherapy; Craniotomy; Prophylactic cranial irradiation; Palliative care; Cancer; Oncology; Surgery; Internal medicine","score_opus":0.04692756101348458,"score_gpt":0.3506770689578603,"score_spread":0.3037495079443757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081216235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97129786,0.0057658562,0.0031481585,0.008334073,0.0004516577,0.00018150642,0.0004991927,0.00018515535,0.010136527],"genre_scores_gemma":[0.9944812,0.0009059949,0.0005383987,0.001208495,0.00043787097,0.000031201427,0.00019937297,0.000017821221,0.0021795386],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998004,0.000027502818,0.00001530923,0.000048760023,0.000025939955,0.00008212079],"domain_scores_gemma":[0.9993554,0.00017955195,0.00011870138,0.000075169286,0.000026426742,0.00024481508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022324006,0.00044332814,0.0005841959,0.00060328864,0.0012354808,0.00042744353,0.00067279255,0.003829772,0.001480513],"category_scores_gemma":[0.0011418925,0.0002887862,0.000729103,0.00036986242,0.0007691082,0.0004376059,0.0006534549,0.002356846,0.0004937838],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021466975,0.00010619811,0.006685023,0.00004907355,0.00001855148,0.98547286,0.00019631538,0.00019690601,0.0016889632,0.00032419976,0.00064050604,0.0044066785],"study_design_scores_gemma":[0.00008130017,0.0005392425,0.018279377,0.000017482524,0.000023740206,0.9770398,0.00007764689,0.00034060964,0.00077341776,0.00036845583,0.002442866,0.000016048543],"about_ca_topic_score_codex":0.0012762028,"about_ca_topic_score_gemma":0.0024096314,"teacher_disagreement_score":0.003829772,"about_ca_system_score_codex":0.00061622437,"about_ca_system_score_gemma":0.00043451082,"threshold_uncertainty_score":0.004952848},"labels":[],"label_agreement":null},{"id":"W3081953801","doi":"10.1634/theoncologist.2020-0193","title":"Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer","year":2020,"lang":"en","type":"review","venue":"The Oncologist","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; McMaster University; Trillium Health Centre; Juravinski Cancer Centre; Hôpital du Sacré-Cœur de Montréal; University of Ottawa; Ottawa Hospital; Princess Margaret Cancer Centre; Université de Montréal; William Osler Health System; University of Toronto; University of British Columbia","funders":"Pfizer Canada; Merck Canada; AstraZeneca Canada","keywords":"Medicine; Oncology; Tremelimumab; Lung cancer; Chemotherapy; Internal medicine; Durvalumab; Ipilimumab; Clinical trial; Immunotherapy; Radiation therapy; Maintenance therapy; Cancer; Stage (stratigraphy); Intensive care medicine; Nivolumab","score_opus":0.08041116675697593,"score_gpt":0.41151793173614376,"score_spread":0.3311067649791678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081953801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009557234,0.9968094,0.00006620194,0.00131813,0.00013636777,0.000015817845,0.00004655414,0.000003911724,0.00064779294],"genre_scores_gemma":[0.0141899735,0.98321366,0.00032718913,0.0012682333,0.0005394182,0.000036164467,0.00009163412,0.0000025558127,0.0003311779],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99953306,0.00017321347,0.00010785853,0.000056218898,0.0001013096,0.000028408414],"domain_scores_gemma":[0.9978941,0.0011905001,0.0005662659,0.000031111675,0.0002417015,0.00007638913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021706396,0.0003749148,0.0012832645,0.0013659637,0.0001642279,0.0009753109,0.0005861477,0.00083119946,0.0039927256],"category_scores_gemma":[0.0030726108,0.000115730145,0.0011087317,0.001755927,0.00030461795,0.0012977466,0.00048490916,0.0012051178,0.00046583096],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010338464,0.00007275468,0.00072918093,0.06742095,0.0005008293,0.00016162726,0.00006508615,0.00042865152,0.0011836734,0.0014340669,0.0091791125,0.91779023],"study_design_scores_gemma":[0.0022929402,0.004926622,0.02046155,0.18720074,0.007619913,0.0033490998,0.000519172,0.0011835744,0.0022334892,0.010359396,0.75973517,0.00011835365],"about_ca_topic_score_codex":0.00073450635,"about_ca_topic_score_gemma":0.002763142,"teacher_disagreement_score":0.0039927256,"about_ca_system_score_codex":0.0006447251,"about_ca_system_score_gemma":0.0013488143,"threshold_uncertainty_score":0.013357043},"labels":[],"label_agreement":null},{"id":"W3083480767","doi":"10.1016/j.ctro.2020.08.005","title":"Stereotactic radiosurgery (SRS) – A new normal for small cell lung cancer?","year":2020,"lang":"en","type":"review","venue":"Clinical and Translational Radiation Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Radiosurgery; Medicine; Lung cancer; Radiation therapy; Oncology; Lung; Cancer; Small Cell Lung Carcinoma; Internal medicine; Radiology; Small-cell carcinoma","score_opus":0.1589078002729063,"score_gpt":0.5039253287010861,"score_spread":0.3450175284281798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083480767","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033877597,0.99919397,0.000033151005,0.00032303281,0.000105119536,0.000001504737,0.000010966834,0.000003645823,0.00029461406],"genre_scores_gemma":[0.0002862905,0.99924517,0.000044726436,0.00017051552,0.00010617489,0.000001859903,0.0000123065975,7.3104155e-7,0.00013213804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998449,0.000034158184,0.000023277289,0.000035268433,0.00004932645,0.000012996464],"domain_scores_gemma":[0.9996575,0.0001827958,0.000048169444,0.000009024619,0.000076026205,0.000026523265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062165526,0.00064530136,0.0012498266,0.0022973914,0.00022707756,0.00077412336,0.00090894557,0.0009669243,0.0046921773],"category_scores_gemma":[0.0009995926,0.00019824506,0.0004889747,0.002150501,0.00046955553,0.0015011623,0.00048811972,0.0014789003,0.0017219548],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006454418,0.000030645282,0.00011342731,0.023041852,0.00008103394,0.00009996179,0.000046992864,0.00017145464,0.0005079098,0.002766643,0.027432894,0.9456426],"study_design_scores_gemma":[0.000028998735,0.000110399036,0.000789598,0.013146069,0.00023290774,0.0008967071,0.00008941129,0.000053988,0.00015017175,0.0024186515,0.9820632,0.000019797704],"about_ca_topic_score_codex":0.0018116495,"about_ca_topic_score_gemma":0.0037738318,"teacher_disagreement_score":0.0046921773,"about_ca_system_score_codex":0.00054372277,"about_ca_system_score_gemma":0.0011475874,"threshold_uncertainty_score":0.015696883},"labels":[],"label_agreement":null},{"id":"W3084355783","doi":"10.1016/j.jtho.2020.08.022","title":"Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC","year":2020,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; National Institutes of Health; Innovent Biologics; Jounce Therapeutics; Jazz Pharmaceuticals; Varian Medical Systems; Sierra Oncology; F. Hoffmann-La Roche; Novartis; National Cancer Institute; Johnson and Johnson; AbbVie; MedImmune; Merck; GlaxoSmithKline; Spectrum Pharmaceuticals; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Boehringer Ingelheim","keywords":"Medicine; Pembrolizumab; Common Terminology Criteria for Adverse Events; Internal medicine; Neutropenia; Oncology; Pneumonitis; Chemoradiotherapy; Radiation therapy; Progression-free survival; Surgery; Chemotherapy; Cancer; Immunotherapy","score_opus":0.11394025076929282,"score_gpt":0.5265962188109286,"score_spread":0.41265596804163573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084355783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98890483,0.002706768,0.00048653872,0.0010125581,0.00038835773,0.0025418568,0.00121229,0.00013926266,0.002607562],"genre_scores_gemma":[0.9807304,0.0023762367,0.0023076588,0.0014883879,0.00039079436,0.0045398767,0.002729617,0.00004903443,0.005387927],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996075,0.00016737176,0.000014543055,0.00008154527,0.000029287006,0.000099723824],"domain_scores_gemma":[0.999368,0.00011747389,0.00009434441,0.000052855386,0.000031777883,0.0003355103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015716845,0.0019086929,0.0025719944,0.0005425192,0.0006167646,0.0012789718,0.00117127,0.0016940548,0.006600406],"category_scores_gemma":[0.001132055,0.0007584239,0.0017296969,0.00040161327,0.0013606936,0.0014840036,0.00047795792,0.0043162205,0.001186549],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9006302,0.029514875,0.001311164,0.00068644935,0.0010272813,0.00009997943,0.0001622492,0.0016357298,0.012877887,0.00030885596,0.0029790967,0.048766285],"study_design_scores_gemma":[0.8628473,0.13038169,0.0031079033,0.000029955783,0.00029588287,0.00007316383,0.000040832012,0.00077905966,0.00085239427,0.00019853539,0.0013765404,0.000016591644],"about_ca_topic_score_codex":0.002077218,"about_ca_topic_score_gemma":0.005351161,"teacher_disagreement_score":0.006600406,"about_ca_system_score_codex":0.0014801247,"about_ca_system_score_gemma":0.0019777166,"threshold_uncertainty_score":0.02208054},"labels":[],"label_agreement":null},{"id":"W3087964189","doi":"10.1016/j.annonc.2020.08.1544","title":"1782MO Health-related quality of life (HRQoL) in KEYNOTE-604: Pembrolizumab (pembro) or placebo added to etoposide and platinum (EP) as first-line therapy for ES-SCLC","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; University of Toronto","funders":"","keywords":"Medicine; Placebo; Discontinuation; Quality of life (healthcare); Nausea; Clinical trial; Clinical endpoint; Pembrolizumab; Internal medicine; Cancer; Alternative medicine","score_opus":0.28409615093826407,"score_gpt":0.5052354451313433,"score_spread":0.22113929419307926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087964189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958026,0.0013865355,0.00006831399,0.000098522076,0.00008694825,0.00014654905,0.0009225687,0.000010937182,0.0014771111],"genre_scores_gemma":[0.9970469,0.00044295905,0.0001676829,0.00009843206,0.00004340241,0.00016649242,0.0009437188,0.0000031182367,0.0010873575],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99924374,0.00041590503,0.00006885657,0.00008031804,0.00006457116,0.00012664466],"domain_scores_gemma":[0.9995598,0.0001474766,0.00010115177,0.00003451014,0.000035036515,0.00012193438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00134937,0.00045128955,0.0011479985,0.00026172702,0.00021927472,0.0005460024,0.00029954806,0.0006447816,0.00759444],"category_scores_gemma":[0.0013385256,0.00025506405,0.0018191066,0.00027153594,0.00025266182,0.00072927115,0.00053882005,0.0015696753,0.0005587882],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91888344,0.009500462,0.017149977,0.0005540127,0.0020914243,0.000044476943,0.00008168711,0.00045452788,0.0074579003,0.00012603607,0.0011405877,0.042515423],"study_design_scores_gemma":[0.24332604,0.43925688,0.28967717,0.00026326848,0.0058980077,0.00022371119,0.00031618317,0.0014347606,0.0122828595,0.00027745726,0.0069728703,0.00007074046],"about_ca_topic_score_codex":0.0013117983,"about_ca_topic_score_gemma":0.0017462092,"teacher_disagreement_score":0.00759444,"about_ca_system_score_codex":0.0004175621,"about_ca_system_score_gemma":0.00059666054,"threshold_uncertainty_score":0.025405943},"labels":[],"label_agreement":null},{"id":"W3089280807","doi":"10.1016/j.annonc.2020.08.1546","title":"1785P Phase Ib expansion study of adavosertib plus olaparib in patients with extensive-stage or relapsed small cell lung cancer","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Neutropenia; Regimen; Gastroenterology; Febrile neutropenia; Olaparib; Phases of clinical research; Lung cancer; Oncology; Toxicity","score_opus":0.1250206933812882,"score_gpt":0.44095299222944834,"score_spread":0.3159322988481601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089280807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926724,0.001587999,0.00038612765,0.0004650538,0.00021449695,0.0010929537,0.0010148487,0.00006969988,0.0024964644],"genre_scores_gemma":[0.99006957,0.0012390186,0.0013445067,0.0008194819,0.00019092899,0.0010969102,0.0024333752,0.000030128329,0.0027760405],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99945205,0.00025079533,0.000022767188,0.000085911655,0.00005351379,0.0001349536],"domain_scores_gemma":[0.999509,0.00008267101,0.000056832017,0.00004746084,0.00003324328,0.00027083006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015939979,0.0014012341,0.0023430109,0.00046418916,0.00042716676,0.0011915949,0.0009177414,0.00079103344,0.004465977],"category_scores_gemma":[0.0008599087,0.0006015638,0.0016127796,0.00043098332,0.0012330255,0.0010234163,0.00045699693,0.0034568436,0.0012172712],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8371551,0.033403046,0.0047386484,0.0004900686,0.0012883432,0.00015457133,0.00018545553,0.0023095463,0.018003441,0.00035675065,0.003406329,0.09850872],"study_design_scores_gemma":[0.66756094,0.3163716,0.009079996,0.000030504687,0.00060749333,0.00013851598,0.000084461666,0.0009819837,0.0018243678,0.00023365403,0.0030585367,0.000027926175],"about_ca_topic_score_codex":0.0019845767,"about_ca_topic_score_gemma":0.0041343705,"teacher_disagreement_score":0.004465977,"about_ca_system_score_codex":0.0013963366,"about_ca_system_score_gemma":0.0020795807,"threshold_uncertainty_score":0.014940143},"labels":[],"label_agreement":null},{"id":"W3089522740","doi":"10.1016/j.jtho.2020.09.013","title":"American Radium Society Appropriate Use Criteria on Radiation Therapy for Extensive-Stage SCLC","year":2020,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Takeda Pharmaceutical Company; Varian Medical Systems; Genentech; RefleXion Medical; AstraZeneca","keywords":"Medicine; Radiation therapy; Prophylactic cranial irradiation; Chemoimmunotherapy; Medical physics; Clinical trial; Randomized controlled trial; Oncology; Radiology; Surgery; Internal medicine; Immunotherapy; Cancer","score_opus":0.09826513809280533,"score_gpt":0.49856045829038376,"score_spread":0.4002953201975784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089522740","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75713307,0.021774912,0.0064053177,0.0049145194,0.0013136787,0.0018409651,0.028586231,0.00026898482,0.17776228],"genre_scores_gemma":[0.97049564,0.0033659493,0.0046602823,0.0011433269,0.00042450303,0.00096852746,0.01142578,0.00011801836,0.007398076],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984964,0.00039280424,0.00035653292,0.000075659664,0.00043433378,0.00024425756],"domain_scores_gemma":[0.9965065,0.0010970361,0.00094137416,0.00020107072,0.000801435,0.0004525127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016741826,0.00045707278,0.0007733057,0.0034356543,0.0009805392,0.00083183695,0.00070329115,0.00077508483,0.009748073],"category_scores_gemma":[0.0063922293,0.00016481035,0.0012021832,0.0031583328,0.0003815244,0.00059238996,0.0008088586,0.0007034839,0.0007948133],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028639908,0.00027779117,0.890976,0.0009754601,0.0003781404,0.0029722755,0.0008015319,0.0018781249,0.005809435,0.0036231473,0.03599669,0.053447418],"study_design_scores_gemma":[0.00016813324,0.0006531262,0.90280735,0.00067181303,0.00035636383,0.0049466738,0.00071856764,0.0023977957,0.0017905791,0.0024563544,0.082987115,0.00004607035],"about_ca_topic_score_codex":0.007989563,"about_ca_topic_score_gemma":0.019969875,"teacher_disagreement_score":0.009748073,"about_ca_system_score_codex":0.0008728956,"about_ca_system_score_gemma":0.002596038,"threshold_uncertainty_score":0.032610536},"labels":[],"label_agreement":null},{"id":"W3092781265","doi":"10.1186/s13019-020-01353-2","title":"Elevated preoperative CEA is associated with subclinical nodal involvement and worse survival in stage I non-small cell lung cancer: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Journal of Cardiothoracic Surgery","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"Medicine; Stage (stratigraphy); Lung cancer; Internal medicine; Oncology; Cardiothoracic surgery; Adenocarcinoma; Subclinical infection; Meta-analysis; Lymph node; Disease; Cancer; Surgery","score_opus":0.12651755555120447,"score_gpt":0.42197121808523586,"score_spread":0.2954536625340314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092781265","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0075041475,0.990936,0.00024608691,0.00016045623,0.00009050063,0.00016557996,0.0006749644,0.000016008806,0.00020627581],"genre_scores_gemma":[0.17593531,0.819614,0.0012095141,0.0006684828,0.0002447176,0.0007927638,0.0011496426,0.000024262536,0.00036128983],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99548846,0.0015987926,0.0015523186,0.0006118324,0.0005394919,0.00020908928],"domain_scores_gemma":[0.9826713,0.012530628,0.0028591852,0.00040940064,0.0012881275,0.0002413053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006469724,0.0019227023,0.014280854,0.00629577,0.00065842783,0.002694023,0.0018411005,0.0019474613,0.0032538318],"category_scores_gemma":[0.019647727,0.0012519045,0.025737414,0.008712562,0.00058565545,0.0013388768,0.0011662985,0.0011751238,0.00030985422],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014199328,0.000035639703,0.014051566,0.5191505,0.4534991,0.0002780791,0.0001404512,0.00044197147,0.00027179378,0.000095127165,0.0007386046,0.009877276],"study_design_scores_gemma":[0.00022350335,0.0001785578,0.010155925,0.033027228,0.9541994,0.0001647443,0.00006822535,0.0001712307,0.0000857952,0.000100523765,0.0015966714,0.000028218155],"about_ca_topic_score_codex":0.007333587,"about_ca_topic_score_gemma":0.018451946,"teacher_disagreement_score":0.014280854,"about_ca_system_score_codex":0.0018627961,"about_ca_system_score_gemma":0.0034993323,"threshold_uncertainty_score":0.03421557},"labels":[],"label_agreement":null},{"id":"W3093884247","doi":"10.1016/j.ijrobp.2020.07.1248","title":"Pattern of Practice and Comparison of Thoracic Radiotherapy for the Radical Treatment of Limited-Stage Small Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Radiation therapy; Stage (stratigraphy); Lung cancer; Medicine; Lung; Oncology; Radiology; Internal medicine; Biology","score_opus":0.059302165904571595,"score_gpt":0.45394378073849234,"score_spread":0.39464161483392074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093884247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890143,0.0048637176,0.0005917106,0.0010733159,0.000035905632,0.000040972525,0.00093174726,0.000030137606,0.003418038],"genre_scores_gemma":[0.9983342,0.00069433666,0.0002990822,0.000086452186,0.00001496401,0.00001610979,0.00025727332,0.000014915185,0.0002826775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673754,0.0010497983,0.0006508134,0.0005665814,0.0006762269,0.00031913057],"domain_scores_gemma":[0.9809955,0.006556283,0.008324662,0.0006208033,0.0024197516,0.0010830115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016241518,0.00009668905,0.00033385627,0.0017690993,0.00033047487,0.0008621242,0.00064903166,0.00070809975,0.0029349476],"category_scores_gemma":[0.018830389,0.0001507891,0.00046427213,0.0038503287,0.0004151887,0.000641171,0.000768264,0.00050671055,0.00033514047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006422753,0.00006637705,0.9671059,0.00016980116,0.00011546164,0.00012415515,0.0007696958,0.00041834966,0.0007058648,0.0003883306,0.0006940911,0.028799795],"study_design_scores_gemma":[0.00001907575,0.00022178338,0.9955852,0.00007520088,0.000036923488,0.00042881386,0.0013392143,0.00059677527,0.00015580187,0.00014473234,0.0013850562,0.000011376309],"about_ca_topic_score_codex":0.009763055,"about_ca_topic_score_gemma":0.016909657,"teacher_disagreement_score":0.009763055,"about_ca_system_score_codex":0.0017914557,"about_ca_system_score_gemma":0.0020314336,"threshold_uncertainty_score":0.019412458},"labels":[],"label_agreement":null},{"id":"W3093993098","doi":"10.1016/j.ijrobp.2020.07.1305","title":"Limited-Stage Small Cell Lung Cancer: Outcomes Associated with Prophylactic Cranial Irradiation Over a 20-year Period at a Single Institution","year":2020,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Western University; Kingston General Hospital; Princess Margaret Cancer Centre; McMaster University; Queen's University","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Surgery; Stage (stratigraphy); Proportional hazards model; Retrospective cohort study; Univariate analysis; Chemotherapy; Lung cancer; Internal medicine; Radiation therapy; Multivariate analysis","score_opus":0.03235396831466503,"score_gpt":0.3413911407597562,"score_spread":0.30903717244509116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093993098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99962604,0.00011400678,0.000017056334,0.000024094566,0.000002114354,0.0000030913893,0.00008623183,0.0000013312331,0.00012596916],"genre_scores_gemma":[0.99971384,0.000055201428,0.000014508999,0.000009399536,0.0000048022553,0.0000020035911,0.00014813383,8.196212e-7,0.000051194464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938977,0.0000869589,0.000071801776,0.00012833787,0.00010205966,0.00022097086],"domain_scores_gemma":[0.9981048,0.00017306447,0.0010722666,0.0000794376,0.00017930998,0.0003911227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005764694,0.00023793818,0.00030928373,0.00089241826,0.0005075156,0.0007801288,0.0004329764,0.00043083608,0.00093008124],"category_scores_gemma":[0.0024990875,0.000167233,0.00064342003,0.0014302159,0.00042803763,0.00081733556,0.0010041627,0.0005120089,0.00015673318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053869054,0.00013756574,0.9961074,0.0000085455085,0.000057617613,0.00018835347,0.00010567376,0.000106165586,0.00027868076,0.00001040091,0.00007762346,0.002383233],"study_design_scores_gemma":[0.000009268261,0.00035852057,0.9986659,0.0000039314714,0.000042245014,0.000299567,0.000344619,0.00010094851,0.000081772276,0.000010462709,0.000077532146,0.00000521377],"about_ca_topic_score_codex":0.016188778,"about_ca_topic_score_gemma":0.01794871,"teacher_disagreement_score":0.016188778,"about_ca_system_score_codex":0.0013565258,"about_ca_system_score_gemma":0.0010633229,"threshold_uncertainty_score":0.03218907},"labels":[],"label_agreement":null},{"id":"W3094020491","doi":"10.1016/j.ijrobp.2020.07.2113","title":"Identifying Novel Epigenetic Radiosensitizers in Small Cell Lung Cancer Using a Custom EpiDrug CRISPR Screen","year":2020,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Institute of Cancer Research; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"Clonogenic assay; Medicine; Cancer research; CRISPR; Lung cancer; Epigenetics; Cancer; Radiation therapy; Gene knockdown; Oncology; Cell; Biology; Gene; Internal medicine; Genetics","score_opus":0.06677782092248206,"score_gpt":0.4060167710226977,"score_spread":0.3392389501002156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094020491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91311467,0.0023295113,0.06418568,0.00069601263,0.00025122662,0.0004993263,0.002955665,0.0026121854,0.013355645],"genre_scores_gemma":[0.95917284,0.0011185256,0.022984525,0.0003068249,0.000015047762,0.00015678602,0.0016561429,0.00017491828,0.014414365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99966,0.000023711327,0.000025401643,0.00008472425,0.00015323929,0.000052890395],"domain_scores_gemma":[0.9998709,0.00004058947,0.000027906366,0.00002377466,0.000017490609,0.00001933744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037606887,0.0004852328,0.000536874,0.00035322402,0.00026022093,0.00056429516,0.00057241507,0.0006239729,0.0034038597],"category_scores_gemma":[0.00032469205,0.00027870614,0.00048560573,0.00017766398,0.0003157116,0.00021109087,0.00045717822,0.00095042883,0.00069789804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060357015,0.00005770643,0.00026307054,0.00006506375,0.000021124255,0.00012514748,0.000016776816,0.00045108056,0.9923935,0.00036071645,0.00024036507,0.0059450655],"study_design_scores_gemma":[0.000032707187,0.0003529704,0.0014740189,0.000008282331,0.0000697905,0.00042215886,0.000022951186,0.0023265951,0.9855424,0.000099117315,0.009634199,0.000014771669],"about_ca_topic_score_codex":0.00076448685,"about_ca_topic_score_gemma":0.0026122113,"teacher_disagreement_score":0.0034038597,"about_ca_system_score_codex":0.0004397088,"about_ca_system_score_gemma":0.0003184765,"threshold_uncertainty_score":0.01138711},"labels":[],"label_agreement":null},{"id":"W3094035833","doi":"10.1016/j.ijrobp.2020.07.1318","title":"Role of Prophylactic Cranial Radiation in Extensive Stage Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","year":2020,"lang":"en","type":"review","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Meta-analysis; Hazard ratio; Randomized controlled trial; Confidence interval; Conventional PCI; Odds ratio; Cochrane Library; Oncology; Internal medicine; Study heterogeneity; Lung cancer; Random effects model; Relative risk; Surgery; Myocardial infarction","score_opus":0.06882513134694297,"score_gpt":0.4376369998979601,"score_spread":0.36881186855101716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094035833","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044189026,0.99462366,0.00028789113,0.0001034669,0.000100787685,0.00011295125,0.00021375326,0.000014976609,0.00012355644],"genre_scores_gemma":[0.16525306,0.8305384,0.0018634824,0.0010239463,0.00021223468,0.00031827917,0.0004837287,0.0000251216,0.00028169926],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99556965,0.0019531037,0.0012443794,0.00064583786,0.00040531292,0.00018179085],"domain_scores_gemma":[0.9911378,0.0066629467,0.001454219,0.00026504492,0.00033950608,0.00014045589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068325275,0.00222753,0.01380286,0.0022630729,0.00045584157,0.0023282066,0.00199751,0.0021889554,0.0038741136],"category_scores_gemma":[0.017953308,0.0011629288,0.022682965,0.0031534096,0.000730369,0.0016243289,0.0012150117,0.0022914796,0.000260274],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069133444,0.000053630578,0.0037256905,0.4037182,0.5621928,0.000105369516,0.00008958677,0.0006100967,0.00040372164,0.00014134547,0.00075586356,0.021290319],"study_design_scores_gemma":[0.0022275017,0.0003570143,0.0034481967,0.017411597,0.97443956,0.00007410217,0.000052054518,0.00012698086,0.00011450024,0.0001995606,0.0015227954,0.000026199157],"about_ca_topic_score_codex":0.0053597614,"about_ca_topic_score_gemma":0.015463307,"teacher_disagreement_score":0.01380286,"about_ca_system_score_codex":0.0017951303,"about_ca_system_score_gemma":0.0023764262,"threshold_uncertainty_score":0.036134303},"labels":[],"label_agreement":null},{"id":"W3096564526","doi":"10.1016/j.cllc.2020.10.018","title":"Deep and Durable Response to Nivolumab and Temozolomide in Small-Cell Lung Cancer Associated With an Early Decrease in Myeloid-Derived Suppressor Cells","year":2020,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Ohio State University Press; Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Nivolumab; Medicine; Temozolomide; Lung cancer; Oncology; Biomarker; Myeloid; Clinical trial; Cancer research; Internal medicine; Cancer; Immunotherapy; Chemotherapy; Biology","score_opus":0.03676326828345943,"score_gpt":0.3743898209165638,"score_spread":0.33762655263310437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096564526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981511,0.0005478431,0.00026697209,0.00009189795,0.000014320907,0.000025944575,0.00010013726,0.000015937503,0.0007859362],"genre_scores_gemma":[0.9989667,0.00010758102,0.00016117543,0.00005341838,0.0000092727505,0.000008786626,0.00022028432,0.0000034670131,0.00046930587],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998627,0.00003379987,0.000010712589,0.000019619072,0.000028744895,0.000044419136],"domain_scores_gemma":[0.99971014,0.000086140855,0.00005469747,0.000040403218,0.000030155088,0.000078381454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044435752,0.00015317222,0.00030018218,0.000164346,0.00011984734,0.00031859768,0.00012493836,0.00019906768,0.0010119564],"category_scores_gemma":[0.00044045548,0.00007825217,0.00023237201,0.00015276106,0.00021431543,0.00017069593,0.00013629576,0.0006705422,0.00017843253],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0233024,0.0026574086,0.15752243,0.00015526713,0.00026282153,0.0018335244,0.00015051245,0.0005617638,0.69194186,0.0004483261,0.0015358625,0.1196277],"study_design_scores_gemma":[0.0007472457,0.02097835,0.89078957,0.000012449682,0.00020671001,0.004964614,0.00020528103,0.0014196231,0.074234,0.00032476627,0.0061011277,0.000016246073],"about_ca_topic_score_codex":0.00046747882,"about_ca_topic_score_gemma":0.00097419653,"teacher_disagreement_score":0.0010119564,"about_ca_system_score_codex":0.00023575316,"about_ca_system_score_gemma":0.00026934274,"threshold_uncertainty_score":0.003385365},"labels":[],"label_agreement":null},{"id":"W3096676736","doi":"10.1016/j.jtho.2020.10.020","title":"American Radium Society Appropriate Use Criteria: Radiation Therapy for Limited-Stage SCLC 2020","year":2020,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Takeda Pharmaceuticals U.S.A.; RefleXion Medical; American Radium Society; Varian Medical Systems; GlaxoSmithKline; Genentech; Philips; Aptitude Health; Australian Carbon Innovation; Bristol-Myers Squibb; AstraZeneca; Boehringer Ingelheim","keywords":"Medicine; Radium; Stage (stratigraphy); Radiation therapy; Radiation oncology; Medical physics; Oncology; Internal medicine; Radiochemistry","score_opus":0.0771952621113736,"score_gpt":0.47788536030754053,"score_spread":0.4006900981961669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096676736","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48289815,0.04250809,0.028354537,0.028821483,0.004961548,0.0064261267,0.070727795,0.001120949,0.3341813],"genre_scores_gemma":[0.9016648,0.005565823,0.029012462,0.00665589,0.0013466428,0.003842167,0.030954575,0.00046514726,0.020492623],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99818724,0.0004960743,0.0005475681,0.00007864534,0.00046837993,0.00022202251],"domain_scores_gemma":[0.9958941,0.0011859677,0.0010508363,0.00019522136,0.0010776445,0.00059635617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020863356,0.0005367284,0.0009995159,0.003307059,0.0011092045,0.0010773055,0.00088615896,0.0012808132,0.015586712],"category_scores_gemma":[0.011003235,0.000196535,0.0013559673,0.003099299,0.00042949474,0.00073904736,0.0009254805,0.0010611103,0.0019171861],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060808198,0.0005545921,0.5741447,0.0030824852,0.000481302,0.005796712,0.0011673715,0.003767042,0.010103631,0.009254753,0.22266445,0.16290209],"study_design_scores_gemma":[0.00050432817,0.000953521,0.6603359,0.0020685866,0.0005319201,0.01014031,0.0009995345,0.0065077036,0.0036244094,0.0070567224,0.30717525,0.00010177168],"about_ca_topic_score_codex":0.009290686,"about_ca_topic_score_gemma":0.024158597,"teacher_disagreement_score":0.015586712,"about_ca_system_score_codex":0.0010177837,"about_ca_system_score_gemma":0.0038089282,"threshold_uncertainty_score":0.05214274},"labels":[],"label_agreement":null},{"id":"W3103821276","doi":"10.1101/2020.11.12.368522","title":"Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer","year":2020,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Alberta Children's Hospital; University of Calgary; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Alberta Innovates; Japanese Respiratory Society; Terry Fox Research Institute; Michael Smith Health Research BC; British Columbia Lung Association; Government of Canada; Alberta Health Services; Eli Lilly and Company","keywords":"MAPK/ERK pathway; Cancer research; Chromatin; Biology; Neuroendocrine differentiation; KRAS; Lineage (genetic); Kinase; Downregulation and upregulation; Cell biology; Cancer; Genetics; Mutation; Gene","score_opus":0.018637511071564652,"score_gpt":0.27873149613732234,"score_spread":0.2600939850657577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103821276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9671705,0.0034510342,0.016362883,0.00073290704,0.00014366418,0.00003947854,0.0011941409,0.0004959192,0.010409579],"genre_scores_gemma":[0.98828006,0.0010221554,0.0031351554,0.00008048049,0.000025594638,0.000019889223,0.001035982,0.000044358057,0.006356375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999324,0.0000084999165,0.0000033240983,0.00001790118,0.000023843791,0.000014063626],"domain_scores_gemma":[0.9999502,0.000009649896,0.00001054243,0.000009937312,0.0000066042976,0.000013174155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012667058,0.0001813102,0.00013577042,0.00013727843,0.00014755805,0.00028828278,0.00010007536,0.00020288149,0.0026893932],"category_scores_gemma":[0.000119410215,0.00009290456,0.00020290897,0.00009679819,0.00016632052,0.00016987872,0.0002595289,0.00049466756,0.0008692341],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008603199,0.000024081271,0.0014028181,0.00007121462,0.00000922644,0.00014901588,0.000024676969,0.0003496126,0.9887994,0.001423583,0.0006004132,0.0070599304],"study_design_scores_gemma":[0.000034819408,0.00013537245,0.033338334,0.000016916707,0.000019689163,0.0007825168,0.00007808931,0.010483878,0.9329594,0.0022969767,0.01984351,0.00001060687],"about_ca_topic_score_codex":0.00027167553,"about_ca_topic_score_gemma":0.0005567935,"teacher_disagreement_score":0.0026893932,"about_ca_system_score_codex":0.0002067059,"about_ca_system_score_gemma":0.00017165141,"threshold_uncertainty_score":0.008996904},"labels":[],"label_agreement":null},{"id":"W3105254545","doi":"10.1158/1078-0432.ccr-20-2845","title":"AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Digital Payment Technologies (Canada)","funders":"Amgen","keywords":"Cancer research; Medicine; Cell; Lung cancer; Ligand (biochemistry); Small molecule; T cell; Oncology; Internal medicine; Receptor; Chemistry; Immunology; Immune system","score_opus":0.307856614907692,"score_gpt":0.5039285427276453,"score_spread":0.1960719278199533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105254545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945379,0.0018276358,0.001568558,0.00006711586,0.000018079209,0.00006189258,0.00024020016,0.00009323635,0.0015854633],"genre_scores_gemma":[0.99734133,0.00056419946,0.0008261312,0.000045585548,0.0000074714458,0.000041825668,0.00025362513,0.0000075502226,0.000912285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998503,0.000023134713,0.000010247705,0.000021643906,0.000056341367,0.00003833393],"domain_scores_gemma":[0.99992645,0.00001272076,0.000020629412,0.000008062015,0.000009589432,0.000022584103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017442039,0.00039354034,0.00030318173,0.00028048496,0.00010616249,0.0002781052,0.00020462979,0.00031728458,0.0009980595],"category_scores_gemma":[0.000097478456,0.00009029675,0.00022215779,0.0001539606,0.00020653963,0.0002198863,0.000114417795,0.0005666164,0.0003541111],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003190587,0.00027227603,0.0004508379,0.0000670509,0.000018703631,0.000041328323,0.000019587276,0.0005883358,0.9921302,0.00007915277,0.00012020789,0.0058931937],"study_design_scores_gemma":[0.00009515287,0.00811886,0.0051706205,0.000009663199,0.000044787263,0.00029619306,0.000025558275,0.0015359649,0.9824624,0.000042380685,0.0021874562,0.000011082517],"about_ca_topic_score_codex":0.00071032235,"about_ca_topic_score_gemma":0.001772573,"teacher_disagreement_score":0.0009980595,"about_ca_system_score_codex":0.0003926245,"about_ca_system_score_gemma":0.00027120503,"threshold_uncertainty_score":0.0033388138},"labels":[],"label_agreement":null},{"id":"W3106497006","doi":"10.3389/fonc.2020.01783","title":"Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer","year":2020,"lang":"en","type":"editorial","venue":"Frontiers in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Lung cancer; Biology; Cancer; Medicine; Cancer research; Bioinformatics; Computational biology; Intensive care medicine; Oncology; Internal medicine","score_opus":0.01813735911018518,"score_gpt":0.3552819961654386,"score_spread":0.33714463705525344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106497006","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023776001,0.0102862865,0.00010397309,0.026988572,0.96069485,0.000017139133,0.00009066489,0.000062738516,0.0017318547],"genre_scores_gemma":[0.00023293073,0.00835327,0.0000949121,0.01658161,0.9673574,0.000018681247,0.000071641494,0.000032409822,0.0072571654],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963664,0.00073339016,0.00052009214,0.00038362836,0.0017214047,0.00027503207],"domain_scores_gemma":[0.9831225,0.0058257487,0.0012048039,0.000325022,0.0067775594,0.0027443985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005554648,0.0038788917,0.0039107297,0.0044392413,0.0025637385,0.006515007,0.003955828,0.009976757,0.02492859],"category_scores_gemma":[0.01852232,0.0010309293,0.0025565093,0.0016172848,0.0016807842,0.004899762,0.00155037,0.014747344,0.025975352],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029840865,0.000007774209,0.000013474301,0.00016721728,0.000010426153,0.000046541456,0.0000044781805,0.000013843003,0.000026152418,0.000113100534,0.99364233,0.0059247026],"study_design_scores_gemma":[0.00007513332,0.00003869066,0.00017965576,0.00060280133,0.000058514164,0.00033915468,0.000027626564,0.00008889399,0.00009468521,0.0007348415,0.99774134,0.000018677742],"about_ca_topic_score_codex":0.0012616226,"about_ca_topic_score_gemma":0.00384861,"teacher_disagreement_score":0.02492859,"about_ca_system_score_codex":0.0026659197,"about_ca_system_score_gemma":0.0027302618,"threshold_uncertainty_score":0.08339447},"labels":[],"label_agreement":null},{"id":"W3107273701","doi":"10.1016/j.jtcvs.2020.10.148","title":"Predictors of survival following surgical resection of limited-stage small cell lung cancer","year":2020,"lang":"en","type":"article","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University Health Network","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; McGill University","keywords":"Medicine; Hazard ratio; Conventional PCI; Proportional hazards model; Univariate analysis; Confidence interval; Surgery; Internal medicine; Stage (stratigraphy); Lung cancer; Oncology; Cancer; Multivariate analysis","score_opus":0.04058821291245301,"score_gpt":0.3299596399808089,"score_spread":0.2893714270683559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107273701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990133,0.00040330229,0.000029794872,0.000068265035,0.000010781811,0.0000017611217,0.0001531574,0.0000015344539,0.00031809424],"genre_scores_gemma":[0.99958855,0.00009842873,0.0000110084975,0.000010581783,0.000012866814,0.0000013951092,0.00017644346,4.7840126e-7,0.00010021808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997148,0.00008863233,0.000032890843,0.000037757825,0.000035013283,0.00009088357],"domain_scores_gemma":[0.9974431,0.00088800874,0.0007288876,0.0001238469,0.00021110187,0.0006050775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000535026,0.00017069724,0.00022674222,0.00047015815,0.00036349357,0.00043721707,0.00027153027,0.0003491361,0.0015104567],"category_scores_gemma":[0.003364628,0.000120310266,0.0004679075,0.0006551776,0.00037526415,0.0004429473,0.0003636589,0.0005604236,0.00014826961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003015412,0.000032182714,0.99824667,0.000007046765,0.000029734892,0.000060254606,0.00002628082,0.000063426996,0.000107708925,0.000013394797,0.0000749411,0.0010368407],"study_design_scores_gemma":[0.0000049133814,0.00012891795,0.9992238,0.0000039684874,0.000032335083,0.00010680918,0.00018604363,0.00012438586,0.000046479738,0.000033237724,0.000106494794,0.000002499976],"about_ca_topic_score_codex":0.005288957,"about_ca_topic_score_gemma":0.0076883784,"teacher_disagreement_score":0.005288957,"about_ca_system_score_codex":0.00030873105,"about_ca_system_score_gemma":0.0005658754,"threshold_uncertainty_score":0.0105163455},"labels":[],"label_agreement":null},{"id":"W3116330208","doi":"10.1111/cts.12928","title":"Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"AbbVie","keywords":"QT interval; Medicine; QRS complex; Proarrhythmia; Cardiology; Internal medicine; Confidence interval; Prolongation; Lung cancer; Heart rate; Repolarization; Blood pressure","score_opus":0.026305087981786986,"score_gpt":0.34854388861810387,"score_spread":0.3222388006363169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116330208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962534,0.0025629601,0.000118256554,0.000081448175,0.0000149643265,0.00004235481,0.000047632468,0.000010127948,0.00086892594],"genre_scores_gemma":[0.9991549,0.00043598356,0.00006280711,0.0001084597,0.000020297375,0.0000127525445,0.000071184026,0.0000014594192,0.00013215182],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99983466,0.000078707184,0.000016322128,0.00001851993,0.000029827217,0.000021983396],"domain_scores_gemma":[0.999671,0.00012483713,0.00009185164,0.000019046836,0.00002629895,0.00006696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038920666,0.00017422574,0.0005976694,0.00010105532,0.00012361657,0.0002105339,0.00011495759,0.00021309366,0.0004224815],"category_scores_gemma":[0.0010260888,0.0000654677,0.00031793953,0.00013982874,0.00012487239,0.0001784509,0.00010099983,0.00051229744,0.00008974085],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09579681,0.0054463195,0.34043568,0.00066194404,0.0017417381,0.0035300716,0.0007166357,0.003441412,0.16814883,0.00019442594,0.0024113932,0.37747476],"study_design_scores_gemma":[0.0067765294,0.14636597,0.82117707,0.00006826018,0.000913704,0.004113207,0.00026335183,0.002921506,0.01099114,0.00021263277,0.0061608097,0.000035738107],"about_ca_topic_score_codex":0.0002392072,"about_ca_topic_score_gemma":0.0006332006,"teacher_disagreement_score":0.0005976694,"about_ca_system_score_codex":0.0001512812,"about_ca_system_score_gemma":0.00013032452,"threshold_uncertainty_score":0.0020583272},"labels":[],"label_agreement":null},{"id":"W3118711697","doi":"10.1200/jco.20.01055","title":"Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":824,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Atezolizumab; Medicine; Internal medicine; Lung cancer; Hazard ratio; Placebo; Carboplatin; Oncology; Etoposide; Interim analysis; Gastroenterology; Surgery; Clinical trial; Cancer; Chemotherapy; Pembrolizumab; Immunotherapy; Confidence interval; Pathology; Cisplatin","score_opus":0.05157558275665592,"score_gpt":0.4224178008924977,"score_spread":0.3708422181358418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118711697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777836,0.0008657066,0.00015875051,0.00005450214,0.00001554799,0.0000845292,0.00077469926,0.000008767985,0.00025901335],"genre_scores_gemma":[0.9977581,0.00012633439,0.00013740081,0.00007497181,0.000028578826,0.00007885632,0.0015536742,0.000002890334,0.00023914159],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99948835,0.0001696188,0.000063001826,0.00015021907,0.00005647377,0.000072322524],"domain_scores_gemma":[0.99936754,0.0001488962,0.00016286701,0.000091820075,0.000038676226,0.00019020156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013351808,0.00055197516,0.0014178575,0.0005137775,0.00022942465,0.0006419374,0.00045077852,0.00060072355,0.001385431],"category_scores_gemma":[0.0010394829,0.00027181854,0.002484047,0.000405759,0.00024231554,0.0004901007,0.00046781852,0.0007442126,0.0001636879],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48756543,0.0015312018,0.438714,0.0005110147,0.010895542,0.00035489388,0.00018784459,0.0023457927,0.013152629,0.00010480283,0.001649668,0.042987194],"study_design_scores_gemma":[0.036396686,0.0379191,0.90336186,0.000057601497,0.010772898,0.0008705322,0.00017062837,0.004446438,0.002723005,0.000367777,0.0028389695,0.00007455524],"about_ca_topic_score_codex":0.0005741516,"about_ca_topic_score_gemma":0.0017581016,"teacher_disagreement_score":0.0014178575,"about_ca_system_score_codex":0.00045607195,"about_ca_system_score_gemma":0.0005039102,"threshold_uncertainty_score":0.0070611835},"labels":[],"label_agreement":null},{"id":"W3118763175","doi":"10.3390/curroncol28010036","title":"Real World Analysis of Small Cell Lung Cancer Patients: Prognostic Factors and Treatment Outcomes","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Oncology; Internal medicine; Cancer; Intensive care medicine; Bioinformatics","score_opus":0.1051696614156578,"score_gpt":0.4555679916574566,"score_spread":0.3503983302417988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118763175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984775,0.00015131033,0.00015975781,0.00007403471,0.0000058593505,0.000007085158,0.00094171806,0.000002039998,0.00018074279],"genre_scores_gemma":[0.99873704,0.000056241293,0.00009846764,0.00003443812,0.000011025396,0.000009040764,0.0010141338,0.0000011122976,0.000038434075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921715,0.00030751966,0.00009104371,0.00017461422,0.00010297446,0.00010680215],"domain_scores_gemma":[0.9972656,0.00038664215,0.0016816582,0.00021382452,0.00016567102,0.000286639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008046627,0.00020487791,0.00031208337,0.0005910686,0.00033198812,0.00070021313,0.0004065624,0.0004010117,0.0010977037],"category_scores_gemma":[0.0026498842,0.000196724,0.0004051462,0.0010597439,0.000273484,0.0005969941,0.0005306919,0.0005588127,0.00018227291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038485952,0.000024961191,0.9993529,0.0000053234266,0.00003578961,0.000022911685,0.000020617143,0.000048511025,0.000042358537,0.000014583984,0.00007212965,0.00032154916],"study_design_scores_gemma":[0.000009625003,0.00008508674,0.9983222,0.0000066072103,0.00003243872,0.00020635489,0.00023259412,0.000703806,0.00005129946,0.00006164282,0.00028275876,0.0000055129603],"about_ca_topic_score_codex":0.0052413247,"about_ca_topic_score_gemma":0.0072779753,"teacher_disagreement_score":0.0052413247,"about_ca_system_score_codex":0.00052511564,"about_ca_system_score_gemma":0.000494051,"threshold_uncertainty_score":0.010421634},"labels":[],"label_agreement":null},{"id":"W3126845260","doi":"10.1016/j.lungcan.2021.01.025","title":"Safety of G-CSF with concurrent chemo-radiotherapy in limited-stage small cell lung cancer - Secondary analysis of the randomised phase 3 CONVERT trial","year":2021,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Neutropenia; Internal medicine; Regimen; Incidence (geometry); Febrile neutropenia; Granulocyte colony-stimulating factor; Gastroenterology; Randomized controlled trial; Radiation therapy; Lung cancer; Chemotherapy; Surgery; Oncology","score_opus":0.01929891310890295,"score_gpt":0.36019842857951406,"score_spread":0.3408995154706111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126845260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98543036,0.0062299254,0.0007362924,0.00068231777,0.0004861743,0.0023836591,0.0018556414,0.00010937363,0.0020861863],"genre_scores_gemma":[0.9921928,0.0012168864,0.000775808,0.000585207,0.00031264988,0.0019324099,0.0013933409,0.00003404663,0.0015569426],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99744093,0.0018225027,0.000094844465,0.000287581,0.00012927281,0.00022484254],"domain_scores_gemma":[0.99758244,0.0009078578,0.00055562507,0.00031409317,0.00017067735,0.00046934147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034892508,0.0017556912,0.0036989334,0.00044169207,0.0005171714,0.0014949541,0.0012371141,0.002024446,0.0054582492],"category_scores_gemma":[0.0045263106,0.00050211675,0.0045370683,0.00066183304,0.0016307032,0.0012138285,0.0007265,0.00393022,0.0008632742],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99156296,0.0008051718,0.00044510418,0.00026740198,0.0008113788,0.000014128117,0.000016743763,0.00026241984,0.0007200597,0.00005275731,0.00033364465,0.0047082254],"study_design_scores_gemma":[0.9300114,0.06307186,0.0036852723,0.0000634218,0.001231522,0.0000460439,0.0000312646,0.0003660808,0.00053639064,0.00031727672,0.0006237839,0.000015732392],"about_ca_topic_score_codex":0.0018653787,"about_ca_topic_score_gemma":0.0026445754,"teacher_disagreement_score":0.0054582492,"about_ca_system_score_codex":0.0014833658,"about_ca_system_score_gemma":0.0020268008,"threshold_uncertainty_score":0.01845318},"labels":[],"label_agreement":null},{"id":"W3127599355","doi":"10.1016/j.annonc.2021.01.075","title":"Combined small-cell lung carcinoma revealed to be an intratumoural metastasis by genetic analysis","year":2021,"lang":"en","type":"letter","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill Genome Centre; McGill University Health Centre; McGill University","funders":"Canadian Institutes of Health Research; Pfizer Canada; Amgen Canada; Bristol-Myers Squibb Canada; National Institutes of Health; Merck Canada; Canada Foundation for Innovation; Advanced Accelerator Applications; Clovis Oncology; Fondation de l'Hôpital Général de Montréal; McMaster University; GlaxoSmithKline; Cancer Research Society; American Surgical Association Foundation; Leon Lowenstein Foundation; March of Dimes Foundation; F. Hoffmann-La Roche; Roche; Samsung; Genentech; Merck; California Institute for Regenerative Medicine; Fonds de Recherche du Québec - Santé; L'Oreal USA; AstraZeneca; Prostate Cancer Foundation; Amgen","keywords":"Medicine; Adenocarcinoma; Carcinoma; Small-cell carcinoma; Large cell; Lung; Pathology; Small Cell Lung Carcinoma; Metastasis; Oncology; Internal medicine; Cancer","score_opus":0.1112573168191713,"score_gpt":0.406147336166251,"score_spread":0.2948900193470797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127599355","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23797639,0.006207323,0.0012466897,0.6671482,0.015460727,0.0001976161,0.00071433623,0.00015446584,0.070894204],"genre_scores_gemma":[0.78684604,0.0059700566,0.0018559445,0.13914344,0.02979699,0.00011507474,0.00039217158,0.0000654257,0.03581498],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993529,0.00018272373,0.00006111648,0.00009747552,0.00015002805,0.00015577626],"domain_scores_gemma":[0.9979399,0.0010130282,0.00015374154,0.00012710106,0.00027474255,0.00049163616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006265208,0.0006877889,0.00065354706,0.0011965187,0.001653432,0.0010825435,0.0008505349,0.009249576,0.003961732],"category_scores_gemma":[0.004098934,0.00046189528,0.00067516783,0.00075809984,0.0010420261,0.00093487266,0.00048116723,0.0048162644,0.0013631482],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044172024,0.00022312727,0.04934929,0.00011415111,0.00007254018,0.8472303,0.00045414898,0.00021240741,0.0045693615,0.0025699888,0.08403739,0.010725509],"study_design_scores_gemma":[0.00027843894,0.0005559129,0.06033284,0.00024976963,0.00028804157,0.79878175,0.0016353423,0.0026979959,0.004207656,0.004732965,0.12615976,0.00007952805],"about_ca_topic_score_codex":0.0030943705,"about_ca_topic_score_gemma":0.004219908,"teacher_disagreement_score":0.009249576,"about_ca_system_score_codex":0.0017516655,"about_ca_system_score_gemma":0.0011312449,"threshold_uncertainty_score":0.013253331},"labels":[],"label_agreement":null},{"id":"W3128084713","doi":"10.1016/j.actbio.2021.02.001","title":"Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models","year":2021,"lang":"en","type":"article","venue":"Acta Biomaterialia","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; Canadian Mennonite University","keywords":"Etoposide; Cisplatin; Prodrug; Chemoradiotherapy; Drug delivery; Chemotherapy; Regimen; Pharmacology; Combination chemotherapy; Doxorubicin; Combination therapy; Medicine; Cancer research; Materials science; Nanotechnology; Internal medicine","score_opus":0.01600420946452221,"score_gpt":0.3072976037732291,"score_spread":0.29129339430870693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128084713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99063605,0.0019260606,0.0050976914,0.00014311144,0.0001239967,0.00006611656,0.00021892281,0.00013579622,0.0016522766],"genre_scores_gemma":[0.9924561,0.00078976253,0.0034350555,0.00003899087,0.000013017592,0.000062764964,0.00016231717,0.000027918904,0.0030142227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997855,0.000031694348,0.00001560627,0.000060941045,0.000059830025,0.00004641751],"domain_scores_gemma":[0.99992657,0.000013319959,0.000016079706,0.000010080028,0.00001553532,0.000018488348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001814662,0.000332655,0.00045076117,0.00026866235,0.00015043696,0.00031910164,0.00027864316,0.00050134986,0.0009039944],"category_scores_gemma":[0.00012398665,0.00020776896,0.00031899003,0.00017464506,0.00021471365,0.0003725077,0.00020085952,0.00061985845,0.00026087326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003142225,0.00010180493,0.00005998357,0.00005006555,0.000010638001,0.00002581887,0.00001256268,0.00022691512,0.9974137,0.00006974233,0.0000990472,0.0016155302],"study_design_scores_gemma":[0.00001547108,0.00031298332,0.00039221387,0.0000023664588,0.000025055755,0.00004293131,0.000007755118,0.0010672536,0.9972107,0.000014110982,0.00090564246,0.0000034958389],"about_ca_topic_score_codex":0.00081005646,"about_ca_topic_score_gemma":0.0013369853,"teacher_disagreement_score":0.0009039944,"about_ca_system_score_codex":0.00024245535,"about_ca_system_score_gemma":0.00028478337,"threshold_uncertainty_score":0.0030241609},"labels":[],"label_agreement":null},{"id":"W3132559292","doi":"10.1016/j.jtho.2021.02.009","title":"Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study","year":2021,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"Merck Sharp and Dohme; Ono Pharmaceutical; PharmaMar; Shionogi; Astellas Pharma; Daiichi-Sankyo; Cancer Research UK; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Amgen; Boehringer Ingelheim; Taiho Pharmaceutical; F. Hoffmann-La Roche; Chugai Pharmaceutical; Roche; Novartis; AbbVie; Merck; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Topotecan; Second line; Oncology; Internal medicine; Phase (matter); First line; Chemotherapy","score_opus":0.0525605755118861,"score_gpt":0.4658585770188332,"score_spread":0.4132980015069471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132559292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957801,0.0027580017,0.00011733882,0.00013230999,0.000034317043,0.00012800489,0.00039881104,0.000028131602,0.00062299904],"genre_scores_gemma":[0.99686205,0.0012428272,0.00023861851,0.00018481066,0.000056916815,0.00011032655,0.0007343396,0.000018412675,0.000551742],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993331,0.0003192365,0.000037901216,0.00010199842,0.000090468886,0.000117393625],"domain_scores_gemma":[0.9991203,0.0002455606,0.0002520594,0.00008436599,0.000044409993,0.00025337536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001716069,0.0008639288,0.0022433598,0.00041655582,0.00033597896,0.0014847302,0.0007631599,0.0008932486,0.0015018772],"category_scores_gemma":[0.0013588896,0.00031386502,0.0019554454,0.00049632776,0.00064230955,0.0011178821,0.0002822108,0.00241863,0.00038110785],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7613052,0.017828016,0.020116642,0.0007392483,0.0044226595,0.00015124629,0.0002760374,0.0041089426,0.028563866,0.00025641063,0.0020874823,0.16014422],"study_design_scores_gemma":[0.40544215,0.46545243,0.10450836,0.00012874232,0.0050474023,0.00064730673,0.0002182117,0.00409139,0.009134663,0.0005120626,0.0046811956,0.00013615508],"about_ca_topic_score_codex":0.0011885279,"about_ca_topic_score_gemma":0.0027613845,"teacher_disagreement_score":0.0022433598,"about_ca_system_score_codex":0.001166634,"about_ca_system_score_gemma":0.0009846602,"threshold_uncertainty_score":0.009075522},"labels":[],"label_agreement":null},{"id":"W3135737422","doi":"10.3390/curroncol28020106","title":"Comparative Efficacy and Safety of Immunotherapeutic Regimens with PD-1/PD-L1 Inhibitors for Previously Untreated Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Atezolizumab; Etoposide; Pembrolizumab; Internal medicine; Oncology; Irinotecan; Durvalumab; Lung cancer; Adverse effect; Cancer; Chemotherapy; Immunotherapy; Colorectal cancer","score_opus":0.26187099327505464,"score_gpt":0.4974725700530229,"score_spread":0.23560157677796828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135737422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013977509,0.98305017,0.0010101994,0.00026535516,0.00014359219,0.00024945266,0.00086079305,0.000025669715,0.0004172772],"genre_scores_gemma":[0.45910454,0.5336005,0.002930508,0.001077193,0.00027876897,0.00091462117,0.001674954,0.000037822385,0.00038106326],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9940362,0.0031201984,0.0013581543,0.0007394164,0.00059457304,0.00015148395],"domain_scores_gemma":[0.9893673,0.007894883,0.001633458,0.0003296186,0.0006283797,0.0001462876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010259399,0.0016728236,0.010871191,0.0039219777,0.00035154718,0.0018138981,0.001341084,0.001299878,0.0022332582],"category_scores_gemma":[0.01821374,0.00094989873,0.02931892,0.004334306,0.00045784545,0.0011988304,0.0009262357,0.0013953528,0.00020652721],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033203885,0.000038128386,0.005747354,0.1723193,0.8013459,0.000067735404,0.000051305786,0.0012093056,0.00030080887,0.00015084428,0.0005339307,0.014914968],"study_design_scores_gemma":[0.00067756453,0.00021734109,0.0036687823,0.006719103,0.9869156,0.00004811819,0.000017975635,0.00035894744,0.000089643545,0.0002126399,0.0010592132,0.000015117152],"about_ca_topic_score_codex":0.0048649185,"about_ca_topic_score_gemma":0.010788725,"teacher_disagreement_score":0.010871191,"about_ca_system_score_codex":0.0018330879,"about_ca_system_score_gemma":0.0018086882,"threshold_uncertainty_score":0.05425757},"labels":[],"label_agreement":null},{"id":"W3156560386","doi":"10.1158/1557-3265.radsci21-po-086","title":"Abstract PO-086: Selective radiosensitization in preclinical models of HPV-negative squamous cell carcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Radioresistance; Cancer research; Clonogenic assay; Cell cycle; Radiosensitivity; Medicine; Cancer; Viability assay; Flow cytometry; Radiation therapy; Cell culture; Oncology; Pharmacology; Biology; Immunology; Internal medicine","score_opus":0.25444523328433466,"score_gpt":0.5329115100054382,"score_spread":0.2784662767211036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156560386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737627,0.00268015,0.01061579,0.00047198206,0.0002925267,0.0007277227,0.0037191666,0.00083876355,0.0068912706],"genre_scores_gemma":[0.96631825,0.002207129,0.0125576155,0.00017890955,0.00003931321,0.0011658728,0.0035472726,0.00014889636,0.013836661],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995883,0.00007503008,0.000046235542,0.00008945991,0.00012102655,0.00007995835],"domain_scores_gemma":[0.9997825,0.000028424123,0.000042050175,0.00004268289,0.00004585249,0.000058388738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005486562,0.00084339065,0.00059848075,0.0007716303,0.00037294847,0.00042020893,0.0006592118,0.0006381341,0.004773842],"category_scores_gemma":[0.00018878054,0.00034849244,0.0005671892,0.00036677168,0.0004148971,0.00045210592,0.00022949818,0.0019864182,0.00089693844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084614917,0.0012946797,0.00022576278,0.00018024303,0.000020659161,0.000047163812,0.000038942537,0.00026844276,0.9920779,0.00020839958,0.00056127046,0.0042303503],"study_design_scores_gemma":[0.0001015208,0.004599005,0.0015091398,0.000013872417,0.00003489165,0.00012520554,0.00002968129,0.00084805884,0.98935485,0.000064819935,0.0033112427,0.000007642519],"about_ca_topic_score_codex":0.0010554092,"about_ca_topic_score_gemma":0.0019059977,"teacher_disagreement_score":0.004773842,"about_ca_system_score_codex":0.00047986934,"about_ca_system_score_gemma":0.00068389036,"threshold_uncertainty_score":0.01597011},"labels":[],"label_agreement":null},{"id":"W3159120388","doi":"10.1158/1078-0432.ccr-20-4259","title":"Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Veliparib; Medicine; Carboplatin; Internal medicine; Hazard ratio; Etoposide; Placebo; Oncology; Lung cancer; Chemotherapy; Clinical endpoint; Surgery; Confidence interval; Clinical trial; Pathology; Cisplatin; Biology","score_opus":0.11156764103209474,"score_gpt":0.509988089102433,"score_spread":0.3984204480703383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159120388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99177414,0.002885946,0.00045045477,0.0003751342,0.00017531654,0.0031021873,0.0004257465,0.000047869537,0.0007632206],"genre_scores_gemma":[0.98949975,0.002599267,0.0013294085,0.0008966565,0.00041534132,0.0032029531,0.0008444752,0.00001653629,0.001195623],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991228,0.0005291294,0.00005286611,0.00013079934,0.00006428809,0.00010006407],"domain_scores_gemma":[0.99913543,0.00021205863,0.00020930424,0.000072620525,0.000052099,0.00031856002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023902648,0.0014174714,0.0028819565,0.00035844877,0.00042364924,0.0012018861,0.0010059936,0.0013573309,0.0040129493],"category_scores_gemma":[0.0012600601,0.0009029334,0.0017732548,0.000498964,0.0010409391,0.0009927006,0.00043392528,0.0027360183,0.0006160813],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9232209,0.036837168,0.0028053115,0.0006663062,0.0013798821,0.00011011886,0.0000775432,0.0006556709,0.007182662,0.00007749329,0.0007145144,0.02627253],"study_design_scores_gemma":[0.8690756,0.1267062,0.0025131325,0.000019110252,0.00039723032,0.000059879254,0.000016343261,0.0003301992,0.00031029328,0.000051006766,0.0005099478,0.000010987897],"about_ca_topic_score_codex":0.0006626605,"about_ca_topic_score_gemma":0.001986493,"teacher_disagreement_score":0.0040129493,"about_ca_system_score_codex":0.00084372255,"about_ca_system_score_gemma":0.001706152,"threshold_uncertainty_score":0.013424635},"labels":[],"label_agreement":null},{"id":"W3159700540","doi":"10.1200/jco.21.00411","title":"Reply to S. Sundar et al and S. Höcht et al","year":2021,"lang":"fr","type":"letter","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Humanities; Philosophy","score_opus":0.20017974508941583,"score_gpt":0.5752673338191591,"score_spread":0.37508758872974324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159700540","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011948443,0.00071934535,0.000022047408,0.9869184,0.011537066,0.000004934567,0.000045938,0.000012647692,0.00062010775],"genre_scores_gemma":[0.0014943435,0.000610131,0.00007486383,0.97169423,0.023823002,0.00002466304,0.000027360802,0.000012642828,0.0022388524],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966151,0.001243667,0.00044794244,0.00040275083,0.0008450288,0.0004454688],"domain_scores_gemma":[0.9858431,0.007670654,0.00093999616,0.0004160235,0.0030586773,0.0020716938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00473676,0.0008308676,0.0017380451,0.0011404016,0.0035776058,0.0034280855,0.0021441653,0.055757653,0.008848885],"category_scores_gemma":[0.0348151,0.0009843239,0.001194821,0.0011212138,0.0028836997,0.0040463093,0.0015665076,0.03532624,0.010877079],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031688134,0.000007983238,0.00024191571,0.000023717703,0.0000058085493,0.00041334657,0.000045745943,0.0000112218095,0.000030167008,0.00045242446,0.99718815,0.0015478103],"study_design_scores_gemma":[0.00021069743,0.0000796936,0.0016880753,0.00040339082,0.000057545196,0.003694429,0.0007753702,0.00031110892,0.00028413505,0.007731056,0.9846538,0.00011077369],"about_ca_topic_score_codex":0.006017401,"about_ca_topic_score_gemma":0.00830848,"teacher_disagreement_score":0.055757653,"about_ca_system_score_codex":0.0035805714,"about_ca_system_score_gemma":0.00448077,"threshold_uncertainty_score":0.029602468},"labels":[],"label_agreement":null},{"id":"W3161006899","doi":"10.3390/curroncol28030179","title":"Cancer Testis Antigen, NOL4, Is an Immunogenic Antigen Specifically Expressed in Small-Cell Lung Cancer","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Pusan National University","keywords":"Antigen; Lung cancer; Immunoscreening; Western blot; Cancer; Cancer research; Immunohistochemistry; Adenocarcinoma; Biology; Medicine; Pathology; Molecular biology; Immunology; Complementary DNA; cDNA library; Gene; Internal medicine","score_opus":0.16747805379984537,"score_gpt":0.46897064528481913,"score_spread":0.30149259148497376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161006899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874413,0.0003160162,0.00035126394,0.00001676784,0.000004746024,0.000013050863,0.00014036168,0.0000104652245,0.0004031002],"genre_scores_gemma":[0.99797434,0.00019262946,0.00050125405,0.000030544867,0.0000086141035,0.0000103825005,0.00064024056,0.0000027157048,0.0006392802],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999254,0.000015444879,0.00000613785,0.000016010814,0.000016027618,0.000021150807],"domain_scores_gemma":[0.99989545,0.000026503785,0.000025704448,0.000008155985,0.000017151178,0.000026923059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008109877,0.00018922873,0.00015089409,0.0002730773,0.00013654266,0.00014354962,0.00010557606,0.0001691759,0.0017004552],"category_scores_gemma":[0.00018869613,0.000080156155,0.00013280731,0.0001716807,0.00015629204,0.00010369153,0.00014976297,0.00018559914,0.00032679856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014459358,0.000033459448,0.012388048,0.000056469155,0.000009262936,0.00017395034,0.000016979564,0.000029413417,0.98554254,0.000021922935,0.00007186437,0.0015113999],"study_design_scores_gemma":[0.00010419056,0.002580077,0.41375476,0.000024760508,0.000120926816,0.009576846,0.0003110019,0.002612931,0.5626018,0.00013992788,0.008156514,0.000016287067],"about_ca_topic_score_codex":0.0006706253,"about_ca_topic_score_gemma":0.00075680163,"teacher_disagreement_score":0.0017004552,"about_ca_system_score_codex":0.00019213479,"about_ca_system_score_gemma":0.00012340622,"threshold_uncertainty_score":0.0056886077},"labels":[],"label_agreement":null},{"id":"W3163369172","doi":"10.1016/j.ijrobp.2021.04.049","title":"Cost-Effectiveness of Prophylactic Cranial Irradiation Versus MRI Surveillance for Extensive-Stage Small Cell Lung Cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Association of Radiation Oncology","keywords":"Medicine; Conventional PCI; Prophylactic cranial irradiation; Context (archaeology); Lung cancer; Cost effectiveness; Quality-adjusted life year; Internal medicine; Radiology; Emergency medicine; Surgery","score_opus":0.055964621398963736,"score_gpt":0.41735329848306696,"score_spread":0.3613886770841032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163369172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905268,0.005585252,0.00048371725,0.00089036766,0.0001391041,0.0001170599,0.00026594667,0.000026821648,0.0019649505],"genre_scores_gemma":[0.9991271,0.0004253108,0.000119188284,0.00006786489,0.000031925123,0.000019368774,0.000080861384,0.0000025763702,0.00012578483],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9990553,0.00052920874,0.00005220105,0.00010360194,0.00008435559,0.00017540602],"domain_scores_gemma":[0.99824464,0.00093449815,0.0003492519,0.00006308374,0.0000448662,0.00036365527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010070115,0.0007410735,0.0011731314,0.00063398347,0.00024192287,0.0008641589,0.0008738955,0.0009902413,0.0049931505],"category_scores_gemma":[0.0056068506,0.00029422127,0.002456671,0.00053790177,0.00061372307,0.0009452376,0.00058652775,0.0010575056,0.00018639186],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5001043,0.0074395663,0.08003031,0.0018524163,0.0046811975,0.0007384787,0.00019458169,0.08565063,0.005254956,0.00326708,0.0025649525,0.30822152],"study_design_scores_gemma":[0.06420383,0.24925019,0.48998553,0.0011572818,0.024685085,0.0034968557,0.0017073157,0.14599428,0.006172847,0.008550543,0.004489349,0.00030697687],"about_ca_topic_score_codex":0.0055100056,"about_ca_topic_score_gemma":0.005400019,"teacher_disagreement_score":0.0055100056,"about_ca_system_score_codex":0.0022512623,"about_ca_system_score_gemma":0.0014483408,"threshold_uncertainty_score":0.016703725},"labels":[],"label_agreement":null},{"id":"W3166305108","doi":"10.7554/elife.66524","title":"Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer","year":2021,"lang":"en","type":"article","venue":"eLife","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Alberta Children's Hospital; University of Calgary; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Alberta Innovates; Japanese Respiratory Society; Michael Smith Health Research BC; Terry Fox Research Institute; National Cancer Institute; British Columbia Lung Association; Canada Research Chairs; Alberta Health Services","keywords":"MAPK/ERK pathway; Cancer research; Biology; Chromatin; Neuroendocrine differentiation; KRAS; Cell biology; Kinase; Cancer; Genetics; Gene","score_opus":0.017026245887767934,"score_gpt":0.329726321255545,"score_spread":0.3127000753677771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166305108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98627,0.0039485404,0.0057176347,0.00021498767,0.000036106314,0.000032197644,0.0005047364,0.000115791925,0.0031600508],"genre_scores_gemma":[0.9956174,0.00094482116,0.0009592392,0.00004714998,0.0000049399587,0.000015455556,0.00032229463,0.000008909954,0.002079732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999033,0.000013114224,0.0000063097295,0.000025424357,0.000027189737,0.00002467611],"domain_scores_gemma":[0.9999448,0.000007842381,0.000018102039,0.000007698342,0.000007265755,0.000014311113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012862438,0.00018036924,0.00012148036,0.00014133532,0.00016972766,0.00031077815,0.000118163116,0.0001906684,0.0012317853],"category_scores_gemma":[0.00010651232,0.00011290681,0.00020766715,0.000088947745,0.0002161544,0.00022856245,0.00028246705,0.00049178564,0.0002894088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000974569,0.000022604036,0.0017775637,0.00006604925,0.000009055563,0.00009432839,0.000030934145,0.00023749868,0.9921422,0.00058089325,0.000113953116,0.004827486],"study_design_scores_gemma":[0.000032119417,0.00028150395,0.06804801,0.000020807329,0.00002920142,0.0008130919,0.00018727026,0.005179707,0.91267383,0.0009622033,0.011759001,0.000013282406],"about_ca_topic_score_codex":0.000617103,"about_ca_topic_score_gemma":0.0016012592,"teacher_disagreement_score":0.0012317853,"about_ca_system_score_codex":0.00025916123,"about_ca_system_score_gemma":0.00021730519,"threshold_uncertainty_score":0.004120767},"labels":[],"label_agreement":null},{"id":"W3167778695","doi":"10.1200/jco.2021.39.15_suppl.e20575","title":"Real-world treatment patterns, clinical outcomes, and health care resource utilization in extensive-stage small cell lung cancer in Canada.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); University of Calgary","funders":"","keywords":"Medicine; Etoposide; Radiation therapy; Carboplatin; Medical record; Population; Chemotherapy; Internal medicine; Stage (stratigraphy); Retrospective cohort study; Cohort; Lung cancer; Disease; Oncology; Cisplatin","score_opus":0.2390552102471624,"score_gpt":0.5576946155708685,"score_spread":0.31863940532370616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167778695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96834487,0.0017079053,0.00010603122,0.0010674612,0.000018276829,0.000091616,0.026669497,0.000015310294,0.0019790784],"genre_scores_gemma":[0.99140733,0.0006568985,0.00017599939,0.0002140594,0.0000067544643,0.000029242146,0.0069979285,0.0000043781533,0.00050741405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988925,0.00007517332,0.000119387456,0.00016996592,0.00034238907,0.00040061763],"domain_scores_gemma":[0.9966988,0.00016812145,0.00092557765,0.00009255437,0.0013296306,0.00078526686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007707708,0.0003274928,0.0004213039,0.0015550073,0.0017967698,0.0014050538,0.0011023906,0.0005230919,0.0016075156],"category_scores_gemma":[0.0028983597,0.00037931872,0.0006529273,0.0066009187,0.0006653883,0.0005039722,0.0010801896,0.0007673966,0.00020545287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004996403,0.00001854525,0.99638087,0.00003996105,0.00003435098,0.000063084364,0.0002189688,0.0001274727,0.000047927333,0.00005975169,0.0011034794,0.001855698],"study_design_scores_gemma":[0.000008836868,0.000017069724,0.9972065,0.000056734305,0.00002348003,0.00007596786,0.0011230352,0.00049541495,0.00003275748,0.0000313816,0.0009177649,0.000011100493],"about_ca_topic_score_codex":0.9948362,"about_ca_topic_score_gemma":0.9966324,"teacher_disagreement_score":0.039289057,"about_ca_system_score_codex":0.039289057,"about_ca_system_score_gemma":0.049828965,"threshold_uncertainty_score":0.2850634},"labels":[],"label_agreement":null},{"id":"W3169994688","doi":"10.1038/sj.bjc.6601930","title":"Oral Presentations 4","year":2004,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine","score_opus":0.03377068451095193,"score_gpt":0.41469568713158056,"score_spread":0.3809250026206286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169994688","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012776376,0.0064130593,0.0025898193,0.013627471,0.033224236,0.00058335793,0.005907933,0.002696427,0.93368],"genre_scores_gemma":[0.0029514877,0.0028649978,0.0008052921,0.0042578443,0.004473043,0.00020256764,0.0026889355,0.0006245005,0.98113143],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932253,0.00010167917,0.000040544433,0.00015251162,0.00027437226,0.00010846444],"domain_scores_gemma":[0.9984705,0.00016009009,0.00006186237,0.00015726294,0.00059295056,0.00055730896],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007974982,0.0009971705,0.0010078523,0.0010804536,0.0013744328,0.0043519316,0.0018889848,0.0036161884,0.85582525],"category_scores_gemma":[0.0037598764,0.00041011715,0.0013509825,0.0007541451,0.0004871559,0.0026555562,0.0036145225,0.0030863276,0.7000969],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006540074,0.00005549123,0.000117595104,0.00020515326,0.0000061382875,0.00017025524,0.000032340875,0.000049954706,0.0002504698,0.0019900594,0.9217102,0.075347014],"study_design_scores_gemma":[0.000015117975,0.000026039215,0.0001517527,0.00014035741,0.0000033685055,0.00021568182,0.0000414175,0.000025818843,0.00009085641,0.0006651411,0.9986186,0.0000056906965],"about_ca_topic_score_codex":0.0016244936,"about_ca_topic_score_gemma":0.002729649,"teacher_disagreement_score":0.14417475,"about_ca_system_score_codex":0.0013069771,"about_ca_system_score_gemma":0.0017880788,"threshold_uncertainty_score":0.20564783},"labels":[],"label_agreement":null},{"id":"W3170470860","doi":"10.3390/cancers13122895","title":"A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis","year":2021,"lang":"en","type":"article","venue":"Cancers","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto; Princess Margaret Cancer Centre; Queen's University","funders":"Terry Fox Foundation","keywords":"Medicine; Radiation therapy; Esophagitis; Retrospective cohort study; Hazard ratio; Internal medicine; Stage (stratigraphy); Toxicity; Pneumonitis; Lung cancer; Oncology; Proportional hazards model; Odds ratio; Gastroenterology; Urology; Lung; Confidence interval; Disease","score_opus":0.04622970254268941,"score_gpt":0.4091437960928496,"score_spread":0.3629140935501602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170470860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887189,0.001572656,0.008840481,0.000054305652,0.000034043787,0.0001719115,0.00029403958,0.000017070604,0.0002965083],"genre_scores_gemma":[0.9976242,0.0001865957,0.0014949042,0.000030491752,0.000018189754,0.00008620363,0.00036297028,0.00001378101,0.00018264649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925721,0.005099937,0.00047304708,0.00096486456,0.00061845453,0.00027152972],"domain_scores_gemma":[0.99111944,0.0052478453,0.0017087026,0.0011634334,0.00045543246,0.00030506792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012970301,0.00086022745,0.0018230191,0.0009132474,0.00022843371,0.00085590844,0.0011262617,0.00051418314,0.0015759419],"category_scores_gemma":[0.015890062,0.0004165844,0.0060770186,0.0006873236,0.0003359471,0.0007027043,0.0014539971,0.00057389855,0.00013097958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.119224265,0.00063360773,0.66941667,0.0019116161,0.09944754,0.00032556144,0.0005624232,0.025813391,0.0047203796,0.0017886886,0.00097124005,0.075184576],"study_design_scores_gemma":[0.0053311866,0.026676664,0.72516555,0.00033548547,0.07759979,0.0008015884,0.0008353582,0.15141009,0.0021071632,0.003269902,0.0062775495,0.00018964877],"about_ca_topic_score_codex":0.0023745075,"about_ca_topic_score_gemma":0.0021548069,"teacher_disagreement_score":0.012970301,"about_ca_system_score_codex":0.00064124895,"about_ca_system_score_gemma":0.00060924253,"threshold_uncertainty_score":0.06859434},"labels":[],"label_agreement":null},{"id":"W3170771486","doi":"10.1200/jco.2021.39.15_suppl.e20592","title":"Incidence of pneumonitis among limited-stage small cell lung cancer patients exposed to concurrent chemoradiation: A systematic literature review and meta-analysis.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomized controlled trial; Pneumonitis; Systematic review; Internal medicine; Observational study; Lung cancer; Meta-analysis; Oncology; MEDLINE; Lung","score_opus":0.15368868871070734,"score_gpt":0.4874924618875805,"score_spread":0.33380377317687315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170771486","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003916361,0.99420965,0.0003966134,0.00015817063,0.0000957392,0.00027858999,0.0007397171,0.000015403044,0.00018961876],"genre_scores_gemma":[0.14022501,0.853595,0.0020866122,0.00086801656,0.00020094395,0.0014446925,0.0013045,0.00002647013,0.00024868464],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9887383,0.0039114156,0.0045147915,0.0011864043,0.0013278566,0.00032128033],"domain_scores_gemma":[0.9805243,0.012961261,0.004034888,0.0005418936,0.0016958856,0.00024178319],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013307561,0.0024572555,0.017887784,0.0108780945,0.0006403667,0.0030954783,0.002210872,0.002373387,0.0033319944],"category_scores_gemma":[0.031480506,0.0016441803,0.043942314,0.01118297,0.0007724752,0.0019916962,0.0018130797,0.0016433556,0.00031024058],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009859027,0.000024382809,0.005676796,0.53089976,0.45202845,0.00013041479,0.00008933597,0.00034058635,0.00016314433,0.00012046016,0.00048824184,0.009052404],"study_design_scores_gemma":[0.00033033287,0.00013923783,0.0051519303,0.041831527,0.9503495,0.00015407887,0.000056557983,0.00015326346,0.00009591357,0.00016212289,0.0015468812,0.000028692715],"about_ca_topic_score_codex":0.007705664,"about_ca_topic_score_gemma":0.016305728,"teacher_disagreement_score":0.9866924,"about_ca_system_score_codex":0.0028123148,"about_ca_system_score_gemma":0.0046506203,"threshold_uncertainty_score":0.070377946},"labels":[],"label_agreement":null},{"id":"W3171042793","doi":"10.1016/j.ctarc.2021.100405","title":"Safety, pharmacokinetics, and efficacy of budigalimab with rovalpituzumab tesirine in patients with small cell lung cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; Takeda Oncology; Chugai Pharmaceutical; Genentech; Aptitude Health; Sierra Oncology; Sociedad Española de Oncología Médica; PharmaMar; European Society for Medical Oncology; Oryzon Genomics; Astellas Pharma; Eisai; MacroGenics; Mersana Therapeutics; Agios Pharmaceuticals; BeiGene; Clovis Oncology; Loxo Oncology; Astex Pharmaceuticals; Les Laboratories Pierre Fabre; Pfizer; Incyte; Taiho Pharmaceutical; Regeneron Pharmaceuticals; Array BioPharma; Daiichi Sankyo Europe; Servier; Gilead Sciences; Glenmark Pharmaceuticals; AbbVie; Exelixis; Sanofi; Bristol-Myers Squibb; Ignyta; Eli Lilly and Company; EUSA Pharma; AstraZeneca; Argenx; American Society of Clinical Oncology; GlaxoSmithKline; Amgen; LAM Therapeutics; Celgene","keywords":"Tolerability; Medicine; Internal medicine; Adverse effect; Lung cancer; Oncology; Pharmacokinetics; Pleural effusion; Clinical trial; Gastroenterology","score_opus":0.06452351404831635,"score_gpt":0.41405822557187255,"score_spread":0.3495347115235562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171042793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99737096,0.0014641223,0.0002609106,0.00007887121,0.000011239967,0.00008316561,0.00008364556,0.000026551732,0.0006204619],"genre_scores_gemma":[0.99927896,0.00014527832,0.0001799388,0.000062299216,0.000020889605,0.00003068837,0.00014050488,0.0000051779316,0.00013622656],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992449,0.00034724898,0.000037061975,0.00014329594,0.0001485642,0.00007897864],"domain_scores_gemma":[0.9989329,0.00028925674,0.0003701909,0.000076787335,0.00006336862,0.00026744505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014900721,0.00032472148,0.0008650759,0.0002454212,0.0002634947,0.00075796724,0.00035239258,0.00048618007,0.00058808585],"category_scores_gemma":[0.002431808,0.00026554835,0.0005273123,0.00028089652,0.00043396006,0.0005671962,0.0002024975,0.0010992954,0.00031789375],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26588613,0.007397161,0.26933724,0.00045674047,0.0013336913,0.0018631555,0.0008543678,0.009807106,0.16422631,0.00027852887,0.0023387175,0.27622083],"study_design_scores_gemma":[0.029614763,0.26276007,0.6445775,0.00008579104,0.0013669232,0.004467581,0.00029489,0.013971505,0.034710016,0.00028340344,0.0077943644,0.00007318535],"about_ca_topic_score_codex":0.0006131092,"about_ca_topic_score_gemma":0.0010415725,"teacher_disagreement_score":0.0014900721,"about_ca_system_score_codex":0.00080379867,"about_ca_system_score_gemma":0.0006718174,"threshold_uncertainty_score":0.00788033},"labels":[],"label_agreement":null},{"id":"W3172939869","doi":"10.1200/jco.2021.39.15_suppl.8563","title":"Analysis of homologous recombination DNA repair gene mutation status in patients with metastatic small cell lung cancer treated with cediranib and olaparib on NCI 9881 study.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health","keywords":"Olaparib; Medicine; PARP inhibitor; Cancer research; Internal medicine; Oncology; Poly ADP ribose polymerase; Biology; Gene; Polymerase","score_opus":0.06330536481527846,"score_gpt":0.44215222228506307,"score_spread":0.37884685746978464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172939869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842924,0.0006114889,0.000055941986,0.0000346587,0.000006885232,0.00008524482,0.00036853747,0.0000049187342,0.00040312047],"genre_scores_gemma":[0.99835014,0.00013895605,0.00009184662,0.00007086481,0.00001862608,0.00006043541,0.0010861662,0.000002161076,0.0001808342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955887,0.00013849694,0.000042073098,0.00011520066,0.000092654744,0.000052709824],"domain_scores_gemma":[0.999479,0.000070057715,0.00014033575,0.00003750527,0.000049469392,0.00022369089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076223357,0.00056490884,0.0012913776,0.00046283207,0.00035930186,0.00070637936,0.00055977923,0.00074537203,0.00090679293],"category_scores_gemma":[0.0006666261,0.00030611202,0.0008321017,0.00057098526,0.00028319645,0.0003257425,0.00028313007,0.0006366173,0.00026107603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07099223,0.0014517036,0.894165,0.00015572009,0.0012686357,0.00092784123,0.00012192888,0.00059516664,0.017912265,0.0000662888,0.0005293928,0.011813922],"study_design_scores_gemma":[0.00663699,0.022367192,0.9637881,0.000022190217,0.00092094124,0.0013175273,0.00009626149,0.0010962397,0.001907635,0.00006153049,0.0017675572,0.000017879296],"about_ca_topic_score_codex":0.0011789472,"about_ca_topic_score_gemma":0.0020431099,"teacher_disagreement_score":0.0012913776,"about_ca_system_score_codex":0.0007281871,"about_ca_system_score_gemma":0.00054081617,"threshold_uncertainty_score":0.0052834153},"labels":[],"label_agreement":null},{"id":"W3176870208","doi":"10.1016/j.radonc.2021.06.026","title":"Stereotactic radiosurgery for brain metastases from small cell lung cancer without prior whole-brain radiotherapy: A meta-analysis","year":2021,"lang":"en","type":"review","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiosurgery; Whole brain radiotherapy; Lung cancer; Radiation therapy; Meta-analysis; Internal medicine; Randomized controlled trial; Cochrane Library; Oncology; Hazard ratio; Brain metastasis; Surgery; Cancer; Confidence interval; Metastasis","score_opus":0.12300602840642384,"score_gpt":0.45126397480220803,"score_spread":0.3282579463957842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176870208","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013460351,0.98419696,0.0007338618,0.00016582469,0.000247537,0.00009464151,0.0006448269,0.000040401137,0.00041554315],"genre_scores_gemma":[0.44798663,0.54598445,0.0018598658,0.0013202507,0.0003352698,0.00025639165,0.0011976865,0.000092694994,0.0009667154],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99695456,0.0013167374,0.0007086499,0.00054520153,0.00028577348,0.00018893267],"domain_scores_gemma":[0.9965229,0.002231157,0.0006968527,0.00022734381,0.00023448511,0.000087311295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004739085,0.002494744,0.009520449,0.0024899964,0.00037878196,0.0019597972,0.0015378497,0.0015525409,0.0050078696],"category_scores_gemma":[0.008971457,0.0013994176,0.033570178,0.0038171366,0.0005397934,0.0011916573,0.0011393472,0.0019507962,0.000527721],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039650146,0.000023225064,0.0039317263,0.08726608,0.8945667,0.00010131896,0.00004794566,0.0005259731,0.00037671134,0.00009713336,0.0006578922,0.008440171],"study_design_scores_gemma":[0.0008970203,0.00013175364,0.003373728,0.002752493,0.9914833,0.000055537548,0.00002613083,0.0000893196,0.000069089,0.00013437838,0.0009709857,0.000016312491],"about_ca_topic_score_codex":0.009465431,"about_ca_topic_score_gemma":0.027624443,"teacher_disagreement_score":0.009520449,"about_ca_system_score_codex":0.0018372228,"about_ca_system_score_gemma":0.0013969404,"threshold_uncertainty_score":0.025062978},"labels":[],"label_agreement":null},{"id":"W3179417079","doi":"10.1158/1538-7445.am2021-1412","title":"Abstract 1412: Whole exome sequencing reveals PI3K-ATK pathway alterations are frequent in relapsed small cell-lung cancer after chemoradiation","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Exome sequencing; Lung cancer; Copy-number variation; Cancer; Oncology; Primary tumor; Medicine; Chemotherapy; Exome; Internal medicine; Cancer research; Biology; Gene; Mutation; Genetics; Genome; Metastasis","score_opus":0.08756969921773325,"score_gpt":0.40525648446732193,"score_spread":0.3176867852495887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179417079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99888474,0.00018477815,0.00015945363,0.0000263202,0.0000024906767,0.0000046708296,0.0004134272,0.00001675011,0.000307371],"genre_scores_gemma":[0.99873596,0.000046298966,0.00012907047,0.000026265783,0.0000032824605,0.000005423198,0.00080601574,0.0000054660195,0.00024219164],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998965,0.000009443145,0.000009418968,0.00003663887,0.000027603848,0.000020254776],"domain_scores_gemma":[0.99987316,0.000026630558,0.000035888414,0.0000173815,0.00002160151,0.000025308778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010912092,0.00016942514,0.0002702554,0.00039428347,0.00022650433,0.00035018614,0.00016923429,0.0003245231,0.0015977725],"category_scores_gemma":[0.00032894535,0.00009214719,0.0002264782,0.00036436456,0.00014301174,0.00012390016,0.00020155209,0.00023228872,0.00032131124],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021117635,0.00013380185,0.42126614,0.00012604246,0.00021657458,0.0043827505,0.00025535276,0.00062312064,0.54032856,0.00007723596,0.0012261516,0.029252479],"study_design_scores_gemma":[0.00002728339,0.00024280898,0.9698371,0.0000065162308,0.00008061283,0.0059804134,0.000100186604,0.0008943968,0.021843493,0.00007694427,0.00090361596,0.0000065541985],"about_ca_topic_score_codex":0.000830969,"about_ca_topic_score_gemma":0.0012559587,"teacher_disagreement_score":0.0015977725,"about_ca_system_score_codex":0.00021912907,"about_ca_system_score_gemma":0.00010433404,"threshold_uncertainty_score":0.0053450465},"labels":[],"label_agreement":null},{"id":"W3180501931","doi":"10.1158/1538-7445.am2021-2874","title":"Abstract 2874: Understanding small cell lung cancer metastasis using circulating tumor cell (CTC)-derived tumor explant (CDX) models","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pathology; Metastasis; Medicine; Tropism; Parenchyma; Lung; Brain metastasis; Primary tumor; Cancer; Ex vivo; Lung cancer; Cancer research; Biology; In vivo; Internal medicine; Immunology","score_opus":0.3469073019242359,"score_gpt":0.45201999508232604,"score_spread":0.10511269315809013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180501931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.865543,0.004678391,0.1199126,0.00077426987,0.00018137548,0.00025487994,0.0029940945,0.00059368956,0.0050677187],"genre_scores_gemma":[0.93733865,0.0038656257,0.04912703,0.00028814017,0.00006351392,0.0002440903,0.0037572752,0.00011403215,0.00520175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998209,0.000027749193,0.0000117795025,0.000039526087,0.00007255471,0.000027459668],"domain_scores_gemma":[0.9998017,0.00005095434,0.000038794158,0.000024807503,0.000047117734,0.000036761357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003659912,0.00045034263,0.00030702743,0.000298866,0.00026440443,0.0005519965,0.00052747893,0.0005967313,0.0015789375],"category_scores_gemma":[0.00025588856,0.00014007722,0.00030449426,0.00020431571,0.00037362354,0.00052466814,0.00034144407,0.0010129286,0.0007270759],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043322874,0.000053552347,0.0008903739,0.0000761815,0.000004489283,0.00006553779,0.000030626412,0.000957008,0.9950309,0.00048198798,0.00018803978,0.0021779833],"study_design_scores_gemma":[0.000020601245,0.0007894855,0.007932519,0.00003638655,0.000028509785,0.00047048484,0.00011248172,0.035153575,0.94634974,0.0007858592,0.008301571,0.000018709232],"about_ca_topic_score_codex":0.0020908935,"about_ca_topic_score_gemma":0.002177096,"teacher_disagreement_score":0.0020908935,"about_ca_system_score_codex":0.00059008633,"about_ca_system_score_gemma":0.00039614804,"threshold_uncertainty_score":0.0052820444},"labels":[],"label_agreement":null},{"id":"W3180586825","doi":"10.1016/j.ctro.2021.06.009","title":"Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre","year":2021,"lang":"en","type":"article","venue":"Clinical and Translational Radiation Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University; University of Toronto; Princess Margaret Cancer Centre; Queen's University","funders":"Canada Foundation for Innovation; Princess Margaret Cancer Foundation; Canadian Institutes of Health Research; International Association for the Study of Lung Cancer; Cancer Research Society; Memorial Sloan-Kettering Cancer Center; National Cancer Institute; National Institutes of Health; Conquer Cancer Foundation","keywords":"Medicine; Conventional PCI; Prophylactic cranial irradiation; Cumulative incidence; Internal medicine; Proportional hazards model; Retrospective cohort study; Incidence (geometry); Lung cancer; Cohort; Population; Exact test; Stage (stratigraphy); Surgery; Oncology; Myocardial infarction","score_opus":0.03946288059495504,"score_gpt":0.3970333386417983,"score_spread":0.35757045804684323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180586825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995615,0.00016282141,0.000016488506,0.000039947026,0.0000015176263,0.000004656562,0.000088736044,0.000001424452,0.00012283305],"genre_scores_gemma":[0.99960846,0.00011147587,0.000019026655,0.000015468444,0.000006840594,0.0000038782014,0.00018164844,8.8653326e-7,0.000052379597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996038,0.00006121997,0.00004865197,0.00007844183,0.00010899941,0.00009895439],"domain_scores_gemma":[0.9977055,0.00020129805,0.0014706432,0.000050864386,0.00019139133,0.0003803662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043487296,0.00014900448,0.00019542205,0.00069592585,0.00047935295,0.0005370877,0.0003120328,0.0002761895,0.00087711803],"category_scores_gemma":[0.0019513348,0.00015166367,0.0002462972,0.0009368177,0.00031925167,0.00039133683,0.00066132395,0.00036346324,0.00012729611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056199147,0.000022664884,0.9983637,0.000006521363,0.000013792882,0.00018777372,0.00006219284,0.00004108615,0.00009928375,0.0000033549227,0.00009134462,0.0010519839],"study_design_scores_gemma":[0.0000041130093,0.00013213037,0.998767,0.0000048709417,0.000012565301,0.00064190995,0.0001590083,0.00007581244,0.000066400244,0.0000044278077,0.0001294416,0.000002291996],"about_ca_topic_score_codex":0.010620382,"about_ca_topic_score_gemma":0.016343279,"teacher_disagreement_score":0.010620382,"about_ca_system_score_codex":0.001164829,"about_ca_system_score_gemma":0.0008360513,"threshold_uncertainty_score":0.02111715},"labels":[],"label_agreement":null},{"id":"W3183328865","doi":"10.1016/j.lungcan.2021.07.007","title":"Stereotactic ablative radiotherapy in T1-2N0M0 small cell lung cancer: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; London Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; SABR volatility model; Meta-analysis; Confidence interval; Radiation therapy; Internal medicine; Lung cancer; Observational study; Systematic review; Surgery; Oncology; MEDLINE","score_opus":0.09116733073286165,"score_gpt":0.45274710486949943,"score_spread":0.3615797741366378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183328865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036790606,0.9950518,0.00026643442,0.000110055866,0.000110786896,0.00013291017,0.0004481934,0.00001666454,0.00018418694],"genre_scores_gemma":[0.14027785,0.85578835,0.0012725471,0.0010834401,0.00017390447,0.0003876723,0.0005707037,0.00002866985,0.00041682873],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964585,0.0014287457,0.001061421,0.00049025303,0.00037081432,0.00019036002],"domain_scores_gemma":[0.99506336,0.0032479728,0.0010782283,0.0001818239,0.00034071575,0.00008787349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005269321,0.0022737202,0.012747714,0.0036495656,0.00049300474,0.002363713,0.0017796431,0.0022042382,0.0045912936],"category_scores_gemma":[0.012391269,0.0013597911,0.026751772,0.0055227946,0.00065491913,0.0016170718,0.0015474793,0.0018772564,0.0004402108],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001860417,0.000031232335,0.0036509705,0.4511517,0.52796465,0.00012812867,0.00010964841,0.0004550844,0.000331197,0.0001266956,0.0009121005,0.0132780345],"study_design_scores_gemma":[0.0007212855,0.00013657325,0.0032345017,0.02040505,0.97323066,0.00007879025,0.00005852504,0.00009069896,0.0000696568,0.0001436673,0.0018054672,0.00002517469],"about_ca_topic_score_codex":0.010532763,"about_ca_topic_score_gemma":0.036064915,"teacher_disagreement_score":0.012747714,"about_ca_system_score_codex":0.002295392,"about_ca_system_score_gemma":0.0027376749,"threshold_uncertainty_score":0.027867138},"labels":[],"label_agreement":null},{"id":"W3183701786","doi":"10.3390/curroncol28040243","title":"Patterns of Relapse in Small Cell Lung Cancer: Competing Risks of Thoracic versus CNS Relapse","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Internal medicine; Retrospective cohort study; Lung cancer; Oncology; Cancer; Disease; Stage (stratigraphy); Cohort; Multivariate analysis; Central nervous system","score_opus":0.20441430667409827,"score_gpt":0.5097476292177541,"score_spread":0.3053333225436558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183701786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969266,0.000833014,0.0005388228,0.0006695796,0.000004289868,0.000013331045,0.0002204376,0.000005813609,0.00078804203],"genre_scores_gemma":[0.99957246,0.00009288205,0.00014483344,0.000024550343,0.0000072752855,0.0000032119372,0.000101900616,0.0000016022474,0.000051179217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987735,0.00056989526,0.000100622674,0.00012970711,0.0002575584,0.00016876665],"domain_scores_gemma":[0.9936392,0.002682646,0.0022798057,0.00018194951,0.0004578245,0.0007586415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019205195,0.00016162037,0.00025356558,0.0007041113,0.0003869538,0.0007786943,0.00043536426,0.00038039262,0.002029028],"category_scores_gemma":[0.006920276,0.000109749344,0.0006248483,0.00077602896,0.0005486873,0.00045373102,0.00060069637,0.0005836569,0.00012476883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001192236,0.000010505838,0.99525994,0.000016775495,0.000035829726,0.000120945624,0.0000999788,0.00024024506,0.000084309104,0.00010582589,0.00012256214,0.0037838933],"study_design_scores_gemma":[0.000011556751,0.00012175663,0.9929351,0.000042877484,0.000054889908,0.0017225891,0.00046466035,0.0033940696,0.00017652125,0.0007643571,0.00029749225,0.000014034116],"about_ca_topic_score_codex":0.00854364,"about_ca_topic_score_gemma":0.018583793,"teacher_disagreement_score":0.00854364,"about_ca_system_score_codex":0.0010010002,"about_ca_system_score_gemma":0.00092981633,"threshold_uncertainty_score":0.0169878},"labels":[],"label_agreement":null},{"id":"W3184397245","doi":"10.1136/thoraxjnl-2020-216555","title":"International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study","year":2021,"lang":"en","type":"article","venue":"Thorax","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University; Nova Scotia Health Authority; CancerCare Manitoba; Saskatchewan Cancer Agency; Cancer Care Ontario; Alberta Health Services","funders":"Cancer Council Victoria; Public Health England; Odense Universitetshospital; Cancer Research UK; Canadian Association of Thoracic Surgeons; University of Twente; Cancer Council NSW; McMaster University; World Health Organization","keywords":"Medicine; Stage (stratigraphy); Lung cancer; Demography; Cancer; Relative survival; Cancer registry; Epidemiology; Internal medicine","score_opus":0.09615459167668594,"score_gpt":0.43238538497101914,"score_spread":0.3362307932943332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184397245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298507,0.000649419,0.00011081985,0.00005341814,0.000011959894,0.000028422293,0.0050934316,0.0000051424004,0.0010623022],"genre_scores_gemma":[0.9912983,0.0003227407,0.00010718999,0.000054318447,0.00002125687,0.000047017937,0.00770982,0.000009042875,0.00043038718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992176,0.00019095503,0.000079439844,0.00021575956,0.0001234462,0.00017283593],"domain_scores_gemma":[0.9976342,0.00030266264,0.0009185356,0.00037109572,0.00036236312,0.00041113334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017934751,0.0005231363,0.0004939799,0.0010952532,0.0005168486,0.0007883613,0.00073230406,0.00061931345,0.00214627],"category_scores_gemma":[0.002273928,0.0003800852,0.0010142834,0.0021940167,0.00047163566,0.0005532446,0.0010205538,0.0006130832,0.00058682915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006176571,0.000028154658,0.9973246,0.0000290677,0.00014538063,0.00006126643,0.00011176898,0.000039742998,0.0000706266,0.000022456743,0.00039147853,0.0011577802],"study_design_scores_gemma":[0.000030705676,0.000096753996,0.9989312,0.000018226216,0.00010185855,0.00011703104,0.00016792196,0.000052088748,0.000022370277,0.000011116511,0.00044648445,0.0000042823976],"about_ca_topic_score_codex":0.046531565,"about_ca_topic_score_gemma":0.057886418,"teacher_disagreement_score":0.046531565,"about_ca_system_score_codex":0.0008351273,"about_ca_system_score_gemma":0.0008489256,"threshold_uncertainty_score":0.09252143},"labels":[],"label_agreement":null},{"id":"W3188488521","doi":"10.6004/jnccn.2020.7796","title":"Cost-Effectiveness Analysis of Durvalumab Plus Chemotherapy in the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Xiangya Hospital, Central South University; Central South University; National Natural Science Foundation of China","keywords":"Durvalumab; Medicine; Etoposide; Oncology; Chemotherapy; Lung cancer; Cost-effectiveness analysis; Internal medicine; Cost effectiveness; Stage (stratigraphy); Cancer; Immunotherapy","score_opus":0.1077639222556304,"score_gpt":0.4199083928252948,"score_spread":0.3121444705696644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188488521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96755844,0.010916108,0.010383865,0.0021392005,0.00011637448,0.0007418538,0.0026020897,0.00010732305,0.0054346807],"genre_scores_gemma":[0.99668044,0.000804896,0.001477977,0.00014159725,0.000017274146,0.00010837335,0.0004251693,0.0000062104004,0.00033806704],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99809223,0.0014781326,0.000053265394,0.00011177535,0.00011912833,0.0001454125],"domain_scores_gemma":[0.994713,0.0043511707,0.00046483247,0.000112375696,0.00013554179,0.00022310458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044113193,0.0012079121,0.0020576154,0.0008692266,0.00019478712,0.0012628217,0.0012179507,0.00092536595,0.0033190427],"category_scores_gemma":[0.010379024,0.00068186375,0.0040519703,0.0005967885,0.00038039713,0.0009860073,0.00072367454,0.0014017626,0.00010321427],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012731911,0.0004073263,0.008721347,0.000835794,0.004567354,0.00027812985,0.000038627233,0.95111716,0.000647547,0.0027682781,0.0009462752,0.016940286],"study_design_scores_gemma":[0.0043553417,0.0049881577,0.013965213,0.00045493746,0.007959017,0.0003859719,0.00010949687,0.9601777,0.00091774476,0.005186712,0.0014204064,0.00007923765],"about_ca_topic_score_codex":0.015570275,"about_ca_topic_score_gemma":0.011185032,"teacher_disagreement_score":0.015570275,"about_ca_system_score_codex":0.005779482,"about_ca_system_score_gemma":0.0031654628,"threshold_uncertainty_score":0.04193324},"labels":[],"label_agreement":null},{"id":"W3193645271","doi":"10.37766/inplasy2021.8.0049","title":"The impact of timing of concurrent chemoradiation in limited stage SCLC undergoing platinum-based chemotherapy","year":2021,"lang":"en","type":"report","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Stage (stratigraphy); Chemotherapy; Oncology; Medicine; Internal medicine; Lung cancer; Biology","score_opus":0.10012407493386774,"score_gpt":0.4446843719408798,"score_spread":0.3445602970070121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193645271","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006398553,0.99012905,0.00022944121,0.0005927717,0.00048232113,0.00069092377,0.0006435326,0.000010396187,0.0008230102],"genre_scores_gemma":[0.20796692,0.7831767,0.001752418,0.0024363955,0.00071656815,0.0023489697,0.00090430013,0.00002496317,0.0006727113],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9935674,0.0032766152,0.0018212186,0.0005458755,0.00057872245,0.00021025837],"domain_scores_gemma":[0.9812066,0.014188373,0.003018811,0.00032772758,0.0010155477,0.00024289283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00883588,0.0006599768,0.004808098,0.0014999263,0.00029713917,0.0015126654,0.0011108096,0.0014508015,0.003952057],"category_scores_gemma":[0.0401685,0.0005358804,0.008372057,0.002142812,0.00035724012,0.0012372219,0.00090806436,0.0013390789,0.00028486157],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009952426,0.00009236809,0.008394024,0.76425415,0.11623465,0.00014691718,0.00018624199,0.000699365,0.00054056547,0.0005405647,0.0036446059,0.095314085],"study_design_scores_gemma":[0.007847746,0.0025761956,0.04214626,0.3523597,0.5615597,0.00045195923,0.00031399785,0.000559498,0.00081895536,0.0013511417,0.029912287,0.00010254931],"about_ca_topic_score_codex":0.005699175,"about_ca_topic_score_gemma":0.012104234,"teacher_disagreement_score":0.00883588,"about_ca_system_score_codex":0.0024679713,"about_ca_system_score_gemma":0.004208794,"threshold_uncertainty_score":0.046729147},"labels":[],"label_agreement":null},{"id":"W3194861611","doi":"10.3390/curroncol28040270","title":"Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell Lung Cancer in Canada","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); University of Calgary","funders":"Canadian Institutes of Health Research; AstraZeneca Canada","keywords":"Medicine; Radiation therapy; Lung cancer; Chemotherapy; Stage (stratigraphy); Population; Internal medicine; Medical record; Cohort; Disease; Chemotherapy regimen; Oncology","score_opus":0.2412574352327262,"score_gpt":0.5305801339327255,"score_spread":0.2893226986999993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194861611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866023,0.0013542151,0.00013738863,0.0008209716,0.00001457313,0.00006125426,0.009633111,0.000013664389,0.0013624246],"genre_scores_gemma":[0.9962626,0.00055828795,0.00016365969,0.0001457945,0.0000055526475,0.000017236696,0.002606995,0.000004054519,0.00023572143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843925,0.00013810307,0.0001496949,0.00027131382,0.00045444787,0.0005472213],"domain_scores_gemma":[0.9965647,0.00023907523,0.0008654088,0.0001222608,0.0012701594,0.0009382821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008502825,0.00037064357,0.0005351969,0.0017853634,0.002426099,0.0017791714,0.0014405656,0.00052233087,0.0015501021],"category_scores_gemma":[0.0037715614,0.00041154944,0.0007896067,0.006846955,0.0010887748,0.00057646993,0.0012609847,0.0009518843,0.00014813918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006363736,0.000027596174,0.99596256,0.000040331266,0.00007926401,0.00006365909,0.00033257084,0.00026068755,0.00006767045,0.00010765368,0.0008932148,0.002101143],"study_design_scores_gemma":[0.000014868085,0.00002096568,0.9968363,0.000053877167,0.000042285246,0.000075197495,0.0012487737,0.00075163523,0.000047143683,0.00005995302,0.000826988,0.000021944432],"about_ca_topic_score_codex":0.9970535,"about_ca_topic_score_gemma":0.99784863,"teacher_disagreement_score":0.058954366,"about_ca_system_score_codex":0.058954366,"about_ca_system_score_gemma":0.052964658,"threshold_uncertainty_score":0.42774588},"labels":[],"label_agreement":null},{"id":"W3203387497","doi":"10.1016/j.cllc.2021.09.006","title":"Longitudinal Assessment of Health Utility Scores, Symptoms and Toxicities in Patients with Small Cell Lung Cancer Using Real World Data","year":2021,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Disease; Lung cancer; Depression (economics); Anxiety; Performance status; Medical record; Cohort; Cancer; Pathological; Chemotherapy; Psychiatry","score_opus":0.17221650362404584,"score_gpt":0.5071352465686404,"score_spread":0.33491874294459456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203387497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793446,0.00018860181,0.00037632708,0.00009461894,0.0000074913337,0.000019702546,0.0012143406,0.000007045314,0.00015736735],"genre_scores_gemma":[0.99651164,0.00008619877,0.00032455963,0.0000309971,0.0000067451097,0.000036421352,0.0029189272,0.0000028811455,0.00008165807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99666876,0.0021403686,0.00029263675,0.00033104286,0.00032048003,0.00024679926],"domain_scores_gemma":[0.9872335,0.0048869033,0.0039158617,0.0018358895,0.0013936323,0.00073423533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074555636,0.00031526134,0.00047058862,0.00087655283,0.0005518058,0.0013808057,0.00050354865,0.0006696478,0.0006886376],"category_scores_gemma":[0.018721724,0.0002949633,0.0010692435,0.0017794085,0.0003858971,0.001356573,0.00088010164,0.0013420735,0.0003217591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041709378,0.0001828179,0.9967499,0.000011951788,0.00019116972,0.000027466116,0.00010251057,0.00031743653,0.00012233356,0.000025671894,0.00016036932,0.0016911852],"study_design_scores_gemma":[0.00003490709,0.00090229337,0.9950539,0.000015960552,0.00013057126,0.00015905417,0.00036919693,0.002573323,0.0001756005,0.00008392459,0.00048221176,0.000019181834],"about_ca_topic_score_codex":0.009453617,"about_ca_topic_score_gemma":0.009382348,"teacher_disagreement_score":0.009453617,"about_ca_system_score_codex":0.0008768172,"about_ca_system_score_gemma":0.0009138388,"threshold_uncertainty_score":0.039429247},"labels":[],"label_agreement":null},{"id":"W3205715890","doi":"10.1038/s41388-021-02070-3","title":"Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium","year":2021,"lang":"en","type":"article","venue":"Oncogene","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Cancer Council Victoria; Victorian Cancer Agency","keywords":"Biology; Cancer research; Phenotype; Small Cell Lung Carcinoma; Neuroendocrine cell; Cell; Pathology; Carcinoma; Immunology; Gene; Immunohistochemistry; Small-cell carcinoma; Genetics","score_opus":0.01177826060905788,"score_gpt":0.29109471281683386,"score_spread":0.27931645220777596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205715890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745184,0.000544378,0.0006651253,0.000050692153,0.00000738122,0.000008413378,0.0001455264,0.000039028295,0.0010875247],"genre_scores_gemma":[0.9982975,0.00020113743,0.00031344962,0.000015710626,0.0000024623669,0.0000064901833,0.00013750134,0.000011858845,0.0010139506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967444,0.00006232827,0.000025551968,0.00005724344,0.00008523198,0.000095304466],"domain_scores_gemma":[0.9997515,0.00003937511,0.000050488252,0.0000448418,0.000024893514,0.000088871144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019013176,0.00019065021,0.00031515583,0.0005481317,0.00024334769,0.00048590766,0.00019585724,0.00033088596,0.0019610978],"category_scores_gemma":[0.00027714515,0.00019186457,0.00023502197,0.00020219921,0.00033431523,0.00032391417,0.00047275686,0.0006542348,0.0003935495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014441842,0.00001783701,0.0016014493,0.000008463797,0.0000038522776,0.00020166668,0.000012843755,0.000038329348,0.9971884,0.00011847155,0.000018561252,0.00064575224],"study_design_scores_gemma":[0.000019079838,0.00040878943,0.09006284,0.00001097221,0.00003558259,0.0038742889,0.000326803,0.0018875257,0.9011979,0.00023785302,0.0019290455,0.000009262182],"about_ca_topic_score_codex":0.0010544469,"about_ca_topic_score_gemma":0.00229426,"teacher_disagreement_score":0.0019610978,"about_ca_system_score_codex":0.00024875914,"about_ca_system_score_gemma":0.00025820968,"threshold_uncertainty_score":0.006560564},"labels":[],"label_agreement":null},{"id":"W3205820819","doi":"10.3390/curroncol28050347","title":"Immunotherapy in Extensive-Stage Small Cell Lung Cancer","year":2021,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Immunotherapy; Disease; Lung cancer; Thriving; Intensive care medicine; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Psychotherapist","score_opus":0.2726057617974544,"score_gpt":0.555082684203195,"score_spread":0.28247692240574057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205820819","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042881366,0.99925023,0.000033202294,0.00015017024,0.00011810919,0.000003231028,0.000009032075,0.0000033607596,0.00038980605],"genre_scores_gemma":[0.00028956364,0.99928254,0.000047953086,0.00010209057,0.00007695089,0.0000033619228,0.000013730301,5.99561e-7,0.00018320586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981123,0.00004677278,0.000028750543,0.000027368891,0.00006587476,0.000020044296],"domain_scores_gemma":[0.9996451,0.00019436386,0.000047794038,0.000009977737,0.000077459255,0.000025304937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069151644,0.0006237318,0.0012837461,0.001980155,0.00023529775,0.0010080967,0.0008123596,0.0009946717,0.0039582113],"category_scores_gemma":[0.0010872092,0.0002040558,0.0006910438,0.0018211025,0.0003570668,0.0011542041,0.00062007294,0.0016932035,0.0016284853],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007821023,0.00006506198,0.00012276687,0.036190897,0.00011874623,0.00012672422,0.00005797327,0.00034500798,0.00084746716,0.0030459862,0.030827437,0.9281738],"study_design_scores_gemma":[0.000026625314,0.000097813936,0.0005643978,0.013032162,0.0001840684,0.0008138741,0.00005203809,0.000060404167,0.00022578677,0.002059572,0.98287016,0.000013191514],"about_ca_topic_score_codex":0.0009410837,"about_ca_topic_score_gemma":0.0016653903,"teacher_disagreement_score":0.0039582113,"about_ca_system_score_codex":0.0005469585,"about_ca_system_score_gemma":0.0011390309,"threshold_uncertainty_score":0.013241589},"labels":[],"label_agreement":null},{"id":"W3206067573","doi":"10.3892/mco.2021.2423","title":"Standard therapy‑resistant small cell lung cancer showing dynamic transition of neuroendocrine fate during the cancer trajectory: A case report","year":2021,"lang":"en","type":"article","venue":"Molecular and Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; School of Medicine, New York University; York University","keywords":"Biology; Neuroendocrine differentiation; Cancer research; Carboplatin; Lung cancer; Oncology; Cancer; Internal medicine; Medicine; Chemotherapy; Prostate cancer; Genetics","score_opus":0.038663195797604945,"score_gpt":0.4214544604542036,"score_spread":0.38279126465659863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206067573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809068,0.0074871015,0.0028597566,0.0024073594,0.00039208264,0.00018886868,0.00026894364,0.00018787473,0.005301257],"genre_scores_gemma":[0.99373996,0.002344107,0.0011912755,0.00065680215,0.0008855155,0.000030262727,0.00014812978,0.000024116393,0.0009798235],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999156,0.00008338154,0.00010026933,0.0002532899,0.00012529365,0.00028168363],"domain_scores_gemma":[0.9984485,0.0003501382,0.00028182802,0.00020812584,0.000112378526,0.00059906894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045869162,0.0023539886,0.0018725708,0.0028882762,0.0035307289,0.0025919555,0.0017192888,0.00744136,0.0017780936],"category_scores_gemma":[0.0023571162,0.0016747708,0.0019191715,0.0020917621,0.0021363492,0.0025408887,0.0020403583,0.0044457302,0.0010985704],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026066898,0.000025527808,0.0033404585,0.000020689224,0.000010173929,0.9951468,0.00012562545,0.000039167564,0.0004976488,0.00007094562,0.00012530644,0.00057163247],"study_design_scores_gemma":[0.000008286443,0.000059088103,0.0031200855,0.000009141708,0.000015475061,0.9957099,0.00010415719,0.0002198333,0.0002656087,0.000083502906,0.0003915728,0.0000134564325],"about_ca_topic_score_codex":0.00307045,"about_ca_topic_score_gemma":0.004120118,"teacher_disagreement_score":0.00744136,"about_ca_system_score_codex":0.0018510972,"about_ca_system_score_gemma":0.00086019427,"threshold_uncertainty_score":0.013430715},"labels":[],"label_agreement":null},{"id":"W3206589224","doi":"10.2196/29017","title":"An Automated Line-of-Therapy Algorithm for Adults With Metastatic Non–Small Cell Lung Cancer: Validation Study Using Blinded Manual Chart Review","year":2021,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cohort; Algorithm; Medicine; Chart; Retrospective cohort study; Electronic health record; Machine learning; Computer science; Surgery; Statistics; Internal medicine; Health care; Mathematics","score_opus":0.0547978510910148,"score_gpt":0.4502776543505282,"score_spread":0.3954798032595134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206589224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726509,0.00034679854,0.020496806,0.00009799914,0.000060758935,0.0027324317,0.0022212777,0.00040828966,0.0009847436],"genre_scores_gemma":[0.96232796,0.00012237688,0.03228849,0.000090921094,0.00003318698,0.0010046887,0.0038745285,0.000044117525,0.00021374295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9808375,0.008979913,0.002743233,0.00368931,0.00337421,0.00037580408],"domain_scores_gemma":[0.8975486,0.04261664,0.017586734,0.015871752,0.025155248,0.001220976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.032496333,0.00068271987,0.00070029584,0.0024628735,0.0006838366,0.0018280369,0.0018436637,0.0008787154,0.0008712432],"category_scores_gemma":[0.07832799,0.00056333997,0.00097095664,0.0011082665,0.0007512949,0.0013586456,0.0016523461,0.0006640134,0.00034642598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029997856,0.00112624,0.9282072,0.00043749143,0.0005634695,0.00013628324,0.0013957811,0.0049346755,0.0026187839,0.0002520829,0.001964278,0.055363838],"study_design_scores_gemma":[0.0011649857,0.0045687696,0.85683566,0.00031837547,0.0007472515,0.0011013517,0.0009795448,0.11690276,0.011221405,0.00038205367,0.0056145643,0.00016332147],"about_ca_topic_score_codex":0.004145232,"about_ca_topic_score_gemma":0.005016,"teacher_disagreement_score":0.032496333,"about_ca_system_score_codex":0.0016151638,"about_ca_system_score_gemma":0.002295554,"threshold_uncertainty_score":0.17185909},"labels":[],"label_agreement":null},{"id":"W3206694174","doi":"10.1097/coc.0000000000000867","title":"Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Research Institute in Oncology and Hematology; University of Manitoba","funders":"","keywords":"Radiation therapy; Prophylactic cranial irradiation; Brain metastasis; Neurocognitive; Lung cancer; Radiosurgery; Central nervous system; Conventional PCI; Chemotherapy","score_opus":0.11089184346273195,"score_gpt":0.5429156578752207,"score_spread":0.4320238144124887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206694174","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016233665,0.9968829,0.00007436411,0.0003859376,0.00009621843,0.00002072571,0.00003702475,0.000003173466,0.0008763508],"genre_scores_gemma":[0.020399604,0.9782799,0.00031042498,0.00048369437,0.0001599637,0.000041983894,0.00007107701,0.0000017286042,0.00025176216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995136,0.00021950001,0.00008568963,0.0000464469,0.00011149517,0.000023238485],"domain_scores_gemma":[0.99876547,0.00082287256,0.0002059327,0.000027121809,0.00014454754,0.000034015517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011329391,0.00022264932,0.000980005,0.0006881282,0.00018431737,0.00048655027,0.00039887987,0.0005479601,0.0020032628],"category_scores_gemma":[0.0032750193,0.000094764946,0.0010208781,0.0007289342,0.00023816424,0.0004083947,0.00022290826,0.0008045619,0.00036993017],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007893858,0.00021536178,0.0023431114,0.07600624,0.0009518188,0.00016312626,0.00009674216,0.00034235296,0.0015899603,0.0011708454,0.006623091,0.90970784],"study_design_scores_gemma":[0.0014798208,0.011580379,0.06478578,0.13599662,0.011092869,0.0045162425,0.00054313004,0.0005343408,0.007958876,0.0048881797,0.75653905,0.00008465282],"about_ca_topic_score_codex":0.0010429055,"about_ca_topic_score_gemma":0.0027577195,"teacher_disagreement_score":0.0020032628,"about_ca_system_score_codex":0.00029437782,"about_ca_system_score_gemma":0.00075592875,"threshold_uncertainty_score":0.006701529},"labels":[],"label_agreement":null},{"id":"W3209942576","doi":"10.1016/j.ijrobp.2021.07.1310","title":"A Comparison of Hypofractionated and Twice Daily Thoracic Irradiation in Limited-Stage Small Cell Lung Cancer: An Overlap Weighted Analysis","year":2021,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University Health Network; University of Toronto; Kingston General Hospital; Princess Margaret Cancer Centre; Cancer Care South East; Queen's University","funders":"","keywords":"Medicine; Retrospective cohort study; Radiation therapy; Confounding; Hazard ratio; Proportional hazards model; Propensity score matching; Cohort; Lung cancer; Internal medicine; Stage (stratigraphy); Oncology; Confidence interval","score_opus":0.04100072426225624,"score_gpt":0.43078195673265235,"score_spread":0.3897812324703961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209942576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938111,0.0015959578,0.003931197,0.000028106513,0.000012531397,0.00002383336,0.00013437556,0.000022527407,0.00044030035],"genre_scores_gemma":[0.99800867,0.00022027128,0.0010695703,0.000014849287,0.000010766143,0.000017472843,0.00025117438,0.000037369966,0.00036998172],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991732,0.0003800904,0.000065216766,0.00017452013,0.00013579178,0.000071075585],"domain_scores_gemma":[0.9984127,0.00087931304,0.00025886306,0.00016081943,0.00020091237,0.000087337256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024358658,0.000552962,0.00096688606,0.00084053894,0.0002220466,0.0006056879,0.0006185053,0.00038671648,0.0012920838],"category_scores_gemma":[0.003677041,0.00021189223,0.001696118,0.0005637801,0.0002526464,0.0005020043,0.0007121144,0.0002517483,0.00011520154],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18375514,0.0008277988,0.44862983,0.0016940833,0.022303378,0.00049145415,0.0011453889,0.03875063,0.054818597,0.0013503518,0.0011321749,0.24510118],"study_design_scores_gemma":[0.0017442255,0.010242681,0.8647668,0.0001090922,0.025200993,0.000831935,0.0010062461,0.08508362,0.0056761396,0.0014216959,0.0037872735,0.00012932418],"about_ca_topic_score_codex":0.0033916477,"about_ca_topic_score_gemma":0.004030988,"teacher_disagreement_score":0.0033916477,"about_ca_system_score_codex":0.00037944224,"about_ca_system_score_gemma":0.00047458254,"threshold_uncertainty_score":0.012882233},"labels":[],"label_agreement":null},{"id":"W3211244077","doi":"10.1016/j.jtocrr.2021.100249","title":"A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Kingston Health Sciences Centre; University of Calgary","funders":"","keywords":"Atezolizumab; Medicine; Etoposide; Hazard ratio; Oncology; Internal medicine; Chemotherapy; Carboplatin; Confidence interval; Cisplatin; Cancer; Pembrolizumab; Immunotherapy","score_opus":0.12703755635832875,"score_gpt":0.4785684825184646,"score_spread":0.35153092616013587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211244077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853814,0.00027913952,0.000054443502,0.0000893695,0.0000024045023,0.00009706455,0.00053705013,0.0000034994177,0.00039892163],"genre_scores_gemma":[0.9988224,0.00021894192,0.00019590875,0.000069712805,0.0000088235365,0.000033009226,0.0005516964,0.0000011151117,0.00009837356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990589,0.0003355572,0.000084491316,0.00012827019,0.00022790041,0.00016487062],"domain_scores_gemma":[0.9967687,0.00059215876,0.0009864658,0.0001027235,0.0008966208,0.00065332005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012174248,0.00019434429,0.000383119,0.00041996405,0.0006272428,0.0007064083,0.0003455311,0.0003051269,0.00082190026],"category_scores_gemma":[0.00388467,0.00014142039,0.00043331887,0.000989256,0.00044056028,0.0002762751,0.0004944446,0.00029276288,0.00008557632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005234108,0.00060741295,0.97421277,0.0001712123,0.00022081235,0.0002847467,0.00026380664,0.0012921361,0.0006586093,0.000067558685,0.0005072524,0.0164796],"study_design_scores_gemma":[0.00077062764,0.0045631756,0.98978454,0.000046118355,0.0001768275,0.0003854643,0.0006206874,0.0018263174,0.0003307084,0.000033444892,0.0014393766,0.000022737395],"about_ca_topic_score_codex":0.43545103,"about_ca_topic_score_gemma":0.523834,"teacher_disagreement_score":0.56454897,"about_ca_system_score_codex":0.008222648,"about_ca_system_score_gemma":0.0076163285,"threshold_uncertainty_score":0.86583287},"labels":[],"label_agreement":null},{"id":"W34930244","doi":"10.1186/s12935-021-02357-1","title":"Montreal Neurological Institute モントリオール留学記","year":2003,"lang":"en","type":"article","venue":"Toho Igakkai Zasshi","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Fundamental Research Funds for the Central Universities; National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Medicine; Audiology","score_opus":0.03716610681098388,"score_gpt":0.34068772616028337,"score_spread":0.3035216193492995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W34930244","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3423812,0.021366082,0.12826689,0.023196544,0.0038810752,0.0030001807,0.11522891,0.007442723,0.35523638],"genre_scores_gemma":[0.55597436,0.010845595,0.13896748,0.0030933728,0.00050098036,0.0022232935,0.048173368,0.00087352947,0.23934804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995252,0.00004309888,0.000029773884,0.00018020126,0.00013325138,0.00008848893],"domain_scores_gemma":[0.9992743,0.000048528353,0.00006932657,0.000112089954,0.0003577011,0.00013804574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010010217,0.0009386118,0.00079666957,0.0016223005,0.0014656598,0.0020864964,0.0011454616,0.00077754894,0.02425924],"category_scores_gemma":[0.0022410909,0.0003411376,0.0008411802,0.0011816961,0.0007778906,0.0010740357,0.0010206511,0.0015855392,0.008508459],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019938285,0.0003992472,0.10245725,0.0009457376,0.00078489014,0.001985734,0.00062045996,0.0038913696,0.031752042,0.02205957,0.1668872,0.6662227],"study_design_scores_gemma":[0.00083036436,0.0017069734,0.39134583,0.0007210586,0.00094606384,0.006291158,0.00053581985,0.016060462,0.045599323,0.031430975,0.50395983,0.00057217333],"about_ca_topic_score_codex":0.11241256,"about_ca_topic_score_gemma":0.17680115,"teacher_disagreement_score":0.11241256,"about_ca_system_score_codex":0.004035997,"about_ca_system_score_gemma":0.007536855,"threshold_uncertainty_score":0.22351652},"labels":[],"label_agreement":null},{"id":"W4200122615","doi":"10.1016/j.annonc.2021.10.132","title":"114TiP KEYNOTE-B99: Phase II study of pembrolizumab plus investigational agents combined with chemotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC)","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Chemotherapy; Oncology; Lung cancer; Internal medicine; Phases of clinical research; Stage (stratigraphy); Cancer; Immunotherapy","score_opus":0.1475345320760051,"score_gpt":0.46159411766718694,"score_spread":0.31405958559118186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200122615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806449,0.0043960265,0.0007898236,0.0010371743,0.000520291,0.003714588,0.0030865169,0.0003369417,0.0054736747],"genre_scores_gemma":[0.97078776,0.00516945,0.003413923,0.0017352508,0.0004066783,0.0031526946,0.0060839443,0.00008868201,0.009161596],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99965453,0.00013986397,0.000016731858,0.000056661633,0.000032732467,0.00009952121],"domain_scores_gemma":[0.9994555,0.000069511276,0.0000621232,0.0000455757,0.00002977408,0.00033751922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012545222,0.0014863139,0.0020657,0.00069653394,0.00054209353,0.0014489596,0.001793168,0.0019061811,0.008716385],"category_scores_gemma":[0.00073280535,0.0007465705,0.0016867941,0.00050280476,0.0008636683,0.001005594,0.0005031257,0.005820453,0.002549783],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6527785,0.10086001,0.004561885,0.0016842121,0.0025492336,0.00034950292,0.00027278406,0.0029111526,0.054917134,0.0006590564,0.010731104,0.16772541],"study_design_scores_gemma":[0.6033191,0.37910792,0.0067975186,0.000059671445,0.00078977074,0.00020801913,0.00005424294,0.0009273397,0.004477331,0.00014236128,0.0040792446,0.000037518024],"about_ca_topic_score_codex":0.0018307467,"about_ca_topic_score_gemma":0.0040825717,"teacher_disagreement_score":0.008716385,"about_ca_system_score_codex":0.0008314878,"about_ca_system_score_gemma":0.0017724474,"threshold_uncertainty_score":0.029159188},"labels":[],"label_agreement":null},{"id":"W4200232423","doi":"10.1186/s12962-021-00329-w","title":"First-line pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer: a United States-based cost-effectiveness analysis","year":2021,"lang":"en","type":"article","venue":"Cost Effectiveness and Resource Allocation","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Natural Science Foundation of Hunan Province; National Natural Science Foundation of China","keywords":"Medicine; Pembrolizumab; Lung cancer; Oncology; Public health; Health services research; Chemotherapy; Health administration; Health economics; Quality of Life Research; Stage (stratigraphy); Internal medicine; Cost effectiveness; Cancer; Immunotherapy; Pathology","score_opus":0.03294104266757879,"score_gpt":0.35881668465723265,"score_spread":0.32587564198965385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200232423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8496395,0.08821522,0.018835261,0.004302721,0.00037993892,0.001797485,0.021098515,0.00021822426,0.015513086],"genre_scores_gemma":[0.9828058,0.0053675077,0.0045118113,0.0004907411,0.000060741608,0.00041331677,0.0057385564,0.000021340516,0.0005903079],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9961755,0.0029625755,0.00015030456,0.0002378455,0.00030277143,0.00017087035],"domain_scores_gemma":[0.99533033,0.0034989591,0.0005335309,0.00016097975,0.00031085842,0.00016526785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067224572,0.0012074169,0.0023115636,0.0025252756,0.00021380375,0.0016368764,0.0010183918,0.0009522902,0.0048640557],"category_scores_gemma":[0.011667457,0.0007411795,0.007522231,0.0022963393,0.0002965446,0.0009705639,0.00079153414,0.0011070732,0.00023204456],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021278288,0.0015930145,0.04663852,0.0062314346,0.037664298,0.0007949402,0.00011341972,0.78697336,0.0012592904,0.0101584215,0.013490143,0.0738048],"study_design_scores_gemma":[0.0072617675,0.0052559236,0.06577129,0.0030578969,0.045027494,0.0012805795,0.00033617447,0.8474562,0.0011529541,0.0100894,0.013067802,0.00024250576],"about_ca_topic_score_codex":0.01682479,"about_ca_topic_score_gemma":0.012530851,"teacher_disagreement_score":0.01682479,"about_ca_system_score_codex":0.0043858374,"about_ca_system_score_gemma":0.0024158107,"threshold_uncertainty_score":0.035552144},"labels":[],"label_agreement":null},{"id":"W4200374965","doi":"10.3390/radiation1040026","title":"Limited-Stage Small-Cell Lung Cancer: Current Progress and the Next Frontier","year":2021,"lang":"en","type":"article","venue":"Radiation","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Weill Cornell Medical College; Canada Foundation for Innovation; Canadian Institutes of Health Research; International Association for the Study of Lung Cancer; Cancer Research Society; Memorial Sloan-Kettering Cancer Center; American Society of Clinical Oncology; National Cancer Institute; Ontario Institute for Cancer Research; Conquer Cancer Foundation","keywords":"Prophylactic cranial irradiation; Medicine; Conventional PCI; Oncology; Radiation therapy; Stage (stratigraphy); Clinical trial; Lung cancer; Internal medicine; Radiology","score_opus":0.03125763640342262,"score_gpt":0.34713092787304717,"score_spread":0.31587329146962456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200374965","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033129202,0.99396825,0.00020012334,0.0042609833,0.00043374865,0.0000053000326,0.000015691785,0.0000137003435,0.00077093],"genre_scores_gemma":[0.0026099605,0.9940691,0.0004815101,0.0013961907,0.0010597139,0.00000882761,0.00003660031,0.0000043250398,0.00033394035],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994462,0.00014576329,0.00010091511,0.0000833889,0.00016245864,0.00006116743],"domain_scores_gemma":[0.99694437,0.0016942257,0.00030787714,0.00006838482,0.00070255285,0.0002825056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024584224,0.0003537688,0.000866234,0.0013668344,0.00039517996,0.0018837175,0.00058145897,0.001092409,0.002159062],"category_scores_gemma":[0.0026985838,0.00016058102,0.0005820525,0.0015884701,0.0009165019,0.0033297024,0.00081851834,0.0020727217,0.00086173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017417409,0.00007327966,0.0014706503,0.010429473,0.000063750245,0.00019451306,0.00013195106,0.00024917044,0.0013047879,0.006551576,0.031094281,0.9482624],"study_design_scores_gemma":[0.000022420727,0.00042650357,0.0022406706,0.0064395205,0.00018549428,0.0012414786,0.00043367536,0.00025323176,0.00075790467,0.006114456,0.9818485,0.000036118665],"about_ca_topic_score_codex":0.0010977127,"about_ca_topic_score_gemma":0.00294002,"teacher_disagreement_score":0.0024584224,"about_ca_system_score_codex":0.00097246567,"about_ca_system_score_gemma":0.0032976435,"threshold_uncertainty_score":0.013001561},"labels":[],"label_agreement":null},{"id":"W4200625024","doi":"10.51731/cjht.2021.145","title":"Durvalumab (Imfinzi)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Reimbursement; Carboplatin; Medicine; Etoposide; Authorization; Cisplatin; Intensive care medicine; Political science; Cancer; Surgery; Chemotherapy; Internal medicine; Law; Computer science; Computer security","score_opus":0.0508276305137164,"score_gpt":0.36922993545455696,"score_spread":0.31840230494084054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200625024","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023153257,0.8789621,0.0015006708,0.004393875,0.0008566611,0.00015848527,0.0017410528,0.00017532535,0.089058496],"genre_scores_gemma":[0.28295317,0.6222809,0.005342944,0.0065082815,0.0004938481,0.00021162962,0.003644885,0.000036803856,0.07852751],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988365,0.00002133061,0.000012078571,0.00001981814,0.000045600354,0.000017536027],"domain_scores_gemma":[0.9999063,0.000025000394,0.000029323208,0.0000033926667,0.000021388621,0.000014640597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003333061,0.00020185036,0.00022890355,0.00032254655,0.00012574105,0.0004380414,0.0003203606,0.00027279288,0.006479558],"category_scores_gemma":[0.00050319935,0.000044858298,0.00024943674,0.00026490554,0.00012601555,0.0003002792,0.00018488485,0.00042095085,0.0011949269],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008027906,0.000051599953,0.00070730544,0.0027298888,0.000110241475,0.00016599138,0.00003932273,0.00014555706,0.005282581,0.0030741652,0.047217228,0.93967336],"study_design_scores_gemma":[0.0005874319,0.00062443834,0.004690406,0.0016417413,0.00023584145,0.0015211285,0.000046084864,0.0001828941,0.0061799777,0.0005803218,0.98369825,0.000011465732],"about_ca_topic_score_codex":0.008440932,"about_ca_topic_score_gemma":0.031068683,"teacher_disagreement_score":0.008440932,"about_ca_system_score_codex":0.0012704132,"about_ca_system_score_gemma":0.00096118863,"threshold_uncertainty_score":0.021676302},"labels":[],"label_agreement":null},{"id":"W4205889660","doi":"10.1016/j.jtocrr.2022.100283","title":"Brief Report: Medical Assistance in Dying in Patients With Lung Cancer","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Lung cancer; Cancer; Internal medicine; Referral; Population; Systemic therapy; Cancer registry; Oncology; Breast cancer; Family medicine","score_opus":0.07544225536086939,"score_gpt":0.5058288438690641,"score_spread":0.4303865885081947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205889660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50884724,0.08428012,0.0013140986,0.21980123,0.04503248,0.0015332471,0.03520351,0.0004474788,0.10354053],"genre_scores_gemma":[0.83228666,0.064965144,0.0012897155,0.034465298,0.03949063,0.0006745575,0.01216578,0.00004344935,0.014618686],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99917346,0.000236099,0.00015538023,0.00011278513,0.00016812597,0.00015398224],"domain_scores_gemma":[0.9948538,0.0013884144,0.001615815,0.00008661112,0.00080751814,0.0012478029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007573961,0.0002499531,0.00025315565,0.001066766,0.0010197831,0.00094495475,0.00036954682,0.0012895142,0.009905721],"category_scores_gemma":[0.004826084,0.00015132102,0.0002238964,0.0012268698,0.00032388422,0.00070952775,0.0007860268,0.0010888542,0.0015812238],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012936363,0.00022373573,0.41683125,0.0013821159,0.000052831176,0.004112668,0.0009581889,0.000078067496,0.00019671403,0.0003384208,0.49999434,0.07570227],"study_design_scores_gemma":[0.00008277265,0.00058561674,0.6563218,0.0024587454,0.00011055236,0.023163658,0.006008917,0.00023775021,0.00032924168,0.00051102415,0.31014356,0.000046405974],"about_ca_topic_score_codex":0.0033288146,"about_ca_topic_score_gemma":0.0050860974,"teacher_disagreement_score":0.009905721,"about_ca_system_score_codex":0.0008582711,"about_ca_system_score_gemma":0.0016226827,"threshold_uncertainty_score":0.033137977},"labels":[],"label_agreement":null},{"id":"W4210807771","doi":"10.1016/j.radonc.2022.01.032","title":"Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials","year":2022,"lang":"en","type":"review","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston General Hospital","funders":"","keywords":"Medicine; Meta-analysis; Prophylactic cranial irradiation; Randomized controlled trial; Radiation therapy; Internal medicine; Conventional PCI; Relative risk; Lung cancer; Oncology; Stage (stratigraphy); Clinical trial; Confidence interval","score_opus":0.4193608039850481,"score_gpt":0.5603529967973521,"score_spread":0.14099219281230396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210807771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01516714,0.98313266,0.0005833267,0.00014808588,0.00018798758,0.00019169039,0.0002632284,0.000030620333,0.00029515065],"genre_scores_gemma":[0.33785948,0.65648204,0.0027487786,0.0010190089,0.00024836758,0.0004410939,0.0005329762,0.000040984345,0.0006272528],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99610376,0.0021542376,0.00082881004,0.0004596449,0.00029805506,0.0001554694],"domain_scores_gemma":[0.99481636,0.003785193,0.0008481345,0.00021354282,0.00019663482,0.00014013043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007554109,0.002515424,0.013012796,0.0019285254,0.00041958952,0.0020603116,0.0015857823,0.0016773408,0.0035771348],"category_scores_gemma":[0.0110660745,0.0012880561,0.025157163,0.00320292,0.000681224,0.0015383345,0.0012138422,0.0025861484,0.00028309983],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028269347,0.00011123715,0.0028242264,0.16722444,0.7720841,0.00007362613,0.00009020999,0.00090441236,0.0005895587,0.00015639018,0.00066162803,0.027010787],"study_design_scores_gemma":[0.0076580863,0.0009916911,0.0030802158,0.0063866694,0.9797299,0.00005777275,0.00005110846,0.00021215306,0.00015285781,0.00027532835,0.0013778271,0.00002638426],"about_ca_topic_score_codex":0.003761582,"about_ca_topic_score_gemma":0.009732656,"teacher_disagreement_score":0.013012796,"about_ca_system_score_codex":0.0015865632,"about_ca_system_score_gemma":0.0011822061,"threshold_uncertainty_score":0.03995043},"labels":[],"label_agreement":null},{"id":"W4213348369","doi":"10.1158/1078-0432.ccr-21-0344","title":"Targeting the Ubiquitin–Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research; International Association for the Study of Lung Cancer; Weill Cornell Medical College; Canada Foundation for Innovation; National Center for Advancing Translational Sciences; Temerty Faculty of Medicine, University of Toronto; Ontario Institute for Cancer Research; Lung Cancer Research Foundation; National Cancer Institute; University of Toronto; Memorial Sloan-Kettering Cancer Center; American Society of Clinical Oncology; Cancer Research Society; National Institutes of Health; Conquer Cancer Foundation","keywords":"Lung cancer; Cancer; Gene; Therapeutic approach; Cell culture; Targeted therapy","score_opus":0.27928867953338987,"score_gpt":0.5313512002930797,"score_spread":0.2520625207596898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213348369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9498312,0.041001808,0.0040379213,0.00057453325,0.00014589312,0.00018817885,0.0006264698,0.00030897887,0.00328514],"genre_scores_gemma":[0.9868019,0.009066644,0.0018090219,0.00015707193,0.00004132562,0.0000867772,0.0006574592,0.000011363267,0.0013684109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999138,0.000014227008,0.0000091010825,0.000017466988,0.000024172425,0.000021197007],"domain_scores_gemma":[0.99993014,0.0000129901,0.000022265413,0.000006733887,0.000009246963,0.00001854602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022058321,0.00042546255,0.00044100356,0.0002844412,0.00018449056,0.000506451,0.0003270856,0.0002848548,0.0017361483],"category_scores_gemma":[0.0001046075,0.00013113079,0.00046100718,0.00026380713,0.00025744812,0.00025834807,0.00016336607,0.0007986185,0.0005090869],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011614806,0.00058970787,0.0014844706,0.00050837547,0.00006903643,0.0002330753,0.000034322195,0.000817439,0.958616,0.00021051681,0.00061897613,0.035656657],"study_design_scores_gemma":[0.00039885787,0.01343171,0.012812123,0.00006496587,0.00026643652,0.0016715785,0.00010010731,0.0027704819,0.9546171,0.00022218253,0.013612868,0.000031603977],"about_ca_topic_score_codex":0.00021983344,"about_ca_topic_score_gemma":0.0007364664,"teacher_disagreement_score":0.0017361483,"about_ca_system_score_codex":0.0002927869,"about_ca_system_score_gemma":0.00030760813,"threshold_uncertainty_score":0.005807936},"labels":[],"label_agreement":null},{"id":"W4214922303","doi":"10.1016/j.jncc.2022.02.003","title":"Radiotherapy for small cell lung cancer in current clinical practice guidelines","year":2022,"lang":"en","type":"review","venue":"Journal of the National Cancer Center","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Guideline; Medicine; Radiation therapy; Prophylactic cranial irradiation; Stage (stratigraphy); Conventional PCI; Lung cancer; Medical physics; Radiology; Oncology; Internal medicine; Pathology","score_opus":0.37240348404292484,"score_gpt":0.6262446593367588,"score_spread":0.25384117529383393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214922303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012853611,0.9701329,0.0025159367,0.014181105,0.001842324,0.001669696,0.0023703275,0.000089482404,0.0059128325],"genre_scores_gemma":[0.024773397,0.92291915,0.028176317,0.013505625,0.0008577209,0.0046494724,0.004022688,0.00006446024,0.0010312125],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9390372,0.023749087,0.0261913,0.0023482977,0.0079458915,0.00072829763],"domain_scores_gemma":[0.8537636,0.08581568,0.02711577,0.002736083,0.028976684,0.0015921562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037945256,0.001020078,0.0030188032,0.0128368605,0.001089154,0.004838326,0.003990686,0.0037056785,0.0070140664],"category_scores_gemma":[0.18183103,0.001090151,0.0052082734,0.014319272,0.0013049844,0.0052025747,0.0023985386,0.0031950288,0.0017244305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012726532,0.00005605062,0.0027958278,0.5458809,0.0023104,0.00017964153,0.0016294451,0.0004860812,0.00025572028,0.0044682017,0.07623804,0.36557242],"study_design_scores_gemma":[0.0002650644,0.00007817382,0.0033319923,0.79210895,0.0045292997,0.00027243223,0.0007094563,0.00021823902,0.00014818934,0.003860712,0.19440916,0.0000683846],"about_ca_topic_score_codex":0.014222331,"about_ca_topic_score_gemma":0.028719766,"teacher_disagreement_score":0.037945256,"about_ca_system_score_codex":0.0071911053,"about_ca_system_score_gemma":0.027146444,"threshold_uncertainty_score":0.20067608},"labels":[],"label_agreement":null},{"id":"W4220732082","doi":"10.1093/neuonc/noac072","title":"Effectiveness and safety of pneumocystis pneumonia prophylaxis for patients receiving temozolomide chemoradiotherapy","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Western University","funders":"Ontario Ministry of Health and Long-Term Care; Canadian Cancer Society; Canadian Centre for Applied Research in Cancer Control","keywords":"Medicine; Temozolomide; Chemoradiotherapy; Internal medicine; Population; Cohort; Retrospective cohort study; Neutropenia; Oncology; Surgery; Cancer; Radiation therapy; Chemotherapy","score_opus":0.014494316526808593,"score_gpt":0.32554737051981536,"score_spread":0.31105305399300676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220732082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966779,0.0018614568,0.000117867734,0.00035598746,0.000010921935,0.000029157622,0.0002471006,0.000005286149,0.0006943812],"genre_scores_gemma":[0.9994923,0.00024053016,0.000054501972,0.000041288502,0.000010391898,0.000004909703,0.00012986672,7.431725e-7,0.000025460335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986406,0.0004362431,0.00014530976,0.00013820366,0.00050615805,0.00013346676],"domain_scores_gemma":[0.99258065,0.0016842621,0.0043763034,0.00021309259,0.0004930211,0.00065257965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001499233,0.0001320022,0.00038775362,0.0002745664,0.00024593255,0.00054094195,0.0002715186,0.00030920087,0.00058761466],"category_scores_gemma":[0.014020847,0.00010428311,0.0006867052,0.0004965558,0.00023455209,0.00025911527,0.00022846855,0.00035556013,0.000062788764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030223895,0.00012566669,0.9636478,0.00011725146,0.0004504,0.00007254644,0.000069091606,0.0006694177,0.0002202549,0.00004383649,0.00036277788,0.031198686],"study_design_scores_gemma":[0.00015537573,0.001398327,0.99601644,0.00004499761,0.00030852776,0.00013897143,0.000049947517,0.0013271013,0.00013486923,0.00005013206,0.0003687818,0.0000064164137],"about_ca_topic_score_codex":0.026756577,"about_ca_topic_score_gemma":0.03626979,"teacher_disagreement_score":0.026756577,"about_ca_system_score_codex":0.002206341,"about_ca_system_score_gemma":0.002493075,"threshold_uncertainty_score":0.053201675},"labels":[],"label_agreement":null},{"id":"W4220777831","doi":"10.21203/rs.3.rs-1375680/v1","title":"Similar Programmed Death Ligand 1 (PD-L1) expression profile in patients with mild COPD and lung cancer","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"COPD; Lung cancer; Medicine; Bronchoalveolar lavage; Lung; Pathology; Parenchyma; Immunohistochemistry; Biomarker; Internal medicine; Immunology; Biology","score_opus":0.05457109385535603,"score_gpt":0.4371590814133415,"score_spread":0.38258798755798545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220777831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905354,0.00018359777,0.000104734936,0.00001571383,0.0000031415643,0.0000074249247,0.00030397644,0.0000041271855,0.00032365718],"genre_scores_gemma":[0.99931026,0.00003323112,0.00006984264,0.000020998319,0.0000048324373,0.000008314034,0.000399334,0.0000011828514,0.00015204721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985063,0.000019059053,0.000016857743,0.000061224404,0.000022671056,0.000029556144],"domain_scores_gemma":[0.99975127,0.00004028061,0.00007148504,0.000016691718,0.000041875424,0.00007836068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013427628,0.00015162911,0.00028549967,0.0006969327,0.00033992116,0.00041434576,0.00014076036,0.0003770532,0.001360218],"category_scores_gemma":[0.00048068605,0.00009513291,0.00019268149,0.000459774,0.00017404891,0.00017420267,0.00025330606,0.0002525137,0.0002603718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049372384,0.00004472228,0.9902874,0.000022719354,0.0000327174,0.00018054614,0.00009321538,0.000027781807,0.006503818,0.000023215358,0.00009680643,0.0021931587],"study_design_scores_gemma":[0.000007776159,0.00015132259,0.9983146,0.0000029897394,0.00002053567,0.00058728753,0.00011753599,0.00010132971,0.00043485375,0.00003192186,0.00022692393,0.0000028924758],"about_ca_topic_score_codex":0.0009678358,"about_ca_topic_score_gemma":0.001086647,"teacher_disagreement_score":0.001360218,"about_ca_system_score_codex":0.00016753018,"about_ca_system_score_gemma":0.00012046869,"threshold_uncertainty_score":0.004550338},"labels":[],"label_agreement":null},{"id":"W4220915836","doi":"10.1016/j.ijrobp.2022.03.020","title":"Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors","year":2022,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; National Institutes of Health; National Center for Advancing Translational Sciences; University of Minnesota","keywords":"Medicine; Lung cancer; Internal medicine; Adenocarcinoma; Oncology; Anaplastic lymphoma kinase; Brain metastasis; Lung; Epidermal growth factor receptor; Cancer; Population; Metastasis","score_opus":0.02320506572987794,"score_gpt":0.37326191633565264,"score_spread":0.3500568506057747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220915836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.629687,0.26633045,0.029780507,0.018594854,0.004027831,0.00090326404,0.009399928,0.0005328806,0.040743228],"genre_scores_gemma":[0.89294535,0.06901916,0.021097073,0.0030760313,0.002263947,0.00044893747,0.0080592865,0.00005871215,0.0030314769],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99962795,0.00008306013,0.00004861994,0.000055017266,0.00013649916,0.000048843336],"domain_scores_gemma":[0.998437,0.00042883135,0.00022174433,0.000086865235,0.0006583351,0.00016723269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019639127,0.0005625332,0.00061468605,0.0012672094,0.00024735453,0.00067274127,0.00063818856,0.00031423327,0.00067224615],"category_scores_gemma":[0.004653389,0.00009423948,0.00068179425,0.0013223793,0.0002738851,0.0008811325,0.00087951694,0.001158206,0.00025478308],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005170635,0.000090614405,0.30142272,0.0005207917,0.0003902356,0.00029275555,0.00012824609,0.00097293174,0.0012261281,0.0014139207,0.016164998,0.6768596],"study_design_scores_gemma":[0.00027656808,0.0019178141,0.8607885,0.0011546474,0.0017566689,0.004934581,0.0005769965,0.006270386,0.0025564304,0.007743336,0.11187831,0.00014572208],"about_ca_topic_score_codex":0.002334404,"about_ca_topic_score_gemma":0.0052285064,"teacher_disagreement_score":0.002334404,"about_ca_system_score_codex":0.00054340204,"about_ca_system_score_gemma":0.00080886827,"threshold_uncertainty_score":0.010386288},"labels":[],"label_agreement":null},{"id":"W4221131077","doi":"10.1016/j.lungcan.2022.03.003","title":"Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer","year":2022,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"United Therapeutics Corporation","keywords":"Irinotecan; Topotecan; Medicine; Tolerability; Internal medicine; Clinical endpoint; Oncology; Lung cancer; Randomized controlled trial; Chemotherapy; Cancer; Adverse effect; Colorectal cancer","score_opus":0.032677582691871036,"score_gpt":0.39410300744961657,"score_spread":0.36142542475774553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221131077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853896,0.00364347,0.000830879,0.00082702504,0.0011151377,0.0035879086,0.0014472889,0.00014855669,0.0030101298],"genre_scores_gemma":[0.9814719,0.0023291819,0.0019084142,0.0018983579,0.000604058,0.0044209147,0.0021179984,0.000070368005,0.005178799],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99894327,0.000619287,0.000042417807,0.00015371847,0.000068068235,0.00017324538],"domain_scores_gemma":[0.99833715,0.000539737,0.0002920732,0.00016615426,0.00009586402,0.0005690108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025309885,0.0021458024,0.004084206,0.0005078043,0.0007035519,0.0016495829,0.0015233236,0.0019899446,0.008340904],"category_scores_gemma":[0.0020712467,0.0009612559,0.0030151242,0.0006002388,0.0016452334,0.0013790749,0.00059455953,0.00527744,0.0011814164],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9891922,0.0041741272,0.0002053314,0.00013926036,0.0006828621,0.000015799473,0.000022786875,0.0002685123,0.0010232109,0.00007184565,0.00040697592,0.0037970103],"study_design_scores_gemma":[0.958862,0.038733434,0.0008551178,0.000012461395,0.00041784177,0.000014756122,0.000017989969,0.0003024096,0.0002489253,0.0001351642,0.0003886458,0.000011390366],"about_ca_topic_score_codex":0.0037515054,"about_ca_topic_score_gemma":0.007854243,"teacher_disagreement_score":0.008340904,"about_ca_system_score_codex":0.0020768761,"about_ca_system_score_gemma":0.0026117172,"threshold_uncertainty_score":0.02790308},"labels":[],"label_agreement":null},{"id":"W4224983146","doi":"10.1016/s1470-2045(22)00155-3","title":"Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431","year":2022,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Cohort; Chemotherapy; Quality of life (healthcare); Hearing loss; Childhood cancer; Cisplatin; Cancer; Scopus","score_opus":0.16263474852385781,"score_gpt":0.4396365639109289,"score_spread":0.27700181538707114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224983146","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01742578,0.8825631,0.0017331393,0.02204904,0.006220533,0.0005872726,0.048532493,0.0002645618,0.020624053],"genre_scores_gemma":[0.09742951,0.7687113,0.0040592733,0.033203408,0.012799939,0.0011564967,0.06913887,0.00028541373,0.013215716],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9974401,0.00060949574,0.0005679952,0.00019644438,0.00095710915,0.00022891843],"domain_scores_gemma":[0.9920007,0.002268321,0.0024769332,0.0004158363,0.0022412403,0.00059699273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050274218,0.00090458937,0.0030551082,0.0028440957,0.0003073924,0.001723667,0.0010071204,0.0016030334,0.007373214],"category_scores_gemma":[0.009670495,0.00044202586,0.0035691455,0.004847744,0.00026865772,0.0012202831,0.00093405036,0.002211322,0.0019493771],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010920401,0.0002822672,0.008360649,0.016184196,0.0064645903,0.00016029475,0.00008351189,0.0013310419,0.0008357233,0.0007341744,0.28450018,0.670143],"study_design_scores_gemma":[0.012503417,0.005114517,0.13549049,0.025695827,0.033765804,0.0008749773,0.0001540796,0.00075704453,0.0014545086,0.0019796593,0.78198963,0.00021995552],"about_ca_topic_score_codex":0.011747534,"about_ca_topic_score_gemma":0.027611613,"teacher_disagreement_score":0.011747534,"about_ca_system_score_codex":0.0020868082,"about_ca_system_score_gemma":0.0033915865,"threshold_uncertainty_score":0.026587903},"labels":[],"label_agreement":null},{"id":"W4232987386","doi":"10.1200/jco.2004.22.14_suppl.4545","title":"Genitourinary (GU) small cell carcinoma (SCC): A retrospective review of treatment and survival patterns at the Ottawa Regional Cancer Center (ORCC)","year":2004,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Cancer; Genitourinary system; Center (category theory); Retrospective cohort study; Oncology; Carcinoma; Internal medicine; Gynecology; General surgery","score_opus":0.24924841216649174,"score_gpt":0.5285793021020718,"score_spread":0.2793308899355801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232987386","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98547167,0.007966752,0.000058151192,0.00010469061,0.000010920679,0.000050321054,0.0052369256,0.000011307059,0.0010892686],"genre_scores_gemma":[0.9940952,0.0033039863,0.00008003104,0.00007791246,0.0000074042205,0.000023689867,0.0021699006,0.0000040888976,0.00023779241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992537,0.00009134317,0.00015251304,0.00016797826,0.00021357331,0.00012093736],"domain_scores_gemma":[0.99757534,0.00033845546,0.0010856624,0.000112053254,0.00065207767,0.00023651063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041803427,0.00018622451,0.00028154,0.001960815,0.0006890867,0.00055854645,0.0005399362,0.00024038284,0.0012495404],"category_scores_gemma":[0.0016014414,0.0002307165,0.00029206398,0.0043669096,0.00041223716,0.00026797366,0.00041928946,0.00017623942,0.00022153444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003655366,0.0000053073104,0.9959115,0.00013166993,0.00002878909,0.0003104153,0.00022572125,0.000017531198,0.0001605419,0.0000074000063,0.00051621144,0.0026483869],"study_design_scores_gemma":[0.0000012994102,0.000021866093,0.99814427,0.000054534456,0.000025924413,0.0005085219,0.00040953592,0.000015377413,0.000070487884,0.0000021663911,0.0007430884,0.0000029308421],"about_ca_topic_score_codex":0.28238574,"about_ca_topic_score_gemma":0.43203813,"teacher_disagreement_score":0.28238574,"about_ca_system_score_codex":0.0021682088,"about_ca_system_score_gemma":0.002708687,"threshold_uncertainty_score":0.5614841},"labels":[],"label_agreement":null},{"id":"W4237148214","doi":"10.21037/tcr.2017.04.14","title":"Targeting angiogenesis in small cell lung cancer","year":2017,"lang":"en","type":"article","venue":"Translational Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Research Society","funders":"","keywords":"Angiogenesis; Lung cancer; Medicine; Cancer research; Cancer; Oncology; Internal medicine","score_opus":0.1453075354616456,"score_gpt":0.48705733587026795,"score_spread":0.34174980040862235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237148214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76260066,0.17437257,0.012745617,0.013722634,0.0010521272,0.00070220086,0.00020012789,0.00021172987,0.034392316],"genre_scores_gemma":[0.94287944,0.046540163,0.004162776,0.0011421909,0.0005410982,0.00025808727,0.00011630962,0.000024734458,0.0043351254],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99952555,0.000299039,0.000015557607,0.00002818726,0.000060344748,0.00007128715],"domain_scores_gemma":[0.999313,0.00034187527,0.00010466767,0.000056043322,0.00006718378,0.00011723106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020640907,0.00024675718,0.00033026322,0.0004524073,0.0003223311,0.0005853516,0.0003446675,0.00048274227,0.0024464536],"category_scores_gemma":[0.0012221757,0.000104393956,0.00027393157,0.00037908758,0.00067255436,0.0006871579,0.0003861735,0.0010017672,0.00023016633],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068819947,0.006556745,0.007476186,0.0028809935,0.0002396549,0.0010293397,0.00062021794,0.0011773447,0.383302,0.027787914,0.011231725,0.55081594],"study_design_scores_gemma":[0.00520601,0.07710265,0.040194254,0.0011122323,0.0012576182,0.0057743336,0.0015098859,0.0043362943,0.5958654,0.017966937,0.24961329,0.00006111167],"about_ca_topic_score_codex":0.00064444245,"about_ca_topic_score_gemma":0.0012842153,"teacher_disagreement_score":0.0024464536,"about_ca_system_score_codex":0.00046130366,"about_ca_system_score_gemma":0.0008559566,"threshold_uncertainty_score":0.010916114},"labels":[],"label_agreement":null},{"id":"W4239651622","doi":"10.1136/ijgc-00009577-200505001-00007","title":"Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Carboplatin; Medicine; Gemcitabine; Ovarian cancer; Internal medicine; Oncology; Hazard ratio; Regimen; Chemotherapy; Cancer; Surgery; Confidence interval; Cisplatin","score_opus":0.03470059525404154,"score_gpt":0.38610234289378614,"score_spread":0.35140174763974463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239651622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95344466,0.041844137,0.00015647967,0.00058991904,0.00021475897,0.0002126555,0.00021160433,0.000026664211,0.0032993304],"genre_scores_gemma":[0.9832072,0.014339453,0.00037149113,0.00020567738,0.00023109477,0.00013793694,0.0002980666,0.000011089057,0.001197817],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990447,0.0006108391,0.0000870324,0.00008068133,0.00009526605,0.00008137728],"domain_scores_gemma":[0.9992144,0.00031907958,0.00016589981,0.00009168937,0.00004290789,0.00016593066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014106662,0.00043030558,0.0019237065,0.0011288191,0.00042370558,0.0004893174,0.000597554,0.00068772305,0.002489944],"category_scores_gemma":[0.0017602191,0.00033871213,0.0012546871,0.0011905023,0.00033216603,0.0006160482,0.0003855088,0.0012065092,0.00036446878],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29856613,0.009770073,0.054343075,0.0023800866,0.0049316213,0.0010714803,0.00067929993,0.0031594431,0.021748358,0.00040236788,0.0038122446,0.5991358],"study_design_scores_gemma":[0.10374955,0.5104014,0.30363083,0.0007698665,0.012301561,0.0048645553,0.00070916663,0.0031866,0.019378448,0.00059865526,0.040283952,0.00012535143],"about_ca_topic_score_codex":0.0025328912,"about_ca_topic_score_gemma":0.0057933656,"teacher_disagreement_score":0.0025328912,"about_ca_system_score_codex":0.0010868737,"about_ca_system_score_gemma":0.0007814815,"threshold_uncertainty_score":0.008329749},"labels":[],"label_agreement":null},{"id":"W4240718667","doi":"10.1158/1538-7445.sabcs18-2699","title":"Abstract 2699: Targeting an ubiquitin-activating enzyme in small-cell lung cancer (SCLC)","year":2019,"lang":"en","type":"article","venue":"Experimental and Molecular Therapeutics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Etoposide; Cancer research; Lung cancer; Cisplatin; Cancer; Cell culture; Medicine; Viability assay; Chemotherapy; Cancer cell; Cell; Biology; Oncology; Internal medicine; Genetics","score_opus":0.02517772543423411,"score_gpt":0.3542647523675444,"score_spread":0.32908702693331027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240718667","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98595643,0.006404739,0.0023481895,0.00027024877,0.00015511269,0.00018679211,0.0012693906,0.00019335038,0.0032156114],"genre_scores_gemma":[0.9872946,0.003700007,0.002958603,0.00012876058,0.000040015806,0.00012677159,0.0020385499,0.00002010029,0.0036925373],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998883,0.000014479487,0.0000114371005,0.000020154757,0.000037730573,0.00002787948],"domain_scores_gemma":[0.9999324,0.000011536375,0.000011209186,0.000005858919,0.00001227982,0.000026710935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017771192,0.00046882476,0.00036202828,0.0002925787,0.00021572366,0.00029476907,0.00028793694,0.00040206473,0.002540114],"category_scores_gemma":[0.000095011244,0.00011830483,0.00033031643,0.00030370505,0.00020352902,0.0001623559,0.00016699987,0.0007341551,0.0009474729],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004990431,0.00024105376,0.00040100465,0.00022948728,0.00002125857,0.00017835555,0.000012642967,0.00023481158,0.9905337,0.00007443884,0.00042404066,0.007150236],"study_design_scores_gemma":[0.0001826735,0.005873649,0.004770065,0.000017126376,0.000097643424,0.0013719191,0.000038313457,0.0009689465,0.9806928,0.000069302914,0.005906054,0.000011380981],"about_ca_topic_score_codex":0.00056883396,"about_ca_topic_score_gemma":0.0012500004,"teacher_disagreement_score":0.002540114,"about_ca_system_score_codex":0.0002606428,"about_ca_system_score_gemma":0.00031307753,"threshold_uncertainty_score":0.008497536},"labels":[],"label_agreement":null},{"id":"W4241797950","doi":"10.1007/978-3-540-47648-1_2076","title":"Extrapulmonary Small Cell Cancer","year":2008,"lang":"en","type":"book-chapter","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Cancer; Medicine; Cancer research; Internal medicine","score_opus":0.06504446233578648,"score_gpt":0.32109718882963434,"score_spread":0.25605272649384786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241797950","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006566479,0.19320315,0.0036090969,0.011254564,0.01066734,0.00008052538,0.00048706567,0.00013336758,0.7799082],"genre_scores_gemma":[0.004104817,0.11505807,0.0028572164,0.0074945255,0.0040484644,0.00011548541,0.0004247675,0.0000809264,0.8658158],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999866,0.00003718761,0.0000068438376,0.000014341708,0.00006487706,0.000010822231],"domain_scores_gemma":[0.9997148,0.00018573554,0.000009387227,0.000019902234,0.00004695485,0.000023175518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041316092,0.00040198982,0.00046800898,0.0008702957,0.0004017067,0.0010137844,0.00043776777,0.00066850195,0.036014266],"category_scores_gemma":[0.00077533076,0.0001757801,0.00020304522,0.0010701602,0.00054442696,0.000953644,0.0007237511,0.00134916,0.009646044],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010248319,0.000029542036,0.00013680934,0.00035462432,0.0000045763786,0.000116151205,0.00012797328,0.00012097792,0.00031504233,0.03757993,0.7006984,0.26050577],"study_design_scores_gemma":[0.0000022808388,0.000006979619,0.00039046275,0.0002008672,0.0000030602514,0.0002931536,0.000043287277,0.000025788551,0.000085579275,0.008784851,0.99016154,0.0000021608103],"about_ca_topic_score_codex":0.0022665726,"about_ca_topic_score_gemma":0.012040425,"teacher_disagreement_score":0.036014266,"about_ca_system_score_codex":0.000834702,"about_ca_system_score_gemma":0.0010123069,"threshold_uncertainty_score":0.1204797},"labels":[],"label_agreement":null},{"id":"W4242351383","doi":"10.4081/mrm.2013.577","title":"CD24+/CD38- as new prognostic marker for non-small cell lung cancer","year":2013,"lang":"en","type":"article","venue":"Multidisciplinary Respiratory Medicine","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"CD24; Medicine; Lung cancer; Biomarker; Oncology; CD38; Cancer research; Cancer; Internal medicine; Pathology; Breast cancer; Biology; Stem cell; CD34","score_opus":0.04814623829855125,"score_gpt":0.3798468214217289,"score_spread":0.33170058312317763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242351383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99414283,0.0032455886,0.001100031,0.00015335095,0.000020574738,0.000055074775,0.0002458861,0.00004058462,0.0009960064],"genre_scores_gemma":[0.99593973,0.00052479375,0.0026222302,0.000028408593,0.000023951836,0.000030762803,0.00034499905,0.0000030265326,0.00048212465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998584,0.000030043297,0.000012464785,0.000023862318,0.00005410435,0.000021105267],"domain_scores_gemma":[0.9997801,0.00004738199,0.00005612848,0.00001254582,0.000055216093,0.00004860754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004196617,0.00027359175,0.00022958792,0.00085055316,0.0001680346,0.00037285534,0.00026297168,0.00027655865,0.00203233],"category_scores_gemma":[0.0005729011,0.00007337012,0.00013989516,0.0004827393,0.00014990527,0.00026745247,0.00016839147,0.00029598307,0.00040038544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017494998,0.00031607057,0.5959903,0.00027081862,0.00010301264,0.0008463018,0.00010317703,0.0006902878,0.31005546,0.00016936586,0.001121812,0.08858388],"study_design_scores_gemma":[0.00013592617,0.0029275476,0.7482471,0.000072919545,0.0003161358,0.009654529,0.0002231285,0.010783751,0.21239342,0.0007104902,0.014496592,0.000038462567],"about_ca_topic_score_codex":0.00032905355,"about_ca_topic_score_gemma":0.00060649816,"teacher_disagreement_score":0.00203233,"about_ca_system_score_codex":0.00023140605,"about_ca_system_score_gemma":0.00018192947,"threshold_uncertainty_score":0.0067988634},"labels":[],"label_agreement":null},{"id":"W4242644534","doi":"10.1007/bf02665359","title":"Pharmacokinetics of etoposide in cancer patients treated with high-dose etoposide and with dexrazoxane (ICRF-187) as a rescue agent","year":2004,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Etoposide; Pharmacokinetics; Dexrazoxane; Pharmacology; Medicine; Toxicity; Chemotherapy; Cancer; Internal medicine; Breast cancer","score_opus":0.018015198205579865,"score_gpt":0.35429900040109963,"score_spread":0.3362838021955198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242644534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745136,0.0011723523,0.000316792,0.000100426805,0.00002697363,0.00004165695,0.00015628249,0.000045247998,0.0006888389],"genre_scores_gemma":[0.9986072,0.0002290327,0.00030651063,0.00006305642,0.000036178462,0.00002623356,0.00024828094,0.000019938265,0.00046362387],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99941695,0.0003552555,0.000027381902,0.00006590557,0.00006797631,0.00006646411],"domain_scores_gemma":[0.9989575,0.00037375683,0.00019942017,0.00013390926,0.00005361745,0.000281773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007022862,0.0004256352,0.0012678282,0.00031273806,0.00031039264,0.000705339,0.00037954445,0.00060763216,0.0015037075],"category_scores_gemma":[0.0026092143,0.0004936398,0.00056066347,0.00034328052,0.0005716929,0.0010715139,0.00018810567,0.001471514,0.00040864572],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58235383,0.004648498,0.07183614,0.00023200944,0.0012845617,0.0019679724,0.0010510291,0.00945303,0.25257483,0.00082408224,0.0032103185,0.07056371],"study_design_scores_gemma":[0.032713354,0.24605694,0.53365225,0.00006616684,0.0015940452,0.0073547526,0.0009917895,0.026369503,0.13954115,0.0008718219,0.010550953,0.00023730056],"about_ca_topic_score_codex":0.0012387353,"about_ca_topic_score_gemma":0.0011857626,"teacher_disagreement_score":0.0015037075,"about_ca_system_score_codex":0.00061880896,"about_ca_system_score_gemma":0.0005659547,"threshold_uncertainty_score":0.0050303936},"labels":[],"label_agreement":null},{"id":"W4242720353","doi":"10.1200/jco.2006.10.4729","title":"In Reply","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine","score_opus":0.2537950998688346,"score_gpt":0.6361347659901684,"score_spread":0.3823396661213338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242720353","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020958351,0.0013279459,0.000058287776,0.9086819,0.08834443,0.000022173395,0.00009607446,0.000023868046,0.0012357712],"genre_scores_gemma":[0.0008384582,0.00048731198,0.00007166175,0.9642188,0.028469019,0.000049803082,0.000027171784,0.000014344464,0.005823451],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932775,0.0016667381,0.000908989,0.0010078772,0.0020392828,0.0010994646],"domain_scores_gemma":[0.9626825,0.020703863,0.0025728547,0.0013182417,0.008264491,0.00445807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007963596,0.0011020865,0.0019387817,0.0017280608,0.005020378,0.008130863,0.0036301818,0.04638428,0.022798944],"category_scores_gemma":[0.066032246,0.0012515045,0.0019245525,0.0014563695,0.0035941475,0.0049644727,0.0045988313,0.0501551,0.014079988],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025182588,0.0000088552515,0.0002983873,0.000041866704,0.000016467726,0.00017242049,0.00007900891,0.000009887305,0.00004561539,0.00049125706,0.99728453,0.0015264634],"study_design_scores_gemma":[0.000110847555,0.00003296384,0.0017445905,0.00024247819,0.00007666077,0.0004557393,0.00091537763,0.00007943107,0.00022305695,0.0019551702,0.9940948,0.00006891081],"about_ca_topic_score_codex":0.0063719274,"about_ca_topic_score_gemma":0.01029963,"teacher_disagreement_score":0.04638428,"about_ca_system_score_codex":0.0050937976,"about_ca_system_score_gemma":0.007947398,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4243006526","doi":"10.21037/tcr.2016.11.51","title":"Combination chemotherapy for relapsed small-cell lung cancer—perspective on mechanisms of chemoresistance","year":2016,"lang":"en","type":"article","venue":"Translational Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Research Society","funders":"","keywords":"Etoposide; Medicine; Topotecan; Chemotherapy; Oncology; Cisplatin; Irinotecan; Regimen; Internal medicine; Combination chemotherapy; Lung cancer; Vinca; Cancer; Cancer research; Pharmacology; Colorectal cancer","score_opus":0.07202568808614888,"score_gpt":0.44274057648487847,"score_spread":0.37071488839872957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243006526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004433865,0.9684721,0.0009635006,0.020018173,0.000989529,0.000028229977,0.000034780005,0.00003523021,0.0050246324],"genre_scores_gemma":[0.037887968,0.9457951,0.0016454186,0.0069336407,0.0058333986,0.00009211126,0.000060735572,0.000019388535,0.0017321742],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99931836,0.00034105065,0.00005322799,0.00006560505,0.00014686953,0.00007491174],"domain_scores_gemma":[0.9985051,0.00094216893,0.00014072558,0.00007445294,0.0002225185,0.000115156065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031328334,0.00050038955,0.0016082588,0.0012542683,0.0002763383,0.0016210976,0.0010007075,0.0013117883,0.0022188893],"category_scores_gemma":[0.0015544092,0.00023341765,0.0008368986,0.00093122467,0.001360772,0.0025473745,0.00080101046,0.0039316462,0.0006244506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016876444,0.0008739967,0.001352873,0.005502627,0.00040590815,0.0007218771,0.0002277352,0.001602461,0.0061293985,0.03335786,0.033923775,0.9142138],"study_design_scores_gemma":[0.0023898971,0.014785876,0.01063156,0.007220555,0.00080627616,0.0042099813,0.0005528939,0.0032452808,0.0037577068,0.05728062,0.89497274,0.00014662139],"about_ca_topic_score_codex":0.0004738035,"about_ca_topic_score_gemma":0.0015267746,"teacher_disagreement_score":0.0031328334,"about_ca_system_score_codex":0.0010669118,"about_ca_system_score_gemma":0.0011580708,"threshold_uncertainty_score":0.016568184},"labels":[],"label_agreement":null},{"id":"W4243150102","doi":"10.1158/1538-7445.am2019-lb-148","title":"Abstract LB-148: Combination treatment of the CHK1 inhibitor, SRA737, and low dose gemcitabine demonstrates profound synergy with anti-PDL1 inducing durable tumor regressions and modulating the immune microenvironment in small cell lung cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Gemcitabine; Cancer research; Immune system; Immune checkpoint; Cytotoxic T cell; Tumor microenvironment; Regimen; Lung cancer; Medicine; Blockade; Immunotherapy; Cancer; Pharmacology; Immunology; Biology; Oncology; Internal medicine; Receptor","score_opus":0.02671144682847327,"score_gpt":0.3339614798496113,"score_spread":0.307250033021138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243150102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968796,0.0008824886,0.00028174336,0.000097791875,0.00004538269,0.000043797714,0.00037206602,0.000119574994,0.0012775403],"genre_scores_gemma":[0.9973104,0.00033617695,0.00049604493,0.000040934992,0.000016562104,0.000042732012,0.0006133633,0.000012390302,0.001131408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998838,0.000022736744,0.000011310122,0.000014334989,0.000026857506,0.00004094847],"domain_scores_gemma":[0.9999095,0.000014673408,0.000015874575,0.000009157583,0.000007089725,0.00004372119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011483795,0.00034449156,0.0005451491,0.00030519234,0.00015872577,0.0002877871,0.00029878854,0.00027016937,0.0019658436],"category_scores_gemma":[0.000095418196,0.00009943384,0.00024889057,0.0002098775,0.00021742996,0.0001499679,0.00012606256,0.00080169656,0.00040676267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006171641,0.002134248,0.000800043,0.00011754236,0.000048179932,0.00012881354,0.000027804557,0.0005405665,0.97556996,0.00011829142,0.0010005508,0.013342358],"study_design_scores_gemma":[0.0008912951,0.023924433,0.006724907,0.0000122510655,0.00010922641,0.00038541824,0.000030105804,0.002123897,0.96338594,0.00003634405,0.0023629148,0.000013172612],"about_ca_topic_score_codex":0.0012806931,"about_ca_topic_score_gemma":0.0023592622,"teacher_disagreement_score":0.0019658436,"about_ca_system_score_codex":0.00022108098,"about_ca_system_score_gemma":0.00047692825,"threshold_uncertainty_score":0.006576419},"labels":[],"label_agreement":null},{"id":"W4245722524","doi":"10.1007/978-1-4419-0461-4_34","title":"CD45 (PTPRC)","year":2012,"lang":"en","type":"book-chapter","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Computer science","score_opus":0.061976767561712345,"score_gpt":0.35397590537197987,"score_spread":0.29199913781026754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245722524","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001671073,0.120761864,0.014709906,0.012167065,0.010209525,0.00009630376,0.0005895752,0.0009108945,0.83888376],"genre_scores_gemma":[0.004449464,0.02058031,0.005065408,0.0036356512,0.001711426,0.000060305392,0.0002656605,0.00012582034,0.96410596],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998572,0.000020354166,0.0000084938,0.00003347671,0.00006582001,0.000014651484],"domain_scores_gemma":[0.9998591,0.00006308208,0.000012114162,0.000012296803,0.000032293156,0.00002103431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033338397,0.0005658266,0.00037380683,0.0006752094,0.0003675512,0.001425469,0.00041874198,0.0008367235,0.060324937],"category_scores_gemma":[0.0006336159,0.00021838235,0.000182539,0.00067272584,0.00031402902,0.0012764789,0.0007591962,0.0013585706,0.02803121],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020166815,0.000025704025,0.00011193679,0.00017903157,0.000003216392,0.000091567046,0.00005187891,0.00010189977,0.0018241839,0.021593519,0.5193159,0.456681],"study_design_scores_gemma":[0.000002117849,0.00000903106,0.00017031422,0.000046071513,0.0000023729895,0.00036278754,0.00001196081,0.000046938276,0.00045962306,0.0037470635,0.99513924,0.0000024127962],"about_ca_topic_score_codex":0.0009414128,"about_ca_topic_score_gemma":0.002726206,"teacher_disagreement_score":0.060324937,"about_ca_system_score_codex":0.0005528008,"about_ca_system_score_gemma":0.0003761128,"threshold_uncertainty_score":0.20180702},"labels":[],"label_agreement":null},{"id":"W4247533665","doi":"10.1002/cncy.21674","title":"Issue Information","year":2016,"lang":"en","type":"paratext","venue":"Cancer Cytopathology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Citation; Medicine; Information retrieval; Library science; World Wide Web; Internet privacy; Computer science","score_opus":0.020997665551220325,"score_gpt":0.3825721909814346,"score_spread":0.36157452543021423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247533665","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029571247,0.0016056983,0.00056428375,0.0115938755,0.034165088,0.0004410111,0.0148794865,0.0011988673,0.93525594],"genre_scores_gemma":[0.0012939927,0.00121517,0.00032415168,0.004536502,0.0062129837,0.00011994239,0.0060207965,0.000326032,0.9799504],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990133,0.00014013384,0.00009702918,0.00011772486,0.0005354931,0.0000963213],"domain_scores_gemma":[0.9942709,0.00096414814,0.00028927796,0.0004006523,0.0027688215,0.0013062408],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010407919,0.0007725323,0.00080842635,0.0023469687,0.0013233653,0.004966388,0.0013833889,0.0022816055,0.8514069],"category_scores_gemma":[0.010236788,0.00034529087,0.00052843,0.0020652432,0.0004665689,0.0031992428,0.0018070353,0.0018707347,0.7422131],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010560615,0.000009960606,0.000047298483,0.00011573435,6.29714e-7,0.000020170797,0.000010394617,0.000011700319,0.00003486361,0.0006844884,0.9751074,0.023946881],"study_design_scores_gemma":[0.000005998886,0.000006614779,0.00015745108,0.00008685627,5.918267e-7,0.000029968785,0.00002103807,0.000013721783,0.000028198641,0.00039711053,0.99925035,0.0000020246484],"about_ca_topic_score_codex":0.0012043954,"about_ca_topic_score_gemma":0.0027865043,"teacher_disagreement_score":0.14859313,"about_ca_system_score_codex":0.0010132673,"about_ca_system_score_gemma":0.0017955329,"threshold_uncertainty_score":0.21195006},"labels":[],"label_agreement":null},{"id":"W4252421162","doi":"10.1016/j.jtho.2016.11.254","title":"OA05.06 Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily versus Twice-Daily RadioTherapy (CONVERT) Trial","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Radiation therapy; Neutropenia; Etoposide; Randomized controlled trial; Chemotherapy; Surgery; Internal medicine","score_opus":0.15799874968648267,"score_gpt":0.52929168415816,"score_spread":0.3712929344716773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252421162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427766,0.003314805,0.0001034161,0.00026308434,0.00015057146,0.000100888574,0.00041393118,0.000021994005,0.0013537328],"genre_scores_gemma":[0.9972524,0.0007565774,0.00012246681,0.00029742933,0.00017068842,0.00007798299,0.0005033153,0.000005506737,0.00081366074],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9995491,0.0002480927,0.000043658813,0.0000723775,0.000032382526,0.000054397628],"domain_scores_gemma":[0.9990024,0.00025190137,0.00034486616,0.00013197334,0.00004689531,0.00022197084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010287836,0.00043146368,0.001520963,0.00015253996,0.00027277312,0.000922766,0.00036650235,0.0007717877,0.0027290299],"category_scores_gemma":[0.0019607944,0.0002172211,0.0015173684,0.0003448879,0.00039582263,0.00047462186,0.00023116963,0.0017439696,0.00031024913],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9408149,0.0024267703,0.01334944,0.0006663049,0.0031603517,0.000068420864,0.00007758424,0.0006290456,0.0030096495,0.00024163192,0.0011952429,0.034360524],"study_design_scores_gemma":[0.579746,0.25677717,0.14221896,0.0003262402,0.0099235205,0.0003968193,0.00022264513,0.0019855693,0.0020886972,0.00089971477,0.005330616,0.00008410736],"about_ca_topic_score_codex":0.000958243,"about_ca_topic_score_gemma":0.0015474012,"teacher_disagreement_score":0.0027290299,"about_ca_system_score_codex":0.00034493505,"about_ca_system_score_gemma":0.0006232751,"threshold_uncertainty_score":0.009129524},"labels":[],"label_agreement":null},{"id":"W4254008234","doi":"10.3410/f.2998962.2676060","title":"Faculty Opinions recommendation of Signaling via Alk5 controls the ontogeny of lung Clara cells.","year":2010,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Ontogeny; Lung; Biology; Cell biology; Internal medicine; Medicine; Endocrinology","score_opus":0.03222470841982423,"score_gpt":0.3895250820406881,"score_spread":0.35730037362086386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254008234","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029195688,0.00025214648,0.000056364326,0.00018200875,0.000051925002,0.000011315917,0.99792814,0.00020582638,0.0010202004],"genre_scores_gemma":[0.0009181165,0.00017635385,0.00027275196,0.00011854185,0.00001948989,0.000038300812,0.9970734,0.0000467729,0.0013361636],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99866045,0.00020960854,0.00015055855,0.00039830426,0.00039029052,0.00019074393],"domain_scores_gemma":[0.99653983,0.0010450206,0.0005364873,0.00057835266,0.00083120086,0.00046917074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013556599,0.0022126955,0.0016965654,0.0033781244,0.0006681061,0.002876021,0.0024982698,0.0026859932,0.06341566],"category_scores_gemma":[0.009042125,0.0006797376,0.0019893784,0.0047874134,0.00034798795,0.0012221751,0.0014647355,0.0016877411,0.06704997],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019875097,0.000027295817,0.0024299202,0.0011514282,0.000092352726,0.000024809695,0.000011756368,0.00021557946,0.00028774605,0.00020480496,0.9914657,0.0038898378],"study_design_scores_gemma":[0.0006965182,0.000046181915,0.018332887,0.0005930206,0.00027160795,0.00013694097,0.000051182862,0.0009844744,0.001254527,0.0009813933,0.9766034,0.000047721463],"about_ca_topic_score_codex":0.027092151,"about_ca_topic_score_gemma":0.06621271,"teacher_disagreement_score":0.06341566,"about_ca_system_score_codex":0.00178077,"about_ca_system_score_gemma":0.0036419358,"threshold_uncertainty_score":0.21214652},"labels":[],"label_agreement":null},{"id":"W4256129842","doi":"10.1158/1538-7445.sabcs18-3925","title":"Abstract 3925: A screen for epigenetic radiosensitizers in small cell lung cancer","year":2019,"lang":"en","type":"article","venue":"Experimental and Molecular Therapeutics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Epigenetics; Cancer; Lung cancer; Computer science; Computational biology; Chemistry; Biology; Medicine; Oncology; Biochemistry; Genetics","score_opus":0.022115013067051548,"score_gpt":0.3432664170486949,"score_spread":0.3211514039816434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256129842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96584165,0.0128193395,0.005689174,0.00038970358,0.00011249395,0.0008645812,0.0047404747,0.0005390145,0.009003568],"genre_scores_gemma":[0.96077013,0.0071533,0.007718532,0.00027479685,0.00003800855,0.0002833512,0.008173233,0.000057394052,0.01553123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998611,0.00001402666,0.000011115659,0.00003272525,0.00005936433,0.000021667312],"domain_scores_gemma":[0.99994504,0.000009284638,0.000009752848,0.0000062400904,0.000010094876,0.000019527874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014418642,0.000630646,0.0005253414,0.0008218427,0.00023948973,0.00023207643,0.00041076634,0.00044289895,0.0043249447],"category_scores_gemma":[0.00012186125,0.0002221184,0.00048591412,0.0004512461,0.00014240171,0.00010730331,0.00025021206,0.0002790305,0.0009062596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018949197,0.00013728526,0.000577685,0.0001267425,0.000026283264,0.0002264736,0.0000154584,0.00022070494,0.9892005,0.000057958692,0.0003028064,0.008918622],"study_design_scores_gemma":[0.00014050552,0.0051898356,0.010359933,0.000042664557,0.00022152718,0.00092100055,0.000049556078,0.0007525426,0.9638919,0.00006165913,0.01835053,0.000018281153],"about_ca_topic_score_codex":0.00076113176,"about_ca_topic_score_gemma":0.002625963,"teacher_disagreement_score":0.0043249447,"about_ca_system_score_codex":0.00023138398,"about_ca_system_score_gemma":0.00030413852,"threshold_uncertainty_score":0.014468372},"labels":[],"label_agreement":null},{"id":"W4280651783","doi":"10.1101/2022.05.12.491321","title":"Cell-free Tumor Methylome Analysis of Small Cell Lung Cancer Patients Identifies Subgroups with Prognostic Associations","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Canada Research Chairs; Ontario Institute for Cancer Research; St Mary's Hospital Centre; Toronto General Hospital; University of Toronto","funders":"Weill Cornell Medical College; Ontario Institute for Cancer Research; Canadian Institutes of Health Research; Cancer Research Society; National Cancer Institute; University of Toronto; Memorial Sloan-Kettering Cancer Center; Daiichi-Sankyo; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"DNA methylation; Methylation; Biology; Epigenetics; Cancer research; Differentially methylated regions; Lung cancer; Epigenomics; Cancer; Oncology; Genetics; Gene; Medicine; Gene expression","score_opus":0.014444489863605373,"score_gpt":0.26740885967778694,"score_spread":0.2529643698141816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280651783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932093,0.0007785742,0.0027233623,0.000094012285,0.000010046278,0.000020427302,0.0026663002,0.000066964174,0.0004309402],"genre_scores_gemma":[0.9961498,0.00010767699,0.0011524783,0.00004175602,0.000008418854,0.000017922255,0.0022126832,0.000009412166,0.00029990284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980396,0.000026365082,0.000018840514,0.00008129998,0.000035602552,0.000033983015],"domain_scores_gemma":[0.9996799,0.000090113856,0.000071366594,0.000038407237,0.00007301617,0.00004711375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033119242,0.00021682461,0.00035082735,0.000837714,0.00028353065,0.0004564027,0.00026173724,0.00032960266,0.002367323],"category_scores_gemma":[0.0008262749,0.000096817574,0.00032923682,0.0005476815,0.0001554259,0.00018458153,0.00044165188,0.00026246396,0.00032163088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010909227,0.000033727043,0.8604328,0.0001323738,0.00032570207,0.00013764184,0.00013517696,0.000944585,0.107104994,0.00010761308,0.00080208987,0.028752308],"study_design_scores_gemma":[0.00003016531,0.00022283025,0.96526337,0.000025256006,0.00020793745,0.00071147614,0.00016895075,0.0058558458,0.024755282,0.000400904,0.0023384225,0.00001956094],"about_ca_topic_score_codex":0.002176283,"about_ca_topic_score_gemma":0.003727909,"teacher_disagreement_score":0.002367323,"about_ca_system_score_codex":0.00026178244,"about_ca_system_score_gemma":0.00021512738,"threshold_uncertainty_score":0.00791949},"labels":[],"label_agreement":null},{"id":"W4281653962","doi":"10.1200/jco.2022.40.16_suppl.7551","title":"Initial safety run-in results of the phase III POLARGO trial: Polatuzumab vedotin plus rituximab, gemcitabine, and oxaliplatin in patients (pts) with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Oxaliplatin; Internal medicine; Tolerability; Gemcitabine; Neutropenia; Diffuse large B-cell lymphoma; Rituximab; Clinical endpoint; Adverse effect; Gastroenterology; Phases of clinical research; Oncology; Surgery; Lymphoma; Clinical trial; Chemotherapy; Cancer; Colorectal cancer","score_opus":0.05272054963104936,"score_gpt":0.428999063772115,"score_spread":0.3762785141410656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281653962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800305,0.0054138056,0.000712151,0.0011679003,0.00022997803,0.0024025198,0.004394707,0.00013077822,0.0055177175],"genre_scores_gemma":[0.98203593,0.0022729242,0.001084744,0.0017522456,0.00028455196,0.0021008477,0.0076364377,0.00005594137,0.0027762745],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99921715,0.0005516903,0.000027457221,0.00006970338,0.00005119695,0.00008266304],"domain_scores_gemma":[0.9985631,0.0004222721,0.00029879124,0.000120334866,0.00010144147,0.00049407117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029884188,0.0013097548,0.0013544648,0.00033183084,0.00029349088,0.001236773,0.0006382786,0.0012011777,0.0042376556],"category_scores_gemma":[0.0023130972,0.00039480568,0.0013998622,0.00033225407,0.0009305497,0.0008882551,0.000722979,0.003056629,0.0008042357],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9344555,0.009774356,0.005524158,0.0008704646,0.0017568071,0.0002455408,0.00025718103,0.0022832463,0.009940441,0.00023422543,0.006324832,0.028333314],"study_design_scores_gemma":[0.7614355,0.20561145,0.018776855,0.00013473055,0.0019656261,0.00041531492,0.00015783854,0.0011968863,0.0025203447,0.00050016365,0.007239592,0.000045652738],"about_ca_topic_score_codex":0.00058841694,"about_ca_topic_score_gemma":0.0017360128,"teacher_disagreement_score":0.0042376556,"about_ca_system_score_codex":0.00075902074,"about_ca_system_score_gemma":0.0008311147,"threshold_uncertainty_score":0.01580441},"labels":[],"label_agreement":null},{"id":"W4281893891","doi":"10.1016/s1470-2045(22)00271-6","title":"Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Institutes of Health Research; American Association of Neurological Surgeons; University of Toronto; AstraZeneca; Congress of Neurological Surgeons; Pfizer","keywords":"Medicine; Radiosurgery; Meta-analysis; Oncology; Hazard ratio; Radiation therapy; Internal medicine; Lung cancer; Confidence interval","score_opus":0.1196381221426109,"score_gpt":0.4222014629856351,"score_spread":0.3025633408430242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281893891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00885896,0.9891145,0.00050851674,0.00017326053,0.00025845747,0.00021030649,0.00059015,0.00003701076,0.00024882177],"genre_scores_gemma":[0.3652165,0.62798446,0.0023950555,0.0017683711,0.00037048868,0.00064940366,0.00077951414,0.00007684663,0.00075927144],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9941397,0.0027755671,0.0015292986,0.00078232825,0.00050221395,0.00027092232],"domain_scores_gemma":[0.99230367,0.005134172,0.0016939649,0.00029909267,0.0004217923,0.00014724673],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0071356203,0.0027281567,0.015419681,0.0030893043,0.0005095772,0.0026195156,0.0020708574,0.0025757859,0.0051044757],"category_scores_gemma":[0.018342594,0.001829084,0.038748406,0.004527813,0.0007814346,0.0015695302,0.0017441225,0.0027254687,0.00048340604],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031987329,0.000025068228,0.0030370997,0.18927148,0.79671234,0.00008561669,0.00008196369,0.00038555762,0.00020847468,0.000087896646,0.0005089494,0.0063968278],"study_design_scores_gemma":[0.0011546264,0.00015490614,0.0021353625,0.0069518625,0.9884417,0.00004731675,0.000039463015,0.000098699085,0.000046903013,0.000105899366,0.0008046843,0.000018636281],"about_ca_topic_score_codex":0.012931271,"about_ca_topic_score_gemma":0.037917353,"teacher_disagreement_score":0.98458034,"about_ca_system_score_codex":0.0028918544,"about_ca_system_score_gemma":0.0026395344,"threshold_uncertainty_score":0.03773719},"labels":[],"label_agreement":null},{"id":"W4282920681","doi":"10.21037/tlcr-22-320","title":"The efficacy of anlotinib as third-line treatment for non-small cell lung cancer by EGFR mutation status: a subgroup analysis of the ALTER0303 randomized phase 3 study","year":2022,"lang":"en","type":"article","venue":"Translational Lung Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Lung cancer; Subgroup analysis; Oncology; Internal medicine; Randomized controlled trial; Mutation; Genetics; Meta-analysis; Gene; Biology","score_opus":0.05746112818263294,"score_gpt":0.4689900606799801,"score_spread":0.4115289324973472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282920681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96417034,0.030137906,0.0012156846,0.0005356399,0.0005319596,0.0008604449,0.0013262266,0.000055289172,0.0011666075],"genre_scores_gemma":[0.9951615,0.0020312387,0.0004404576,0.00047662578,0.00025821876,0.0004987615,0.0007392445,0.000017543105,0.00037647018],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950369,0.003189141,0.0007002336,0.00042878886,0.00041023313,0.00023478993],"domain_scores_gemma":[0.9962837,0.001963811,0.0007903143,0.0005449074,0.0001924152,0.00022497869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008838791,0.0013729838,0.004445863,0.0007230944,0.00033138128,0.0012180738,0.0007735238,0.0012942053,0.0016641454],"category_scores_gemma":[0.0056900894,0.00042631046,0.013311625,0.0006756651,0.00047452713,0.00057847454,0.0005184317,0.0014168108,0.00021885011],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87250566,0.0006839696,0.0228969,0.0020584397,0.076444596,0.00021073324,0.000089953755,0.00091613276,0.0030520537,0.00017671143,0.0009829748,0.019981813],"study_design_scores_gemma":[0.6724117,0.041744318,0.09200919,0.00050655246,0.18018413,0.00048552713,0.00020061753,0.004709673,0.0026185694,0.0017507296,0.003242098,0.00013687192],"about_ca_topic_score_codex":0.0007744738,"about_ca_topic_score_gemma":0.0022410143,"teacher_disagreement_score":0.008838791,"about_ca_system_score_codex":0.00074459286,"about_ca_system_score_gemma":0.00077027077,"threshold_uncertainty_score":0.046744525},"labels":[],"label_agreement":null},{"id":"W4282937497","doi":"10.1158/1538-7445.am2022-ct572","title":"Abstract CT572: Phase 1b dose-escalation and dose-expansion study evaluating trastuzumab deruxtecan (T-DXd) in combination with durvalumab and cisplatin, carboplatin, or pemetrexed in advanced or metastatic, HER2-overexpressing, nonsquamous non-small cell lung cancer (NSCLC): DESTINY-Lung03","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nuvo Pharmaceuticals (Canada)","funders":"","keywords":"Medicine; Carboplatin; Pemetrexed; Internal medicine; Oncology; Trastuzumab; Tolerability; Durvalumab; Lapatinib; Cancer; Lung cancer; Chemotherapy; Cisplatin; Nivolumab; Breast cancer; Immunotherapy; Adverse effect","score_opus":0.0972688980441431,"score_gpt":0.4678346401220942,"score_spread":0.3705657420779511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282937497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98870754,0.0019804258,0.0006502589,0.00060058385,0.00014326954,0.0024448887,0.0020285225,0.00022184476,0.003222661],"genre_scores_gemma":[0.9758714,0.0025770543,0.0020545796,0.0014101365,0.0000907503,0.0025119323,0.006537247,0.000078498444,0.008868473],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99977154,0.00007219903,0.000010616109,0.00005039497,0.00003941426,0.000055816585],"domain_scores_gemma":[0.9996793,0.00003364248,0.000053766882,0.000029038989,0.000029577186,0.00017466467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010463569,0.0016265707,0.0014662979,0.0005231365,0.00033323208,0.001210563,0.0011045886,0.0011332197,0.0065938123],"category_scores_gemma":[0.00060968543,0.0006641982,0.0011546051,0.00043885014,0.0008911441,0.00071769796,0.00035983385,0.003590556,0.0017311489],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5073661,0.1293476,0.00772711,0.0015422549,0.0021622465,0.0005264518,0.0005379609,0.007206176,0.17378043,0.0011756761,0.01742288,0.15120503],"study_design_scores_gemma":[0.6281161,0.33763146,0.011414068,0.000090435584,0.00058588176,0.00051092234,0.00009393093,0.0032490157,0.011707862,0.00033600364,0.0062116715,0.000052623585],"about_ca_topic_score_codex":0.0023078506,"about_ca_topic_score_gemma":0.0055942605,"teacher_disagreement_score":0.0065938123,"about_ca_system_score_codex":0.0017182783,"about_ca_system_score_gemma":0.0019073099,"threshold_uncertainty_score":0.022058547},"labels":[],"label_agreement":null},{"id":"W4282971362","doi":"10.1158/1538-7445.am2022-5731","title":"Abstract 5731: Structure-based development of a novel MYC inhibitor for neuroendocrine prostate cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"LNCaP; Prostate cancer; Cancer research; In silico; Cancer; Drug discovery; Biology; Chemistry; Gene; Computational biology; Bioinformatics; Genetics","score_opus":0.1123499322314152,"score_gpt":0.45688991081849545,"score_spread":0.34453997858708024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282971362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9584973,0.010979215,0.012809784,0.00043676174,0.00015374327,0.0010808471,0.00212669,0.00043390537,0.013481592],"genre_scores_gemma":[0.9695709,0.0066211424,0.012005959,0.00039944533,0.000026846983,0.00023874776,0.004075543,0.000047653695,0.007013892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999217,0.000008482077,0.000005602056,0.000017948816,0.000025991392,0.00002025202],"domain_scores_gemma":[0.9999691,0.0000026133143,0.000005731743,0.0000025097556,0.0000064792885,0.0000136032395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001331333,0.0005425784,0.00052360795,0.0003877503,0.00015438192,0.0003204412,0.0005605366,0.00029696926,0.0024002232],"category_scores_gemma":[0.000078567326,0.00017414137,0.00038534126,0.0002681981,0.00014735882,0.00018786137,0.00021403769,0.0005235191,0.00084588357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068449276,0.0008090278,0.00041920447,0.0005006762,0.000089798676,0.00040124942,0.000036399084,0.004230798,0.9585037,0.00069672964,0.0012057244,0.032422088],"study_design_scores_gemma":[0.0019527627,0.014104587,0.00515464,0.00009975434,0.00037722941,0.0014838999,0.00005213031,0.013658403,0.93277574,0.00032348407,0.02994176,0.000075556185],"about_ca_topic_score_codex":0.0014956647,"about_ca_topic_score_gemma":0.0021230986,"teacher_disagreement_score":0.0024002232,"about_ca_system_score_codex":0.00037987187,"about_ca_system_score_gemma":0.00056677335,"threshold_uncertainty_score":0.0080295205},"labels":[],"label_agreement":null},{"id":"W4282979011","doi":"10.1158/1538-7445.am2022-324","title":"Abstract 324: Discovery of novel functional TROP2 antibodies for treatment of epithelial cancers","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"Cancer research; In vivo; Cancer; Metastasis; Antibody; Intracellular; Cancer cell; Downregulation and upregulation; Extracellular; Antibody-drug conjugate; Biology; Immunology; Cell biology; Monoclonal antibody; Genetics","score_opus":0.17824344595736766,"score_gpt":0.46742746372008676,"score_spread":0.28918401776271907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282979011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94790053,0.02111789,0.01335919,0.0009701677,0.00019970068,0.00041018162,0.00096478185,0.00022039216,0.014857331],"genre_scores_gemma":[0.9720293,0.007657466,0.008539699,0.00047073947,0.00008001628,0.00014056907,0.0012034852,0.000029401835,0.009849227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995446,0.000008192312,0.0000022484148,0.000005686556,0.00001251975,0.000016933102],"domain_scores_gemma":[0.9999665,0.0000033251308,0.000004523873,0.0000021225178,0.000009499112,0.000014034668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012379764,0.00033402245,0.00014121988,0.00025058305,0.00008750041,0.00016228517,0.00020079347,0.0003016726,0.0014054518],"category_scores_gemma":[0.0000759895,0.00008544732,0.00018382049,0.00011160455,0.000067239685,0.0001319647,0.00013995933,0.00043339183,0.00046643507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012764063,0.00011236425,0.00024501636,0.000092032504,0.000014341916,0.00013772145,0.000020023903,0.00027779484,0.9832941,0.0003057443,0.0006701535,0.014703106],"study_design_scores_gemma":[0.00033941484,0.002470326,0.006217208,0.000041055668,0.000086391745,0.0013449991,0.0000209452,0.002550655,0.9418284,0.00026535342,0.044820946,0.000014379962],"about_ca_topic_score_codex":0.00043628638,"about_ca_topic_score_gemma":0.00064543326,"teacher_disagreement_score":0.0014054518,"about_ca_system_score_codex":0.00023795041,"about_ca_system_score_gemma":0.00018399094,"threshold_uncertainty_score":0.004701674},"labels":[],"label_agreement":null},{"id":"W4283453063","doi":"10.1016/j.jtho.2022.05.016","title":"Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and Etoposide","year":2022,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Pharmaceuticals; Chugai Pharmaceutical; Merck Sharp and Dohme; Genentech; Eisai; G1 Therapeutics; Puma Biotechnology; Yuhan; BeiGene; Mirati Therapeutics; Clovis Oncology; Jazz Pharmaceuticals; Regeneron Pharmaceuticals; F. Hoffmann-La Roche; Takeda Pharmaceutical Company; AbbVie; Teva Pharmaceutical Industries; Boehringer Ingelheim Japan; Merck KGaA; Daiichi Sankyo Europe; National Cancer Institute; Bayer; Gilead Sciences; Roche; Novartis; Mesothelioma Applied Research Foundation; GlaxoSmithKline; Canadian Asian Studies Association; AstraZeneca; Ono Pharmaceutical; U.S. Department of Defense; Eli Lilly and Company; Bristol-Myers Squibb; Kyowa Hakko Kirin; Sanofi; Amgen; Boehringer Ingelheim; Pfizer","keywords":"Atezolizumab; Medicine; Placebo; Maintenance therapy; Hazard ratio; Internal medicine; Oncology; Carboplatin; Population; Chemotherapy; Cancer; Confidence interval; Immunotherapy; Pembrolizumab; Pathology; Cisplatin","score_opus":0.025664155582500087,"score_gpt":0.377302734165158,"score_spread":0.35163857858265796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283453063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978682,0.0004724916,0.00014859003,0.000123667,0.0000129119235,0.000051611307,0.0008490995,0.000009817732,0.00046354526],"genre_scores_gemma":[0.9968285,0.0002068062,0.0003052119,0.00014256386,0.00007987436,0.000045899138,0.001973087,0.0000054533375,0.00041259656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965155,0.00013304524,0.000036174464,0.000063814136,0.000057689434,0.00005768811],"domain_scores_gemma":[0.99902225,0.00033291528,0.00026672974,0.000107829626,0.00009813431,0.00017213976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057740946,0.00027961956,0.0005208538,0.00032608802,0.00024877102,0.000522415,0.0002639921,0.0003626995,0.0016766214],"category_scores_gemma":[0.0016308438,0.00012962033,0.0010364639,0.0005486437,0.00015862261,0.0003663024,0.00028316324,0.00036592231,0.00024786164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027769554,0.0010951025,0.9258184,0.0001690235,0.0009756308,0.0019426472,0.00017826664,0.00036548404,0.009454758,0.000077045486,0.0014522106,0.030701987],"study_design_scores_gemma":[0.00070380885,0.009634566,0.9828828,0.000015993495,0.00069306116,0.0024751283,0.0002160467,0.0005217077,0.0011990634,0.000064052365,0.0015780161,0.000015698055],"about_ca_topic_score_codex":0.001211172,"about_ca_topic_score_gemma":0.0014601697,"teacher_disagreement_score":0.0016766214,"about_ca_system_score_codex":0.00036264228,"about_ca_system_score_gemma":0.00054147566,"threshold_uncertainty_score":0.0056088567},"labels":[],"label_agreement":null},{"id":"W4283713334","doi":"10.1200/op.22.00345","title":"Reply to M.Z. Farooq et al","year":2022,"lang":"en","type":"letter","venue":"JCO Oncology Practice","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Chemistry","score_opus":0.07133152843313753,"score_gpt":0.4879265315011695,"score_spread":0.416595003068032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283713334","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013350413,0.00072867924,0.000019850697,0.9883356,0.009726287,0.0000056567683,0.0000420402,0.000012089127,0.0009962472],"genre_scores_gemma":[0.0010942378,0.0004120521,0.000051780466,0.98600113,0.009983003,0.000018886369,0.000017261564,0.000010418452,0.0024111338],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959508,0.0014732017,0.00048769015,0.0005045632,0.0010232354,0.00056052714],"domain_scores_gemma":[0.9864087,0.007080882,0.0007885163,0.00037673314,0.0026548621,0.0026903485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005872533,0.00080472557,0.0017083432,0.0010689782,0.005019778,0.0043339888,0.0023593171,0.05176807,0.008941233],"category_scores_gemma":[0.032764502,0.0010373079,0.0009864104,0.0012633043,0.0031018357,0.004283508,0.002053254,0.035812072,0.008653614],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028053286,0.000009256711,0.0003528925,0.00002574513,0.000006391697,0.000416409,0.000084873056,0.000012099445,0.000031934323,0.00058150635,0.9968194,0.001631364],"study_design_scores_gemma":[0.00012866812,0.000048544003,0.0017337437,0.00035646517,0.000036750098,0.0020630474,0.0010947403,0.00020746396,0.0002120689,0.0062331143,0.98780674,0.0000785734],"about_ca_topic_score_codex":0.01079881,"about_ca_topic_score_gemma":0.017586619,"teacher_disagreement_score":0.05176807,"about_ca_system_score_codex":0.0039462727,"about_ca_system_score_gemma":0.0066324803,"threshold_uncertainty_score":0.031057298},"labels":[],"label_agreement":null},{"id":"W4284959841","doi":"10.1007/s40471-022-00295-8","title":"Considerations of Biomarker Application for Cancer Continuum in the Era of Precision Medicine","year":2022,"lang":"en","type":"article","venue":"Current Epidemiology Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Precision medicine; Biomarker; Medicine; Computational biology; Internal medicine; Oncology; Biology; Pathology; Genetics","score_opus":0.17609164285120027,"score_gpt":0.49943965261987233,"score_spread":0.32334800976867206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284959841","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007973915,0.09705128,0.063450314,0.8029266,0.009378043,0.00043021573,0.0004116191,0.0002938277,0.01808414],"genre_scores_gemma":[0.36532772,0.05206116,0.2682515,0.26940697,0.03871735,0.0022325686,0.00037281655,0.00032338945,0.0033066277],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.7336201,0.19582339,0.021638593,0.010957228,0.034815002,0.0031456444],"domain_scores_gemma":[0.36384648,0.53470445,0.017568834,0.01952563,0.057826426,0.006528174],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.39525518,0.0020162151,0.0076281046,0.007972291,0.005763743,0.025190922,0.010724893,0.015729489,0.005384534],"category_scores_gemma":[0.540945,0.0017980677,0.0040885704,0.004899483,0.023830868,0.02626841,0.014072192,0.021042788,0.0012757119],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019856605,0.0005137221,0.054677438,0.00699489,0.0026262852,0.0017860457,0.006532704,0.007872475,0.0019872047,0.4509697,0.07355179,0.3905022],"study_design_scores_gemma":[0.00047658102,0.0018036073,0.021345908,0.019124916,0.0019515759,0.0037162795,0.0075145117,0.011197888,0.002957219,0.70489186,0.22449642,0.00052320876],"about_ca_topic_score_codex":0.009496126,"about_ca_topic_score_gemma":0.01072929,"teacher_disagreement_score":0.39525518,"about_ca_system_score_codex":0.009304372,"about_ca_system_score_gemma":0.036307104,"threshold_uncertainty_score":0.74575806},"labels":[],"label_agreement":null},{"id":"W4286295221","doi":"10.1200/jco.2022.40.16_suppl.e20602","title":"Population kinetics assessment of limited small cell lung cancer (L-SCLC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Population; Internal medicine; Survival analysis; Area under the curve; Proportional hazards model; Progression-free survival; Nuclear medicine; Oncology; Overall survival","score_opus":0.1782929049983703,"score_gpt":0.5676061630957456,"score_spread":0.3893132580973753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286295221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6687811,0.15129629,0.06893586,0.0028327962,0.00032971727,0.0021896553,0.06181572,0.0025257673,0.041293025],"genre_scores_gemma":[0.9468702,0.011536487,0.017124088,0.00096483337,0.00008209667,0.0013606201,0.01511909,0.00036189103,0.006580797],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99857664,0.0005544201,0.00014359246,0.0002490899,0.00040169474,0.000074638],"domain_scores_gemma":[0.99389017,0.0035544978,0.0012306417,0.00024827174,0.00092862884,0.00014773173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0082172835,0.0003498134,0.00066914316,0.00223225,0.00021597001,0.0012466979,0.00043203557,0.00065926835,0.0080020595],"category_scores_gemma":[0.011068871,0.0003298243,0.0009148294,0.0021699488,0.00030308202,0.0011698267,0.00050594413,0.0005950485,0.0014497883],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010903953,0.00056754844,0.33504578,0.013345401,0.002594196,0.0008764313,0.00067344465,0.017377615,0.04953149,0.0043327846,0.028906345,0.53584504],"study_design_scores_gemma":[0.001149029,0.007754959,0.64405817,0.0020558161,0.0037630429,0.0061062337,0.0008097233,0.04403218,0.08626965,0.009754882,0.19401349,0.00023297413],"about_ca_topic_score_codex":0.0013579974,"about_ca_topic_score_gemma":0.0021651397,"teacher_disagreement_score":0.0082172835,"about_ca_system_score_codex":0.0010051323,"about_ca_system_score_gemma":0.0008851759,"threshold_uncertainty_score":0.043457687},"labels":[],"label_agreement":null},{"id":"W4286296236","doi":"10.1200/jco.2022.40.16_suppl.8570","title":"Stereotactic radiosurgery (SRS) versus whole brain radiation therapy (WBRT) in patients with small cell lung cancer (SCLC) and intracranial metastatic disease (IMD): A systematic review and meta-analysis.","year":2022,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Radiosurgery; Meta-analysis; Hazard ratio; Internal medicine; Confidence interval; Oncology; Radiation therapy","score_opus":0.24485543690621728,"score_gpt":0.5107754946513745,"score_spread":0.26592005774515726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286296236","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010595298,0.9874752,0.00040060762,0.00018529959,0.0001459296,0.00030627695,0.00057370524,0.000026110096,0.00029146188],"genre_scores_gemma":[0.3505558,0.6434539,0.0018837933,0.0011173177,0.00025757548,0.00112161,0.0010967104,0.00003607535,0.00047718774],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9951828,0.0023763126,0.001250453,0.00056193135,0.00046170456,0.0001668096],"domain_scores_gemma":[0.99346876,0.00434491,0.0014374744,0.00017603564,0.0004276359,0.00014512205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007851731,0.0022223545,0.013750086,0.0036726973,0.00046675882,0.0020725785,0.0016105598,0.0018381308,0.002614833],"category_scores_gemma":[0.0144246165,0.0011806773,0.033974435,0.0045953225,0.00053757883,0.0013671056,0.0011484601,0.0017084822,0.00029241142],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050163274,0.000045125187,0.003319254,0.26150942,0.7184572,0.000075819444,0.000071082395,0.00049320684,0.0002594195,0.00007995287,0.0004300317,0.010243184],"study_design_scores_gemma":[0.0011636545,0.00039098106,0.0033540328,0.0115244435,0.9821268,0.000060895618,0.00003507241,0.00015171632,0.00010252637,0.00011682946,0.0009557448,0.00001720809],"about_ca_topic_score_codex":0.0072154794,"about_ca_topic_score_gemma":0.01770116,"teacher_disagreement_score":0.013750086,"about_ca_system_score_codex":0.0022706825,"about_ca_system_score_gemma":0.0022724702,"threshold_uncertainty_score":0.04152441},"labels":[],"label_agreement":null},{"id":"W4288081531","doi":"10.21037/tlcr-22-489","title":"The extent of mediastinal lymph node dissection correlates with survival of small cell lung cancer patients after resection: a propensity score-matched cohort study analysis","year":2022,"lang":"en","type":"article","venue":"Translational Lung Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Propensity score matching; Dissection (medical); Lymphadenectomy; Proportional hazards model; Lymph node; Lung cancer; Surveillance, Epidemiology, and End Results; Survival analysis; Surgery; Confounding; Mediastinal lymph node; Surgical oncology; Cancer registry; Cancer; Radiology; Internal medicine; Metastasis","score_opus":0.04560001679536454,"score_gpt":0.3675098791055545,"score_spread":0.32190986231019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288081531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99876,0.00021583171,0.00038089987,0.000030170475,0.0000098678165,0.000016551932,0.00033792344,0.0000033950946,0.00024536016],"genre_scores_gemma":[0.9995158,0.000052263324,0.0000872683,0.0000108279055,0.000006694357,0.000010251567,0.00026024797,0.0000015472563,0.0000550388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938977,0.00011869493,0.000105782616,0.0001892952,0.0001143135,0.00008211211],"domain_scores_gemma":[0.9986619,0.0001799905,0.0006022178,0.00026024936,0.00014342598,0.00015212705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001039927,0.00022525928,0.00033989557,0.00068772066,0.00045915463,0.0006284884,0.00027387805,0.0002523397,0.0013200954],"category_scores_gemma":[0.0020160875,0.00020705385,0.0009516716,0.0011992267,0.00024623427,0.00033069804,0.0003403106,0.00044219004,0.0001794804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024749167,0.00001713608,0.9982705,0.000008311357,0.00016296728,0.000055491095,0.00003272358,0.00007928594,0.00021335258,0.00002954869,0.000082887156,0.00080019474],"study_design_scores_gemma":[0.00002380779,0.00013980825,0.9978125,0.000005398141,0.00018893914,0.00026690852,0.00008805612,0.0008563223,0.00012454254,0.00008945585,0.00039842268,0.000005780991],"about_ca_topic_score_codex":0.001761411,"about_ca_topic_score_gemma":0.0025596519,"teacher_disagreement_score":0.001761411,"about_ca_system_score_codex":0.00028983902,"about_ca_system_score_gemma":0.00045536886,"threshold_uncertainty_score":0.0054997206},"labels":[],"label_agreement":null},{"id":"W4288905840","doi":"10.1016/j.semcancer.2022.07.008","title":"Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review","year":2022,"lang":"en","type":"review","venue":"Seminars in Cancer Biology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Cancer research; Lung cancer; Oncology","score_opus":0.09554822133260871,"score_gpt":0.45139660855054026,"score_spread":0.35584838721793155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288905840","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006751837,0.9989711,0.000087489665,0.00023886283,0.00018960156,0.0000072652874,0.000019176143,0.0000076485685,0.00041135872],"genre_scores_gemma":[0.00054501253,0.9984383,0.00017308778,0.00036653836,0.00015581356,0.0000084170415,0.000036335186,0.0000016651627,0.00027480378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997708,0.000047900172,0.000031403273,0.000043171392,0.00007568518,0.00003103277],"domain_scores_gemma":[0.9995461,0.00028398642,0.0000532193,0.000009882735,0.000070709226,0.000036105852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093224103,0.0010208354,0.002413989,0.0015194888,0.00024786542,0.001116406,0.0013379686,0.0011224236,0.0050240853],"category_scores_gemma":[0.0011109854,0.00031259138,0.001021711,0.0014605208,0.00046432033,0.0013622871,0.00071710284,0.002816293,0.001806803],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020266886,0.00009326569,0.00009996238,0.01984312,0.0002088617,0.00014222336,0.000030382753,0.0004884674,0.0013298596,0.0023352986,0.03991439,0.93531144],"study_design_scores_gemma":[0.00018565629,0.00045179384,0.0008173365,0.008310649,0.00069032755,0.0010195979,0.000062453735,0.00022724923,0.00065789174,0.0025630256,0.9849785,0.00003546087],"about_ca_topic_score_codex":0.00057162996,"about_ca_topic_score_gemma":0.0021053124,"teacher_disagreement_score":0.0050240853,"about_ca_system_score_codex":0.00059389375,"about_ca_system_score_gemma":0.00087261654,"threshold_uncertainty_score":0.016807199},"labels":[],"label_agreement":null},{"id":"W4289261182","doi":"10.1101/2022.07.31.22277301","title":"The Blood Proteome of Imminent Lung Cancer Diagnosis","year":2022,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto","funders":"National Cancer Institute; Cancer Research UK; Institut National Du Cancer; Fondation ARC pour la Recherche sur le Cancer; Centre International de Recherche sur le Cancer; World Health Organization","keywords":"Lung cancer; Cancer; Medicine; Internal medicine; Metastasis; Oncology; Biomarker; Odds ratio; Lung; Chemokine; Pathology; Immunology; Inflammation; Biology","score_opus":0.02904364612096589,"score_gpt":0.3775979276224786,"score_spread":0.34855428150151274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289261182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939176,0.0034234652,0.0006447932,0.00016685257,0.000027878332,0.0000072406774,0.0012728816,0.000021446362,0.00051790924],"genre_scores_gemma":[0.99734145,0.0005917544,0.00054514006,0.000093564835,0.00002351274,0.0000052971295,0.0009794963,0.0000041500316,0.00041558305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966407,0.00009506048,0.000025336083,0.0000805173,0.00009204831,0.00004303455],"domain_scores_gemma":[0.9993117,0.0001344945,0.0003184865,0.00005113972,0.00011426904,0.000069990354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006282129,0.0002709626,0.00039303268,0.0008371322,0.00025833797,0.0009998636,0.00018601086,0.00046282215,0.0009730885],"category_scores_gemma":[0.0012619412,0.00022079259,0.00026375384,0.0010661259,0.00021627746,0.0002654337,0.00038523032,0.00044187866,0.00039394438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010686506,0.000054526412,0.89692664,0.00019146515,0.00024405998,0.0005647678,0.00019956463,0.00031259478,0.08849659,0.00019239515,0.0008467535,0.010902023],"study_design_scores_gemma":[0.000010052283,0.000100549914,0.9886445,0.00001900577,0.00006110729,0.00070179295,0.000110237816,0.0011876676,0.007504891,0.00020280633,0.0014504868,0.0000070939295],"about_ca_topic_score_codex":0.0018383687,"about_ca_topic_score_gemma":0.0013843251,"teacher_disagreement_score":0.0018383687,"about_ca_system_score_codex":0.00032013832,"about_ca_system_score_gemma":0.00024200891,"threshold_uncertainty_score":0.003655374},"labels":[],"label_agreement":null},{"id":"W4292185501","doi":"10.1158/2767-9764.crc-21-0135","title":"Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; Physicians' Services Incorporated Foundation; National Institute of Dental and Craniofacial Research; Free To Breathe; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; North Carolina Biotechnology Center; Lung Cancer Research Foundation; National Cancer Institute; National Institutes of Health; Yale University","keywords":"Immunohistochemistry; Tissue microarray; Head and neck squamous-cell carcinoma; Immunostaining; Medicine; Cancer; Head and neck cancer; Cancer research; Pathology; Oncology; Immune system; HPV infection; Biomarker; Biology; Internal medicine; Cervical cancer; Immunology","score_opus":0.13157024526347763,"score_gpt":0.4713348231637256,"score_spread":0.33976457790024794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292185501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979286,0.001257825,0.00039332605,0.00003974902,0.000004828638,0.000007768846,0.000111428504,0.000012844846,0.00024356751],"genre_scores_gemma":[0.9991748,0.00021158902,0.00036899792,0.00001293718,0.000004760966,0.000005446286,0.0001348089,0.0000017544104,0.00008490987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997242,0.00008777718,0.000019872814,0.00005945002,0.0000670742,0.000041532065],"domain_scores_gemma":[0.9995838,0.00010196486,0.00013861574,0.000035741457,0.00008331118,0.00005663326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008185585,0.00021855357,0.000280405,0.00071163574,0.00017627171,0.0004560387,0.0002495162,0.0003154429,0.0003912335],"category_scores_gemma":[0.0009997269,0.00013560132,0.00022487645,0.00055829075,0.00028560805,0.00025715033,0.00043193073,0.00031295398,0.00012354882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006783445,0.000033082844,0.9693944,0.000041063213,0.0000970781,0.00009342464,0.000039478848,0.00036958867,0.018672435,0.000030871615,0.00015792805,0.010392274],"study_design_scores_gemma":[0.000009941196,0.00020743441,0.98770183,0.000009292904,0.000106743566,0.00049150153,0.00011376901,0.0040217615,0.0067675347,0.00012909963,0.00043235102,0.000008754353],"about_ca_topic_score_codex":0.0011980919,"about_ca_topic_score_gemma":0.0021225489,"teacher_disagreement_score":0.0011980919,"about_ca_system_score_codex":0.0003531848,"about_ca_system_score_gemma":0.00018897287,"threshold_uncertainty_score":0.0043290257},"labels":[],"label_agreement":null},{"id":"W4293778660","doi":"10.3892/ol.2022.13454","title":"Long‑term survival in a patient with extensive‑stage small cell lung cancer treated with multiple courses of salvage stereotactic radiation after whole brain radiotherapy: A case report","year":2022,"lang":"en","type":"article","venue":"Oncology Letters","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"London Health Sciences Centre","keywords":"Medicine; Radiation therapy; Radiosurgery; Lung cancer; Prophylactic cranial irradiation; Stereotactic radiation therapy; Stage (stratigraphy); Salvage therapy; Cancer; Radiology; Surgery; Oncology; Chemotherapy; Internal medicine","score_opus":0.014298012171305031,"score_gpt":0.3152644065497084,"score_spread":0.30096639437840333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293778660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99315405,0.0013897443,0.0009832171,0.0012743564,0.000085599204,0.000041104257,0.000066250745,0.000040266583,0.0029654833],"genre_scores_gemma":[0.9978035,0.0006128109,0.00042143674,0.00030868954,0.00021863621,0.000010134772,0.000054659522,0.0000075768667,0.00056245795],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999859,0.000016829901,0.000014414652,0.000033878812,0.000020982576,0.00005484294],"domain_scores_gemma":[0.9995241,0.00009996878,0.00012096478,0.000039973158,0.000028354378,0.00018671338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001774131,0.00048470584,0.0006298105,0.00058664795,0.0015097434,0.0009056769,0.00047944003,0.002065425,0.00085287343],"category_scores_gemma":[0.0010257199,0.00029466988,0.0006594983,0.0005115901,0.00073128974,0.00064350833,0.00054737757,0.0014532848,0.00039452052],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006157429,0.00007479257,0.023467915,0.000023450244,0.000012767903,0.97066855,0.00035974223,0.00014327583,0.0012206973,0.00011775482,0.00027510335,0.0035743732],"study_design_scores_gemma":[0.000008380482,0.00019869089,0.00992767,0.000010947944,0.000022989218,0.98817307,0.00017667434,0.00038544077,0.0003710219,0.000113228685,0.0006012839,0.00001057308],"about_ca_topic_score_codex":0.0013130872,"about_ca_topic_score_gemma":0.002829466,"teacher_disagreement_score":0.002065425,"about_ca_system_score_codex":0.0006537875,"about_ca_system_score_gemma":0.00055843306,"threshold_uncertainty_score":0.004743576},"labels":[],"label_agreement":null},{"id":"W4294934458","doi":"10.1016/j.jtho.2022.07.995","title":"EP14.05-020 Population-based Outcomes for Patients with Extensive-Stage Small-cell Lung Cancer from the Canadian SCLC Database (CASCADE)","year":2022,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Cancer Care South East; Northeast Cancer Centre; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba","funders":"","keywords":"Medicine; Stage (stratigraphy); Oncology; Internal medicine; Population; Cascade; Lung cancer; Cancer; Database; Environmental health","score_opus":0.04046655758585513,"score_gpt":0.4247877452949683,"score_spread":0.38432118770911317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294934458","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10490229,0.000637103,0.00010779656,0.00044193296,0.000044587992,0.00018357177,0.8877918,0.00006352207,0.0058273626],"genre_scores_gemma":[0.3038073,0.001130878,0.000698467,0.0006483801,0.00007418817,0.0005070039,0.68682903,0.000045831406,0.0062588686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985239,0.000061486295,0.00015633629,0.0002757086,0.00052298495,0.00045961273],"domain_scores_gemma":[0.9950335,0.0002011453,0.00076140196,0.00018060252,0.0030829604,0.00074040884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008530416,0.00088398746,0.0010013045,0.004959117,0.001418237,0.0015854035,0.0018004992,0.0007502471,0.010897541],"category_scores_gemma":[0.005242235,0.0005176806,0.0013214691,0.011791942,0.00029167664,0.00074910297,0.0013397315,0.0010750905,0.0017682315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009936924,0.00012885404,0.77411264,0.00078163686,0.00089626695,0.00023417696,0.00028320096,0.00082051236,0.0002597334,0.0013563539,0.21043043,0.00970252],"study_design_scores_gemma":[0.00017316299,0.000029323875,0.98192596,0.000148028,0.00017452895,0.00009788226,0.0002271403,0.00039863074,0.000073694704,0.00011100688,0.016606614,0.00003405576],"about_ca_topic_score_codex":0.9770249,"about_ca_topic_score_gemma":0.9845605,"teacher_disagreement_score":0.022975087,"about_ca_system_score_codex":0.018243782,"about_ca_system_score_gemma":0.034410365,"threshold_uncertainty_score":0.1323685},"labels":[],"label_agreement":null},{"id":"W4294940201","doi":"10.1016/j.jtho.2022.07.954","title":"EP14.01-019 Identifying Circulating DNA Methylation Patterns in Small Cell Lung Cancer Patients","year":2022,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; DNA methylation; Lung cancer; DNA; Methylation; Cancer; Cancer research; Computational biology; Oncology; Internal medicine; Genetics; Gene; Gene expression; Biology","score_opus":0.05116896901006629,"score_gpt":0.46292772861565523,"score_spread":0.41175875960558894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294940201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99244505,0.0005027832,0.0003550939,0.00042787532,0.00009626465,0.000036376823,0.0031804063,0.000023210689,0.0029329201],"genre_scores_gemma":[0.9924132,0.00024113119,0.00048484025,0.0002621631,0.00009407185,0.00005829757,0.003313174,0.00002171837,0.0031113245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995584,0.000092617855,0.00004236042,0.00011989151,0.00006776623,0.00011880783],"domain_scores_gemma":[0.99906176,0.00025701383,0.00020969457,0.00006205592,0.00020492864,0.00020444627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061779236,0.0002990624,0.00036724174,0.00059701805,0.0005010661,0.0008789075,0.0005016888,0.00084651203,0.006636638],"category_scores_gemma":[0.002473069,0.00024582984,0.00039274295,0.0007772653,0.00017945284,0.00047640913,0.00052695855,0.00083635806,0.0012496744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009872816,0.00010915498,0.9765518,0.000066206216,0.00012802321,0.00031940293,0.00010436829,0.00012556989,0.004874135,0.00015717687,0.0025267971,0.014050198],"study_design_scores_gemma":[0.00012253372,0.00052389124,0.9887085,0.0000375691,0.00021143134,0.0014264615,0.00031895872,0.00085878844,0.0019593544,0.0003773629,0.0054406268,0.000014514379],"about_ca_topic_score_codex":0.0020574722,"about_ca_topic_score_gemma":0.0031249716,"teacher_disagreement_score":0.006636638,"about_ca_system_score_codex":0.0002946019,"about_ca_system_score_gemma":0.00047246495,"threshold_uncertainty_score":0.022201777},"labels":[],"label_agreement":null},{"id":"W4294940874","doi":"10.1016/j.jtho.2022.07.974","title":"EP14.04-001 Treatment and Outcomes of Patients with Limited-Stage Small-cell Lung Cancer in the Canadian SCLC Database (CASCADE)","year":2022,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Cancer Care South East; Northeast Cancer Centre; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Oncology; Cascade; Internal medicine; Cancer; Lung cancer; Database","score_opus":0.0379800896193987,"score_gpt":0.4213255832223028,"score_spread":0.3833454936029041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294940874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5524596,0.003570379,0.00011725039,0.0025661485,0.00014305145,0.00018002986,0.42356917,0.000060782833,0.017333632],"genre_scores_gemma":[0.8401717,0.0021053283,0.000380412,0.0011762977,0.00010050062,0.00016991008,0.15036723,0.00003026545,0.005498421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990213,0.000060253937,0.00008469748,0.00015915059,0.0003012737,0.00037326722],"domain_scores_gemma":[0.99679667,0.00019477318,0.0006001061,0.00011620714,0.001635025,0.00065722095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006202358,0.00044409835,0.00062064285,0.0018309487,0.0013977854,0.0012960427,0.0015572966,0.00075217354,0.00955226],"category_scores_gemma":[0.0042594904,0.00032499433,0.0010736617,0.006024875,0.00033347105,0.0006260321,0.0009032273,0.0010231814,0.00082103565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008432051,0.000086155334,0.92938566,0.0003508839,0.00042407142,0.0001082561,0.00015886218,0.00032647795,0.00016456738,0.000517349,0.05930531,0.008329114],"study_design_scores_gemma":[0.0001237221,0.000035276837,0.99131864,0.00015336792,0.00018864484,0.00008017169,0.00028601053,0.00026794177,0.000053024476,0.00007669949,0.0073946146,0.000021858206],"about_ca_topic_score_codex":0.96857744,"about_ca_topic_score_gemma":0.9838366,"teacher_disagreement_score":0.031422555,"about_ca_system_score_codex":0.014561407,"about_ca_system_score_gemma":0.029041799,"threshold_uncertainty_score":0.1056509},"labels":[],"label_agreement":null},{"id":"W4294942898","doi":"10.1016/j.jtho.2022.07.411","title":"EP03.01-016 The Canadian Small Cell Lung Cancer Database (CASCADE): Results from a Multi-Institutional Real-World Evidence Collaboration","year":2022,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; Cancer Care South East; Northeast Cancer Centre","funders":"","keywords":"Medicine; Cascade; Database; Lung cancer; Oncology","score_opus":0.08650866978257099,"score_gpt":0.47472910042043553,"score_spread":0.38822043063786454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294942898","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03848208,0.010135398,0.0006386358,0.011359348,0.00038536236,0.004216038,0.87584,0.00013226918,0.05881087],"genre_scores_gemma":[0.3729252,0.014354891,0.013661795,0.014990598,0.0004828928,0.009749677,0.55421025,0.0004675834,0.019157074],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9757367,0.0075607817,0.0032432203,0.0015492064,0.009941048,0.0019690571],"domain_scores_gemma":[0.8706059,0.04518763,0.010023152,0.0047367364,0.06158958,0.0078570135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020628758,0.0005674531,0.0012191272,0.0043629557,0.0017696013,0.004821471,0.0023709282,0.0013759054,0.03486025],"category_scores_gemma":[0.12433566,0.000560765,0.0014190463,0.012586352,0.0009283601,0.0013945863,0.0032805046,0.0011940667,0.0037474993],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065801516,0.00051791215,0.11022601,0.01570174,0.004702279,0.00028037405,0.0010914676,0.000730825,0.0002888011,0.006015904,0.74469656,0.10916797],"study_design_scores_gemma":[0.009132193,0.00047571244,0.6114631,0.021709038,0.005345117,0.00024284955,0.0024283347,0.00064082636,0.00039941567,0.0019674455,0.3459938,0.00020215925],"about_ca_topic_score_codex":0.7641867,"about_ca_topic_score_gemma":0.8626651,"teacher_disagreement_score":0.23581332,"about_ca_system_score_codex":0.020031003,"about_ca_system_score_gemma":0.11142019,"threshold_uncertainty_score":0.4744041},"labels":[],"label_agreement":null},{"id":"W4294958749","doi":"10.1136/jitc-2022-004913","title":"Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer","year":2022,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Foundation Medicine; Pfizer; G1 Therapeutics; York University; NYU Grossman School of Medicine; Genentech; AstraZeneca; Bristol-Myers Squibb","keywords":"Immune system; CD8; Cancer research; Medicine; Immunotherapy; Immunology; Cytotoxic T cell; Chemotherapy; Tumor microenvironment; Cisplatin; Biology; Internal medicine","score_opus":0.01763794552398114,"score_gpt":0.3215746549365428,"score_spread":0.3039367094125617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294958749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946465,0.0012446349,0.0028628935,0.000074525546,0.000023898709,0.000045971607,0.00024619047,0.00007419862,0.0007811153],"genre_scores_gemma":[0.99587125,0.0007129581,0.0020988055,0.0000312952,0.000008161318,0.00004609072,0.00026796974,0.000009483994,0.00095402566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999926,0.000011522754,0.0000062975428,0.0000145408085,0.000024477538,0.000017162794],"domain_scores_gemma":[0.9999608,0.0000060015886,0.000014527827,0.000004310621,0.0000037798627,0.000010509677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092066904,0.00028769163,0.00017110005,0.00016927172,0.00008132103,0.00015677758,0.0001397429,0.0001818613,0.0005655201],"category_scores_gemma":[0.000053417367,0.000067232955,0.00016753002,0.0000964088,0.0001780829,0.00013236457,0.0001111961,0.00042104116,0.00018123967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011312841,0.000042621577,0.00011201887,0.000021166847,0.0000025262455,0.000017968181,0.0000032306982,0.00013063986,0.99821496,0.000038665417,0.000030852116,0.0012721893],"study_design_scores_gemma":[0.00004954959,0.00089192414,0.0015599927,0.000003579935,0.0000132805135,0.00020269754,0.000009225764,0.0010051031,0.9941626,0.00003233087,0.002066826,0.0000029359971],"about_ca_topic_score_codex":0.00016473337,"about_ca_topic_score_gemma":0.00026293882,"teacher_disagreement_score":0.0005655201,"about_ca_system_score_codex":0.00019877996,"about_ca_system_score_gemma":0.00013013801,"threshold_uncertainty_score":0.001891911},"labels":[],"label_agreement":null},{"id":"W4295836988","doi":"10.1016/j.annonc.2022.07.1641","title":"1547P Predictors of short-, medium-, and long-term survival with limited stage small cell lung cancer in the real-world","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; AstraZeneca (Canada); University of Manitoba; CancerCare Manitoba","funders":"Daiichi Sankyo Europe; Shionogi; Astellas Pharma; Ono Pharmaceutical; Eisai; Chugai Pharmaceutical; Celltrion; Kissei; Taiho Pharmaceutical; Daiichi-Sankyo; Amgen; Pfizer; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Kyowa Hakko Kirin","keywords":"Medicine; Prophylactic cranial irradiation; Internal medicine; Cohort; Proportional hazards model; Survival analysis; Radiation therapy; Cancer; Retrospective cohort study; Oncology; Stage (stratigraphy); Surgery; Conventional PCI; Myocardial infarction","score_opus":0.09098211067852403,"score_gpt":0.42048352447356657,"score_spread":0.32950141379504255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295836988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633646,0.00036923238,0.00009727031,0.0003718163,0.00002806784,0.0000041497187,0.0017730896,0.0000052903383,0.0010146239],"genre_scores_gemma":[0.9989298,0.00007276896,0.00002554063,0.000029206227,0.000024299072,0.0000036528486,0.0006872601,0.000002466169,0.00022492684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953616,0.00014850649,0.00004936307,0.00008519312,0.00005972066,0.00012117764],"domain_scores_gemma":[0.997672,0.00063336006,0.0008228909,0.00012953555,0.00020290488,0.00053928123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000564724,0.0002349028,0.0002695223,0.00065977214,0.00038429518,0.00095820776,0.0003967083,0.0005726593,0.004231246],"category_scores_gemma":[0.0034877239,0.00018056403,0.0006471583,0.0012359569,0.00049977226,0.0007985861,0.00075510296,0.00094681635,0.00055355683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012631468,0.000020623156,0.9985257,0.00000627522,0.00004108161,0.0000659112,0.000021830809,0.00007717081,0.00005614542,0.000022850665,0.00022134777,0.0008148371],"study_design_scores_gemma":[0.0000057173193,0.00003498604,0.99892825,0.0000051166453,0.00003147493,0.00015709709,0.00022611067,0.00029177996,0.000024026,0.00006518125,0.00022641126,0.0000038724074],"about_ca_topic_score_codex":0.011386363,"about_ca_topic_score_gemma":0.0123956455,"teacher_disagreement_score":0.011386363,"about_ca_system_score_codex":0.00033219138,"about_ca_system_score_gemma":0.00039567417,"threshold_uncertainty_score":0.022640169},"labels":[],"label_agreement":null},{"id":"W4295837114","doi":"10.1016/j.annonc.2022.07.1631","title":"1536P Synthetic control arm (SCA) analysis of lurbinectedin compared to the standard of care (SoC) among patients with small cell lung cancer (SCLC) previously treated with platinum-based chemotherapy","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Calgary","funders":"","keywords":"Medicine; Hazard ratio; Chemotherapy; Oncology; Internal medicine; Population; Proportional hazards model; Confidence interval","score_opus":0.02381458618281122,"score_gpt":0.3388116935326948,"score_spread":0.31499710734988356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295837114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684227,0.0011845911,0.0001158999,0.000108116124,0.00009686496,0.00009122673,0.00041019177,0.000021780705,0.0011291162],"genre_scores_gemma":[0.99868745,0.00021490517,0.0001402662,0.000109490466,0.000055578003,0.00006667198,0.00030076547,0.000004079319,0.0004206778],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99920446,0.0003748199,0.000056435878,0.0001955142,0.00006323177,0.000105469284],"domain_scores_gemma":[0.99923766,0.0002484299,0.00020070364,0.000084814375,0.00005832704,0.00017000065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009631136,0.0004987966,0.001730962,0.0003123647,0.00013485034,0.0006555798,0.00044009794,0.00072527246,0.0031757758],"category_scores_gemma":[0.0018481603,0.00026859678,0.0013778402,0.0002963123,0.0004037068,0.00057315757,0.00025129147,0.0012230391,0.00033895051],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.953566,0.0017185364,0.014586197,0.00023849914,0.0028947443,0.00006032135,0.00003569446,0.00035633764,0.0035066416,0.00013486142,0.00070592825,0.02219637],"study_design_scores_gemma":[0.32507828,0.37872285,0.2613696,0.00015543471,0.019353835,0.00029387116,0.00022228606,0.004654906,0.004382814,0.0006793895,0.0050043333,0.00008239439],"about_ca_topic_score_codex":0.0015221961,"about_ca_topic_score_gemma":0.0025185847,"teacher_disagreement_score":0.0031757758,"about_ca_system_score_codex":0.0007059691,"about_ca_system_score_gemma":0.0007149421,"threshold_uncertainty_score":0.0106239915},"labels":[],"label_agreement":null},{"id":"W4296099256","doi":"10.3389/fonc.2022.1002385","title":"Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer","year":2022,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"AstraZeneca","keywords":"Stage (stratigraphy); Lung cancer; Platinum; Oncology; Immune checkpoint; Medicine; Cancer research; PD-L1; Cancer; Internal medicine; Immune system; Immunology; Immunotherapy; Biology","score_opus":0.03261963511411389,"score_gpt":0.3869636982292617,"score_spread":0.35434406311514777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296099256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972556,0.0004401182,0.000055926183,0.00009370072,0.0000058927494,0.000018606066,0.0013451045,0.0000037380123,0.00078125234],"genre_scores_gemma":[0.99870586,0.00016936338,0.000049341776,0.00004592734,0.000006470233,0.00000850797,0.0009268084,0.0000013697751,0.00008646242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925655,0.00008971313,0.00011175185,0.00017242943,0.00023016355,0.00013945461],"domain_scores_gemma":[0.99769247,0.0002714187,0.0013524992,0.00011007549,0.0002488361,0.00032473882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006461691,0.00010373168,0.00022217282,0.0006603911,0.0006242855,0.0007739821,0.00047809075,0.00026693405,0.0019400193],"category_scores_gemma":[0.002327417,0.00013287914,0.00026282706,0.0013481446,0.0003212858,0.00032005622,0.00044060985,0.0003598344,0.00016449417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060561753,0.000008444155,0.99842715,0.000013283494,0.000015042312,0.000114321294,0.000027390182,0.000040924122,0.000052030897,0.000014465139,0.00017066197,0.001055738],"study_design_scores_gemma":[0.0000074263858,0.000031008265,0.9981938,0.00002483601,0.000019881658,0.00064837,0.00018140556,0.00020423652,0.00007120494,0.00002851373,0.0005859328,0.0000033881774],"about_ca_topic_score_codex":0.055656534,"about_ca_topic_score_gemma":0.13075544,"teacher_disagreement_score":0.055656534,"about_ca_system_score_codex":0.0016404338,"about_ca_system_score_gemma":0.0016710263,"threshold_uncertainty_score":0.11066514},"labels":[],"label_agreement":null},{"id":"W4297253552","doi":"10.4049/jimmunol.2100901","title":"Negative Cross-Talk between TLR2/4-Independent AMPKα1 and TLR2/4-Dependent JNK Regulates <i>S. pneumoniae</i>–Induced Mucosal Innate Immune Response","year":2022,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institutes of Health; Ministry of Education, Culture, Sports, Science and Technology; National Institute on Deafness and Other Communication Disorders; Japan Society for the Promotion of Science; Georgia Research Alliance","keywords":"TLR2; Innate immune system; AMPK; Protein kinase A; Cell biology; Mucin; Immune system; Signal transduction; Biology; Pneumolysin; Downregulation and upregulation; Kinase; Streptococcus pneumoniae; Immunology; Chemistry; Microbiology","score_opus":0.023511746423171703,"score_gpt":0.32991962030180927,"score_spread":0.30640787387863755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297253552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98158044,0.008309825,0.0044279294,0.00071791385,0.00031454331,0.00007589485,0.0009678352,0.00013123563,0.0034744893],"genre_scores_gemma":[0.99196285,0.0021362703,0.0018067774,0.0002829927,0.000069215625,0.00009139791,0.0007175807,0.000018743649,0.0029143437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997347,0.000036458572,0.000025342513,0.00006035231,0.00004734036,0.00009583942],"domain_scores_gemma":[0.9998915,0.0000053814074,0.000044519315,0.0000071722034,0.000016949742,0.000034528173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020588744,0.0005241977,0.00044018205,0.00024013841,0.0003448078,0.00034971038,0.00022552749,0.0003820684,0.0028903973],"category_scores_gemma":[0.00009940692,0.00021093294,0.00075645914,0.00013698892,0.000355233,0.00032278127,0.0004010922,0.0008112055,0.0006091996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010243139,0.00006301434,0.0006050516,0.00032611928,0.000026526726,0.00012451805,0.000025280617,0.000075185766,0.9958417,0.00016020579,0.00019925616,0.0015289277],"study_design_scores_gemma":[0.00021551897,0.0010183692,0.0470199,0.00008026191,0.00013238908,0.00096367806,0.0002936343,0.0027042578,0.9369351,0.0003809449,0.01022105,0.0000348747],"about_ca_topic_score_codex":0.00033629622,"about_ca_topic_score_gemma":0.00053922256,"teacher_disagreement_score":0.0028903973,"about_ca_system_score_codex":0.00034312118,"about_ca_system_score_gemma":0.00030885587,"threshold_uncertainty_score":0.0096693635},"labels":[],"label_agreement":null},{"id":"W4297830820","doi":"10.30683/1927-7229.2022.11.04","title":"Clinical Features of de Novo Lung Neuroendocrine Tumor after Liver Transplantation for Hepatocellular Carcinoma","year":2022,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Lung; Liver transplantation; Internal medicine; Etoposide; Carcinoma; Gastroenterology; Pathological; Chemotherapy; Transplantation; Radiology","score_opus":0.03791791447402312,"score_gpt":0.40468108486019,"score_spread":0.3667631703861669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297830820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917966,0.00030429417,0.00006298736,0.000022367285,0.000003780784,0.000006028852,0.000076380384,0.0000028650472,0.00034159652],"genre_scores_gemma":[0.99963367,0.00006895672,0.00004427191,0.000013183432,0.000008879531,0.0000026002308,0.00015839208,7.4117673e-7,0.00006921499],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99977905,0.000029168512,0.000035790603,0.000051153387,0.000050154333,0.000054680007],"domain_scores_gemma":[0.9989473,0.00017140545,0.0004859624,0.000038099093,0.00006410845,0.00029310666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002856628,0.00016399473,0.0002734624,0.0006692494,0.00031962077,0.00043286686,0.00025979677,0.00040847025,0.0011356225],"category_scores_gemma":[0.001055909,0.00014745159,0.00021808875,0.00064242276,0.0003011057,0.00040648994,0.00029912314,0.00029975633,0.00021148977],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011977551,0.000014860861,0.98860395,0.000010346986,0.000011008134,0.00891445,0.000040105653,0.000048383296,0.0011129151,0.000013797316,0.000051645206,0.00105885],"study_design_scores_gemma":[0.000008100359,0.00011051503,0.9590275,0.000004542057,0.000013470101,0.040019684,0.0001255631,0.0001552033,0.0003026153,0.000019728235,0.00020799458,0.000005054362],"about_ca_topic_score_codex":0.0015361279,"about_ca_topic_score_gemma":0.0022652647,"teacher_disagreement_score":0.0015361279,"about_ca_system_score_codex":0.0003517899,"about_ca_system_score_gemma":0.00028396212,"threshold_uncertainty_score":0.0037990212},"labels":[],"label_agreement":null},{"id":"W4297973571","doi":"10.3390/curroncol29100565","title":"External Validation of the Graded Prognostic Assessment in Patients with Brain Metastases from Small Cell Lung Cancer","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Oncology; Brain metastasis; Lung; Internal medicine; Pathology; Cancer; Metastasis","score_opus":0.07784989185794236,"score_gpt":0.4295213568732286,"score_spread":0.35167146501528623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297973571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961659,0.00016110105,0.0015376117,0.000036965954,0.000034310142,0.00008658791,0.0010252435,0.000012003881,0.0009402629],"genre_scores_gemma":[0.99710566,0.000033073236,0.0006048532,0.000024340668,0.000010398909,0.00006311425,0.0020459285,0.0000058742517,0.000106835956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729127,0.0014325605,0.00026852568,0.00036675026,0.00046858203,0.00017225894],"domain_scores_gemma":[0.9918671,0.0027327882,0.0016424839,0.0013895355,0.0020003642,0.0003676657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070028543,0.00039861855,0.00024872975,0.0009797609,0.0002972253,0.0006007353,0.00052099477,0.00034463432,0.0009088308],"category_scores_gemma":[0.018412,0.00008537222,0.00038644252,0.0007919506,0.0005059347,0.00034492588,0.00093841064,0.00027581502,0.000375614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000513347,0.000041996587,0.99127567,0.000024120589,0.0000800382,0.000040770068,0.000097233045,0.00035177852,0.0005477087,0.000086118576,0.00035375907,0.0065874495],"study_design_scores_gemma":[0.00007065748,0.00045263802,0.99388313,0.00003826673,0.00010020316,0.00037431423,0.00016386734,0.0014411823,0.0009973871,0.00020502278,0.0022641649,0.000009242613],"about_ca_topic_score_codex":0.0017100386,"about_ca_topic_score_gemma":0.0017688754,"teacher_disagreement_score":0.0070028543,"about_ca_system_score_codex":0.00041198672,"about_ca_system_score_gemma":0.00058971863,"threshold_uncertainty_score":0.037035108},"labels":[],"label_agreement":null},{"id":"W4300573232","doi":"","title":"Lung cancer.","year":2009,"lang":"en","type":"review","venue":"PubMed","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Erlotinib; Lung cancer; Chemotherapy; Oncology; Radiation therapy; Systematic review; Cochrane Library; Cancer; Intensive care medicine; Gefitinib; Internal medicine; MEDLINE; Randomized controlled trial; Epidermal growth factor receptor","score_opus":0.11321257530201834,"score_gpt":0.44533948901758486,"score_spread":0.3321269137155665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300573232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014487245,0.7717757,0.00074970204,0.024826534,0.008001372,0.0007273673,0.016814558,0.00035850925,0.17529744],"genre_scores_gemma":[0.029356232,0.7976639,0.0026715333,0.04141056,0.009930245,0.0013510657,0.020185303,0.00019016638,0.09724098],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99692684,0.0011071175,0.000601616,0.0003767611,0.00084334373,0.00014437929],"domain_scores_gemma":[0.995033,0.0020873758,0.0009453537,0.00022392253,0.0013730386,0.00033728973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024408707,0.00064143684,0.0013876145,0.0028501563,0.00049310556,0.0029754003,0.0011794217,0.0022271995,0.1983846],"category_scores_gemma":[0.014106728,0.00030568126,0.0015819119,0.0030343076,0.00058896793,0.0026072357,0.0016923115,0.0018438374,0.058599066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002203801,0.000062183004,0.0019728518,0.050218195,0.0003576979,0.00022081863,0.00018100937,0.00007794179,0.00013799324,0.005584128,0.39682347,0.5441433],"study_design_scores_gemma":[0.00014631716,0.00011334291,0.0034873774,0.02946808,0.00036977202,0.0008576268,0.00013193414,0.00003579407,0.00008659527,0.002717991,0.96256495,0.000020241518],"about_ca_topic_score_codex":0.0033917688,"about_ca_topic_score_gemma":0.0034332387,"teacher_disagreement_score":0.1983846,"about_ca_system_score_codex":0.0014428261,"about_ca_system_score_gemma":0.004144238,"threshold_uncertainty_score":0.66366255},"labels":[],"label_agreement":null},{"id":"W4302037882","doi":"","title":"Lung cancer.","year":2010,"lang":"en","type":"review","venue":"PubMed","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Erlotinib; Lung cancer; Cochrane Library; Radiation therapy; Systematic review; Oncology; MEDLINE; Chemotherapy; Intensive care medicine; Gefitinib; Cancer; Psychological intervention; Internal medicine; Surgery; Randomized controlled trial; Epidermal growth factor receptor","score_opus":0.09964664190625337,"score_gpt":0.4412358088684417,"score_spread":0.34158916696218833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302037882","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016693932,0.6920143,0.0009132457,0.029225744,0.009270803,0.0008412893,0.021882128,0.00049197034,0.24369112],"genre_scores_gemma":[0.03330782,0.7355809,0.0031523516,0.048891194,0.01144272,0.0016067841,0.025998326,0.00026083126,0.13975897],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99708515,0.0010369057,0.00056372245,0.0003681021,0.00079756026,0.00014857146],"domain_scores_gemma":[0.99540436,0.0018562304,0.00084295566,0.00022881996,0.0013239213,0.00034372884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023165485,0.00065377663,0.0013440704,0.0028075473,0.000522304,0.003074316,0.0011926378,0.0023171646,0.23191626],"category_scores_gemma":[0.013361263,0.00030537398,0.0015304054,0.00295771,0.00057897175,0.00263433,0.0017889047,0.0018585728,0.07611699],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020572818,0.00006128247,0.0018257195,0.038478967,0.0002973044,0.00021565649,0.0001707756,0.00007108701,0.00013655274,0.0055066375,0.43765196,0.5153784],"study_design_scores_gemma":[0.00012859395,0.000098073106,0.0029410094,0.02110977,0.00027264052,0.00076181,0.00011873435,0.00003161426,0.000079331105,0.002522636,0.97191757,0.000018081453],"about_ca_topic_score_codex":0.0032717958,"about_ca_topic_score_gemma":0.0032893475,"teacher_disagreement_score":0.23191626,"about_ca_system_score_codex":0.0014519134,"about_ca_system_score_gemma":0.0040482753,"threshold_uncertainty_score":0.7758372},"labels":[],"label_agreement":null},{"id":"W4306247391","doi":"10.1016/s2213-2600(22)00309-5","title":"Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial","year":2022,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Lakeridge Health","funders":"Chugai Pharmaceutical; Genentech; Ipsen; Jazz Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Servier; Amgen; Pfizer; PharmaMar; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Clinical endpoint; Chemotherapy; Population; Febrile neutropenia; Oncology; Doxorubicin; Topotecan; Vincristine; Anthracycline; Clinical trial; Surgery; Cyclophosphamide; Cancer; Neutropenia; Breast cancer","score_opus":0.0657955502563836,"score_gpt":0.3892918764154446,"score_spread":0.323496326159061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306247391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892266,0.0049724,0.0003644629,0.0009487774,0.0006780668,0.0013295041,0.0008024774,0.00010977131,0.0015679039],"genre_scores_gemma":[0.9886048,0.0025977176,0.0010849923,0.0010705029,0.00048408334,0.0017756477,0.0010647655,0.00002516554,0.0032924416],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993117,0.00038517689,0.000028085553,0.0001264475,0.000037212743,0.000111435336],"domain_scores_gemma":[0.9988952,0.00037288712,0.0002104778,0.000074046184,0.00004528943,0.00040204977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001692139,0.0018655077,0.0037151743,0.00046055103,0.00042945627,0.001259618,0.001171871,0.002196795,0.007348928],"category_scores_gemma":[0.0016952076,0.0007219941,0.0022734508,0.0005047231,0.0014913249,0.0013057919,0.00053992175,0.004155117,0.0013105746],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9852213,0.0034548338,0.00035530963,0.0003283153,0.0005464078,0.000018767121,0.000039563896,0.00025942147,0.0009809454,0.00006839113,0.0004797012,0.00824704],"study_design_scores_gemma":[0.95105755,0.047138486,0.00082015246,0.000019386522,0.0002496855,0.000015359888,0.00002072902,0.00023600415,0.000105138606,0.00007096897,0.00025568315,0.00001090858],"about_ca_topic_score_codex":0.0018524774,"about_ca_topic_score_gemma":0.004279659,"teacher_disagreement_score":0.007348928,"about_ca_system_score_codex":0.0011640054,"about_ca_system_score_gemma":0.0011754631,"threshold_uncertainty_score":0.024584591},"labels":[],"label_agreement":null},{"id":"W4306655086","doi":"10.1016/j.radonc.2022.09.017","title":"In reply to Li et al. Letter to the editor. “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials.”","year":2022,"lang":"en","type":"letter","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Meta-analysis; Medicine; Oncology; Stage (stratigraphy); Randomized controlled trial; Lung cancer; Internal medicine; Biology","score_opus":0.1580808550286847,"score_gpt":0.48006860970875204,"score_spread":0.32198775468006735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306655086","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014363,0.001630726,0.00007546627,0.951256,0.045981735,0.00001465044,0.0002646066,0.000034940786,0.0005982817],"genre_scores_gemma":[0.00065721624,0.00075051835,0.00009481606,0.9617962,0.034924697,0.000041977823,0.00006473495,0.000019751049,0.0016500448],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941783,0.0018483072,0.0011039831,0.00077330624,0.0015741452,0.00052203477],"domain_scores_gemma":[0.97760457,0.012151387,0.0017940251,0.00054976594,0.0057496545,0.0021505882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008773949,0.0011540157,0.0027428323,0.0013642658,0.0028698535,0.004315583,0.0030597085,0.033888455,0.0065714545],"category_scores_gemma":[0.052753456,0.0014098488,0.0021034312,0.0015188544,0.0017612417,0.0038185548,0.0016287947,0.034566224,0.009881133],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006706359,0.0000109518305,0.00022037655,0.00006707331,0.000022263632,0.00014133747,0.000026623038,0.000017939283,0.000034901168,0.00018276148,0.99656206,0.0026466113],"study_design_scores_gemma":[0.0005593411,0.00012324759,0.0020193327,0.0008363163,0.00021217958,0.0011043272,0.00028993105,0.00042401106,0.00037714985,0.004639518,0.989286,0.00012868323],"about_ca_topic_score_codex":0.0064088446,"about_ca_topic_score_gemma":0.010800441,"teacher_disagreement_score":0.033888455,"about_ca_system_score_codex":0.0034997617,"about_ca_system_score_gemma":0.0060663535,"threshold_uncertainty_score":0.04640168},"labels":[],"label_agreement":null},{"id":"W4307101139","doi":"10.14740/wjon1494","title":"Precise Therapeutic Benefits and Underlying Mechanisms of Anlotinib Combined With Checkpoint Immunotherapy in Advanced Non-Small-Cell Lung Cancer","year":2022,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Gannan Medical University; Beijing Medical and Health Foundation","keywords":"Medicine; Immunotherapy; Lung cancer; Oncology; Cancer research; Cancer; Internal medicine","score_opus":0.037985730280862134,"score_gpt":0.3591037669550723,"score_spread":0.32111803667421013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307101139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8127017,0.17491955,0.0015155675,0.0027305088,0.0004261181,0.00013603117,0.00031168506,0.0000437022,0.007215111],"genre_scores_gemma":[0.9806349,0.0171323,0.0004727696,0.0002962077,0.00022276814,0.000059357804,0.00016582265,0.0000049686646,0.001010812],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99975365,0.00007746552,0.000022709602,0.00003222395,0.00004079048,0.00007314408],"domain_scores_gemma":[0.99986553,0.000043998625,0.000040154384,0.000012485575,0.000018709245,0.000019057956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066614593,0.00032775456,0.00068296515,0.00027157893,0.00020576555,0.0008371996,0.00022794961,0.00034565022,0.001361739],"category_scores_gemma":[0.00049588655,0.00011775257,0.000604038,0.00021658163,0.0003190098,0.00083171285,0.00022833311,0.0008537869,0.0001705448],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03587269,0.005176794,0.038030487,0.0047753234,0.0017622034,0.0010746615,0.00032432427,0.006031755,0.2282919,0.016139505,0.0056377472,0.6568827],"study_design_scores_gemma":[0.012497134,0.090587765,0.48772582,0.0023256326,0.010345276,0.0067043076,0.0018842636,0.027427858,0.16786304,0.040744852,0.15156199,0.00033215928],"about_ca_topic_score_codex":0.00022739627,"about_ca_topic_score_gemma":0.0008986283,"teacher_disagreement_score":0.001361739,"about_ca_system_score_codex":0.00034300523,"about_ca_system_score_gemma":0.00048640097,"threshold_uncertainty_score":0.004555404},"labels":[],"label_agreement":null},{"id":"W4307657760","doi":"10.3390/curroncol29100631","title":"The Impact of Chemosensitivity on the Outcome of Brain Metastases in Small-Cell Lung Cancer: A Retrospective Analysis","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Retrospective cohort study; Lung cancer; Cancer; Internal medicine; Pathology; Cancer research; Bioinformatics; Biology","score_opus":0.11488748989150868,"score_gpt":0.4945503053120081,"score_spread":0.3796628154204994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307657760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987614,0.00082027307,0.00008491441,0.000012771152,0.0000032202393,0.0000059701547,0.00014600778,0.0000020108664,0.00016330137],"genre_scores_gemma":[0.9996644,0.00012312438,0.000023419745,0.0000062395115,0.0000050320637,0.0000035541123,0.00015512649,7.1974205e-7,0.000018415496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959415,0.000086944674,0.000081221326,0.00010059074,0.00008345336,0.000053625063],"domain_scores_gemma":[0.99887055,0.00022948692,0.0005444197,0.00010875131,0.00011025046,0.00013647263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054324546,0.00018171156,0.00032189133,0.0008255997,0.00027877232,0.00035687757,0.0002133948,0.00024415227,0.0006617725],"category_scores_gemma":[0.0012588055,0.00016306275,0.00044736298,0.000888407,0.00027534473,0.00033372137,0.00027003494,0.00023487814,0.000110589244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009865225,0.0000054601437,0.99872476,0.000008461515,0.00005601258,0.00012168783,0.000013222215,0.000033710377,0.00014117369,0.0000061979313,0.000019158053,0.0007714101],"study_design_scores_gemma":[0.0000052116197,0.00008316212,0.99837023,0.0000054516872,0.00007207467,0.0009274765,0.000058849142,0.0001498428,0.00011902555,0.000015445083,0.00019008081,0.000003338135],"about_ca_topic_score_codex":0.0014867733,"about_ca_topic_score_gemma":0.0018491062,"teacher_disagreement_score":0.0014867733,"about_ca_system_score_codex":0.00023150137,"about_ca_system_score_gemma":0.00024150274,"threshold_uncertainty_score":0.0029562712},"labels":[],"label_agreement":null},{"id":"W4308326586","doi":"10.1016/j.isci.2022.105487","title":"Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction","year":2022,"lang":"en","type":"article","venue":"iScience","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; Canada Research Chairs; St Mary's Hospital Centre; University of Toronto","funders":"Memorial Sloan-Kettering Cancer Center; University of Toronto; Canada Foundation for Innovation; National Cancer Institute; National Institutes of Health; Ontario Institute for Cancer Research; Canadian Institutes of Health Research; Cancer Research Society","keywords":"DNA methylation; Methylation; Biology; Methylated DNA immunoprecipitation; Differentially methylated regions; Epigenomics; Cancer research; Epigenetics; Lung cancer; Molecular biology; DNA; Genetics; Oncology; Gene; Medicine; Gene expression","score_opus":0.027333121702545444,"score_gpt":0.3252409477923015,"score_spread":0.2979078260897561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308326586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957703,0.000610762,0.0022458415,0.000056371486,0.000004071412,0.000016712938,0.00092709996,0.000036360638,0.00033254756],"genre_scores_gemma":[0.9968432,0.00016131486,0.0013612942,0.000039603754,0.000004033873,0.00001741732,0.001249832,0.0000070535875,0.00031617974],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998921,0.000019333222,0.000007835808,0.00003712731,0.00002561739,0.000017925673],"domain_scores_gemma":[0.9998808,0.00003747043,0.000029325955,0.000015362426,0.000020656875,0.00001644005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018976229,0.00014459493,0.0002337281,0.00045515294,0.00018850011,0.0002760339,0.00014367438,0.0001894246,0.0009274623],"category_scores_gemma":[0.00045238723,0.00008221131,0.00015020161,0.00032135475,0.00012524349,0.00011669513,0.00027504773,0.00021567123,0.0001629844],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008208178,0.00003930784,0.27812737,0.00012290246,0.00020746863,0.00015459427,0.00022692441,0.0007726795,0.6837736,0.000216697,0.000525292,0.035012353],"study_design_scores_gemma":[0.000042009062,0.000442484,0.83162975,0.000026726151,0.0002291078,0.0011403625,0.00033062184,0.006562236,0.15384662,0.00078302756,0.004948143,0.000018825745],"about_ca_topic_score_codex":0.0013467169,"about_ca_topic_score_gemma":0.003783751,"teacher_disagreement_score":0.0013467169,"about_ca_system_score_codex":0.00016649094,"about_ca_system_score_gemma":0.00021506115,"threshold_uncertainty_score":0.0031026006},"labels":[],"label_agreement":null},{"id":"W4308653809","doi":"10.1158/0008-5472.can-22-1433","title":"Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institute of General Medical Sciences; National Cancer Institute; Canadian Institutes of Health Research; Genentech; National Institutes of Health; University of California, San Francisco; Scheme for Promotion of Academic and Research Collaboration; Astellas Pharma; Clovis Oncology; U.S. Department of Defense; Sanofi; Celgene; Prostate Cancer Foundation; AstraZeneca; Amgen; Pfizer; Advanced Accelerator Applications","keywords":"Prostate cancer; Medicine; Immunotherapy; Cancer; Cancer research; T cell; Immunology; Internal medicine; Immune system","score_opus":0.053846302946261894,"score_gpt":0.41391753279444676,"score_spread":0.36007122984818485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308653809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990299,0.0024261442,0.0049066916,0.0002631891,0.000012957426,0.000045732533,0.00013298377,0.00013218276,0.001781046],"genre_scores_gemma":[0.99565977,0.0006763792,0.0028157674,0.00008073893,0.00000494317,0.000017627914,0.00010483297,0.000010491242,0.0006293251],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999405,0.000014534933,0.0000026476948,0.000010661534,0.000018079412,0.000013493594],"domain_scores_gemma":[0.9999721,0.0000059517606,0.0000075835787,0.0000029227763,0.0000037233233,0.000007702422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016550154,0.00016424965,0.00014262185,0.0001878078,0.00009023125,0.00027980065,0.00024760253,0.0003052325,0.0005528387],"category_scores_gemma":[0.00011506222,0.000096311946,0.00014642751,0.0001317316,0.00020036811,0.00018944427,0.00013871098,0.0003914047,0.00014845097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030083148,0.000086407425,0.001932266,0.00007494996,0.000013193257,0.00020605198,0.000021711796,0.0008795064,0.98763627,0.00018470766,0.000238473,0.008425678],"study_design_scores_gemma":[0.00013548014,0.0017656997,0.020017818,0.00001856353,0.00005736021,0.004063544,0.00008093361,0.013210772,0.95613366,0.00017581826,0.0043242485,0.000016186876],"about_ca_topic_score_codex":0.0016650852,"about_ca_topic_score_gemma":0.0022431165,"teacher_disagreement_score":0.0016650852,"about_ca_system_score_codex":0.00050430425,"about_ca_system_score_gemma":0.0003011367,"threshold_uncertainty_score":0.0036589503},"labels":[],"label_agreement":null},{"id":"W4309680566","doi":"10.3390/curroncol29120709","title":"Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Meta-analysis; Immunotherapy; Lung cancer; Oncology; Stage (stratigraphy); Internal medicine; Cancer research; Cancer; Biology","score_opus":0.33216281371612116,"score_gpt":0.5244035456527203,"score_spread":0.19224073193659913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309680566","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024003854,0.9963917,0.00027634948,0.00012620146,0.000085392014,0.00020871732,0.0003194473,0.000015806632,0.00017593538],"genre_scores_gemma":[0.0888019,0.90687674,0.0014283522,0.00082053756,0.00016015301,0.0009623037,0.00062476954,0.000022974391,0.00030241214],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99375266,0.0029514,0.0017822405,0.0005857045,0.00069658953,0.00023137829],"domain_scores_gemma":[0.98820007,0.008292594,0.0019771068,0.00032268546,0.0010062533,0.00020131879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010529583,0.00250568,0.019761637,0.0056153163,0.00058101414,0.0028034425,0.0019966017,0.002138602,0.003855023],"category_scores_gemma":[0.022648087,0.0014024208,0.03247772,0.0069740517,0.0006141637,0.0016317866,0.0013961829,0.0016856518,0.00038303935],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013922176,0.000025066844,0.0015049053,0.55338866,0.4317041,0.00009827403,0.00006653747,0.00039497277,0.00019739535,0.00010423662,0.00059259706,0.010531162],"study_design_scores_gemma":[0.000505255,0.00019994029,0.0025069485,0.04225102,0.9520911,0.00009428168,0.00003804347,0.00013343099,0.00008884328,0.00014907196,0.0019212316,0.000020867981],"about_ca_topic_score_codex":0.008834498,"about_ca_topic_score_gemma":0.020398922,"teacher_disagreement_score":0.019761637,"about_ca_system_score_codex":0.0028430382,"about_ca_system_score_gemma":0.0040223426,"threshold_uncertainty_score":0.055686414},"labels":[],"label_agreement":null},{"id":"W4310753331","doi":"10.1016/j.annonc.2022.10.396","title":"358P Intracranial metastatic disease (IMD) burden and management of patients with small cell lung cancer (SCLC): A population-based analysis of 8705 patients","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Cancer Care Ontario; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Oncology; Internal medicine; Disease; Lung cancer; Population; Disease burden","score_opus":0.03618631874369391,"score_gpt":0.37250374823269977,"score_spread":0.3363174294890059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310753331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982247,0.0003205478,0.000045310942,0.00003833567,0.0000036656093,0.0000045553033,0.0010857135,0.000002597237,0.0002744794],"genre_scores_gemma":[0.9987649,0.00015241286,0.000027959044,0.000026765123,0.000008311025,0.0000062884064,0.0009331737,0.0000011901492,0.000078878766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994505,0.00013948434,0.00007419992,0.00015529575,0.00009443034,0.00008596955],"domain_scores_gemma":[0.9992592,0.000112361275,0.00037898286,0.000065280256,0.00007174367,0.00011249648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049458625,0.0002496611,0.00040113728,0.0007669071,0.00034910097,0.00065433886,0.00033578314,0.0004369204,0.0010184806],"category_scores_gemma":[0.0013043657,0.00030113012,0.0007053474,0.002138259,0.00024161559,0.00056678656,0.00046261415,0.00048023267,0.00019029371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009461945,0.000017711638,0.99893194,0.000006336515,0.00011419402,0.000038509457,0.000028451042,0.000036619065,0.00006262575,0.000009208766,0.000097064316,0.00056277006],"study_design_scores_gemma":[0.0000062030354,0.0000412679,0.9995167,0.0000026995415,0.00003849329,0.000093462055,0.00009226595,0.00008969568,0.00001251957,0.00000800811,0.000096643,0.000002106427],"about_ca_topic_score_codex":0.011530742,"about_ca_topic_score_gemma":0.014919875,"teacher_disagreement_score":0.011530742,"about_ca_system_score_codex":0.00044449113,"about_ca_system_score_gemma":0.00036401858,"threshold_uncertainty_score":0.022927284},"labels":[],"label_agreement":null},{"id":"W4310754084","doi":"10.1016/j.annonc.2022.10.395","title":"357P Molecular stratification of small cell lung carcinoma subtypes by immunoexpression of ASCL1, NEUROD1, POU2F3 and YAP1 with clinicopathological correlation","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"YAP1; Medicine; Lung; Correlation; Cancer research; Pathology; Internal medicine; Biology; Genetics; Gene; Transcription factor","score_opus":0.052204182496479,"score_gpt":0.3770225237112079,"score_spread":0.3248183412147289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310754084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979844,0.0002977993,0.00030383712,0.000049684742,0.000007846513,0.0000071249938,0.00021971374,0.000009206561,0.0011202825],"genre_scores_gemma":[0.9991738,0.000059334616,0.00014969776,0.000008873466,0.000008172937,0.000007262563,0.00022046619,0.00000222419,0.00037011903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979085,0.000040794253,0.000024909503,0.000040887342,0.000046250992,0.00005628614],"domain_scores_gemma":[0.99956125,0.00010248783,0.00013711039,0.000033935034,0.000065062966,0.00010013691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046416634,0.00021759442,0.00017354415,0.0011963026,0.0003158293,0.0005720676,0.00024653072,0.000308802,0.0030303218],"category_scores_gemma":[0.00091214257,0.00014483076,0.00031993786,0.00071956316,0.00042302272,0.0003112523,0.00044653623,0.0002801303,0.0005153961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038408843,0.000025651148,0.98291355,0.000015502814,0.0000570964,0.0003087745,0.00007335365,0.00014797412,0.011558015,0.000093259914,0.00020393803,0.0042188787],"study_design_scores_gemma":[0.000012900934,0.000070049406,0.9928676,0.000004407682,0.00006195939,0.0013133545,0.00027706797,0.0012821228,0.0026137466,0.0002904085,0.0011994796,0.000006915567],"about_ca_topic_score_codex":0.00078162266,"about_ca_topic_score_gemma":0.0009933729,"teacher_disagreement_score":0.0030303218,"about_ca_system_score_codex":0.00023698095,"about_ca_system_score_gemma":0.00020544426,"threshold_uncertainty_score":0.010137439},"labels":[],"label_agreement":null},{"id":"W4311150526","doi":"10.51731/cjht.2022.523","title":"Atezolizumab (Tecentriq)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Atezolizumab; Carboplatin; Medicine; Intensive care medicine; Family medicine; Political science; Cancer; Surgery; Internal medicine; Chemotherapy; Health care; Law","score_opus":0.037319562789226685,"score_gpt":0.3405334726099894,"score_spread":0.3032139098207627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311150526","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013742325,0.78286594,0.0027056797,0.0076015713,0.0023342886,0.00038851713,0.004027869,0.0004242202,0.18590966],"genre_scores_gemma":[0.17895485,0.56627655,0.008103583,0.014965719,0.0015510826,0.00040051845,0.010329872,0.00008992954,0.21932787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996599,0.000059742066,0.000040372342,0.00004880695,0.00014823719,0.00004293537],"domain_scores_gemma":[0.9996433,0.00007634371,0.00009405324,0.00001125372,0.00013400681,0.00004094749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069133594,0.0003416276,0.000277604,0.00083294214,0.00022774083,0.00077210215,0.00042552565,0.00067958276,0.015711067],"category_scores_gemma":[0.00096875045,0.00008381761,0.0005054356,0.0004572248,0.00022651104,0.00043337303,0.00036091555,0.0005591593,0.003952029],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005905076,0.000075976306,0.00073464,0.0039752363,0.00008428381,0.00015719191,0.00004057549,0.0001737371,0.00783198,0.0031615838,0.10188982,0.8812844],"study_design_scores_gemma":[0.00031995118,0.00073954085,0.003004292,0.0014934756,0.00013781535,0.0008216071,0.000033416934,0.00010222208,0.0054000267,0.00026491238,0.98766965,0.0000132232035],"about_ca_topic_score_codex":0.01147475,"about_ca_topic_score_gemma":0.028001674,"teacher_disagreement_score":0.015711067,"about_ca_system_score_codex":0.001276471,"about_ca_system_score_gemma":0.0019757526,"threshold_uncertainty_score":0.05255878},"labels":[],"label_agreement":null},{"id":"W4311980609","doi":"10.3390/curroncol29120765","title":"Real World Patient Eligibility for Second Line Lurbinectedin Based Treatment in Small Cell Lung Cancer: Understanding Epidemiology and Estimating Health Care Utilization","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"AstraZeneca Canada","keywords":"Medicine; Retrospective cohort study; Population; Internal medicine; Radiation therapy; Lung cancer; Conventional PCI; Cancer; Surgery","score_opus":0.34319917607191924,"score_gpt":0.5363135905518455,"score_spread":0.19311441447992622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311980609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99713147,0.00074300024,0.00046968553,0.00025414408,0.000004687876,0.00002347813,0.0009580163,0.000004757088,0.00041085426],"genre_scores_gemma":[0.9988262,0.00024932282,0.00024782127,0.00003563537,0.000010442255,0.000016792968,0.0005820036,0.000001307691,0.000030502733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985184,0.0007130122,0.0002434065,0.00019238995,0.00019506013,0.00013770959],"domain_scores_gemma":[0.99368685,0.0015505971,0.0040135365,0.0001939327,0.00028009797,0.00027490838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018477928,0.00014179091,0.0002284679,0.0015428776,0.00020487656,0.0007673023,0.0004526027,0.0003617378,0.00092640205],"category_scores_gemma":[0.0059797945,0.00018257505,0.0003287209,0.0018611302,0.0002768816,0.00087998016,0.00054204365,0.00038502383,0.00015293127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001362506,0.0000081275975,0.9989479,0.000006928155,0.000010479645,0.000008584127,0.000015501477,0.00004416684,0.00001422277,0.000015758538,0.000046416542,0.00086825807],"study_design_scores_gemma":[0.0000032971195,0.000056824378,0.99763584,0.000018943707,0.000017532502,0.00014077802,0.00027973115,0.0014302565,0.000052456013,0.000067751964,0.00029336236,0.0000032260477],"about_ca_topic_score_codex":0.0060504205,"about_ca_topic_score_gemma":0.008322627,"teacher_disagreement_score":0.0060504205,"about_ca_system_score_codex":0.00065549766,"about_ca_system_score_gemma":0.0005464314,"threshold_uncertainty_score":0.012030363},"labels":[],"label_agreement":null},{"id":"W4312186829","doi":"10.3390/curroncol30010008","title":"Stereotactic Body Radiotherapy (SBRT) in Very Limited-Stage Small Cell Lung Cancer (VLS-SCLC)","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cohort; Radiation therapy; Radiosurgery; Retrospective cohort study; Oncology; Stage (stratigraphy); Internal medicine; Lung cancer; Overall survival","score_opus":0.09737665455314672,"score_gpt":0.44644402928962457,"score_spread":0.34906737473647786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312186829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99121594,0.0074871355,0.00025985177,0.000065396256,0.00000843211,0.000031564203,0.00025330632,0.0000065199997,0.0006718956],"genre_scores_gemma":[0.99751943,0.0019162527,0.0001879432,0.00003671236,0.000014675474,0.000009666992,0.00023183264,0.0000019724396,0.000081605125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952555,0.00017272044,0.00010110799,0.0000599835,0.00009861965,0.00004189696],"domain_scores_gemma":[0.9988085,0.00038528265,0.0005566062,0.00007525149,0.00008102979,0.00009324614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010163558,0.00006559899,0.00025223097,0.0010657451,0.0002636329,0.00041461087,0.00026112582,0.00019986076,0.0005745805],"category_scores_gemma":[0.0021661175,0.00011318656,0.00032870864,0.0014146233,0.00038932357,0.00023899952,0.00034899765,0.0001562074,0.00012890862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020999317,0.000028563329,0.9714651,0.00021875248,0.000051155806,0.00072141323,0.000103839615,0.00019282557,0.0017288597,0.000039735834,0.00024376459,0.024995951],"study_design_scores_gemma":[0.000020032701,0.00078177976,0.99108726,0.00011797364,0.00010265448,0.00449494,0.00032001224,0.00023695084,0.0013083204,0.00006123265,0.0014631436,0.0000056706567],"about_ca_topic_score_codex":0.0049850387,"about_ca_topic_score_gemma":0.015036809,"teacher_disagreement_score":0.0049850387,"about_ca_system_score_codex":0.00041719325,"about_ca_system_score_gemma":0.0008374877,"threshold_uncertainty_score":0.009912014},"labels":[],"label_agreement":null},{"id":"W4315853248","doi":"10.51731/cjht.2023.538","title":"Lurbinectedin (Zepzelca)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Disease; Lung cancer; Oncology; Intensive care medicine; Clinical trial; Cancer; Overall survival; Internal medicine; Stage (stratigraphy); Surgery","score_opus":0.06750447713632651,"score_gpt":0.38564942484924675,"score_spread":0.31814494771292023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315853248","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.042248152,0.67463124,0.0039552813,0.032583255,0.0034211245,0.0008953116,0.007929203,0.002422124,0.2319144],"genre_scores_gemma":[0.44146794,0.31324747,0.012178356,0.036438722,0.0015329996,0.00096715405,0.012903594,0.0002760069,0.18098767],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997136,0.00008828382,0.000030247937,0.000044379613,0.00007846451,0.000045077246],"domain_scores_gemma":[0.9996866,0.00010244948,0.00009163041,0.000019630008,0.00004620949,0.000053510277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068990403,0.000247351,0.0005134607,0.00085925503,0.00023359199,0.00079568743,0.00077099557,0.0009564962,0.030041924],"category_scores_gemma":[0.0013159523,0.00011613863,0.0004959539,0.0005130307,0.0004214409,0.00050246314,0.00048910733,0.0015344752,0.007792362],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046049687,0.00031039145,0.0009174904,0.005098086,0.00018607466,0.00045419784,0.000053079893,0.0002691535,0.009851806,0.007517175,0.14238052,0.82835704],"study_design_scores_gemma":[0.005437574,0.0033484672,0.006809928,0.002002799,0.00029728477,0.0022496083,0.00008889103,0.00047620139,0.009412357,0.0019025452,0.967917,0.000057368783],"about_ca_topic_score_codex":0.003824618,"about_ca_topic_score_gemma":0.009430827,"teacher_disagreement_score":0.030041924,"about_ca_system_score_codex":0.0009520176,"about_ca_system_score_gemma":0.0009610421,"threshold_uncertainty_score":0.100500286},"labels":[],"label_agreement":null},{"id":"W4320914516","doi":"10.6004/jnccn.2022.7089","title":"Small Cell Lung Cancer in Light/Never Smokers – A Role for Molecular Testing?","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Lung cancer; Chemotherapy; Oncology; Disease; Cancer; Internal medicine; Incidence (geometry); Cancer research","score_opus":0.06197872644611645,"score_gpt":0.37007329462359173,"score_spread":0.30809456817747527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320914516","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27158904,0.39892057,0.00786377,0.270151,0.00436903,0.00014971494,0.00018564206,0.0002836504,0.046487562],"genre_scores_gemma":[0.81187314,0.13059472,0.014431377,0.028292226,0.010882903,0.00007162513,0.00015945775,0.00007277089,0.0036217042],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993787,0.000255473,0.0000779144,0.000057178062,0.00016165918,0.000069058886],"domain_scores_gemma":[0.9963245,0.0020748375,0.0003630693,0.00015872066,0.00061418914,0.000464656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031508596,0.00027887465,0.0005989907,0.0008813932,0.0003493478,0.0012610664,0.000907085,0.0017832369,0.0022158497],"category_scores_gemma":[0.0070411526,0.00018074473,0.00034947856,0.000382976,0.001101301,0.0025515044,0.00046150817,0.0017897246,0.0005562094],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006779532,0.00037187373,0.2924549,0.00074368576,0.00012702854,0.01984784,0.00043400153,0.00056965766,0.0060316147,0.004418435,0.015988931,0.658334],"study_design_scores_gemma":[0.00040691879,0.002906713,0.38551146,0.012037303,0.0007314535,0.29775983,0.01008597,0.0072840415,0.0042791218,0.052368943,0.2263862,0.00024201573],"about_ca_topic_score_codex":0.0017277055,"about_ca_topic_score_gemma":0.0045142453,"teacher_disagreement_score":0.0031508596,"about_ca_system_score_codex":0.00043096853,"about_ca_system_score_gemma":0.0009779278,"threshold_uncertainty_score":0.016663551},"labels":[],"label_agreement":null},{"id":"W4321370565","doi":"10.1097/01.cot.0000920704.38427.0f","title":"Avasopasem for Radiotherapy-Induced Oral Mucositis in Head &amp; Neck Cancer","year":2023,"lang":"en","type":"article","venue":"Oncology Times","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mucositis; Medicine; Radiation therapy; Head and neck cancer; Placebo; Cancer; Randomized controlled trial; Internal medicine; Surgery; Oncology; Alternative medicine; Pathology","score_opus":0.09215289734530328,"score_gpt":0.4705246043207524,"score_spread":0.3783717069754491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321370565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6724993,0.23957343,0.0010421927,0.018344324,0.002181872,0.0021289461,0.0041018547,0.0005040236,0.059624054],"genre_scores_gemma":[0.90677714,0.05415643,0.0020489965,0.010507658,0.0012475147,0.0007792299,0.0022066424,0.00003690146,0.022239521],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999808,0.00008229388,0.000021127242,0.000023954024,0.000042142663,0.00002249708],"domain_scores_gemma":[0.9998105,0.000052758656,0.000050780585,0.000009094157,0.000029563864,0.00004727316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059118384,0.00030810124,0.0006489439,0.00021758633,0.00032698334,0.00053682487,0.00020467682,0.0006952838,0.009633293],"category_scores_gemma":[0.00052732864,0.00009988668,0.00052258983,0.00032944497,0.00016093129,0.00029676067,0.00029934853,0.0010283706,0.0011577322],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0327489,0.0044714846,0.023314511,0.0046701664,0.0006151682,0.0010108543,0.00019342934,0.00037087535,0.02222243,0.0010482601,0.09932544,0.81000847],"study_design_scores_gemma":[0.054504447,0.12774076,0.15630604,0.0036299045,0.002327805,0.012268311,0.00065723626,0.0021650938,0.024691692,0.0018318536,0.6137341,0.000142758],"about_ca_topic_score_codex":0.00062126043,"about_ca_topic_score_gemma":0.0037714841,"teacher_disagreement_score":0.009633293,"about_ca_system_score_codex":0.0004997263,"about_ca_system_score_gemma":0.00066702324,"threshold_uncertainty_score":0.032226622},"labels":[],"label_agreement":null},{"id":"W4322772055","doi":"10.1158/1538-7445.sabcs22-ot1-03-05","title":"Abstract OT1-03-05: TROPION-Breast02: Phase 3, open-label, randomized study of first-line datopotamab deruxtecan versus chemotherapy in patients with locally recurrent inoperable or metastatic TNBC who are not candidates for anti-PD-(L)1 therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Phases of clinical research; Metastatic breast cancer; Neutropenia; Chemotherapy; Cancer; Breast cancer","score_opus":0.18287316189759106,"score_gpt":0.49214510451055715,"score_spread":0.3092719426129661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322772055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97929686,0.0033747896,0.0008008974,0.0012975808,0.00057552836,0.0071750744,0.0034829667,0.0002551783,0.003741231],"genre_scores_gemma":[0.97030187,0.002907939,0.0019821876,0.0026518835,0.00050797156,0.008057006,0.004326693,0.00008239203,0.00918196],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995939,0.00018836763,0.000017100901,0.000075483666,0.000035815316,0.00008923223],"domain_scores_gemma":[0.9992482,0.000119705466,0.00014096669,0.000052701584,0.00005437161,0.0003840678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016502623,0.0015446483,0.0020538785,0.00032908932,0.0003985606,0.001561529,0.0009827563,0.0017358721,0.010148761],"category_scores_gemma":[0.0010088927,0.00066152436,0.001604197,0.00043064103,0.0010510014,0.0010232175,0.00037279757,0.004147248,0.0020789425],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9237917,0.03049957,0.0012113194,0.0006804742,0.0009695047,0.00006722797,0.00008769125,0.00079820195,0.0101308925,0.00021274973,0.0038217495,0.027728815],"study_design_scores_gemma":[0.8111819,0.18296772,0.0021981813,0.000035194367,0.00034482998,0.00006513989,0.00003458346,0.0006544697,0.000812908,0.00016722984,0.0015181379,0.000019768475],"about_ca_topic_score_codex":0.0012777189,"about_ca_topic_score_gemma":0.0032862148,"teacher_disagreement_score":0.010148761,"about_ca_system_score_codex":0.0012793166,"about_ca_system_score_gemma":0.0015687064,"threshold_uncertainty_score":0.033950984},"labels":[],"label_agreement":null},{"id":"W4323664765","doi":"10.1016/j.lungcan.2023.03.002","title":"Use of radiation therapy among patients with Extensive-stage Small-cell lung cancer receiving Immunotherapy: Canadian consensus recommendations","year":2023,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Surrey Memorial Hospital; Sunnybrook Health Science Centre; Surrey Place Centre; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; McGill University; University Health Network; Health Sciences Centre; St. John’s Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Medicine; Radiation therapy; Lung cancer; Immunotherapy; Oncology; Stage (stratigraphy); Intensive care medicine; Consensus conference; Internal medicine; Cancer","score_opus":0.0804489223633583,"score_gpt":0.39027321538339904,"score_spread":0.3098242930200408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323664765","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004281862,0.56860006,0.0049302923,0.37880188,0.0084247235,0.0021005482,0.0057697496,0.0001935755,0.026897352],"genre_scores_gemma":[0.069644295,0.73007715,0.09588769,0.08113546,0.0027975144,0.0033769673,0.010154082,0.00014119208,0.0067857928],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9781154,0.0048168977,0.007078507,0.0014096583,0.007309753,0.0012697746],"domain_scores_gemma":[0.8849403,0.021834709,0.009230329,0.0012293749,0.07625137,0.0065138116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031264555,0.0013463796,0.0023054664,0.009908556,0.0038822722,0.0037154956,0.007864278,0.006483052,0.004106833],"category_scores_gemma":[0.08064258,0.0010447188,0.0049836384,0.009394401,0.002273598,0.002847859,0.003075478,0.0051964824,0.0012343444],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023100314,0.00015249522,0.013239582,0.08401415,0.0012230693,0.00057417504,0.0028218525,0.0012093495,0.00094796275,0.005821986,0.463382,0.42638245],"study_design_scores_gemma":[0.0004174758,0.00011302606,0.0214543,0.20758708,0.0037818754,0.0006578768,0.0027737033,0.00094483065,0.0006583287,0.005790882,0.75550324,0.00031753175],"about_ca_topic_score_codex":0.5273359,"about_ca_topic_score_gemma":0.5956375,"teacher_disagreement_score":0.47266412,"about_ca_system_score_codex":0.030649384,"about_ca_system_score_gemma":0.16020828,"threshold_uncertainty_score":0.9508955},"labels":[],"label_agreement":null},{"id":"W4327947028","doi":"10.3390/curroncol30030265","title":"Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Exon; Adenocarcinoma; Lung cancer; Medicine; Point mutation; Cancer research; Mutation; Phenotype; Epidermal growth factor receptor; Malignant transformation; Transformation (genetics); Mutant; Gene; Cancer; Pathology; Genetics; Biology; Internal medicine","score_opus":0.2670269450661654,"score_gpt":0.5538121025375843,"score_spread":0.28678515747141886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327947028","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008247073,0.99822646,0.000052242816,0.00018125463,0.00008648062,0.000013918596,0.00006996097,0.000005302427,0.0005396934],"genre_scores_gemma":[0.0049036625,0.99432856,0.00016819802,0.00025969086,0.00012741763,0.000013129335,0.0000683487,0.0000017626176,0.0001292129],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99943227,0.00007118397,0.000280693,0.00007139786,0.000116299256,0.00002812604],"domain_scores_gemma":[0.99836904,0.00096241146,0.00043407403,0.000039776536,0.00014790523,0.00004675041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005051331,0.00071635115,0.0013727283,0.009373869,0.000546682,0.001115426,0.00084855163,0.0011269524,0.0038347724],"category_scores_gemma":[0.0020994472,0.00038996336,0.000951498,0.008613947,0.000611539,0.0015521315,0.000666159,0.00061569246,0.00071308896],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017624925,0.0001614012,0.006083705,0.3641853,0.0012373236,0.040583145,0.00092129846,0.00047171468,0.0027586604,0.001886389,0.033588026,0.54794675],"study_design_scores_gemma":[0.0000778074,0.00022143028,0.018451056,0.2431615,0.0072323964,0.2568571,0.0018301838,0.00021347609,0.0012717479,0.0023278552,0.46822292,0.00013249123],"about_ca_topic_score_codex":0.0020761508,"about_ca_topic_score_gemma":0.0051284637,"teacher_disagreement_score":0.009373869,"about_ca_system_score_codex":0.00069241563,"about_ca_system_score_gemma":0.0021279207,"threshold_uncertainty_score":0.012828648},"labels":[],"label_agreement":null},{"id":"W4361953683","doi":"10.1158/1078-0432.c.6530028.v1","title":"Data from AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phoenix Technologies (Canada)","funders":"Amgen","keywords":"Medicine; Tolerability; Cancer research; T cell; Lung cancer; Cell; Internal medicine; Chemistry; Immunology; Adverse effect; Immune system","score_opus":0.21373206253175525,"score_gpt":0.4117611795012103,"score_spread":0.19802911696945502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361953683","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92580867,0.013989467,0.0075713703,0.0015961868,0.00054302363,0.00089125586,0.021582082,0.00090706703,0.027110988],"genre_scores_gemma":[0.95032984,0.0071487767,0.002920997,0.0010181193,0.000099376804,0.0007610105,0.019294055,0.00014131756,0.018286586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99960667,0.00008120019,0.00004710688,0.000056236655,0.00012687445,0.000081961385],"domain_scores_gemma":[0.999627,0.000077621335,0.00006573919,0.000057960435,0.0000735653,0.00009809478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060017564,0.0008518777,0.00078982377,0.00042054197,0.00028416605,0.0005089185,0.00048535934,0.0006937602,0.0054716766],"category_scores_gemma":[0.0003541506,0.00024655,0.0006404201,0.0003159591,0.00031470548,0.0005029517,0.00015273585,0.0016618868,0.0015775077],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010845186,0.0035005333,0.001334998,0.0008621595,0.0002591666,0.00030129324,0.00010871576,0.0020560536,0.9200536,0.0005644033,0.011064531,0.04904939],"study_design_scores_gemma":[0.0014003301,0.033297874,0.011442026,0.00006907835,0.00038464228,0.000981342,0.000100875506,0.0015851106,0.9067156,0.0002554316,0.043704852,0.00006284636],"about_ca_topic_score_codex":0.0016220339,"about_ca_topic_score_gemma":0.0029141575,"teacher_disagreement_score":0.0054716766,"about_ca_system_score_codex":0.0005149144,"about_ca_system_score_gemma":0.00069308176,"threshold_uncertainty_score":0.018304586},"labels":[],"label_agreement":null},{"id":"W4361958509","doi":"10.1158/1078-0432.c.6530718.v1","title":"Data from Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Veliparib; Medicine; Carboplatin; Internal medicine; Hazard ratio; Etoposide; Placebo; Lung cancer; Clinical endpoint; PARP inhibitor; Chemotherapy; Oncology; Surgery; Confidence interval; Clinical trial; Cisplatin; Biology; Pathology","score_opus":0.06618949606572638,"score_gpt":0.3835364755736122,"score_spread":0.3173469795078858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361958509","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97862154,0.008707567,0.0007881083,0.0012006277,0.0004374531,0.0035973634,0.0034073368,0.00009636964,0.0031435466],"genre_scores_gemma":[0.98511696,0.0041254745,0.0009960801,0.0016421776,0.00040654346,0.0024223726,0.0036517119,0.000033193213,0.0016052944],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856454,0.0009989492,0.000093666444,0.00013899502,0.000109880115,0.000093999515],"domain_scores_gemma":[0.9979381,0.0006315667,0.0005529312,0.00023165076,0.00013461636,0.00051102455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029837564,0.001265537,0.0028899673,0.00033535878,0.0003909442,0.0013400549,0.00093049917,0.0013101764,0.0051874486],"category_scores_gemma":[0.0022742471,0.0007044789,0.003076003,0.000660092,0.0007694311,0.0011587174,0.00041632977,0.0033307502,0.0007767891],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9520135,0.010339029,0.0025561026,0.00090887415,0.0030304112,0.00009143302,0.000052337044,0.00080344017,0.0044427007,0.000091285874,0.002103356,0.023567488],"study_design_scores_gemma":[0.913785,0.07632349,0.0060510663,0.00005211169,0.0013913298,0.000086605214,0.000020063657,0.0003538028,0.00040916572,0.000105988656,0.0014004947,0.0000208846],"about_ca_topic_score_codex":0.0006135093,"about_ca_topic_score_gemma":0.0015658649,"teacher_disagreement_score":0.0051874486,"about_ca_system_score_codex":0.00065716903,"about_ca_system_score_gemma":0.0014341658,"threshold_uncertainty_score":0.017353773},"labels":[],"label_agreement":null},{"id":"W4361959346","doi":"10.1158/1078-0432.c.6530028","title":"Data from AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phoenix Technologies (Canada)","funders":"Amgen","keywords":"Medicine; Tolerability; Cancer research; T cell; Lung cancer; Cell; Internal medicine; Chemistry; Immunology; Adverse effect; Immune system","score_opus":0.21373206253175525,"score_gpt":0.4117611795012103,"score_spread":0.19802911696945502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361959346","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92580867,0.013989467,0.0075713703,0.0015961868,0.00054302363,0.00089125586,0.021582082,0.00090706703,0.027110988],"genre_scores_gemma":[0.95032984,0.0071487767,0.002920997,0.0010181193,0.000099376804,0.0007610105,0.019294055,0.00014131756,0.018286586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99960667,0.00008120019,0.00004710688,0.000056236655,0.00012687445,0.000081961385],"domain_scores_gemma":[0.999627,0.000077621335,0.00006573919,0.000057960435,0.0000735653,0.00009809478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060017564,0.0008518777,0.00078982377,0.00042054197,0.00028416605,0.0005089185,0.00048535934,0.0006937602,0.0054716766],"category_scores_gemma":[0.0003541506,0.00024655,0.0006404201,0.0003159591,0.00031470548,0.0005029517,0.00015273585,0.0016618868,0.0015775077],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010845186,0.0035005333,0.001334998,0.0008621595,0.0002591666,0.00030129324,0.00010871576,0.0020560536,0.9200536,0.0005644033,0.011064531,0.04904939],"study_design_scores_gemma":[0.0014003301,0.033297874,0.011442026,0.00006907835,0.00038464228,0.000981342,0.000100875506,0.0015851106,0.9067156,0.0002554316,0.043704852,0.00006284636],"about_ca_topic_score_codex":0.0016220339,"about_ca_topic_score_gemma":0.0029141575,"teacher_disagreement_score":0.0054716766,"about_ca_system_score_codex":0.0005149144,"about_ca_system_score_gemma":0.00069308176,"threshold_uncertainty_score":0.018304586},"labels":[],"label_agreement":null},{"id":"W4362452239","doi":"10.7759/cureus.37015","title":"Prevalence of Thyroid Transcription Factor-1 (TTF-1)-Negative Small Cell Carcinoma and Napsin A Positivity in Small Cell Carcinoma in a Cross-Sectional Study of Lung Core Biopsies","year":2023,"lang":"en","type":"article","venue":"Cureus","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Medicine; Small-cell carcinoma; Pathology; Small Cell Lung Carcinoma; Carcinoma; Biopsy; Immunostaining; Lung; Thyroid Transcription Factor 1; Thyroid; Lung cancer; Immunohistochemistry; Oncology; Cancer; Internal medicine; Adenocarcinoma","score_opus":0.06283292988453881,"score_gpt":0.3359408671562166,"score_spread":0.2731079372716778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362452239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994653,0.00013247493,0.00007438445,0.0000075144326,0.0000020663706,0.0000087048575,0.00012382821,0.000002814649,0.00018289946],"genre_scores_gemma":[0.99966073,0.000052827225,0.000074918324,0.000012648871,0.0000052332675,0.000008058959,0.00014815535,0.0000016143714,0.00003570707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989837,0.00022432223,0.00015326784,0.00034645633,0.00018122027,0.000110957466],"domain_scores_gemma":[0.9978067,0.00055548403,0.00068746787,0.00018298591,0.00036069038,0.00040661555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010892926,0.00027235007,0.00032722848,0.0017451447,0.00048702562,0.0006291344,0.00039946646,0.0004499236,0.0012191811],"category_scores_gemma":[0.002766325,0.00044764386,0.00029350404,0.0009288657,0.000492806,0.0006241775,0.00045052575,0.00029721254,0.00031571582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022828108,0.000011106798,0.9992071,0.000004535482,0.00001518784,0.000094684416,0.00006672207,0.000006057488,0.00030614273,0.0000032290923,0.000016822345,0.00024575624],"study_design_scores_gemma":[0.0000020160599,0.00007760575,0.9983516,0.0000029170467,0.000021512964,0.0011254249,0.00021445623,0.00005256754,0.00007497929,0.000005202787,0.000069537215,0.0000022363022],"about_ca_topic_score_codex":0.0040907594,"about_ca_topic_score_gemma":0.0040062745,"teacher_disagreement_score":0.0040907594,"about_ca_system_score_codex":0.0003040174,"about_ca_system_score_gemma":0.00025400476,"threshold_uncertainty_score":0.008133888},"labels":[],"label_agreement":null},{"id":"W4362544178","doi":"10.1158/1538-7445.am2023-3434","title":"Abstract 3434: Selective glucocorticoid receptor modulation reveals a new role for CLEC10A in patients with solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Glucocorticoid receptor; Medicine; Internal medicine; Oncology; Glucocorticoid; Confounding; Bioinformatics; Pharmacology; Biology","score_opus":0.059963316763689066,"score_gpt":0.4351800655281019,"score_spread":0.37521674876441286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362544178","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671495,0.0010245802,0.00047746795,0.00019851419,0.000010483898,0.000027828128,0.00036948133,0.000029798079,0.0011469102],"genre_scores_gemma":[0.99916613,0.00009213188,0.00027350307,0.00006780039,0.000010532286,0.0000062975478,0.00025907988,0.0000034814532,0.000121139026],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997254,0.00008065196,0.000020702513,0.00008654905,0.000051776944,0.000034936373],"domain_scores_gemma":[0.99946874,0.00019462522,0.00015376077,0.000046569672,0.000066914035,0.000069262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004273091,0.00022350159,0.0005267692,0.00032601345,0.00020049005,0.0003843485,0.00015761725,0.00029263925,0.0013031407],"category_scores_gemma":[0.0010980034,0.0001002275,0.00024548577,0.00042237437,0.00017614922,0.00019835019,0.000113137554,0.00032392718,0.0002820147],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036374286,0.00014690234,0.91437334,0.000061560764,0.000111152716,0.00049958064,0.00006726398,0.0003987831,0.035374396,0.00009538074,0.0010410452,0.044193216],"study_design_scores_gemma":[0.00007754882,0.00089376216,0.9913816,0.000010738896,0.00008348554,0.001229698,0.000052431893,0.0015136367,0.0034437298,0.00010878625,0.0011974336,0.000007152644],"about_ca_topic_score_codex":0.0010890746,"about_ca_topic_score_gemma":0.0017069766,"teacher_disagreement_score":0.0013031407,"about_ca_system_score_codex":0.00032483047,"about_ca_system_score_gemma":0.00022136551,"threshold_uncertainty_score":0.004359424},"labels":[],"label_agreement":null},{"id":"W4362587019","doi":"10.1016/s1556-0864(23)00423-9","title":"169P Phase I dose escalation trial combining olaparib and thoracic radiation therapy in extensive-stage small cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"PharmaMar; Castle Biosciences; Daiichi Sankyo Europe; Exelixis; ViewRay; Novocure; Elekta; Varian Medical Systems; Pfizer; Eli Lilly and Company; AstraZeneca; Accuray; LUNGevity Foundation; MedImmune; Mesothelioma Applied Research Foundation","keywords":"Medicine; Olaparib; Atezolizumab; Internal medicine; Oncology; Dysgeusia; Lung cancer; Adverse effect; Radiation therapy; Urology; Cancer; Gastroenterology; Nivolumab; Immunotherapy","score_opus":0.07487591896206015,"score_gpt":0.50855599154978,"score_spread":0.4336800725877199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362587019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98385394,0.0032918428,0.00086555566,0.0012369424,0.00057280046,0.0027726875,0.0021340123,0.00019792379,0.0050742975],"genre_scores_gemma":[0.97863114,0.002977381,0.0027402774,0.0017998723,0.00033399076,0.0030798658,0.0037377628,0.000059819027,0.006639983],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996643,0.00015143861,0.000014208246,0.000064781445,0.000028370636,0.00007696348],"domain_scores_gemma":[0.99952674,0.00009733603,0.00006579895,0.000046864654,0.000023374152,0.00023998487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011350585,0.0014791052,0.0020645817,0.0004393265,0.0004110791,0.0012702565,0.00085595244,0.0011336796,0.0069177994],"category_scores_gemma":[0.00081481796,0.00050070917,0.0017594377,0.0004322817,0.00091744453,0.00080548937,0.0005172966,0.003868097,0.0013395209],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79272836,0.029458553,0.002019525,0.0013334823,0.0016521292,0.00016089938,0.00017267052,0.00481469,0.02186036,0.0008376013,0.006480041,0.13848172],"study_design_scores_gemma":[0.7443761,0.24273087,0.0049707624,0.000064582084,0.00046550305,0.0001616559,0.00007253263,0.0013731425,0.0015748194,0.00064510375,0.0035285403,0.000036355774],"about_ca_topic_score_codex":0.0011335625,"about_ca_topic_score_gemma":0.002819619,"teacher_disagreement_score":0.0069177994,"about_ca_system_score_codex":0.0011033425,"about_ca_system_score_gemma":0.0017090809,"threshold_uncertainty_score":0.023142338},"labels":[],"label_agreement":null},{"id":"W4362588741","doi":"10.1016/s1556-0864(23)00424-0","title":"170P Preliminary results from LUMINANCE: A phase IIIb, single-arm study of 1L durvalumab (D) + platinum-etoposide (EP) for patients with extensive-stage SCLC (ES-SCLC)","year":2023,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Symphogen; GlaxoSmithKline; Daiichi-Sankyo; Amgen; Pfizer; AstraZeneca; Daiichi Sankyo Europe; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Durvalumab; Etoposide; Internal medicine; Phases of clinical research; Oncology; Chemotherapy; Cancer; Nivolumab","score_opus":0.06322569750506297,"score_gpt":0.45745489743307094,"score_spread":0.394229199928008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362588741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810798,0.0040271683,0.0009884061,0.0017319571,0.0003028903,0.0030441424,0.0042749466,0.00020005551,0.0043505407],"genre_scores_gemma":[0.9710071,0.004153252,0.0035824857,0.002708618,0.0004765841,0.004127411,0.0067742816,0.000115564675,0.0070546623],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993887,0.00033555788,0.000022604012,0.00006628,0.00004562645,0.00014123102],"domain_scores_gemma":[0.9991591,0.00020122004,0.00010328466,0.00006574596,0.000048527854,0.000422186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00185552,0.0016525318,0.0020611894,0.00039637243,0.0005176917,0.0010295307,0.0009781301,0.0014258954,0.0052179126],"category_scores_gemma":[0.0011710301,0.00053996575,0.0017729459,0.0004197701,0.0008961846,0.0008914763,0.00031743405,0.003294207,0.0014004222],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79909074,0.040496364,0.0051350626,0.0008972036,0.0019894904,0.00027233554,0.00031802137,0.0019777312,0.03523339,0.00034517667,0.007899945,0.10634449],"study_design_scores_gemma":[0.6809003,0.2970719,0.013528992,0.00004817294,0.0007629783,0.00016857086,0.000064790154,0.0006311555,0.0025676314,0.00027227853,0.0039508855,0.000032306947],"about_ca_topic_score_codex":0.0033030093,"about_ca_topic_score_gemma":0.009706574,"teacher_disagreement_score":0.0052179126,"about_ca_system_score_codex":0.0011134801,"about_ca_system_score_gemma":0.002131012,"threshold_uncertainty_score":0.017455637},"labels":[],"label_agreement":null},{"id":"W4365512763","doi":"10.1158/1538-7445.am2023-ct058","title":"Abstract CT058: TROPION-PanTumor03: Phase 2, multicenter study of datopotamab deruxtecan (Dato-DXd) as monotherapy and in combination with anticancer agents in patients (pts) with advanced/metastatic solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Prostate cancer; Internal medicine; Combination therapy; Cancer; Oncology; Bevacizumab; Phases of clinical research; Immunotherapy; Chemotherapy","score_opus":0.07314861898670705,"score_gpt":0.47179241001322003,"score_spread":0.398643791026513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98846114,0.0018343129,0.00059964653,0.0005695441,0.000089639085,0.002470496,0.0035614064,0.00018969411,0.0022240912],"genre_scores_gemma":[0.98158354,0.0014944532,0.001959467,0.00096629123,0.00015129872,0.002744445,0.0069293794,0.000066289176,0.0041048434],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99959034,0.00020241826,0.000019431958,0.000067013374,0.00004504436,0.00007575715],"domain_scores_gemma":[0.999424,0.0000667857,0.00011154068,0.0000456523,0.000044804972,0.0003072643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014485568,0.0016282923,0.0012166672,0.0005020179,0.00040903798,0.0011235982,0.0010543228,0.0012882204,0.0051549897],"category_scores_gemma":[0.00077413145,0.00056286843,0.0010993116,0.000598231,0.0008255911,0.000844776,0.00036007664,0.003057228,0.0014112176],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7112346,0.07446562,0.012364726,0.00091572,0.0018383538,0.00042539006,0.00041711653,0.003536575,0.0931215,0.0004690823,0.011324263,0.08988699],"study_design_scores_gemma":[0.5415701,0.42700446,0.016081134,0.000048459613,0.0006014123,0.00056950666,0.00008881438,0.0015795797,0.007506342,0.00021421329,0.004695396,0.000040580406],"about_ca_topic_score_codex":0.0018508381,"about_ca_topic_score_gemma":0.0041794153,"teacher_disagreement_score":0.0051549897,"about_ca_system_score_codex":0.0013512856,"about_ca_system_score_gemma":0.0016964152,"threshold_uncertainty_score":0.017245173},"labels":[],"label_agreement":null},{"id":"W4366334545","doi":"10.46747/cfp.6904e74","title":"Cours accéléré sur le cancer du poumon","year":2023,"lang":"fr","type":"article","venue":"Canadian Family Physician","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.044833204727703815,"score_gpt":0.3144413035088692,"score_spread":0.2696080987811654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366334545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76016307,0.09097378,0.0011191508,0.02122214,0.0016060185,0.000108703935,0.024833085,0.00010261549,0.099871375],"genre_scores_gemma":[0.9213909,0.0319381,0.0006633703,0.0018310251,0.0008639678,0.00006139911,0.0062724007,0.000051132993,0.036927816],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992574,0.00010648923,0.000018674982,0.00010745204,0.0003133372,0.000196622],"domain_scores_gemma":[0.99822885,0.0003317097,0.00046131067,0.00004737014,0.0005699837,0.0003607337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006454219,0.00029275648,0.00030562736,0.0011293149,0.0013124808,0.0012602012,0.00036069285,0.0005861142,0.013626546],"category_scores_gemma":[0.004134761,0.00017255083,0.00045991055,0.0019139715,0.00033488366,0.00050408964,0.00072354736,0.0010290291,0.0010657812],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020460356,0.0001208212,0.7950915,0.00084634736,0.00041053534,0.00069456885,0.0023607134,0.000689646,0.0014576537,0.004179471,0.050945766,0.14115699],"study_design_scores_gemma":[0.00003472023,0.00021969658,0.91141605,0.00048467825,0.00021886511,0.00041141015,0.0015530462,0.000187614,0.0004685944,0.00061561866,0.08435848,0.00003123994],"about_ca_topic_score_codex":0.59908193,"about_ca_topic_score_gemma":0.7270836,"teacher_disagreement_score":0.59908193,"about_ca_system_score_codex":0.004759747,"about_ca_system_score_gemma":0.006779248,"threshold_uncertainty_score":0.8065583},"labels":[],"label_agreement":null},{"id":"W4366998885","doi":"10.1186/s13046-023-02678-1","title":"MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostat","year":2023,"lang":"en","type":"article","venue":"Journal of Experimental & Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Cancer Council Victoria; State Government of Victoria; Australian Government; National Imaging Facility; Marshfield Clinic Research Foundation; Victorian Cancer Agency","keywords":"Cancer research; Platinum; Dual (grammatical number); Apoptosis; PI3K/AKT/mTOR pathway; Chemistry; Medicine; Biochemistry","score_opus":0.26930834829172673,"score_gpt":0.5712986221216317,"score_spread":0.301990273829905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366998885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941571,0.0009988953,0.0015613727,0.00017618701,0.000033954733,0.000048941325,0.00056676444,0.00019830104,0.0022584812],"genre_scores_gemma":[0.9958782,0.0006348504,0.0011452569,0.000052850493,0.0000056764065,0.000042807394,0.0005300169,0.000018341918,0.0016919409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989545,0.000009691432,0.000011052995,0.0000180199,0.00004063342,0.000025063382],"domain_scores_gemma":[0.999931,0.000014247402,0.000022551663,0.000009623612,0.0000059343824,0.000016691663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009932855,0.0002607693,0.00027595417,0.00023647038,0.00013709516,0.00035850448,0.00023751908,0.00026032564,0.0016177593],"category_scores_gemma":[0.000095610914,0.00010974358,0.00028109987,0.00017780869,0.00021700311,0.00016327901,0.00015935847,0.0007688408,0.00035361166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011705868,0.00008598404,0.0004415006,0.00004943561,0.000010392441,0.000103051134,0.000011419896,0.00016563207,0.99495476,0.00015587585,0.00022703283,0.003677718],"study_design_scores_gemma":[0.000041560674,0.00080783706,0.0047182683,0.000009184861,0.000025855494,0.0006883357,0.000021459602,0.0017701001,0.9876128,0.000045111017,0.004254478,0.0000050698086],"about_ca_topic_score_codex":0.0006575067,"about_ca_topic_score_gemma":0.0017481179,"teacher_disagreement_score":0.0016177593,"about_ca_system_score_codex":0.00035672195,"about_ca_system_score_gemma":0.0002630246,"threshold_uncertainty_score":0.005411923},"labels":[],"label_agreement":null},{"id":"W4368341244","doi":"10.1093/jnci/djad073","title":"Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE)","year":2023,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Sherbrooke","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Hazard ratio; Oncology; Internal medicine; Brain metastasis; Retrospective cohort study; Lung cancer; Radiosurgery; Proportional hazards model; Anaplastic lymphoma kinase; Confidence interval; Cancer; Metastasis; Radiation therapy","score_opus":0.11825364100405085,"score_gpt":0.4429461179180069,"score_spread":0.3246924769139561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4368341244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99638075,0.0024327382,0.00022653319,0.00003940015,0.000020372145,0.000037637,0.00031027084,0.000011351693,0.0005408712],"genre_scores_gemma":[0.99809664,0.0005319596,0.0001596477,0.00006388487,0.000024651525,0.000030951684,0.0008794523,0.000005731785,0.00020719614],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993193,0.00025446404,0.00007523786,0.00014306806,0.00014084946,0.00006711825],"domain_scores_gemma":[0.99810636,0.00056335994,0.0007157078,0.0001624223,0.00017368197,0.00027842767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021608337,0.0002877525,0.00065111247,0.0003859041,0.00010879612,0.00042941392,0.00048665836,0.0003897922,0.00096341426],"category_scores_gemma":[0.002967361,0.00011105295,0.0014320721,0.0002359587,0.00016617659,0.00039087355,0.00025267867,0.0003870276,0.00013856213],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18411826,0.001508422,0.6173838,0.0010945266,0.008548344,0.00022354333,0.0002631694,0.00767229,0.007998043,0.00028755082,0.0016803489,0.16922174],"study_design_scores_gemma":[0.0038964702,0.047407653,0.9385996,0.00009157871,0.0021125064,0.00060220185,0.00009925543,0.0029643972,0.0024232308,0.00013777427,0.001639447,0.000025927364],"about_ca_topic_score_codex":0.0018926744,"about_ca_topic_score_gemma":0.0043976903,"teacher_disagreement_score":0.0021608337,"about_ca_system_score_codex":0.00078000425,"about_ca_system_score_gemma":0.0005293248,"threshold_uncertainty_score":0.0114277005},"labels":[],"label_agreement":null},{"id":"W4379340377","doi":"10.1200/jco.2023.41.16_suppl.8503","title":"Exploratory biomarker analysis of the phase 3 KEYNOTE-604 study of pembrolizumab plus etoposide for extensive-stage SCLC.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; University of Toronto","funders":"","keywords":"Medicine; Pembrolizumab; Oncology; Internal medicine; Cancer research; Cancer; Immunotherapy","score_opus":0.39782845581144777,"score_gpt":0.6052007752304426,"score_spread":0.2073723194189948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379340377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901697,0.0014121397,0.00056717644,0.00020932761,0.00002871736,0.0010953422,0.0054129106,0.000058303343,0.0010463835],"genre_scores_gemma":[0.98379636,0.00038232634,0.0013844989,0.00040588388,0.000036319216,0.0011655942,0.011434122,0.000023074012,0.0013719349],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99901485,0.00053241133,0.00003841046,0.00016819294,0.00011185169,0.00013422176],"domain_scores_gemma":[0.9990182,0.00018332814,0.00027892608,0.0001237445,0.00008246062,0.00031342293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038137238,0.0010197811,0.0013443878,0.0003271614,0.00033992506,0.00089755864,0.0008775361,0.0007227403,0.0036253904],"category_scores_gemma":[0.0018831734,0.0004243968,0.0018008797,0.00052840734,0.00040016908,0.00047761112,0.000762554,0.0010578039,0.00074843265],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74730194,0.008865932,0.1302287,0.0012386764,0.011565985,0.00048491082,0.00025013566,0.005045938,0.04191332,0.0004410824,0.007196337,0.045467056],"study_design_scores_gemma":[0.15988259,0.2458278,0.5441544,0.00014328792,0.013484441,0.001190942,0.0002995296,0.007300795,0.010919706,0.0011131761,0.015577821,0.00010538661],"about_ca_topic_score_codex":0.0010079901,"about_ca_topic_score_gemma":0.0029230092,"teacher_disagreement_score":0.0038137238,"about_ca_system_score_codex":0.0010021672,"about_ca_system_score_gemma":0.0019033154,"threshold_uncertainty_score":0.020169139},"labels":[],"label_agreement":null},{"id":"W4379341468","doi":"10.1200/jco.2023.41.16_suppl.e20636","title":"Prophylactic cranial irradiation in small cell lung cancer patients in the era of magnetic resonance imaging: A systematic review and meta-analysis.","year":2023,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Conventional PCI; Prophylactic cranial irradiation; Hazard ratio; Internal medicine; Meta-analysis; Retrospective cohort study; Lung cancer; Oncology; Magnetic resonance imaging; Surgery; Radiology; Confidence interval; Myocardial infarction","score_opus":0.23733862060632313,"score_gpt":0.540150651919288,"score_spread":0.30281203131296486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379341468","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032356128,0.99556375,0.00025820785,0.00015013291,0.00009917389,0.000147685,0.0003699306,0.00001465946,0.00016083365],"genre_scores_gemma":[0.15064709,0.84515464,0.0013759892,0.0008253077,0.00022486076,0.00074988767,0.0007384293,0.000025931182,0.0002578083],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9938175,0.0029854097,0.0016322869,0.0006848569,0.0006273971,0.0002524525],"domain_scores_gemma":[0.98655033,0.009684041,0.0023648092,0.0003650908,0.0008308888,0.00020486349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010303252,0.002303163,0.014912379,0.0059031057,0.00049266673,0.0025555138,0.0018146416,0.002273969,0.003391282],"category_scores_gemma":[0.0233182,0.0013572255,0.036862582,0.0067614266,0.00062541466,0.001564091,0.0013418506,0.0017603332,0.00033674666],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024376023,0.000027146869,0.0038203823,0.3980778,0.58289504,0.0001088062,0.00006601243,0.0005005269,0.00019177752,0.00010984264,0.000688381,0.011076706],"study_design_scores_gemma":[0.0006161748,0.00020697081,0.0038222638,0.029467005,0.9639029,0.00007795328,0.00003822497,0.00015082526,0.00008420163,0.0001465721,0.0014656135,0.000021272845],"about_ca_topic_score_codex":0.0078068865,"about_ca_topic_score_gemma":0.018174248,"teacher_disagreement_score":0.014912379,"about_ca_system_score_codex":0.0024129015,"about_ca_system_score_gemma":0.0032347115,"threshold_uncertainty_score":0.054489493},"labels":[],"label_agreement":null},{"id":"W4379341601","doi":"10.1200/jco.2023.41.16_suppl.8596","title":"Brain metastasis burden and management in small cell lung cancer: An analysis of 8705 patients.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University Health Network; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiosurgery; Hazard ratio; Brain metastasis; Confidence interval; Lung cancer; Internal medicine; Radiation therapy; Incidence (geometry); Chemotherapy; Population; Oncology; Cancer; Metastasis; Surgery","score_opus":0.1354225464933262,"score_gpt":0.5332530314402404,"score_spread":0.3978304849469142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379341601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98748386,0.0025798613,0.00006323048,0.000101130805,0.0000063350376,0.00006010637,0.009169429,0.0000063722423,0.0005296122],"genre_scores_gemma":[0.9932001,0.0009391549,0.00008490477,0.00010364013,0.000011284689,0.000045526504,0.005402809,0.000002932159,0.00020963154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991394,0.0000809902,0.00017700094,0.00017533265,0.00028396372,0.00014324025],"domain_scores_gemma":[0.99856275,0.00017050895,0.0007508943,0.00006888337,0.00025147037,0.00019548147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072811183,0.00030141932,0.0007720558,0.0012301485,0.0006858377,0.0007779714,0.00065893505,0.0003785695,0.0010369276],"category_scores_gemma":[0.0017364846,0.00041402492,0.0009990057,0.004524899,0.00033426392,0.0003291728,0.00056285044,0.00034586826,0.00025937677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014406878,0.000013807505,0.99774987,0.00008425806,0.00012241087,0.000097204516,0.00009353569,0.00004773961,0.000055978555,0.000009441492,0.00035610414,0.0012256665],"study_design_scores_gemma":[0.00002074267,0.00004427817,0.99882394,0.00004468891,0.00009816799,0.0001346412,0.00019379587,0.0001220522,0.000017022228,0.000007101208,0.00048888236,0.0000045134157],"about_ca_topic_score_codex":0.40564898,"about_ca_topic_score_gemma":0.49277887,"teacher_disagreement_score":0.40564898,"about_ca_system_score_codex":0.00456174,"about_ca_system_score_gemma":0.0040679676,"threshold_uncertainty_score":0.80657566},"labels":[],"label_agreement":null},{"id":"W4379341825","doi":"10.1200/jco.2023.41.16_suppl.tps8611","title":"Randomized phase 3 study of tarlatamab, a DLL3-targeting bispecific T-cell engager (BiTE),compared to standard of care in patients with relapsed small cell lung cancer (DeLLphi-304).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Amgen","keywords":"Topotecan; Medicine; Refractory (planetary science); Internal medicine; Discontinuation; Oncology; Chemotherapy; Lung cancer; Cancer; Malignancy","score_opus":0.08975948839399366,"score_gpt":0.4811738018165464,"score_spread":0.39141431342255273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379341825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812221,0.0027517646,0.0007230272,0.0009874969,0.0007180282,0.0071310094,0.002603777,0.00020629223,0.0036565366],"genre_scores_gemma":[0.981499,0.0014475673,0.0015623688,0.0017884381,0.0003750436,0.006694409,0.0025214248,0.000048174992,0.0040636496],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994561,0.0002503373,0.000026111182,0.00010915348,0.00004114562,0.0001171971],"domain_scores_gemma":[0.9989195,0.00028385333,0.00020088232,0.00008579287,0.000077285295,0.00043272928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017546404,0.001791935,0.0025400682,0.00039104107,0.0004500105,0.0014211783,0.0009265212,0.0018130661,0.009844058],"category_scores_gemma":[0.0015247428,0.000744579,0.0018972551,0.00037810387,0.0011166518,0.0012966902,0.000463552,0.004902313,0.0015586822],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96387535,0.014812282,0.0006735177,0.00034458705,0.00070324494,0.000048101076,0.000053952706,0.00044969612,0.0034495615,0.00012274619,0.0014205449,0.014046387],"study_design_scores_gemma":[0.8097417,0.18595757,0.0017548082,0.00002287246,0.0002953041,0.000056661953,0.000028975277,0.00053158845,0.00044872327,0.00022661993,0.0009174135,0.000017763672],"about_ca_topic_score_codex":0.0012444366,"about_ca_topic_score_gemma":0.0030687805,"teacher_disagreement_score":0.009844058,"about_ca_system_score_codex":0.0012865645,"about_ca_system_score_gemma":0.0014987577,"threshold_uncertainty_score":0.032931685},"labels":[],"label_agreement":null},{"id":"W4379377976","doi":"10.1080/0284186x.2023.2216339","title":"FOLFIRI in advanced platinum-resistant/refractory small-cell lung cancer: a retrospective study","year":2023,"lang":"en","type":"article","venue":"Acta Oncologica","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Biotech; Eisai; Mylan; Ipsen; Astellas Pharma Canada; Takeda Pharmaceutical Company; Gilead Sciences; Roche; Novartis; GlaxoSmithKline Australia; Meso Scale Diagnostics; Sanofi; Merck; British Microcirculation Society; Amgen; Pfizer; Bayer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Internal medicine; Irinotecan; FOLFIRI; Population; Regimen; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Topotecan; Refractory (planetary science); Surgery; Lung cancer; Retrospective cohort study; Chemotherapy regimen; Oncology; Progressive disease; Cancer; Chemotherapy; Colorectal cancer; Clinical trial","score_opus":0.03943207050000615,"score_gpt":0.385076322317816,"score_spread":0.3456442518178099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379377976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970289,0.002224916,0.00009520666,0.000023658233,0.0000048901675,0.000032483043,0.00021436378,0.0000034891268,0.0003721645],"genre_scores_gemma":[0.99875903,0.00066834164,0.00006798568,0.00004529004,0.000018965071,0.000015879767,0.0003373863,0.0000018454901,0.00008529087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995016,0.00008691466,0.000092916394,0.00015246929,0.00009988782,0.00006620138],"domain_scores_gemma":[0.99881697,0.00022035005,0.0005638479,0.00011159408,0.00014077919,0.00014641638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072818855,0.00026930965,0.00053499517,0.00097202935,0.0004449,0.00060195156,0.00028217284,0.00043033305,0.0010486541],"category_scores_gemma":[0.001279962,0.00025207206,0.00062832783,0.001181928,0.00031534338,0.00035924054,0.00027146863,0.0003019149,0.00022073956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030057644,0.000057105164,0.99507844,0.00006535959,0.00011839282,0.0011307546,0.00009984261,0.000036739293,0.00026181864,0.000022504504,0.00012231922,0.00270613],"study_design_scores_gemma":[0.00007498311,0.0009497738,0.98763883,0.000040325023,0.0003541308,0.008232237,0.0003728379,0.00021474244,0.00023867203,0.00002864967,0.0018421347,0.000012682468],"about_ca_topic_score_codex":0.002524232,"about_ca_topic_score_gemma":0.0027318266,"teacher_disagreement_score":0.002524232,"about_ca_system_score_codex":0.00058606925,"about_ca_system_score_gemma":0.00057519774,"threshold_uncertainty_score":0.0050191283},"labels":[],"label_agreement":null},{"id":"W4380422654","doi":"10.1007/s41030-023-00229-9","title":"Symptoms and Experiences with Small Cell Lung Cancer: A Mixed Methods Study of Patients and Caregivers","year":2023,"lang":"en","type":"article","venue":"Pulmonary Therapy","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Amgen","keywords":"Lung cancer; Medicine; Intensive care medicine; Oncology","score_opus":0.02504368870819661,"score_gpt":0.36270935911924335,"score_spread":0.3376656704110467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380422654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863523,0.00043656916,0.00014278645,0.00011802659,0.0000064710407,0.00022507441,0.00011064218,0.0000018932066,0.0003232746],"genre_scores_gemma":[0.9975931,0.0006047473,0.00034429,0.00025527785,0.000013607296,0.0008334593,0.00013865762,0.0000028220081,0.0002140919],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99539953,0.0031074653,0.00038121385,0.00026382893,0.00039231332,0.0004556681],"domain_scores_gemma":[0.99679846,0.0014494135,0.0007851548,0.00018240882,0.00045471988,0.00032983604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076909508,0.00060624874,0.0009141341,0.0014929496,0.002878767,0.0020286178,0.0007005459,0.00063779793,0.0020683599],"category_scores_gemma":[0.009186161,0.0006127943,0.0006979832,0.0014199052,0.00090250344,0.0017898185,0.0021310963,0.0008340962,0.00034221628],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081978744,0.001870283,0.71428853,0.000529913,0.00016245715,0.00088666065,0.25887817,0.00006308697,0.0006175172,0.0001636979,0.0008920226,0.0208279],"study_design_scores_gemma":[0.00020192114,0.0033397076,0.3865296,0.00043837857,0.00012713928,0.001433261,0.6034088,0.00035916714,0.00041008124,0.0003123124,0.0033709337,0.00006871148],"about_ca_topic_score_codex":0.0048760283,"about_ca_topic_score_gemma":0.007915619,"teacher_disagreement_score":0.0076909508,"about_ca_system_score_codex":0.0012299939,"about_ca_system_score_gemma":0.0013716709,"threshold_uncertainty_score":0.04067415},"labels":[],"label_agreement":null},{"id":"W4382023243","doi":"10.3390/curroncol30070449","title":"Management of Very Early Small Cell Lung Cancer: A Canadian Survey Study","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital Research Institute","keywords":"Medicine; Radiation therapy; Chemoradiotherapy; Lung cancer; Lesion; Stage (stratigraphy); Internal medicine; Surgery; Family medicine","score_opus":0.17913059590505878,"score_gpt":0.4761600256705797,"score_spread":0.29702942976552094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382023243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894315,0.00037423652,0.000088418674,0.0006078402,0.000013588427,0.0001585599,0.005554533,0.0000062917843,0.0037650685],"genre_scores_gemma":[0.99632865,0.00050431484,0.00019000443,0.00029869494,0.000007834166,0.000055160242,0.0019766851,0.0000040975915,0.0006345564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981822,0.00016065003,0.00015877748,0.00021550267,0.0007701874,0.0005127629],"domain_scores_gemma":[0.99484116,0.0002593957,0.00088187924,0.00013404498,0.0026576812,0.0012258707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014555043,0.00035569794,0.00038619188,0.0014931444,0.0030023514,0.0011604798,0.0011938688,0.0006438497,0.002404042],"category_scores_gemma":[0.0040511102,0.0004652818,0.00073152885,0.0059247725,0.00071114494,0.0006704058,0.0010378971,0.00088626373,0.00034048632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004619126,0.00006419961,0.9943024,0.00005539194,0.000027744783,0.00005291694,0.0014363542,0.000045642973,0.000084086816,0.0000577913,0.0012175262,0.0026097915],"study_design_scores_gemma":[0.000008167614,0.000040842977,0.99551576,0.00003113652,0.0000144535425,0.000043962784,0.0029541645,0.00017375732,0.000023528035,0.000009658658,0.001172825,0.000011650877],"about_ca_topic_score_codex":0.99101865,"about_ca_topic_score_gemma":0.99402726,"teacher_disagreement_score":0.9753703,"about_ca_system_score_codex":0.024629707,"about_ca_system_score_gemma":0.03080183,"threshold_uncertainty_score":0.17870188},"labels":[],"label_agreement":null},{"id":"W4382983283","doi":"10.3390/curroncol30070465","title":"Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"William Osler Health System; University of British Columbia; Surrey Place Centre; McMaster University; University of Manitoba; Juravinski Cancer Centre; University of Alberta; University of Ottawa; Centre Hospitalier de l’Université de Montréal; University Health Network; CancerCare Manitoba; Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"Jazz Pharmaceuticals; F. Hoffmann-La Roche; AstraZeneca","keywords":"Medicine; Consensus conference; Intensive care medicine; Randomized controlled trial; Lung cancer; Stage (stratigraphy); MEDLINE; Systemic therapy; Neuroendocrine tumors; Radiation therapy; Oncology; Cancer; Pathology; Internal medicine","score_opus":0.4128847573331576,"score_gpt":0.5497326315138387,"score_spread":0.13684787418068106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382983283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006078719,0.77691054,0.005816044,0.15856116,0.02031644,0.0038104262,0.009265979,0.00029310954,0.024418378],"genre_scores_gemma":[0.009220544,0.8386368,0.06784099,0.050020654,0.002743161,0.004901611,0.012539874,0.00012850422,0.013967857],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.978315,0.0057400162,0.006558231,0.00095089345,0.0070403647,0.0013954827],"domain_scores_gemma":[0.9315714,0.010239767,0.0061055087,0.0009667939,0.04785557,0.0032608781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02872913,0.002233118,0.004178407,0.0155979125,0.0027705517,0.0040495098,0.010265235,0.0075817206,0.010886835],"category_scores_gemma":[0.065069996,0.0014079544,0.009395327,0.012872475,0.002021252,0.0032038186,0.003758828,0.0070015173,0.0041088443],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019287306,0.000070999995,0.0009784964,0.09422238,0.0009864037,0.0004921144,0.00073862827,0.00091639516,0.00055262144,0.008684786,0.5987388,0.29342544],"study_design_scores_gemma":[0.00021800178,0.000042080832,0.0022801615,0.114666425,0.0015439318,0.0002907731,0.0003250358,0.0001781265,0.00020735522,0.003975394,0.876174,0.000098733115],"about_ca_topic_score_codex":0.28118682,"about_ca_topic_score_gemma":0.3427462,"teacher_disagreement_score":0.7188132,"about_ca_system_score_codex":0.024063865,"about_ca_system_score_gemma":0.12434813,"threshold_uncertainty_score":0.5591003},"labels":[],"label_agreement":null},{"id":"W4385685238","doi":"10.4049/jimmunol.210.supp.233.15","title":"Using lung-on-a-chip to characterize HIF-1α-dependent inflammatory responses during acute <i>Streptococcus pneumoniae</i> infection","year":2023,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Immune system; Biology; Streptococcus pneumoniae; Western blot; Gene knockdown; Immunology; Hypoxia-inducible factors; Cytokine; Lung; Gene; Microbiology; Medicine","score_opus":0.04108608355596852,"score_gpt":0.35426107446247745,"score_spread":0.3131749909065089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385685238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8991258,0.0043048584,0.076745145,0.00045024717,0.00030913562,0.00024690904,0.013305602,0.002161302,0.0033510402],"genre_scores_gemma":[0.92561233,0.0021525694,0.055160142,0.001004764,0.00010727319,0.000725564,0.011105641,0.00028520243,0.003846495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995963,0.000031329746,0.000018250374,0.00015116284,0.00010562431,0.00009747601],"domain_scores_gemma":[0.9998324,0.000035437377,0.000038750644,0.00001780896,0.00003763148,0.00003797701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026880173,0.00036633573,0.0005132948,0.0003076756,0.00027447325,0.00051485305,0.00031466587,0.0003568922,0.0015027183],"category_scores_gemma":[0.0001985426,0.00025135066,0.00057850784,0.00016881332,0.00025556696,0.00017875659,0.0003590805,0.000667123,0.00079141796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000805201,0.000017086411,0.00051372894,0.000081414335,0.000012231878,0.000017537704,0.000012344084,0.00019626966,0.99718803,0.0000379322,0.0002768923,0.0015660172],"study_design_scores_gemma":[0.000025805592,0.0002371054,0.023264848,0.000016948981,0.00004533378,0.00017217112,0.000059701164,0.007580774,0.96101326,0.00010876835,0.007443395,0.000031905332],"about_ca_topic_score_codex":0.0010024795,"about_ca_topic_score_gemma":0.0023104555,"teacher_disagreement_score":0.0015027183,"about_ca_system_score_codex":0.00036271522,"about_ca_system_score_gemma":0.00032556927,"threshold_uncertainty_score":0.0050271153},"labels":[],"label_agreement":null},{"id":"W4386137644","doi":"10.1177/17588359231192399","title":"The role of thoracic consolidative radiotherapy in the setting of immunotherapy in extensive stage small cell lung cancer","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Medical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Durvalumab; Atezolizumab; Chemoimmunotherapy; Oncology; Radiation therapy; Immunotherapy; Lung cancer; Internal medicine; Chemotherapy; Prophylactic cranial irradiation; Pembrolizumab; Clinical trial; Cancer","score_opus":0.05325617056729078,"score_gpt":0.5120078415180879,"score_spread":0.4587516709507971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386137644","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0758444,0.8608251,0.0027403636,0.040305905,0.0028710535,0.00019020204,0.0002508128,0.000060609702,0.016911687],"genre_scores_gemma":[0.5506503,0.41185105,0.005236108,0.01658924,0.011444769,0.00030791954,0.00062262063,0.000047463942,0.0032504075],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9980166,0.0012441552,0.00017734614,0.00019646685,0.00023730335,0.00012800054],"domain_scores_gemma":[0.9917319,0.0043221163,0.0014665311,0.0004410827,0.0010512447,0.00098712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006105164,0.0003002463,0.00082133966,0.00052882504,0.00041118098,0.0022452306,0.00082004344,0.0009872589,0.004727014],"category_scores_gemma":[0.015652008,0.00015948951,0.0007314654,0.0007521162,0.0010100987,0.002427771,0.0011502962,0.0024694048,0.0006454828],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032523293,0.00047037812,0.01948558,0.0038148272,0.00028717352,0.00046535957,0.00031707433,0.0013292327,0.0013795033,0.004374443,0.017406093,0.94741803],"study_design_scores_gemma":[0.0032368477,0.018239189,0.1874208,0.023271168,0.0033585553,0.008124856,0.0031048602,0.0073399823,0.0046960544,0.04246626,0.69837517,0.00036630325],"about_ca_topic_score_codex":0.0013425549,"about_ca_topic_score_gemma":0.0036799896,"teacher_disagreement_score":0.006105164,"about_ca_system_score_codex":0.0010431121,"about_ca_system_score_gemma":0.0026490476,"threshold_uncertainty_score":0.032287598},"labels":[],"label_agreement":null},{"id":"W4386346584","doi":"10.1007/s11523-023-00995-1","title":"Comparative Effectiveness of Lurbinectedin for the Treatment of Relapsed Small Cell Lung Cancer in the Post-Platinum Setting: A Real-World Canadian Synthetic Control Arm Analysis","year":2023,"lang":"en","type":"article","venue":"Targeted Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba; University of Calgary","funders":"Jazz Pharmaceuticals Canada","keywords":"Medicine; Hazard ratio; Confidence interval; Proportional hazards model; Population; Internal medicine; Oncology; Chemotherapy; Surgery; Environmental health","score_opus":0.027790270941448557,"score_gpt":0.3760701408180536,"score_spread":0.3482798698766051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386346584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563554,0.029535554,0.00056313764,0.0010414207,0.0002969749,0.0011049077,0.0037067544,0.000055505105,0.0073403963],"genre_scores_gemma":[0.99211204,0.0041189264,0.00055886764,0.0003299142,0.00010700476,0.00015432922,0.0013123138,0.0000149837915,0.0012916565],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9957777,0.002541528,0.00017368938,0.0004087004,0.00063680846,0.0004614944],"domain_scores_gemma":[0.9962005,0.0011888503,0.0009844032,0.00032130547,0.0004893264,0.00081563444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049249376,0.0012236189,0.0026127768,0.0008893671,0.0006272535,0.0016176592,0.0016170301,0.0014158391,0.0030204253],"category_scores_gemma":[0.0064087682,0.00049084006,0.0032934616,0.001658081,0.001642048,0.00081323175,0.0005258993,0.0024638225,0.00024173612],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9424806,0.0026548565,0.004203841,0.0012106391,0.0057186005,0.00006273012,0.00012854788,0.0025486888,0.0016280161,0.0007071877,0.0016312113,0.037025087],"study_design_scores_gemma":[0.59396666,0.23421179,0.122226134,0.0006222131,0.028496146,0.00023344845,0.00041690195,0.0048221173,0.0021013117,0.00064226805,0.011989527,0.00027147194],"about_ca_topic_score_codex":0.34747925,"about_ca_topic_score_gemma":0.48180413,"teacher_disagreement_score":0.6525208,"about_ca_system_score_codex":0.017499782,"about_ca_system_score_gemma":0.010863451,"threshold_uncertainty_score":0.69091344},"labels":[],"label_agreement":null},{"id":"W4386391777","doi":"10.1007/s10143-023-02129-7","title":"Whole-tumor histogram analysis of multi-parametric MRI for differentiating brain metastases histological subtypes in lung cancers: relationship with the Ki-67 proliferation index","year":2023,"lang":"en","type":"article","venue":"Neurosurgical Review","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Natural Science Foundation of China","keywords":"Medicine; Kurtosis; Effective diffusion coefficient; Lung cancer; Percentile; Nuclear medicine; Skewness; Coefficient of variation; Adenocarcinoma; Standard deviation; Ki-67; Histogram; Radiology; Pathology; Cancer; Internal medicine; Magnetic resonance imaging; Immunohistochemistry; Mathematics; Statistics","score_opus":0.07793797974727316,"score_gpt":0.3945653936290378,"score_spread":0.31662741388176463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386391777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8390224,0.10762201,0.044934526,0.0007058033,0.00022122751,0.00014411249,0.0009339074,0.00041519545,0.006000852],"genre_scores_gemma":[0.9741096,0.014788406,0.009778982,0.00006213709,0.0001148239,0.000041297397,0.0003121746,0.000044382356,0.0007482227],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99962294,0.00010651,0.000038597962,0.00007341992,0.00011816902,0.00004026853],"domain_scores_gemma":[0.9977043,0.0011389136,0.00041919792,0.000108581255,0.0005386352,0.00009030111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017350197,0.0003477033,0.00049976987,0.0026511373,0.00021715296,0.0011758714,0.00046856806,0.00038879816,0.0008386628],"category_scores_gemma":[0.0044142082,0.00022267438,0.0005262182,0.001613045,0.00034668713,0.0010267538,0.0003770884,0.00067100313,0.00026670535],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014215721,0.000249786,0.39045286,0.0015760163,0.0015916852,0.0005188051,0.00028241266,0.0030342564,0.04581488,0.0007037598,0.0019457503,0.5524083],"study_design_scores_gemma":[0.000050022485,0.0013784551,0.91335183,0.0003299975,0.0022902992,0.0054546106,0.00079650385,0.03255929,0.03245007,0.0020192207,0.009121378,0.00019820555],"about_ca_topic_score_codex":0.001572561,"about_ca_topic_score_gemma":0.0024177649,"teacher_disagreement_score":0.0026511373,"about_ca_system_score_codex":0.0003248091,"about_ca_system_score_gemma":0.0004498027,"threshold_uncertainty_score":0.009175777},"labels":[],"label_agreement":null},{"id":"W4386570892","doi":"10.1016/j.jtocrr.2023.100572","title":"Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; University of Toronto","funders":"Daiichi Sankyo Europe; National Cancer Institute; Chugai Pharmaceutical; Merck Sharp and Dohme; Genentech; Oryzon Genomics; BeiGene; Merck KGaA; Gilead Sciences; GlaxoSmithKline; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pembrolizumab; Medicine; Placebo; Internal medicine; Lung cancer; Quality of life (healthcare); Hazard ratio; Confidence interval; Etoposide; Oncology; Chemotherapy; Surgery; Cancer; Pathology; Immunotherapy; Nursing","score_opus":0.3304689780494397,"score_gpt":0.5523388797000741,"score_spread":0.22186990165063442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386570892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951527,0.0027487527,0.000160764,0.00013813873,0.00008773994,0.0003766213,0.00040089406,0.00004368246,0.0008907275],"genre_scores_gemma":[0.99718827,0.0008434953,0.00032034755,0.00016735199,0.000066128014,0.000501235,0.00037737854,0.0000048784505,0.00053106045],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99955124,0.00019844786,0.000051368836,0.0000855436,0.000054464963,0.000058952875],"domain_scores_gemma":[0.99968743,0.00006296229,0.000113133865,0.000018876372,0.00001588704,0.000101851125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011465232,0.00065667724,0.0017505975,0.00024227904,0.00019085356,0.00058842084,0.00052473234,0.00074053067,0.0052797985],"category_scores_gemma":[0.0008730836,0.00030998868,0.00078673725,0.00026577886,0.00051908783,0.00054116757,0.0004036739,0.0013905592,0.00043123937],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86921644,0.013180642,0.003454318,0.0012918822,0.0009797753,0.00006709158,0.00007551464,0.00091044966,0.038914885,0.000079728256,0.0012938965,0.070535295],"study_design_scores_gemma":[0.4373004,0.5128333,0.035181973,0.00013487421,0.0013998771,0.0002105897,0.00006185914,0.0012221372,0.00943587,0.00015427996,0.0020287358,0.000036022564],"about_ca_topic_score_codex":0.00033948445,"about_ca_topic_score_gemma":0.00063266273,"teacher_disagreement_score":0.0052797985,"about_ca_system_score_codex":0.00044260014,"about_ca_system_score_gemma":0.00049801863,"threshold_uncertainty_score":0.017662704},"labels":[],"label_agreement":null},{"id":"W4386600587","doi":"10.1016/j.ccell.2023.08.007","title":"Unfolding the secrets of small cell lung cancer progression: Novel approaches and insights through rapid autopsies","year":2023,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Moonshot; National Cancer Institute; National Research, Development and Innovation Office; University of Texas MD Anderson Cancer Center; National Institutes of Health; International Association for the Study of Lung Cancer; Hungarian-American Enterprise Scholarship Fund; Fru Berta Kamprads Stiftelse; Sierra Oncology; Innovációs és Technológiai Minisztérium; Magyar Tudományos Akadémia; BeiGene; Magyar Tüdőgyógyász Társaság; Cancer Prevention and Research Institute of Texas; Austrian Science Fund; Moonshot Research and Development Program; AstraZeneca; Bristol-Myers Squibb","keywords":"Biology; Lung cancer; Cancer; Cancer research; Cell; Computational biology; Medicine; Pathology; Genetics","score_opus":0.09589570687595671,"score_gpt":0.3582686172030531,"score_spread":0.26237291032709636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386600587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81794417,0.055081587,0.090094104,0.010037682,0.0015161622,0.000190644,0.0006232802,0.00054871105,0.023963733],"genre_scores_gemma":[0.9709561,0.011220696,0.011509947,0.0006854137,0.0002717779,0.0000710334,0.00015618297,0.00006304864,0.005065778],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997054,0.000045966724,0.000012410891,0.00007129541,0.00009538907,0.00006956176],"domain_scores_gemma":[0.99942553,0.00019091628,0.00011173345,0.00013113665,0.000058823825,0.00008183221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085351,0.00040836845,0.00039042518,0.00049593404,0.0006582641,0.0014483926,0.00047543357,0.00062162324,0.00304613],"category_scores_gemma":[0.0011321672,0.000252519,0.00046556778,0.00027238953,0.0013391254,0.0030780404,0.0015600311,0.0023863283,0.00041125197],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007944951,0.0001964635,0.0051532257,0.0007357345,0.00012602391,0.0012760962,0.0013045446,0.003807996,0.7519874,0.11876509,0.003607966,0.112244934],"study_design_scores_gemma":[0.00013747724,0.0009985009,0.02053499,0.0002692703,0.00017184686,0.0031407075,0.0023352958,0.032422237,0.6873217,0.16291007,0.08959574,0.00016214773],"about_ca_topic_score_codex":0.00036510362,"about_ca_topic_score_gemma":0.0005407187,"teacher_disagreement_score":0.00304613,"about_ca_system_score_codex":0.000783693,"about_ca_system_score_gemma":0.0005032401,"threshold_uncertainty_score":0.010190308},"labels":[],"label_agreement":null},{"id":"W4386784419","doi":"10.1158/1557-3265.aacrahns23-po-016","title":"Abstract PO-016: SSTR2 use and molecular profile in EBV-positive nasopharyngeal carcinoma: A single institution experience","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Somatostatin receptor 2; Immunohistochemistry; Medicine; Nasopharyngeal carcinoma; Malignancy; Microsatellite instability; Internal medicine; Oncology; Biopsy; Pathology; Cancer research; Somatostatin receptor; Receptor; Biology; Radiation therapy; Microsatellite; Gene; Genetics","score_opus":0.2902034492759341,"score_gpt":0.5352508114987602,"score_spread":0.24504736222282608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99879706,0.00029871054,0.00014702884,0.00002375767,0.000004452348,0.000012924818,0.00006335976,0.000008428855,0.00064424286],"genre_scores_gemma":[0.9992736,0.00019080681,0.00012713262,0.000024753195,0.0000093710205,0.0000063136986,0.00008768274,0.000006977659,0.00027340837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962306,0.00006259933,0.000061633626,0.0000920476,0.000085245316,0.00007551035],"domain_scores_gemma":[0.9992975,0.0001260871,0.00015648307,0.00008006517,0.00008066481,0.0002592091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041886195,0.0003867117,0.00034109905,0.00053663715,0.0006455477,0.0006922286,0.00036858313,0.00039195563,0.0022432383],"category_scores_gemma":[0.001142449,0.0002742321,0.0003837819,0.0007448345,0.00032448163,0.0005716586,0.000720346,0.00044038668,0.0009745232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027594608,0.0003183859,0.95599264,0.000054851604,0.000054968277,0.026100747,0.00071955007,0.00011065313,0.003871827,0.000025593334,0.00022329684,0.012251592],"study_design_scores_gemma":[0.000050628376,0.0022720736,0.7995298,0.00004696518,0.00013207231,0.18773721,0.0023861476,0.00067571807,0.004729171,0.00007223245,0.0023300014,0.00003803175],"about_ca_topic_score_codex":0.001337359,"about_ca_topic_score_gemma":0.001588247,"teacher_disagreement_score":0.0022432383,"about_ca_system_score_codex":0.00039330163,"about_ca_system_score_gemma":0.00044251827,"threshold_uncertainty_score":0.0075044036},"labels":[],"label_agreement":null},{"id":"W4386848086","doi":"10.3389/fonc.2023.1191855","title":"Real-world predictors of survival in patients with extensive-stage small-cell lung cancer in Manitoba, Canada: a retrospective cohort study","year":2023,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; AstraZeneca (Canada); University of Manitoba; CancerCare Manitoba","funders":"Manitoba Medical Service Foundation","keywords":"Medicine; Cohort; Internal medicine; Retrospective cohort study; Cancer registry; Lung cancer; Proportional hazards model; Oncology; Radiation therapy; Cancer; Prophylactic cranial irradiation; Chemotherapy; Survival analysis; Stage (stratigraphy); Performance status; Surgery; Conventional PCI","score_opus":0.01587972647602231,"score_gpt":0.30716899989587293,"score_spread":0.2912892734198506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386848086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925991,0.00046552354,0.000103238664,0.00018613343,0.000010639414,0.00008582457,0.0056717386,0.000008244436,0.00086959766],"genre_scores_gemma":[0.99660695,0.0003731554,0.00015391588,0.00012474705,0.000008694818,0.000046761183,0.0023862184,0.0000041207823,0.00029545694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916625,0.00007369131,0.00007586625,0.00019924034,0.00023177553,0.00025315996],"domain_scores_gemma":[0.99720806,0.00013835542,0.00074903877,0.00019635617,0.0010650018,0.0006432213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006761476,0.00047587635,0.000466413,0.0014087865,0.0021302,0.0011766646,0.0012494641,0.00047036662,0.0012184829],"category_scores_gemma":[0.001822044,0.0004950124,0.0005262618,0.004522683,0.0007226377,0.0003549231,0.0009480452,0.00071140146,0.00023845279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032022963,0.000012298288,0.9990305,0.000009225023,0.000025685766,0.00004911388,0.00012329002,0.000036065176,0.000056943336,0.000015492073,0.00024689312,0.00036250416],"study_design_scores_gemma":[0.000010204431,0.000029541105,0.9980895,0.000021824975,0.00003799438,0.0001201149,0.0007352234,0.00021899796,0.000038071674,0.000014855348,0.0006751343,0.000008619586],"about_ca_topic_score_codex":0.9728453,"about_ca_topic_score_gemma":0.9825392,"teacher_disagreement_score":0.027154684,"about_ca_system_score_codex":0.01733182,"about_ca_system_score_gemma":0.023193695,"threshold_uncertainty_score":0.1257518},"labels":[],"label_agreement":null},{"id":"W4387206412","doi":"10.1016/j.ijrobp.2023.06.779","title":"Survival Outcomes of Extensive Stage Small Cell Lung Cancer Patients Treated with Consolidative Thoracic Radiotherapy at a Tertiary Cancer Center","year":2023,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Lung cancer; Radiation therapy; Pneumonitis; Chemoradiotherapy; Tolerability; Chemotherapy; Survival rate; Radiology; Surgery; Internal medicine; Lung; Adverse effect","score_opus":0.028754974698601592,"score_gpt":0.39726293108172067,"score_spread":0.36850795638311906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387206412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99936837,0.000073365314,0.00002008401,0.0000344906,0.0000037791838,0.000003916395,0.00015067619,0.0000012483991,0.0003440435],"genre_scores_gemma":[0.99945694,0.000033636436,0.000010919453,0.000025096535,0.0000075544717,0.0000024655794,0.00031453997,7.6141544e-7,0.00014813474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978715,0.00002744942,0.00001837171,0.000046478362,0.00002649351,0.00009416003],"domain_scores_gemma":[0.99960774,0.000040559364,0.00010046881,0.000013904532,0.00005167397,0.00018559064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016808524,0.00018812002,0.00030478905,0.00036789296,0.0005781763,0.00056421285,0.00027982998,0.00027637678,0.0017377671],"category_scores_gemma":[0.00049913215,0.00011167758,0.00043216549,0.00064980035,0.00032322377,0.00038747833,0.00071278017,0.00036773132,0.00017430534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005089853,0.00013850711,0.9936055,0.000011860179,0.00006523833,0.00034498802,0.00017716529,0.00036860205,0.00062080583,0.00003966641,0.00029298698,0.0038256464],"study_design_scores_gemma":[0.000024825753,0.0005562174,0.9977054,0.0000055647465,0.000054863453,0.00035457403,0.0005329466,0.00032352665,0.00012028828,0.000042874643,0.00027153204,0.000007464607],"about_ca_topic_score_codex":0.010208924,"about_ca_topic_score_gemma":0.024222882,"teacher_disagreement_score":0.010208924,"about_ca_system_score_codex":0.000959187,"about_ca_system_score_gemma":0.00071141205,"threshold_uncertainty_score":0.020299017},"labels":[],"label_agreement":null},{"id":"W4387207571","doi":"10.1016/j.ijrobp.2023.06.738","title":"A Survey Study of Practice Patterns in Management of Very Early Small Cell Lung Cancer in Canada","year":2023,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Radiation therapy; Lung cancer; Chemoradiotherapy; Stage (stratigraphy); Lesion; Chemotherapy; Demographics; Adjuvant chemotherapy; Cancer; Internal medicine; Surgery; Family medicine; Radiology","score_opus":0.035320653426812156,"score_gpt":0.3908238424059557,"score_spread":0.3555031889791435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387207571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430275,0.00055041333,0.00005745418,0.0006697664,0.000010886103,0.00005894172,0.002243319,0.0000069845755,0.0020995305],"genre_scores_gemma":[0.9979742,0.0004590713,0.000106437816,0.0002227362,0.0000048453267,0.000025274785,0.000585604,0.0000046391315,0.0006171812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977272,0.00021684227,0.0002762579,0.0002926515,0.00072990084,0.0007570683],"domain_scores_gemma":[0.9927603,0.0006480231,0.0018070223,0.000098638615,0.0026959332,0.0019901325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070761505,0.00025614805,0.00044484294,0.0019481556,0.0031028325,0.0017182588,0.0015628434,0.0008283799,0.002955527],"category_scores_gemma":[0.005118739,0.00052222185,0.00056334503,0.008343926,0.0010663073,0.00064830686,0.0012249284,0.0009621016,0.00027750424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046181027,0.00006233568,0.9935353,0.000050047158,0.000029583098,0.00009908553,0.0025436997,0.000055967525,0.0001036238,0.000104150684,0.0007213684,0.0026485692],"study_design_scores_gemma":[0.0000070314363,0.00004527857,0.98988956,0.000043732463,0.000013210386,0.00009251701,0.008807837,0.00016075384,0.00003272035,0.000016554373,0.00087752,0.000013353773],"about_ca_topic_score_codex":0.98891234,"about_ca_topic_score_gemma":0.9931185,"teacher_disagreement_score":0.03351681,"about_ca_system_score_codex":0.03351681,"about_ca_system_score_gemma":0.05473708,"threshold_uncertainty_score":0.2431826},"labels":[],"label_agreement":null},{"id":"W4387207935","doi":"10.1016/j.ijrobp.2023.06.380","title":"The Effect of PARP Inhibitor Radiosensitization on the mRNA Translational Regulation of T Cell Chemokines","year":2023,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McGill University; University Health Network","funders":"","keywords":"Cancer research; Olaparib; Chemokine; CXCL10; CCL5; PARP inhibitor; Medicine; Immunotherapy; Molecular biology; T cell; Biology; Immunology; Poly ADP ribose polymerase; Immune system; Gene; IL-2 receptor","score_opus":0.017688799030240253,"score_gpt":0.34276262769586285,"score_spread":0.3250738286656226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387207935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99377865,0.0023500829,0.00046984357,0.00025106737,0.00021668288,0.00003377313,0.0007150263,0.0000635398,0.0021213267],"genre_scores_gemma":[0.9952952,0.0011312334,0.00031223884,0.00012742916,0.000049663933,0.000054585955,0.0007231547,0.000013785627,0.0022925234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982446,0.000021806129,0.000011079121,0.000036552578,0.000022249518,0.00008383669],"domain_scores_gemma":[0.99989307,0.000035228582,0.00002034139,0.000016935677,0.000010000259,0.000024373612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018096218,0.0002935757,0.0003168227,0.00014693479,0.00026801124,0.00040281823,0.00025948387,0.00029472297,0.0048821266],"category_scores_gemma":[0.0002646246,0.00018293437,0.00041505633,0.0001812184,0.00032068603,0.00032554878,0.00012162791,0.0010908553,0.0005140444],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011174353,0.00070387905,0.00069978647,0.00017537017,0.000040708284,0.00010702512,0.00008799885,0.0005939243,0.97495645,0.00048590117,0.0011782462,0.009796388],"study_design_scores_gemma":[0.00033204484,0.0056682522,0.020015597,0.000017793387,0.000089446934,0.00015795138,0.00017196123,0.0011514672,0.9668792,0.00016970582,0.005323495,0.00002309627],"about_ca_topic_score_codex":0.0008469917,"about_ca_topic_score_gemma":0.0010602297,"teacher_disagreement_score":0.0048821266,"about_ca_system_score_codex":0.0002808869,"about_ca_system_score_gemma":0.0004137389,"threshold_uncertainty_score":0.016332328},"labels":[],"label_agreement":null},{"id":"W4387517250","doi":"10.1200/jco.23.01435","title":"Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Hamilton Health Sciences; Windsor Regional Hospital; Western University; Juravinski Cancer Centre","funders":"Hamilton Health Sciences; Brown University; American Society of Clinical Oncology; University of California","keywords":"Medicine; Guideline; Lung cancer; Systemic therapy; Randomized controlled trial; Systematic review; Intensive care medicine; Radiation therapy; Cancer; Evidence-based medicine; Oncology; MEDLINE; Quality of life (healthcare); Family medicine; Disease; Internal medicine; Alternative medicine; Pathology; Nursing; Breast cancer","score_opus":0.22785546923338496,"score_gpt":0.5706298294869827,"score_spread":0.34277436025359775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387517250","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0088873645,0.43574062,0.014003191,0.34693378,0.015920596,0.0131443385,0.04742416,0.000878977,0.11706699],"genre_scores_gemma":[0.08744503,0.45218477,0.16300733,0.13384824,0.0064254124,0.01613629,0.073802926,0.00042363987,0.06672633],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938123,0.001395826,0.0015485199,0.00032407953,0.0023988315,0.0005203505],"domain_scores_gemma":[0.9879496,0.0013893126,0.0015374981,0.00019024799,0.007820222,0.0011131127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007270679,0.0012346674,0.0019740139,0.0032143109,0.0019396906,0.0018441948,0.005709049,0.0044210516,0.0047744606],"category_scores_gemma":[0.015817946,0.0007373639,0.0036116745,0.004533615,0.0012989616,0.0013177458,0.0017236975,0.003861564,0.0020522175],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001364975,0.000092748705,0.004207462,0.015233826,0.00041432166,0.00026265334,0.00036719666,0.00083515723,0.00063303375,0.0033553306,0.87397337,0.10048845],"study_design_scores_gemma":[0.0008544911,0.00012431509,0.019249327,0.05526384,0.001812738,0.0005867423,0.00037570883,0.0009550199,0.00038561423,0.00396114,0.916331,0.0001001755],"about_ca_topic_score_codex":0.49973974,"about_ca_topic_score_gemma":0.740225,"teacher_disagreement_score":0.9762313,"about_ca_system_score_codex":0.023768717,"about_ca_system_score_gemma":0.07820163,"threshold_uncertainty_score":0.9936619},"labels":[],"label_agreement":null},{"id":"W4387812459","doi":"10.1016/j.annonc.2023.09.1327","title":"2300P Clonal hematopoiesis of indeterminate potential (CHIP) in patients with advanced NSCLC treated with immune checkpoint blockers (ICB) as monotherapy: Analysis of the PREMIS study","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; Chugai Pharmaceutical; Genentech; Aptitude Health; Sierra Oncology; Eisai; Astellas Pharma; Basilea Pharmaceutica; Daiichi Sankyo Europe; Servier; AstraZeneca; Institut National Du Cancer; Pfizer; Incyte; BeiGene; Astex Pharmaceuticals; Les Laboratories Pierre Fabre; Ipsen; Jazz Pharmaceuticals; Bayer HealthCare; Exelixis; Sanofi; Amgen; American Association for Cancer Research; Eli Lilly and Company; Bristol-Myers Squibb; Agios Pharmaceuticals; Society for Immunotherapy of Cancer; PharmaMar; Celgene","keywords":"Medicine; Internal medicine; Oncology; Pembrolizumab; Lung cancer; Cancer; Immunotherapy","score_opus":0.02526084698264695,"score_gpt":0.366198722378926,"score_spread":0.340937875396279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387812459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980247,0.0008741658,0.000067370056,0.00004159072,0.000008009268,0.000019743415,0.0005008072,0.0000028426134,0.00046080415],"genre_scores_gemma":[0.99873585,0.00025221583,0.00008614181,0.000054166878,0.000025885462,0.000020839621,0.0006933221,0.0000021598935,0.00012945003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966013,0.00014430826,0.000027097709,0.00007370256,0.000057109028,0.000037708836],"domain_scores_gemma":[0.998971,0.00039005312,0.00031239324,0.00010052995,0.00006894979,0.0001571056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009192479,0.00032809688,0.00049045304,0.00038961333,0.00020120032,0.0007022454,0.0004569597,0.00034066293,0.0010223833],"category_scores_gemma":[0.0017506634,0.00023550064,0.00056897436,0.00063697057,0.00027561735,0.0004131087,0.00045829083,0.0006043746,0.000117309755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011984659,0.00016290315,0.969191,0.0001029752,0.0012664306,0.0002035802,0.000049886956,0.000276569,0.0024458405,0.00022004545,0.000532683,0.013563366],"study_design_scores_gemma":[0.0009261841,0.0027128058,0.9916363,0.00002280639,0.001300607,0.0006296893,0.00009849668,0.00061173004,0.000516585,0.00022325605,0.001308461,0.00001311488],"about_ca_topic_score_codex":0.0006039016,"about_ca_topic_score_gemma":0.0010638041,"teacher_disagreement_score":0.0010223833,"about_ca_system_score_codex":0.00022912365,"about_ca_system_score_gemma":0.0002678368,"threshold_uncertainty_score":0.0048615336},"labels":[],"label_agreement":null},{"id":"W4387812581","doi":"10.1016/j.annonc.2023.09.1257","title":"2027P Immune checkpoint inhibitors in the treatment of small cell lung cancer: A systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; BC Cancer Agency; McMaster University; Western University","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Oncology; Lung cancer; Meta-analysis; Cochrane Library; Adverse effect; Chemotherapy; Clinical endpoint; Confidence interval; Randomized controlled trial; Subgroup analysis","score_opus":0.33720105477581636,"score_gpt":0.5258642158560765,"score_spread":0.1886631610802601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387812581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023429983,0.99653625,0.00029018155,0.00012810159,0.00013432182,0.00010193425,0.00029353102,0.000015097489,0.00015767949],"genre_scores_gemma":[0.11798828,0.8777814,0.0014114765,0.001118596,0.00030272666,0.0004170783,0.0005019375,0.000025138348,0.00045339638],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9954188,0.0019794498,0.0012679937,0.00057908194,0.0005282054,0.00022646537],"domain_scores_gemma":[0.9932153,0.0048573073,0.0011658927,0.00019706869,0.00044571306,0.00011880451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060854745,0.0024666097,0.014977832,0.0036974875,0.0005851118,0.0025467991,0.0017820013,0.0023147748,0.005008497],"category_scores_gemma":[0.016465288,0.001347898,0.031046996,0.0047724107,0.00063681026,0.0016332313,0.0015473518,0.0024459998,0.00047090344],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002577104,0.00003069039,0.002690342,0.38944036,0.5877389,0.00012285644,0.000061183855,0.0004093793,0.00030836248,0.0001346165,0.0008327541,0.01565348],"study_design_scores_gemma":[0.00080693763,0.00013341698,0.0023277444,0.01761418,0.9771269,0.00006829678,0.000033567918,0.00011329918,0.00008251114,0.00015539864,0.0015168975,0.000020926465],"about_ca_topic_score_codex":0.008044668,"about_ca_topic_score_gemma":0.02284367,"teacher_disagreement_score":0.014977832,"about_ca_system_score_codex":0.0019426025,"about_ca_system_score_gemma":0.0025651313,"threshold_uncertainty_score":0.03218341},"labels":[],"label_agreement":null},{"id":"W4388045013","doi":"10.1016/j.jtho.2023.09.674","title":"P2.17-07 Real-world Safety and Dosing of Lurbinectedin-Treated Patients with Small Cell Lung Cancer: Jazz EMERGE 402 Preliminary Analysis","year":2023,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Dosing; Jazz; Lung cancer; Intensive care medicine; Internal medicine; Acoustics","score_opus":0.023414895978585516,"score_gpt":0.4081311427605147,"score_spread":0.38471624678192917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388045013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95616853,0.0031402977,0.00200934,0.0021383245,0.00021338489,0.0018696078,0.017982166,0.00028146317,0.016196933],"genre_scores_gemma":[0.97087777,0.0015356042,0.002449347,0.0010472471,0.00027224363,0.001258439,0.015315554,0.000102238,0.0071416185],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9987361,0.00078345934,0.00006205256,0.00012194224,0.00019030704,0.00010621679],"domain_scores_gemma":[0.9978756,0.0007242614,0.00051573484,0.00025014198,0.00028393496,0.00035026966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023944823,0.00049303623,0.001123352,0.00024097832,0.00032080803,0.001373713,0.00053950044,0.000705,0.009305532],"category_scores_gemma":[0.0034988003,0.0002650008,0.0014430102,0.00036880194,0.0003676111,0.00041255992,0.00034971486,0.0014268917,0.0021668896],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67108154,0.0094078155,0.0680745,0.0016196338,0.0040481905,0.00039959772,0.00023715854,0.0055017024,0.03959744,0.0008250921,0.026565101,0.1726422],"study_design_scores_gemma":[0.21227251,0.37051776,0.32890174,0.00036730015,0.005607788,0.0010590721,0.00027456396,0.0061248406,0.01713368,0.00061783666,0.05700514,0.00011780531],"about_ca_topic_score_codex":0.0019992837,"about_ca_topic_score_gemma":0.0023866019,"teacher_disagreement_score":0.009305532,"about_ca_system_score_codex":0.0009844173,"about_ca_system_score_gemma":0.0013945352,"threshold_uncertainty_score":0.031130135},"labels":[],"label_agreement":null},{"id":"W4388086806","doi":"10.1016/j.jtho.2023.09.1368","title":"EP13.07-08 Canadian Consensus Recommendations: Use of Radiation Therapy among Patients with ES-SCLC receiving Immunotherapy","year":2023,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Radiation therapy; Immunotherapy; Magnetic resonance imaging; Oncology; Radiology; Internal medicine; Cancer","score_opus":0.05251884460915777,"score_gpt":0.4249657968331807,"score_spread":0.3724469522240229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388086806","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046418626,0.067214616,0.007963417,0.66361916,0.043414265,0.0070812805,0.08565682,0.00065764395,0.11975097],"genre_scores_gemma":[0.06614881,0.09212185,0.1020155,0.51427877,0.01931373,0.019018114,0.0927554,0.0008187122,0.09352917],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96539545,0.009444432,0.0075823935,0.0016035005,0.012427276,0.003546901],"domain_scores_gemma":[0.85977405,0.022852821,0.009021359,0.0017019182,0.09341941,0.013230456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0374011,0.0016513806,0.0036478548,0.007968796,0.004425593,0.0043605454,0.011102693,0.01807399,0.014005741],"category_scores_gemma":[0.08550853,0.0017354938,0.010931335,0.0070863757,0.0025058899,0.0017870492,0.0037285448,0.012208414,0.006810605],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002835589,0.00019892157,0.0065428307,0.005174418,0.00050849735,0.00013114275,0.00025273077,0.0007531042,0.0002715346,0.0017529345,0.9405123,0.043618068],"study_design_scores_gemma":[0.0015403315,0.0001948038,0.053258993,0.047832143,0.0024627165,0.00026132792,0.0011223021,0.000712991,0.0008355128,0.0031293584,0.88826776,0.00038185937],"about_ca_topic_score_codex":0.79052305,"about_ca_topic_score_gemma":0.78975886,"teacher_disagreement_score":0.9602286,"about_ca_system_score_codex":0.03977139,"about_ca_system_score_gemma":0.17939754,"threshold_uncertainty_score":0.42142117},"labels":[],"label_agreement":null},{"id":"W4388557462","doi":"10.1016/s0167-8140(23)89310-0","title":"218 Management of Very Early Small Cell Lung Cancer: A Canadian Survey Study","year":2023,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Medicine; Oncology; Cancer; Lung; Internal medicine","score_opus":0.04239821605233692,"score_gpt":0.3835605425912749,"score_spread":0.341162326538938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388557462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765288,0.0032296302,0.0001860187,0.0018983391,0.000049248512,0.00020835987,0.00902725,0.0000108814875,0.008861449],"genre_scores_gemma":[0.99154145,0.002853676,0.00031721636,0.0008830089,0.000022384558,0.00008188305,0.0021211584,0.000011085514,0.0021681688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975836,0.00031232764,0.00019114834,0.00027738226,0.00066434656,0.0009712087],"domain_scores_gemma":[0.99499005,0.00030559208,0.0010399602,0.00014072102,0.002382832,0.0011408491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001341098,0.00063134875,0.0006968679,0.0023958315,0.0045696935,0.001711784,0.0018454503,0.0010256569,0.0039182203],"category_scores_gemma":[0.0044612205,0.00085205666,0.0011662324,0.010715295,0.00092245126,0.0008639255,0.0013680395,0.0016473675,0.00040884796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092563016,0.00012693886,0.9918383,0.00012232414,0.00008593209,0.00016286033,0.0016935272,0.000049728416,0.00011272091,0.00020195576,0.001989817,0.0035233686],"study_design_scores_gemma":[0.000021539026,0.000053842818,0.99374974,0.00010125844,0.00006347067,0.00010408964,0.0038315929,0.00008009698,0.00002838175,0.000026749365,0.0019108115,0.00002848922],"about_ca_topic_score_codex":0.99576783,"about_ca_topic_score_gemma":0.99776936,"teacher_disagreement_score":0.9685567,"about_ca_system_score_codex":0.031443313,"about_ca_system_score_gemma":0.05431215,"threshold_uncertainty_score":0.22813827},"labels":[],"label_agreement":null},{"id":"W4388577101","doi":"10.1016/s0167-8140(23)89980-7","title":"95 Use of Radiation Therapy Among Patients with Extensive-Stage Small-Cell Lung Cancer Receiving Immunotherapy: Canadian Consensus Recommendations","year":2023,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Radiation therapy; Immunotherapy; Oncology; Stage (stratigraphy); Intensive care medicine; Internal medicine; Cancer; Biology","score_opus":0.03621660484755423,"score_gpt":0.34397554471795266,"score_spread":0.30775893987039843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388577101","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012765382,0.29483625,0.005543028,0.5809609,0.013841189,0.0019556698,0.021446068,0.00041132324,0.0682402],"genre_scores_gemma":[0.18403791,0.3329779,0.08669693,0.33016017,0.007014563,0.005784773,0.027828358,0.0004316586,0.025067765],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.980663,0.0037502034,0.005170146,0.0013161855,0.0069409613,0.0021594325],"domain_scores_gemma":[0.92081517,0.015838467,0.0076255733,0.0009018405,0.04454838,0.01027046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02654744,0.0012632055,0.0023716448,0.0077694785,0.005341082,0.00457667,0.008683938,0.00851811,0.006612476],"category_scores_gemma":[0.053405333,0.0014536987,0.006938868,0.0084505435,0.0025310102,0.001968049,0.0030856952,0.0087735,0.0011763385],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003962347,0.0002882302,0.0593159,0.012764019,0.0014433744,0.0003215405,0.0016262977,0.0017171385,0.00046084693,0.006301154,0.76464695,0.15071845],"study_design_scores_gemma":[0.0015991064,0.00018547809,0.16615604,0.078711264,0.0047764494,0.0005057077,0.0048973383,0.0013281151,0.0006950087,0.004932321,0.7356311,0.0005819944],"about_ca_topic_score_codex":0.9272893,"about_ca_topic_score_gemma":0.93500566,"teacher_disagreement_score":0.07271069,"about_ca_system_score_codex":0.050464816,"about_ca_system_score_gemma":0.21887067,"threshold_uncertainty_score":0.3661496},"labels":[],"label_agreement":null},{"id":"W4388799926","doi":"10.14740/wjon1726","title":"Efficacy of First-Line Immunotherapy Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients With Different Brain Metastases Status: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"World Journal of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Brain metastasis; Immunotherapy; Chemotherapy; Internal medicine; Oncology; Hazard ratio; Lung cancer; Meta-analysis; Cochrane Library; Randomized controlled trial; Confidence interval; Cancer; Metastasis","score_opus":0.07540190027459537,"score_gpt":0.4124079862341873,"score_spread":0.3370060859595919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388799926","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004109971,0.9949287,0.00023728833,0.000094958654,0.000101628895,0.00015890392,0.00021890443,0.000012606706,0.00013703026],"genre_scores_gemma":[0.17360899,0.82181853,0.0017581846,0.0008585958,0.00027505908,0.0008233901,0.00062641205,0.000022543112,0.00020826446],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9918236,0.0038353847,0.002392841,0.00089856866,0.00080266135,0.00024690002],"domain_scores_gemma":[0.9821223,0.013169912,0.0030804917,0.00042896182,0.00095229625,0.00024606206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011223402,0.0022723684,0.020898668,0.0054952153,0.00051574426,0.0028351208,0.0019286207,0.0022049316,0.0025392252],"category_scores_gemma":[0.024799457,0.0013149882,0.03628885,0.0057955906,0.0006975915,0.0013712497,0.0011085501,0.0015743513,0.00019982933],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003026384,0.000045074627,0.0028388645,0.3854561,0.59659547,0.00008777089,0.00005494815,0.00042794336,0.00023146922,0.000081802966,0.0002939235,0.010860338],"study_design_scores_gemma":[0.0009913526,0.00035534403,0.002731667,0.020621818,0.9739052,0.0000780846,0.000026695101,0.00013314484,0.00010169322,0.00008751918,0.0009500721,0.00001736439],"about_ca_topic_score_codex":0.0058194655,"about_ca_topic_score_gemma":0.013421479,"teacher_disagreement_score":0.020898668,"about_ca_system_score_codex":0.0023246827,"about_ca_system_score_gemma":0.0031014227,"threshold_uncertainty_score":0.059355736},"labels":[],"label_agreement":null},{"id":"W4389227682","doi":"10.1158/2326-6074.tumimm23-b028","title":"Abstract B028: WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in small cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Wee1; Cancer research; Immune checkpoint; Cell cycle checkpoint; Blockade; Immunotherapy; Cell cycle; Medicine; Biology; Immunology; Immune system; Cancer; Cyclin-dependent kinase 1; Internal medicine","score_opus":0.07118017525727223,"score_gpt":0.4046953547627054,"score_spread":0.3335151795054332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949793,0.0013643433,0.0006897934,0.0001617705,0.000058479647,0.00004876814,0.00051344605,0.00013589523,0.0020482547],"genre_scores_gemma":[0.99517196,0.00055431953,0.0007112447,0.0000758713,0.000011478212,0.00007346962,0.00088674587,0.000015143612,0.002499676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991786,0.000012527331,0.000007169103,0.000011138001,0.000017754735,0.000033584332],"domain_scores_gemma":[0.99994814,0.0000059238027,0.000008896211,0.0000041512394,0.0000057037155,0.000027071028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010526191,0.00040841478,0.00030535532,0.00025071637,0.00013446424,0.00026210985,0.00023185016,0.0002658237,0.003767797],"category_scores_gemma":[0.000073429546,0.00010714942,0.00027527413,0.0001699633,0.000183181,0.0001996979,0.00014016233,0.0009343614,0.00061395945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017693794,0.0005809328,0.00022974682,0.00013288765,0.000018939441,0.000046887686,0.000018703638,0.00022248678,0.991706,0.00011075914,0.00048437068,0.004678917],"study_design_scores_gemma":[0.0003765243,0.0071556806,0.0038611132,0.000016190577,0.000043393655,0.00020713548,0.000032577736,0.0018151655,0.9823499,0.000052915613,0.0040819715,0.000007382942],"about_ca_topic_score_codex":0.0006548695,"about_ca_topic_score_gemma":0.0011294483,"teacher_disagreement_score":0.003767797,"about_ca_system_score_codex":0.00022922765,"about_ca_system_score_gemma":0.00036288332,"threshold_uncertainty_score":0.012604535},"labels":[],"label_agreement":null},{"id":"W4389227733","doi":"10.1158/2326-6074.tumimm23-b027","title":"Abstract B027: ATR inhibition upregulates PD-L1 and potentiates the antitumor immune response to chemoimmunotherapy in small-cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Blockade; Lung cancer; Immune system; Medicine; Immunology; Chemoimmunotherapy; Immunotherapy; Biology; Pharmacology; Oncology; Internal medicine; Receptor","score_opus":0.05111201229879783,"score_gpt":0.4114197291463439,"score_spread":0.36030771684754603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908925,0.003740161,0.0010743558,0.00030307833,0.00009813788,0.00007450728,0.00062045665,0.00021505823,0.0029816607],"genre_scores_gemma":[0.99341315,0.0012987555,0.0011026186,0.0001521869,0.000033384953,0.00008838395,0.0011354327,0.000021527192,0.0027545362],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988043,0.000021883496,0.000011079445,0.000020219712,0.000032013886,0.000034275105],"domain_scores_gemma":[0.99994206,0.000007039291,0.0000134000275,0.000006865166,0.000006329514,0.000024344792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015771558,0.00039172065,0.00040794045,0.00029027928,0.00013745512,0.00035169133,0.00027331253,0.00027640734,0.002460885],"category_scores_gemma":[0.000077525314,0.00012429409,0.0002970392,0.00017831872,0.00020801832,0.00015871838,0.00016986884,0.0011102511,0.00072719686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010571933,0.00064834266,0.0003011843,0.000114466995,0.00002348812,0.000052603395,0.00001475875,0.00015519334,0.9897928,0.0000978444,0.0005429449,0.0071991747],"study_design_scores_gemma":[0.0004055453,0.00924261,0.0074980007,0.000024060886,0.00007435253,0.00044620578,0.000031633896,0.0014805497,0.9742775,0.000064248205,0.0064470675,0.000008163485],"about_ca_topic_score_codex":0.00037269527,"about_ca_topic_score_gemma":0.00066702423,"teacher_disagreement_score":0.002460885,"about_ca_system_score_codex":0.0002252391,"about_ca_system_score_gemma":0.00030323956,"threshold_uncertainty_score":0.008232534},"labels":[],"label_agreement":null},{"id":"W4389243260","doi":"10.1182/blood-2023-180567","title":"Targeting CDK9 in KMT2A-Rearranged Infant Leukemia: Evidence for Activity and Drug Synergy with Enitociclib","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Propidium iodide; Cancer research; Leukemia; Biology; Apoptosis; Programmed cell death; Immunology; Biochemistry","score_opus":0.040844396706024015,"score_gpt":0.35252926437032056,"score_spread":0.31168486766429654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794326,0.015288768,0.0006917608,0.00021188469,0.00003325487,0.00008756647,0.0010601602,0.000057299916,0.0031367282],"genre_scores_gemma":[0.988345,0.007625784,0.00094677816,0.0000852295,0.000016594453,0.000038571266,0.0019451812,0.000011988028,0.0009847002],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999026,0.000020211446,0.000011082142,0.000014332484,0.000026761365,0.00002491595],"domain_scores_gemma":[0.9999287,0.000013220719,0.0000146003085,0.000008875935,0.000011905428,0.000022676179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027633095,0.00034246626,0.0005358579,0.00027019795,0.00010109802,0.0004042502,0.000346867,0.00016644031,0.001324174],"category_scores_gemma":[0.00013938213,0.00009505193,0.00019748833,0.00034447236,0.00014916382,0.00014701764,0.00016353688,0.0006497682,0.00030255658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054858574,0.0008805298,0.012414447,0.0005071167,0.0001660497,0.0008210204,0.00009326374,0.0013054407,0.91664994,0.0003820815,0.0014787348,0.05981549],"study_design_scores_gemma":[0.0012008146,0.01626677,0.06435429,0.00008249509,0.0004611355,0.0066017513,0.0001411783,0.0027383207,0.8744721,0.00015576932,0.03349456,0.000030704112],"about_ca_topic_score_codex":0.0014753221,"about_ca_topic_score_gemma":0.0044777035,"teacher_disagreement_score":0.0014753221,"about_ca_system_score_codex":0.00057545054,"about_ca_system_score_gemma":0.0003664098,"threshold_uncertainty_score":0.004429817},"labels":[],"label_agreement":null},{"id":"W4389392859","doi":"10.3389/fonc.2023.1191920","title":"Real-world predictors of survival in patients with limited-stage small-cell lung cancer in Manitoba, Canada","year":2023,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; AstraZeneca (Canada); University of Manitoba; CancerCare Manitoba","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Medicine; Cohort; Internal medicine; Proportional hazards model; Radiation therapy; Lung cancer; Retrospective cohort study; Cancer registry; Stage (stratigraphy); Survival analysis; Cancer; Oncology; Chemotherapy; Performance status; Hazard ratio; Surgery; Confidence interval","score_opus":0.018975249284334448,"score_gpt":0.30184871221770915,"score_spread":0.2828734629333747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389392859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925444,0.0007100226,0.000083929335,0.0004424934,0.000015056888,0.00004949041,0.0051883166,0.0000088251645,0.0009575561],"genre_scores_gemma":[0.99669397,0.0004340284,0.00013749835,0.00011772461,0.0000085169295,0.000026905382,0.0021241114,0.0000035171859,0.00045363014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956566,0.000045810426,0.00004106138,0.000078821875,0.000105412575,0.00016310884],"domain_scores_gemma":[0.9977368,0.00012554848,0.0004737825,0.00007838326,0.0009676202,0.0006179925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049876235,0.00033644194,0.00030647032,0.0011809837,0.0020096898,0.0010321175,0.0011313909,0.00037240278,0.0013994997],"category_scores_gemma":[0.0016404752,0.00029382407,0.00037026076,0.0035059364,0.0006228829,0.00028857647,0.00080715475,0.00062159565,0.00021100414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028650315,0.000010918837,0.99857163,0.000013050302,0.000015276144,0.0000501297,0.00015533509,0.0000590835,0.000059504662,0.00001910365,0.0003982299,0.000619049],"study_design_scores_gemma":[0.0000074974514,0.000020815807,0.9978116,0.000028474366,0.000021486201,0.00007667548,0.0009699449,0.000232877,0.000037127164,0.000016395767,0.00077011855,0.000007102297],"about_ca_topic_score_codex":0.98750997,"about_ca_topic_score_gemma":0.9939633,"teacher_disagreement_score":0.020785624,"about_ca_system_score_codex":0.020785624,"about_ca_system_score_gemma":0.025560426,"threshold_uncertainty_score":0.15081096},"labels":[],"label_agreement":null},{"id":"W4389480655","doi":"10.1016/j.iotech.2023.100692","title":"LBA2 First-line (1L) durvalumab (D) + platinum-etoposide (EP) for patients (pts) with extensive-stage SCLC (ES-SCLC): Primary results from the phase IIIb LUMINANCE study","year":2023,"lang":"en","type":"article","venue":"Immuno-Oncology Technology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Symphogen; Astellas Pharma; Gilead Sciences; Daiichi-Sankyo; Amgen; Pfizer; AstraZeneca; Daiichi Sankyo Europe; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Durvalumab; Internal medicine; Neutropenia; Gastroenterology; Etoposide; Cancer; Chemotherapy; Immunotherapy; Pembrolizumab","score_opus":0.032707548856386964,"score_gpt":0.3655740603058458,"score_spread":0.3328665114494589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389480655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98600477,0.005467269,0.0004981833,0.00036688216,0.000060973496,0.00062168797,0.0026734567,0.00014680291,0.0041600466],"genre_scores_gemma":[0.9900934,0.0016510417,0.0007990863,0.000477647,0.000044706358,0.000386032,0.004104325,0.000024724513,0.002419042],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99978644,0.000107546875,0.0000103083985,0.00002986164,0.000031666797,0.000034227367],"domain_scores_gemma":[0.9997826,0.000037592446,0.0000554829,0.000020972311,0.000015046196,0.00008828175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008755853,0.0002823187,0.000828456,0.00022599955,0.00015776402,0.0005847388,0.00040868644,0.00028082795,0.003050161],"category_scores_gemma":[0.0005554331,0.000165381,0.0005352491,0.00025161824,0.00021900541,0.00038919903,0.0001855862,0.0009520729,0.0006350526],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3677121,0.017023016,0.05628551,0.0017673749,0.0021138107,0.00037822805,0.00027212247,0.005351107,0.046966888,0.0005971396,0.02348013,0.47805265],"study_design_scores_gemma":[0.34006643,0.39046597,0.20076777,0.00030132695,0.002802701,0.0019763105,0.00028399768,0.00888904,0.018533528,0.00080294133,0.03502852,0.00008148329],"about_ca_topic_score_codex":0.0011949508,"about_ca_topic_score_gemma":0.0058443397,"teacher_disagreement_score":0.003050161,"about_ca_system_score_codex":0.0007893299,"about_ca_system_score_gemma":0.00065694575,"threshold_uncertainty_score":0.010203779},"labels":[],"label_agreement":null},{"id":"W4389789420","doi":"10.1016/j.ijrobp.2023.12.011","title":"CRISPR Screen of Druggable Targets in Small Cell Lung Cancer Identified ATM Inhibitor (AZD1390) as a Radiosensitizer","year":2023,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Radiosensitizer; Radiosensitivity; Clonogenic assay; Cancer research; Radioresistance; Viability assay; DNA damage; Biology; Cell culture; Medicine; Radiation therapy; Internal medicine; Genetics; DNA","score_opus":0.02469730288463872,"score_gpt":0.38191726990410485,"score_spread":0.3572199670194661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389789420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9520095,0.004118827,0.024717435,0.00054866914,0.00025218507,0.00022989803,0.0045139156,0.0018127894,0.011796745],"genre_scores_gemma":[0.97170436,0.001425105,0.0133965,0.00018216917,0.0000112869975,0.000080344274,0.0024666996,0.000122025675,0.010611637],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997725,0.00001403398,0.000016052778,0.00006586196,0.00010209787,0.000029424662],"domain_scores_gemma":[0.99993324,0.00002287524,0.000015720558,0.000007606483,0.0000090553385,0.000011526079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013746103,0.00042394252,0.00054042996,0.00031946175,0.0002713962,0.0004173701,0.0004129725,0.0005493297,0.0028640274],"category_scores_gemma":[0.00017669982,0.00020374688,0.00039681286,0.00023509053,0.00018488786,0.00013908566,0.00024421277,0.00066666416,0.0007348137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000464907,0.00002528427,0.00015186021,0.000047580445,0.0000103219445,0.00013610377,0.00000607741,0.00019068675,0.99671245,0.00012692329,0.00015859587,0.0023876536],"study_design_scores_gemma":[0.000015090881,0.00016926236,0.0014153931,0.0000044533663,0.000041047642,0.00030394905,0.000011021272,0.0015152048,0.990836,0.000042718468,0.005638064,0.000007739082],"about_ca_topic_score_codex":0.001216472,"about_ca_topic_score_gemma":0.002498094,"teacher_disagreement_score":0.0028640274,"about_ca_system_score_codex":0.0003828576,"about_ca_system_score_gemma":0.00027074877,"threshold_uncertainty_score":0.009581149},"labels":[],"label_agreement":null},{"id":"W4389839591","doi":"10.1016/j.jtocrr.2023.100623","title":"Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Genentech; National Institutes of Health; Mirati Therapeutics; Regeneron Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Eli Lilly and Company; AstraZeneca; Damon Runyon Cancer Research Foundation; LUNGevity Foundation; Computer Modelling Group; Amgen; Cancer Prevention and Research Institute of Texas; University of Texas MD Anderson Cancer Center; V Foundation for Cancer Research","keywords":"Profiling (computer programming); Mutant; Transformation (genetics); Cancer research; Oncology; Computational biology; Medicine; Biology; Computer science; Gene; Genetics","score_opus":0.1404393992648889,"score_gpt":0.44822864770405335,"score_spread":0.30778924843916444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389839591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86282855,0.03993579,0.010434925,0.015286804,0.005645889,0.0005426205,0.04452401,0.0016140563,0.019187236],"genre_scores_gemma":[0.93505317,0.014414433,0.0052523552,0.0027123427,0.005239313,0.00017324499,0.026700886,0.000182355,0.0102719385],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9997116,0.00004059659,0.000032560383,0.00008560564,0.000078295045,0.00005139947],"domain_scores_gemma":[0.99919397,0.00013126527,0.00014832348,0.00005996784,0.00023016539,0.00023643258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005148199,0.0003288334,0.00035005095,0.000801225,0.00034754522,0.00096092623,0.0002629867,0.000571123,0.0050238855],"category_scores_gemma":[0.00082209765,0.00015140069,0.00022390939,0.0006670627,0.00018723939,0.00033091815,0.0004111238,0.0004368428,0.002022983],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022027267,0.00027014612,0.37340122,0.0012248531,0.00029379086,0.016803125,0.00046640815,0.00059537095,0.11245069,0.00076731964,0.23172843,0.25979587],"study_design_scores_gemma":[0.00011422413,0.0012532601,0.6390106,0.00021272029,0.00036648018,0.05889466,0.00077864487,0.0012409671,0.031091556,0.0008937771,0.26604682,0.000096225354],"about_ca_topic_score_codex":0.00045314792,"about_ca_topic_score_gemma":0.00093259773,"teacher_disagreement_score":0.0050238855,"about_ca_system_score_codex":0.00033998306,"about_ca_system_score_gemma":0.00048215338,"threshold_uncertainty_score":0.016806602},"labels":[],"label_agreement":null},{"id":"W4390521315","doi":"10.1016/j.eclinm.2023.102396","title":"Re-examining prophylactic cranial irradiation in small cell lung cancer: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"EClinicalMedicine","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Canada Research Chairs; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Meta-analysis; Prophylactic cranial irradiation; Lung cancer; Pooled analysis; Pathology; Internal medicine","score_opus":0.24139725108261756,"score_gpt":0.5048452527919505,"score_spread":0.2634480017093329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390521315","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002876309,0.99503374,0.0005634878,0.00025097915,0.0002004418,0.00026519553,0.00052439264,0.000027697937,0.00025779835],"genre_scores_gemma":[0.1984109,0.7926032,0.003189422,0.0018221163,0.00042788955,0.0018032604,0.0012243089,0.00006418854,0.000454645],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98333734,0.008890475,0.0042742277,0.0014592785,0.0015139065,0.00052474684],"domain_scores_gemma":[0.97132504,0.021841517,0.0034798384,0.0011035041,0.0019767445,0.00027322705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024729652,0.003069567,0.02218488,0.0069196606,0.0006736549,0.0042359717,0.0024769125,0.002610263,0.004081265],"category_scores_gemma":[0.053717405,0.0018100052,0.053345244,0.0076850173,0.0008750782,0.002330068,0.0016825789,0.0024224322,0.00041867114],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011801205,0.000015418285,0.0028943373,0.3379447,0.6490494,0.000087026165,0.00006515796,0.00048216115,0.00014322816,0.0001249873,0.0005851929,0.007428281],"study_design_scores_gemma":[0.00043410144,0.00011727716,0.0024203425,0.027533237,0.9676508,0.000057095465,0.000034774308,0.00013611319,0.000067835535,0.00018991374,0.0013406884,0.000017939434],"about_ca_topic_score_codex":0.011529258,"about_ca_topic_score_gemma":0.025597656,"teacher_disagreement_score":0.024729652,"about_ca_system_score_codex":0.0038215145,"about_ca_system_score_gemma":0.005471246,"threshold_uncertainty_score":0.13078445},"labels":[],"label_agreement":null},{"id":"W4390757470","doi":"10.1158/1538-7445.dnarepair24-ia003","title":"Abstract IA003: Molecular and imaging biomarkers of PARP inhibitors for small cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lung cancer; Medicine; Context (archaeology); PARP inhibitor; Cancer; Cancer research; Liquid biopsy; Positron emission tomography; Biomarker; Oncology; Poly ADP ribose polymerase; Bioinformatics; Pathology; Internal medicine; Nuclear medicine; DNA; Biology; Genetics","score_opus":0.04924374847328876,"score_gpt":0.4434771862253096,"score_spread":0.39423343775202085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390757470","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08236216,0.5149429,0.030270945,0.06967707,0.015451943,0.0016733912,0.017241413,0.0059466413,0.26243353],"genre_scores_gemma":[0.39334598,0.21895693,0.041215733,0.020718249,0.010050572,0.0014037539,0.02569981,0.0006172604,0.2879917],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99971753,0.000087514636,0.000015895128,0.000026859647,0.00012277398,0.000029461542],"domain_scores_gemma":[0.99975127,0.00006344553,0.00003889151,0.000009282928,0.00007574897,0.000061387516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008402862,0.0007452839,0.0004304701,0.0013821286,0.00023077345,0.0017173928,0.00051867904,0.0012933488,0.015618997],"category_scores_gemma":[0.0011943068,0.00018470407,0.00035020916,0.0007605307,0.0002080814,0.0005843193,0.00044259927,0.0011197872,0.007247659],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019266298,0.0002590746,0.00790298,0.0020352383,0.000106525156,0.0010723362,0.00006974827,0.0005277833,0.06659763,0.0060831006,0.40512103,0.508298],"study_design_scores_gemma":[0.00041569636,0.0029793074,0.043517802,0.0009600904,0.00026554288,0.0077146282,0.00015360824,0.002401078,0.07805696,0.0057224603,0.857688,0.00012495005],"about_ca_topic_score_codex":0.00067365577,"about_ca_topic_score_gemma":0.0009515066,"teacher_disagreement_score":0.015618997,"about_ca_system_score_codex":0.0010577887,"about_ca_system_score_gemma":0.0006740987,"threshold_uncertainty_score":0.052250803},"labels":[],"label_agreement":null},{"id":"W4390978892","doi":"10.1080/1120009x.2024.2302736","title":"Review of real-world experience with lurbinectedin in relapsed/refractory small cell lung cancer","year":2024,"lang":"en","type":"review","venue":"Journal of Chemotherapy","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"American Society of Hematology","keywords":"Food and drug administration; Medicine; Refractory (planetary science); Clinical trial; Lung cancer; Drug approval; Intensive care medicine; Family medicine; Drug; Oncology; Internal medicine; Medical emergency; Pharmacology","score_opus":0.04827015999822119,"score_gpt":0.42860374637497983,"score_spread":0.3803335863767586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390978892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014250171,0.9994154,0.000028922774,0.00009559515,0.000050446062,0.000010113054,0.000034376793,0.000001946991,0.0002206916],"genre_scores_gemma":[0.0013678769,0.9982552,0.000094531446,0.00014703501,0.000037695867,0.000012255049,0.000034894314,0.0000013307356,0.00004917875],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99876106,0.00039484733,0.0004635096,0.00011684807,0.00023025223,0.000033433724],"domain_scores_gemma":[0.99557906,0.0032604975,0.00056414783,0.00007837966,0.0004449664,0.000073011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025328444,0.000692479,0.0026912317,0.0037319488,0.00027686416,0.0011326936,0.0011849197,0.00075142557,0.0037036475],"category_scores_gemma":[0.0076673105,0.00035325435,0.0015714242,0.005011435,0.00045337997,0.0011011275,0.0006436485,0.00074231194,0.00052418426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025770548,0.000041031,0.0004035754,0.4689871,0.001791306,0.000311101,0.00025990757,0.0002526132,0.00069306936,0.0008526582,0.01457497,0.511575],"study_design_scores_gemma":[0.00019326457,0.0005422152,0.005271098,0.43680692,0.01439811,0.0037920664,0.0004587525,0.0001256817,0.0007347811,0.0010409949,0.53656226,0.00007388081],"about_ca_topic_score_codex":0.0016739699,"about_ca_topic_score_gemma":0.0043678405,"teacher_disagreement_score":0.0037319488,"about_ca_system_score_codex":0.00075290963,"about_ca_system_score_gemma":0.0022110296,"threshold_uncertainty_score":0.013395071},"labels":[],"label_agreement":null},{"id":"W4391041972","doi":"10.14740/wjon1765","title":"Treatment Patterns and Survival Outcomes in Patients With Stage T1-2N0M0 Small Cell Lung Cancer Undergoing Surgery: A Retrospective Cohort Study","year":2024,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Hazard ratio; Surgery; Chemoradiotherapy; Radiation therapy; Chemotherapy; Retrospective cohort study; Confidence interval; Proportional hazards model; Stage (stratigraphy); Internal medicine","score_opus":0.024039291431935863,"score_gpt":0.35889634482448024,"score_spread":0.3348570533925444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391041972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999231,0.00016915292,0.000055903893,0.000012884506,0.0000028716556,0.000009818847,0.00036632086,0.000001381658,0.00015067932],"genre_scores_gemma":[0.99916387,0.000103446335,0.000058860605,0.000015675734,0.0000059414624,0.000012253812,0.00058612815,0.0000014869076,0.0000524288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994678,0.00010347533,0.00008056108,0.00015014435,0.000101746045,0.00009627161],"domain_scores_gemma":[0.99884963,0.00015819754,0.00059565005,0.000106878695,0.00010981415,0.000179873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006943379,0.00025343435,0.00041573428,0.00087771413,0.00045789193,0.00057404133,0.00032617975,0.00037513894,0.0009055634],"category_scores_gemma":[0.0013937273,0.00029328305,0.00063047954,0.0012893806,0.0002384478,0.0005570477,0.00039413595,0.00046398918,0.0002102821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005379478,0.00001276978,0.9994849,0.0000030872586,0.000022563174,0.000048821865,0.000024539813,0.000012855889,0.000060881834,0.0000033577328,0.000019877192,0.00025246755],"study_design_scores_gemma":[0.00000754058,0.0001474416,0.99876714,0.0000046890414,0.000043507076,0.00054096815,0.0001826081,0.0001011402,0.000043247703,0.000010479497,0.00014748225,0.0000036725748],"about_ca_topic_score_codex":0.004470137,"about_ca_topic_score_gemma":0.0061501525,"teacher_disagreement_score":0.004470137,"about_ca_system_score_codex":0.00033818264,"about_ca_system_score_gemma":0.00046857767,"threshold_uncertainty_score":0.008888245},"labels":[],"label_agreement":null},{"id":"W4391219445","doi":"10.1016/j.ccell.2024.01.001","title":"Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes","year":2024,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Horizon 2020; Daiichi Sankyo Europe; National Cancer Institute; HORIZON EUROPE Framework Programme; University of Texas MD Anderson Cancer Center; EMD Serono; Foundation Medicine; Sierra Oncology; Sociedad Española de Oncología Médica; Birla Institute of Scientific Research; PharmaMar; European Society for Medical Oncology; Rexanna's Foundation; BeiGene; Mirati Therapeutics; Pfizer; Innovent Biologics; Medical Research Council; Les Laboratories Pierre Fabre; Jazz Pharmaceuticals; Francis Crick Institute; National Institutes of Health; Regeneron Pharmaceuticals; Cancer Moonshot; Albert Einstein Cancer Center; Genentech; Cancer Prevention and Research Institute of Texas; Moonshot Research and Development Program; Sanofi; GlaxoSmithKline; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Wellcome Trust; Cancer Research UK; Spectrum Pharmaceuticals; Amgen; Agence Nationale de la Recherche; LUNGevity Foundation","keywords":"Subtyping; DNA methylation; Epigenetics; Biology; Lung cancer; Malignancy; Cancer research; Methylation; Oncology; Gene; Medicine; Gene expression; Genetics","score_opus":0.03025156051891841,"score_gpt":0.36322397436800746,"score_spread":0.33297241384908904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391219445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994642,0.00064102333,0.0030896252,0.00009985252,0.000009665009,0.000017489725,0.00071148144,0.000064705724,0.000723949],"genre_scores_gemma":[0.9971942,0.00011401624,0.0016161955,0.000039762668,0.000007268608,0.000011741656,0.0006311614,0.000009653026,0.00037602978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973494,0.00005145531,0.000022244216,0.000100076206,0.00005790039,0.000033338427],"domain_scores_gemma":[0.9995815,0.00015255566,0.00007927877,0.00005439047,0.00007754523,0.000054744545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044521884,0.00017881181,0.000370563,0.00059753435,0.00019939327,0.0005439728,0.0001966008,0.00045249745,0.001154015],"category_scores_gemma":[0.001816549,0.00011489283,0.00017608222,0.00032112838,0.00019045419,0.00023214259,0.00022200195,0.00040855026,0.00025184482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013033777,0.0000989207,0.7027807,0.00009560004,0.00013577232,0.00015786165,0.000280772,0.0018592058,0.2351981,0.00033289724,0.00069116254,0.057065688],"study_design_scores_gemma":[0.00005048738,0.0006556694,0.868113,0.00003590184,0.00016820895,0.001193328,0.00031974775,0.023638872,0.101736374,0.00097173173,0.0030839841,0.000032583364],"about_ca_topic_score_codex":0.003380323,"about_ca_topic_score_gemma":0.006057728,"teacher_disagreement_score":0.003380323,"about_ca_system_score_codex":0.00033869548,"about_ca_system_score_gemma":0.0002734019,"threshold_uncertainty_score":0.006721318},"labels":[],"label_agreement":null},{"id":"W4392282412","doi":"10.1101/2024.02.28.582577","title":"A Lung Cancer Mouse Model Database","year":2024,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"University of Texas Southwestern Medical Center","keywords":"Lung cancer; Database; Computer science; Medicine; Internal medicine","score_opus":0.02869371616307937,"score_gpt":0.320126543131461,"score_spread":0.29143282696838163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392282412","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008146027,0.0010967209,0.023262642,0.00032571403,0.00013802409,0.00037799237,0.95090747,0.011408048,0.0043373965],"genre_scores_gemma":[0.0050003002,0.00047737733,0.011623873,0.00017121351,0.000015191006,0.0006373711,0.979996,0.00081502035,0.001263661],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984909,0.00022535825,0.00029859875,0.00032713875,0.00054884685,0.00010912703],"domain_scores_gemma":[0.99797696,0.00048937585,0.00020625813,0.00072642823,0.00034661326,0.00025436663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00237514,0.0016209678,0.0015646107,0.0046176813,0.0007409221,0.0015980835,0.002828465,0.0017006692,0.018034635],"category_scores_gemma":[0.0027176505,0.00083992153,0.0012631923,0.0035240145,0.00037781056,0.0010106373,0.0019028654,0.0019388305,0.014513234],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028520776,0.00086199114,0.015523722,0.0040122913,0.00095217826,0.00144088,0.00023481625,0.008956206,0.095262244,0.011799823,0.7814034,0.076700315],"study_design_scores_gemma":[0.00081854215,0.00048182707,0.01500677,0.00035722507,0.0005267696,0.0020154973,0.00008543268,0.009187783,0.029307237,0.010477954,0.9315798,0.00015517882],"about_ca_topic_score_codex":0.0025025369,"about_ca_topic_score_gemma":0.0048920326,"teacher_disagreement_score":0.018034635,"about_ca_system_score_codex":0.00076183164,"about_ca_system_score_gemma":0.0017354656,"threshold_uncertainty_score":0.06033188},"labels":[],"label_agreement":null},{"id":"W4392987004","doi":"10.3390/curroncol31030122","title":"Population Survival Kinetics Derived from Clinical Trials of Potentially Curable Lung Cancers","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Adjuvant; Oncology; Internal medicine; Lung cancer; Population; Chemoradiotherapy; Chemotherapy; Osimertinib; Cancer; Adenocarcinoma","score_opus":0.38898023172426777,"score_gpt":0.5979591709863932,"score_spread":0.2089789392621254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392987004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67978054,0.008983925,0.26162773,0.00085182,0.00017455182,0.0066449544,0.022279218,0.0018716651,0.01778554],"genre_scores_gemma":[0.93343896,0.001521269,0.0312812,0.0005299711,0.00007724102,0.009210769,0.020180285,0.00026064145,0.0034995663],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9787676,0.014727206,0.0014439443,0.0017692985,0.0027767452,0.0005152356],"domain_scores_gemma":[0.8588575,0.109043874,0.013895742,0.011328672,0.0059779487,0.00089622504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.053774215,0.0010674665,0.002008707,0.0028166668,0.00030052525,0.0016509583,0.00091840356,0.00095190917,0.004645024],"category_scores_gemma":[0.122702576,0.0005952646,0.002549583,0.0019331689,0.0008468162,0.0020464726,0.0013733016,0.0024387026,0.0009576027],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024601864,0.00079496345,0.21929851,0.005477778,0.009580895,0.00061902724,0.003300561,0.33577502,0.021162678,0.046165768,0.011495221,0.32172778],"study_design_scores_gemma":[0.003291827,0.020136626,0.3120823,0.0011622852,0.0050649354,0.0020252343,0.0007343252,0.47737798,0.034544613,0.08373901,0.05924228,0.0005986173],"about_ca_topic_score_codex":0.0007978426,"about_ca_topic_score_gemma":0.0006542921,"teacher_disagreement_score":0.053774215,"about_ca_system_score_codex":0.0016819262,"about_ca_system_score_gemma":0.0012128697,"threshold_uncertainty_score":0.28438866},"labels":[],"label_agreement":null},{"id":"W4393089268","doi":"10.1158/1538-7445.am2024-7335","title":"Abstract 7335: Characterizing germline variants in patients with small cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Toronto General Hospital; Western University","funders":"","keywords":"Germline; Cancer; Lung cancer; Medicine; Oncology; Internal medicine; Biology; Cancer research; Genetics; Gene","score_opus":0.06340972096898669,"score_gpt":0.4157031245460039,"score_spread":0.3522934035770172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393089268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978823,0.00021412292,0.00032585923,0.000026929292,0.0000056428885,0.000015295664,0.0009828457,0.000024725521,0.00052216864],"genre_scores_gemma":[0.9985349,0.000050035625,0.00034143453,0.00002655105,0.000007116195,0.00000838515,0.00089979696,0.000009761513,0.00012204109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968827,0.000025566362,0.000035662215,0.0001281201,0.00007241368,0.00005001318],"domain_scores_gemma":[0.999613,0.00012442494,0.00009866205,0.000025337156,0.00006481259,0.00007372897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027297085,0.00027719827,0.0002785048,0.0011495086,0.00040331026,0.0004654337,0.00030677931,0.0004381362,0.0025456715],"category_scores_gemma":[0.0011824202,0.00011114406,0.00022724955,0.0011109938,0.00022661581,0.00018160364,0.0003110998,0.00027225062,0.0004665402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018222783,0.000029003864,0.98274475,0.000027704835,0.000031030668,0.0019769112,0.0001097672,0.00016154656,0.008641915,0.00006302534,0.0004664238,0.005565679],"study_design_scores_gemma":[0.000019116844,0.00024734778,0.98556364,0.000012775082,0.000062913554,0.009207323,0.00016093522,0.00076034234,0.0024931617,0.00016359592,0.0012987563,0.000010097531],"about_ca_topic_score_codex":0.0030541108,"about_ca_topic_score_gemma":0.003173333,"teacher_disagreement_score":0.0030541108,"about_ca_system_score_codex":0.00025242032,"about_ca_system_score_gemma":0.00023297587,"threshold_uncertainty_score":0.008516192},"labels":[],"label_agreement":null},{"id":"W4393092556","doi":"10.1158/1538-7445.am2024-675","title":"Abstract 675: Targeting Bcl-2/Bcl-xl for small cell lung cancer treatment with LP-118","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lung cancer; Cancer; Cancer research; Oncology; Internal medicine","score_opus":0.10506868197426737,"score_gpt":0.47593163215635753,"score_spread":0.37086295018209015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98738885,0.0048180376,0.002492078,0.0003736155,0.00009663646,0.0002707999,0.00051561836,0.0002494074,0.0037948661],"genre_scores_gemma":[0.9922201,0.0019359301,0.0020520685,0.00013917894,0.000031442876,0.0001368792,0.00091237534,0.000015907146,0.0025560323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999379,0.00000978785,0.000005520977,0.0000070207716,0.000021567748,0.000018216922],"domain_scores_gemma":[0.9999629,0.0000047862904,0.0000069919342,0.0000028943905,0.0000070772144,0.000015337864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012346095,0.0002826985,0.00029091927,0.00034845638,0.0001266776,0.00026217083,0.00030804132,0.00029598025,0.0033142932],"category_scores_gemma":[0.00009074137,0.00007573254,0.00024119094,0.00022068861,0.00011963166,0.00024379542,0.00020113836,0.0006849099,0.00051309966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034491573,0.0021847307,0.0016417764,0.00060168514,0.00007159549,0.00033390167,0.000056151806,0.00077879283,0.8894244,0.0004511595,0.002765762,0.09824091],"study_design_scores_gemma":[0.0024369275,0.033681568,0.011643202,0.000075589574,0.00021143974,0.0015157933,0.00008073463,0.005368591,0.91950196,0.00026194542,0.02519528,0.000026897802],"about_ca_topic_score_codex":0.0004987224,"about_ca_topic_score_gemma":0.0009656533,"teacher_disagreement_score":0.0033142932,"about_ca_system_score_codex":0.00023519501,"about_ca_system_score_gemma":0.00035610338,"threshold_uncertainty_score":0.011087418},"labels":[],"label_agreement":null},{"id":"W4393092679","doi":"10.1158/1538-7445.am2024-6465","title":"Abstract 6465: A population-based analysis of brain metastasis burden and management in 8705 small cell lung cancer patients","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University; University of Toronto","funders":"","keywords":"Medicine; Brain metastasis; Lung cancer; Cancer; Metastasis; Oncology; Internal medicine; Population; Pathology; Environmental health","score_opus":0.06127359750672997,"score_gpt":0.44992459586566036,"score_spread":0.3886509983589304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971373,0.00016833711,0.000037688827,0.000037796992,0.0000024724682,0.000013928837,0.0021980228,0.0000035568987,0.00040097418],"genre_scores_gemma":[0.99820447,0.00007716548,0.00003262028,0.000025984964,0.0000045960146,0.000008376734,0.0015121329,0.0000014733914,0.00013301997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995567,0.000036939426,0.000042807107,0.00010436234,0.00014980671,0.00010935004],"domain_scores_gemma":[0.9990151,0.000055941833,0.00044799308,0.000057684712,0.00022860004,0.00019454985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003646806,0.000245424,0.0003387328,0.00089715555,0.0007585739,0.0007470445,0.0005199537,0.00033494114,0.0013089821],"category_scores_gemma":[0.0009782102,0.0002349122,0.00045963287,0.002498196,0.00031321845,0.00029184157,0.00039411738,0.00033447304,0.0002805529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033481927,0.0000060397238,0.99933136,0.000004308586,0.00002330306,0.000023663373,0.00003268795,0.000024021603,0.000048932798,0.000004782802,0.00013583801,0.00033178987],"study_design_scores_gemma":[0.0000037404611,0.000018341725,0.99955195,0.0000032417024,0.000012814751,0.000049583483,0.000111719346,0.000077089695,0.000011587745,0.0000034410205,0.00015449148,0.0000018498321],"about_ca_topic_score_codex":0.50322574,"about_ca_topic_score_gemma":0.5259274,"teacher_disagreement_score":0.50322574,"about_ca_system_score_codex":0.003424487,"about_ca_system_score_gemma":0.0030034534,"threshold_uncertainty_score":0.9993997},"labels":[],"label_agreement":null},{"id":"W4393096830","doi":"10.1158/1538-7445.am2024-6028","title":"Abstract 6028: Preferential tumor-to-normal tissue biodistribution and single-dose efficacy with ABD147, a DLL3-targeted engineered antibody-based radiotherapeutic, in preclinical small cell lung cancer models","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"iCo Therapeutics (Canada)","funders":"","keywords":"Biodistribution; Medicine; Cancer; Pathology; Radioimmunotherapy; Lung cancer; Cancer research; Antibody; Monoclonal antibody; Internal medicine; Biology; In vivo; Immunology","score_opus":0.10323605793788523,"score_gpt":0.4506887193218676,"score_spread":0.34745266138398234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336445,0.00083797646,0.0032259366,0.00011727216,0.000035154582,0.00011898621,0.000619899,0.0002038706,0.0014764577],"genre_scores_gemma":[0.9884821,0.0006129841,0.0034539185,0.00007817679,0.0000115133735,0.00015873637,0.0014432175,0.00011110547,0.0056482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997603,0.000034381508,0.000018964705,0.00005707756,0.00006475975,0.00006453785],"domain_scores_gemma":[0.9997969,0.000038408984,0.000046489895,0.000026311245,0.000037407157,0.00005443821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028592054,0.0004539274,0.0005177586,0.00038908533,0.00014010233,0.0003058929,0.00029632132,0.0005235835,0.0015442425],"category_scores_gemma":[0.00018629484,0.00018398937,0.00034592464,0.00017699474,0.00032283945,0.00028958268,0.00014451912,0.00081937475,0.0006787006],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063975854,0.0002422243,0.00015192394,0.00004092184,0.0000071710256,0.00004586387,0.000022133967,0.00020059566,0.99685884,0.000058363694,0.00013655843,0.0015956713],"study_design_scores_gemma":[0.00006611098,0.0029074007,0.0013290362,0.0000035658259,0.000015249207,0.00014443751,0.000013223229,0.001529259,0.99300873,0.000025504514,0.00095224776,0.0000053400136],"about_ca_topic_score_codex":0.00173865,"about_ca_topic_score_gemma":0.0011523119,"teacher_disagreement_score":0.00173865,"about_ca_system_score_codex":0.00046668164,"about_ca_system_score_gemma":0.0004283005,"threshold_uncertainty_score":0.005165994},"labels":[],"label_agreement":null},{"id":"W4393465895","doi":"10.5281/zenodo.7235988","title":"Processed counts data of cfMeDIP-seq profiles of small cell lung cancer patients","year":2022,"lang":"en","type":"dataset","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Lung cancer; RNA-Seq; Computational biology; Biology; Medicine; Oncology; Transcriptome; Genetics; Gene","score_opus":0.053081263262401486,"score_gpt":0.31797597246758064,"score_spread":0.26489470920517916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393465895","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014178694,0.00018001543,0.00031982054,0.000066015506,0.000043721393,0.000022801818,0.9966174,0.000761535,0.00057087134],"genre_scores_gemma":[0.0011731043,0.000045602115,0.00047158997,0.000056462577,0.000004748447,0.00004666324,0.9977399,0.000057471036,0.0004044196],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905294,0.00012425754,0.000089580986,0.00042453766,0.0001818927,0.00012689357],"domain_scores_gemma":[0.9990778,0.00025532272,0.00008508148,0.00026980526,0.00022845331,0.000083532286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009703019,0.0020289007,0.0013822595,0.001567023,0.00073644053,0.0016176199,0.0019390769,0.0018101447,0.024496648],"category_scores_gemma":[0.0027805774,0.0006000149,0.0014083118,0.0022625874,0.00042805276,0.0005041259,0.0011297206,0.0014323832,0.034696918],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008763517,0.00013461942,0.0074484427,0.0017752599,0.00026944987,0.00017398533,0.0000755986,0.0018921923,0.0057623917,0.0006847902,0.96824425,0.012662654],"study_design_scores_gemma":[0.0009211514,0.00018250603,0.03207539,0.00038869676,0.00026301175,0.0008413391,0.00016474388,0.0032370428,0.008959092,0.0020340865,0.9508204,0.000112578186],"about_ca_topic_score_codex":0.014181975,"about_ca_topic_score_gemma":0.024679242,"teacher_disagreement_score":0.024496648,"about_ca_system_score_codex":0.0011691483,"about_ca_system_score_gemma":0.0017352526,"threshold_uncertainty_score":0.08194941},"labels":[],"label_agreement":null},{"id":"W4393538845","doi":"10.5281/zenodo.8286762","title":"Processed counts data of cfMeDIP-seq profiles of small cell lung cancer patients","year":2022,"lang":"en","type":"dataset","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Lung cancer; Computational biology; Medicine; Oncology; Biology","score_opus":0.053081263262401486,"score_gpt":0.31797597246758064,"score_spread":0.26489470920517916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393538845","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014178694,0.00018001543,0.00031982054,0.000066015506,0.000043721393,0.000022801818,0.9966174,0.000761535,0.00057087134],"genre_scores_gemma":[0.0011731043,0.000045602115,0.00047158997,0.000056462577,0.000004748447,0.00004666324,0.9977399,0.000057471036,0.0004044196],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905294,0.00012425754,0.000089580986,0.00042453766,0.0001818927,0.00012689357],"domain_scores_gemma":[0.9990778,0.00025532272,0.00008508148,0.00026980526,0.00022845331,0.000083532286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009703019,0.0020289007,0.0013822595,0.001567023,0.00073644053,0.0016176199,0.0019390769,0.0018101447,0.024496648],"category_scores_gemma":[0.0027805774,0.0006000149,0.0014083118,0.0022625874,0.00042805276,0.0005041259,0.0011297206,0.0014323832,0.034696918],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008763517,0.00013461942,0.0074484427,0.0017752599,0.00026944987,0.00017398533,0.0000755986,0.0018921923,0.0057623917,0.0006847902,0.96824425,0.012662654],"study_design_scores_gemma":[0.0009211514,0.00018250603,0.03207539,0.00038869676,0.00026301175,0.0008413391,0.00016474388,0.0032370428,0.008959092,0.0020340865,0.9508204,0.000112578186],"about_ca_topic_score_codex":0.014181975,"about_ca_topic_score_gemma":0.024679242,"teacher_disagreement_score":0.024496648,"about_ca_system_score_codex":0.0011691483,"about_ca_system_score_gemma":0.0017352526,"threshold_uncertainty_score":0.08194941},"labels":[],"label_agreement":null},{"id":"W4393931655","doi":"10.1002/mp.16993","title":"In reply to Masjedi et al","year":2024,"lang":"en","type":"editorial","venue":"Medical Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; Kelowna General Hospital; University of British Columbia","funders":"","keywords":"Philosophy","score_opus":0.019733729945420247,"score_gpt":0.4170086054486865,"score_spread":0.39727487550326623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393931655","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016636962,0.003427266,0.00016861912,0.833552,0.16184874,0.000017002243,0.00008307623,0.00008443915,0.000652498],"genre_scores_gemma":[0.0011642232,0.0023042576,0.00020586685,0.89749974,0.09547071,0.000047646754,0.000045609726,0.000042229753,0.0032197512],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99431324,0.0012926176,0.00076995126,0.0010836453,0.0019049618,0.00063562434],"domain_scores_gemma":[0.9826124,0.007670672,0.0014642281,0.00061502174,0.005741686,0.001896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065368526,0.0016504201,0.0021323438,0.0015561687,0.0031773187,0.0051283105,0.004725735,0.036956225,0.008316246],"category_scores_gemma":[0.05745749,0.0011465056,0.0016666141,0.001349298,0.0043424666,0.008419368,0.0032175025,0.054927237,0.0108821895],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017475235,0.000010265816,0.00013387496,0.00008363862,0.00000908653,0.00037557527,0.00008192239,0.00001790262,0.00003960598,0.00040553833,0.9957172,0.0031079443],"study_design_scores_gemma":[0.00003592524,0.000031393956,0.00043109778,0.00040107153,0.000024269273,0.0019759391,0.0004443422,0.000120042605,0.0002276512,0.0019229423,0.9943165,0.00006885536],"about_ca_topic_score_codex":0.0032296237,"about_ca_topic_score_gemma":0.003585672,"teacher_disagreement_score":0.036956225,"about_ca_system_score_codex":0.0038935852,"about_ca_system_score_gemma":0.0048669484,"threshold_uncertainty_score":0.034570634},"labels":[],"label_agreement":null},{"id":"W4393988374","doi":"10.1158/1538-7445.am2024-ct256","title":"Abstract CT256: Results from KEYNOTE-B98: A phase 1b/2 study of pembrolizumab plus investigational agents in patients with anti-PD-(L)1-refractory extensive-stage small-cell lung cancer (ES-SCLC)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Refractory (planetary science); Medicine; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Investigational Drugs; Phases of clinical research; Lung cancer; Chemotherapy; Clinical trial; Immunotherapy; Biology","score_opus":0.12428141881778623,"score_gpt":0.44922300988849573,"score_spread":0.3249415910707095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97779,0.0027290871,0.0006299145,0.0010532612,0.00024207294,0.005963027,0.007228076,0.00019145309,0.0041730334],"genre_scores_gemma":[0.96993065,0.0023867525,0.002400087,0.0016880925,0.00037107978,0.0049019405,0.01229277,0.00007120404,0.005957485],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994287,0.00030126065,0.0000457934,0.00008802531,0.000045214507,0.00009093185],"domain_scores_gemma":[0.9988267,0.0002085272,0.00022082299,0.00010176139,0.00008648559,0.00055564573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022958368,0.002269041,0.0022048107,0.000449628,0.0005966224,0.0010494591,0.0013404493,0.002088331,0.011877378],"category_scores_gemma":[0.001589247,0.0006790112,0.0016449922,0.00053728203,0.0011426286,0.001231614,0.0005339775,0.0043627196,0.002476174],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9019904,0.042422526,0.0023950082,0.000765905,0.0010240162,0.00019345664,0.00009386659,0.0008682106,0.021448322,0.00012695028,0.0043602926,0.024311103],"study_design_scores_gemma":[0.7692641,0.22054903,0.0054457504,0.000045221226,0.00061643,0.00018255919,0.000031512292,0.000318834,0.0018444736,0.00010946028,0.0015709666,0.000021666325],"about_ca_topic_score_codex":0.0010905707,"about_ca_topic_score_gemma":0.0030587513,"teacher_disagreement_score":0.011877378,"about_ca_system_score_codex":0.0010939055,"about_ca_system_score_gemma":0.0023400164,"threshold_uncertainty_score":0.039733827},"labels":[],"label_agreement":null},{"id":"W4393988846","doi":"10.1158/1538-7445.am2024-ct253","title":"Abstract CT253: Results from KEYNOTE-B99: Phase 2 study of first-line (1L) pembrolizumab (pembro) plus investigational agents and chemotherapy (chemo) for extensive-stage small-cell lung cancer (ES-SCLC)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Pembrolizumab; Medicine; Investigational Drugs; Chemotherapy; Cancer; Oncology; Stage (stratigraphy); Lung cancer; Internal medicine; Clinical trial; Immunotherapy; Biology","score_opus":0.16508682338391562,"score_gpt":0.4784425243929593,"score_spread":0.3133557010090437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649242,0.004835955,0.0008453675,0.0010184989,0.00026126573,0.0063298224,0.014889398,0.00028654883,0.0066088727],"genre_scores_gemma":[0.9560478,0.0028598343,0.002216921,0.0018820183,0.00030322716,0.0053517316,0.023811013,0.00008266149,0.007444698],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999482,0.00024996995,0.000033081466,0.000086526976,0.000048164384,0.00010029468],"domain_scores_gemma":[0.99910295,0.00012379418,0.0001466807,0.000072307186,0.000055334098,0.00049884105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019491025,0.002071027,0.0020635044,0.00048701104,0.00065167923,0.0011885546,0.001607341,0.0019957712,0.0137311835],"category_scores_gemma":[0.0010777941,0.0006390364,0.0015241345,0.00066823344,0.0010161782,0.00115184,0.00056029245,0.004083,0.0024830727],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8911004,0.034289725,0.003047185,0.0010462883,0.0012503123,0.00027059,0.000099588,0.0012710172,0.030586112,0.00018466456,0.008449389,0.028404688],"study_design_scores_gemma":[0.7576853,0.22425365,0.009704796,0.00007040977,0.00087687303,0.00028879923,0.000038959017,0.00046926882,0.0032226534,0.00016174035,0.0031915514,0.00003612279],"about_ca_topic_score_codex":0.0013749289,"about_ca_topic_score_gemma":0.004163005,"teacher_disagreement_score":0.0137311835,"about_ca_system_score_codex":0.0012230193,"about_ca_system_score_gemma":0.0026030156,"threshold_uncertainty_score":0.045935392},"labels":[],"label_agreement":null},{"id":"W4394878299","doi":"10.1016/j.lungcan.2024.107733","title":"172 Stage and Survival of Screen Detected Small Cell Lung Cancer from the SUMMIT Study","year":2024,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Summit; Medicine; Stage (stratigraphy); Lung cancer; Oncology; Internal medicine; Cartography","score_opus":0.028990671029437663,"score_gpt":0.36243275310084566,"score_spread":0.333442082071408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394878299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928202,0.001277207,0.000047123227,0.00027433824,0.000036536625,0.000009412394,0.0043864218,0.0000050515623,0.0011436184],"genre_scores_gemma":[0.99467766,0.00031217994,0.000022782197,0.00008281298,0.000048772792,0.000016286236,0.0038067263,0.0000052716177,0.0010275138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993981,0.0002164356,0.000049358037,0.00009864,0.00009034518,0.00014718511],"domain_scores_gemma":[0.9983026,0.00037031804,0.00043018733,0.00020548246,0.0002929133,0.00039849197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012837803,0.0004354014,0.0005506171,0.00091318216,0.0006372875,0.000931048,0.0006658476,0.00072132493,0.0025320915],"category_scores_gemma":[0.0032766543,0.00033675515,0.0010754822,0.00142204,0.00027767415,0.0007100327,0.0007092269,0.000875758,0.0003901545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022316773,0.00008348896,0.9929721,0.00004097349,0.00040753407,0.00016485836,0.00017262877,0.00006782616,0.00043803197,0.00007390317,0.0016202264,0.0017268822],"study_design_scores_gemma":[0.000065535365,0.000116528754,0.9986493,0.000010346482,0.0002340575,0.00005778139,0.00019023479,0.00006959372,0.000061510844,0.00002177437,0.0005164499,0.00000690768],"about_ca_topic_score_codex":0.06250679,"about_ca_topic_score_gemma":0.07763135,"teacher_disagreement_score":0.06250679,"about_ca_system_score_codex":0.00078075315,"about_ca_system_score_gemma":0.00084856903,"threshold_uncertainty_score":0.12428594},"labels":[],"label_agreement":null},{"id":"W4396769086","doi":"10.1016/j.lungcan.2024.107819","title":"Natural history of SCLC patients treated in third-line and beyond: A retrospective real world study","year":2024,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Amgen","keywords":"Medicine; Natural history; Retrospective cohort study; Real world evidence; Natural (archaeology); Internal medicine; Archaeology; History","score_opus":0.015157342278014005,"score_gpt":0.35070606231962614,"score_spread":0.3355487200416121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396769086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885917,0.00016747644,0.000096190604,0.000028649027,0.0000020141763,0.000013172741,0.00059547264,0.0000031970221,0.00023460398],"genre_scores_gemma":[0.99926275,0.00006536384,0.000056831075,0.000020615009,0.000004076787,0.000009954631,0.000547475,0.0000013233495,0.00003170667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993661,0.00017160198,0.00011295522,0.00016586772,0.000103206316,0.000080285536],"domain_scores_gemma":[0.99744797,0.00026645375,0.0017168382,0.00016572629,0.00017912553,0.00022390114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058617734,0.00014683523,0.00026837407,0.00073419634,0.00035827537,0.00060197443,0.0003155822,0.0003407422,0.0007545897],"category_scores_gemma":[0.002253144,0.00018727976,0.00035063692,0.0010237035,0.00029467267,0.0006855214,0.00041016232,0.00040556295,0.0001868734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034622786,0.000014730548,0.9994342,0.0000034242416,0.00001665658,0.000047161724,0.000030777643,0.00002489684,0.000054371772,0.00000551998,0.000031483094,0.00030214703],"study_design_scores_gemma":[0.000004732053,0.00010748341,0.9983935,0.000005854043,0.000014440312,0.00062731653,0.0002613044,0.0002467656,0.000073256575,0.000013246398,0.00024729967,0.0000047345043],"about_ca_topic_score_codex":0.0034363414,"about_ca_topic_score_gemma":0.0037404348,"teacher_disagreement_score":0.0034363414,"about_ca_system_score_codex":0.0004082939,"about_ca_system_score_gemma":0.0003374976,"threshold_uncertainty_score":0.0068326592},"labels":[],"label_agreement":null},{"id":"W4396817571","doi":"10.2139/ssrn.4819356","title":"Real World Outcomes of Prophylactic Cranial Irradiation Utilization and Efficacy for Patients with Extensive-Stage Small Cell Lung Cancer Treated with Consolidative Thoracic Radiotherapy","year":2024,"lang":"en","type":"preprint","venue":"SSRN Electronic Journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Prophylactic cranial irradiation; Radiation therapy; Stage (stratigraphy); Medicine; Lung cancer; Radiology; Oncology; Internal medicine; Biology","score_opus":0.022701520062784895,"score_gpt":0.3613556800085309,"score_spread":0.338654159945746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396817571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753726,0.000553744,0.000039076294,0.000097259835,0.000010394624,0.00000719779,0.0012703565,0.00000239005,0.000482486],"genre_scores_gemma":[0.9984396,0.000114181516,0.000023989618,0.000023314327,0.000010740082,0.0000069260427,0.0012850389,0.0000018551842,0.00009434472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926156,0.00028358758,0.00009318351,0.00011950802,0.00008560016,0.00015658373],"domain_scores_gemma":[0.9971783,0.0007626634,0.0013657804,0.00014597764,0.00020435377,0.00034301725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009611148,0.0002137151,0.0003407417,0.0005388714,0.00025488975,0.0010478811,0.0003370031,0.0005976506,0.0017273437],"category_scores_gemma":[0.0045970175,0.00013588155,0.0009405669,0.001136765,0.0004477034,0.0007616807,0.0005596581,0.00080648006,0.00024392168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039312616,0.00022308998,0.98859555,0.000049859154,0.00050112884,0.000087218774,0.00013867304,0.0008776639,0.00011200907,0.00008226157,0.0004984283,0.0049028196],"study_design_scores_gemma":[0.000084703825,0.0007839149,0.9976004,0.000015418167,0.00022998071,0.000120952885,0.00025651505,0.00032585944,0.0000723538,0.00008277876,0.0004111439,0.00001599984],"about_ca_topic_score_codex":0.0059417337,"about_ca_topic_score_gemma":0.005853819,"teacher_disagreement_score":0.0059417337,"about_ca_system_score_codex":0.0011027629,"about_ca_system_score_gemma":0.00049732724,"threshold_uncertainty_score":0.011814356},"labels":[],"label_agreement":null},{"id":"W4399280225","doi":"10.1200/jco.2024.42.16_suppl.e23266","title":"Real-world safety and healthcare resource utilization (HCRU) of lurbinectedin (lurbi) in patients (pts) with small cell lung cancer (SCLC): Jazz EMERGE 402 updated analysis.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Jazz Pharmaceuticals","keywords":"Medicine; Standard of care; Oncology; Lung cancer; Health care; Healthcare system; Internal medicine; Intensive care medicine","score_opus":0.10058853251565913,"score_gpt":0.4898858693503855,"score_spread":0.3892973368347264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399280225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74527514,0.016326353,0.0007998444,0.0010425403,0.0000648553,0.0007105346,0.23070753,0.00008129419,0.0049919887],"genre_scores_gemma":[0.84057295,0.0034569148,0.00080097216,0.000883106,0.000102762584,0.0006318615,0.15241104,0.000027784521,0.0011125761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737823,0.00070569164,0.00039143965,0.0003963956,0.0009418567,0.00018636495],"domain_scores_gemma":[0.9922053,0.0016957995,0.0040522353,0.00044758627,0.001167701,0.00043132956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041033886,0.0003693269,0.00082254934,0.001065727,0.0001767057,0.0009961193,0.00070340245,0.0004390987,0.0019255246],"category_scores_gemma":[0.0053542,0.00026591826,0.0018735959,0.003051474,0.00020854996,0.00054701924,0.0006521685,0.00082282844,0.0003487354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017473625,0.00027562934,0.9291192,0.0017567198,0.0070797196,0.00007101893,0.00006927645,0.0014711233,0.0006453192,0.00019986022,0.014735383,0.027103133],"study_design_scores_gemma":[0.0015134291,0.001000493,0.98570746,0.00017446712,0.0022611013,0.00013847405,0.000069941845,0.0009806933,0.00034015157,0.000071832605,0.007713676,0.000028312177],"about_ca_topic_score_codex":0.027676752,"about_ca_topic_score_gemma":0.052232865,"teacher_disagreement_score":0.027676752,"about_ca_system_score_codex":0.0017838827,"about_ca_system_score_gemma":0.0018526228,"threshold_uncertainty_score":0.0550313},"labels":[],"label_agreement":null},{"id":"W4399325908","doi":"10.1200/jco.2024.42.16_suppl.e15030","title":"Circulating tumor cells enumeration and characterization in patients with lung cancer treated with immunotherapy.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Cancer Care Ontario; Western University","funders":"Academic Medical Organization of Southwestern Ontario","keywords":"Medicine; Lung cancer; Immunotherapy; Enumeration; Cancer immunotherapy; Cancer research; Cancer; Tumor cells; Oncology; Internal medicine","score_opus":0.04006512856295487,"score_gpt":0.4478770831718037,"score_spread":0.40781195460884884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399325908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833775,0.0006010462,0.00037773393,0.000023322491,0.000009396504,0.000022748922,0.0002468488,0.000015908074,0.00036527892],"genre_scores_gemma":[0.9989957,0.00007911505,0.00033536932,0.000022869732,0.000009349769,0.00001678445,0.0003251528,0.0000032566418,0.00021235275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995784,0.00009880383,0.000050698396,0.00011491181,0.00011666788,0.000040538955],"domain_scores_gemma":[0.99895704,0.0003184673,0.0003830825,0.00004844443,0.00015432916,0.00013862875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005191695,0.00016635667,0.0003689018,0.0005977457,0.00016071506,0.00052373327,0.00024031133,0.00041799003,0.0009935295],"category_scores_gemma":[0.0018543359,0.00018977368,0.00015342745,0.0006005063,0.00016478899,0.0002631771,0.0002072996,0.00035911732,0.00029980237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013886691,0.00013743709,0.98094386,0.000047252386,0.000025150395,0.0003440234,0.000096132666,0.00017221992,0.0067623463,0.000028702716,0.00020830924,0.009845914],"study_design_scores_gemma":[0.00007119039,0.0022273515,0.9906901,0.000011299234,0.000042810007,0.0021175833,0.00009139048,0.0013012933,0.0026981775,0.000039841332,0.000700135,0.000008802102],"about_ca_topic_score_codex":0.00073707907,"about_ca_topic_score_gemma":0.0007510805,"teacher_disagreement_score":0.0009935295,"about_ca_system_score_codex":0.0002682656,"about_ca_system_score_gemma":0.00021421268,"threshold_uncertainty_score":0.0033236742},"labels":[],"label_agreement":null},{"id":"W4399374116","doi":"10.1200/jco.2024.42.17_suppl.lba5","title":"ADRIATIC: Durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Durvalumab; Oncology; Internal medicine; Stage (stratigraphy); Lung cancer; Cancer; Immunotherapy; Pembrolizumab","score_opus":0.13536777185527651,"score_gpt":0.522701672356838,"score_spread":0.38733390050156147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399374116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98539275,0.0058655394,0.00058752415,0.0007039732,0.00021400128,0.0018095128,0.0012915768,0.0001216954,0.0040133987],"genre_scores_gemma":[0.9936505,0.0015868911,0.00091881986,0.0004022285,0.00007343892,0.00088440196,0.00063194183,0.000007899464,0.0018438805],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999785,0.00010451109,0.000015944435,0.000036556783,0.000017360322,0.00004054803],"domain_scores_gemma":[0.99968445,0.000057701676,0.00006417901,0.00002352325,0.000013464627,0.00015660787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005625402,0.00040762307,0.0007514399,0.00018401709,0.00020887294,0.00035460872,0.00048316765,0.00039289202,0.0055477065],"category_scores_gemma":[0.00062043447,0.00015756706,0.00040082863,0.00024567966,0.00034472402,0.00037034173,0.00024930335,0.0009234498,0.0005857035],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7240891,0.007893068,0.0060237595,0.0010241391,0.0007300274,0.00013479571,0.0000981281,0.00086002494,0.020909816,0.00042621937,0.0043579373,0.23345314],"study_design_scores_gemma":[0.70678526,0.24655743,0.019815087,0.00013341951,0.0010216989,0.0005038318,0.00006730421,0.0013614737,0.007155091,0.0005093922,0.016066907,0.000023158453],"about_ca_topic_score_codex":0.0006325341,"about_ca_topic_score_gemma":0.0026554062,"teacher_disagreement_score":0.0055477065,"about_ca_system_score_codex":0.00045406545,"about_ca_system_score_gemma":0.0008568411,"threshold_uncertainty_score":0.01855892},"labels":[],"label_agreement":null},{"id":"W4399505409","doi":"10.1158/1538-8514.synthleth24-pr006","title":"Abstract PR006: DNA repair inhibition via targeting ATR activates cGAS/STING signaling, promotes anti-tumor immunity, and is a synthetic lethal strategy to augment immunotherapy response in preclinical models and clinical samples of small cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Blockade; Immunotherapy; Immune checkpoint; Tumor microenvironment; Biology; Immune system; Immunology; Medicine; Receptor","score_opus":0.08230421986962153,"score_gpt":0.4102955688589184,"score_spread":0.3279913489892968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399505409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843424,0.0040548802,0.0046123075,0.00052376755,0.00017215089,0.00013728233,0.0014832608,0.000518537,0.004155465],"genre_scores_gemma":[0.98546207,0.001790413,0.0033144038,0.00016664508,0.000050643896,0.00009747057,0.0019623693,0.00003786977,0.007118108],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988425,0.000014349481,0.000008064581,0.000024972273,0.000043509655,0.000024854498],"domain_scores_gemma":[0.9999341,0.0000069870403,0.000019684157,0.000007024629,0.0000059840427,0.00002632364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015086848,0.0005835454,0.00030963274,0.00029277377,0.00014310463,0.00029555388,0.00028418042,0.00033096326,0.00384119],"category_scores_gemma":[0.00007398383,0.00010306211,0.00033215684,0.00019565698,0.00025100843,0.00019646868,0.00015842912,0.0014029332,0.00073075574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047860638,0.00023950158,0.00016872783,0.00007242161,0.000011547279,0.00003780986,0.0000068502914,0.00015244816,0.9931579,0.00008702062,0.0003838937,0.005203035],"study_design_scores_gemma":[0.00012942043,0.0032745884,0.002569003,0.000009157048,0.000028637356,0.00023047034,0.000012732133,0.00086202356,0.989417,0.000045272976,0.003417159,0.000004493289],"about_ca_topic_score_codex":0.00031333673,"about_ca_topic_score_gemma":0.0007229983,"teacher_disagreement_score":0.00384119,"about_ca_system_score_codex":0.00022828477,"about_ca_system_score_gemma":0.0003302204,"threshold_uncertainty_score":0.012850046},"labels":[],"label_agreement":null},{"id":"W4399670437","doi":"10.1200/jco.2024.42.16_suppl.e20123","title":"Treatment of relapsed small cell lung cancer in the real-world: A comparison of platinum-etoposide rechallenge and cyclophosphamide-doxorubicin-vincristine (CAV) chemotherapy.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Etoposide; Vincristine; Doxorubicin; Cyclophosphamide; Chemotherapy; Oncology; Internal medicine","score_opus":0.13541354670541178,"score_gpt":0.5286251097895158,"score_spread":0.39321156308410404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399670437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93952185,0.054907285,0.00014934501,0.0013394019,0.00024121079,0.00026491846,0.0006762053,0.000015628766,0.0028841193],"genre_scores_gemma":[0.9927031,0.006106968,0.00017339484,0.00032287763,0.0000898529,0.000048395705,0.00032891662,0.0000024202143,0.00022415367],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99870265,0.0006843187,0.00014765187,0.00016625218,0.00016539726,0.00013375221],"domain_scores_gemma":[0.9979715,0.0005571654,0.00079501985,0.00007746707,0.000118952834,0.0004798428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015871496,0.0002766665,0.000678378,0.00043097138,0.00022679976,0.00082240516,0.0005763524,0.00079581863,0.0018888015],"category_scores_gemma":[0.0037718548,0.00017075878,0.0011657648,0.0004723501,0.00048945827,0.00068294693,0.00042490932,0.00093938876,0.00017993893],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34686792,0.007598217,0.1985509,0.0062418524,0.00735584,0.0007148072,0.0008504415,0.006069233,0.0033250027,0.0007910622,0.004322471,0.4173122],"study_design_scores_gemma":[0.034679152,0.19918227,0.73164433,0.0016322106,0.004658684,0.0019371449,0.0014442035,0.003679005,0.0012569956,0.00039296926,0.019360397,0.00013270316],"about_ca_topic_score_codex":0.008288635,"about_ca_topic_score_gemma":0.036396068,"teacher_disagreement_score":0.008288635,"about_ca_system_score_codex":0.0038064464,"about_ca_system_score_gemma":0.0014679345,"threshold_uncertainty_score":0.027617812},"labels":[],"label_agreement":null},{"id":"W4399670554","doi":"10.1200/jco.2024.42.16_suppl.e20111","title":"Real world outcomes in extensive stage small cell lung cancer (ES-SCLC) treated with consolidative thoracic radiation (cTRT) and chemoimmunotherapy (CIT): A population level study.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Chemoimmunotherapy; Medicine; Lung cancer; Stage (stratigraphy); Oncology; Radiation therapy; Population; Internal medicine; Radiology; Chemotherapy; Surgery; Cyclophosphamide","score_opus":0.16477889486802624,"score_gpt":0.5439998163855461,"score_spread":0.37922092151751985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399670554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525577,0.0002805335,0.00008951941,0.000040107247,0.0000055843657,0.000051737723,0.003892522,0.000004485085,0.0003798312],"genre_scores_gemma":[0.9951475,0.00011685624,0.00008677296,0.00004593331,0.00001475915,0.00007664094,0.0043849773,0.0000027368912,0.00012389923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916863,0.00019353026,0.00011477853,0.0002344686,0.00015242358,0.00013611569],"domain_scores_gemma":[0.99754614,0.0003504861,0.0013906292,0.0001870759,0.00020957543,0.00031617974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095463847,0.00023960049,0.0003857391,0.0010459692,0.00044210994,0.0008526686,0.0005101672,0.0005385312,0.0017866571],"category_scores_gemma":[0.0030212065,0.00030148457,0.00067595724,0.002549646,0.00036677744,0.00068322296,0.0008362067,0.0006859413,0.00038441663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035931656,0.00007293442,0.99809605,0.000032839336,0.0001174753,0.00005441675,0.00004619219,0.000048109712,0.000054953125,0.000013704023,0.00022900217,0.00087499194],"study_design_scores_gemma":[0.00005167479,0.00031701865,0.99860495,0.000016882823,0.00007834552,0.00020885801,0.00015627294,0.00012366193,0.00003574455,0.00002155264,0.00037960825,0.0000054536654],"about_ca_topic_score_codex":0.00757304,"about_ca_topic_score_gemma":0.013090058,"teacher_disagreement_score":0.00757304,"about_ca_system_score_codex":0.0009773653,"about_ca_system_score_gemma":0.00095736736,"threshold_uncertainty_score":0.015057921},"labels":[],"label_agreement":null},{"id":"W4399705795","doi":"10.1016/j.jtocrr.2024.100696","title":"Brief Report: Real-World Eligibility for Clinical Trials in Patients With Extensive-Stage SCLC at a Tertiary Care Center","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Center (category theory); Tertiary care; Stage (stratigraphy); Medicine; Lung cancer; Cancer; Clinical trial; Oncology; Internal medicine; Family medicine","score_opus":0.2734519420320826,"score_gpt":0.6070180270986795,"score_spread":0.33356608506659685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399705795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86502504,0.01647322,0.0031527332,0.057103813,0.0017527718,0.008026174,0.017093936,0.00028603146,0.0310863],"genre_scores_gemma":[0.9642015,0.0037959737,0.003932028,0.01094173,0.0038019028,0.003392673,0.0061355093,0.00006199094,0.0037366985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9864668,0.007972154,0.0028330383,0.00060175115,0.0015762617,0.00054998393],"domain_scores_gemma":[0.88261104,0.059377003,0.038845565,0.003851233,0.007999564,0.007315625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016565181,0.0001966831,0.0005796512,0.00059537415,0.0008226293,0.0020896073,0.00044727363,0.0011993302,0.0073041846],"category_scores_gemma":[0.060569517,0.00018218777,0.0004387855,0.0011509192,0.0005273495,0.0008516731,0.00085738377,0.000972134,0.0008609565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014025341,0.0010305555,0.6179408,0.0046517407,0.00052643707,0.0022043674,0.0011858883,0.0009053101,0.0018937127,0.0011507422,0.16272005,0.19176503],"study_design_scores_gemma":[0.0075285626,0.009826351,0.73991877,0.002411758,0.0007294689,0.0066327145,0.0013717095,0.0027397678,0.0031747387,0.002115298,0.22336254,0.00018834896],"about_ca_topic_score_codex":0.0008010269,"about_ca_topic_score_gemma":0.0016612539,"teacher_disagreement_score":0.016565181,"about_ca_system_score_codex":0.0013552636,"about_ca_system_score_gemma":0.003240998,"threshold_uncertainty_score":0.08760613},"labels":[],"label_agreement":null},{"id":"W4399781814","doi":"10.3390/curroncol31060254","title":"Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Conquer Cancer Foundation","keywords":"Medicine; Cancer research; Etoposide; Disease; Mutation; Cancer; Suppressor; Chemotherapy; Gene; Oncology; Genetics; Biology; Internal medicine","score_opus":0.06926260446440863,"score_gpt":0.43661754399225333,"score_spread":0.3673549395278447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399781814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887294,0.0053939326,0.0024495088,0.0005069975,0.000057005494,0.00015924528,0.000119864075,0.00013932682,0.0024446617],"genre_scores_gemma":[0.99571675,0.0012758129,0.0013675828,0.00021046516,0.000027832702,0.000039604525,0.0001734589,0.000014254136,0.0011742908],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9999211,0.000014761469,0.0000072484468,0.000016485208,0.000012269285,0.000028166673],"domain_scores_gemma":[0.99990714,0.000022016211,0.00001229302,0.0000142175,0.0000071579175,0.000037139056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016439648,0.00024387865,0.00043213993,0.00021762968,0.00017073858,0.00026064875,0.00021449062,0.00034159695,0.00068424473],"category_scores_gemma":[0.0001833734,0.00008338433,0.00022594503,0.000119575765,0.00017850928,0.00016021487,0.00018142554,0.00055758614,0.00022625741],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040326808,0.0022628126,0.010644962,0.00050254166,0.00011685874,0.009071827,0.00023252374,0.0020116959,0.6959985,0.00064465345,0.0013419053,0.27313912],"study_design_scores_gemma":[0.0021837975,0.05153276,0.09017516,0.00012839652,0.0004673869,0.056392316,0.00020087686,0.008628549,0.74828076,0.00070906186,0.041218523,0.00008244152],"about_ca_topic_score_codex":0.00029120067,"about_ca_topic_score_gemma":0.0013368789,"teacher_disagreement_score":0.00068424473,"about_ca_system_score_codex":0.0003090615,"about_ca_system_score_gemma":0.00020194451,"threshold_uncertainty_score":0.0022889972},"labels":[],"label_agreement":null},{"id":"W4400103914","doi":"10.3390/curroncol31070271","title":"Durable Response to Atezolizumab in Extensive-Stage Small-Cell Lung Cancer Leading to 60 Months Overall Survival: A Case Report","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Atezolizumab; Medicine; Stage (stratigraphy); Lung cancer; Oncology; Lung; Cancer; Overall survival; Internal medicine; Cancer research; Immunotherapy; Nivolumab; Biology","score_opus":0.12771728508599753,"score_gpt":0.48482095162714567,"score_spread":0.3571036665411481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400103914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97898453,0.0055492157,0.0029069139,0.0025072647,0.00025116478,0.0001220289,0.00018871317,0.00013692694,0.009353305],"genre_scores_gemma":[0.99378777,0.0015742984,0.0011898192,0.0007539558,0.00053697627,0.00001766259,0.0001257982,0.000018584988,0.0019950804],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995871,0.000057955356,0.000053526997,0.00010450755,0.00006230761,0.00013459689],"domain_scores_gemma":[0.9990363,0.00030066862,0.0001964936,0.000116302304,0.00006917237,0.00028099367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035155806,0.0008442726,0.000834033,0.00098535,0.0011951807,0.0010899148,0.00084971957,0.003375292,0.0013642651],"category_scores_gemma":[0.0015405276,0.00046801346,0.000815884,0.00062739046,0.00088090845,0.0011669442,0.000851508,0.0018939358,0.00070547446],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003499738,0.000044275483,0.005785538,0.000027610324,0.000007845309,0.99083495,0.00010017766,0.000055622684,0.0007502513,0.000086928354,0.00021734255,0.0020544487],"study_design_scores_gemma":[0.000009858381,0.00009089154,0.0038215003,0.000008307268,0.0000148050285,0.9944971,0.00005497971,0.0002273714,0.00050944276,0.00006387107,0.000696696,0.000005259845],"about_ca_topic_score_codex":0.0011345424,"about_ca_topic_score_gemma":0.0019801878,"teacher_disagreement_score":0.003375292,"about_ca_system_score_codex":0.00070238224,"about_ca_system_score_gemma":0.00044775524,"threshold_uncertainty_score":0.0050961375},"labels":[],"label_agreement":null},{"id":"W4400412031","doi":"10.1016/j.jtocrr.2024.100702","title":"Identifying Novel Germline Mutations and Copy Number Variations in Patients With SCLC","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Toronto General Hospital; University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; St Mary's Hospital Centre; Western University","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Canadian Institutes of Health Research; Weill Cornell Medical College; University of Toronto; Memorial Sloan-Kettering Cancer Center","keywords":"Germline; Germline mutation; Genetics; Biology; Copy-number variation; Mutation; Affect (linguistics); Oncology; Medicine; Gene; Genome; Psychology","score_opus":0.1449493709868936,"score_gpt":0.5350573537025527,"score_spread":0.3901079827156591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400412031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992442,0.00021486262,0.00015233587,0.000021407792,0.000001967359,0.0000055960286,0.00012086196,0.000007687301,0.0002310666],"genre_scores_gemma":[0.9995022,0.000061973544,0.000217671,0.000012385374,0.0000043493337,0.0000026645453,0.00014365402,0.0000016434444,0.000053353713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997359,0.00003910946,0.000037185782,0.000079746176,0.00007422181,0.000033866563],"domain_scores_gemma":[0.9992262,0.00033522682,0.00023798963,0.00004210051,0.000081587285,0.000076823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000412258,0.00021789524,0.00018309089,0.0012658486,0.0002610285,0.00040192177,0.00020922594,0.00035990647,0.0012635732],"category_scores_gemma":[0.0019169699,0.00010465749,0.00014019055,0.0008149512,0.00022759735,0.00020053919,0.00028479693,0.00020207683,0.00014088416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009833589,0.000016447515,0.99104625,0.000012993548,0.000017484397,0.0007391789,0.00005819235,0.000093126175,0.0036933173,0.000024148747,0.00007939672,0.0041211247],"study_design_scores_gemma":[0.000015662306,0.00017798525,0.9875236,0.000011227278,0.00005581998,0.0070344573,0.00015015874,0.0007656792,0.0036637012,0.00011880437,0.00047653404,0.0000063595185],"about_ca_topic_score_codex":0.001222306,"about_ca_topic_score_gemma":0.001568091,"teacher_disagreement_score":0.0012658486,"about_ca_system_score_codex":0.0001769944,"about_ca_system_score_gemma":0.00018462834,"threshold_uncertainty_score":0.004227042},"labels":[],"label_agreement":null},{"id":"W4400452226","doi":"10.1016/j.jtho.2024.05.344","title":"PP01.119 Real-World Use of Lurbinectedin in Patients with Small Cell Lung Cancer: Jazz EMERGE 402 Updated Analysis","year":2024,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Jazz; Lung cancer; Internal medicine; Acoustics","score_opus":0.03104700443746073,"score_gpt":0.42867154048630385,"score_spread":0.3976245360488431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400452226","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26179156,0.17497522,0.0016954567,0.015612274,0.002751116,0.0007964327,0.45389527,0.00043312943,0.08804958],"genre_scores_gemma":[0.5004871,0.09675045,0.003735319,0.01172023,0.0049955216,0.0009980287,0.3620542,0.00018842761,0.01907077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987062,0.000264006,0.0002809059,0.00015306461,0.0004982394,0.0000976027],"domain_scores_gemma":[0.9952341,0.0016534354,0.0012763934,0.00024536147,0.0013141228,0.0002766704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018856404,0.00041263152,0.0008684741,0.0018899039,0.00023488957,0.0013153189,0.0006508972,0.000594278,0.0114457635],"category_scores_gemma":[0.005911584,0.00028076052,0.0016872133,0.003181537,0.00013031333,0.00080066745,0.0006624619,0.0010093532,0.0018552779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064101224,0.00032822546,0.45307237,0.0076889964,0.006094391,0.00028620881,0.0001189095,0.00070857693,0.000871132,0.0007489116,0.25293234,0.27073982],"study_design_scores_gemma":[0.0013366328,0.00043473285,0.8745237,0.0011988344,0.004148602,0.00044354785,0.00015299,0.00040034423,0.00034293128,0.00022808599,0.116742365,0.00004719572],"about_ca_topic_score_codex":0.014281182,"about_ca_topic_score_gemma":0.023974143,"teacher_disagreement_score":0.014281182,"about_ca_system_score_codex":0.0009775222,"about_ca_system_score_gemma":0.0009355743,"threshold_uncertainty_score":0.038289905},"labels":[],"label_agreement":null},{"id":"W4401094899","doi":"10.21037/jtd-24-278","title":"Pleural pro-gastrin releasing peptide is a potential diagnostic marker for malignant pleural effusion induced by small-cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Journal of Thoracic Disease","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Inner Mongolia Medical University","keywords":"Medicine; Pleural effusion; Malignant pleural effusion; Pathology; Lung; Lung cancer; Cancer; Gastrin-releasing peptide; Gastrin; Pleural cavity; Oncology; Internal medicine; Radiology; Cancer research; Surgery; Bombesin; Secretion","score_opus":0.026747527689240568,"score_gpt":0.38138781588710413,"score_spread":0.3546402881978636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401094899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987178,0.0007288172,0.00018166858,0.000026488631,0.000006317202,0.000011117379,0.00008767075,0.000007204639,0.00023298316],"genre_scores_gemma":[0.9995708,0.00008902369,0.00017538846,0.000012715218,0.000009980374,0.0000050203666,0.00010868816,9.226275e-7,0.000027352393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994655,0.00017781748,0.000064384396,0.00008351435,0.0001401434,0.00006864974],"domain_scores_gemma":[0.9974239,0.00076857297,0.0010640768,0.000111778296,0.00036534274,0.0002663076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011381757,0.000331865,0.00035676637,0.00093917403,0.00022666182,0.00058537,0.00030159153,0.00032395063,0.000595335],"category_scores_gemma":[0.0026092937,0.00014483517,0.000256453,0.0006274188,0.00034262906,0.00023488801,0.00036342113,0.00030386378,0.00012704109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018717682,0.000013264869,0.99670404,0.000017639202,0.000024312192,0.000084380394,0.000018940242,0.000036573194,0.0012229062,0.0000061325754,0.000033967328,0.0016507894],"study_design_scores_gemma":[0.000011043419,0.00016540608,0.9974955,0.000005941529,0.000037355876,0.0006038935,0.000044563632,0.00053040875,0.0009579708,0.000017510352,0.00012741039,0.0000030957463],"about_ca_topic_score_codex":0.00095572014,"about_ca_topic_score_gemma":0.0014389594,"teacher_disagreement_score":0.0011381757,"about_ca_system_score_codex":0.0003211633,"about_ca_system_score_gemma":0.00025626723,"threshold_uncertainty_score":0.006019354},"labels":[],"label_agreement":null},{"id":"W4402183332","doi":"10.1200/op.24.00394","title":"Impact of an Etoposide Chemotherapy Shortage on Patients With Extensive-Stage Small-Cell Lung Cancer: Results of a Natural Experiment","year":2024,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Oakville-Trafalgar Memorial Hospital; University of British Columbia; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Etoposide; Hazard ratio; Internal medicine; Lung cancer; Irinotecan; Confidence interval; Proportional hazards model; Chemotherapy; Odds ratio; Surgery; Oncology; Cancer","score_opus":0.023182339556315146,"score_gpt":0.4419740678812649,"score_spread":0.41879172832494976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402183332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994684,0.00006209722,0.00007024932,0.00010244676,0.0000036899103,0.000023143197,0.000113205984,0.0000021579208,0.0001546236],"genre_scores_gemma":[0.9996438,0.000023937373,0.000055341457,0.00003456383,0.00000469824,0.000017370407,0.0001519298,7.4998115e-7,0.00006767024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986313,0.00082294573,0.000070065944,0.00014455596,0.0001343728,0.00019663284],"domain_scores_gemma":[0.9927705,0.0034588822,0.001955359,0.0004561587,0.0004540639,0.00090497563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004171179,0.0001728802,0.00025762984,0.00023581699,0.00041756267,0.0006209032,0.00036347157,0.0002590918,0.0014987084],"category_scores_gemma":[0.007768662,0.00013544934,0.0008628277,0.0002119185,0.0005138541,0.00054609374,0.00081073184,0.00049152994,0.000087093096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034603064,0.00065795024,0.9893941,0.00003425808,0.00016938135,0.00016104846,0.00029292723,0.0007450357,0.00029769517,0.00015162729,0.00037372578,0.0042618164],"study_design_scores_gemma":[0.00023667423,0.0048970007,0.9864622,0.00002325759,0.00011147398,0.00017369902,0.0016548355,0.0052779256,0.0002693317,0.00024845646,0.0006262484,0.000018942723],"about_ca_topic_score_codex":0.020932257,"about_ca_topic_score_gemma":0.026683914,"teacher_disagreement_score":0.020932257,"about_ca_system_score_codex":0.0015218678,"about_ca_system_score_gemma":0.0023329717,"threshold_uncertainty_score":0.04162085},"labels":[],"label_agreement":null},{"id":"W4402565972","doi":"10.1016/j.annonc.2024.08.1889","title":"1798P Relapsed and refractory systemic therapy real-world outcomes in the Canadian small cell lung cancer database (CASCADE)","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; CancerCare Manitoba; St. Michael's Hospital; Ottawa Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Systemic therapy; Refractory (planetary science); Lung cancer; Oncology; Internal medicine; Database; Cancer","score_opus":0.1196713710788802,"score_gpt":0.45891073948268385,"score_spread":0.33923936840380364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402565972","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16525896,0.0011435054,0.00013494736,0.001475202,0.00006837749,0.0002590941,0.8215762,0.00007104576,0.010012673],"genre_scores_gemma":[0.46572933,0.0016639892,0.00077365077,0.0012773782,0.00008855074,0.0005784149,0.525121,0.00005878243,0.0047089984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981351,0.0001143861,0.00019768972,0.00034273163,0.00066218677,0.0005479391],"domain_scores_gemma":[0.9938206,0.00035977986,0.0010052505,0.0002900788,0.0032856183,0.0012387105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097073044,0.00069236715,0.0009223797,0.0032602064,0.0020876017,0.0018542566,0.0020316618,0.00081163895,0.010311015],"category_scores_gemma":[0.0075376923,0.00040580682,0.0011287906,0.011214339,0.000490573,0.00082882826,0.0016138216,0.001166474,0.0016389044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012578119,0.0001345195,0.6993265,0.0007992665,0.00070634915,0.00020302639,0.00043605108,0.0007246841,0.00017637742,0.0012169507,0.27997246,0.015046047],"study_design_scores_gemma":[0.00026136165,0.000047177567,0.97415644,0.00028457414,0.00024826772,0.00016145218,0.0005994212,0.00056725036,0.00008518056,0.00015314073,0.023388432,0.00004732709],"about_ca_topic_score_codex":0.98438406,"about_ca_topic_score_gemma":0.9912969,"teacher_disagreement_score":0.026635861,"about_ca_system_score_codex":0.026635861,"about_ca_system_score_gemma":0.049716283,"threshold_uncertainty_score":0.19325763},"labels":[],"label_agreement":null},{"id":"W4402566002","doi":"10.1016/j.annonc.2024.08.1884","title":"1793P Treatment and outcomes of limited disease small cell lung cancer (LD-SCLC) in the Canadian small cell lung cancer database (CASCADE)","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Jewish General Hospital; Western University; Capital District Health Authority; AstraZeneca (Canada); Ottawa Hospital; Princess Margaret Cancer Centre; BC Cancer Agency; CancerCare Manitoba","funders":"","keywords":"Medicine; Lung cancer; Oncology; Disease; Internal medicine; Cascade","score_opus":0.10322854119174955,"score_gpt":0.43619415135617623,"score_spread":0.33296561016442666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402566002","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4201619,0.0045513012,0.00013687382,0.0021354223,0.0001332998,0.00022902669,0.5585326,0.000055160228,0.014064383],"genre_scores_gemma":[0.80849075,0.0030016033,0.00042430958,0.0011181632,0.00008586678,0.00023147711,0.18322738,0.000029483339,0.0033909467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870527,0.00009289037,0.00014709485,0.00021384853,0.00046560622,0.0003752414],"domain_scores_gemma":[0.99582773,0.00021147393,0.0008712264,0.0001728776,0.0021494036,0.0007673233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073392666,0.00043413736,0.000645921,0.0020837926,0.0013369279,0.0012744459,0.001417437,0.0006803212,0.0060414025],"category_scores_gemma":[0.0048886244,0.00030484484,0.0012031319,0.008671865,0.0003532129,0.0006355449,0.0009765234,0.0009972897,0.00065972056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006068155,0.000071008595,0.9397993,0.00041302684,0.00052780105,0.000084369276,0.00014942586,0.00027260464,0.00011466749,0.00052244007,0.050560366,0.0068781045],"study_design_scores_gemma":[0.00010787905,0.000028506263,0.9908343,0.00017376202,0.00021323498,0.000064710985,0.00029807276,0.00023894671,0.000051417035,0.00008544522,0.007882227,0.000021434258],"about_ca_topic_score_codex":0.9801185,"about_ca_topic_score_gemma":0.98931587,"teacher_disagreement_score":0.019881487,"about_ca_system_score_codex":0.01596286,"about_ca_system_score_gemma":0.033068128,"threshold_uncertainty_score":0.115819216},"labels":[],"label_agreement":null},{"id":"W4402616149","doi":"10.3390/cancers16183179","title":"Metabolomic Profiling of Pulmonary Neuroendocrine Neoplasms","year":2024,"lang":"en","type":"article","venue":"Cancers","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Centre hospitalier universitaire de Québec; University of Alberta; Université Laval; The Metabolomics Innovation Centre; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; Institut de Valorisation des Données; MEDTEQ+; Mitacs","keywords":"Metabolomics; Profiling (computer programming); Computational biology; Medicine; Pathology; Bioinformatics; Biology; Computer science","score_opus":0.025177995786751423,"score_gpt":0.3437458890967281,"score_spread":0.3185678933099767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402616149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838102,0.009184756,0.0034547236,0.00021210795,0.00003491868,0.00004735504,0.0023259437,0.000061791776,0.00086816173],"genre_scores_gemma":[0.99271846,0.0017793656,0.0033303502,0.00014205882,0.000022006498,0.000034782017,0.001439779,0.000009678801,0.0005235669],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99984586,0.000039538085,0.000014557764,0.000046206053,0.000032633216,0.000021153564],"domain_scores_gemma":[0.99985063,0.000031560437,0.00005047135,0.000008556119,0.000039387807,0.000019516887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021869554,0.00033165878,0.00027881484,0.0009647617,0.00020268583,0.00037454005,0.000113421986,0.00027203708,0.00072965486],"category_scores_gemma":[0.00037281215,0.00007715861,0.00028137982,0.00070259545,0.00012395428,0.00016845636,0.00029767508,0.00021794283,0.00016304036],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029494746,0.00017827125,0.20787859,0.00056222285,0.00055061124,0.0007589628,0.00015134765,0.00092267914,0.7283241,0.00017033586,0.00057175447,0.05698157],"study_design_scores_gemma":[0.00008991722,0.0017585348,0.6888043,0.000102918995,0.00061252445,0.0040690154,0.0004396356,0.0056329304,0.2890454,0.0006958228,0.008693121,0.000055938424],"about_ca_topic_score_codex":0.00068290695,"about_ca_topic_score_gemma":0.0009958432,"teacher_disagreement_score":0.0009647617,"about_ca_system_score_codex":0.00021288247,"about_ca_system_score_gemma":0.00019396479,"threshold_uncertainty_score":0.0024409294},"labels":[],"label_agreement":null},{"id":"W4402906184","doi":"10.1016/j.ijrobp.2024.07.166","title":"Phase I Trial of Concurrent Talazoparib and Consolidative Thoracic Radiotherapy for Patients with Extensive-Stage Small Cell Lung Cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stage (stratigraphy); Radiation therapy; Medicine; Lung cancer; Oncology; Radiology; Biology","score_opus":0.033374533425620634,"score_gpt":0.4356903169352997,"score_spread":0.40231578350967906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402906184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902688,0.0022446944,0.000525584,0.0008560051,0.00038354084,0.0014600503,0.0010641357,0.00015268594,0.0030443599],"genre_scores_gemma":[0.98793924,0.0018165591,0.0010621072,0.00078707136,0.00021268596,0.0014155771,0.0025200148,0.00004635785,0.004200331],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996537,0.00011192524,0.0000131272645,0.00008444911,0.000028088361,0.00010873294],"domain_scores_gemma":[0.9994074,0.000079228834,0.00009359864,0.000054120705,0.000025344221,0.00034025256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010395789,0.0020298122,0.0022912999,0.0004438484,0.000515402,0.001519501,0.0014279479,0.0011386388,0.0065259268],"category_scores_gemma":[0.0008309417,0.0007976491,0.0018279455,0.00052585517,0.0014791257,0.0011242962,0.00057406543,0.0039057005,0.0014594712],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86204743,0.032641165,0.0035192142,0.0006958701,0.0019206261,0.00014248109,0.00028765315,0.0050482727,0.016713869,0.00059248833,0.0047735954,0.07161724],"study_design_scores_gemma":[0.726488,0.25973037,0.0064991293,0.000031904416,0.00070435216,0.00016301766,0.000121957724,0.002001151,0.0014467743,0.0003709205,0.002408683,0.000033709224],"about_ca_topic_score_codex":0.0033208905,"about_ca_topic_score_gemma":0.009195726,"teacher_disagreement_score":0.0065259268,"about_ca_system_score_codex":0.0018219964,"about_ca_system_score_gemma":0.0024058542,"threshold_uncertainty_score":0.021831453},"labels":[],"label_agreement":null},{"id":"W4402908729","doi":"10.1016/j.ijrobp.2024.08.024","title":"Safety Profile of Durvalumab (D) as Consolidation Treatment (tx) in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) in ADRIATIC: Focus on Pneumonitis and Immune-Mediated Adverse Events (imAEs)","year":2024,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Pneumonitis; Medicine; Adverse effect; Stage (stratigraphy); Immune system; Oncology; Lung; Internal medicine; Immunology; Immunotherapy; Pembrolizumab; Biology","score_opus":0.022623903191408546,"score_gpt":0.3684291593653184,"score_spread":0.34580525617390984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402908729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99179256,0.0066903294,0.00017066699,0.00014289112,0.000026009406,0.00003433949,0.00021026803,0.000011651644,0.00092127407],"genre_scores_gemma":[0.9980946,0.0011595478,0.00011041725,0.00011305664,0.00001886183,0.000016605298,0.00018704869,0.0000026826644,0.0002970544],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998565,0.00005648913,0.000012718828,0.000025032166,0.000025235018,0.000023981793],"domain_scores_gemma":[0.99978155,0.00005581134,0.00006950333,0.00001795904,0.000016414278,0.000058725367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037482652,0.00013952906,0.00046782722,0.00010314067,0.00010865989,0.000346973,0.00019515747,0.00019151584,0.0008954206],"category_scores_gemma":[0.00060455635,0.00005828254,0.00028626068,0.00014029484,0.00013874154,0.00019792566,0.000087345856,0.00053800456,0.00015662068],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16282657,0.0046800035,0.11575684,0.0011594653,0.0018446008,0.0008499754,0.00032984713,0.0026084671,0.083876245,0.00074778474,0.0032806918,0.62203956],"study_design_scores_gemma":[0.049776122,0.3498643,0.48057562,0.0004942615,0.004842535,0.0090567395,0.00062764256,0.009855726,0.057859313,0.0011585449,0.035804383,0.0000847787],"about_ca_topic_score_codex":0.00045541898,"about_ca_topic_score_gemma":0.0010747069,"teacher_disagreement_score":0.0008954206,"about_ca_system_score_codex":0.00034455265,"about_ca_system_score_gemma":0.00029182655,"threshold_uncertainty_score":0.0029954314},"labels":[],"label_agreement":null},{"id":"W4403095475","doi":"10.1016/j.eclinm.2024.102871","title":"Brain metastasis burden and management in patients with small cell lung cancer in Canada: a retrospective, population-based cohort study","year":2024,"lang":"en","type":"article","venue":"EClinicalMedicine","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University; University of Toronto","funders":"Ministry of Long-Term Care; Canadian Institutes of Health Research; Seagen; Institute for Clinical Evaluative Sciences; University of Oxford; Elekta; Bristol-Myers Squibb; Kementerian Kesihatan Malaysia; AstraZeneca; Congress of Neurological Surgeons; Cancer Care Ontario; Pfizer; Ministry of Health, Ontario","keywords":"Medicine; Retrospective cohort study; Brain metastasis; Lung cancer; Cohort; Cancer; Metastasis; Population; Oncology; General surgery; Internal medicine; Environmental health","score_opus":0.01739674314544606,"score_gpt":0.3429313140409801,"score_spread":0.32553457089553406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403095475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913679,0.00072183704,0.00010301438,0.0002020543,0.000009703213,0.000074634794,0.0063971444,0.000009400167,0.0011143446],"genre_scores_gemma":[0.9968233,0.00043354748,0.00010795304,0.000092063936,0.000008526551,0.000028980614,0.0022818074,0.0000036870165,0.00022012068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992249,0.000041961765,0.000066413966,0.0001649345,0.00025363493,0.0002481099],"domain_scores_gemma":[0.99827564,0.00007065923,0.0005865898,0.000093826886,0.00062845263,0.00034483016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005575811,0.0003788166,0.000532905,0.0012257985,0.0019636126,0.0010750582,0.0009805915,0.00043248202,0.0011677392],"category_scores_gemma":[0.001490204,0.00038476844,0.0006242608,0.0042941184,0.00062486826,0.0004151489,0.0007820093,0.0006492785,0.00020156668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003755381,0.000008889207,0.9987361,0.0000152260345,0.00003188318,0.00006906479,0.00011374355,0.000037331247,0.00006486539,0.000019609754,0.00032555006,0.00054035214],"study_design_scores_gemma":[0.000008959781,0.000025714024,0.9985104,0.000022644814,0.000037369682,0.00015792076,0.0004210493,0.00015775126,0.000023622904,0.00001623786,0.0006108849,0.0000073948054],"about_ca_topic_score_codex":0.9500174,"about_ca_topic_score_gemma":0.9623242,"teacher_disagreement_score":0.049982607,"about_ca_system_score_codex":0.014493931,"about_ca_system_score_gemma":0.019043164,"threshold_uncertainty_score":0.10516131},"labels":[],"label_agreement":null},{"id":"W4403250115","doi":"10.1016/j.ygyno.2024.07.485","title":"Practice patterns in the treatment of small cell carcinoma of the cervix: Analysis of a Canadian multidisciplinary survey","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Multidisciplinary approach; Cervix; Gynecology; Carcinoma; Oncology; General surgery; Internal medicine; Cancer","score_opus":0.0803598955646283,"score_gpt":0.38781550183967584,"score_spread":0.30745560627504753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99292564,0.0017014311,0.00007833202,0.000830543,0.000011948326,0.000056146637,0.0025151926,0.000006497753,0.0018743796],"genre_scores_gemma":[0.9974287,0.0011438797,0.0001447569,0.00017472307,0.000007707284,0.000024773182,0.00082162314,0.0000031125305,0.0002507779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975305,0.00032807697,0.00025717873,0.00032334967,0.0009762425,0.00058454537],"domain_scores_gemma":[0.9938869,0.0007018632,0.0020180712,0.00010926531,0.0019614801,0.0013225051],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0011578287,0.00028538267,0.0004284034,0.0023367128,0.0018222426,0.0009342218,0.0017600282,0.00097287283,0.0018162411],"category_scores_gemma":[0.0072466843,0.0004144484,0.00058562506,0.0068200137,0.0006794105,0.00047249623,0.0011604445,0.0007280161,0.00014005667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037359296,0.000041750383,0.99572563,0.000055298828,0.000043248692,0.000041978074,0.0008641044,0.000073006144,0.000098742275,0.000047683796,0.0005616184,0.002409558],"study_design_scores_gemma":[0.0000030404772,0.000015686755,0.9983581,0.0000221901,0.000009993071,0.000034989116,0.0011621112,0.00012313575,0.000013678565,0.0000060566604,0.00024517864,0.0000058388596],"about_ca_topic_score_codex":0.9742371,"about_ca_topic_score_gemma":0.9835649,"teacher_disagreement_score":0.9988422,"about_ca_system_score_codex":0.018228581,"about_ca_system_score_gemma":0.024222448,"threshold_uncertainty_score":0.13225824},"labels":[],"label_agreement":null},{"id":"W4403259921","doi":"10.1111/1759-7714.15463","title":"Prophylactic cranial irradiation in patients with resected small‐cell lung cancer: A systematic review and meta‐analysis","year":2024,"lang":"en","type":"review","venue":"Thoracic Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"West China Hospital, Sichuan University; Sichuan University","keywords":"Medicine; Conventional PCI; Prophylactic cranial irradiation; Hazard ratio; Meta-analysis; Internal medicine; Subgroup analysis; Oncology; Chemoradiotherapy; Lung cancer; Confidence interval; Surgery; Gastroenterology; Cancer; Myocardial infarction","score_opus":0.054745677474583754,"score_gpt":0.4321879469504419,"score_spread":0.3774422694758581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403259921","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0061158417,0.99257565,0.00030375645,0.00013885317,0.00009043019,0.00015233684,0.0004117942,0.000017535476,0.00019383967],"genre_scores_gemma":[0.19406866,0.8016067,0.0013714866,0.00081563555,0.00021534791,0.0007095832,0.00085623015,0.000027037728,0.00032933196],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955052,0.0019325303,0.0013503928,0.0005520837,0.00047586352,0.0001838203],"domain_scores_gemma":[0.98988414,0.007221349,0.0016809654,0.0003159112,0.0007311337,0.00016648033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074000503,0.0021180564,0.01470894,0.0041522374,0.0005345741,0.0024672188,0.0017222909,0.0017772485,0.002805551],"category_scores_gemma":[0.016244981,0.0011532013,0.027848864,0.0058452124,0.0005378636,0.0012170728,0.001042835,0.0014301568,0.00023571719],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022215575,0.000029586266,0.0053184023,0.362968,0.61711854,0.0001495377,0.00009059192,0.000480875,0.00026571527,0.000100204314,0.0006022169,0.010654668],"study_design_scores_gemma":[0.00038543268,0.0001606145,0.00483824,0.01728483,0.9755402,0.00008411814,0.000037973423,0.00013060568,0.00008965865,0.000097284195,0.0013321576,0.000018959669],"about_ca_topic_score_codex":0.0063611194,"about_ca_topic_score_gemma":0.014513097,"teacher_disagreement_score":0.01470894,"about_ca_system_score_codex":0.0017420697,"about_ca_system_score_gemma":0.002298593,"threshold_uncertainty_score":0.039135695},"labels":[],"label_agreement":null},{"id":"W4403302105","doi":"10.3390/cancers16203438","title":"Strategies to Target Chemoradiotherapy Resistance in Small Cell Lung Cancer","year":2024,"lang":"en","type":"review","venue":"Cancers","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Weill Cornell Medical College; Canadian Institutes of Health Research; Cancer Research Society; Memorial Sloan-Kettering Cancer Center","keywords":"Chemoradiotherapy; Lung cancer; Medicine; Resistance (ecology); Oncology; Cancer; Internal medicine; Cancer research; Biology","score_opus":0.05217455957717654,"score_gpt":0.42742310539681266,"score_spread":0.3752485458196361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403302105","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009360114,0.9989567,0.00008356956,0.00014383161,0.00010429422,0.00000752563,0.00001229799,0.0000062471527,0.00059195166],"genre_scores_gemma":[0.0008212508,0.9984034,0.00016249262,0.00015581702,0.00006548662,0.000010863127,0.00002880223,0.0000013352136,0.0003507057],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984276,0.000039375176,0.00002184393,0.0000222984,0.000055040582,0.000018680292],"domain_scores_gemma":[0.99975675,0.0001244414,0.00003692336,0.00000877291,0.000056531135,0.00001662686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064385583,0.00063748553,0.0013709846,0.0022253722,0.00020012277,0.0008187972,0.00088144536,0.0009562788,0.0047903024],"category_scores_gemma":[0.000731274,0.00021444379,0.0007688803,0.0012190529,0.00031949283,0.0009184141,0.0005141532,0.0017393817,0.0016490512],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009578048,0.00010156775,0.00013038176,0.03337768,0.00017750968,0.00015788054,0.000055103323,0.00041448313,0.0019116167,0.0038945335,0.017968029,0.9417154],"study_design_scores_gemma":[0.00005830797,0.00017457338,0.00080239744,0.008909073,0.00030070372,0.0010528553,0.00006739967,0.00011191538,0.00071283453,0.0020121904,0.9857793,0.000018481094],"about_ca_topic_score_codex":0.00082631473,"about_ca_topic_score_gemma":0.0017114354,"teacher_disagreement_score":0.0047903024,"about_ca_system_score_codex":0.0004839918,"about_ca_system_score_gemma":0.0007161464,"threshold_uncertainty_score":0.016025186},"labels":[],"label_agreement":null},{"id":"W4403419865","doi":"10.1016/j.jtho.2024.09.379","title":"P1.13A.10 Efficacy and Safety of Lurbinectedin for Small Cell Lung Cancer in a Real-World Setting: Jazz EMERGE 402 Study","year":2024,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Southlake Regional Health Center","funders":"","keywords":"Medicine; Jazz; Lung cancer; Oncology; Acoustics","score_opus":0.04138748019909001,"score_gpt":0.49237024254741807,"score_spread":0.45098276234832807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403419865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98749304,0.0063617243,0.00019556015,0.0009033542,0.0001650577,0.00057754456,0.0011673627,0.00006390233,0.0030724218],"genre_scores_gemma":[0.98889685,0.003508333,0.0006201535,0.00083374727,0.00032355543,0.0005862498,0.0016568123,0.000028730708,0.003545572],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9994555,0.00025391276,0.0000316776,0.00009823681,0.00007043584,0.00009029016],"domain_scores_gemma":[0.9994068,0.00014983625,0.0001335004,0.00005814984,0.000051036805,0.00020071196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012353814,0.0010058758,0.0021720384,0.0003559089,0.00043358025,0.0011581696,0.0008798208,0.0011179859,0.0042876382],"category_scores_gemma":[0.0010455681,0.0003820658,0.0012192241,0.00031680218,0.0008665613,0.0006572689,0.0003368579,0.002508498,0.0011538222],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7815011,0.029229239,0.018198676,0.0020177157,0.0039831265,0.0003268991,0.00019520734,0.0010996866,0.035902552,0.00049085746,0.005536556,0.12151832],"study_design_scores_gemma":[0.54365504,0.3646754,0.06831574,0.00017423823,0.004680071,0.0004675066,0.00015653059,0.00131683,0.006542573,0.00020210908,0.009705196,0.00010868729],"about_ca_topic_score_codex":0.001450298,"about_ca_topic_score_gemma":0.002335227,"teacher_disagreement_score":0.0042876382,"about_ca_system_score_codex":0.00095548603,"about_ca_system_score_gemma":0.0009055656,"threshold_uncertainty_score":0.01434356},"labels":[],"label_agreement":null},{"id":"W4403420098","doi":"10.1016/j.jtho.2024.09.222","title":"MA17.03 30 Years of International Real World Outcomes in Patients with Limited Disease Small Cell Lung Cancer","year":2024,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lung cancer; Disease; Lung disease; Intensive care medicine; Oncology; Internal medicine; Lung","score_opus":0.023121765768051753,"score_gpt":0.4367275228555888,"score_spread":0.41360575708753705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403420098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907582,0.0016870085,0.0000951036,0.001189137,0.0001570894,0.000008769844,0.003029822,0.000006936849,0.003067964],"genre_scores_gemma":[0.9958631,0.0003780289,0.000027096847,0.00017690305,0.00012209447,0.000013838317,0.0022971763,0.00000567697,0.0011161158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938834,0.00013478255,0.000058669026,0.00011303683,0.00006077548,0.0002444205],"domain_scores_gemma":[0.997232,0.00036861195,0.0012673406,0.00015608162,0.00023794793,0.0007379312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010750158,0.00029966747,0.0004593234,0.000620863,0.0006632459,0.0019179673,0.00057167193,0.0008209031,0.0048548873],"category_scores_gemma":[0.004126517,0.0001887397,0.0012582642,0.0013419124,0.0004767012,0.001406347,0.0011564046,0.0016856759,0.00088087237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075014815,0.00007645948,0.9939585,0.000025361953,0.000267167,0.00011217668,0.000100697034,0.00014149648,0.00010156998,0.00021286744,0.0011369013,0.0031165958],"study_design_scores_gemma":[0.000029904086,0.0001950555,0.99729186,0.000026003952,0.00020185982,0.00015432647,0.0004041507,0.00019225664,0.00003472473,0.00026182583,0.0011930772,0.000014958525],"about_ca_topic_score_codex":0.007421327,"about_ca_topic_score_gemma":0.007916008,"teacher_disagreement_score":0.007421327,"about_ca_system_score_codex":0.0007054164,"about_ca_system_score_gemma":0.00088628783,"threshold_uncertainty_score":0.016241193},"labels":[],"label_agreement":null},{"id":"W4403464924","doi":"10.1016/j.jtho.2024.09.1286","title":"EP.13D.12 International Consortium Real-World Outcomes in Extensive Disease Small Cell Lung Cancer Compared to IMPOWER133 And CASPIAN","year":2024,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Medicine; Lung cancer; Disease; Internal medicine; Oncology; Intensive care medicine","score_opus":0.04067733677870837,"score_gpt":0.4912064786779988,"score_spread":0.45052914189929044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403464924","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051691905,0.016587159,0.0022965865,0.04834989,0.02620874,0.0019607875,0.44748914,0.0010016428,0.40441424],"genre_scores_gemma":[0.24695095,0.008053876,0.003661062,0.012295818,0.0054530287,0.004760496,0.10612694,0.0009592375,0.6117386],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9990121,0.000402149,0.00008266917,0.00010238602,0.00023981191,0.00016085368],"domain_scores_gemma":[0.9956168,0.0020301465,0.0004646285,0.0004587871,0.0008003457,0.00062933366],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002037469,0.00031821945,0.0007167079,0.001385412,0.00041463165,0.0013249998,0.0008475997,0.0011968076,0.36147523],"category_scores_gemma":[0.0110359015,0.00019851554,0.0013863135,0.0015769708,0.00045375543,0.00082859216,0.0009985993,0.0014319664,0.038003072],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011068093,0.00021919995,0.007956482,0.0011219276,0.00035828075,0.00015049598,0.00006110763,0.00042886217,0.00022154495,0.0032622924,0.8833419,0.09180986],"study_design_scores_gemma":[0.015060491,0.0036039276,0.33570588,0.00834268,0.00128909,0.0006420053,0.00072744564,0.001877949,0.001829194,0.013279659,0.61746323,0.00017835817],"about_ca_topic_score_codex":0.013458478,"about_ca_topic_score_gemma":0.018201035,"teacher_disagreement_score":0.36147523,"about_ca_system_score_codex":0.0011862896,"about_ca_system_score_gemma":0.0013520187,"threshold_uncertainty_score":0.9107781},"labels":[],"label_agreement":null},{"id":"W4403688538","doi":"10.3390/curroncol31110482","title":"Prognostic Factors for Patients with Small-Cell Lung Cancer Treated with Chemoimmunotherapy: A Retrospective Multicenter Study","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemoimmunotherapy; Medicine; Multicenter study; Lung cancer; Retrospective cohort study; Oncology; Lung; Internal medicine; Cancer; Surgery; Immunotherapy; Randomized controlled trial","score_opus":0.05682987250388637,"score_gpt":0.4117551903969849,"score_spread":0.3549253178930985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403688538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992494,0.0003032296,0.000083831954,0.000022482582,0.0000041425033,0.0000098882565,0.00013990386,0.0000019953245,0.00018516053],"genre_scores_gemma":[0.9995951,0.00007510211,0.00004549126,0.000013477092,0.000012524051,0.00000950614,0.00020837101,9.5055907e-7,0.00003956784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963355,0.0001080918,0.000045686134,0.00008986971,0.00006086279,0.00006190106],"domain_scores_gemma":[0.9988444,0.00019083875,0.0005501382,0.00007844431,0.00009848113,0.00023768122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006270195,0.00028575023,0.000361478,0.00065226987,0.00041624048,0.00046076573,0.00022173984,0.00037501863,0.0010195504],"category_scores_gemma":[0.0014008445,0.00020919144,0.00040633557,0.00093385467,0.0002624537,0.0004322811,0.00026348213,0.0003426846,0.00019214705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010392227,0.000016664135,0.9992774,0.0000032423884,0.000017198852,0.00004779382,0.000013149684,0.000015758806,0.0000783479,0.0000038606463,0.000019653191,0.0004030868],"study_design_scores_gemma":[0.00001614356,0.00022473934,0.9985493,0.0000042585566,0.000038743787,0.0006496165,0.00009466036,0.0001331045,0.00006123588,0.000014920915,0.00020950886,0.0000037348423],"about_ca_topic_score_codex":0.0011323246,"about_ca_topic_score_gemma":0.0012288035,"teacher_disagreement_score":0.0011323246,"about_ca_system_score_codex":0.00023010706,"about_ca_system_score_gemma":0.00033608355,"threshold_uncertainty_score":0.003410697},"labels":[],"label_agreement":null},{"id":"W4403812934","doi":"10.1093/eurheartj/ehae666.3038","title":"Treatment of Post-COVID-19 POTS by inhibiting FcRn: a phase 2 randomized, placebo controlled, double-blind, proof of concept study with efgartigimod","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Placebo; Double blind; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Randomized controlled trial; Proof of concept; Internal medicine; Virology; Pharmacology; Pathology; Disease","score_opus":0.06484357411088452,"score_gpt":0.40801393386563733,"score_spread":0.3431703597547528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403812934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9483319,0.0075663906,0.0036343357,0.0016889202,0.0016145579,0.032274168,0.0024660768,0.00042637522,0.0019972257],"genre_scores_gemma":[0.93245524,0.0055590803,0.009702002,0.003481324,0.0013474463,0.0408486,0.0019911346,0.00006264316,0.004552565],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992416,0.00031402503,0.00006497786,0.00013437738,0.00006716783,0.0001779812],"domain_scores_gemma":[0.9991001,0.0001752634,0.00021302566,0.000085472544,0.00011636742,0.00030975873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030114884,0.0024796028,0.0039780657,0.00054640434,0.00063117454,0.0013297492,0.0015717555,0.003452124,0.0064147892],"category_scores_gemma":[0.001645079,0.0008260596,0.0021575524,0.00044261152,0.0014013929,0.0017028523,0.00039642135,0.0031947587,0.0008859125],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9233691,0.03862627,0.0004446103,0.0016936699,0.0012258565,0.00007772217,0.00006317327,0.00023873629,0.016340904,0.00018191137,0.0012496683,0.016488263],"study_design_scores_gemma":[0.8950467,0.102330916,0.0008899206,0.000034334123,0.00028308397,0.00002544075,0.000013571091,0.00018037537,0.0005941932,0.00008192943,0.0005072312,0.000012236979],"about_ca_topic_score_codex":0.0005342741,"about_ca_topic_score_gemma":0.0012381839,"teacher_disagreement_score":0.0064147892,"about_ca_system_score_codex":0.0006185256,"about_ca_system_score_gemma":0.0017161155,"threshold_uncertainty_score":0.02145964},"labels":[],"label_agreement":null},{"id":"W4404059690","doi":"10.3390/curroncol31110501","title":"Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Oncology; Clinical Oncology; Lung cancer; Internal medicine; Immunotherapy; Stage (stratigraphy); Radiation oncology; Family medicine; Cancer; Medical physics; Intensive care medicine","score_opus":0.14185551874276126,"score_gpt":0.5144830345141657,"score_spread":0.3726275157714044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404059690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896882,0.0012723252,0.00015615018,0.001213685,0.000024455134,0.00007089594,0.0034035034,0.00001794562,0.0041529485],"genre_scores_gemma":[0.9963636,0.00069019065,0.00017174866,0.00030815206,0.000033212727,0.00007807885,0.0020738447,0.0000060780176,0.0002751336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877185,0.00043226813,0.00016950481,0.00016836704,0.00026906675,0.00018883821],"domain_scores_gemma":[0.9959174,0.0007795975,0.0021319005,0.00018152704,0.00042294862,0.00056665856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018176197,0.00014141419,0.00023978103,0.0009338702,0.00021490802,0.00046563943,0.0003207756,0.0003901097,0.0014922753],"category_scores_gemma":[0.0040583294,0.00011836735,0.00034258774,0.0015732792,0.00023854467,0.00035846603,0.0005654953,0.0003446494,0.00036696333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004329206,0.000028950359,0.99265563,0.00008799255,0.000026311805,0.000042997908,0.000505975,0.000075337695,0.00012411887,0.000030931387,0.0017164221,0.0046619917],"study_design_scores_gemma":[0.0000028753757,0.000040407685,0.9974349,0.000033665812,0.0000086779155,0.00011110105,0.00040987376,0.00012526823,0.000026639496,0.0000074809745,0.0017964451,0.0000027703031],"about_ca_topic_score_codex":0.010529503,"about_ca_topic_score_gemma":0.009316788,"teacher_disagreement_score":0.010529503,"about_ca_system_score_codex":0.0007555964,"about_ca_system_score_gemma":0.00071189867,"threshold_uncertainty_score":0.02093643},"labels":[],"label_agreement":null},{"id":"W4404559853","doi":"10.1200/op-24-00840","title":"Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights","year":2024,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital; Western University","funders":"","keywords":"Guideline; Lung cancer; Medicine; Systemic therapy; Intensive care medicine; Oncology; Medical physics; Clinical Oncology; Internal medicine; Cancer; Pathology; Breast cancer","score_opus":0.09883768673068831,"score_gpt":0.5222914815626931,"score_spread":0.4234537948320048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404559853","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003744256,0.22626144,0.0037153093,0.64854205,0.021840606,0.0018903748,0.0129053425,0.00046238588,0.08063826],"genre_scores_gemma":[0.035940748,0.39646408,0.049738582,0.40163243,0.0362593,0.0053492333,0.04240104,0.0005528664,0.031661786],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9862679,0.0051556895,0.0030687128,0.0004898348,0.0041576223,0.00086017774],"domain_scores_gemma":[0.95288825,0.013146533,0.007371161,0.0012303266,0.021807157,0.003556515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013614847,0.0010013536,0.002990637,0.0036531168,0.0012860653,0.0037589564,0.0026911818,0.007129178,0.0098922895],"category_scores_gemma":[0.060542744,0.00090516877,0.003586885,0.004261451,0.00077028177,0.002358912,0.0030103119,0.008022434,0.005366808],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014187844,0.00011085675,0.0023640862,0.003126942,0.00024669347,0.00009301811,0.00007794445,0.0002607606,0.00017991116,0.0012661875,0.8316245,0.16050728],"study_design_scores_gemma":[0.00079015596,0.00019250845,0.007800438,0.024399359,0.0009723896,0.00040539057,0.00016274673,0.00036690966,0.00027439307,0.0027941035,0.96176845,0.000073205854],"about_ca_topic_score_codex":0.024672318,"about_ca_topic_score_gemma":0.07271742,"teacher_disagreement_score":0.024672318,"about_ca_system_score_codex":0.0048786965,"about_ca_system_score_gemma":0.020676501,"threshold_uncertainty_score":0.07200307},"labels":[],"label_agreement":null},{"id":"W4404595681","doi":"10.1038/s41590-024-02014-5","title":"A STAT3–STING–IFN axis controls the metastatic spread of small cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Nature Immunology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Cancer Council Victoria; Victorian Cancer Agency","keywords":"STAT3; STAT protein; Cancer research; Stimulator of interferon genes; Interferon; Biology; Immune system; Metastasis; Immunotherapy; Sting; Innate immune system; Signal transduction; Immunology; Medicine; Cancer; Cell biology","score_opus":0.014727437349149164,"score_gpt":0.3590550363570377,"score_spread":0.34432759900788856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404595681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98356724,0.0044755177,0.0019227517,0.00091990316,0.00015391131,0.000032593915,0.0005322719,0.00020875719,0.008186951],"genre_scores_gemma":[0.99624485,0.0006467975,0.00041166134,0.00010180556,0.000028525634,0.000010458915,0.00019354431,0.000016152466,0.0023463015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978274,0.00003192174,0.000008862562,0.000026163892,0.00006638763,0.00008398628],"domain_scores_gemma":[0.99985385,0.000017197404,0.000036842946,0.00001854747,0.000021223328,0.000052286035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023846963,0.00026053446,0.00018378353,0.00036522234,0.00034075146,0.00070805755,0.0002228987,0.00030955186,0.00309381],"category_scores_gemma":[0.00021001961,0.00017942804,0.00025966726,0.00017302913,0.00040695816,0.00034656306,0.00027950364,0.0008323376,0.0005834628],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009191406,0.00007896888,0.003718554,0.000052413267,0.000015524229,0.00014778534,0.000057694695,0.00029064063,0.9822496,0.0014608825,0.00087054895,0.010138117],"study_design_scores_gemma":[0.00029817704,0.0012311169,0.12789895,0.00006320398,0.00010296834,0.0011628518,0.00060124084,0.009050213,0.83615667,0.0029293827,0.020471727,0.00003351684],"about_ca_topic_score_codex":0.0017959363,"about_ca_topic_score_gemma":0.0035202776,"teacher_disagreement_score":0.00309381,"about_ca_system_score_codex":0.00080425607,"about_ca_system_score_gemma":0.0006542581,"threshold_uncertainty_score":0.01034981},"labels":[],"label_agreement":null},{"id":"W4404722329","doi":"10.3390/diagnostics14232660","title":"Novel Immunohistochemical Profiling of Small-Cell Lung Cancer: Correlations Between Tumor Subtypes and Immune Microenvironment","year":2024,"lang":"en","type":"article","venue":"Diagnostics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Immunohistochemistry; Tumor-infiltrating lymphocytes; Tumor microenvironment; CD8; Malignancy; Lung cancer; Immune system; Oncology; Cancer research; Immunotherapy; Biology; Medicine; Internal medicine; Immunology","score_opus":0.017461678260209675,"score_gpt":0.30987438428550007,"score_spread":0.2924127060252904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404722329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974166,0.0007524429,0.00090648496,0.000017521445,0.000004140659,0.000015134205,0.00015928656,0.000015486485,0.00071294245],"genre_scores_gemma":[0.9988225,0.00015210279,0.000667456,0.00000947161,0.0000067208625,0.000012411728,0.00015589864,0.000002591442,0.00017081309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980205,0.000033115488,0.000028406386,0.0000417958,0.00005035649,0.000044268476],"domain_scores_gemma":[0.9997249,0.000041382205,0.00010659261,0.000021513857,0.0000649959,0.000040669052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003435169,0.00014399765,0.00016795851,0.0010489334,0.0002002854,0.00038350196,0.00017704148,0.0001890682,0.0009115027],"category_scores_gemma":[0.00033206027,0.00008024878,0.00015008062,0.00061344035,0.00018807536,0.00021406423,0.00021471221,0.00013693982,0.00022593253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043113285,0.000043980617,0.82433015,0.00009490676,0.000064679945,0.0005818209,0.000107604596,0.00019157365,0.16232312,0.00005070894,0.00015173826,0.011628543],"study_design_scores_gemma":[0.000010494897,0.00018517848,0.9646292,0.000012753173,0.00010256873,0.003928076,0.0004695388,0.0017023581,0.027307315,0.000107146094,0.0015388399,0.0000066333046],"about_ca_topic_score_codex":0.000541026,"about_ca_topic_score_gemma":0.0011183721,"teacher_disagreement_score":0.0010489334,"about_ca_system_score_codex":0.00018979992,"about_ca_system_score_gemma":0.00010316191,"threshold_uncertainty_score":0.003049314},"labels":[],"label_agreement":null},{"id":"W4404939528","doi":"","title":"Immune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non&ndash;Small Cell Lung Cancer: Emerging Mechanisms and Perspectives","year":2020,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stage (stratigraphy); Lung cancer; Immune system; Cancer research; Cancer; Medicine; Oncology; Immunology; Internal medicine; Biology","score_opus":0.19703219933805025,"score_gpt":0.5301286365175516,"score_spread":0.3330964371795013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404939528","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007041576,0.9828485,0.0007197962,0.0071652825,0.00053305604,0.00003289054,0.00006549217,0.000043298085,0.0015500903],"genre_scores_gemma":[0.041044425,0.9490952,0.0012398275,0.0044189515,0.0028317117,0.00010286307,0.00016048293,0.000010876151,0.0010957823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997702,0.000061724815,0.000024166533,0.000028284541,0.000059284146,0.00005631784],"domain_scores_gemma":[0.999488,0.00018862395,0.00010922954,0.00001662534,0.000112722126,0.00008474893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017581425,0.00065164105,0.0012593972,0.00062861503,0.0002202558,0.0012632061,0.0007875856,0.00096318714,0.0020512275],"category_scores_gemma":[0.0006688668,0.00017659891,0.000720758,0.0005360372,0.00069312175,0.0017910968,0.000654735,0.002717703,0.00051984616],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023588645,0.0010747997,0.0021864148,0.005091463,0.00035327554,0.0005390007,0.00015539803,0.0011573168,0.012100848,0.008938839,0.037529085,0.92851466],"study_design_scores_gemma":[0.0067511075,0.01887762,0.019629903,0.007704865,0.002046445,0.0041491836,0.0008442261,0.009418343,0.011515304,0.025926597,0.8929363,0.00020012181],"about_ca_topic_score_codex":0.0003238197,"about_ca_topic_score_gemma":0.0013691384,"teacher_disagreement_score":0.0020512275,"about_ca_system_score_codex":0.00042945935,"about_ca_system_score_gemma":0.00083922956,"threshold_uncertainty_score":0.009298086},"labels":[],"label_agreement":null},{"id":"W4404984759","doi":"10.1007/s00259-024-07011-2","title":"Preclinical safety and effectiveness of a long-acting somatostatin analogue [225Ac]Ac-EBTATE against small cell lung cancer and pancreatic neuroendocrine tumors","year":2024,"lang":"en","type":"article","venue":"European Journal of Nuclear Medicine and Molecular Imaging","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; Université Laval; University of Saskatchewan","funders":"","keywords":"Biodistribution; Medicine; Somatostatin receptor 2; Pharmacokinetics; Somatostatin receptor; Neuroendocrine tumors; Internal medicine; Radionuclide therapy; Somatostatin; Radioligand; Octreotide; Endocrinology; Pharmacology; Receptor; Biology; In vivo","score_opus":0.016936122211568046,"score_gpt":0.3281207674784843,"score_spread":0.31118464526691625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404984759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586535,0.0018983667,0.00045991194,0.00015450084,0.00008165649,0.00013529461,0.00030879205,0.00004331742,0.00105276],"genre_scores_gemma":[0.996729,0.0009720216,0.00032169983,0.00005295374,0.00006232993,0.000067170404,0.0005536757,0.000016969381,0.0012241981],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994325,0.00026563677,0.00004057148,0.00006120814,0.00006492554,0.00013507098],"domain_scores_gemma":[0.9991254,0.00025767912,0.00015965578,0.000107364205,0.000089681685,0.00026029197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091206253,0.00061180687,0.00078761566,0.00052275247,0.0003110725,0.0007041311,0.00078105304,0.00081890414,0.0025986913],"category_scores_gemma":[0.0008370892,0.0004206161,0.00075921643,0.0003011614,0.00094176765,0.0008001693,0.00019208458,0.0018899812,0.0005764417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17227559,0.03195242,0.002316169,0.00045651323,0.0004965841,0.00050655723,0.0003097215,0.0037721803,0.7442475,0.00060856214,0.0011130957,0.041945133],"study_design_scores_gemma":[0.014236921,0.6022137,0.009051511,0.000040529612,0.00071264524,0.00082776695,0.0002521099,0.0030418904,0.3652539,0.00022417409,0.0040974705,0.000047385496],"about_ca_topic_score_codex":0.0018493659,"about_ca_topic_score_gemma":0.0017588934,"teacher_disagreement_score":0.0025986913,"about_ca_system_score_codex":0.0005701429,"about_ca_system_score_gemma":0.00087735587,"threshold_uncertainty_score":0.008693516},"labels":[],"label_agreement":null},{"id":"W4405333204","doi":"10.1007/s12022-024-09844-x","title":"Insights into Biologic Evolution of Grade 3 Neuroendocrine Tumors Reflect Classification Challenges","year":2024,"lang":"en","type":"editorial","venue":"Endocrine Pathology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Neuroendocrine tumors; Medicine; Biology; Computational biology; Pathology; Oncology","score_opus":0.046479539844225044,"score_gpt":0.380929945337969,"score_spread":0.33445040549374394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405333204","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050067796,0.0048919963,0.00017886076,0.04351519,0.95067835,0.000013439347,0.00004263869,0.000033423315,0.00059610076],"genre_scores_gemma":[0.00029858504,0.0025131817,0.00012338159,0.018983686,0.9757776,0.0000141477585,0.000019099356,0.00001910156,0.0022511948],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922725,0.0020479637,0.0012856452,0.00092716346,0.0030335325,0.0004332311],"domain_scores_gemma":[0.93038523,0.040750165,0.0026878447,0.0015935694,0.019795852,0.0047874125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020164877,0.003165398,0.0041912,0.0044805827,0.002992045,0.00823361,0.0035971918,0.016026845,0.0054446384],"category_scores_gemma":[0.053687535,0.0015690081,0.0027542962,0.0019922678,0.0039452473,0.0057776985,0.0020036087,0.029747944,0.0052937507],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062676554,0.000013425064,0.00011192895,0.0002659275,0.000047719248,0.00012755117,0.00002522881,0.000036669215,0.000084040956,0.00043378546,0.98881406,0.009976942],"study_design_scores_gemma":[0.00014682324,0.000077801335,0.0015367505,0.0012014369,0.0002555244,0.00077746896,0.00016549425,0.00046705207,0.00026493796,0.004056188,0.9909758,0.000074659794],"about_ca_topic_score_codex":0.002260518,"about_ca_topic_score_gemma":0.006732255,"teacher_disagreement_score":0.020164877,"about_ca_system_score_codex":0.003713849,"about_ca_system_score_gemma":0.0034497825,"threshold_uncertainty_score":0.10664332},"labels":[],"label_agreement":null},{"id":"W4405740627","doi":"10.1093/neuonc/noae271","title":"Hippocampal avoidance prophylactic cranial irradiation (HA-PCI) for small-cell lung cancer better preserves white matter networks compared to conventional PCI","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"KWF Kankerbestrijding; Vlaamse regering; Vlaamse Liga Tegen Kanker; Fonds NutsOhra","keywords":"Conventional PCI; Prophylactic cranial irradiation; Hippocampal formation; Neurocognitive; White matter; Hippocampus; Medicine; Neuropsychology; Neuroscience; Cardiology; Internal medicine; Cognition; Psychology; Radiology; Magnetic resonance imaging","score_opus":0.029815567915925222,"score_gpt":0.35491882690403387,"score_spread":0.32510325898810866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405740627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979133,0.0012618063,0.00026180915,0.0000456529,0.00001664112,0.000061492305,0.000052634743,0.000015648277,0.00037106717],"genre_scores_gemma":[0.99899095,0.00041932322,0.00031242243,0.00003431981,0.000014247684,0.000044285916,0.00008118066,0.000002524812,0.00010078711],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999312,0.000016057638,0.000004996656,0.00001811934,0.000013820811,0.00001578305],"domain_scores_gemma":[0.99985445,0.00002489057,0.00005883229,0.0000170959,0.000008654449,0.00003602404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001781211,0.00024164279,0.00041585576,0.00016971746,0.00015441167,0.00021990913,0.00023473374,0.00018106814,0.0010669988],"category_scores_gemma":[0.00033608754,0.00007381477,0.000339355,0.00019457052,0.00024640665,0.00023384155,0.0001535804,0.00040279882,0.000079474354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15603788,0.020703359,0.07191047,0.0025235729,0.0030346722,0.00030430753,0.00025407897,0.011168819,0.18289775,0.0009107008,0.0028350286,0.5474194],"study_design_scores_gemma":[0.025702238,0.5288672,0.3658905,0.00023534059,0.0028583864,0.0014451944,0.00024710663,0.008471135,0.05585267,0.001189264,0.0091654435,0.00007564409],"about_ca_topic_score_codex":0.0007673596,"about_ca_topic_score_gemma":0.0021673434,"teacher_disagreement_score":0.0010669988,"about_ca_system_score_codex":0.00025874816,"about_ca_system_score_gemma":0.00045964753,"threshold_uncertainty_score":0.0035694838},"labels":[],"label_agreement":null},{"id":"W4406061941","doi":"10.1016/j.lungcan.2025.108080","title":"Assessing the feasibility and external validity of natural language processing-extracted data for advanced lung cancer patients","year":2025,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); University Health Network; Systems, Applications & Products in Data Processing (Canada); Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation; F. Hoffmann-La Roche","keywords":"Medicine; Lung cancer; Intensive care medicine; Natural language processing; Medical physics; Oncology; Computer science","score_opus":0.060318550680282884,"score_gpt":0.48930471986458773,"score_spread":0.4289861691843049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406061941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9186535,0.0021429353,0.056424245,0.0026455927,0.0005450443,0.0041610817,0.008595969,0.00044930508,0.0063823853],"genre_scores_gemma":[0.96565264,0.0003297944,0.023521459,0.0005572633,0.00022767718,0.0025636351,0.0067728683,0.000103646424,0.00027105442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.8304647,0.109880835,0.027534071,0.011816003,0.018761888,0.0015425308],"domain_scores_gemma":[0.34347436,0.5134349,0.05579402,0.03973525,0.045836233,0.0017252483],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2018125,0.00082262227,0.0009717872,0.004938737,0.0011395264,0.0035156705,0.0016953327,0.0012743634,0.0017992894],"category_scores_gemma":[0.46185532,0.0005299869,0.0037367297,0.004597426,0.003178272,0.0025497903,0.004334071,0.0012584182,0.0008510266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028913745,0.00037608686,0.92563003,0.0012081169,0.0014398444,0.00016970649,0.0023384658,0.0032808464,0.0009010384,0.0009398295,0.0025919955,0.058232702],"study_design_scores_gemma":[0.00094696175,0.0027838608,0.9004292,0.00161597,0.0016445923,0.00095598353,0.003277971,0.05865235,0.0075334325,0.006697562,0.015237825,0.00022438247],"about_ca_topic_score_codex":0.0016514198,"about_ca_topic_score_gemma":0.0014224247,"teacher_disagreement_score":0.2018125,"about_ca_system_score_codex":0.0017489808,"about_ca_system_score_gemma":0.0034545134,"threshold_uncertainty_score":0.9843073},"labels":[],"label_agreement":null},{"id":"W4406135453","doi":"10.1016/j.ctro.2025.100917","title":"Real-world outcomes of prophylactic cranial irradiation utilization and efficacy for patients with extensive-stage small cell lung cancer treated with consolidative thoracic radiotherapy","year":2025,"lang":"en","type":"article","venue":"Clinical and Translational Radiation Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; Canadian Institutes of Health Research; Weill Cornell Medical College; Terry Fox Research Institute; Canada Foundation for Innovation; Princess Margaret Cancer Foundation; National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Conventional PCI; Prophylactic cranial irradiation; Medicine; Cumulative incidence; Incidence (geometry); Proportional hazards model; Hazard ratio; Internal medicine; Randomized controlled trial; Radiation therapy; Radiology; Surgery; Oncology; Confidence interval; Myocardial infarction; Transplantation","score_opus":0.05676862559185449,"score_gpt":0.4621101044452192,"score_spread":0.40534147885336475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406135453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985592,0.00057312706,0.00007572087,0.000056302644,0.000003871597,0.000014703132,0.00036977703,0.0000027769563,0.0003444708],"genre_scores_gemma":[0.99944526,0.00009513099,0.000036864505,0.000014890374,0.000008629902,0.000009866445,0.00036610742,8.6153193e-7,0.000022504042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992465,0.00028898296,0.00011789504,0.00012048545,0.000121111916,0.000105053],"domain_scores_gemma":[0.9946406,0.0011765368,0.0031655312,0.00014622205,0.0002753174,0.00059584307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011496602,0.00013650008,0.0003120923,0.00048905466,0.0002208067,0.0006921425,0.00027611817,0.0002635869,0.0008950602],"category_scores_gemma":[0.005139933,0.00007778598,0.0005045554,0.00082063593,0.00032294134,0.00048527512,0.00043256138,0.00041234816,0.00010599125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016047113,0.00008892208,0.99053055,0.00003408626,0.0001538722,0.00005607374,0.00004095574,0.00053192297,0.00011926981,0.00003104495,0.00017882607,0.006629843],"study_design_scores_gemma":[0.000049887167,0.0009931528,0.9976279,0.000012604733,0.0001001731,0.00021745061,0.000081636426,0.0005187645,0.00010569335,0.000042895485,0.00024318964,0.000006666908],"about_ca_topic_score_codex":0.0018616555,"about_ca_topic_score_gemma":0.0028414233,"teacher_disagreement_score":0.0018616555,"about_ca_system_score_codex":0.0007138896,"about_ca_system_score_gemma":0.00043491877,"threshold_uncertainty_score":0.0060800314},"labels":[],"label_agreement":null},{"id":"W4406400630","doi":"10.3390/cancers17020260","title":"Neuroendocrine Transformation as a Mechanism of Resistance to Targeted Lung Cancer Therapies: Emerging Mechanisms and Their Therapeutic Implications","year":2025,"lang":"en","type":"review","venue":"Cancers","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital Research Institute of Manitoba; University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Canadian Institutes of Health Research; CancerCare Manitoba Foundation","keywords":"Lung cancer; Medicine; Mechanism (biology); Targeted therapy; Cancer; Oncology; Treatment of lung cancer; Bioinformatics; Internal medicine; Biology","score_opus":0.03350607489971705,"score_gpt":0.39180885245938524,"score_spread":0.3583027775596682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406400630","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007556892,0.99888366,0.000058360118,0.0002974554,0.0001357971,0.0000024463511,0.000009512483,0.0000037951556,0.0005333646],"genre_scores_gemma":[0.00046760478,0.99886453,0.000079248806,0.00017674733,0.0001180484,0.0000034533243,0.000012857544,7.588856e-7,0.00027674247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998029,0.000043228272,0.000028818271,0.000032926473,0.000070728136,0.000021476686],"domain_scores_gemma":[0.99961406,0.00019079121,0.000047120575,0.000010646705,0.00010824081,0.0000292252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006673024,0.0006297904,0.0011355106,0.0018953885,0.00023885761,0.0010726352,0.00081142894,0.0010126743,0.0031469513],"category_scores_gemma":[0.0008363597,0.0001917947,0.00053300476,0.0018492014,0.0005310306,0.0013021555,0.0005716711,0.0018003774,0.001216808],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009465499,0.000070511545,0.00028677288,0.021065118,0.00009841069,0.00027837715,0.000079231395,0.00038907654,0.0018212432,0.006452586,0.033097133,0.93626684],"study_design_scores_gemma":[0.000021910038,0.00013997819,0.001102917,0.0055648373,0.00015471553,0.0017789986,0.0000944306,0.00012542515,0.00052373967,0.0027756235,0.98769534,0.000022156004],"about_ca_topic_score_codex":0.0009137862,"about_ca_topic_score_gemma":0.0018725048,"teacher_disagreement_score":0.0031469513,"about_ca_system_score_codex":0.00071078923,"about_ca_system_score_gemma":0.0010647816,"threshold_uncertainty_score":0.010527611},"labels":[],"label_agreement":null},{"id":"W4406554841","doi":"10.1016/s1634-6939(18)75846-8","title":"10.1016/s1634-6939(18)75846-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.014862781422329267,"score_gpt":0.26855525853075324,"score_spread":0.25369247710842396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406554841","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035316005,0.00043335342,0.0003867881,0.00040634652,0.0003465308,0.00009890313,0.00069480843,0.0006701483,0.99660987],"genre_scores_gemma":[0.00042563977,0.00020669519,0.00028241324,0.00022304556,0.000103868755,0.000053801778,0.00038033348,0.00011913053,0.99820495],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993573,0.00004203361,0.000057634952,0.00019870987,0.0001983121,0.00014593391],"domain_scores_gemma":[0.9975146,0.0005859534,0.00015636218,0.00025308254,0.00046376363,0.0010262243],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001131302,0.002708951,0.0017864828,0.0032136953,0.002441513,0.0036196932,0.0031148056,0.0055913245,0.99010545],"category_scores_gemma":[0.0018819969,0.0010077803,0.0016574393,0.002312281,0.0016112316,0.0047675283,0.0035803737,0.0027501269,0.99277097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036924926,0.00024791958,0.00086161593,0.00056026597,0.000033867305,0.00022354074,0.00008318466,0.000343325,0.0016278654,0.003859356,0.3938785,0.5979113],"study_design_scores_gemma":[0.00007136124,0.00012117108,0.0010134187,0.00031008435,0.000012852099,0.00035990714,0.00009730744,0.00013919824,0.00029996736,0.00051354524,0.9970381,0.000023094191],"about_ca_topic_score_codex":0.004287223,"about_ca_topic_score_gemma":0.004131703,"teacher_disagreement_score":0.00989455,"about_ca_system_score_codex":0.0010891779,"about_ca_system_score_gemma":0.0013251506,"threshold_uncertainty_score":0.014113367},"labels":[],"label_agreement":null},{"id":"W4406583287","doi":"10.1016/s1155-195x(20)30207-3","title":"10.1016/s1155-195x(20)30207-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology","score_opus":0.010257737401582204,"score_gpt":0.2525233760039636,"score_spread":0.24226563860238137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406583287","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003359371,0.0003747883,0.00045084985,0.0003491924,0.0003095363,0.00009528384,0.00063342805,0.0006724793,0.99677855],"genre_scores_gemma":[0.00045007744,0.00019189052,0.0003057749,0.00021423047,0.00008287029,0.000056594883,0.00032916106,0.0001229536,0.99824643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99929893,0.000044702567,0.000060927305,0.00024435972,0.00020714205,0.00014392125],"domain_scores_gemma":[0.99772817,0.000571418,0.00013413074,0.000260174,0.00041647517,0.000889602],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011863128,0.002831765,0.0019403924,0.003319762,0.0028192059,0.004246268,0.0034666243,0.006327069,0.99137175],"category_scores_gemma":[0.0017823176,0.001081351,0.0018987022,0.002614011,0.0019337289,0.004887585,0.0037363714,0.002783031,0.9937403],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042356746,0.00023676615,0.0008332691,0.0006939537,0.00004017797,0.00023457863,0.00009971189,0.00045752767,0.0018809579,0.0055722045,0.35935056,0.6301767],"study_design_scores_gemma":[0.000062334024,0.00012612947,0.000792836,0.0003257232,0.000014247357,0.00031841037,0.00011011421,0.00018336283,0.00031735448,0.00057168276,0.9971529,0.000024838664],"about_ca_topic_score_codex":0.0051290356,"about_ca_topic_score_gemma":0.004843837,"teacher_disagreement_score":0.008628249,"about_ca_system_score_codex":0.0013366491,"about_ca_system_score_gemma":0.0013892594,"threshold_uncertainty_score":0.012307048},"labels":[],"label_agreement":null},{"id":"W4406738245","doi":"10.1016/s1052-3359(25)00558-7","title":"Small-Cell Lung Cancer","year":2001,"lang":"en","type":"article","venue":"Chest Surgery Clinics of North America","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Lung cancer; Cancer; Oncology; Internal medicine","score_opus":0.06512340970010452,"score_gpt":0.3656849645134011,"score_spread":0.3005615548132966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406738245","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7493267,0.016784832,0.000388135,0.0056766653,0.0010019809,0.0018409091,0.051280864,0.0001049799,0.173595],"genre_scores_gemma":[0.88110846,0.010770288,0.0005497149,0.0035569686,0.0011153596,0.0012801889,0.02659905,0.000025387924,0.07499456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993069,0.00020275572,0.00007930244,0.000109874476,0.0001543579,0.00014672308],"domain_scores_gemma":[0.9986498,0.00027480617,0.00018233573,0.00013943123,0.0003072785,0.00044636463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006332835,0.00019915482,0.00032051792,0.0019834945,0.0013362966,0.0006747228,0.00033032557,0.00033894842,0.022701617],"category_scores_gemma":[0.001901769,0.00019922662,0.0003080877,0.0025771237,0.00027281916,0.000628312,0.0006216964,0.0004982575,0.004213811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014268915,0.0009050921,0.8278912,0.0005683919,0.0001324222,0.000799077,0.0007228149,0.00006455528,0.0015210026,0.0014585091,0.085383885,0.079126224],"study_design_scores_gemma":[0.00027239326,0.0006570851,0.8992736,0.00011597146,0.00010293165,0.0009581776,0.00069787994,0.000054417225,0.00043615626,0.00014792898,0.097275205,0.000008250398],"about_ca_topic_score_codex":0.020273274,"about_ca_topic_score_gemma":0.056805648,"teacher_disagreement_score":0.022701617,"about_ca_system_score_codex":0.0007231313,"about_ca_system_score_gemma":0.0017776308,"threshold_uncertainty_score":0.07594448},"labels":[],"label_agreement":null},{"id":"W4406787938","doi":"10.1016/j.jtho.2025.01.013","title":"The International Association for the Study of Lung Cancer Staging Project: The Database and Proposal for the Revision of the Staging of Pulmonary Neuroendocrine Carcinoma in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"International Association for the Study of Lung Cancer; Sanofi; AstraZeneca","keywords":"Medicine; Ninth; Neuroendocrine carcinoma; Lung cancer staging; Lung cancer; Oncology; General surgery; Carcinoma; Internal medicine","score_opus":0.04515490801387808,"score_gpt":0.4892663703647838,"score_spread":0.44411146235090576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406787938","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07645711,0.04041235,0.05158279,0.18741886,0.046440795,0.013078996,0.55526465,0.0016963999,0.027648095],"genre_scores_gemma":[0.109748945,0.019325865,0.16212338,0.022743316,0.008795171,0.02744998,0.6383512,0.00087495893,0.010587109],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9877927,0.0035691676,0.0035780251,0.0007453281,0.0034169636,0.0008977195],"domain_scores_gemma":[0.93195415,0.009141837,0.0075864065,0.0051744296,0.038834132,0.0073090005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033463635,0.0018176662,0.005472505,0.0078105363,0.0022919746,0.004941778,0.007447061,0.003927721,0.0035018157],"category_scores_gemma":[0.046182103,0.0019955423,0.0032478415,0.017857509,0.0015426589,0.002426414,0.0049546342,0.011530116,0.0029162492],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018723289,0.0007316408,0.16368574,0.0017158155,0.0011189866,0.00027265574,0.00065918517,0.0016347236,0.0021188927,0.0090193935,0.686058,0.13111258],"study_design_scores_gemma":[0.002373954,0.00045820014,0.6592809,0.0020825372,0.0017456927,0.0005118187,0.0008799972,0.0026024838,0.0015663399,0.005214147,0.3229539,0.00033006698],"about_ca_topic_score_codex":0.0810859,"about_ca_topic_score_gemma":0.07777852,"teacher_disagreement_score":0.0810859,"about_ca_system_score_codex":0.0067873313,"about_ca_system_score_gemma":0.043205813,"threshold_uncertainty_score":0.17697477},"labels":[],"label_agreement":null},{"id":"W4406809476","doi":"10.21037/tcr-24-1711","title":"On the precipice of a new generation of biomarkers for immunotherapy in small cell lung cancer","year":2025,"lang":"en","type":"letter","venue":"Translational Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Immunotherapy; Lung cancer; Medicine; Cancer; Cancer immunotherapy; Oncology; Cancer research; Immunology; Internal medicine","score_opus":0.18517779788675498,"score_gpt":0.4655473992923152,"score_spread":0.2803696014055602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406809476","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004656885,0.0033087137,0.00015320828,0.97776073,0.016867656,0.000012345143,0.00003076613,0.000015911637,0.0013849639],"genre_scores_gemma":[0.0048033306,0.0032467162,0.0003924039,0.8938827,0.094238415,0.000048159898,0.000032394662,0.000026366983,0.0033295916],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9893211,0.005199195,0.0011489558,0.0008670214,0.0027521355,0.00071158085],"domain_scores_gemma":[0.9431323,0.044912264,0.0016842749,0.0012635575,0.0051895995,0.0038179862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014021309,0.0009592277,0.0029549077,0.0010391853,0.0037307523,0.0043406524,0.0024848143,0.06043201,0.004861206],"category_scores_gemma":[0.04545358,0.00086637144,0.0013108485,0.00084576674,0.0066577992,0.0071994574,0.002235882,0.04718767,0.0039649415],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030759218,0.00010392583,0.0011473597,0.00017199633,0.000045287667,0.0023006182,0.0001709781,0.00011691138,0.00057190016,0.0073732235,0.96394026,0.023749916],"study_design_scores_gemma":[0.0005974885,0.0003445254,0.0018123393,0.00054897554,0.00009228524,0.0023028182,0.00056939997,0.0008306425,0.00071116746,0.030379213,0.9617037,0.00010740413],"about_ca_topic_score_codex":0.0021525945,"about_ca_topic_score_gemma":0.0045947772,"teacher_disagreement_score":0.06043201,"about_ca_system_score_codex":0.004656109,"about_ca_system_score_gemma":0.004954526,"threshold_uncertainty_score":0.07415265},"labels":[],"label_agreement":null},{"id":"W4408065122","doi":"10.1016/j.lungcan.2025.108334","title":"225 Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial","year":2025,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Durvalumab; Regimen; Oncology; Chemoradiotherapy; Conventional PCI; Internal medicine; Radiation therapy; Cancer; Immunotherapy","score_opus":0.03159646343939662,"score_gpt":0.39573207681587,"score_spread":0.3641356133764734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408065122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924616,0.005576192,0.000088352106,0.00024732595,0.00010671283,0.00010240222,0.00042819066,0.000010721813,0.0009786004],"genre_scores_gemma":[0.99673104,0.0014864772,0.00012221033,0.00029366484,0.00009137379,0.000054092074,0.0006340711,0.0000027940866,0.0005841808],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99956006,0.00022415559,0.000032847824,0.00006255384,0.000035809047,0.00008445602],"domain_scores_gemma":[0.9994784,0.00011658803,0.00013705864,0.000055065248,0.00003263339,0.00018032469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088798895,0.00055440806,0.001248905,0.00015389103,0.00020429838,0.00096061593,0.00044135956,0.00042813437,0.0013637942],"category_scores_gemma":[0.00091096264,0.00021787385,0.0017118442,0.00027177448,0.00038055566,0.00048869115,0.00030812796,0.0013770032,0.00025171592],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.882997,0.0029267676,0.037012246,0.00064159394,0.008079928,0.00009742132,0.00007927249,0.0010344645,0.004067577,0.0003568431,0.0022157137,0.0604911],"study_design_scores_gemma":[0.5041981,0.18076666,0.27384317,0.0003784595,0.020280683,0.00045494878,0.00033259776,0.0037905497,0.004667104,0.001212774,0.009971686,0.00010327805],"about_ca_topic_score_codex":0.0028285244,"about_ca_topic_score_gemma":0.0055187475,"teacher_disagreement_score":0.0028285244,"about_ca_system_score_codex":0.00087638333,"about_ca_system_score_gemma":0.00077750377,"threshold_uncertainty_score":0.0063586235},"labels":[],"label_agreement":null},{"id":"W4408144109","doi":"10.1016/j.jtho.2024.12.021","title":"Predictive Biomarker for SCLC Therapeutics: A Broken Promise or a Complex Disease With Missing Links","year":2025,"lang":"en","type":"editorial","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Medicine; Biomarker; Disease; Biomarker discovery; Oncology; Internal medicine; Proteomics; Gene; Genetics","score_opus":0.07089036606738772,"score_gpt":0.5033168943564978,"score_spread":0.4324265282891101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408144109","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029678307,0.006880407,0.00014915399,0.025950164,0.96636325,0.000018658524,0.00005135395,0.000048513117,0.0005087417],"genre_scores_gemma":[0.00023146138,0.0045151766,0.00012867553,0.015807012,0.9770756,0.000016555457,0.000025668216,0.000019077328,0.0021807542],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99033725,0.0023823553,0.0015895247,0.0010282199,0.0041346275,0.0005280845],"domain_scores_gemma":[0.93544567,0.03569139,0.002820776,0.0013867633,0.018503824,0.006151642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020175597,0.0051506944,0.009022999,0.0046798834,0.0031359908,0.01102415,0.005599074,0.022085425,0.010911829],"category_scores_gemma":[0.048265554,0.001898282,0.0050002174,0.0019324594,0.0036048975,0.0065022483,0.0020167362,0.030769562,0.00886658],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015432935,0.00002143741,0.00004743301,0.0005940778,0.00009312715,0.00011873605,0.000010731589,0.000034102446,0.00007060418,0.000415191,0.9898825,0.008557724],"study_design_scores_gemma":[0.00060098094,0.0001927167,0.00075407117,0.002687698,0.0007633096,0.00067936303,0.00010592128,0.00087924075,0.00031185482,0.004769796,0.9881523,0.00010284156],"about_ca_topic_score_codex":0.0017627077,"about_ca_topic_score_gemma":0.0039399914,"teacher_disagreement_score":0.022085425,"about_ca_system_score_codex":0.003925619,"about_ca_system_score_gemma":0.005054974,"threshold_uncertainty_score":0.1067},"labels":[],"label_agreement":null},{"id":"W4408153935","doi":"10.1038/s41467-025-57257-z","title":"PARP inhibitor radiosensitization enhances anti-PD-L1 immunotherapy through stabilizing chemokine mRNA in small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Nature Communications","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto; Princess Margaret Cancer Centre; McGill University; University Health Network","funders":"National Center for Advancing Translational Sciences; Terry Fox Research Institute; National Cancer Institute; Foundation for the National Institutes of Health","keywords":"Chemokine; Immunotherapy; Lung cancer; Cancer research; PARP inhibitor; Poly ADP ribose polymerase; Medicine; Cancer immunotherapy; Immunology; Immune system; Biology; Oncology; DNA; Polymerase; Genetics","score_opus":0.020724234770475542,"score_gpt":0.377221889949697,"score_spread":0.3564976551792215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408153935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882798,0.0042175464,0.0036771223,0.00020365452,0.000082250044,0.00009301256,0.00045712886,0.0002493279,0.0027402397],"genre_scores_gemma":[0.9940631,0.0016474433,0.0018497327,0.00008856425,0.00001971924,0.000080544516,0.00040450649,0.00001659757,0.0018299149],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992585,0.0000125744955,0.000006295608,0.00001476813,0.000018982884,0.00002155223],"domain_scores_gemma":[0.9999682,0.000005473197,0.00000947864,0.0000036474023,0.000004238435,0.000008830406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009009411,0.00022734945,0.00023222582,0.00018442479,0.00009848895,0.00023757592,0.00015471055,0.00017930182,0.0015818676],"category_scores_gemma":[0.00006729107,0.000095816,0.00024218432,0.0001252147,0.0001235837,0.00017690346,0.00010690224,0.00061683665,0.00030602913],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046797766,0.00025524947,0.00023142107,0.00011748973,0.000010316467,0.000038067818,0.000012994954,0.0003452185,0.98806363,0.000096251846,0.00033590596,0.01002546],"study_design_scores_gemma":[0.00013293466,0.0036060445,0.0044365874,0.000006794959,0.000038135957,0.00027899357,0.000016857814,0.0015115888,0.9845666,0.000053603664,0.005344594,0.0000071885934],"about_ca_topic_score_codex":0.00027141042,"about_ca_topic_score_gemma":0.00057510287,"teacher_disagreement_score":0.0015818676,"about_ca_system_score_codex":0.00020638626,"about_ca_system_score_gemma":0.00020195106,"threshold_uncertainty_score":0.005291879},"labels":[],"label_agreement":null},{"id":"W4408387396","doi":"10.3390/curroncol32030163","title":"A Recurrent Small Cell Lung Carcinoma Harboring an EML4–ALK Fusion Mutation with Sustained Response to Ensartinib: A Case Report","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Fusion gene; Cancer research; Mutation; Lung cancer; Gene; Oncology; Biology; Genetics","score_opus":0.06957705211892619,"score_gpt":0.44324317419409703,"score_spread":0.37366612207517086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408387396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97375,0.0063953474,0.005083444,0.004477628,0.000574094,0.00021563076,0.00034172626,0.00036364462,0.00879856],"genre_scores_gemma":[0.9918516,0.001702308,0.0020468892,0.000955642,0.0011149538,0.000036522986,0.00017022235,0.00003763333,0.0020841486],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9990765,0.000086060565,0.00011929676,0.000261446,0.0001611572,0.00029548092],"domain_scores_gemma":[0.9983512,0.0003695793,0.0003632999,0.00021636997,0.000109815686,0.0005896164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044385792,0.0019583073,0.0018465329,0.0028789272,0.0032646381,0.0017395407,0.0016962286,0.0074264323,0.0024114868],"category_scores_gemma":[0.002106451,0.001263611,0.002145987,0.0016533486,0.0018807477,0.002237311,0.0014908556,0.0037467675,0.0015308231],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002163991,0.000030914813,0.0019749445,0.000020608733,0.000008610018,0.99621,0.00009499664,0.000046211124,0.0005680375,0.00007533402,0.00015177425,0.0007968724],"study_design_scores_gemma":[0.000008298884,0.00006280678,0.0018163745,0.0000065970653,0.000021342248,0.9969766,0.000058301826,0.00022978408,0.00041487336,0.00005354262,0.00033916175,0.0000122443735],"about_ca_topic_score_codex":0.0027106225,"about_ca_topic_score_gemma":0.003453338,"teacher_disagreement_score":0.0074264323,"about_ca_system_score_codex":0.0015391243,"about_ca_system_score_gemma":0.00096025865,"threshold_uncertainty_score":0.011167169},"labels":[],"label_agreement":null},{"id":"W4408431596","doi":"10.1186/s13195-025-01706-w","title":"Beyond expectations: investigating nilotinib’s potential in attenuating neurodegeneration in Alzheimer’s disease","year":2025,"lang":"en","type":"review","venue":"Alzheimer s Research & Therapy","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"National Institute on Aging","keywords":"Neurodegeneration; Neurology; Disease; Medicine; Geriatric psychiatry; Psychopharmacology; Neuroscience; Nilotinib; Psychology; Psychiatry; Internal medicine","score_opus":0.2501518016237052,"score_gpt":0.4991603195452006,"score_spread":0.24900851792149542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408431596","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009469973,0.99878937,0.000042781383,0.00037392994,0.00013753575,0.0000031252862,0.000011755864,0.0000038317053,0.000542995],"genre_scores_gemma":[0.0006642629,0.9984059,0.00008091252,0.00040395575,0.00010676634,0.0000068751697,0.000018752438,0.0000011464355,0.0003113715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997193,0.0000786987,0.000047999034,0.000038402737,0.00009176624,0.000023795872],"domain_scores_gemma":[0.999506,0.0002779205,0.000057304354,0.000010193548,0.0001189963,0.00002956061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010929581,0.00062982494,0.0014321649,0.0017345763,0.00022978784,0.0012200199,0.0008665097,0.0011599849,0.00284516],"category_scores_gemma":[0.0013136769,0.00019745952,0.0007574196,0.001771355,0.000427292,0.0017376421,0.00054125785,0.0018485175,0.001231237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000188649,0.00005408958,0.00013765562,0.04731521,0.000239002,0.00018849272,0.00012679036,0.00037586593,0.0018935539,0.006237984,0.03043248,0.9128102],"study_design_scores_gemma":[0.00006687077,0.0001945595,0.00082768925,0.01765951,0.00039308434,0.00082839123,0.00013553974,0.00013220945,0.0005555826,0.004294284,0.97488683,0.000025491341],"about_ca_topic_score_codex":0.0010992913,"about_ca_topic_score_gemma":0.002133907,"teacher_disagreement_score":0.00284516,"about_ca_system_score_codex":0.0006997735,"about_ca_system_score_gemma":0.0017356491,"threshold_uncertainty_score":0.009518027},"labels":[],"label_agreement":null},{"id":"W4408745550","doi":"10.1136/bmjopen-2024-093943","title":"Retrospective cohort study assessing clinical outcomes of patients with extensive-stage small cell lung cancer treated with and without consolidative thoracic radiotherapy at the Princess Margaret Cancer Centre","year":2025,"lang":"en","type":"article","venue":"BMJ Open","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Retrospective cohort study; Lung cancer; Internal medicine; Tolerability; Chemotherapy; Radiation therapy; Stage (stratigraphy); Regimen; Surgery; Oncology; Adverse effect","score_opus":0.05923953237721239,"score_gpt":0.49160016638802295,"score_spread":0.43236063401081054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408745550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993075,0.00010376298,0.000044027027,0.000009017702,0.0000032301655,0.0000341158,0.00033405362,0.000001456733,0.00016285536],"genre_scores_gemma":[0.99907184,0.00005530784,0.000051353305,0.000022596845,0.000009015532,0.00003340266,0.0006915567,0.000002030036,0.00006273843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914885,0.00016435374,0.00010609097,0.0002635963,0.00017236875,0.0001447494],"domain_scores_gemma":[0.9977227,0.00034040248,0.0010390371,0.00016293407,0.00025345947,0.00048146438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008288298,0.0003070965,0.00070164603,0.0010041858,0.0006925064,0.00068992085,0.0004009937,0.00044442213,0.0013687608],"category_scores_gemma":[0.0019824433,0.00038595227,0.00056953676,0.0013072373,0.00047277444,0.00068178936,0.0006228799,0.0005958362,0.0002547231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027139008,0.000048007467,0.99875236,0.000008261839,0.000043258322,0.00019777348,0.00006870741,0.000018416426,0.00015232027,0.000007522656,0.00004338462,0.0003886516],"study_design_scores_gemma":[0.000038648996,0.00072973,0.99762446,0.000006629838,0.000040010695,0.0008454237,0.00032802465,0.00009494347,0.000068540874,0.000009382486,0.00020762414,0.0000066131233],"about_ca_topic_score_codex":0.004845433,"about_ca_topic_score_gemma":0.0048849466,"teacher_disagreement_score":0.004845433,"about_ca_system_score_codex":0.0006718657,"about_ca_system_score_gemma":0.0007634087,"threshold_uncertainty_score":0.009634495},"labels":[],"label_agreement":null},{"id":"W4408929714","doi":"10.6004/jnccn.2024.7262","title":"HSR25-180: Real-World (rw) Characteristics, Treatment (tx) Patterns and Clinical Outcomes in Patients (pts) With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Received Chemoradiotherapy (CRT)","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Chemoradiotherapy; Stage (stratigraphy); Oncology; Internal medicine; Lung cancer; Cancer","score_opus":0.046397441055767874,"score_gpt":0.39264714849384935,"score_spread":0.3462497074380815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408929714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99129593,0.0002655148,0.000045200344,0.00030977093,0.000028271816,0.000045175046,0.0072874078,0.0000062690724,0.0007164857],"genre_scores_gemma":[0.9911157,0.00012456901,0.00012812977,0.00016569307,0.000043780285,0.000054947144,0.007706694,0.000004194092,0.0006563446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968266,0.0001098569,0.000036371763,0.000056670524,0.000051415733,0.00006305688],"domain_scores_gemma":[0.9985532,0.00013120963,0.000732077,0.00006810929,0.00012673868,0.0003885619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007315584,0.0002194659,0.00023849326,0.0005775507,0.00028306068,0.0004546352,0.0003743332,0.0004112355,0.0024544834],"category_scores_gemma":[0.001504402,0.00014743471,0.00053507264,0.0011626829,0.00019177714,0.00042066444,0.00046769236,0.00041977593,0.0005525276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001230017,0.00013404145,0.9918516,0.000036576912,0.00019278457,0.00004221926,0.000066776214,0.00010442922,0.00016678942,0.00003500517,0.0030908738,0.0030488917],"study_design_scores_gemma":[0.00008988833,0.0003117083,0.9984275,0.000011805522,0.000060984632,0.00005097853,0.000107145446,0.00010126377,0.00004799474,0.00001571158,0.000768885,0.000006221322],"about_ca_topic_score_codex":0.007459136,"about_ca_topic_score_gemma":0.013739698,"teacher_disagreement_score":0.007459136,"about_ca_system_score_codex":0.000516401,"about_ca_system_score_gemma":0.0007525861,"threshold_uncertainty_score":0.014831424},"labels":[],"label_agreement":null},{"id":"W4408981555","doi":"10.1016/s1556-0864(25)00491-5","title":"299P: First-line (1L) durvalumab (D) + platinum-etoposide (EP) in extensive-stage SCLC (ES-SCLC): Final results and exploratory biomarker analyses from LUMINANCE","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Durvalumab; Etoposide; Oncology; Biomarker; Stage (stratigraphy); Internal medicine; Cancer; Nivolumab; Chemotherapy","score_opus":0.12809308711444112,"score_gpt":0.5083823957932491,"score_spread":0.38028930867880795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408981555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97457844,0.0063386397,0.00058623723,0.00082519965,0.00009905961,0.00039101345,0.011323547,0.00009854862,0.005759273],"genre_scores_gemma":[0.96838766,0.0025636354,0.0016678928,0.0007548206,0.00006847839,0.0003120108,0.022915984,0.0000459665,0.0032834522],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99956125,0.00012089788,0.000027673337,0.00011503692,0.00010106359,0.00007411323],"domain_scores_gemma":[0.9995035,0.000108144966,0.00009683897,0.000060825278,0.00008433108,0.00014626041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011411296,0.0004984874,0.0008965783,0.0003215101,0.000252946,0.00089507643,0.0004999316,0.0004330517,0.0036924111],"category_scores_gemma":[0.0015037884,0.00018901324,0.00092699844,0.0004729915,0.00022813921,0.0007474155,0.00038667725,0.000859237,0.001110936],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15628439,0.0025710585,0.2846478,0.0012257297,0.004997511,0.0009069285,0.00020706956,0.002944884,0.022226322,0.00040445768,0.024122342,0.4994615],"study_design_scores_gemma":[0.030134866,0.03069115,0.88086236,0.00046922828,0.006316732,0.0028163353,0.0002769564,0.003107534,0.013955732,0.0009528857,0.03032943,0.00008673173],"about_ca_topic_score_codex":0.0025987036,"about_ca_topic_score_gemma":0.006552273,"teacher_disagreement_score":0.0036924111,"about_ca_system_score_codex":0.0011382863,"about_ca_system_score_gemma":0.00088625913,"threshold_uncertainty_score":0.012352347},"labels":[],"label_agreement":null},{"id":"W4408981570","doi":"10.1016/s1556-0864(25)00489-7","title":"297MO: Patterns of disease progression with durvalumab (D) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC): Results from ADRIATIC","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Medicine; Oncology; Stage (stratigraphy); Chemoradiotherapy; Internal medicine; Disease; Cancer; Lung cancer; Immunotherapy","score_opus":0.022631747890215565,"score_gpt":0.4437401101460588,"score_spread":0.42110836225584325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408981570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984151,0.0005599402,0.000026641628,0.000013578383,0.0000040905034,0.000016612341,0.0004879071,0.000003783357,0.00047233867],"genre_scores_gemma":[0.998252,0.0002399711,0.000075624484,0.0000204881,0.000007595743,0.000012888121,0.00095740636,0.0000022927636,0.000431767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996698,0.00010205175,0.000037057827,0.0000751419,0.00006533044,0.000050703904],"domain_scores_gemma":[0.9995402,0.0001029341,0.0001675665,0.000047544912,0.00006017644,0.00008158311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061493093,0.00020625329,0.00031006994,0.0006202736,0.00020051107,0.0004625767,0.00029266856,0.00023908271,0.0012990488],"category_scores_gemma":[0.0010173668,0.000101974845,0.00050545606,0.00060872623,0.00014684517,0.00039034573,0.00022614612,0.0002425365,0.0002793984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025348322,0.0007775559,0.9240904,0.00010595302,0.00048610638,0.000117606,0.00015221222,0.00019227246,0.0049645007,0.000033759017,0.0003441763,0.043387134],"study_design_scores_gemma":[0.00044775152,0.0032576295,0.99357504,0.000010899965,0.00030186962,0.00019689676,0.00008522292,0.00024142108,0.0010143885,0.000014024237,0.00084731576,0.000007482646],"about_ca_topic_score_codex":0.0050841793,"about_ca_topic_score_gemma":0.006964007,"teacher_disagreement_score":0.0050841793,"about_ca_system_score_codex":0.00042214032,"about_ca_system_score_gemma":0.0002851651,"threshold_uncertainty_score":0.010109186},"labels":[],"label_agreement":null},{"id":"W4409625082","doi":"10.1158/1538-7445.am2025-541","title":"Abstract 541: PARP and autophagy inhibition synergy in small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Autophagy; Lung cancer; Poly ADP ribose polymerase; Cancer research; Cancer; Biology; Medicine; Internal medicine; Apoptosis; Genetics; DNA","score_opus":0.05385608005567917,"score_gpt":0.4419410958944348,"score_spread":0.38808501583875565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93154395,0.024680683,0.0058275987,0.001664922,0.00072989485,0.00040298127,0.009110488,0.001624442,0.024415039],"genre_scores_gemma":[0.9773113,0.005797964,0.0026010915,0.00037941203,0.00005829639,0.00016420601,0.0045875534,0.000069107366,0.009031072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998348,0.000019444886,0.000020206297,0.00003541074,0.00005205925,0.000038012317],"domain_scores_gemma":[0.9999157,0.000011982491,0.000019187706,0.0000092179935,0.000015307754,0.000028669323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020978287,0.00043944226,0.00075229106,0.0003838234,0.0003116181,0.00069996127,0.00039861718,0.0004966733,0.0077536586],"category_scores_gemma":[0.00014358439,0.0001650557,0.00053394726,0.00035238653,0.00018614676,0.0003042354,0.0003565963,0.0010002756,0.0019403731],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024403986,0.0005395676,0.0012599608,0.00095091603,0.00013589906,0.00037421836,0.00003972397,0.001046451,0.94498116,0.00065944926,0.0051666447,0.04240568],"study_design_scores_gemma":[0.00086845196,0.0080517465,0.01597307,0.00012993,0.0004232618,0.0017530234,0.00009347964,0.003918513,0.9213507,0.0005493915,0.046843175,0.000045191602],"about_ca_topic_score_codex":0.00045797924,"about_ca_topic_score_gemma":0.0009926405,"teacher_disagreement_score":0.0077536586,"about_ca_system_score_codex":0.00044439477,"about_ca_system_score_gemma":0.0005165174,"threshold_uncertainty_score":0.02593863},"labels":[],"label_agreement":null},{"id":"W4409633818","doi":"10.1158/1538-7445.am2025-2758","title":"Abstract 2758: Methylome plasticity as a biomarker of treatment response in small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Princess Margaret Cancer Centre","funders":"","keywords":"Biomarker; Lung cancer; Cancer; Biology; DNA methylation; Medicine; Cancer research; Oncology; Internal medicine; Genetics; Gene expression; Gene","score_opus":0.10422788769621784,"score_gpt":0.49205316455889025,"score_spread":0.38782527686267243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98921996,0.0026229208,0.0013434918,0.00015479603,0.000015492264,0.00003578865,0.0055637117,0.00008513387,0.00095867773],"genre_scores_gemma":[0.99529123,0.00029209434,0.00086296216,0.000048348662,0.000009553586,0.00002377113,0.00299831,0.000011486388,0.00046218332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980456,0.00003389856,0.00001642214,0.00004609821,0.00006643284,0.000032602908],"domain_scores_gemma":[0.9994542,0.00016142827,0.00019808713,0.000032891017,0.00007938563,0.00007393601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036177746,0.00020911923,0.00040798305,0.0006333997,0.00018516695,0.00039132952,0.00022669294,0.00029107992,0.002708191],"category_scores_gemma":[0.00096897944,0.000072383715,0.00026040457,0.0008426596,0.00017119879,0.00021399627,0.0002837908,0.000387044,0.00042981523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061397506,0.00013145825,0.66089773,0.00076082017,0.00057000027,0.00025940995,0.00015084216,0.002164229,0.28235844,0.00015110908,0.0015678259,0.04484846],"study_design_scores_gemma":[0.000027924587,0.00051485817,0.9729442,0.000022678576,0.00016649958,0.00033526847,0.00007385873,0.0023006075,0.02183489,0.00023212034,0.0015359968,0.000011155682],"about_ca_topic_score_codex":0.001359028,"about_ca_topic_score_gemma":0.0021065332,"teacher_disagreement_score":0.002708191,"about_ca_system_score_codex":0.00042172562,"about_ca_system_score_gemma":0.00029077815,"threshold_uncertainty_score":0.009059846},"labels":[],"label_agreement":null},{"id":"W4409690046","doi":"10.1158/1538-7445.am2025-427","title":"Abstract 427: Genome-wide CRISPR knockout screen identifies novel determinant of PARP inhibitor resistance in small-cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Princess Margaret Cancer Centre","funders":"","keywords":"CRISPR; PARP inhibitor; Cancer; Biology; Genetics; Genome; Cancer research; Knockout mouse; Lung cancer; Poly ADP ribose polymerase; Computational biology; Medicine; Gene; Pathology","score_opus":0.06454410470683547,"score_gpt":0.4333816477657002,"score_spread":0.36883754305886474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94212514,0.0027937982,0.025924807,0.0006905521,0.00020214521,0.00029002395,0.020404782,0.0017878441,0.0057807774],"genre_scores_gemma":[0.96559584,0.00124832,0.01212151,0.00029769057,0.00001758777,0.00017372899,0.0120506985,0.00022831782,0.008266214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997936,0.000021989707,0.000024098696,0.00004951602,0.00007749093,0.000033342516],"domain_scores_gemma":[0.9998599,0.000034571927,0.00003722219,0.000015958138,0.000018962743,0.00003338135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020313624,0.00037043515,0.00060869695,0.00034800524,0.00024769013,0.0004206943,0.00038071148,0.00050251797,0.0034548827],"category_scores_gemma":[0.000186667,0.00017153457,0.000501817,0.0002989618,0.00020582089,0.00012171829,0.00023354788,0.0006291587,0.0014419772],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014333717,0.000039994648,0.00078495307,0.0001262821,0.000022487533,0.00034462655,0.000021997237,0.0002389011,0.9946372,0.00013031074,0.0005581518,0.002951663],"study_design_scores_gemma":[0.00007500371,0.0005719675,0.02321414,0.000055476154,0.0001757182,0.0028498361,0.000099829755,0.0064063743,0.94734955,0.000198542,0.018956505,0.00004709682],"about_ca_topic_score_codex":0.0013590228,"about_ca_topic_score_gemma":0.0021297785,"teacher_disagreement_score":0.0034548827,"about_ca_system_score_codex":0.00031586664,"about_ca_system_score_gemma":0.00033138227,"threshold_uncertainty_score":0.011557758},"labels":[],"label_agreement":null},{"id":"W4409690532","doi":"10.1158/1538-7445.am2025-2147","title":"Abstract 2147: Radiosensitization via ATM inhibition in small cell lung cancer leads to increased immunogenicity and tumor infiltration","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Immunogenicity; Medicine; Infiltration (HVAC); Cancer research; Lung cancer; Cancer; Oncology; Pathology; Immune system; Internal medicine; Immunology","score_opus":0.032968959835324746,"score_gpt":0.39751457076864183,"score_spread":0.36454561093331705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297863,0.002216302,0.0011037576,0.00017302581,0.00007686634,0.00005314422,0.0006393307,0.00013138677,0.0026276193],"genre_scores_gemma":[0.9938559,0.0007196934,0.0009153466,0.00008595454,0.00001954157,0.000060149694,0.0006930943,0.000016179254,0.0036341373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983907,0.000022988552,0.00001584856,0.00002550541,0.000057055608,0.000039414215],"domain_scores_gemma":[0.99993515,0.000011432141,0.00001651559,0.000006097816,0.000008702341,0.00002204946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014220834,0.00033610934,0.00039951308,0.00026482952,0.00015884389,0.00023009435,0.00021452786,0.00032493885,0.0051858],"category_scores_gemma":[0.00007958561,0.000103165454,0.00031221434,0.00014468955,0.00020179032,0.00014130851,0.00017505203,0.00076514354,0.0007181831],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027634852,0.00009476108,0.00023091919,0.00006763737,0.000007961003,0.000033387616,0.000006599954,0.00006281438,0.99704033,0.00004027135,0.00015299054,0.0019858873],"study_design_scores_gemma":[0.000044724806,0.0024455588,0.00474694,0.000011222191,0.00002516956,0.0003449899,0.000021644897,0.00067333697,0.98933136,0.000024883773,0.0023274985,0.0000028068857],"about_ca_topic_score_codex":0.00042999108,"about_ca_topic_score_gemma":0.00062989246,"teacher_disagreement_score":0.0051858,"about_ca_system_score_codex":0.00023081065,"about_ca_system_score_gemma":0.00022392969,"threshold_uncertainty_score":0.01734829},"labels":[],"label_agreement":null},{"id":"W4409822191","doi":"10.1158/1538-7445.am2025-ct094","title":"Abstract CT094: Durvalumab (D) vs placebo (P) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC): Outcomes by PD-L1 expression in ADRIATIC","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Medicine; Oncology; Internal medicine; Stage (stratigraphy); Chemoradiotherapy; Placebo; Cancer; Pathology; Immunotherapy; Biology","score_opus":0.04740485122507896,"score_gpt":0.4421369264632889,"score_spread":0.3947320752382099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956375,0.0010671574,0.00020639038,0.00021506628,0.00015469753,0.0006167816,0.00082519196,0.00006789488,0.0012093977],"genre_scores_gemma":[0.9962399,0.00042618884,0.00034353754,0.00016886143,0.00009175305,0.00050606503,0.0006987194,0.000008480264,0.001516449],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996208,0.00018400238,0.000027769423,0.00006418949,0.000030024818,0.00007314204],"domain_scores_gemma":[0.99942964,0.00012822627,0.00012882467,0.000053020307,0.000030214094,0.00023001953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079852366,0.0008650404,0.0016998637,0.00031392905,0.00024818798,0.00057137123,0.000752061,0.0007600721,0.0047739237],"category_scores_gemma":[0.00083002454,0.00027396448,0.0009046428,0.00032227024,0.0007438712,0.0005348274,0.0002600773,0.0022100306,0.0006479927],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9534936,0.0069615515,0.0009801888,0.0002370258,0.0004248796,0.000034711273,0.000023856459,0.0004536096,0.01061309,0.00007719725,0.0009128404,0.025787545],"study_design_scores_gemma":[0.55463284,0.42440152,0.010585619,0.00004517866,0.0008592913,0.00012433667,0.000031182593,0.0013727567,0.0065671243,0.00020716229,0.0011482273,0.000024638262],"about_ca_topic_score_codex":0.000923573,"about_ca_topic_score_gemma":0.002358037,"teacher_disagreement_score":0.0047739237,"about_ca_system_score_codex":0.00067757384,"about_ca_system_score_gemma":0.00106529,"threshold_uncertainty_score":0.01597035},"labels":[],"label_agreement":null},{"id":"W4409912100","doi":"10.1016/j.xhgg.2025.100445","title":"Pathogenic germline variants in small cell lung cancer: A systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Human Genetics and Genomics Advances","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; Canada Research Chairs; Ontario Institute for Cancer Research; St. Michael's Hospital; Western University","funders":"National Cancer Institute; National Institutes of Health; Terry Fox Research Institute; Memorial Sloan-Kettering Cancer Center; University of Toronto; Canada Foundation for Innovation; Princess Margaret Cancer Foundation; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Meta-analysis; Germline; Lung cancer; Biology; Cancer; Genetics; Medicine; Oncology; Internal medicine; Gene","score_opus":0.07090975319869,"score_gpt":0.41188827442225434,"score_spread":0.3409785212235643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409912100","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039517735,0.99419445,0.00054258836,0.00019646244,0.000115391034,0.00018045901,0.00057909405,0.000023770719,0.00021596035],"genre_scores_gemma":[0.15285838,0.8412648,0.0024895153,0.00079653173,0.00027459228,0.0009845388,0.0009956518,0.000033861394,0.00030220207],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9918791,0.004027033,0.0021144096,0.0008733943,0.00077593705,0.0003302283],"domain_scores_gemma":[0.98517954,0.011288854,0.0017590153,0.0004436234,0.0011431703,0.00018566071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012190142,0.0028944418,0.016682513,0.0069514206,0.00064050406,0.0031045985,0.0020258394,0.0020332846,0.003386782],"category_scores_gemma":[0.028225008,0.0015651166,0.03883703,0.008810297,0.0005721268,0.0016104195,0.0014741247,0.0016657622,0.00033148366],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011612474,0.000018150306,0.004597157,0.3558555,0.62561774,0.00016023373,0.00007712339,0.00074256427,0.00021975081,0.00015876662,0.00072870404,0.010663037],"study_design_scores_gemma":[0.00027019158,0.00012448177,0.0033721044,0.023187695,0.9710726,0.00010590415,0.000038841063,0.00017304007,0.000079977406,0.00017495314,0.0013804447,0.000019742442],"about_ca_topic_score_codex":0.008887907,"about_ca_topic_score_gemma":0.019967373,"teacher_disagreement_score":0.016682513,"about_ca_system_score_codex":0.002531971,"about_ca_system_score_gemma":0.0036449202,"threshold_uncertainty_score":0.06446844},"labels":[],"label_agreement":null},{"id":"W4409931474","doi":"10.3390/curroncol32050258","title":"A Population Survival Kinetics Assessment of Extensive Small Cell Lung Cancer and Rationale for Maintenance Therapy","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Lung cancer; Population; Cancer therapy; Oncology; Cancer; Bioinformatics; Intensive care medicine; Internal medicine; Biology; Environmental health","score_opus":0.12066166537994488,"score_gpt":0.5026773819871048,"score_spread":0.3820157166071599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409931474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93979794,0.004626065,0.03323,0.0010710665,0.000048831913,0.00067948934,0.0014793394,0.0004166358,0.018650685],"genre_scores_gemma":[0.99350935,0.00046989456,0.0038667736,0.00008343811,0.000026190097,0.00014540808,0.0004522333,0.000029685592,0.0014171088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953103,0.00015119664,0.000035211193,0.00006964314,0.00017638941,0.00003650973],"domain_scores_gemma":[0.99805695,0.0009634838,0.00033321173,0.00017073346,0.0003334514,0.00014206095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026296447,0.00025676566,0.00041035045,0.0007160256,0.0001890217,0.000857783,0.00040162494,0.00035014606,0.002438459],"category_scores_gemma":[0.005188637,0.00014850052,0.00037224588,0.00043928582,0.0002670015,0.0006532095,0.00028982715,0.0006123902,0.0004016602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032769677,0.00054646767,0.6383322,0.000348218,0.00021156916,0.00084509107,0.0004569475,0.018296419,0.039150193,0.006536414,0.0032136205,0.28878585],"study_design_scores_gemma":[0.00011703407,0.0064818924,0.87665856,0.00014377353,0.0002456013,0.003433887,0.00035496234,0.061168075,0.019871557,0.006392315,0.025062764,0.00006951672],"about_ca_topic_score_codex":0.0011053387,"about_ca_topic_score_gemma":0.0012751622,"teacher_disagreement_score":0.0026296447,"about_ca_system_score_codex":0.0008374107,"about_ca_system_score_gemma":0.00064858835,"threshold_uncertainty_score":0.013907015},"labels":[],"label_agreement":null},{"id":"W4409965915","doi":"10.3390/curroncol32050261","title":"ADCs and TCE in SCLC Therapy: The Beginning of a New Era?","year":2025,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Milestone; Drug development; Monoclonal antibody; Chemotherapy; Drug; Immunotherapy; Lung cancer; Intensive care medicine; Oncology; Cancer; Internal medicine; Antibody; Immunology; Pharmacology","score_opus":0.37186130948611357,"score_gpt":0.5912302124212313,"score_spread":0.21936890293511774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409965915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009230551,0.9989568,0.000051574567,0.0003667801,0.00011494149,0.0000022998372,0.000010108577,0.0000034299644,0.00040181447],"genre_scores_gemma":[0.00054575,0.9986687,0.000103285674,0.00027164596,0.00012791206,0.000003909162,0.000016984673,8.7841676e-7,0.00026091895],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981886,0.00004847485,0.000027716922,0.000023484628,0.000060517163,0.000020909503],"domain_scores_gemma":[0.999655,0.00018847598,0.000038091806,0.000009921417,0.00007922715,0.000029230887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072105584,0.00043716977,0.0011075473,0.0014379238,0.00019509792,0.0009694157,0.000558674,0.001027735,0.0035216445],"category_scores_gemma":[0.00086387485,0.00020103522,0.00052581204,0.0014815835,0.00040208007,0.00166173,0.00048981485,0.0018022757,0.0013015703],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120492165,0.000059499715,0.00014170421,0.018718323,0.00008099875,0.00014677893,0.00006709962,0.00029297514,0.0013120195,0.0042531053,0.024863211,0.9499438],"study_design_scores_gemma":[0.000040139246,0.0001723026,0.00059199013,0.0071210563,0.00013299489,0.00083329,0.00008077864,0.000096549826,0.0003963627,0.002352911,0.9881665,0.000015166136],"about_ca_topic_score_codex":0.000998169,"about_ca_topic_score_gemma":0.00266402,"teacher_disagreement_score":0.0035216445,"about_ca_system_score_codex":0.000535489,"about_ca_system_score_gemma":0.0012243184,"threshold_uncertainty_score":0.011781096},"labels":[],"label_agreement":null},{"id":"W4410477751","doi":"10.3389/fonc.2025.1508563","title":"Diagnostic significance of the novel biomarker combination for early-stage non-small cell lung cancer detection: results of the blind clinical study","year":2025,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alpha Cancer Technologies","funders":"","keywords":"Medicine; Stage (stratigraphy); Lung cancer; Biomarker; Clinical significance; Oncology; Internal medicine; Cancer; Prospective cohort study; Radiology","score_opus":0.0463737174783091,"score_gpt":0.41474014284698096,"score_spread":0.36836642536867187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410477751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98932236,0.0026346236,0.0063135666,0.000053441283,0.0000726182,0.0004450343,0.00021426028,0.000049943512,0.0008941541],"genre_scores_gemma":[0.99517703,0.00022002347,0.003827968,0.0000489384,0.0000526941,0.00014283445,0.00022233315,0.000009634814,0.0002985956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99559104,0.0021356088,0.000288092,0.0010994866,0.0007588483,0.00012694878],"domain_scores_gemma":[0.994009,0.002613241,0.0006515255,0.0007732443,0.0014764826,0.00047653235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008080755,0.00079769926,0.00076414197,0.00063710986,0.00035017292,0.0007148423,0.0002916644,0.0009835566,0.0012950031],"category_scores_gemma":[0.009709893,0.00031893316,0.0004576094,0.00032099188,0.00079384027,0.00058635307,0.00054049486,0.0004223957,0.0005668025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.121835,0.0053259786,0.6007453,0.00054624345,0.0015445631,0.00033833645,0.000680178,0.0016641399,0.17411432,0.00023245421,0.0009275584,0.09204586],"study_design_scores_gemma":[0.0062811817,0.10030191,0.7404445,0.00010765595,0.003148936,0.004924684,0.00035531636,0.012961544,0.12314885,0.0009453174,0.007136182,0.00024400282],"about_ca_topic_score_codex":0.00012928383,"about_ca_topic_score_gemma":0.00012763972,"teacher_disagreement_score":0.008080755,"about_ca_system_score_codex":0.00022276591,"about_ca_system_score_gemma":0.00025906015,"threshold_uncertainty_score":0.042735577},"labels":[],"label_agreement":null},{"id":"W4410820333","doi":"10.1200/jco.2025.43.16_suppl.8014","title":"Clinical and molecular characteristics of early progressors (EPs) and long-term progression-free survivors (LTPs) from the phase 3 ADRIATIC trial of consolidation durvalumab (D) vs placebo (P) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Medicine; Placebo; Chemoradiotherapy; Internal medicine; Oncology; Phases of clinical research; Clinical trial; Cancer; Pathology; Pembrolizumab; Immunotherapy; Alternative medicine","score_opus":0.06979469026144287,"score_gpt":0.5023767545804756,"score_spread":0.43258206431903273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410820333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775094,0.00028153145,0.00009502181,0.000047560527,0.00001377498,0.00013641172,0.0010639144,0.0000062244985,0.00060462963],"genre_scores_gemma":[0.996218,0.000096230484,0.00009311416,0.000110420486,0.00003473779,0.00018527219,0.0024654747,0.000002676431,0.00079407496],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99975795,0.00007109588,0.00002371469,0.00004834199,0.00003695511,0.000061944964],"domain_scores_gemma":[0.9990007,0.00019183563,0.00017522191,0.00007560121,0.00005987339,0.0004967459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010107957,0.0003453882,0.00071618694,0.0002573085,0.00026378274,0.00037467986,0.00030168126,0.0005479742,0.0026539303],"category_scores_gemma":[0.00082328176,0.00017722644,0.000582239,0.00020725689,0.0002596138,0.00039205168,0.00030941144,0.0010074256,0.0004342712],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5342804,0.008201398,0.3618252,0.0002945983,0.001465378,0.0006703355,0.0002293575,0.0022362103,0.017266354,0.0001644306,0.0048356513,0.068530664],"study_design_scores_gemma":[0.040429115,0.13367255,0.81494826,0.00004570224,0.0010879642,0.0011018106,0.0001472374,0.0019183601,0.0030147878,0.0002554074,0.0033370024,0.00004181844],"about_ca_topic_score_codex":0.0005015411,"about_ca_topic_score_gemma":0.00089617685,"teacher_disagreement_score":0.0026539303,"about_ca_system_score_codex":0.00026527507,"about_ca_system_score_gemma":0.0003209769,"threshold_uncertainty_score":0.008878291},"labels":[],"label_agreement":null},{"id":"W4410823142","doi":"10.1200/jco.2025.43.16_suppl.e20126","title":"Survival outcomes for patients with extensive stage small cell lung cancer (ES-SCLC) treated with consolidative thoracic radiation therapy (cTRT) and chemoimmunotherapy (CIT): A population level study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Calgary","funders":"","keywords":"Medicine; Chemoimmunotherapy; Oncology; Radiation therapy; Lung cancer; Stage (stratigraphy); Population; Internal medicine; Chemotherapy; Radiology; Cyclophosphamide","score_opus":0.13281562938069374,"score_gpt":0.516175931575943,"score_spread":0.38336030219524925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410823142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801314,0.00032101,0.00004668559,0.000036639572,0.0000058224323,0.0000208528,0.0011396612,0.0000033369442,0.0004128343],"genre_scores_gemma":[0.998212,0.00010501352,0.00003459509,0.000034551173,0.000013472351,0.000023613502,0.0014526431,0.0000013694358,0.00012280217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999572,0.00009885031,0.00004931731,0.00012549246,0.000064195665,0.000090115725],"domain_scores_gemma":[0.998973,0.00018767986,0.00051336543,0.000052296804,0.00008280575,0.00019085912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064713485,0.00022137776,0.000362281,0.00079906755,0.00039631914,0.00064153655,0.00028399922,0.00050875527,0.0015624841],"category_scores_gemma":[0.0016916309,0.0001913014,0.00070051814,0.0011776912,0.00027818978,0.0006233963,0.0005189731,0.0005845421,0.00028459635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007587394,0.00010884999,0.99727815,0.000021618987,0.00010738617,0.000050111477,0.000034462177,0.000087167326,0.000087951994,0.000011331131,0.00016882153,0.0012854239],"study_design_scores_gemma":[0.00006687515,0.0008805643,0.9980482,0.000011820107,0.000107806096,0.00020467641,0.000109467765,0.00017749758,0.00003597649,0.000022857324,0.00032861682,0.0000056081253],"about_ca_topic_score_codex":0.003088918,"about_ca_topic_score_gemma":0.004435715,"teacher_disagreement_score":0.003088918,"about_ca_system_score_codex":0.000616205,"about_ca_system_score_gemma":0.00051796396,"threshold_uncertainty_score":0.006141901},"labels":[],"label_agreement":null},{"id":"W4411059462","doi":"10.3390/curroncol32060332","title":"Quality of Life of Lung Cancer Patients with Immune-Related Endocrinopathies During Immunotherapy: A Prospective Study Based on the EORTC QLQ-C30 and QLQ-LC13 Questionnaires in Romania","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Prospective cohort study; Quality of life (healthcare); Cancer; Internal medicine; Adverse effect; Cohort; Oncology; Population; Immunotherapy; Nursing","score_opus":0.029085719694515365,"score_gpt":0.41454819175111085,"score_spread":0.3854624720565955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411059462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999223,0.00023136842,0.00005954598,0.000018409419,0.0000052868863,0.000034911493,0.00017975259,9.719014e-7,0.00024678293],"genre_scores_gemma":[0.99932694,0.000101680394,0.0000797887,0.000040268395,0.000007698899,0.000045419674,0.00032375005,0.0000013848407,0.00007313727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999141,0.0002582672,0.00012632804,0.00017817931,0.0001468957,0.0001493012],"domain_scores_gemma":[0.99888986,0.00014526567,0.00051916955,0.00009321915,0.0001581582,0.0001943836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014467873,0.00036486215,0.00060501636,0.0012011491,0.00051845366,0.00073997054,0.00029752668,0.00049326237,0.00077292114],"category_scores_gemma":[0.0024422887,0.00029579407,0.0011320021,0.0010941076,0.0004364409,0.0005376124,0.0007675107,0.0005745074,0.00016907752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010840613,0.00011040065,0.99813396,0.000017659942,0.000051237763,0.0000883999,0.00015984561,0.000039652994,0.00011250405,0.000009164925,0.000041929463,0.0011270111],"study_design_scores_gemma":[0.000014827445,0.0003742819,0.9987232,0.000008895844,0.000025276873,0.00029113778,0.00024710005,0.00008696076,0.000035257537,0.000007213292,0.00018127481,0.000004582005],"about_ca_topic_score_codex":0.0015049808,"about_ca_topic_score_gemma":0.0014579153,"teacher_disagreement_score":0.0015049808,"about_ca_system_score_codex":0.00050348026,"about_ca_system_score_gemma":0.0003430077,"threshold_uncertainty_score":0.0076513886},"labels":[],"label_agreement":null},{"id":"W4411174277","doi":"10.1200/gdl.23.1011","title":"Systemic Therapy for SCLC: ASCO-OH (CCO) Guideline","year":2024,"lang":"en","type":"dataset","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Guideline; Medicine; Internal medicine; Oncology; Pathology","score_opus":0.05174471415785745,"score_gpt":0.44499250608857166,"score_spread":0.39324779193071424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411174277","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006077777,0.01801217,0.0010445245,0.035355374,0.001839339,0.0011973412,0.8795498,0.00066797814,0.061725702],"genre_scores_gemma":[0.0038528333,0.02863382,0.008015549,0.023408858,0.0010622467,0.0038147122,0.90208787,0.00055701553,0.028567184],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970374,0.00078500574,0.00079492293,0.00020663958,0.0009272998,0.0002487892],"domain_scores_gemma":[0.9921096,0.0014043943,0.001291465,0.0003371943,0.0041117165,0.0007456076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002583025,0.00073939847,0.0013918775,0.002245892,0.0006908811,0.0026867494,0.00250951,0.0024296609,0.052427743],"category_scores_gemma":[0.018075043,0.0005592038,0.0020680272,0.005345337,0.00028609534,0.001814038,0.0019044707,0.0026685633,0.037447892],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001809255,0.000006833369,0.00025289156,0.00064439554,0.000019536421,0.000007874662,0.000005425606,0.000046385703,0.000015472691,0.00034647455,0.98746526,0.011171405],"study_design_scores_gemma":[0.00027802237,0.000011225234,0.0027775753,0.0055427514,0.00009099218,0.00007999122,0.00001891847,0.00013429266,0.000060989947,0.0013701692,0.98961747,0.000017710976],"about_ca_topic_score_codex":0.05197951,"about_ca_topic_score_gemma":0.12229552,"teacher_disagreement_score":0.052427743,"about_ca_system_score_codex":0.004592636,"about_ca_system_score_gemma":0.011205714,"threshold_uncertainty_score":0.17538828},"labels":[],"label_agreement":null},{"id":"W4411306851","doi":"10.14740/wjon2543","title":"Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Small Cell Carcinoma of Ovary Patients: A Retrospective Cohort Study","year":2025,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Natural Science Foundation of Gansu Province","keywords":"Medicine; Nomogram; Retrospective cohort study; Oncology; Cohort; Cancer; Ovary; Internal medicine; Overall survival; Cancer survival; Survival analysis","score_opus":0.030380243542358337,"score_gpt":0.3452886023781528,"score_spread":0.31490835883579443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411306851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775225,0.00034284306,0.0009425182,0.000034957084,0.000014130877,0.000031980097,0.00061507075,0.0000099939525,0.0002563061],"genre_scores_gemma":[0.9984269,0.0001601086,0.0005234034,0.00001176805,0.000012037898,0.000031564887,0.00076616596,0.000004589995,0.00006340482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908185,0.0003225844,0.000105760104,0.00021267487,0.00018518158,0.00009191831],"domain_scores_gemma":[0.99607676,0.0010270228,0.0013442135,0.0007495759,0.00046939348,0.0003330438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034466197,0.00050447154,0.00040142552,0.0019278206,0.0004891743,0.000921402,0.00046089228,0.000354248,0.00079703936],"category_scores_gemma":[0.009042646,0.0002931637,0.0008211077,0.0012530211,0.00028931448,0.000748997,0.0005572432,0.0005793154,0.00023771731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052173156,0.00000921373,0.9985177,0.0000037868792,0.000036369696,0.000042067128,0.00003174824,0.00006789844,0.000035406443,0.00001705298,0.00006192951,0.0011247393],"study_design_scores_gemma":[0.000021206177,0.00019951619,0.99379104,0.000020210391,0.00014004436,0.0012108132,0.0002925126,0.0030158863,0.00013654138,0.00011960023,0.0010365774,0.000016045778],"about_ca_topic_score_codex":0.0026336822,"about_ca_topic_score_gemma":0.0030440656,"teacher_disagreement_score":0.0034466197,"about_ca_system_score_codex":0.00045846077,"about_ca_system_score_gemma":0.0005430774,"threshold_uncertainty_score":0.018227696},"labels":[],"label_agreement":null},{"id":"W4411475146","doi":"10.70389/pjs.100084","title":"Outcomes of Clinical Trials on the Roles of Immune Checkpoint Inhibitors in the Management of Lung Cancers: A Comprehensive Review","year":2025,"lang":"en","type":"review","venue":"Premier journal of science.","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Lung cancer; Oncology; Internal medicine; Clinical trial; Chemotherapy; Cancer; Radiation therapy; Immunotherapy; Adverse effect; Pembrolizumab; Treatment of lung cancer","score_opus":0.2463859360446617,"score_gpt":0.5542475828009386,"score_spread":0.30786164675627686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411475146","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022852852,0.998295,0.00013560051,0.00033708732,0.00013301188,0.0001000236,0.00027353526,0.000007545416,0.00048976735],"genre_scores_gemma":[0.0028949245,0.9950788,0.00042154657,0.00084400584,0.00014417723,0.00019265834,0.00030731628,0.0000071582544,0.00010941095],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9939406,0.0017869408,0.0025926817,0.00042525548,0.0010938471,0.0001606103],"domain_scores_gemma":[0.9733533,0.018897781,0.0043650377,0.00033088625,0.0027095345,0.0003435356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01069789,0.0011610681,0.006530201,0.0046586264,0.00034703186,0.0023854305,0.0019253716,0.001677189,0.005206705],"category_scores_gemma":[0.027818618,0.0005248264,0.005077372,0.005479111,0.0005797183,0.0018997154,0.001156847,0.0014160932,0.0007582693],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000984053,0.00005416216,0.00072809024,0.5628377,0.0061150156,0.000083925515,0.000116783034,0.0002721252,0.0004950546,0.00086100475,0.0110061085,0.4164459],"study_design_scores_gemma":[0.0009168619,0.0010861026,0.0052294633,0.7009849,0.05135884,0.00062426575,0.00022715633,0.0001828137,0.00064653135,0.0019862882,0.23667265,0.000084069245],"about_ca_topic_score_codex":0.0014239901,"about_ca_topic_score_gemma":0.0032608774,"teacher_disagreement_score":0.01069789,"about_ca_system_score_codex":0.0017409812,"about_ca_system_score_gemma":0.005578267,"threshold_uncertainty_score":0.05657649},"labels":[],"label_agreement":null},{"id":"W4411715496","doi":"10.6004/jnccn.2025.7029","title":"Association of Polypharmacy and Potentially Inappropriate Medications With Outcomes in Older Adults With DLBCL: A Population Study","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; University Health Network; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Polypharmacy; Hazard ratio; Internal medicine; Population; Comorbidity; Proportional hazards model; Emergency medicine; Confidence interval; Environmental health","score_opus":0.015517056097077942,"score_gpt":0.3569374022833494,"score_spread":0.3414203461862715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411715496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986224,0.00036210893,0.0001023781,0.000057200323,0.0000067862024,0.000024013878,0.0005203234,0.0000031640889,0.00030148216],"genre_scores_gemma":[0.99915814,0.0001689958,0.00007282309,0.00007909909,0.000019532243,0.0000225239,0.0003989347,0.0000012086929,0.00007870953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920803,0.00020722061,0.00011381174,0.00021197193,0.0001485284,0.00011053094],"domain_scores_gemma":[0.99864167,0.0001337698,0.0007079612,0.00012678617,0.00017367801,0.00021606416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089939806,0.00033941196,0.0004359903,0.00089699443,0.00048564322,0.0008737152,0.00035195865,0.00052201154,0.0008180353],"category_scores_gemma":[0.0022908584,0.00034839215,0.00079605833,0.0014053334,0.00027013975,0.00071035855,0.0006535181,0.0008296007,0.00020338935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006601075,0.000054363525,0.9988901,0.000008265469,0.0001061653,0.00003854951,0.000045106353,0.000013352882,0.00005415081,0.0000065766476,0.00006576356,0.0006515674],"study_design_scores_gemma":[0.0000162183,0.00015564694,0.9990289,0.000009092109,0.00008528171,0.00022343095,0.00014747462,0.00010845678,0.000017243608,0.000018694856,0.00018620524,0.0000033191127],"about_ca_topic_score_codex":0.0062182443,"about_ca_topic_score_gemma":0.008867172,"teacher_disagreement_score":0.0062182443,"about_ca_system_score_codex":0.00039389724,"about_ca_system_score_gemma":0.0003758515,"threshold_uncertainty_score":0.012364149},"labels":[],"label_agreement":null},{"id":"W4412816997","doi":"10.3322/caac.70026","title":"Multidisciplinary assessment of patients with extensive stage small cell lung cancer: A geriatric tumor board","year":2025,"lang":"en","type":"article","venue":"CA A Cancer Journal for Clinicians","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multidisciplinary approach; Lung cancer; Stage (stratigraphy); Cancer; Oncology; Geriatric oncology; Intensive care medicine; Internal medicine","score_opus":0.02501476209211731,"score_gpt":0.42295476984659197,"score_spread":0.3979400077544747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412816997","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818844,0.0031036001,0.0005487034,0.004209178,0.00023909775,0.00013725527,0.0003362147,0.000050550974,0.009490954],"genre_scores_gemma":[0.9959264,0.0009844867,0.00063956284,0.00089666236,0.00018686889,0.00003891116,0.00021419577,0.0000045379247,0.0011084372],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983394,0.000034238823,0.000023959605,0.00002439026,0.000026987158,0.000056474553],"domain_scores_gemma":[0.999678,0.000025345766,0.00004997052,0.0000058698984,0.000045178367,0.00019568953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022001316,0.00032132163,0.00027939308,0.000671305,0.0007567227,0.00041973853,0.00022383918,0.0004284471,0.0028143586],"category_scores_gemma":[0.00091757876,0.00018220705,0.00019493297,0.0003428496,0.00019837893,0.0003808545,0.0005824272,0.00039727768,0.00041909158],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013984079,0.00015157629,0.9444154,0.000086300606,0.000058824466,0.020635612,0.0003591883,0.00015973869,0.002619267,0.000081421604,0.010096518,0.021196371],"study_design_scores_gemma":[0.00004008011,0.00042209253,0.9515692,0.00014683054,0.00005318012,0.034261778,0.001681856,0.0014401365,0.0003364108,0.00021403402,0.009817142,0.000017230088],"about_ca_topic_score_codex":0.003424295,"about_ca_topic_score_gemma":0.011931639,"teacher_disagreement_score":0.003424295,"about_ca_system_score_codex":0.00048281657,"about_ca_system_score_gemma":0.00048747894,"threshold_uncertainty_score":0.009414971},"labels":[],"label_agreement":null},{"id":"W4413108138","doi":"10.1200/jco-25-00221","title":"Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Internal medicine; Hazard ratio; Lung cancer; Randomized controlled trial; Surgery; Oncology; Urology; Confidence interval; Myocardial infarction","score_opus":0.052532914754491816,"score_gpt":0.46942480112778784,"score_spread":0.416891886373296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413108138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884674,0.0024220059,0.000374688,0.0006480601,0.0003053315,0.0042948057,0.0010247113,0.00013593123,0.0023270599],"genre_scores_gemma":[0.9845095,0.0018048254,0.0013120933,0.0015114248,0.00036070458,0.0060893577,0.0013929629,0.00002488845,0.0029942612],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996358,0.00018299017,0.000016299626,0.000061021183,0.0000342661,0.00006955001],"domain_scores_gemma":[0.99953127,0.00010424668,0.00011982596,0.000040221123,0.000028123784,0.00017634033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011824016,0.0014308698,0.0017840052,0.00033853232,0.00036662034,0.0006683968,0.0009433757,0.0011903231,0.0052399873],"category_scores_gemma":[0.0010326387,0.00034257534,0.0011399292,0.00046970596,0.0009451228,0.0005041845,0.00030300373,0.0020127841,0.0007823078],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94524956,0.010900156,0.00199098,0.0004979309,0.00058748934,0.00008717634,0.000060201342,0.0006094221,0.0033762022,0.00017110378,0.002595573,0.03387409],"study_design_scores_gemma":[0.9306225,0.06624537,0.0016642819,0.000020330916,0.00017260523,0.000039391463,0.000012699317,0.0003263455,0.00024011084,0.00009698708,0.000550929,0.000008462877],"about_ca_topic_score_codex":0.002150064,"about_ca_topic_score_gemma":0.006673491,"teacher_disagreement_score":0.0052399873,"about_ca_system_score_codex":0.0008746678,"about_ca_system_score_gemma":0.0018833373,"threshold_uncertainty_score":0.017529547},"labels":[],"label_agreement":null},{"id":"W4413329353","doi":"10.3390/curroncol32080472","title":"Real-World Effectiveness and Safety of Immune Checkpoint Inhibitors Combined with Chemotherapy in Taiwanese Patients with Extensive-Stage Small Cell Lung Cancer","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Taiwan University; Far Eastern Memorial Hospital; National Taiwan University Hospital Yunlin Branch; National Taiwan University Hospital","keywords":"Medicine; Lung cancer; Chemotherapy; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Intensive care medicine; Cancer research; Biology","score_opus":0.02236862853258093,"score_gpt":0.3767170663839872,"score_spread":0.3543484378514063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413329353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989912,0.0006552096,0.0000401102,0.000051255225,0.000004637079,0.000010361055,0.00009783747,0.0000016974619,0.00014777949],"genre_scores_gemma":[0.99949896,0.00014739072,0.00003426611,0.000034402954,0.0000115358935,0.0000097303755,0.00022018173,6.686572e-7,0.000042758653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993098,0.00028506422,0.00010211867,0.00013151922,0.0000984979,0.000073006406],"domain_scores_gemma":[0.99757606,0.0004828712,0.0013807049,0.00015614022,0.00016294306,0.00024139229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013066821,0.000215152,0.00037131697,0.00031524297,0.0002180634,0.00054157263,0.00020088001,0.0003220095,0.0006109967],"category_scores_gemma":[0.0026897374,0.00010637418,0.0007476592,0.0004183759,0.00031666236,0.0003476718,0.00037874168,0.0004361311,0.000091418384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004391358,0.00020498772,0.9833188,0.00007730082,0.00055649376,0.00013859505,0.00007082795,0.00046271458,0.00069453765,0.000022774697,0.00012811128,0.009933491],"study_design_scores_gemma":[0.00042148458,0.0043515125,0.9910617,0.0000436931,0.0006169736,0.00044601192,0.00019439714,0.0012814188,0.0006320087,0.000046572717,0.0008894461,0.000014738022],"about_ca_topic_score_codex":0.0014836313,"about_ca_topic_score_gemma":0.002830572,"teacher_disagreement_score":0.0014836313,"about_ca_system_score_codex":0.0008121604,"about_ca_system_score_gemma":0.00057711126,"threshold_uncertainty_score":0.006910503},"labels":[],"label_agreement":null},{"id":"W4413382855","doi":"10.58931/cot.2025.2239","title":"Small-Cell Lung Cancer: Integration of Radiation and Immunotherapy for All Stages","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Immunotherapy; Lung cancer; Cancer; Medicine; Radiation therapy; Oncology; Cancer research; Internal medicine","score_opus":0.025115515050603034,"score_gpt":0.3782479123245323,"score_spread":0.35313239727392925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413382855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011079968,0.9876873,0.0007382462,0.003937384,0.00050554844,0.000027580629,0.000017612925,0.000017328784,0.0059610847],"genre_scores_gemma":[0.010698262,0.98257494,0.001985096,0.0013471196,0.0012793924,0.000023097136,0.000042755142,0.0000076279316,0.0020417257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954957,0.0001334991,0.000040308565,0.000032640663,0.00019606411,0.00004795607],"domain_scores_gemma":[0.99963784,0.000136497,0.000047041096,0.000014026256,0.00010517315,0.00005934479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015065653,0.00036674808,0.00054117816,0.0009123977,0.00037785183,0.0008827236,0.00038855843,0.0005461619,0.0021454867],"category_scores_gemma":[0.0008362465,0.00010046498,0.00043924147,0.0007375315,0.00044166198,0.0009909936,0.000670866,0.00087340974,0.00049083657],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008666822,0.00006019476,0.001044741,0.004628854,0.00005895634,0.00024130085,0.00012523551,0.00018019162,0.0037546386,0.005349643,0.013596241,0.97087336],"study_design_scores_gemma":[0.000040699404,0.00063634716,0.0067365733,0.0030078741,0.00018019247,0.0023180647,0.00024065551,0.0001018407,0.0016958265,0.0037394618,0.98127365,0.00002888432],"about_ca_topic_score_codex":0.003899632,"about_ca_topic_score_gemma":0.020223932,"teacher_disagreement_score":0.003899632,"about_ca_system_score_codex":0.0010391214,"about_ca_system_score_gemma":0.0034761853,"threshold_uncertainty_score":0.007967591},"labels":[],"label_agreement":null},{"id":"W4413836422","doi":"10.1158/1078-0432.ccr-24-4342","title":"Phase I Dose-Escalation Trial Combining Olaparib and Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca; AstraZeneca United States","keywords":"Medicine; Olaparib; Pneumonitis; Esophagitis; Internal medicine; PARP inhibitor; Radiation therapy; Adverse effect; Oncology; Gastroenterology; Urology; Surgery; Lung","score_opus":0.24740009084507647,"score_gpt":0.6157291510270154,"score_spread":0.36832906018193895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413836422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959531,0.0007699714,0.0003149171,0.00018752855,0.00007399282,0.0016541346,0.0002770179,0.00006347413,0.0007058516],"genre_scores_gemma":[0.99424875,0.0005421002,0.0010808385,0.00036560092,0.00010363544,0.0018024183,0.0007849129,0.00001426349,0.001057512],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995734,0.0001935051,0.000030170639,0.00008513481,0.000040848365,0.000076894714],"domain_scores_gemma":[0.9990251,0.00016121483,0.00022967703,0.00009834408,0.00004679755,0.00043884382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013749937,0.0013520663,0.0017782324,0.0003949689,0.00038022184,0.0009878164,0.001052717,0.0010150863,0.0027962376],"category_scores_gemma":[0.00087226985,0.00055468234,0.0010310541,0.00043829743,0.0010574537,0.000737398,0.00039495967,0.0037256216,0.0005243579],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7716689,0.10737618,0.0060423585,0.00067633047,0.0009983798,0.00023315693,0.00024725543,0.004357439,0.041049168,0.00019226271,0.0020911586,0.065067396],"study_design_scores_gemma":[0.57741994,0.4084127,0.0067992737,0.000024452105,0.00026561273,0.00020543828,0.000036101283,0.0016689476,0.003856026,0.0001588337,0.0011288368,0.000023887722],"about_ca_topic_score_codex":0.0005262937,"about_ca_topic_score_gemma":0.001628956,"teacher_disagreement_score":0.0027962376,"about_ca_system_score_codex":0.0009022782,"about_ca_system_score_gemma":0.0015175171,"threshold_uncertainty_score":0.009354353},"labels":[],"label_agreement":null},{"id":"W4413956624","doi":"10.1158/1535-7163.mct-24-0861","title":"CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer","year":2025,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Terry Fox Research Institute; Canada Foundation for Innovation; Deutsche Forschungsgemeinschaft; Clinical and Translational Science Center, Weill Cornell Medical College; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Radioresistance; Cancer research; Clonogenic assay; DNA repair; Olaparib; HDAC3; Gene knockdown; DNA damage; Radiosensitivity; Synthetic lethality; Biology; Radiosensitizer; Cell; Chemistry; Cell culture; Poly ADP ribose polymerase; Radiation therapy; Medicine; Histone; Genetics; DNA; Histone deacetylase; Internal medicine","score_opus":0.02859787776326449,"score_gpt":0.36494875402170607,"score_spread":0.33635087625844157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413956624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95847666,0.0029624773,0.02434297,0.0003600301,0.00010945999,0.00028657643,0.0058399877,0.0014254799,0.006196338],"genre_scores_gemma":[0.9785992,0.0015103616,0.011551148,0.00018393267,0.000010420783,0.00010500277,0.0036831994,0.00013594536,0.0042208624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982846,0.000017938535,0.0000204903,0.000037383375,0.00006626263,0.000029448853],"domain_scores_gemma":[0.9999274,0.000019280968,0.000017250348,0.00000970111,0.000010382719,0.000015954936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019398904,0.0003900866,0.00058787595,0.00027400575,0.0002133303,0.0003599368,0.00033747102,0.00042507905,0.0015207755],"category_scores_gemma":[0.0001425986,0.00016370273,0.00051363325,0.00023675509,0.00018847533,0.00009296722,0.00022144467,0.00050780864,0.0005967344],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075991295,0.000024335692,0.0004344465,0.00006646049,0.000016668748,0.00015738886,0.000010050103,0.0001868768,0.99623555,0.00009231622,0.00017451306,0.0025255105],"study_design_scores_gemma":[0.000042917804,0.00031530723,0.006341132,0.000014610739,0.0001038749,0.0008629767,0.00003263554,0.0030063482,0.98033947,0.000065062355,0.008860345,0.000015332877],"about_ca_topic_score_codex":0.0016512633,"about_ca_topic_score_gemma":0.003609791,"teacher_disagreement_score":0.0016512633,"about_ca_system_score_codex":0.0003822706,"about_ca_system_score_gemma":0.00028154187,"threshold_uncertainty_score":0.0050875545},"labels":[],"label_agreement":null},{"id":"W4413974852","doi":"10.1101/2025.09.04.674147","title":"γδ T cells modulate anti-tumor immunity in small cell lung cancer","year":2025,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Institut National Du Cancer; National Health and Medical Research Council; State Government of Victoria; Bundesministerium für Bildung und Forschung; Cancer Council Victoria; Deutsche Forschungsgemeinschaft; Australian Government; Marshfield Clinic Research Foundation; Wellcome Trust; International Association for the Study of Lung Cancer","keywords":"Immunity; Lung cancer; Cancer research; Tumor cells; Cell mediated immunity; Medicine; Immunology; Immune system; Oncology","score_opus":0.017754942945400913,"score_gpt":0.28238433777502375,"score_spread":0.26462939482962283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413974852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98667485,0.005338096,0.0037516777,0.0006348171,0.000115525036,0.00005825485,0.00027622722,0.00010469775,0.0030458919],"genre_scores_gemma":[0.99520314,0.0013246196,0.001179082,0.0001888956,0.000027761711,0.000028490671,0.00018745742,0.000010787584,0.0018496541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999243,0.000019697298,0.0000062520767,0.000014707081,0.00001687768,0.000018124832],"domain_scores_gemma":[0.9999541,0.000011165292,0.000008425544,0.00000632892,0.0000066669977,0.000013275762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019847788,0.00019255605,0.0001567009,0.00021788901,0.00010754147,0.00037808547,0.00012135127,0.00025094,0.0022014335],"category_scores_gemma":[0.000112640126,0.00007618271,0.00015732956,0.000119483,0.0002215881,0.0001739021,0.00019327214,0.0005785578,0.0005373022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052591803,0.00009910038,0.0024446093,0.00015061829,0.000013769378,0.00017631242,0.00006540623,0.0005123305,0.9833755,0.0006963954,0.0006111191,0.011329012],"study_design_scores_gemma":[0.00021295914,0.0012451295,0.018347692,0.000052116317,0.00006152991,0.00076822983,0.0002998569,0.0041060443,0.9566773,0.0018824944,0.016336665,0.000009954744],"about_ca_topic_score_codex":0.00019674351,"about_ca_topic_score_gemma":0.00023520848,"teacher_disagreement_score":0.0022014335,"about_ca_system_score_codex":0.00017993686,"about_ca_system_score_gemma":0.00018165108,"threshold_uncertainty_score":0.007364571},"labels":[],"label_agreement":null},{"id":"W4414377875","doi":"10.1016/j.jtcvs.2025.09.017","title":"TROPION-Lung12: A phase 3 study of adjuvant datopotamab deruxtecan and rilvegostomig in ctDNA-positive or high-risk pathology stage I non–small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"National Cancer Institute; AstraZeneca","keywords":"Clinical endpoint; Stage (stratigraphy); Adenocarcinoma; Adjuvant; Lung cancer; Randomized controlled trial; Phases of clinical research; Adjuvant therapy","score_opus":0.015638285913113642,"score_gpt":0.3483685570031425,"score_spread":0.33273027109002884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414377875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98778313,0.0040357253,0.00049945415,0.00064955116,0.00019682346,0.0027262992,0.0019936636,0.00018084735,0.0019345948],"genre_scores_gemma":[0.9744133,0.0050177244,0.0024968977,0.0017023807,0.00020769941,0.004239095,0.0063794246,0.00010712617,0.0054363697],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99932814,0.00030396285,0.000026276095,0.000098635624,0.000060054073,0.00018290174],"domain_scores_gemma":[0.99942267,0.00007097213,0.000088308385,0.00005748518,0.00003710641,0.00032355296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00205989,0.001987448,0.0027455988,0.0007032737,0.00053968583,0.001603022,0.0012667689,0.0017512776,0.004882615],"category_scores_gemma":[0.0008324589,0.00087978813,0.0024321147,0.00069725857,0.0013679424,0.00093884836,0.0005601491,0.0045861383,0.0013140155],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.756741,0.07162713,0.008135324,0.001304276,0.002794482,0.0002075455,0.00045540032,0.0034163822,0.0389899,0.000375359,0.0056106998,0.11034253],"study_design_scores_gemma":[0.61905515,0.3622682,0.009677755,0.00006260644,0.0009695353,0.00025110733,0.00011285131,0.00069261855,0.0029654936,0.00015394553,0.00374486,0.000045780747],"about_ca_topic_score_codex":0.0037419968,"about_ca_topic_score_gemma":0.010497246,"teacher_disagreement_score":0.004882615,"about_ca_system_score_codex":0.0013712412,"about_ca_system_score_gemma":0.0020995243,"threshold_uncertainty_score":0.016333938},"labels":[],"label_agreement":null},{"id":"W4414422734","doi":"10.1016/j.euo.2025.07.007","title":"Genomic Predictors of Response to Metastasis-directed Therapy With or Without Androgen Deprivation Therapy","year":2025,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"McMaster University; Movember Foundation; National Cancer Institute; National Institutes of Health; Prostate Cancer Foundation; Foundation for the National Institutes of Health; U.S. Department of Defense","keywords":"Androgen deprivation therapy; Prostate cancer; Predictive testing; Personalized medicine; Personalization; Precision medicine; Androgen","score_opus":0.03536143272135039,"score_gpt":0.35896742767318646,"score_spread":0.32360599495183606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414422734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704057,0.0013374889,0.00025377533,0.00013408152,0.000016112144,0.000009479541,0.00039614542,0.000009438685,0.0008028708],"genre_scores_gemma":[0.9994986,0.00008021917,0.00007309035,0.00002371055,0.0000141369665,0.0000031363074,0.0002025959,0.0000014907131,0.000102929414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997613,0.00007776693,0.000024866187,0.00005508215,0.000037487396,0.000043478507],"domain_scores_gemma":[0.99864036,0.0006118087,0.00037663674,0.00006175057,0.000077645374,0.00023176403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004571697,0.00014859033,0.00027364833,0.00043513504,0.000108103464,0.00033584397,0.00013793858,0.00026827917,0.0018317803],"category_scores_gemma":[0.0024608334,0.000057443114,0.0002751461,0.00041736354,0.00014819512,0.00021594179,0.00016635304,0.00032867418,0.00015366434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018404067,0.00007287385,0.9803258,0.000023459477,0.00014160888,0.00010064977,0.000019862047,0.00060151843,0.0026922382,0.000061190265,0.00019377138,0.013926641],"study_design_scores_gemma":[0.00002905846,0.00045260208,0.9968659,0.000006503946,0.00013174977,0.00024024429,0.000034296885,0.0010201642,0.0006146354,0.000101665995,0.00049889943,0.0000042605375],"about_ca_topic_score_codex":0.001065128,"about_ca_topic_score_gemma":0.0014742196,"teacher_disagreement_score":0.0018317803,"about_ca_system_score_codex":0.00021286382,"about_ca_system_score_gemma":0.00017300915,"threshold_uncertainty_score":0.006127894},"labels":[],"label_agreement":null},{"id":"W4414492606","doi":"10.3390/curroncol32100536","title":"Bridging Knowledge Gaps in Small Cell Lung Cancer: Data, Challenges and Priorities","year":2025,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Limiting; Malignancy; Clinical trial; Biomarker; Lung cancer; Biomarker discovery; Acquired resistance; Immune system","score_opus":0.31855522871559755,"score_gpt":0.5447749419546917,"score_spread":0.22621971323909412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414492606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028749864,0.9965815,0.000084927764,0.0025833491,0.00034941596,0.0000045587994,0.000025643334,0.000008077611,0.00033384812],"genre_scores_gemma":[0.0003582376,0.99729687,0.0003143973,0.0013991849,0.00041703318,0.000012510448,0.000045436733,0.0000027934022,0.00015355927],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99880624,0.00042019595,0.00022875809,0.00012279235,0.0003189684,0.00010307543],"domain_scores_gemma":[0.98939985,0.0073493943,0.0007818458,0.00018980763,0.001715452,0.0005636682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068947626,0.0010501686,0.0036974575,0.004176098,0.000541694,0.0032057639,0.002381962,0.0032669075,0.007297308],"category_scores_gemma":[0.00867862,0.0005360191,0.0014679345,0.0047426824,0.0013927659,0.006660361,0.0026270684,0.004637019,0.002624234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001458729,0.000058394056,0.00017001346,0.06458928,0.0002453867,0.00020284069,0.00016234003,0.00039505857,0.0003485018,0.010545596,0.06861301,0.8545238],"study_design_scores_gemma":[0.000034321045,0.00007895417,0.0003836197,0.04797999,0.00028684523,0.00046389378,0.0002697163,0.00010235646,0.00009671213,0.0076212236,0.9426527,0.000029577079],"about_ca_topic_score_codex":0.0024014176,"about_ca_topic_score_gemma":0.0048451037,"teacher_disagreement_score":0.007297308,"about_ca_system_score_codex":0.0021120603,"about_ca_system_score_gemma":0.007648743,"threshold_uncertainty_score":0.03646344},"labels":[],"label_agreement":null},{"id":"W4414520286","doi":"10.3389/fphar.2025.1607255","title":"Efficacy and safety of anlotinib in the treatment of brain metastases from non-small cell lung cancer: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Frontiers in Pharmacology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung; Cell; Cell growth; Lung cancer; Clinical trial; Safety profile","score_opus":0.05666635317085317,"score_gpt":0.43167140022410183,"score_spread":0.37500504705324866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414520286","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023448735,0.99636996,0.00040391227,0.00013192608,0.0000945648,0.00026761912,0.00023654653,0.000013595823,0.00013706554],"genre_scores_gemma":[0.0953325,0.8994394,0.002163883,0.00069493765,0.00027376608,0.0012830117,0.0005554178,0.000021276086,0.00023580134],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9875059,0.0056898533,0.004023663,0.00097458664,0.0015074891,0.00029841057],"domain_scores_gemma":[0.97664034,0.017315745,0.0035532974,0.00055104046,0.001702754,0.0002369225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017886534,0.002903851,0.02253901,0.008819296,0.00064532104,0.003587173,0.0024106312,0.0025775712,0.0026901131],"category_scores_gemma":[0.034361325,0.0014616366,0.038425595,0.007679311,0.00077347335,0.001797165,0.0014064254,0.0017311019,0.00023194746],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013879176,0.00003323957,0.0018039247,0.5011426,0.48347387,0.00011462343,0.00006691277,0.0005224082,0.00023828832,0.00013072803,0.00032974718,0.010755755],"study_design_scores_gemma":[0.00034631632,0.00022144383,0.0017824703,0.03134324,0.96435845,0.00009222739,0.000033520177,0.00019318763,0.00012474213,0.00015055644,0.0013337182,0.000020127252],"about_ca_topic_score_codex":0.005053538,"about_ca_topic_score_gemma":0.011601725,"teacher_disagreement_score":0.02253901,"about_ca_system_score_codex":0.0028422542,"about_ca_system_score_gemma":0.004630819,"threshold_uncertainty_score":0.09459418},"labels":[],"label_agreement":null},{"id":"W4414557925","doi":"10.1016/j.ijrobp.2025.06.3722","title":"Multidisciplinary Team (MDT) Perceptions Towards the Treatment of Limited-Stage Small-Cell Lung Cancer (LS-SCLC): A US Physician Survey","year":2025,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Lung cancer; Multidisciplinary approach; Multidisciplinary team; Perception; MEDLINE; Lung disease","score_opus":0.04471187721567959,"score_gpt":0.4112612050795816,"score_spread":0.366549327863902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414557925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998437,0.00011736892,0.00004202155,0.00058439316,0.00000791934,0.00001163172,0.00014547548,0.0000016405473,0.0006525314],"genre_scores_gemma":[0.99896514,0.00015816589,0.00008059125,0.00044550048,0.000014263331,0.000012167388,0.00010875352,0.0000014829799,0.00021385706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892575,0.00039203206,0.00014893971,0.000096676544,0.00022662368,0.00020995656],"domain_scores_gemma":[0.99347514,0.0012666177,0.0028492268,0.000085115265,0.00067670096,0.001647145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011443202,0.0001017851,0.00016333305,0.0005684789,0.00073461415,0.00052903604,0.0002208947,0.00058416836,0.002826481],"category_scores_gemma":[0.0063899583,0.00020668146,0.00025471265,0.00058727566,0.0003211921,0.0005512533,0.00082970504,0.00059978786,0.00027220132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047600955,0.00013975936,0.9926998,0.000027074242,0.000020244997,0.000110969886,0.0033767933,0.000046460074,0.00021335325,0.00002581189,0.00064303627,0.0026490665],"study_design_scores_gemma":[0.000007469751,0.00016766861,0.9846501,0.000028064767,0.000013319052,0.00023892778,0.013831733,0.0001619297,0.00006661184,0.000020433095,0.00080741243,0.0000062524286],"about_ca_topic_score_codex":0.018569002,"about_ca_topic_score_gemma":0.026645264,"teacher_disagreement_score":0.018569002,"about_ca_system_score_codex":0.0007748086,"about_ca_system_score_gemma":0.00085472455,"threshold_uncertainty_score":0.0369218},"labels":[],"label_agreement":null},{"id":"W4414873690","doi":"10.3390/curroncol32100558","title":"Incidence of Hypothyroidism and Thyroid Function Monitoring After Immune Checkpoint Inhibitor Therapy Completion for Lung Cancer: A Nationwide Analysis of a Japanese Claims Database","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Thyroid; Bevacizumab; Adverse effect; Thyroid function; Thyroid cancer; Lung cancer; Cumulative incidence","score_opus":0.06824818010564082,"score_gpt":0.4450663110306363,"score_spread":0.3768181309249955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414873690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659675,0.00073258346,0.000114031754,0.00006554609,0.000006262906,0.000021019654,0.002181701,0.0000042679953,0.00027774685],"genre_scores_gemma":[0.9973314,0.00024576698,0.00010504833,0.00006459926,0.000012352136,0.00002162841,0.0021404093,0.0000021363826,0.000076713746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982444,0.00036793866,0.00051058776,0.00037552422,0.00031277843,0.00018881481],"domain_scores_gemma":[0.9949007,0.00072451204,0.003002943,0.00039462344,0.0006101227,0.00036708516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016899019,0.00024388888,0.000453811,0.0014818226,0.00044719072,0.00076066016,0.0005418458,0.00037029042,0.00078163156],"category_scores_gemma":[0.0039906595,0.00037556278,0.00094812346,0.0029660803,0.00025254933,0.00051870086,0.00069280603,0.0005172059,0.00012484155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061106024,0.000015068351,0.9989286,0.000027879456,0.0000933595,0.000035190507,0.000045224697,0.00001958768,0.00005342098,0.000009399286,0.00012325241,0.0005878028],"study_design_scores_gemma":[0.000009309566,0.00003088265,0.9991153,0.00001264291,0.00011594238,0.00011570865,0.00013111233,0.00023974178,0.000036408193,0.000008384336,0.0001803725,0.0000042444185],"about_ca_topic_score_codex":0.035347793,"about_ca_topic_score_gemma":0.03778227,"teacher_disagreement_score":0.035347793,"about_ca_system_score_codex":0.0010149959,"about_ca_system_score_gemma":0.0010770869,"threshold_uncertainty_score":0.07028407},"labels":[],"label_agreement":null},{"id":"W4415519091","doi":"10.1016/j.jtho.2025.09.967","title":"P3.13.31 Real-World Effectiveness and Safety of Lurbinectedin for Small Cell Lung Cancer (SCLC): Updates From Jazz EMERGE 402","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Southlake Regional Health Center","funders":"","keywords":"Jazz; Lung cancer; MEDLINE; Small Cell Lung Carcinoma","score_opus":0.021141748485960583,"score_gpt":0.45212914127192616,"score_spread":0.4309873927859656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415519091","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02155493,0.6491013,0.0018787141,0.13593376,0.01253085,0.0016829589,0.023826273,0.0009095097,0.15258162],"genre_scores_gemma":[0.13077624,0.6573067,0.012806975,0.08774657,0.028416326,0.003303519,0.030549234,0.0007549217,0.048339613],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99806255,0.00066434045,0.00031361415,0.00012808092,0.00070665,0.0001247641],"domain_scores_gemma":[0.9793627,0.011317036,0.0023412348,0.0005859935,0.0052958257,0.001097071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007425139,0.0005611425,0.001808208,0.001105585,0.0004347882,0.002370848,0.001732063,0.00207456,0.019795481],"category_scores_gemma":[0.016656697,0.00031031866,0.0017778033,0.0013630366,0.0005979086,0.0014047553,0.00096289255,0.002977019,0.007094101],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051585054,0.00028877583,0.0020774675,0.005607772,0.00041595972,0.0000890613,0.00006725919,0.00027738386,0.001235717,0.0013208626,0.29136288,0.69209844],"study_design_scores_gemma":[0.00445928,0.0025460117,0.017329803,0.0073956633,0.0009648749,0.0003724839,0.00008112046,0.00028825077,0.0012744034,0.001679148,0.9635509,0.00005806154],"about_ca_topic_score_codex":0.0029358282,"about_ca_topic_score_gemma":0.0071170507,"teacher_disagreement_score":0.019795481,"about_ca_system_score_codex":0.0019341432,"about_ca_system_score_gemma":0.0022383216,"threshold_uncertainty_score":0.06622249},"labels":[],"label_agreement":null},{"id":"W4415520521","doi":"10.1016/j.jtho.2025.09.700","title":"P2.10.06 Docetaxel in NSCLC: A Multi-Centre Real World Evidence Analysis in the Immunotherapy Era","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Docetaxel; Immunotherapy; Lung cancer; Real world evidence; Standard of care; Second line; Chemotherapy; Nivolumab","score_opus":0.057748108346006,"score_gpt":0.5180295112931637,"score_spread":0.46028140294715764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415520521","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13702193,0.80597556,0.002656549,0.014621809,0.0016023935,0.0015139339,0.015730582,0.00008485603,0.020792393],"genre_scores_gemma":[0.8818964,0.102199,0.0037356014,0.0046398356,0.0013368947,0.00074734044,0.003807267,0.00007147959,0.0015661006],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.97652656,0.016196605,0.0032335243,0.0012850105,0.0020975491,0.00066077785],"domain_scores_gemma":[0.9100101,0.06670077,0.015537672,0.0016195975,0.0044943155,0.001637461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017181821,0.00067744404,0.0032406405,0.0017673335,0.00044447844,0.004376532,0.0012198496,0.0016968512,0.012574453],"category_scores_gemma":[0.050785217,0.0005676573,0.011620791,0.0036587599,0.0008576808,0.0023156726,0.0010879475,0.0031858813,0.00093631365],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12450073,0.00066514936,0.07502769,0.21054748,0.3301114,0.0007715724,0.0003652113,0.0038563926,0.0017814577,0.0038596615,0.016247015,0.23226629],"study_design_scores_gemma":[0.058995146,0.014001208,0.17969796,0.084986076,0.5804961,0.0021127008,0.00088902906,0.0025840427,0.0012524987,0.0057300166,0.06896936,0.00028597508],"about_ca_topic_score_codex":0.0023548186,"about_ca_topic_score_gemma":0.004941679,"teacher_disagreement_score":0.017181821,"about_ca_system_score_codex":0.0017262782,"about_ca_system_score_gemma":0.0031068353,"threshold_uncertainty_score":0.09086728},"labels":[],"label_agreement":null},{"id":"W4415537250","doi":"10.1007/s00253-025-13577-0","title":"Genetically encoded fluorescent probes to assist in the diagnosis of small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Applied Microbiology and Biotechnology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"123 Certification (Canada)","funders":"","keywords":"Peptide; Detection limit; Fluorescence; Enolase; Phage display; Lung cancer; Binding selectivity; Molecular probe","score_opus":0.0100182625724784,"score_gpt":0.28899144555107403,"score_spread":0.27897318297859564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415537250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7147644,0.01816253,0.25498942,0.0019893597,0.00036834425,0.0003070493,0.0009033808,0.0018665169,0.0066489778],"genre_scores_gemma":[0.8354732,0.0062679336,0.15176512,0.0008050938,0.00006860842,0.00022744542,0.00067364785,0.00006141064,0.0046574795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996805,0.000092386916,0.000012860403,0.00007339293,0.00009793094,0.000042837895],"domain_scores_gemma":[0.9998247,0.00006409289,0.00003801005,0.00001674053,0.00003637371,0.00002012628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004216933,0.0004164002,0.00028499003,0.0004075224,0.00013432097,0.00031173843,0.0003595959,0.0010427729,0.0006928513],"category_scores_gemma":[0.0006373276,0.0002289686,0.00028008997,0.00033028086,0.00025683816,0.00035767833,0.00042109052,0.00066833536,0.00044479952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053887783,0.000015536547,0.00017561945,0.00005190281,0.0000043396394,0.000086332395,0.000015186634,0.00020173771,0.9920779,0.00022720126,0.00015582333,0.0069344733],"study_design_scores_gemma":[0.000017144375,0.0002642037,0.001356559,0.000013894111,0.000025974652,0.0006638717,0.000029886893,0.0072301705,0.98292637,0.00025831908,0.0071961987,0.000017416252],"about_ca_topic_score_codex":0.0004335019,"about_ca_topic_score_gemma":0.00058364245,"teacher_disagreement_score":0.0010427729,"about_ca_system_score_codex":0.00037804208,"about_ca_system_score_gemma":0.00019152423,"threshold_uncertainty_score":0.0027428865},"labels":[],"label_agreement":null},{"id":"W4415817108","doi":"10.1016/j.lungcan.2025.108812","title":"Systematic review and network meta-analysis: evaluation of systemic therapies for platinum refractory or resistant small cell lung cancer","year":2025,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Waterloo","funders":"","keywords":"Refractory (planetary science); Lung cancer; Platinum; Chemotherapy; Clinical trial","score_opus":0.15357206138554297,"score_gpt":0.4720203776983185,"score_spread":0.31844831631277554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415817108","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005020957,0.9926878,0.00071259047,0.00021632598,0.00023864013,0.0002618483,0.00052361994,0.000037004527,0.0003011968],"genre_scores_gemma":[0.25178307,0.740124,0.003518721,0.0017840745,0.0003719421,0.000868306,0.0008686352,0.00006646428,0.00061478117],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.986421,0.008507636,0.0027163073,0.001078154,0.00091700075,0.00035994512],"domain_scores_gemma":[0.98172504,0.014119007,0.0023686797,0.0006444688,0.0008795824,0.00026314473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013783711,0.0030104264,0.01827757,0.004013586,0.00062614796,0.0032255368,0.0021727402,0.0022520414,0.0055775205],"category_scores_gemma":[0.04053715,0.001487824,0.031630296,0.0055898214,0.00092779857,0.0021225854,0.0023085624,0.0029661846,0.00043429027],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002286468,0.00001824138,0.001933261,0.2416345,0.7456156,0.000074687225,0.000055168308,0.00031633506,0.00015871323,0.00011192715,0.0005764096,0.0072186287],"study_design_scores_gemma":[0.0013598214,0.00013658013,0.001929037,0.012920447,0.98200274,0.000050569844,0.00003342673,0.00013563245,0.000050148894,0.00019411839,0.0011686095,0.000018914727],"about_ca_topic_score_codex":0.012408489,"about_ca_topic_score_gemma":0.033706024,"teacher_disagreement_score":0.01827757,"about_ca_system_score_codex":0.0030023241,"about_ca_system_score_gemma":0.003927361,"threshold_uncertainty_score":0.07289606},"labels":[],"label_agreement":null},{"id":"W4415939802","doi":"10.1016/j.annonc.2025.08.3399","title":"2788P Real-world third-line treatment patterns and outcomes for recurrent or extensive stage small cell lung cancer (SCLC) in the Canadian small cell lung cancer database (CASCADE)","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Capital District Health Authority; London Health Sciences Centre; Western University; Atlantic School of Theology; Atlantic Cancer Research Institute; BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network; Jewish General Hospital; Ottawa Regional Cancer Foundation; CancerCare Manitoba","funders":"","keywords":"Lung cancer; Small Cell Lung Carcinoma; Cancer; Small-cell carcinoma; Stage (stratigraphy)","score_opus":0.14396334498684643,"score_gpt":0.4763903635046531,"score_spread":0.33242701851780665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415939802","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07013865,0.0005688864,0.00007840476,0.0005841694,0.000040597995,0.00009307794,0.92368245,0.000050642968,0.0047630686],"genre_scores_gemma":[0.41395903,0.0011498822,0.0007639899,0.000694365,0.00006125711,0.00030639538,0.5792787,0.000046651712,0.0037397703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990062,0.00005326416,0.00013327037,0.00017950735,0.00034513068,0.0002826801],"domain_scores_gemma":[0.994323,0.00045672723,0.0013600993,0.00029752875,0.0026777615,0.0008849221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005674414,0.000549535,0.0007031323,0.0030713582,0.001192505,0.0014507358,0.0013873271,0.0006921435,0.017780624],"category_scores_gemma":[0.0074671786,0.0004040614,0.0012057625,0.011263402,0.00032813475,0.00061688194,0.0010584368,0.00086973445,0.0016340074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006092076,0.00006456708,0.7975231,0.00059183926,0.0004841114,0.0001383879,0.00018464788,0.0005832416,0.00011853075,0.0006711063,0.18938799,0.009643178],"study_design_scores_gemma":[0.00017517009,0.00002627886,0.9807982,0.00022826517,0.00016026906,0.0001286621,0.00032105102,0.00063939625,0.000065410415,0.00013385083,0.017293148,0.000030452571],"about_ca_topic_score_codex":0.9790302,"about_ca_topic_score_gemma":0.9859637,"teacher_disagreement_score":0.020969808,"about_ca_system_score_codex":0.012529276,"about_ca_system_score_gemma":0.027045578,"threshold_uncertainty_score":0.09090662},"labels":[],"label_agreement":null},{"id":"W4415942153","doi":"10.1016/j.annonc.2025.08.3374","title":"2763P Treatment patterns and outcomes of clinical stage I small cell lung cancer (SCLC) in the Canadian SCLC database (CASCADE)","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Ottawa Regional Cancer Foundation; CancerCare Manitoba; Princess Margaret Cancer Centre; BC Cancer Agency; University Health Network; University of Ottawa","funders":"","keywords":"Stage (stratigraphy); Radiation therapy; Small Cell Lung Carcinoma; Chemotherapy; Prophylactic cranial irradiation; Modalities; Stereotactic radiotherapy","score_opus":0.21553980894216113,"score_gpt":0.5431567617882272,"score_spread":0.3276169528460661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415942153","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44196504,0.0021533538,0.00014876266,0.0019503613,0.00007707526,0.0001870703,0.54041,0.00007238314,0.013035907],"genre_scores_gemma":[0.8538015,0.0017230179,0.00058919034,0.0007578207,0.00005092882,0.00017450565,0.13959113,0.00003154949,0.0032804455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987532,0.00007293262,0.00015598879,0.00022752908,0.0004027866,0.0003876238],"domain_scores_gemma":[0.99439335,0.00031129437,0.001036385,0.00021837598,0.0030791324,0.00096150883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069645466,0.00047162033,0.0005435655,0.0035258855,0.0017803353,0.0012783386,0.0015595359,0.0006390559,0.0102775665],"category_scores_gemma":[0.0070037823,0.00039739982,0.0011467831,0.011725295,0.00039445204,0.0006903119,0.0011616832,0.0008499216,0.0009324472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027439848,0.0000459126,0.9501354,0.00026642423,0.00022962935,0.00007853203,0.00021121648,0.00023387338,0.00008853717,0.00042117486,0.0414341,0.006580704],"study_design_scores_gemma":[0.00005647592,0.000017520719,0.9933041,0.00012618827,0.00011712779,0.00008019195,0.00038253647,0.00027057866,0.000052203453,0.00006550097,0.0055108187,0.000016675329],"about_ca_topic_score_codex":0.99184763,"about_ca_topic_score_gemma":0.9947785,"teacher_disagreement_score":0.020068496,"about_ca_system_score_codex":0.020068496,"about_ca_system_score_gemma":0.044857055,"threshold_uncertainty_score":0.14560783},"labels":[],"label_agreement":null},{"id":"W4416019187","doi":"10.1016/j.ijgc.2025.102731","title":"PHASE 3 ROSELLA (GOG-3073, ENGOT-OV72) TRIAL OF RELACORILANT + NAB-PACLITAXEL VS NAB-PACLITAXEL IN PLATINUM-RESISTANT OVARIAN CANCER: PRIMARY RESULTS AND OUTCOMES IN OLDER PATIENTS","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Phase (matter); Phases of clinical research; Clinical trial; MEDLINE","score_opus":0.022602088258806528,"score_gpt":0.39534424490579323,"score_spread":0.3727421566469867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98503613,0.008215075,0.00022443262,0.00094111275,0.00020478426,0.00051660603,0.0022552656,0.00009994799,0.0025066333],"genre_scores_gemma":[0.9797902,0.005441179,0.0010088554,0.002205168,0.00032263872,0.0009790438,0.0051557086,0.00006106941,0.005036231],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996264,0.00018713665,0.0000134016245,0.000052969885,0.000030845833,0.00008922704],"domain_scores_gemma":[0.99948704,0.00011059428,0.00014246491,0.000040850875,0.000024629358,0.00019429218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014582889,0.0010646507,0.0016512492,0.00036982913,0.00027815346,0.0009442703,0.0007867526,0.0008565016,0.0046565114],"category_scores_gemma":[0.0010572718,0.00034141788,0.0022280982,0.0004627747,0.0006442496,0.000720939,0.00043625993,0.0029389889,0.00073127303],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8781523,0.0072666844,0.009184096,0.0011260835,0.0041726707,0.0001370703,0.0001816243,0.0014269628,0.007181884,0.00039865635,0.007678853,0.08309313],"study_design_scores_gemma":[0.8312486,0.118298694,0.03903237,0.00017242091,0.0030863942,0.00026945476,0.00016587252,0.0009342328,0.001082915,0.0004935372,0.0051585906,0.00005699454],"about_ca_topic_score_codex":0.0023804666,"about_ca_topic_score_gemma":0.008290403,"teacher_disagreement_score":0.0046565114,"about_ca_system_score_codex":0.00097051077,"about_ca_system_score_gemma":0.00094565237,"threshold_uncertainty_score":0.015577614},"labels":[],"label_agreement":null},{"id":"W4416345611","doi":"10.1016/j.lungcan.2025.108840","title":"Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)","year":2025,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Western University; AstraZeneca (Canada); London Health Sciences Centre; Dalhousie University; University of Ottawa; McGill University; Princess Margaret Cancer Centre; University of Calgary; Jewish General Hospital; Occupational Cancer Research Centre; CancerCare Manitoba","funders":"Princess Margaret Cancer Foundation; AstraZeneca","keywords":"Immunotherapy; Small-cell carcinoma; Lung cancer; Overall survival; Stage (stratigraphy); Small Cell Lung Carcinoma","score_opus":0.028782662505763917,"score_gpt":0.3607694565274413,"score_spread":0.3319867940216774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416345611","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40251893,0.006019615,0.0001728008,0.0021303738,0.00012796037,0.00033962194,0.5782486,0.00005652214,0.010385574],"genre_scores_gemma":[0.77685887,0.0041088634,0.00061445055,0.0010462145,0.00008695096,0.00041630003,0.21361834,0.00002559166,0.003224315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979266,0.00015525531,0.0002611436,0.000358276,0.0007386846,0.0005600602],"domain_scores_gemma":[0.9939243,0.000317502,0.0011530617,0.0002530543,0.0032904877,0.0010616294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011680924,0.0006379645,0.0010188387,0.0031610844,0.0018985865,0.0013634071,0.0021876812,0.00089172,0.0056069302],"category_scores_gemma":[0.007582206,0.00044388397,0.0015902816,0.011655219,0.0004578372,0.0008053818,0.0012984526,0.0012396112,0.00056470087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007405208,0.00010464241,0.92249095,0.0006725869,0.0007520277,0.000089286295,0.00028403552,0.00042247435,0.00012210694,0.0006883425,0.066750735,0.00688225],"study_design_scores_gemma":[0.00011887233,0.00002577902,0.9930519,0.00018310046,0.00023270366,0.00005546015,0.0003298387,0.00025260105,0.000036031277,0.00007886808,0.0056088404,0.000026066631],"about_ca_topic_score_codex":0.9892833,"about_ca_topic_score_gemma":0.9944142,"teacher_disagreement_score":0.027070763,"about_ca_system_score_codex":0.027070763,"about_ca_system_score_gemma":0.053732615,"threshold_uncertainty_score":0.19641304},"labels":[],"label_agreement":null},{"id":"W4416398904","doi":"10.1016/j.lungcan.2025.108844","title":"Tarlatamab population survival kinetics in extensive-stage small cell lung cancer: brief report","year":2025,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Population; Lung; Survival analysis; Duration (music); Cell","score_opus":0.021190006092245132,"score_gpt":0.37352279612439293,"score_spread":0.3523327900321478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416398904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94422346,0.040151063,0.0030904624,0.0014194951,0.00023686688,0.00010869798,0.0018585909,0.00017190377,0.008739478],"genre_scores_gemma":[0.9796948,0.011511121,0.001083223,0.0002697349,0.00039383202,0.000047456015,0.0013158368,0.000026979833,0.0056570447],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999848,0.000035249173,0.000013630576,0.000038621565,0.000028516266,0.000035976776],"domain_scores_gemma":[0.9994267,0.00029468045,0.00007988819,0.000052574043,0.000096609605,0.000049487375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006995941,0.00017747452,0.00033319552,0.0003788921,0.0002049133,0.00055134477,0.00017937209,0.0003669901,0.0026356871],"category_scores_gemma":[0.0009529831,0.000116961055,0.0002487978,0.00044960593,0.00017725956,0.00050054,0.00021130714,0.00045209882,0.0006939354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021782149,0.001178555,0.19279653,0.0013454227,0.0002551889,0.003160553,0.0011044487,0.001639419,0.23844638,0.0022000936,0.012439306,0.52365196],"study_design_scores_gemma":[0.00027954127,0.021399464,0.68292946,0.00010978966,0.00084930996,0.014400028,0.0011624749,0.0040915646,0.15428731,0.0012971783,0.11908183,0.00011215051],"about_ca_topic_score_codex":0.0015342407,"about_ca_topic_score_gemma":0.001124602,"teacher_disagreement_score":0.0026356871,"about_ca_system_score_codex":0.00036058316,"about_ca_system_score_gemma":0.00033902904,"threshold_uncertainty_score":0.0088172555},"labels":[],"label_agreement":null},{"id":"W4416822418","doi":"10.1016/j.jlb.2025.100449","title":"Cancer in a drop: Liquid biopsy highlights from the World Conference on Lung Cancer (WCLC) 2025","year":2025,"lang":"en","type":"article","venue":"The Journal of Liquid Biopsy","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Institutes of Health","keywords":"Liquid biopsy; Lung cancer; Biopsy; Targeted therapy; Disease; Cancer; Malignancy; Minimal residual disease","score_opus":0.039971330608888155,"score_gpt":0.3780679746078897,"score_spread":0.3380966439990016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416822418","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022959951,0.5228416,0.0029180408,0.28655472,0.15652195,0.00016586989,0.0008048909,0.00034485233,0.027552111],"genre_scores_gemma":[0.019577565,0.5832421,0.0043618493,0.16921017,0.17526168,0.00023759027,0.002607502,0.00032441277,0.0451771],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871385,0.00025764815,0.00012603425,0.00017278489,0.0005675148,0.00016205931],"domain_scores_gemma":[0.99558485,0.0009162314,0.00025747047,0.0001000601,0.0020685366,0.0010729205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003860073,0.0007674833,0.0006572357,0.0013507695,0.0007395204,0.0027827611,0.0010486685,0.003151953,0.011816521],"category_scores_gemma":[0.005721174,0.0002679481,0.000947114,0.0008735482,0.0008332295,0.0025756974,0.0017866564,0.0051640896,0.005231243],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010945797,0.000033328684,0.00067114533,0.00086493103,0.000021378724,0.0004239393,0.000054394848,0.00010860946,0.0008323808,0.0023655968,0.7709841,0.22353077],"study_design_scores_gemma":[0.0000114314835,0.00005276089,0.0009133743,0.0008499769,0.000017932183,0.0007482051,0.00007396691,0.00007032622,0.0002697973,0.000711533,0.9962645,0.000016170246],"about_ca_topic_score_codex":0.003694141,"about_ca_topic_score_gemma":0.008394937,"teacher_disagreement_score":0.011816521,"about_ca_system_score_codex":0.002301601,"about_ca_system_score_gemma":0.0032914006,"threshold_uncertainty_score":0.039530218},"labels":[],"label_agreement":null},{"id":"W4417168166","doi":"10.1097/coc.0000000000001265","title":"Immunotherapy in Extensive Stage Small-Cell Lung Cancer in First-Line and Second-Line Setting","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; BC Cancer Agency; London Health Sciences Centre; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Lung cancer; Immunotherapy; Stage (stratigraphy); Respiratory disease; MEDLINE; Neoplasm staging; Retrospective cohort study","score_opus":0.04850980863133062,"score_gpt":0.49210545852412857,"score_spread":0.4435956498927979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417168166","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005106185,0.99416685,0.00012200967,0.00012202131,0.00009855564,0.00007169331,0.00009036507,0.0000049331516,0.00021736661],"genre_scores_gemma":[0.27180216,0.7246751,0.0010245137,0.001046166,0.00043298263,0.00040454217,0.00030064356,0.00000876333,0.00030508675],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99702746,0.0016324726,0.0006363357,0.00030660734,0.00029546773,0.0001016276],"domain_scores_gemma":[0.9947055,0.003667859,0.0011993775,0.00010527344,0.00023688919,0.00008510332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048988345,0.00091230596,0.00732045,0.0017509268,0.00021063488,0.0016900621,0.00078371953,0.001265267,0.001843025],"category_scores_gemma":[0.010708215,0.0004289385,0.013403395,0.00154451,0.0003075058,0.0010021272,0.0005285658,0.0012467888,0.00012951938],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012037118,0.00017496811,0.00547987,0.49334386,0.3813602,0.0001910822,0.00009732992,0.0016841402,0.0011807515,0.00041968504,0.0011042791,0.102926746],"study_design_scores_gemma":[0.0091667315,0.004755134,0.016255978,0.10424925,0.85216546,0.0005902763,0.0001284033,0.0010016802,0.00080227735,0.0008747928,0.009951137,0.00005886844],"about_ca_topic_score_codex":0.0021051853,"about_ca_topic_score_gemma":0.006013586,"teacher_disagreement_score":0.00732045,"about_ca_system_score_codex":0.0012166313,"about_ca_system_score_gemma":0.0014909052,"threshold_uncertainty_score":0.025907815},"labels":[],"label_agreement":null},{"id":"W4417407062","doi":"10.1016/j.lungcan.2025.108875","title":"Corrigendum to “Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)” [Lung Cancer 210 (2025) 108840]","year":2025,"lang":"en","type":"erratum","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Western University; AstraZeneca (Canada); London Health Sciences Centre; Dalhousie University; University of Ottawa; McGill University; Princess Margaret Cancer Centre; University of Calgary; Jewish General Hospital; Occupational Cancer Research Centre; CancerCare Manitoba","funders":"","keywords":"Cancer; Lung cancer; Stage (stratigraphy); Cell; Small-cell carcinoma","score_opus":0.03818360186285828,"score_gpt":0.3594488226258624,"score_spread":0.3212652207630041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417407062","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027801257,0.0024480768,0.00023862846,0.13446271,0.71536136,0.00028146573,0.11748488,0.0005841095,0.028860666],"genre_scores_gemma":[0.007595507,0.0073534395,0.0020321892,0.21336815,0.1355837,0.0013922387,0.13499527,0.000960773,0.4967188],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.993489,0.00070217135,0.0011652878,0.000698379,0.0030884123,0.00085678196],"domain_scores_gemma":[0.95095694,0.006541078,0.0016389446,0.0012596706,0.036889154,0.0027140572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045345277,0.0015299821,0.0027871246,0.005893306,0.0038276094,0.0041676983,0.0032396428,0.005930257,0.20436983],"category_scores_gemma":[0.05875568,0.0012499957,0.0025347483,0.006297545,0.0011366901,0.0012582048,0.0019615663,0.0051870155,0.07605082],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000054752063,0.0000016637284,0.00004481492,0.000020385449,0.0000020026773,0.000006340408,0.0000013212145,0.0000042692704,0.0000011137844,0.000041009065,0.9993685,0.0005031537],"study_design_scores_gemma":[0.00023579368,0.000022193426,0.008339307,0.0007554394,0.00007723583,0.000071935574,0.00008453398,0.00019605223,0.00005522113,0.000476404,0.98961735,0.00006848885],"about_ca_topic_score_codex":0.6078252,"about_ca_topic_score_gemma":0.7318234,"teacher_disagreement_score":0.39217478,"about_ca_system_score_codex":0.015311112,"about_ca_system_score_gemma":0.028672816,"threshold_uncertainty_score":0.78896874},"labels":[],"label_agreement":null},{"id":"W4417451585","doi":"10.1016/j.ejca.2025.116190","title":"Ambient air pollution and survival in SCLC/LCNEC: Analysis of a single centre retrospective cohort","year":2025,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Retrospective cohort study; Air pollution; Cohort; Pollution; Cohort study; Risk factor","score_opus":0.014090027745508923,"score_gpt":0.31947163993190025,"score_spread":0.3053816121863913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417451585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991371,0.00022301594,0.00007086928,0.000012057105,0.000005505235,0.0000056639137,0.00041523884,0.000003375781,0.000127246],"genre_scores_gemma":[0.9990707,0.00011853342,0.00005455281,0.000012938079,0.0000084315025,0.000006381273,0.00061586767,0.000002793968,0.00010984212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910223,0.00015993477,0.00009892001,0.00034857358,0.00011178245,0.00017843119],"domain_scores_gemma":[0.99895823,0.00012467771,0.00033871704,0.00023834163,0.00015236127,0.000187775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008272893,0.0005127865,0.0007363387,0.00093190453,0.0007881423,0.001273742,0.0006434709,0.00074552046,0.0012040129],"category_scores_gemma":[0.0013218796,0.0007523492,0.0014718861,0.0018900089,0.00046889044,0.00062374404,0.00092167815,0.00078775117,0.00030771492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038542374,0.00004105775,0.9981476,0.000009294006,0.00023104163,0.00012391902,0.000067591645,0.000046739373,0.00037135964,0.000013141932,0.00006196131,0.00050080393],"study_design_scores_gemma":[0.000012671617,0.00012264586,0.9989467,0.000004953085,0.00011180727,0.00030014603,0.0002121891,0.00012335306,0.00004918251,0.0000114235745,0.000099154604,0.000005795168],"about_ca_topic_score_codex":0.016704297,"about_ca_topic_score_gemma":0.014198965,"teacher_disagreement_score":0.016704297,"about_ca_system_score_codex":0.00054939435,"about_ca_system_score_gemma":0.00067812135,"threshold_uncertainty_score":0.03321415},"labels":[],"label_agreement":null},{"id":"W4417482148","doi":"10.1016/j.jval.2025.09.1376","title":"EPH247 The Incidence, Mortality, and Survival of Malignant Non-Small Cell Lung Cancer (NSCLC) in the United States: A Surveillance Epidemiology and End Results (SEER) 2000-2022 Database Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Surveillance, Epidemiology, and End Results; Epidemiology; Lung cancer; Epidemiological surveillance; Cancer; Lung","score_opus":0.08724169503674144,"score_gpt":0.42320669820038004,"score_spread":0.3359650031636386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9065273,0.0031290192,0.00021061151,0.00018258675,0.000018058427,0.000048450394,0.088266715,0.000018429688,0.0015988372],"genre_scores_gemma":[0.9344961,0.001840509,0.0003774765,0.00015629831,0.000034747914,0.00009580135,0.062111616,0.000010481375,0.0008769347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906224,0.00023248434,0.00019868133,0.00019308014,0.00023065094,0.00008292078],"domain_scores_gemma":[0.99840575,0.00033343118,0.00077817735,0.00014639812,0.0002061025,0.00013015604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008379259,0.0002835074,0.0006054421,0.0016007768,0.00015130616,0.0006373631,0.00047108476,0.0004163738,0.0010037993],"category_scores_gemma":[0.0025423972,0.00025441314,0.0013086163,0.004270038,0.000120575576,0.00050416775,0.0004693338,0.00042558895,0.00028370452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010569686,0.000044750046,0.9892301,0.00021795969,0.0019479909,0.0000817405,0.000027911105,0.00037722476,0.00018836324,0.00009368261,0.002965412,0.0037678236],"study_design_scores_gemma":[0.00015534196,0.0000790643,0.9957942,0.000045334185,0.0007978661,0.00020390494,0.00007146435,0.000701068,0.00013274436,0.000047826034,0.0019607458,0.000010546401],"about_ca_topic_score_codex":0.016724389,"about_ca_topic_score_gemma":0.021544928,"teacher_disagreement_score":0.016724389,"about_ca_system_score_codex":0.0005835863,"about_ca_system_score_gemma":0.00056159945,"threshold_uncertainty_score":0.033254087},"labels":[],"label_agreement":null},{"id":"W4417535783","doi":"10.1200/go-25-00638","title":"Durvalumab in Limited-Stage Small Cell Lung Cancer: Clinical Triumph and Toward Sustainable Value","year":2025,"lang":"en","type":"article","venue":"JCO Global Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Durvalumab; Value (mathematics); Lung; Immune system; Sustainable development","score_opus":0.038634724482300764,"score_gpt":0.45614707482075234,"score_spread":0.4175123503384516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417535783","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13902548,0.3426908,0.0019184017,0.48443615,0.0046303133,0.00010910357,0.0007365682,0.0000681451,0.02638502],"genre_scores_gemma":[0.7681355,0.16448301,0.0031422821,0.0504885,0.0076259035,0.00011540637,0.00066617597,0.00005809492,0.0052851783],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985122,0.0007367612,0.00013251253,0.00010374944,0.0003017575,0.00021303802],"domain_scores_gemma":[0.9931672,0.0038709352,0.00071133795,0.00023342777,0.00083162205,0.0011855231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008336988,0.00024212476,0.000825846,0.0003720889,0.00036190267,0.0026468113,0.00070476724,0.0009945679,0.0039619654],"category_scores_gemma":[0.00932649,0.00010986526,0.0004841132,0.0005976013,0.0014540913,0.004080455,0.0010986254,0.0030159,0.0004573504],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041787024,0.0004150794,0.014096134,0.0010185816,0.00032167792,0.00023607067,0.00034073176,0.00075559865,0.0026457326,0.036285553,0.054162256,0.8855438],"study_design_scores_gemma":[0.0051757246,0.011230837,0.081769384,0.008110431,0.0013738641,0.0018176538,0.0036345168,0.005316513,0.006163168,0.1273694,0.7478363,0.00020233098],"about_ca_topic_score_codex":0.0018551737,"about_ca_topic_score_gemma":0.006840398,"teacher_disagreement_score":0.008336988,"about_ca_system_score_codex":0.0028571207,"about_ca_system_score_gemma":0.0043157777,"threshold_uncertainty_score":0.044090748},"labels":[],"label_agreement":null},{"id":"W46269388","doi":"10.1593/neo.101524","title":"Optimization of Circulating Biomarkers of Obatoclax-Induced Cell Death in Patients with Small Cell Lung Cancer","year":2011,"lang":"en","type":"article","venue":"Neoplasia","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"Cancer Research UK; Moffitt Cancer Center","keywords":"Etoposide; Carboplatin; Lung cancer; Pharmacology; Medicine; Cisplatin; Oncology; Internal medicine; Apoptosis; Chemotherapy; Cancer research; Biology","score_opus":0.02953228557169934,"score_gpt":0.27724635827513283,"score_spread":0.24771407270343349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W46269388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945478,0.0029932447,0.000892468,0.00009757057,0.00002068245,0.00031102283,0.00024775014,0.0000679717,0.0008215808],"genre_scores_gemma":[0.9970464,0.0004390921,0.0011896316,0.00014579696,0.000030047046,0.0002632876,0.0005797365,0.000007909909,0.00029800725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996275,0.00015754055,0.00003901403,0.00006564137,0.000062422245,0.00004792094],"domain_scores_gemma":[0.99933213,0.00018022007,0.0001957155,0.00003844656,0.000085710184,0.00016774297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006213218,0.0005407909,0.0011873806,0.00042921747,0.00022628286,0.00056704757,0.00025081178,0.00037812552,0.00051993586],"category_scores_gemma":[0.0014992973,0.00018431139,0.00022516266,0.0003986189,0.0002158218,0.00031745978,0.0002013433,0.0006400433,0.00020231318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11922705,0.0029176679,0.48968947,0.00047893712,0.00043958394,0.0010061121,0.00052691076,0.0052372,0.17361672,0.00025461303,0.0021190431,0.20448677],"study_design_scores_gemma":[0.006669952,0.10483976,0.7614951,0.000105359744,0.0007042647,0.0023742518,0.00032602,0.011687264,0.10374249,0.0004973244,0.0074906982,0.00006764962],"about_ca_topic_score_codex":0.00037896002,"about_ca_topic_score_gemma":0.00052281376,"teacher_disagreement_score":0.0011873806,"about_ca_system_score_codex":0.00034294935,"about_ca_system_score_gemma":0.00043346098,"threshold_uncertainty_score":0.0032858849},"labels":[],"label_agreement":null},{"id":"W6908707646","doi":"10.3205/23swdgu046","title":"Lebensqualität und Patienten-relevante Endpunkte unter Darolutamid-Therapie in der Phase-3-Studie ARASENS","year":2023,"lang":"de","type":"article","venue":"German Medical Science (German Research Foundation)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Placebo; Long-term prediction; Term (time); Work (physics)","score_opus":0.1326690753293251,"score_gpt":0.5501395070951672,"score_spread":0.41747043176584214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6908707646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9106804,0.07239512,0.0014817438,0.00085933873,0.0006047604,0.0025457225,0.007881521,0.000076839235,0.0034745615],"genre_scores_gemma":[0.97650427,0.009676148,0.0016137338,0.0010660012,0.00026839843,0.0042649237,0.0048112017,0.00003903545,0.0017563091],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9980509,0.0012355897,0.00022678677,0.00017258852,0.00016050105,0.00015366863],"domain_scores_gemma":[0.99775416,0.0011424517,0.00055252045,0.00013778357,0.00015690512,0.00025627922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061981604,0.00096073997,0.00255916,0.0002745816,0.00023981326,0.0010903827,0.0004592847,0.0007873958,0.003698784],"category_scores_gemma":[0.0043924805,0.00034400256,0.0064369314,0.00047697013,0.00027604602,0.000837094,0.0006069755,0.0023404765,0.00047321987],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87680763,0.0028786983,0.0143516995,0.0066948496,0.034214396,0.000056328103,0.00017446048,0.0020419736,0.003153268,0.00033451096,0.0032609582,0.056031294],"study_design_scores_gemma":[0.49988,0.22068244,0.14016746,0.0024284574,0.101443864,0.00026838257,0.00023075733,0.002590604,0.0074597867,0.002206452,0.022473995,0.00016781101],"about_ca_topic_score_codex":0.00048197558,"about_ca_topic_score_gemma":0.0012914606,"teacher_disagreement_score":0.0061981604,"about_ca_system_score_codex":0.00054945087,"about_ca_system_score_gemma":0.0011499982,"threshold_uncertainty_score":0.032779336},"labels":[],"label_agreement":null},{"id":"W6929858119","doi":"10.5061/dryad.cz8w9gj75","title":"Functional profiling and evolutionary analysis of a marine microalgal virus pangenome","year":2023,"lang":"en","type":"dataset","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Context (archaeology); Nucleofection; Identification (biology); Population; Proteogenomics","score_opus":0.04467216541675376,"score_gpt":0.28978101661942274,"score_spread":0.24510885120266898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6929858119","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98564446,0.0008427877,0.0029213524,0.00006694603,0.000010160047,0.000022401153,0.009387399,0.00018738485,0.0009172162],"genre_scores_gemma":[0.92302054,0.0013277672,0.017847965,0.00007434941,0.000015563037,0.00007024192,0.056723922,0.00021980463,0.0006998846],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998215,0.000021541784,0.000012793732,0.000072666095,0.000036521942,0.00003512616],"domain_scores_gemma":[0.99968827,0.00009108324,0.000056725887,0.000026513106,0.00008650408,0.00005085555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036824317,0.00042342293,0.000341595,0.0016761601,0.0004369723,0.00061861257,0.00020343105,0.00029554742,0.00073375885],"category_scores_gemma":[0.00083115906,0.00014542899,0.00073882134,0.0015433009,0.00015512682,0.0005337819,0.000567383,0.00033990527,0.00037147434],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001177297,0.00023533042,0.14454038,0.0017065287,0.0002567493,0.0006549211,0.0013704564,0.007912633,0.7733903,0.001175035,0.0019502387,0.06563008],"study_design_scores_gemma":[0.000046263194,0.001101196,0.75074476,0.00032201924,0.0006524897,0.0020122568,0.0023458712,0.09268616,0.11875285,0.0021137006,0.02910219,0.00012020193],"about_ca_topic_score_codex":0.0022162348,"about_ca_topic_score_gemma":0.001993105,"teacher_disagreement_score":0.0022162348,"about_ca_system_score_codex":0.00031765414,"about_ca_system_score_gemma":0.00035991537,"threshold_uncertainty_score":0.004406631},"labels":[],"label_agreement":null},{"id":"W6930519948","doi":"10.5281/zenodo.12360361","title":"Oedipus at colonus pdf","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ridiculous; Spectacle; Blame; Lament; Character (mathematics)","score_opus":0.03221269340577838,"score_gpt":0.2951358253615847,"score_spread":0.26292313195580636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930519948","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025110666,0.0027398746,0.0006981954,0.0012672103,0.0025107376,0.00012688794,0.009761641,0.0027514952,0.97763294],"genre_scores_gemma":[0.007536142,0.0027529793,0.0005583642,0.0007188781,0.00044548252,0.000028235248,0.0042387065,0.0006283443,0.9830929],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987686,0.0000073777164,0.000004476933,0.00001527502,0.000065901695,0.000030073837],"domain_scores_gemma":[0.99965596,0.000029838018,0.000017794984,0.000026326157,0.00011227262,0.00015788466],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011529066,0.0006592532,0.00042696056,0.0013102008,0.0007580211,0.0016269579,0.00041462333,0.00068681326,0.7152052],"category_scores_gemma":[0.0005546879,0.00020617916,0.0003878248,0.00085749413,0.00032702793,0.001278372,0.001464405,0.0010772716,0.4820567],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017399594,0.00005369308,0.0003098026,0.00057258527,0.0000046045034,0.000640835,0.0000697688,0.00006737345,0.008241085,0.001966326,0.8163579,0.17154203],"study_design_scores_gemma":[0.000010438227,0.00004489128,0.0015543615,0.000092567876,0.0000024335552,0.0004919301,0.000055203847,0.000028365626,0.0014517177,0.0003247581,0.9959359,0.0000074533077],"about_ca_topic_score_codex":0.0018592541,"about_ca_topic_score_gemma":0.003360486,"teacher_disagreement_score":0.2847948,"about_ca_system_score_codex":0.00043317376,"about_ca_system_score_gemma":0.0005233041,"threshold_uncertainty_score":0.4062252},"labels":[],"label_agreement":null},{"id":"W6930662333","doi":"10.5281/zenodo.15785673","title":"Rhaphitelus maculatus Walker 1834","year":2025,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Holotype; Bark beetle; Genus; Subfamily; Scarabaeoidea; Braconidae","score_opus":0.027297863168135247,"score_gpt":0.3024273562868514,"score_spread":0.27512949311871615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930662333","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41137016,0.016595244,0.005419953,0.0009849,0.000662404,0.0006536835,0.0050476077,0.0014300259,0.55783606],"genre_scores_gemma":[0.93999696,0.0032595713,0.0036845328,0.00038164094,0.00017034166,0.00016035544,0.0014759869,0.000055664343,0.050814997],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999275,0.000010081865,0.000007602683,0.000019070338,0.000026832311,0.000008903955],"domain_scores_gemma":[0.99993455,0.000009268413,0.00002896309,0.000005767322,0.000014537551,0.000006917962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006014427,0.0004374399,0.00017350278,0.0008607703,0.0006450176,0.00020204157,0.00032170664,0.00027120762,0.019581305],"category_scores_gemma":[0.00022375897,0.00015061967,0.00010918722,0.00037961177,0.00035080078,0.00038419248,0.0006307223,0.0002183305,0.0059037744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002973253,0.00008856398,0.044542797,0.0010070335,0.00007078148,0.0019707659,0.0014448211,0.0005947141,0.023065833,0.003775488,0.07294287,0.850199],"study_design_scores_gemma":[0.00006912696,0.00027688144,0.37918952,0.00052829215,0.000103462946,0.008414451,0.0009982692,0.00075941166,0.006193514,0.0014589056,0.60197663,0.000031548545],"about_ca_topic_score_codex":0.0038558396,"about_ca_topic_score_gemma":0.008540611,"teacher_disagreement_score":0.019581305,"about_ca_system_score_codex":0.00033101565,"about_ca_system_score_gemma":0.00015816603,"threshold_uncertainty_score":0.06550604},"labels":[],"label_agreement":null},{"id":"W6931583484","doi":"10.5683/sp3/wfvdeq","title":"Obabigan Lake Ontario. 1:50,000. Map Sheet 053A12, ed. 1, 1977","year":2021,"lang":"en","type":"dataset","venue":"Borealis","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Georeference; General partnership; Raster graphics; Natural (archaeology); Aerial photography; Topographic map (neuroanatomy); Viewshed analysis; Digital mapping","score_opus":0.024693891053948893,"score_gpt":0.31795312737210857,"score_spread":0.2932592363181597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931583484","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000069759495,0.00006271972,0.00001637247,0.000029414652,0.000008610817,0.0000047208364,0.9983311,0.000052680283,0.0014246526],"genre_scores_gemma":[0.0007399813,0.00021166293,0.00016386708,0.000025889758,0.0000067141873,0.0000528153,0.99309796,0.000068695335,0.005632424],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994018,0.000032631884,0.000056041627,0.00013445853,0.00021923654,0.00015585196],"domain_scores_gemma":[0.99812466,0.00012898928,0.00017954575,0.00018386457,0.0011671922,0.00021563232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041934417,0.0015593242,0.0012798151,0.0047693183,0.0012993074,0.0024792806,0.0015073437,0.00054638635,0.13190834],"category_scores_gemma":[0.0030511662,0.00088429835,0.0006814451,0.022505246,0.0004375083,0.00091767753,0.0010225305,0.0007784486,0.09798315],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018489774,0.0000028735803,0.0009771595,0.00032059278,0.000010551143,0.000011355198,0.000031016178,0.00005656565,0.000025846224,0.00018773864,0.9956748,0.00268303],"study_design_scores_gemma":[0.000049432147,0.0000033396893,0.016001955,0.00020848123,0.0000151715185,0.000024145678,0.00014286653,0.00007207936,0.00006938928,0.00018955243,0.98320895,0.000014586468],"about_ca_topic_score_codex":0.9049456,"about_ca_topic_score_gemma":0.9466289,"teacher_disagreement_score":0.13190834,"about_ca_system_score_codex":0.0084905,"about_ca_system_score_gemma":0.01599182,"threshold_uncertainty_score":0.44127738},"labels":[],"label_agreement":null},{"id":"W6931622709","doi":"10.5683/sp3/p7mhpo","title":"Entrance (East) Alberta. 1:50,000. Map Sheet 083F05, ed. 1, 1958","year":2022,"lang":"en","type":"dataset","venue":"Borealis","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Georeference; General partnership; Raster graphics; Natural (archaeology); Digital mapping; Aerial photography; Geographic information system; Government (linguistics)","score_opus":0.017784846497199233,"score_gpt":0.3155693224285967,"score_spread":0.29778447593139745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931622709","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020251445,0.00016427827,0.000036757723,0.000042508727,0.000025347414,0.0000075881203,0.9952036,0.00015859898,0.0041588014],"genre_scores_gemma":[0.0013874973,0.0002475656,0.00032018306,0.000041769843,0.000011209622,0.000030173986,0.986265,0.000091898604,0.011604704],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952567,0.000023463417,0.000029289246,0.00011049534,0.00018988547,0.000121094236],"domain_scores_gemma":[0.99882764,0.000074054384,0.000090496804,0.00011539008,0.0007326405,0.00015977344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044177016,0.0013881611,0.00097426,0.0042177783,0.0010970038,0.0029550383,0.0014748768,0.0004971317,0.1124542],"category_scores_gemma":[0.0018058667,0.00068010506,0.0005256688,0.01500774,0.0003617761,0.0007342551,0.00079511025,0.0009382018,0.09020853],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029267134,0.0000046326236,0.0013992715,0.00018785485,0.000011090081,0.000013879838,0.000028111297,0.000098612916,0.00002940781,0.00027374038,0.99301755,0.00490676],"study_design_scores_gemma":[0.00004645774,0.0000040259984,0.02182298,0.00016875191,0.0000141597075,0.000029752526,0.00018154368,0.00011510207,0.00009922949,0.0003043203,0.97719795,0.000015876036],"about_ca_topic_score_codex":0.88866264,"about_ca_topic_score_gemma":0.9380563,"teacher_disagreement_score":0.1124542,"about_ca_system_score_codex":0.006008449,"about_ca_system_score_gemma":0.011073784,"threshold_uncertainty_score":0.3761968},"labels":[],"label_agreement":null},{"id":"W6931623283","doi":"10.5281/zenodo.7503708","title":"Quedius pallipes Lucas 1849","year":2022,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Agriculture and Agri-Food Canada","funders":"","keywords":"Subspecies; Synonym (taxonomy); Variety (cybernetics); Type (biology); Taxonomy (biology)","score_opus":0.04239560790659652,"score_gpt":0.29245552730168334,"score_spread":0.2500599193950868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931623283","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16499308,0.014425385,0.004725834,0.0014324029,0.0006366599,0.00018054702,0.002456409,0.0006288382,0.8105208],"genre_scores_gemma":[0.91654646,0.0043102005,0.004326136,0.00085630495,0.0001857491,0.00008261108,0.0017419178,0.000085114996,0.0718656],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999075,0.000008657946,0.000004872478,0.000031710493,0.000031688967,0.000015591186],"domain_scores_gemma":[0.99994636,0.000009406619,0.000018780818,0.0000054732336,0.000015389698,0.000004590457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007858171,0.0004098948,0.000160794,0.0008683235,0.0009951228,0.0003685292,0.00048414525,0.00041341028,0.012223881],"category_scores_gemma":[0.00028968486,0.00012324806,0.00010715147,0.0005187438,0.00056330365,0.0006764518,0.0005885039,0.00043958722,0.0035167348],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019439262,0.0000462167,0.026963495,0.00056883827,0.00003545464,0.0016631549,0.0040060286,0.0006048701,0.015507692,0.020867178,0.05040839,0.8791343],"study_design_scores_gemma":[0.0000135328155,0.000051190615,0.06623826,0.00020832071,0.000023177536,0.0029353632,0.0007327813,0.00023030957,0.0013743871,0.0014907126,0.92668617,0.000015750948],"about_ca_topic_score_codex":0.009068088,"about_ca_topic_score_gemma":0.01927088,"teacher_disagreement_score":0.012223881,"about_ca_system_score_codex":0.00087568583,"about_ca_system_score_gemma":0.00031058476,"threshold_uncertainty_score":0.0408929},"labels":[],"label_agreement":null},{"id":"W6939892695","doi":"10.6084/m9.figshare.26703448","title":"Additional file 1 of Segmentation of patients with small cell lung cancer into responders and non-responders using the optimal cross-validation technique","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Victoria","funders":"","keywords":"Segmentation; Lung cancer; Pattern recognition (psychology); Image segmentation; Computed tomography; Small-cell carcinoma","score_opus":0.031226824338127054,"score_gpt":0.35306310269138114,"score_spread":0.32183627835325407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939892695","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058117457,0.000052540385,0.0016027511,0.00013944278,0.00008328868,0.00011703667,0.9944718,0.0018590102,0.0010929026],"genre_scores_gemma":[0.014304444,0.00015273046,0.013569407,0.00046347766,0.00022328153,0.002069628,0.95465523,0.0044593704,0.010102514],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992243,0.00017685263,0.00013514243,0.00025162927,0.000120879835,0.00009111515],"domain_scores_gemma":[0.97234243,0.022669647,0.0006795819,0.0015771005,0.0023106479,0.0004206544],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019877488,0.001472749,0.0011638064,0.0025432366,0.00086104753,0.0018054122,0.0016460394,0.0014550928,0.8418517],"category_scores_gemma":[0.033299156,0.0006693868,0.00119559,0.0020084162,0.0003076049,0.0010907863,0.00102221,0.0009043477,0.22575802],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006874924,0.00010259753,0.0027752009,0.0017383954,0.00008263889,0.00009031243,0.000064377215,0.00070660195,0.00040207378,0.00047220118,0.97357947,0.01929861],"study_design_scores_gemma":[0.0053117475,0.00055500004,0.05533715,0.0029089854,0.0004522639,0.00164197,0.0004913285,0.008650025,0.0045120455,0.014670843,0.9052183,0.0002503882],"about_ca_topic_score_codex":0.0039734794,"about_ca_topic_score_gemma":0.008263907,"teacher_disagreement_score":0.8418517,"about_ca_system_score_codex":0.0007869885,"about_ca_system_score_gemma":0.0012805455,"threshold_uncertainty_score":0.22557926},"labels":[],"label_agreement":null},{"id":"W6969153818","doi":"10.5281/zenodo.7462743","title":"Ligation Independent Cloning of transporter gene into BacMam vector","year":2022,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Horizon 2020 Framework Programme","keywords":"Gene; Cloning (programming); Vector (molecular biology); clone (Java method); Transfection; Ligation; Molecular cloning","score_opus":0.02834462510341702,"score_gpt":0.27420402723037024,"score_spread":0.24585940212695323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6969153818","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2059886,0.010712349,0.6771159,0.001409945,0.002814744,0.00863888,0.03629429,0.0135062095,0.043519065],"genre_scores_gemma":[0.25067812,0.008561329,0.45763615,0.0010282195,0.0004902819,0.005500845,0.15733671,0.0036682412,0.11510016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820435,0.00031252913,0.00022805993,0.0005107601,0.00045349338,0.00029080317],"domain_scores_gemma":[0.9994598,0.00011698872,0.000072863484,0.00013868634,0.00012310328,0.00008853328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014661687,0.0013519222,0.0020501085,0.0017890459,0.0009937349,0.0012408213,0.001693834,0.0016417925,0.012946539],"category_scores_gemma":[0.0010745954,0.0009974218,0.0013838309,0.0019166413,0.0007211792,0.00072793034,0.0011962837,0.0033797268,0.01590902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020841125,0.00014034219,0.00026207548,0.0006174721,0.000037349546,0.0002764832,0.00016129151,0.000107311,0.9789098,0.002410359,0.004103881,0.012765185],"study_design_scores_gemma":[0.0001619547,0.00056336744,0.002886629,0.00013333063,0.00016088864,0.0014696955,0.00010029659,0.002053078,0.72128445,0.00097342744,0.27012104,0.000091859474],"about_ca_topic_score_codex":0.000829858,"about_ca_topic_score_gemma":0.0013019727,"teacher_disagreement_score":0.012946539,"about_ca_system_score_codex":0.00051720615,"about_ca_system_score_gemma":0.0007353366,"threshold_uncertainty_score":0.043310523},"labels":[],"label_agreement":null},{"id":"W6981747667","doi":"","title":"Exploring Involvement of Community of Water Users in Collaborative Water Resource Governance and Management Regime for Lake Diefenbaker, Saskatchewan, Canada.","year":2022,"lang":"en","type":"dissertation","venue":"University Library (University of Saskatchewan)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Collaborative governance; Corporate governance; Natural resource management; Incentive; Resource management (computing); Recreation; Resource (disambiguation); Natural resource; Ecosystem-based management; Water resources","score_opus":0.02263888034026521,"score_gpt":0.21772987577017416,"score_spread":0.19509099542990896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6981747667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98436815,0.00023920495,0.0008815003,0.0039675175,0.000020465719,0.0002799108,0.00024094983,0.000018343286,0.0099840555],"genre_scores_gemma":[0.98911804,0.0002900339,0.001727114,0.0006162979,0.00000408625,0.00018510407,0.00015555606,0.00001282508,0.007890866],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99776196,0.00077980326,0.000062056504,0.00029667062,0.00042490958,0.0006746126],"domain_scores_gemma":[0.9949929,0.0015517478,0.0003884478,0.00016351581,0.0014226546,0.0014807311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003175442,0.00023742375,0.00027009673,0.0012037812,0.013820663,0.003406476,0.001415339,0.0008973808,0.0033834085],"category_scores_gemma":[0.004422976,0.0002722971,0.00024729135,0.0013867888,0.004087274,0.0014751955,0.0038846368,0.0010770414,0.00017048237],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012307933,0.00030064606,0.20474191,0.00031832993,0.000050093728,0.0024524436,0.71064866,0.00049532996,0.0044581806,0.00425379,0.0070090718,0.06514852],"study_design_scores_gemma":[0.000008672628,0.00007592931,0.1507879,0.00013864458,0.000017503608,0.00009139253,0.82240313,0.00075600843,0.00047721434,0.0006957842,0.024496473,0.000051366744],"about_ca_topic_score_codex":0.9379117,"about_ca_topic_score_gemma":0.98778594,"teacher_disagreement_score":0.06208831,"about_ca_system_score_codex":0.042087216,"about_ca_system_score_gemma":0.07525083,"threshold_uncertainty_score":0.3053655},"labels":[],"label_agreement":null},{"id":"W6995929217","doi":"","title":"Political Wine in a Judicial Bottle: Justice Sotomayor's Surprising Concurrence in &lt;em&gt;Aurelius&lt;/em&gt;","year":2020,"lang":"en","type":"article","venue":"eYLS (Yale Law School)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Economic Justice; Politics; Concurrence; Sovereignty; Constitution","score_opus":0.029318235660281716,"score_gpt":0.32170331994554424,"score_spread":0.29238508428526255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995929217","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011051952,0.0028905717,0.00047119567,0.95670724,0.002063731,0.000015698868,0.000048183294,0.000016943342,0.026734376],"genre_scores_gemma":[0.1921539,0.0019592482,0.000751102,0.7641883,0.0028934004,0.00008110888,0.000033762204,0.000050622406,0.037888575],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99236053,0.0030978746,0.00019187533,0.00096692465,0.0017127941,0.0016700183],"domain_scores_gemma":[0.9924576,0.0048716734,0.00028083325,0.0002352616,0.0012955788,0.00085893186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007989835,0.00038777632,0.0005810526,0.00067205913,0.025874216,0.0093570305,0.0019948266,0.017598115,0.00248095],"category_scores_gemma":[0.016366828,0.000463485,0.00063803565,0.0009900196,0.009837112,0.0044022,0.003041809,0.022266775,0.00036272767],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035495697,0.00003707726,0.001160358,0.000042879565,0.000017844373,0.0009900475,0.009048623,0.00017815272,0.00036586166,0.35263547,0.62645423,0.0090339305],"study_design_scores_gemma":[0.000046888956,0.000033460303,0.0034979025,0.00025240463,0.00005246633,0.00025686523,0.02072731,0.0007143016,0.0011214844,0.055051066,0.9181368,0.000109096734],"about_ca_topic_score_codex":0.10687955,"about_ca_topic_score_gemma":0.19824855,"teacher_disagreement_score":0.10687955,"about_ca_system_score_codex":0.00868677,"about_ca_system_score_gemma":0.014214653,"threshold_uncertainty_score":0.21251488},"labels":[],"label_agreement":null},{"id":"W6995937880","doi":"","title":"Placebos in medicine: from conceptualizations in medical school to integration in clinical practice","year":2012,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; McGill University","keywords":"Psychosocial; Placebo; Clinical Practice; Medical practice; Clinical trial; Alternative medicine; Inclusion (mineral); Medical school","score_opus":0.055821790209035174,"score_gpt":0.42958685427694965,"score_spread":0.3737650640679145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995937880","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052202992,0.08131251,0.054644458,0.7150125,0.0045533897,0.00016471598,0.00007566525,0.00011616392,0.09191761],"genre_scores_gemma":[0.9292826,0.020404782,0.0082382485,0.03666402,0.0029228427,0.00022856258,0.000024895593,0.000046147645,0.002187977],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.952828,0.039394747,0.0011339351,0.0014610805,0.00419392,0.0009883705],"domain_scores_gemma":[0.93798256,0.04862248,0.004502541,0.0025652405,0.0038265188,0.002500677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.042163894,0.0004896795,0.00075435644,0.0034503215,0.0043198983,0.010085768,0.0025546302,0.0057446714,0.0024358379],"category_scores_gemma":[0.03668519,0.00044283245,0.0006119743,0.0022309166,0.106183976,0.014853647,0.00585463,0.011524069,0.00029379886],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008827724,0.00004901789,0.0018943212,0.0004313326,0.00002048593,0.000092395334,0.070415534,0.0002981014,0.00018524865,0.8928207,0.00477413,0.028930312],"study_design_scores_gemma":[0.00010387481,0.00026233966,0.0053314823,0.0024593887,0.000036024725,0.00032135478,0.04208983,0.0009839702,0.00028053235,0.8419553,0.10609228,0.0000835266],"about_ca_topic_score_codex":0.007399924,"about_ca_topic_score_gemma":0.0053568995,"teacher_disagreement_score":0.042163894,"about_ca_system_score_codex":0.014304681,"about_ca_system_score_gemma":0.011284216,"threshold_uncertainty_score":0.22298664},"labels":[],"label_agreement":null},{"id":"W6998430133","doi":"","title":"2014 Allen D Leman Conference Recent Research Reports","year":2014,"lang":"en","type":"article","venue":"University of Minnesota Digital Conservancy (University of Minnesota)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Swine Health Board; Ontario Ministry of Agriculture, Food and Rural Affairs; Diamond V; Agricultural Adaptation Council; University of Minnesota","keywords":"Field (mathematics); Perspective (graphical); Agency (philosophy); Identification (biology)","score_opus":0.054854082283159473,"score_gpt":0.2884977654331173,"score_spread":0.23364368314995781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6998430133","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020630532,0.067372866,0.0011034758,0.32350123,0.16170485,0.00029992565,0.003210797,0.00045026487,0.44029352],"genre_scores_gemma":[0.012807061,0.07173314,0.0020395464,0.045103468,0.034597818,0.00037756647,0.0026541227,0.00023499459,0.8304523],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998159,0.00032519537,0.000087715845,0.00020855939,0.0009436328,0.00027599817],"domain_scores_gemma":[0.99212295,0.00087919383,0.00028418435,0.0004159494,0.004409939,0.0018877486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036904537,0.0007600127,0.00053812127,0.002665888,0.0015055141,0.0034652706,0.0014949384,0.0035906911,0.2328917],"category_scores_gemma":[0.0088433,0.00041800836,0.000679586,0.0017949775,0.0008654848,0.0014569154,0.002321439,0.0023044639,0.08591214],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025191597,0.000021642352,0.00018157109,0.00008940843,0.000004759706,0.00003584148,0.000012982693,0.000011278708,0.00007052152,0.00045953147,0.97118807,0.027899161],"study_design_scores_gemma":[0.000009225494,0.000012334895,0.0007509954,0.00021113691,0.0000064923693,0.000061447856,0.0000749237,0.00000977584,0.00012758022,0.00021784782,0.99851376,0.000004504464],"about_ca_topic_score_codex":0.008103249,"about_ca_topic_score_gemma":0.02283938,"teacher_disagreement_score":0.2328917,"about_ca_system_score_codex":0.0027921693,"about_ca_system_score_gemma":0.0077781333,"threshold_uncertainty_score":0.7791003},"labels":[],"label_agreement":null},{"id":"W7008610139","doi":"","title":"Challenges with Estimating Long-Term Overall Survival in Extensive Stage Small-Cell Lung Cancer: A Validation-Based Case Study","year":2024,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Survival analysis; Clinical trial; Covariate; Markov model; Lung cancer; Stage (stratigraphy); Overall survival","score_opus":0.32648579091045726,"score_gpt":0.592727764153825,"score_spread":0.26624197324336774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7008610139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88971364,0.00092543405,0.10252498,0.0022869103,0.00005240931,0.0003846516,0.0011761104,0.00010530903,0.0028305873],"genre_scores_gemma":[0.97185206,0.00016367353,0.026575448,0.000107849184,0.000016933118,0.00014395073,0.00082877715,0.000029007591,0.00028237424],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9670738,0.027837083,0.0014170591,0.0014796663,0.0015940836,0.0005983446],"domain_scores_gemma":[0.6856869,0.28746518,0.006708321,0.01227842,0.0070012556,0.0008600185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.079775505,0.0009612124,0.0009973025,0.0007545847,0.00069033814,0.002046058,0.0032147802,0.0030118078,0.0013655281],"category_scores_gemma":[0.16504386,0.0006347455,0.0020063873,0.0014450138,0.0017771873,0.0017025549,0.002057494,0.0028808124,0.0002578682],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018190247,0.00079361396,0.26725757,0.00051389186,0.0006845409,0.0029996496,0.0030499254,0.6528365,0.00070250203,0.011282239,0.0031569179,0.054903787],"study_design_scores_gemma":[0.0003199827,0.0012083168,0.03348032,0.00047981454,0.00019700002,0.00145279,0.0019763832,0.93831265,0.0015681261,0.016487863,0.004386464,0.00013023627],"about_ca_topic_score_codex":0.024388853,"about_ca_topic_score_gemma":0.016796872,"teacher_disagreement_score":0.079775505,"about_ca_system_score_codex":0.0025688221,"about_ca_system_score_gemma":0.003007311,"threshold_uncertainty_score":0.42189825},"labels":[],"label_agreement":null},{"id":"W7039851288","doi":"","title":"Northland Power, Air Canada, and More By The Motley Fool","year":2021,"lang":"en","type":"other","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Motley; Moonlight; Thunder","score_opus":0.007905477337263949,"score_gpt":0.2920552218876832,"score_spread":0.28414974455041925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7039851288","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000605448,0.008345613,0.00021030428,0.0564469,0.009659188,0.00014068182,0.019905126,0.00035238187,0.9043343],"genre_scores_gemma":[0.00059935474,0.0011880038,0.0000799933,0.0020044667,0.00031487131,0.000041561172,0.0010051619,0.00008483501,0.99468166],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910825,0.00008438275,0.00004168526,0.00011290357,0.00044128604,0.00021142424],"domain_scores_gemma":[0.99481106,0.0008894228,0.00022239365,0.00029690334,0.0018250832,0.0019551567],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010622988,0.0010588247,0.0009680326,0.0032040987,0.0029767135,0.0034725382,0.001371752,0.004366431,0.51885027],"category_scores_gemma":[0.0055768965,0.0005765686,0.00078172656,0.0039408277,0.000980188,0.001507577,0.0021889533,0.0031177446,0.2998559],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021075852,0.0000109012935,0.00026520528,0.00003117103,0.0000016093322,0.000012286414,0.000010938638,0.000009862202,0.000019274095,0.00085539866,0.98564917,0.0131131485],"study_design_scores_gemma":[0.000028010318,0.000009499632,0.0031103631,0.00013971515,0.000005031628,0.000017998154,0.00008904259,0.00003903119,0.000035103138,0.00039531235,0.9961235,0.000007429963],"about_ca_topic_score_codex":0.38962698,"about_ca_topic_score_gemma":0.71346116,"teacher_disagreement_score":0.51885027,"about_ca_system_score_codex":0.004166236,"about_ca_system_score_gemma":0.012837597,"threshold_uncertainty_score":0.77471817},"labels":[],"label_agreement":null},{"id":"W7071992068","doi":"","title":"Validation of 8th edition AJCC staging system of small cell lung cancer in a North American cohort","year":2024,"lang":"en","type":"dissertation","venue":"Mspace (University of Manitoba)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Lung cancer; Cohort; Lung cancer staging; Proportional hazards model; AJCC staging system; Cancer; Staging system; Retrospective cohort study; TNM staging system","score_opus":0.011619996960912518,"score_gpt":0.2621523437341635,"score_spread":0.250532346773251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7071992068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831535,0.0006389321,0.0034824898,0.00028721252,0.00016893697,0.0005810784,0.008487032,0.00006612789,0.0031347398],"genre_scores_gemma":[0.97340727,0.0004846207,0.0051756706,0.00023989753,0.00013247858,0.0012019596,0.018296251,0.000052856845,0.001008908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99544734,0.0016570863,0.00053633994,0.001062372,0.001045168,0.0002515998],"domain_scores_gemma":[0.9890331,0.002672143,0.0020012835,0.0025486897,0.0032812671,0.00046363106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011864956,0.00042716556,0.00047082777,0.0017136175,0.0009385975,0.001340676,0.0009915475,0.00046280248,0.0017604321],"category_scores_gemma":[0.018068848,0.00030526685,0.0009907354,0.0012797066,0.0005097783,0.0005330922,0.0009969453,0.0006311839,0.0009275294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030653714,0.00008609761,0.98764145,0.00007672314,0.0001717705,0.00010103588,0.0004169442,0.00041621717,0.00076689606,0.0001879623,0.00285996,0.0069685215],"study_design_scores_gemma":[0.00007457824,0.00026451203,0.9869702,0.00013072012,0.00022602116,0.000394997,0.000510336,0.002071286,0.000700194,0.0002502461,0.008388217,0.000018729177],"about_ca_topic_score_codex":0.0071152346,"about_ca_topic_score_gemma":0.010012337,"teacher_disagreement_score":0.011864956,"about_ca_system_score_codex":0.0005508468,"about_ca_system_score_gemma":0.0015732589,"threshold_uncertainty_score":0.06274867},"labels":[],"label_agreement":null},{"id":"W7097137035","doi":"","title":"previously untreated patients with extensive small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group","year":2013,"lang":"en","type":"article","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Etoposide; Chemotherapy; Carboplatin; Regimen; Clinical trial; Lung cancer; Progressive disease; Cisplatin","score_opus":0.07551501458178837,"score_gpt":0.40603959854712984,"score_spread":0.33052458396534146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7097137035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761376,0.012721984,0.00024733387,0.0009758904,0.000070465074,0.002237929,0.0034834938,0.000017459703,0.0041078012],"genre_scores_gemma":[0.9822581,0.0060345232,0.0007577235,0.0016483496,0.0001724898,0.0014053974,0.0048831296,0.0000140433895,0.002826151],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9970701,0.0014198446,0.0001693319,0.00023400695,0.0006670289,0.00043962064],"domain_scores_gemma":[0.995481,0.0009791285,0.00093151425,0.00023363958,0.00093475526,0.0014398854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055495724,0.00078897376,0.0022976112,0.0005237832,0.0019449985,0.0012480352,0.0009506163,0.0010843208,0.002679525],"category_scores_gemma":[0.0039480347,0.0005345698,0.001288077,0.0019922983,0.0012059963,0.0005528432,0.00045727627,0.0011377849,0.00036767963],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2566003,0.007847718,0.65081376,0.0021878015,0.006131497,0.0012156161,0.00088273815,0.0021825884,0.0061524906,0.0006954569,0.01175254,0.053537484],"study_design_scores_gemma":[0.098985106,0.033514,0.8502027,0.0002967941,0.0024277992,0.0005373253,0.00036594088,0.0012092604,0.000435499,0.00018959305,0.011754051,0.00008201511],"about_ca_topic_score_codex":0.41149133,"about_ca_topic_score_gemma":0.6830382,"teacher_disagreement_score":0.58850867,"about_ca_system_score_codex":0.008545037,"about_ca_system_score_gemma":0.015804151,"threshold_uncertainty_score":0.81819236},"labels":[],"label_agreement":null},{"id":"W7132914567","doi":"","title":"Role of the mTOR Pathway and Autophagy in Mediating PARP Inhibitor Sensitivity in Small Cell Lung Cancer","year":2022,"lang":"","type":"dissertation","venue":"TSpace","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Autophagy; Sensitization; PI3K/AKT/mTOR pathway; mTORC1; PARP inhibitor; Lung cancer; Synthetic lethality; Poly ADP ribose polymerase","score_opus":0.012489069735870151,"score_gpt":0.34395841611532074,"score_spread":0.3314693463794506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132914567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967861,0.016105652,0.0015745886,0.0007736845,0.00005450248,0.00009218445,0.00071840576,0.000110298766,0.012709734],"genre_scores_gemma":[0.98546624,0.0071477904,0.0012773199,0.00015315456,0.000013271529,0.00005273894,0.00043481588,0.000014539923,0.005440089],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999946,0.000008865702,0.00000436092,0.000010026935,0.000015461144,0.000015256071],"domain_scores_gemma":[0.99996233,0.000008951774,0.0000083348095,0.0000032345608,0.0000061392884,0.00001099878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012960636,0.0001498607,0.0001751953,0.00022762688,0.00028306205,0.00033937473,0.00011037643,0.00022169121,0.0019493864],"category_scores_gemma":[0.00010468893,0.0000998522,0.00019522148,0.00015255973,0.00014923241,0.00016587137,0.00015600958,0.00035903582,0.00035255722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003386537,0.000098147495,0.0009738741,0.00018528833,0.000011304826,0.00013262723,0.000036286914,0.00017036205,0.9833883,0.00066949066,0.00040876135,0.013586931],"study_design_scores_gemma":[0.000058797486,0.00085865386,0.036330182,0.000037614962,0.00004274236,0.0005272465,0.0001104998,0.00093377,0.9514187,0.00041793843,0.00925159,0.0000123157515],"about_ca_topic_score_codex":0.00051850657,"about_ca_topic_score_gemma":0.0010498706,"teacher_disagreement_score":0.0019493864,"about_ca_system_score_codex":0.00031315367,"about_ca_system_score_gemma":0.0004062107,"threshold_uncertainty_score":0.006521404},"labels":[],"label_agreement":null},{"id":"W7135856747","doi":"","title":"Onkologi \"metronomisk\" chemotherapi:why less may be more","year":2010,"lang":"da","type":"article","venue":"Research at the University of Copenhagen (University of Copenhagen)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Privy Council Office","funders":"","keywords":"Identification (biology); Set (abstract data type); Work (physics)","score_opus":0.07125759978039221,"score_gpt":0.3406673691142023,"score_spread":0.2694097693338101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7135856747","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12251489,0.12289237,0.0008141723,0.72050315,0.005689574,0.00004482468,0.0008958796,0.00004938452,0.02659571],"genre_scores_gemma":[0.7143502,0.05433464,0.0021279694,0.21144067,0.010687111,0.00010345452,0.00049465516,0.00009251953,0.006368694],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9917869,0.004989583,0.00066301436,0.0006728901,0.001296564,0.0005910465],"domain_scores_gemma":[0.9685883,0.015897658,0.006001828,0.0016141211,0.0036676752,0.0042304494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010643142,0.00021685481,0.0010792043,0.00060759013,0.00076114445,0.0024076768,0.00070305157,0.002070334,0.015281752],"category_scores_gemma":[0.029564764,0.00017785041,0.0007312956,0.0010699725,0.0032786839,0.0029214101,0.0010610967,0.0036724878,0.0012295657],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008001971,0.0024953356,0.07940207,0.0068752677,0.0022273913,0.0003632505,0.0015221132,0.00069607043,0.005461678,0.052620556,0.16837732,0.6719569],"study_design_scores_gemma":[0.0031050995,0.0042964458,0.41555488,0.009583129,0.0032173246,0.0018152688,0.0054354654,0.00046945966,0.0029171132,0.14097811,0.41241005,0.00021764108],"about_ca_topic_score_codex":0.003694671,"about_ca_topic_score_gemma":0.0090550715,"teacher_disagreement_score":0.015281752,"about_ca_system_score_codex":0.0023554852,"about_ca_system_score_gemma":0.0036086095,"threshold_uncertainty_score":0.05628699},"labels":[],"label_agreement":null},{"id":"W75391978","doi":"10.1155/2005/376404","title":"Does Sex Influence the Impact That Smoking, Treatment Interruption and Impaired Pulmonary Function Have on Outcomes in Limited Stage Small Cell Lung Cancer Treatment?","year":2005,"lang":"en","type":"article","venue":"Canadian Respiratory Journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Western University; BC Cancer Agency","funders":"","keywords":"Medicine; DLCO; Radiation therapy; Internal medicine; Lung cancer; Pulmonary function testing; Diffusing capacity; Chemotherapy; Stage (stratigraphy); Surgery; Gastroenterology; Lung; Lung function","score_opus":0.054517910325286315,"score_gpt":0.35356224820194493,"score_spread":0.29904433787665863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W75391978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698342,0.027896468,0.0001555712,0.0005653192,0.00007081545,0.000016326198,0.00038229403,0.000003744287,0.0010751933],"genre_scores_gemma":[0.9973417,0.0021207933,0.000042330135,0.00015798883,0.00008224306,0.0000048822126,0.00012744177,0.0000023321084,0.000120324614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986584,0.0006367979,0.00017851325,0.00016430314,0.00024581858,0.000116210875],"domain_scores_gemma":[0.99379796,0.0029010777,0.0024993976,0.00023505128,0.00027120003,0.00029534887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020755571,0.00011051693,0.00045603127,0.00046016375,0.00020466704,0.00060470705,0.00029301224,0.00048692262,0.0016397592],"category_scores_gemma":[0.008647063,0.00012619005,0.0007420658,0.0007052829,0.0005340488,0.00041460159,0.00022336461,0.00026820117,0.00022740605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008963503,0.000019939564,0.984118,0.000114733426,0.00038348095,0.00009507211,0.00007577352,0.000032116484,0.0001338266,0.000031557473,0.000116913245,0.013982226],"study_design_scores_gemma":[0.00002845537,0.00026016976,0.99828774,0.00005733667,0.0003020625,0.0002848574,0.0001082249,0.000055951663,0.000059929105,0.00005381779,0.0004974222,0.000004090614],"about_ca_topic_score_codex":0.0021974067,"about_ca_topic_score_gemma":0.005561746,"teacher_disagreement_score":0.0021974067,"about_ca_system_score_codex":0.00028430508,"about_ca_system_score_gemma":0.0003753597,"threshold_uncertainty_score":0.010976732},"labels":[],"label_agreement":null},{"id":"W79586950","doi":"","title":"Diagnostic value of tumor marker pro-gastrin-releasing peptide in patients with small cell lung cancer: a systematic review.","year":2011,"lang":"en","type":"review","venue":"PubMed","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northern College","funders":"","keywords":"Medicine; Meta-analysis; Lung cancer; Receiver operating characteristic; Cochrane Library; MEDLINE; Internal medicine; Cancer; Tumor marker; Oncology; Systematic review; Pathological; Pathology","score_opus":0.03579943465697798,"score_gpt":0.3020399575085808,"score_spread":0.2662405228516028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W79586950","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020505425,0.9970106,0.000115482406,0.0001261579,0.00007520197,0.0002408162,0.0002560106,0.0000053848185,0.00011976899],"genre_scores_gemma":[0.0666167,0.93021315,0.0010532795,0.0005514697,0.00018411949,0.0008539811,0.0004088595,0.000007696494,0.00011075233],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9913953,0.0033198425,0.0033012312,0.0007064754,0.001112715,0.0001644742],"domain_scores_gemma":[0.9569157,0.031947255,0.007599524,0.0004590963,0.0027548603,0.00032350386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009787152,0.0014099805,0.01213408,0.007883219,0.000461713,0.0022742946,0.0019153266,0.0020304401,0.0027555355],"category_scores_gemma":[0.04423825,0.0010425682,0.010417582,0.008517482,0.0007849135,0.001824862,0.0010379549,0.0009388448,0.00023697122],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091341784,0.000020856254,0.0030409945,0.92551255,0.04899156,0.00011430012,0.000104021135,0.00010425493,0.0001892938,0.000059375765,0.0005841246,0.02036526],"study_design_scores_gemma":[0.0014578607,0.0007411353,0.015005231,0.39981383,0.57416874,0.0007571913,0.00023621612,0.00029084954,0.0003309148,0.00024265052,0.0068910783,0.00006432837],"about_ca_topic_score_codex":0.004958668,"about_ca_topic_score_gemma":0.012699759,"teacher_disagreement_score":0.01213408,"about_ca_system_score_codex":0.0026345968,"about_ca_system_score_gemma":0.0061480626,"threshold_uncertainty_score":0.051760077},"labels":[],"label_agreement":null},{"id":"W851077011","doi":"10.1097/jto.0000000000000548","title":"Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer","year":2015,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Surrogate endpoint; Medicine; Hazard ratio; Progression-free survival; Internal medicine; Confidence interval; Proportional hazards model; Oncology; Lung cancer; Clinical endpoint; Randomized controlled trial; Overall survival","score_opus":0.13755274537181256,"score_gpt":0.5236198700037795,"score_spread":0.38606712463196696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W851077011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97871464,0.009873953,0.0021712498,0.0009931959,0.0006426041,0.0032575736,0.0011645473,0.000059262253,0.003122943],"genre_scores_gemma":[0.99261755,0.0013002631,0.0013870861,0.000343723,0.00021148106,0.0025873114,0.0006925764,0.000025225578,0.00083478505],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9884022,0.0096080145,0.00060839264,0.00046779437,0.00045452573,0.0004591263],"domain_scores_gemma":[0.98984677,0.00404782,0.0024738566,0.0013581548,0.0011270402,0.0011463459],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.024414605,0.001402087,0.0026324915,0.00041504094,0.00056219735,0.0018948403,0.00089228863,0.0018977401,0.0026821168],"category_scores_gemma":[0.013501922,0.00058221177,0.0032172594,0.00067065377,0.001291935,0.0017088872,0.0009406906,0.0046143965,0.00054061465],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9630519,0.0035659096,0.0058660572,0.0008838189,0.003752603,0.00003276637,0.00017211515,0.0008811014,0.0027722747,0.00044095062,0.0006396845,0.01794075],"study_design_scores_gemma":[0.582077,0.38054338,0.023343341,0.0003517036,0.004654109,0.00013518421,0.000244788,0.0018510703,0.0021532772,0.0009095885,0.0036692843,0.00006725526],"about_ca_topic_score_codex":0.0005196735,"about_ca_topic_score_gemma":0.001785366,"teacher_disagreement_score":0.9755854,"about_ca_system_score_codex":0.0011362111,"about_ca_system_score_gemma":0.0019483236,"threshold_uncertainty_score":0.12911826},"labels":[],"label_agreement":null},{"id":"W96443023","doi":"10.1007/978-2-287-48618-0_11","title":"Les cancers bronchiques à petites cellules du sujet âgé","year":2007,"lang":"fr","type":"book-chapter","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine","score_opus":0.09560753856126977,"score_gpt":0.37477642059574223,"score_spread":0.27916888203447243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W96443023","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008601367,0.62414736,0.0021464804,0.02435853,0.003738883,0.000049955495,0.0010664548,0.00006503629,0.33582595],"genre_scores_gemma":[0.063152656,0.46484348,0.0035836312,0.009973618,0.007407262,0.000117656025,0.0008165658,0.00007761495,0.4500276],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99942076,0.00023435049,0.000020740621,0.00007040719,0.00019885028,0.00005489916],"domain_scores_gemma":[0.9990551,0.00076781726,0.000042193777,0.000032580178,0.00007331805,0.00002894399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011922102,0.00048697647,0.0004618708,0.0015150446,0.00071747985,0.001541932,0.0004919244,0.001424094,0.011468781],"category_scores_gemma":[0.0025746746,0.00036276726,0.000578995,0.0015744226,0.00096807594,0.0015171365,0.0004459745,0.0017977238,0.0017434957],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015382239,0.00007273119,0.003643016,0.0010057912,0.000056711484,0.0008571321,0.003492724,0.0005934542,0.0016963901,0.19503741,0.3254324,0.46795845],"study_design_scores_gemma":[0.000012917162,0.00006743028,0.009567872,0.0005392383,0.000021216361,0.0012151042,0.0005449774,0.00006364747,0.00067041675,0.009900411,0.9773835,0.000013290339],"about_ca_topic_score_codex":0.041206773,"about_ca_topic_score_gemma":0.04779383,"teacher_disagreement_score":0.041206773,"about_ca_system_score_codex":0.0018575416,"about_ca_system_score_gemma":0.0013566324,"threshold_uncertainty_score":0.081933856},"labels":[],"label_agreement":null}]}